<!DOCTYPE html>

<html>

<head>

<meta charset="utf-8" />
<meta name="generator" content="pandoc" />
<meta http-equiv="X-UA-Compatible" content="IE=EDGE" />




<title>Lab 06 - Regular Expressions and Web Scraping</title>

<script>// Pandoc 2.9 adds attributes on both header and div. We remove the former (to
// be compatible with the behavior of Pandoc < 2.8).
document.addEventListener('DOMContentLoaded', function(e) {
  var hs = document.querySelectorAll("div.section[class*='level'] > :first-child");
  var i, h, a;
  for (i = 0; i < hs.length; i++) {
    h = hs[i];
    if (!/^h[1-6]$/i.test(h.tagName)) continue;  // it should be a header h1-h6
    a = h.attributes;
    while (a.length > 0) h.removeAttribute(a[0].name);
  }
});
</script>
<script>/*! jQuery v3.6.0 | (c) OpenJS Foundation and other contributors | jquery.org/license */
!function(e,t){"use strict";"object"==typeof module&&"object"==typeof module.exports?module.exports=e.document?t(e,!0):function(e){if(!e.document)throw new Error("jQuery requires a window with a document");return t(e)}:t(e)}("undefined"!=typeof window?window:this,function(C,e){"use strict";var t=[],r=Object.getPrototypeOf,s=t.slice,g=t.flat?function(e){return t.flat.call(e)}:function(e){return t.concat.apply([],e)},u=t.push,i=t.indexOf,n={},o=n.toString,v=n.hasOwnProperty,a=v.toString,l=a.call(Object),y={},m=function(e){return"function"==typeof e&&"number"!=typeof e.nodeType&&"function"!=typeof e.item},x=function(e){return null!=e&&e===e.window},E=C.document,c={type:!0,src:!0,nonce:!0,noModule:!0};function b(e,t,n){var r,i,o=(n=n||E).createElement("script");if(o.text=e,t)for(r in c)(i=t[r]||t.getAttribute&&t.getAttribute(r))&&o.setAttribute(r,i);n.head.appendChild(o).parentNode.removeChild(o)}function w(e){return null==e?e+"":"object"==typeof e||"function"==typeof e?n[o.call(e)]||"object":typeof e}var f="3.6.0",S=function(e,t){return new S.fn.init(e,t)};function p(e){var t=!!e&&"length"in e&&e.length,n=w(e);return!m(e)&&!x(e)&&("array"===n||0===t||"number"==typeof t&&0<t&&t-1 in e)}S.fn=S.prototype={jquery:f,constructor:S,length:0,toArray:function(){return s.call(this)},get:function(e){return null==e?s.call(this):e<0?this[e+this.length]:this[e]},pushStack:function(e){var t=S.merge(this.constructor(),e);return t.prevObject=this,t},each:function(e){return S.each(this,e)},map:function(n){return this.pushStack(S.map(this,function(e,t){return n.call(e,t,e)}))},slice:function(){return this.pushStack(s.apply(this,arguments))},first:function(){return this.eq(0)},last:function(){return this.eq(-1)},even:function(){return this.pushStack(S.grep(this,function(e,t){return(t+1)%2}))},odd:function(){return this.pushStack(S.grep(this,function(e,t){return t%2}))},eq:function(e){var t=this.length,n=+e+(e<0?t:0);return this.pushStack(0<=n&&n<t?[this[n]]:[])},end:function(){return this.prevObject||this.constructor()},push:u,sort:t.sort,splice:t.splice},S.extend=S.fn.extend=function(){var e,t,n,r,i,o,a=arguments[0]||{},s=1,u=arguments.length,l=!1;for("boolean"==typeof a&&(l=a,a=arguments[s]||{},s++),"object"==typeof a||m(a)||(a={}),s===u&&(a=this,s--);s<u;s++)if(null!=(e=arguments[s]))for(t in e)r=e[t],"__proto__"!==t&&a!==r&&(l&&r&&(S.isPlainObject(r)||(i=Array.isArray(r)))?(n=a[t],o=i&&!Array.isArray(n)?[]:i||S.isPlainObject(n)?n:{},i=!1,a[t]=S.extend(l,o,r)):void 0!==r&&(a[t]=r));return a},S.extend({expando:"jQuery"+(f+Math.random()).replace(/\D/g,""),isReady:!0,error:function(e){throw new Error(e)},noop:function(){},isPlainObject:function(e){var t,n;return!(!e||"[object Object]"!==o.call(e))&&(!(t=r(e))||"function"==typeof(n=v.call(t,"constructor")&&t.constructor)&&a.call(n)===l)},isEmptyObject:function(e){var t;for(t in e)return!1;return!0},globalEval:function(e,t,n){b(e,{nonce:t&&t.nonce},n)},each:function(e,t){var n,r=0;if(p(e)){for(n=e.length;r<n;r++)if(!1===t.call(e[r],r,e[r]))break}else for(r in e)if(!1===t.call(e[r],r,e[r]))break;return e},makeArray:function(e,t){var n=t||[];return null!=e&&(p(Object(e))?S.merge(n,"string"==typeof e?[e]:e):u.call(n,e)),n},inArray:function(e,t,n){return null==t?-1:i.call(t,e,n)},merge:function(e,t){for(var n=+t.length,r=0,i=e.length;r<n;r++)e[i++]=t[r];return e.length=i,e},grep:function(e,t,n){for(var r=[],i=0,o=e.length,a=!n;i<o;i++)!t(e[i],i)!==a&&r.push(e[i]);return r},map:function(e,t,n){var r,i,o=0,a=[];if(p(e))for(r=e.length;o<r;o++)null!=(i=t(e[o],o,n))&&a.push(i);else for(o in e)null!=(i=t(e[o],o,n))&&a.push(i);return g(a)},guid:1,support:y}),"function"==typeof Symbol&&(S.fn[Symbol.iterator]=t[Symbol.iterator]),S.each("Boolean Number String Function Array Date RegExp Object Error Symbol".split(" "),function(e,t){n["[object "+t+"]"]=t.toLowerCase()});var d=function(n){var e,d,b,o,i,h,f,g,w,u,l,T,C,a,E,v,s,c,y,S="sizzle"+1*new Date,p=n.document,k=0,r=0,m=ue(),x=ue(),A=ue(),N=ue(),j=function(e,t){return e===t&&(l=!0),0},D={}.hasOwnProperty,t=[],q=t.pop,L=t.push,H=t.push,O=t.slice,P=function(e,t){for(var n=0,r=e.length;n<r;n++)if(e[n]===t)return n;return-1},R="checked|selected|async|autofocus|autoplay|controls|defer|disabled|hidden|ismap|loop|multiple|open|readonly|required|scoped",M="[\\x20\\t\\r\\n\\f]",I="(?:\\\\[\\da-fA-F]{1,6}"+M+"?|\\\\[^\\r\\n\\f]|[\\w-]|[^\0-\\x7f])+",W="\\["+M+"*("+I+")(?:"+M+"*([*^$|!~]?=)"+M+"*(?:'((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\"|("+I+"))|)"+M+"*\\]",F=":("+I+")(?:\\((('((?:\\\\.|[^\\\\'])*)'|\"((?:\\\\.|[^\\\\\"])*)\")|((?:\\\\.|[^\\\\()[\\]]|"+W+")*)|.*)\\)|)",B=new RegExp(M+"+","g"),$=new RegExp("^"+M+"+|((?:^|[^\\\\])(?:\\\\.)*)"+M+"+$","g"),_=new RegExp("^"+M+"*,"+M+"*"),z=new RegExp("^"+M+"*([>+~]|"+M+")"+M+"*"),U=new RegExp(M+"|>"),X=new RegExp(F),V=new RegExp("^"+I+"$"),G={ID:new RegExp("^#("+I+")"),CLASS:new RegExp("^\\.("+I+")"),TAG:new RegExp("^("+I+"|[*])"),ATTR:new RegExp("^"+W),PSEUDO:new RegExp("^"+F),CHILD:new RegExp("^:(only|first|last|nth|nth-last)-(child|of-type)(?:\\("+M+"*(even|odd|(([+-]|)(\\d*)n|)"+M+"*(?:([+-]|)"+M+"*(\\d+)|))"+M+"*\\)|)","i"),bool:new RegExp("^(?:"+R+")$","i"),needsContext:new RegExp("^"+M+"*[>+~]|:(even|odd|eq|gt|lt|nth|first|last)(?:\\("+M+"*((?:-\\d)?\\d*)"+M+"*\\)|)(?=[^-]|$)","i")},Y=/HTML$/i,Q=/^(?:input|select|textarea|button)$/i,J=/^h\d$/i,K=/^[^{]+\{\s*\[native \w/,Z=/^(?:#([\w-]+)|(\w+)|\.([\w-]+))$/,ee=/[+~]/,te=new RegExp("\\\\[\\da-fA-F]{1,6}"+M+"?|\\\\([^\\r\\n\\f])","g"),ne=function(e,t){var n="0x"+e.slice(1)-65536;return t||(n<0?String.fromCharCode(n+65536):String.fromCharCode(n>>10|55296,1023&n|56320))},re=/([\0-\x1f\x7f]|^-?\d)|^-$|[^\0-\x1f\x7f-\uFFFF\w-]/g,ie=function(e,t){return t?"\0"===e?"\ufffd":e.slice(0,-1)+"\\"+e.charCodeAt(e.length-1).toString(16)+" ":"\\"+e},oe=function(){T()},ae=be(function(e){return!0===e.disabled&&"fieldset"===e.nodeName.toLowerCase()},{dir:"parentNode",next:"legend"});try{H.apply(t=O.call(p.childNodes),p.childNodes),t[p.childNodes.length].nodeType}catch(e){H={apply:t.length?function(e,t){L.apply(e,O.call(t))}:function(e,t){var n=e.length,r=0;while(e[n++]=t[r++]);e.length=n-1}}}function se(t,e,n,r){var i,o,a,s,u,l,c,f=e&&e.ownerDocument,p=e?e.nodeType:9;if(n=n||[],"string"!=typeof t||!t||1!==p&&9!==p&&11!==p)return n;if(!r&&(T(e),e=e||C,E)){if(11!==p&&(u=Z.exec(t)))if(i=u[1]){if(9===p){if(!(a=e.getElementById(i)))return n;if(a.id===i)return n.push(a),n}else if(f&&(a=f.getElementById(i))&&y(e,a)&&a.id===i)return n.push(a),n}else{if(u[2])return H.apply(n,e.getElementsByTagName(t)),n;if((i=u[3])&&d.getElementsByClassName&&e.getElementsByClassName)return H.apply(n,e.getElementsByClassName(i)),n}if(d.qsa&&!N[t+" "]&&(!v||!v.test(t))&&(1!==p||"object"!==e.nodeName.toLowerCase())){if(c=t,f=e,1===p&&(U.test(t)||z.test(t))){(f=ee.test(t)&&ye(e.parentNode)||e)===e&&d.scope||((s=e.getAttribute("id"))?s=s.replace(re,ie):e.setAttribute("id",s=S)),o=(l=h(t)).length;while(o--)l[o]=(s?"#"+s:":scope")+" "+xe(l[o]);c=l.join(",")}try{return H.apply(n,f.querySelectorAll(c)),n}catch(e){N(t,!0)}finally{s===S&&e.removeAttribute("id")}}}return g(t.replace($,"$1"),e,n,r)}function ue(){var r=[];return function e(t,n){return r.push(t+" ")>b.cacheLength&&delete e[r.shift()],e[t+" "]=n}}function le(e){return e[S]=!0,e}function ce(e){var t=C.createElement("fieldset");try{return!!e(t)}catch(e){return!1}finally{t.parentNode&&t.parentNode.removeChild(t),t=null}}function fe(e,t){var n=e.split("|"),r=n.length;while(r--)b.attrHandle[n[r]]=t}function pe(e,t){var n=t&&e,r=n&&1===e.nodeType&&1===t.nodeType&&e.sourceIndex-t.sourceIndex;if(r)return r;if(n)while(n=n.nextSibling)if(n===t)return-1;return e?1:-1}function de(t){return function(e){return"input"===e.nodeName.toLowerCase()&&e.type===t}}function he(n){return function(e){var t=e.nodeName.toLowerCase();return("input"===t||"button"===t)&&e.type===n}}function ge(t){return function(e){return"form"in e?e.parentNode&&!1===e.disabled?"label"in e?"label"in e.parentNode?e.parentNode.disabled===t:e.disabled===t:e.isDisabled===t||e.isDisabled!==!t&&ae(e)===t:e.disabled===t:"label"in e&&e.disabled===t}}function ve(a){return le(function(o){return o=+o,le(function(e,t){var n,r=a([],e.length,o),i=r.length;while(i--)e[n=r[i]]&&(e[n]=!(t[n]=e[n]))})})}function ye(e){return e&&"undefined"!=typeof e.getElementsByTagName&&e}for(e in d=se.support={},i=se.isXML=function(e){var t=e&&e.namespaceURI,n=e&&(e.ownerDocument||e).documentElement;return!Y.test(t||n&&n.nodeName||"HTML")},T=se.setDocument=function(e){var t,n,r=e?e.ownerDocument||e:p;return r!=C&&9===r.nodeType&&r.documentElement&&(a=(C=r).documentElement,E=!i(C),p!=C&&(n=C.defaultView)&&n.top!==n&&(n.addEventListener?n.addEventListener("unload",oe,!1):n.attachEvent&&n.attachEvent("onunload",oe)),d.scope=ce(function(e){return a.appendChild(e).appendChild(C.createElement("div")),"undefined"!=typeof e.querySelectorAll&&!e.querySelectorAll(":scope fieldset div").length}),d.attributes=ce(function(e){return e.className="i",!e.getAttribute("className")}),d.getElementsByTagName=ce(function(e){return e.appendChild(C.createComment("")),!e.getElementsByTagName("*").length}),d.getElementsByClassName=K.test(C.getElementsByClassName),d.getById=ce(function(e){return a.appendChild(e).id=S,!C.getElementsByName||!C.getElementsByName(S).length}),d.getById?(b.filter.ID=function(e){var t=e.replace(te,ne);return function(e){return e.getAttribute("id")===t}},b.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&E){var n=t.getElementById(e);return n?[n]:[]}}):(b.filter.ID=function(e){var n=e.replace(te,ne);return function(e){var t="undefined"!=typeof e.getAttributeNode&&e.getAttributeNode("id");return t&&t.value===n}},b.find.ID=function(e,t){if("undefined"!=typeof t.getElementById&&E){var n,r,i,o=t.getElementById(e);if(o){if((n=o.getAttributeNode("id"))&&n.value===e)return[o];i=t.getElementsByName(e),r=0;while(o=i[r++])if((n=o.getAttributeNode("id"))&&n.value===e)return[o]}return[]}}),b.find.TAG=d.getElementsByTagName?function(e,t){return"undefined"!=typeof t.getElementsByTagName?t.getElementsByTagName(e):d.qsa?t.querySelectorAll(e):void 0}:function(e,t){var n,r=[],i=0,o=t.getElementsByTagName(e);if("*"===e){while(n=o[i++])1===n.nodeType&&r.push(n);return r}return o},b.find.CLASS=d.getElementsByClassName&&function(e,t){if("undefined"!=typeof t.getElementsByClassName&&E)return t.getElementsByClassName(e)},s=[],v=[],(d.qsa=K.test(C.querySelectorAll))&&(ce(function(e){var t;a.appendChild(e).innerHTML="<a id='"+S+"'></a><select id='"+S+"-\r\\' msallowcapture=''><option selected=''></option></select>",e.querySelectorAll("[msallowcapture^='']").length&&v.push("[*^$]="+M+"*(?:''|\"\")"),e.querySelectorAll("[selected]").length||v.push("\\["+M+"*(?:value|"+R+")"),e.querySelectorAll("[id~="+S+"-]").length||v.push("~="),(t=C.createElement("input")).setAttribute("name",""),e.appendChild(t),e.querySelectorAll("[name='']").length||v.push("\\["+M+"*name"+M+"*="+M+"*(?:''|\"\")"),e.querySelectorAll(":checked").length||v.push(":checked"),e.querySelectorAll("a#"+S+"+*").length||v.push(".#.+[+~]"),e.querySelectorAll("\\\f"),v.push("[\\r\\n\\f]")}),ce(function(e){e.innerHTML="<a href='' disabled='disabled'></a><select disabled='disabled'><option/></select>";var t=C.createElement("input");t.setAttribute("type","hidden"),e.appendChild(t).setAttribute("name","D"),e.querySelectorAll("[name=d]").length&&v.push("name"+M+"*[*^$|!~]?="),2!==e.querySelectorAll(":enabled").length&&v.push(":enabled",":disabled"),a.appendChild(e).disabled=!0,2!==e.querySelectorAll(":disabled").length&&v.push(":enabled",":disabled"),e.querySelectorAll("*,:x"),v.push(",.*:")})),(d.matchesSelector=K.test(c=a.matches||a.webkitMatchesSelector||a.mozMatchesSelector||a.oMatchesSelector||a.msMatchesSelector))&&ce(function(e){d.disconnectedMatch=c.call(e,"*"),c.call(e,"[s!='']:x"),s.push("!=",F)}),v=v.length&&new RegExp(v.join("|")),s=s.length&&new RegExp(s.join("|")),t=K.test(a.compareDocumentPosition),y=t||K.test(a.contains)?function(e,t){var n=9===e.nodeType?e.documentElement:e,r=t&&t.parentNode;return e===r||!(!r||1!==r.nodeType||!(n.contains?n.contains(r):e.compareDocumentPosition&&16&e.compareDocumentPosition(r)))}:function(e,t){if(t)while(t=t.parentNode)if(t===e)return!0;return!1},j=t?function(e,t){if(e===t)return l=!0,0;var n=!e.compareDocumentPosition-!t.compareDocumentPosition;return n||(1&(n=(e.ownerDocument||e)==(t.ownerDocument||t)?e.compareDocumentPosition(t):1)||!d.sortDetached&&t.compareDocumentPosition(e)===n?e==C||e.ownerDocument==p&&y(p,e)?-1:t==C||t.ownerDocument==p&&y(p,t)?1:u?P(u,e)-P(u,t):0:4&n?-1:1)}:function(e,t){if(e===t)return l=!0,0;var n,r=0,i=e.parentNode,o=t.parentNode,a=[e],s=[t];if(!i||!o)return e==C?-1:t==C?1:i?-1:o?1:u?P(u,e)-P(u,t):0;if(i===o)return pe(e,t);n=e;while(n=n.parentNode)a.unshift(n);n=t;while(n=n.parentNode)s.unshift(n);while(a[r]===s[r])r++;return r?pe(a[r],s[r]):a[r]==p?-1:s[r]==p?1:0}),C},se.matches=function(e,t){return se(e,null,null,t)},se.matchesSelector=function(e,t){if(T(e),d.matchesSelector&&E&&!N[t+" "]&&(!s||!s.test(t))&&(!v||!v.test(t)))try{var n=c.call(e,t);if(n||d.disconnectedMatch||e.document&&11!==e.document.nodeType)return n}catch(e){N(t,!0)}return 0<se(t,C,null,[e]).length},se.contains=function(e,t){return(e.ownerDocument||e)!=C&&T(e),y(e,t)},se.attr=function(e,t){(e.ownerDocument||e)!=C&&T(e);var n=b.attrHandle[t.toLowerCase()],r=n&&D.call(b.attrHandle,t.toLowerCase())?n(e,t,!E):void 0;return void 0!==r?r:d.attributes||!E?e.getAttribute(t):(r=e.getAttributeNode(t))&&r.specified?r.value:null},se.escape=function(e){return(e+"").replace(re,ie)},se.error=function(e){throw new Error("Syntax error, unrecognized expression: "+e)},se.uniqueSort=function(e){var t,n=[],r=0,i=0;if(l=!d.detectDuplicates,u=!d.sortStable&&e.slice(0),e.sort(j),l){while(t=e[i++])t===e[i]&&(r=n.push(i));while(r--)e.splice(n[r],1)}return u=null,e},o=se.getText=function(e){var t,n="",r=0,i=e.nodeType;if(i){if(1===i||9===i||11===i){if("string"==typeof e.textContent)return e.textContent;for(e=e.firstChild;e;e=e.nextSibling)n+=o(e)}else if(3===i||4===i)return e.nodeValue}else while(t=e[r++])n+=o(t);return n},(b=se.selectors={cacheLength:50,createPseudo:le,match:G,attrHandle:{},find:{},relative:{">":{dir:"parentNode",first:!0}," ":{dir:"parentNode"},"+":{dir:"previousSibling",first:!0},"~":{dir:"previousSibling"}},preFilter:{ATTR:function(e){return e[1]=e[1].replace(te,ne),e[3]=(e[3]||e[4]||e[5]||"").replace(te,ne),"~="===e[2]&&(e[3]=" "+e[3]+" "),e.slice(0,4)},CHILD:function(e){return e[1]=e[1].toLowerCase(),"nth"===e[1].slice(0,3)?(e[3]||se.error(e[0]),e[4]=+(e[4]?e[5]+(e[6]||1):2*("even"===e[3]||"odd"===e[3])),e[5]=+(e[7]+e[8]||"odd"===e[3])):e[3]&&se.error(e[0]),e},PSEUDO:function(e){var t,n=!e[6]&&e[2];return G.CHILD.test(e[0])?null:(e[3]?e[2]=e[4]||e[5]||"":n&&X.test(n)&&(t=h(n,!0))&&(t=n.indexOf(")",n.length-t)-n.length)&&(e[0]=e[0].slice(0,t),e[2]=n.slice(0,t)),e.slice(0,3))}},filter:{TAG:function(e){var t=e.replace(te,ne).toLowerCase();return"*"===e?function(){return!0}:function(e){return e.nodeName&&e.nodeName.toLowerCase()===t}},CLASS:function(e){var t=m[e+" "];return t||(t=new RegExp("(^|"+M+")"+e+"("+M+"|$)"))&&m(e,function(e){return t.test("string"==typeof e.className&&e.className||"undefined"!=typeof e.getAttribute&&e.getAttribute("class")||"")})},ATTR:function(n,r,i){return function(e){var t=se.attr(e,n);return null==t?"!="===r:!r||(t+="","="===r?t===i:"!="===r?t!==i:"^="===r?i&&0===t.indexOf(i):"*="===r?i&&-1<t.indexOf(i):"$="===r?i&&t.slice(-i.length)===i:"~="===r?-1<(" "+t.replace(B," ")+" ").indexOf(i):"|="===r&&(t===i||t.slice(0,i.length+1)===i+"-"))}},CHILD:function(h,e,t,g,v){var y="nth"!==h.slice(0,3),m="last"!==h.slice(-4),x="of-type"===e;return 1===g&&0===v?function(e){return!!e.parentNode}:function(e,t,n){var r,i,o,a,s,u,l=y!==m?"nextSibling":"previousSibling",c=e.parentNode,f=x&&e.nodeName.toLowerCase(),p=!n&&!x,d=!1;if(c){if(y){while(l){a=e;while(a=a[l])if(x?a.nodeName.toLowerCase()===f:1===a.nodeType)return!1;u=l="only"===h&&!u&&"nextSibling"}return!0}if(u=[m?c.firstChild:c.lastChild],m&&p){d=(s=(r=(i=(o=(a=c)[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]||[])[0]===k&&r[1])&&r[2],a=s&&c.childNodes[s];while(a=++s&&a&&a[l]||(d=s=0)||u.pop())if(1===a.nodeType&&++d&&a===e){i[h]=[k,s,d];break}}else if(p&&(d=s=(r=(i=(o=(a=e)[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]||[])[0]===k&&r[1]),!1===d)while(a=++s&&a&&a[l]||(d=s=0)||u.pop())if((x?a.nodeName.toLowerCase()===f:1===a.nodeType)&&++d&&(p&&((i=(o=a[S]||(a[S]={}))[a.uniqueID]||(o[a.uniqueID]={}))[h]=[k,d]),a===e))break;return(d-=v)===g||d%g==0&&0<=d/g}}},PSEUDO:function(e,o){var t,a=b.pseudos[e]||b.setFilters[e.toLowerCase()]||se.error("unsupported pseudo: "+e);return a[S]?a(o):1<a.length?(t=[e,e,"",o],b.setFilters.hasOwnProperty(e.toLowerCase())?le(function(e,t){var n,r=a(e,o),i=r.length;while(i--)e[n=P(e,r[i])]=!(t[n]=r[i])}):function(e){return a(e,0,t)}):a}},pseudos:{not:le(function(e){var r=[],i=[],s=f(e.replace($,"$1"));return s[S]?le(function(e,t,n,r){var i,o=s(e,null,r,[]),a=e.length;while(a--)(i=o[a])&&(e[a]=!(t[a]=i))}):function(e,t,n){return r[0]=e,s(r,null,n,i),r[0]=null,!i.pop()}}),has:le(function(t){return function(e){return 0<se(t,e).length}}),contains:le(function(t){return t=t.replace(te,ne),function(e){return-1<(e.textContent||o(e)).indexOf(t)}}),lang:le(function(n){return V.test(n||"")||se.error("unsupported lang: "+n),n=n.replace(te,ne).toLowerCase(),function(e){var t;do{if(t=E?e.lang:e.getAttribute("xml:lang")||e.getAttribute("lang"))return(t=t.toLowerCase())===n||0===t.indexOf(n+"-")}while((e=e.parentNode)&&1===e.nodeType);return!1}}),target:function(e){var t=n.location&&n.location.hash;return t&&t.slice(1)===e.id},root:function(e){return e===a},focus:function(e){return e===C.activeElement&&(!C.hasFocus||C.hasFocus())&&!!(e.type||e.href||~e.tabIndex)},enabled:ge(!1),disabled:ge(!0),checked:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&!!e.checked||"option"===t&&!!e.selected},selected:function(e){return e.parentNode&&e.parentNode.selectedIndex,!0===e.selected},empty:function(e){for(e=e.firstChild;e;e=e.nextSibling)if(e.nodeType<6)return!1;return!0},parent:function(e){return!b.pseudos.empty(e)},header:function(e){return J.test(e.nodeName)},input:function(e){return Q.test(e.nodeName)},button:function(e){var t=e.nodeName.toLowerCase();return"input"===t&&"button"===e.type||"button"===t},text:function(e){var t;return"input"===e.nodeName.toLowerCase()&&"text"===e.type&&(null==(t=e.getAttribute("type"))||"text"===t.toLowerCase())},first:ve(function(){return[0]}),last:ve(function(e,t){return[t-1]}),eq:ve(function(e,t,n){return[n<0?n+t:n]}),even:ve(function(e,t){for(var n=0;n<t;n+=2)e.push(n);return e}),odd:ve(function(e,t){for(var n=1;n<t;n+=2)e.push(n);return e}),lt:ve(function(e,t,n){for(var r=n<0?n+t:t<n?t:n;0<=--r;)e.push(r);return e}),gt:ve(function(e,t,n){for(var r=n<0?n+t:n;++r<t;)e.push(r);return e})}}).pseudos.nth=b.pseudos.eq,{radio:!0,checkbox:!0,file:!0,password:!0,image:!0})b.pseudos[e]=de(e);for(e in{submit:!0,reset:!0})b.pseudos[e]=he(e);function me(){}function xe(e){for(var t=0,n=e.length,r="";t<n;t++)r+=e[t].value;return r}function be(s,e,t){var u=e.dir,l=e.next,c=l||u,f=t&&"parentNode"===c,p=r++;return e.first?function(e,t,n){while(e=e[u])if(1===e.nodeType||f)return s(e,t,n);return!1}:function(e,t,n){var r,i,o,a=[k,p];if(n){while(e=e[u])if((1===e.nodeType||f)&&s(e,t,n))return!0}else while(e=e[u])if(1===e.nodeType||f)if(i=(o=e[S]||(e[S]={}))[e.uniqueID]||(o[e.uniqueID]={}),l&&l===e.nodeName.toLowerCase())e=e[u]||e;else{if((r=i[c])&&r[0]===k&&r[1]===p)return a[2]=r[2];if((i[c]=a)[2]=s(e,t,n))return!0}return!1}}function we(i){return 1<i.length?function(e,t,n){var r=i.length;while(r--)if(!i[r](e,t,n))return!1;return!0}:i[0]}function Te(e,t,n,r,i){for(var o,a=[],s=0,u=e.length,l=null!=t;s<u;s++)(o=e[s])&&(n&&!n(o,r,i)||(a.push(o),l&&t.push(s)));return a}function Ce(d,h,g,v,y,e){return v&&!v[S]&&(v=Ce(v)),y&&!y[S]&&(y=Ce(y,e)),le(function(e,t,n,r){var i,o,a,s=[],u=[],l=t.length,c=e||function(e,t,n){for(var r=0,i=t.length;r<i;r++)se(e,t[r],n);return n}(h||"*",n.nodeType?[n]:n,[]),f=!d||!e&&h?c:Te(c,s,d,n,r),p=g?y||(e?d:l||v)?[]:t:f;if(g&&g(f,p,n,r),v){i=Te(p,u),v(i,[],n,r),o=i.length;while(o--)(a=i[o])&&(p[u[o]]=!(f[u[o]]=a))}if(e){if(y||d){if(y){i=[],o=p.length;while(o--)(a=p[o])&&i.push(f[o]=a);y(null,p=[],i,r)}o=p.length;while(o--)(a=p[o])&&-1<(i=y?P(e,a):s[o])&&(e[i]=!(t[i]=a))}}else p=Te(p===t?p.splice(l,p.length):p),y?y(null,t,p,r):H.apply(t,p)})}function Ee(e){for(var i,t,n,r=e.length,o=b.relative[e[0].type],a=o||b.relative[" "],s=o?1:0,u=be(function(e){return e===i},a,!0),l=be(function(e){return-1<P(i,e)},a,!0),c=[function(e,t,n){var r=!o&&(n||t!==w)||((i=t).nodeType?u(e,t,n):l(e,t,n));return i=null,r}];s<r;s++)if(t=b.relative[e[s].type])c=[be(we(c),t)];else{if((t=b.filter[e[s].type].apply(null,e[s].matches))[S]){for(n=++s;n<r;n++)if(b.relative[e[n].type])break;return Ce(1<s&&we(c),1<s&&xe(e.slice(0,s-1).concat({value:" "===e[s-2].type?"*":""})).replace($,"$1"),t,s<n&&Ee(e.slice(s,n)),n<r&&Ee(e=e.slice(n)),n<r&&xe(e))}c.push(t)}return we(c)}return me.prototype=b.filters=b.pseudos,b.setFilters=new me,h=se.tokenize=function(e,t){var n,r,i,o,a,s,u,l=x[e+" "];if(l)return t?0:l.slice(0);a=e,s=[],u=b.preFilter;while(a){for(o in n&&!(r=_.exec(a))||(r&&(a=a.slice(r[0].length)||a),s.push(i=[])),n=!1,(r=z.exec(a))&&(n=r.shift(),i.push({value:n,type:r[0].replace($," ")}),a=a.slice(n.length)),b.filter)!(r=G[o].exec(a))||u[o]&&!(r=u[o](r))||(n=r.shift(),i.push({value:n,type:o,matches:r}),a=a.slice(n.length));if(!n)break}return t?a.length:a?se.error(e):x(e,s).slice(0)},f=se.compile=function(e,t){var n,v,y,m,x,r,i=[],o=[],a=A[e+" "];if(!a){t||(t=h(e)),n=t.length;while(n--)(a=Ee(t[n]))[S]?i.push(a):o.push(a);(a=A(e,(v=o,m=0<(y=i).length,x=0<v.length,r=function(e,t,n,r,i){var o,a,s,u=0,l="0",c=e&&[],f=[],p=w,d=e||x&&b.find.TAG("*",i),h=k+=null==p?1:Math.random()||.1,g=d.length;for(i&&(w=t==C||t||i);l!==g&&null!=(o=d[l]);l++){if(x&&o){a=0,t||o.ownerDocument==C||(T(o),n=!E);while(s=v[a++])if(s(o,t||C,n)){r.push(o);break}i&&(k=h)}m&&((o=!s&&o)&&u--,e&&c.push(o))}if(u+=l,m&&l!==u){a=0;while(s=y[a++])s(c,f,t,n);if(e){if(0<u)while(l--)c[l]||f[l]||(f[l]=q.call(r));f=Te(f)}H.apply(r,f),i&&!e&&0<f.length&&1<u+y.length&&se.uniqueSort(r)}return i&&(k=h,w=p),c},m?le(r):r))).selector=e}return a},g=se.select=function(e,t,n,r){var i,o,a,s,u,l="function"==typeof e&&e,c=!r&&h(e=l.selector||e);if(n=n||[],1===c.length){if(2<(o=c[0]=c[0].slice(0)).length&&"ID"===(a=o[0]).type&&9===t.nodeType&&E&&b.relative[o[1].type]){if(!(t=(b.find.ID(a.matches[0].replace(te,ne),t)||[])[0]))return n;l&&(t=t.parentNode),e=e.slice(o.shift().value.length)}i=G.needsContext.test(e)?0:o.length;while(i--){if(a=o[i],b.relative[s=a.type])break;if((u=b.find[s])&&(r=u(a.matches[0].replace(te,ne),ee.test(o[0].type)&&ye(t.parentNode)||t))){if(o.splice(i,1),!(e=r.length&&xe(o)))return H.apply(n,r),n;break}}}return(l||f(e,c))(r,t,!E,n,!t||ee.test(e)&&ye(t.parentNode)||t),n},d.sortStable=S.split("").sort(j).join("")===S,d.detectDuplicates=!!l,T(),d.sortDetached=ce(function(e){return 1&e.compareDocumentPosition(C.createElement("fieldset"))}),ce(function(e){return e.innerHTML="<a href='#'></a>","#"===e.firstChild.getAttribute("href")})||fe("type|href|height|width",function(e,t,n){if(!n)return e.getAttribute(t,"type"===t.toLowerCase()?1:2)}),d.attributes&&ce(function(e){return e.innerHTML="<input/>",e.firstChild.setAttribute("value",""),""===e.firstChild.getAttribute("value")})||fe("value",function(e,t,n){if(!n&&"input"===e.nodeName.toLowerCase())return e.defaultValue}),ce(function(e){return null==e.getAttribute("disabled")})||fe(R,function(e,t,n){var r;if(!n)return!0===e[t]?t.toLowerCase():(r=e.getAttributeNode(t))&&r.specified?r.value:null}),se}(C);S.find=d,S.expr=d.selectors,S.expr[":"]=S.expr.pseudos,S.uniqueSort=S.unique=d.uniqueSort,S.text=d.getText,S.isXMLDoc=d.isXML,S.contains=d.contains,S.escapeSelector=d.escape;var h=function(e,t,n){var r=[],i=void 0!==n;while((e=e[t])&&9!==e.nodeType)if(1===e.nodeType){if(i&&S(e).is(n))break;r.push(e)}return r},T=function(e,t){for(var n=[];e;e=e.nextSibling)1===e.nodeType&&e!==t&&n.push(e);return n},k=S.expr.match.needsContext;function A(e,t){return e.nodeName&&e.nodeName.toLowerCase()===t.toLowerCase()}var N=/^<([a-z][^\/\0>:\x20\t\r\n\f]*)[\x20\t\r\n\f]*\/?>(?:<\/\1>|)$/i;function j(e,n,r){return m(n)?S.grep(e,function(e,t){return!!n.call(e,t,e)!==r}):n.nodeType?S.grep(e,function(e){return e===n!==r}):"string"!=typeof n?S.grep(e,function(e){return-1<i.call(n,e)!==r}):S.filter(n,e,r)}S.filter=function(e,t,n){var r=t[0];return n&&(e=":not("+e+")"),1===t.length&&1===r.nodeType?S.find.matchesSelector(r,e)?[r]:[]:S.find.matches(e,S.grep(t,function(e){return 1===e.nodeType}))},S.fn.extend({find:function(e){var t,n,r=this.length,i=this;if("string"!=typeof e)return this.pushStack(S(e).filter(function(){for(t=0;t<r;t++)if(S.contains(i[t],this))return!0}));for(n=this.pushStack([]),t=0;t<r;t++)S.find(e,i[t],n);return 1<r?S.uniqueSort(n):n},filter:function(e){return this.pushStack(j(this,e||[],!1))},not:function(e){return this.pushStack(j(this,e||[],!0))},is:function(e){return!!j(this,"string"==typeof e&&k.test(e)?S(e):e||[],!1).length}});var D,q=/^(?:\s*(<[\w\W]+>)[^>]*|#([\w-]+))$/;(S.fn.init=function(e,t,n){var r,i;if(!e)return this;if(n=n||D,"string"==typeof e){if(!(r="<"===e[0]&&">"===e[e.length-1]&&3<=e.length?[null,e,null]:q.exec(e))||!r[1]&&t)return!t||t.jquery?(t||n).find(e):this.constructor(t).find(e);if(r[1]){if(t=t instanceof S?t[0]:t,S.merge(this,S.parseHTML(r[1],t&&t.nodeType?t.ownerDocument||t:E,!0)),N.test(r[1])&&S.isPlainObject(t))for(r in t)m(this[r])?this[r](t[r]):this.attr(r,t[r]);return this}return(i=E.getElementById(r[2]))&&(this[0]=i,this.length=1),this}return e.nodeType?(this[0]=e,this.length=1,this):m(e)?void 0!==n.ready?n.ready(e):e(S):S.makeArray(e,this)}).prototype=S.fn,D=S(E);var L=/^(?:parents|prev(?:Until|All))/,H={children:!0,contents:!0,next:!0,prev:!0};function O(e,t){while((e=e[t])&&1!==e.nodeType);return e}S.fn.extend({has:function(e){var t=S(e,this),n=t.length;return this.filter(function(){for(var e=0;e<n;e++)if(S.contains(this,t[e]))return!0})},closest:function(e,t){var n,r=0,i=this.length,o=[],a="string"!=typeof e&&S(e);if(!k.test(e))for(;r<i;r++)for(n=this[r];n&&n!==t;n=n.parentNode)if(n.nodeType<11&&(a?-1<a.index(n):1===n.nodeType&&S.find.matchesSelector(n,e))){o.push(n);break}return this.pushStack(1<o.length?S.uniqueSort(o):o)},index:function(e){return e?"string"==typeof e?i.call(S(e),this[0]):i.call(this,e.jquery?e[0]:e):this[0]&&this[0].parentNode?this.first().prevAll().length:-1},add:function(e,t){return this.pushStack(S.uniqueSort(S.merge(this.get(),S(e,t))))},addBack:function(e){return this.add(null==e?this.prevObject:this.prevObject.filter(e))}}),S.each({parent:function(e){var t=e.parentNode;return t&&11!==t.nodeType?t:null},parents:function(e){return h(e,"parentNode")},parentsUntil:function(e,t,n){return h(e,"parentNode",n)},next:function(e){return O(e,"nextSibling")},prev:function(e){return O(e,"previousSibling")},nextAll:function(e){return h(e,"nextSibling")},prevAll:function(e){return h(e,"previousSibling")},nextUntil:function(e,t,n){return h(e,"nextSibling",n)},prevUntil:function(e,t,n){return h(e,"previousSibling",n)},siblings:function(e){return T((e.parentNode||{}).firstChild,e)},children:function(e){return T(e.firstChild)},contents:function(e){return null!=e.contentDocument&&r(e.contentDocument)?e.contentDocument:(A(e,"template")&&(e=e.content||e),S.merge([],e.childNodes))}},function(r,i){S.fn[r]=function(e,t){var n=S.map(this,i,e);return"Until"!==r.slice(-5)&&(t=e),t&&"string"==typeof t&&(n=S.filter(t,n)),1<this.length&&(H[r]||S.uniqueSort(n),L.test(r)&&n.reverse()),this.pushStack(n)}});var P=/[^\x20\t\r\n\f]+/g;function R(e){return e}function M(e){throw e}function I(e,t,n,r){var i;try{e&&m(i=e.promise)?i.call(e).done(t).fail(n):e&&m(i=e.then)?i.call(e,t,n):t.apply(void 0,[e].slice(r))}catch(e){n.apply(void 0,[e])}}S.Callbacks=function(r){var e,n;r="string"==typeof r?(e=r,n={},S.each(e.match(P)||[],function(e,t){n[t]=!0}),n):S.extend({},r);var i,t,o,a,s=[],u=[],l=-1,c=function(){for(a=a||r.once,o=i=!0;u.length;l=-1){t=u.shift();while(++l<s.length)!1===s[l].apply(t[0],t[1])&&r.stopOnFalse&&(l=s.length,t=!1)}r.memory||(t=!1),i=!1,a&&(s=t?[]:"")},f={add:function(){return s&&(t&&!i&&(l=s.length-1,u.push(t)),function n(e){S.each(e,function(e,t){m(t)?r.unique&&f.has(t)||s.push(t):t&&t.length&&"string"!==w(t)&&n(t)})}(arguments),t&&!i&&c()),this},remove:function(){return S.each(arguments,function(e,t){var n;while(-1<(n=S.inArray(t,s,n)))s.splice(n,1),n<=l&&l--}),this},has:function(e){return e?-1<S.inArray(e,s):0<s.length},empty:function(){return s&&(s=[]),this},disable:function(){return a=u=[],s=t="",this},disabled:function(){return!s},lock:function(){return a=u=[],t||i||(s=t=""),this},locked:function(){return!!a},fireWith:function(e,t){return a||(t=[e,(t=t||[]).slice?t.slice():t],u.push(t),i||c()),this},fire:function(){return f.fireWith(this,arguments),this},fired:function(){return!!o}};return f},S.extend({Deferred:function(e){var o=[["notify","progress",S.Callbacks("memory"),S.Callbacks("memory"),2],["resolve","done",S.Callbacks("once memory"),S.Callbacks("once memory"),0,"resolved"],["reject","fail",S.Callbacks("once memory"),S.Callbacks("once memory"),1,"rejected"]],i="pending",a={state:function(){return i},always:function(){return s.done(arguments).fail(arguments),this},"catch":function(e){return a.then(null,e)},pipe:function(){var i=arguments;return S.Deferred(function(r){S.each(o,function(e,t){var n=m(i[t[4]])&&i[t[4]];s[t[1]](function(){var e=n&&n.apply(this,arguments);e&&m(e.promise)?e.promise().progress(r.notify).done(r.resolve).fail(r.reject):r[t[0]+"With"](this,n?[e]:arguments)})}),i=null}).promise()},then:function(t,n,r){var u=0;function l(i,o,a,s){return function(){var n=this,r=arguments,e=function(){var e,t;if(!(i<u)){if((e=a.apply(n,r))===o.promise())throw new TypeError("Thenable self-resolution");t=e&&("object"==typeof e||"function"==typeof e)&&e.then,m(t)?s?t.call(e,l(u,o,R,s),l(u,o,M,s)):(u++,t.call(e,l(u,o,R,s),l(u,o,M,s),l(u,o,R,o.notifyWith))):(a!==R&&(n=void 0,r=[e]),(s||o.resolveWith)(n,r))}},t=s?e:function(){try{e()}catch(e){S.Deferred.exceptionHook&&S.Deferred.exceptionHook(e,t.stackTrace),u<=i+1&&(a!==M&&(n=void 0,r=[e]),o.rejectWith(n,r))}};i?t():(S.Deferred.getStackHook&&(t.stackTrace=S.Deferred.getStackHook()),C.setTimeout(t))}}return S.Deferred(function(e){o[0][3].add(l(0,e,m(r)?r:R,e.notifyWith)),o[1][3].add(l(0,e,m(t)?t:R)),o[2][3].add(l(0,e,m(n)?n:M))}).promise()},promise:function(e){return null!=e?S.extend(e,a):a}},s={};return S.each(o,function(e,t){var n=t[2],r=t[5];a[t[1]]=n.add,r&&n.add(function(){i=r},o[3-e][2].disable,o[3-e][3].disable,o[0][2].lock,o[0][3].lock),n.add(t[3].fire),s[t[0]]=function(){return s[t[0]+"With"](this===s?void 0:this,arguments),this},s[t[0]+"With"]=n.fireWith}),a.promise(s),e&&e.call(s,s),s},when:function(e){var n=arguments.length,t=n,r=Array(t),i=s.call(arguments),o=S.Deferred(),a=function(t){return function(e){r[t]=this,i[t]=1<arguments.length?s.call(arguments):e,--n||o.resolveWith(r,i)}};if(n<=1&&(I(e,o.done(a(t)).resolve,o.reject,!n),"pending"===o.state()||m(i[t]&&i[t].then)))return o.then();while(t--)I(i[t],a(t),o.reject);return o.promise()}});var W=/^(Eval|Internal|Range|Reference|Syntax|Type|URI)Error$/;S.Deferred.exceptionHook=function(e,t){C.console&&C.console.warn&&e&&W.test(e.name)&&C.console.warn("jQuery.Deferred exception: "+e.message,e.stack,t)},S.readyException=function(e){C.setTimeout(function(){throw e})};var F=S.Deferred();function B(){E.removeEventListener("DOMContentLoaded",B),C.removeEventListener("load",B),S.ready()}S.fn.ready=function(e){return F.then(e)["catch"](function(e){S.readyException(e)}),this},S.extend({isReady:!1,readyWait:1,ready:function(e){(!0===e?--S.readyWait:S.isReady)||(S.isReady=!0)!==e&&0<--S.readyWait||F.resolveWith(E,[S])}}),S.ready.then=F.then,"complete"===E.readyState||"loading"!==E.readyState&&!E.documentElement.doScroll?C.setTimeout(S.ready):(E.addEventListener("DOMContentLoaded",B),C.addEventListener("load",B));var $=function(e,t,n,r,i,o,a){var s=0,u=e.length,l=null==n;if("object"===w(n))for(s in i=!0,n)$(e,t,s,n[s],!0,o,a);else if(void 0!==r&&(i=!0,m(r)||(a=!0),l&&(a?(t.call(e,r),t=null):(l=t,t=function(e,t,n){return l.call(S(e),n)})),t))for(;s<u;s++)t(e[s],n,a?r:r.call(e[s],s,t(e[s],n)));return i?e:l?t.call(e):u?t(e[0],n):o},_=/^-ms-/,z=/-([a-z])/g;function U(e,t){return t.toUpperCase()}function X(e){return e.replace(_,"ms-").replace(z,U)}var V=function(e){return 1===e.nodeType||9===e.nodeType||!+e.nodeType};function G(){this.expando=S.expando+G.uid++}G.uid=1,G.prototype={cache:function(e){var t=e[this.expando];return t||(t={},V(e)&&(e.nodeType?e[this.expando]=t:Object.defineProperty(e,this.expando,{value:t,configurable:!0}))),t},set:function(e,t,n){var r,i=this.cache(e);if("string"==typeof t)i[X(t)]=n;else for(r in t)i[X(r)]=t[r];return i},get:function(e,t){return void 0===t?this.cache(e):e[this.expando]&&e[this.expando][X(t)]},access:function(e,t,n){return void 0===t||t&&"string"==typeof t&&void 0===n?this.get(e,t):(this.set(e,t,n),void 0!==n?n:t)},remove:function(e,t){var n,r=e[this.expando];if(void 0!==r){if(void 0!==t){n=(t=Array.isArray(t)?t.map(X):(t=X(t))in r?[t]:t.match(P)||[]).length;while(n--)delete r[t[n]]}(void 0===t||S.isEmptyObject(r))&&(e.nodeType?e[this.expando]=void 0:delete e[this.expando])}},hasData:function(e){var t=e[this.expando];return void 0!==t&&!S.isEmptyObject(t)}};var Y=new G,Q=new G,J=/^(?:\{[\w\W]*\}|\[[\w\W]*\])$/,K=/[A-Z]/g;function Z(e,t,n){var r,i;if(void 0===n&&1===e.nodeType)if(r="data-"+t.replace(K,"-$&").toLowerCase(),"string"==typeof(n=e.getAttribute(r))){try{n="true"===(i=n)||"false"!==i&&("null"===i?null:i===+i+""?+i:J.test(i)?JSON.parse(i):i)}catch(e){}Q.set(e,t,n)}else n=void 0;return n}S.extend({hasData:function(e){return Q.hasData(e)||Y.hasData(e)},data:function(e,t,n){return Q.access(e,t,n)},removeData:function(e,t){Q.remove(e,t)},_data:function(e,t,n){return Y.access(e,t,n)},_removeData:function(e,t){Y.remove(e,t)}}),S.fn.extend({data:function(n,e){var t,r,i,o=this[0],a=o&&o.attributes;if(void 0===n){if(this.length&&(i=Q.get(o),1===o.nodeType&&!Y.get(o,"hasDataAttrs"))){t=a.length;while(t--)a[t]&&0===(r=a[t].name).indexOf("data-")&&(r=X(r.slice(5)),Z(o,r,i[r]));Y.set(o,"hasDataAttrs",!0)}return i}return"object"==typeof n?this.each(function(){Q.set(this,n)}):$(this,function(e){var t;if(o&&void 0===e)return void 0!==(t=Q.get(o,n))?t:void 0!==(t=Z(o,n))?t:void 0;this.each(function(){Q.set(this,n,e)})},null,e,1<arguments.length,null,!0)},removeData:function(e){return this.each(function(){Q.remove(this,e)})}}),S.extend({queue:function(e,t,n){var r;if(e)return t=(t||"fx")+"queue",r=Y.get(e,t),n&&(!r||Array.isArray(n)?r=Y.access(e,t,S.makeArray(n)):r.push(n)),r||[]},dequeue:function(e,t){t=t||"fx";var n=S.queue(e,t),r=n.length,i=n.shift(),o=S._queueHooks(e,t);"inprogress"===i&&(i=n.shift(),r--),i&&("fx"===t&&n.unshift("inprogress"),delete o.stop,i.call(e,function(){S.dequeue(e,t)},o)),!r&&o&&o.empty.fire()},_queueHooks:function(e,t){var n=t+"queueHooks";return Y.get(e,n)||Y.access(e,n,{empty:S.Callbacks("once memory").add(function(){Y.remove(e,[t+"queue",n])})})}}),S.fn.extend({queue:function(t,n){var e=2;return"string"!=typeof t&&(n=t,t="fx",e--),arguments.length<e?S.queue(this[0],t):void 0===n?this:this.each(function(){var e=S.queue(this,t,n);S._queueHooks(this,t),"fx"===t&&"inprogress"!==e[0]&&S.dequeue(this,t)})},dequeue:function(e){return this.each(function(){S.dequeue(this,e)})},clearQueue:function(e){return this.queue(e||"fx",[])},promise:function(e,t){var n,r=1,i=S.Deferred(),o=this,a=this.length,s=function(){--r||i.resolveWith(o,[o])};"string"!=typeof e&&(t=e,e=void 0),e=e||"fx";while(a--)(n=Y.get(o[a],e+"queueHooks"))&&n.empty&&(r++,n.empty.add(s));return s(),i.promise(t)}});var ee=/[+-]?(?:\d*\.|)\d+(?:[eE][+-]?\d+|)/.source,te=new RegExp("^(?:([+-])=|)("+ee+")([a-z%]*)$","i"),ne=["Top","Right","Bottom","Left"],re=E.documentElement,ie=function(e){return S.contains(e.ownerDocument,e)},oe={composed:!0};re.getRootNode&&(ie=function(e){return S.contains(e.ownerDocument,e)||e.getRootNode(oe)===e.ownerDocument});var ae=function(e,t){return"none"===(e=t||e).style.display||""===e.style.display&&ie(e)&&"none"===S.css(e,"display")};function se(e,t,n,r){var i,o,a=20,s=r?function(){return r.cur()}:function(){return S.css(e,t,"")},u=s(),l=n&&n[3]||(S.cssNumber[t]?"":"px"),c=e.nodeType&&(S.cssNumber[t]||"px"!==l&&+u)&&te.exec(S.css(e,t));if(c&&c[3]!==l){u/=2,l=l||c[3],c=+u||1;while(a--)S.style(e,t,c+l),(1-o)*(1-(o=s()/u||.5))<=0&&(a=0),c/=o;c*=2,S.style(e,t,c+l),n=n||[]}return n&&(c=+c||+u||0,i=n[1]?c+(n[1]+1)*n[2]:+n[2],r&&(r.unit=l,r.start=c,r.end=i)),i}var ue={};function le(e,t){for(var n,r,i,o,a,s,u,l=[],c=0,f=e.length;c<f;c++)(r=e[c]).style&&(n=r.style.display,t?("none"===n&&(l[c]=Y.get(r,"display")||null,l[c]||(r.style.display="")),""===r.style.display&&ae(r)&&(l[c]=(u=a=o=void 0,a=(i=r).ownerDocument,s=i.nodeName,(u=ue[s])||(o=a.body.appendChild(a.createElement(s)),u=S.css(o,"display"),o.parentNode.removeChild(o),"none"===u&&(u="block"),ue[s]=u)))):"none"!==n&&(l[c]="none",Y.set(r,"display",n)));for(c=0;c<f;c++)null!=l[c]&&(e[c].style.display=l[c]);return e}S.fn.extend({show:function(){return le(this,!0)},hide:function(){return le(this)},toggle:function(e){return"boolean"==typeof e?e?this.show():this.hide():this.each(function(){ae(this)?S(this).show():S(this).hide()})}});var ce,fe,pe=/^(?:checkbox|radio)$/i,de=/<([a-z][^\/\0>\x20\t\r\n\f]*)/i,he=/^$|^module$|\/(?:java|ecma)script/i;ce=E.createDocumentFragment().appendChild(E.createElement("div")),(fe=E.createElement("input")).setAttribute("type","radio"),fe.setAttribute("checked","checked"),fe.setAttribute("name","t"),ce.appendChild(fe),y.checkClone=ce.cloneNode(!0).cloneNode(!0).lastChild.checked,ce.innerHTML="<textarea>x</textarea>",y.noCloneChecked=!!ce.cloneNode(!0).lastChild.defaultValue,ce.innerHTML="<option></option>",y.option=!!ce.lastChild;var ge={thead:[1,"<table>","</table>"],col:[2,"<table><colgroup>","</colgroup></table>"],tr:[2,"<table><tbody>","</tbody></table>"],td:[3,"<table><tbody><tr>","</tr></tbody></table>"],_default:[0,"",""]};function ve(e,t){var n;return n="undefined"!=typeof e.getElementsByTagName?e.getElementsByTagName(t||"*"):"undefined"!=typeof e.querySelectorAll?e.querySelectorAll(t||"*"):[],void 0===t||t&&A(e,t)?S.merge([e],n):n}function ye(e,t){for(var n=0,r=e.length;n<r;n++)Y.set(e[n],"globalEval",!t||Y.get(t[n],"globalEval"))}ge.tbody=ge.tfoot=ge.colgroup=ge.caption=ge.thead,ge.th=ge.td,y.option||(ge.optgroup=ge.option=[1,"<select multiple='multiple'>","</select>"]);var me=/<|&#?\w+;/;function xe(e,t,n,r,i){for(var o,a,s,u,l,c,f=t.createDocumentFragment(),p=[],d=0,h=e.length;d<h;d++)if((o=e[d])||0===o)if("object"===w(o))S.merge(p,o.nodeType?[o]:o);else if(me.test(o)){a=a||f.appendChild(t.createElement("div")),s=(de.exec(o)||["",""])[1].toLowerCase(),u=ge[s]||ge._default,a.innerHTML=u[1]+S.htmlPrefilter(o)+u[2],c=u[0];while(c--)a=a.lastChild;S.merge(p,a.childNodes),(a=f.firstChild).textContent=""}else p.push(t.createTextNode(o));f.textContent="",d=0;while(o=p[d++])if(r&&-1<S.inArray(o,r))i&&i.push(o);else if(l=ie(o),a=ve(f.appendChild(o),"script"),l&&ye(a),n){c=0;while(o=a[c++])he.test(o.type||"")&&n.push(o)}return f}var be=/^([^.]*)(?:\.(.+)|)/;function we(){return!0}function Te(){return!1}function Ce(e,t){return e===function(){try{return E.activeElement}catch(e){}}()==("focus"===t)}function Ee(e,t,n,r,i,o){var a,s;if("object"==typeof t){for(s in"string"!=typeof n&&(r=r||n,n=void 0),t)Ee(e,s,n,r,t[s],o);return e}if(null==r&&null==i?(i=n,r=n=void 0):null==i&&("string"==typeof n?(i=r,r=void 0):(i=r,r=n,n=void 0)),!1===i)i=Te;else if(!i)return e;return 1===o&&(a=i,(i=function(e){return S().off(e),a.apply(this,arguments)}).guid=a.guid||(a.guid=S.guid++)),e.each(function(){S.event.add(this,t,i,r,n)})}function Se(e,i,o){o?(Y.set(e,i,!1),S.event.add(e,i,{namespace:!1,handler:function(e){var t,n,r=Y.get(this,i);if(1&e.isTrigger&&this[i]){if(r.length)(S.event.special[i]||{}).delegateType&&e.stopPropagation();else if(r=s.call(arguments),Y.set(this,i,r),t=o(this,i),this[i](),r!==(n=Y.get(this,i))||t?Y.set(this,i,!1):n={},r!==n)return e.stopImmediatePropagation(),e.preventDefault(),n&&n.value}else r.length&&(Y.set(this,i,{value:S.event.trigger(S.extend(r[0],S.Event.prototype),r.slice(1),this)}),e.stopImmediatePropagation())}})):void 0===Y.get(e,i)&&S.event.add(e,i,we)}S.event={global:{},add:function(t,e,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,v=Y.get(t);if(V(t)){n.handler&&(n=(o=n).handler,i=o.selector),i&&S.find.matchesSelector(re,i),n.guid||(n.guid=S.guid++),(u=v.events)||(u=v.events=Object.create(null)),(a=v.handle)||(a=v.handle=function(e){return"undefined"!=typeof S&&S.event.triggered!==e.type?S.event.dispatch.apply(t,arguments):void 0}),l=(e=(e||"").match(P)||[""]).length;while(l--)d=g=(s=be.exec(e[l])||[])[1],h=(s[2]||"").split(".").sort(),d&&(f=S.event.special[d]||{},d=(i?f.delegateType:f.bindType)||d,f=S.event.special[d]||{},c=S.extend({type:d,origType:g,data:r,handler:n,guid:n.guid,selector:i,needsContext:i&&S.expr.match.needsContext.test(i),namespace:h.join(".")},o),(p=u[d])||((p=u[d]=[]).delegateCount=0,f.setup&&!1!==f.setup.call(t,r,h,a)||t.addEventListener&&t.addEventListener(d,a)),f.add&&(f.add.call(t,c),c.handler.guid||(c.handler.guid=n.guid)),i?p.splice(p.delegateCount++,0,c):p.push(c),S.event.global[d]=!0)}},remove:function(e,t,n,r,i){var o,a,s,u,l,c,f,p,d,h,g,v=Y.hasData(e)&&Y.get(e);if(v&&(u=v.events)){l=(t=(t||"").match(P)||[""]).length;while(l--)if(d=g=(s=be.exec(t[l])||[])[1],h=(s[2]||"").split(".").sort(),d){f=S.event.special[d]||{},p=u[d=(r?f.delegateType:f.bindType)||d]||[],s=s[2]&&new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"),a=o=p.length;while(o--)c=p[o],!i&&g!==c.origType||n&&n.guid!==c.guid||s&&!s.test(c.namespace)||r&&r!==c.selector&&("**"!==r||!c.selector)||(p.splice(o,1),c.selector&&p.delegateCount--,f.remove&&f.remove.call(e,c));a&&!p.length&&(f.teardown&&!1!==f.teardown.call(e,h,v.handle)||S.removeEvent(e,d,v.handle),delete u[d])}else for(d in u)S.event.remove(e,d+t[l],n,r,!0);S.isEmptyObject(u)&&Y.remove(e,"handle events")}},dispatch:function(e){var t,n,r,i,o,a,s=new Array(arguments.length),u=S.event.fix(e),l=(Y.get(this,"events")||Object.create(null))[u.type]||[],c=S.event.special[u.type]||{};for(s[0]=u,t=1;t<arguments.length;t++)s[t]=arguments[t];if(u.delegateTarget=this,!c.preDispatch||!1!==c.preDispatch.call(this,u)){a=S.event.handlers.call(this,u,l),t=0;while((i=a[t++])&&!u.isPropagationStopped()){u.currentTarget=i.elem,n=0;while((o=i.handlers[n++])&&!u.isImmediatePropagationStopped())u.rnamespace&&!1!==o.namespace&&!u.rnamespace.test(o.namespace)||(u.handleObj=o,u.data=o.data,void 0!==(r=((S.event.special[o.origType]||{}).handle||o.handler).apply(i.elem,s))&&!1===(u.result=r)&&(u.preventDefault(),u.stopPropagation()))}return c.postDispatch&&c.postDispatch.call(this,u),u.result}},handlers:function(e,t){var n,r,i,o,a,s=[],u=t.delegateCount,l=e.target;if(u&&l.nodeType&&!("click"===e.type&&1<=e.button))for(;l!==this;l=l.parentNode||this)if(1===l.nodeType&&("click"!==e.type||!0!==l.disabled)){for(o=[],a={},n=0;n<u;n++)void 0===a[i=(r=t[n]).selector+" "]&&(a[i]=r.needsContext?-1<S(i,this).index(l):S.find(i,this,null,[l]).length),a[i]&&o.push(r);o.length&&s.push({elem:l,handlers:o})}return l=this,u<t.length&&s.push({elem:l,handlers:t.slice(u)}),s},addProp:function(t,e){Object.defineProperty(S.Event.prototype,t,{enumerable:!0,configurable:!0,get:m(e)?function(){if(this.originalEvent)return e(this.originalEvent)}:function(){if(this.originalEvent)return this.originalEvent[t]},set:function(e){Object.defineProperty(this,t,{enumerable:!0,configurable:!0,writable:!0,value:e})}})},fix:function(e){return e[S.expando]?e:new S.Event(e)},special:{load:{noBubble:!0},click:{setup:function(e){var t=this||e;return pe.test(t.type)&&t.click&&A(t,"input")&&Se(t,"click",we),!1},trigger:function(e){var t=this||e;return pe.test(t.type)&&t.click&&A(t,"input")&&Se(t,"click"),!0},_default:function(e){var t=e.target;return pe.test(t.type)&&t.click&&A(t,"input")&&Y.get(t,"click")||A(t,"a")}},beforeunload:{postDispatch:function(e){void 0!==e.result&&e.originalEvent&&(e.originalEvent.returnValue=e.result)}}}},S.removeEvent=function(e,t,n){e.removeEventListener&&e.removeEventListener(t,n)},S.Event=function(e,t){if(!(this instanceof S.Event))return new S.Event(e,t);e&&e.type?(this.originalEvent=e,this.type=e.type,this.isDefaultPrevented=e.defaultPrevented||void 0===e.defaultPrevented&&!1===e.returnValue?we:Te,this.target=e.target&&3===e.target.nodeType?e.target.parentNode:e.target,this.currentTarget=e.currentTarget,this.relatedTarget=e.relatedTarget):this.type=e,t&&S.extend(this,t),this.timeStamp=e&&e.timeStamp||Date.now(),this[S.expando]=!0},S.Event.prototype={constructor:S.Event,isDefaultPrevented:Te,isPropagationStopped:Te,isImmediatePropagationStopped:Te,isSimulated:!1,preventDefault:function(){var e=this.originalEvent;this.isDefaultPrevented=we,e&&!this.isSimulated&&e.preventDefault()},stopPropagation:function(){var e=this.originalEvent;this.isPropagationStopped=we,e&&!this.isSimulated&&e.stopPropagation()},stopImmediatePropagation:function(){var e=this.originalEvent;this.isImmediatePropagationStopped=we,e&&!this.isSimulated&&e.stopImmediatePropagation(),this.stopPropagation()}},S.each({altKey:!0,bubbles:!0,cancelable:!0,changedTouches:!0,ctrlKey:!0,detail:!0,eventPhase:!0,metaKey:!0,pageX:!0,pageY:!0,shiftKey:!0,view:!0,"char":!0,code:!0,charCode:!0,key:!0,keyCode:!0,button:!0,buttons:!0,clientX:!0,clientY:!0,offsetX:!0,offsetY:!0,pointerId:!0,pointerType:!0,screenX:!0,screenY:!0,targetTouches:!0,toElement:!0,touches:!0,which:!0},S.event.addProp),S.each({focus:"focusin",blur:"focusout"},function(e,t){S.event.special[e]={setup:function(){return Se(this,e,Ce),!1},trigger:function(){return Se(this,e),!0},_default:function(){return!0},delegateType:t}}),S.each({mouseenter:"mouseover",mouseleave:"mouseout",pointerenter:"pointerover",pointerleave:"pointerout"},function(e,i){S.event.special[e]={delegateType:i,bindType:i,handle:function(e){var t,n=e.relatedTarget,r=e.handleObj;return n&&(n===this||S.contains(this,n))||(e.type=r.origType,t=r.handler.apply(this,arguments),e.type=i),t}}}),S.fn.extend({on:function(e,t,n,r){return Ee(this,e,t,n,r)},one:function(e,t,n,r){return Ee(this,e,t,n,r,1)},off:function(e,t,n){var r,i;if(e&&e.preventDefault&&e.handleObj)return r=e.handleObj,S(e.delegateTarget).off(r.namespace?r.origType+"."+r.namespace:r.origType,r.selector,r.handler),this;if("object"==typeof e){for(i in e)this.off(i,t,e[i]);return this}return!1!==t&&"function"!=typeof t||(n=t,t=void 0),!1===n&&(n=Te),this.each(function(){S.event.remove(this,e,n,t)})}});var ke=/<script|<style|<link/i,Ae=/checked\s*(?:[^=]|=\s*.checked.)/i,Ne=/^\s*<!(?:\[CDATA\[|--)|(?:\]\]|--)>\s*$/g;function je(e,t){return A(e,"table")&&A(11!==t.nodeType?t:t.firstChild,"tr")&&S(e).children("tbody")[0]||e}function De(e){return e.type=(null!==e.getAttribute("type"))+"/"+e.type,e}function qe(e){return"true/"===(e.type||"").slice(0,5)?e.type=e.type.slice(5):e.removeAttribute("type"),e}function Le(e,t){var n,r,i,o,a,s;if(1===t.nodeType){if(Y.hasData(e)&&(s=Y.get(e).events))for(i in Y.remove(t,"handle events"),s)for(n=0,r=s[i].length;n<r;n++)S.event.add(t,i,s[i][n]);Q.hasData(e)&&(o=Q.access(e),a=S.extend({},o),Q.set(t,a))}}function He(n,r,i,o){r=g(r);var e,t,a,s,u,l,c=0,f=n.length,p=f-1,d=r[0],h=m(d);if(h||1<f&&"string"==typeof d&&!y.checkClone&&Ae.test(d))return n.each(function(e){var t=n.eq(e);h&&(r[0]=d.call(this,e,t.html())),He(t,r,i,o)});if(f&&(t=(e=xe(r,n[0].ownerDocument,!1,n,o)).firstChild,1===e.childNodes.length&&(e=t),t||o)){for(s=(a=S.map(ve(e,"script"),De)).length;c<f;c++)u=e,c!==p&&(u=S.clone(u,!0,!0),s&&S.merge(a,ve(u,"script"))),i.call(n[c],u,c);if(s)for(l=a[a.length-1].ownerDocument,S.map(a,qe),c=0;c<s;c++)u=a[c],he.test(u.type||"")&&!Y.access(u,"globalEval")&&S.contains(l,u)&&(u.src&&"module"!==(u.type||"").toLowerCase()?S._evalUrl&&!u.noModule&&S._evalUrl(u.src,{nonce:u.nonce||u.getAttribute("nonce")},l):b(u.textContent.replace(Ne,""),u,l))}return n}function Oe(e,t,n){for(var r,i=t?S.filter(t,e):e,o=0;null!=(r=i[o]);o++)n||1!==r.nodeType||S.cleanData(ve(r)),r.parentNode&&(n&&ie(r)&&ye(ve(r,"script")),r.parentNode.removeChild(r));return e}S.extend({htmlPrefilter:function(e){return e},clone:function(e,t,n){var r,i,o,a,s,u,l,c=e.cloneNode(!0),f=ie(e);if(!(y.noCloneChecked||1!==e.nodeType&&11!==e.nodeType||S.isXMLDoc(e)))for(a=ve(c),r=0,i=(o=ve(e)).length;r<i;r++)s=o[r],u=a[r],void 0,"input"===(l=u.nodeName.toLowerCase())&&pe.test(s.type)?u.checked=s.checked:"input"!==l&&"textarea"!==l||(u.defaultValue=s.defaultValue);if(t)if(n)for(o=o||ve(e),a=a||ve(c),r=0,i=o.length;r<i;r++)Le(o[r],a[r]);else Le(e,c);return 0<(a=ve(c,"script")).length&&ye(a,!f&&ve(e,"script")),c},cleanData:function(e){for(var t,n,r,i=S.event.special,o=0;void 0!==(n=e[o]);o++)if(V(n)){if(t=n[Y.expando]){if(t.events)for(r in t.events)i[r]?S.event.remove(n,r):S.removeEvent(n,r,t.handle);n[Y.expando]=void 0}n[Q.expando]&&(n[Q.expando]=void 0)}}}),S.fn.extend({detach:function(e){return Oe(this,e,!0)},remove:function(e){return Oe(this,e)},text:function(e){return $(this,function(e){return void 0===e?S.text(this):this.empty().each(function(){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||(this.textContent=e)})},null,e,arguments.length)},append:function(){return He(this,arguments,function(e){1!==this.nodeType&&11!==this.nodeType&&9!==this.nodeType||je(this,e).appendChild(e)})},prepend:function(){return He(this,arguments,function(e){if(1===this.nodeType||11===this.nodeType||9===this.nodeType){var t=je(this,e);t.insertBefore(e,t.firstChild)}})},before:function(){return He(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this)})},after:function(){return He(this,arguments,function(e){this.parentNode&&this.parentNode.insertBefore(e,this.nextSibling)})},empty:function(){for(var e,t=0;null!=(e=this[t]);t++)1===e.nodeType&&(S.cleanData(ve(e,!1)),e.textContent="");return this},clone:function(e,t){return e=null!=e&&e,t=null==t?e:t,this.map(function(){return S.clone(this,e,t)})},html:function(e){return $(this,function(e){var t=this[0]||{},n=0,r=this.length;if(void 0===e&&1===t.nodeType)return t.innerHTML;if("string"==typeof e&&!ke.test(e)&&!ge[(de.exec(e)||["",""])[1].toLowerCase()]){e=S.htmlPrefilter(e);try{for(;n<r;n++)1===(t=this[n]||{}).nodeType&&(S.cleanData(ve(t,!1)),t.innerHTML=e);t=0}catch(e){}}t&&this.empty().append(e)},null,e,arguments.length)},replaceWith:function(){var n=[];return He(this,arguments,function(e){var t=this.parentNode;S.inArray(this,n)<0&&(S.cleanData(ve(this)),t&&t.replaceChild(e,this))},n)}}),S.each({appendTo:"append",prependTo:"prepend",insertBefore:"before",insertAfter:"after",replaceAll:"replaceWith"},function(e,a){S.fn[e]=function(e){for(var t,n=[],r=S(e),i=r.length-1,o=0;o<=i;o++)t=o===i?this:this.clone(!0),S(r[o])[a](t),u.apply(n,t.get());return this.pushStack(n)}});var Pe=new RegExp("^("+ee+")(?!px)[a-z%]+$","i"),Re=function(e){var t=e.ownerDocument.defaultView;return t&&t.opener||(t=C),t.getComputedStyle(e)},Me=function(e,t,n){var r,i,o={};for(i in t)o[i]=e.style[i],e.style[i]=t[i];for(i in r=n.call(e),t)e.style[i]=o[i];return r},Ie=new RegExp(ne.join("|"),"i");function We(e,t,n){var r,i,o,a,s=e.style;return(n=n||Re(e))&&(""!==(a=n.getPropertyValue(t)||n[t])||ie(e)||(a=S.style(e,t)),!y.pixelBoxStyles()&&Pe.test(a)&&Ie.test(t)&&(r=s.width,i=s.minWidth,o=s.maxWidth,s.minWidth=s.maxWidth=s.width=a,a=n.width,s.width=r,s.minWidth=i,s.maxWidth=o)),void 0!==a?a+"":a}function Fe(e,t){return{get:function(){if(!e())return(this.get=t).apply(this,arguments);delete this.get}}}!function(){function e(){if(l){u.style.cssText="position:absolute;left:-11111px;width:60px;margin-top:1px;padding:0;border:0",l.style.cssText="position:relative;display:block;box-sizing:border-box;overflow:scroll;margin:auto;border:1px;padding:1px;width:60%;top:1%",re.appendChild(u).appendChild(l);var e=C.getComputedStyle(l);n="1%"!==e.top,s=12===t(e.marginLeft),l.style.right="60%",o=36===t(e.right),r=36===t(e.width),l.style.position="absolute",i=12===t(l.offsetWidth/3),re.removeChild(u),l=null}}function t(e){return Math.round(parseFloat(e))}var n,r,i,o,a,s,u=E.createElement("div"),l=E.createElement("div");l.style&&(l.style.backgroundClip="content-box",l.cloneNode(!0).style.backgroundClip="",y.clearCloneStyle="content-box"===l.style.backgroundClip,S.extend(y,{boxSizingReliable:function(){return e(),r},pixelBoxStyles:function(){return e(),o},pixelPosition:function(){return e(),n},reliableMarginLeft:function(){return e(),s},scrollboxSize:function(){return e(),i},reliableTrDimensions:function(){var e,t,n,r;return null==a&&(e=E.createElement("table"),t=E.createElement("tr"),n=E.createElement("div"),e.style.cssText="position:absolute;left:-11111px;border-collapse:separate",t.style.cssText="border:1px solid",t.style.height="1px",n.style.height="9px",n.style.display="block",re.appendChild(e).appendChild(t).appendChild(n),r=C.getComputedStyle(t),a=parseInt(r.height,10)+parseInt(r.borderTopWidth,10)+parseInt(r.borderBottomWidth,10)===t.offsetHeight,re.removeChild(e)),a}}))}();var Be=["Webkit","Moz","ms"],$e=E.createElement("div").style,_e={};function ze(e){var t=S.cssProps[e]||_e[e];return t||(e in $e?e:_e[e]=function(e){var t=e[0].toUpperCase()+e.slice(1),n=Be.length;while(n--)if((e=Be[n]+t)in $e)return e}(e)||e)}var Ue=/^(none|table(?!-c[ea]).+)/,Xe=/^--/,Ve={position:"absolute",visibility:"hidden",display:"block"},Ge={letterSpacing:"0",fontWeight:"400"};function Ye(e,t,n){var r=te.exec(t);return r?Math.max(0,r[2]-(n||0))+(r[3]||"px"):t}function Qe(e,t,n,r,i,o){var a="width"===t?1:0,s=0,u=0;if(n===(r?"border":"content"))return 0;for(;a<4;a+=2)"margin"===n&&(u+=S.css(e,n+ne[a],!0,i)),r?("content"===n&&(u-=S.css(e,"padding"+ne[a],!0,i)),"margin"!==n&&(u-=S.css(e,"border"+ne[a]+"Width",!0,i))):(u+=S.css(e,"padding"+ne[a],!0,i),"padding"!==n?u+=S.css(e,"border"+ne[a]+"Width",!0,i):s+=S.css(e,"border"+ne[a]+"Width",!0,i));return!r&&0<=o&&(u+=Math.max(0,Math.ceil(e["offset"+t[0].toUpperCase()+t.slice(1)]-o-u-s-.5))||0),u}function Je(e,t,n){var r=Re(e),i=(!y.boxSizingReliable()||n)&&"border-box"===S.css(e,"boxSizing",!1,r),o=i,a=We(e,t,r),s="offset"+t[0].toUpperCase()+t.slice(1);if(Pe.test(a)){if(!n)return a;a="auto"}return(!y.boxSizingReliable()&&i||!y.reliableTrDimensions()&&A(e,"tr")||"auto"===a||!parseFloat(a)&&"inline"===S.css(e,"display",!1,r))&&e.getClientRects().length&&(i="border-box"===S.css(e,"boxSizing",!1,r),(o=s in e)&&(a=e[s])),(a=parseFloat(a)||0)+Qe(e,t,n||(i?"border":"content"),o,r,a)+"px"}function Ke(e,t,n,r,i){return new Ke.prototype.init(e,t,n,r,i)}S.extend({cssHooks:{opacity:{get:function(e,t){if(t){var n=We(e,"opacity");return""===n?"1":n}}}},cssNumber:{animationIterationCount:!0,columnCount:!0,fillOpacity:!0,flexGrow:!0,flexShrink:!0,fontWeight:!0,gridArea:!0,gridColumn:!0,gridColumnEnd:!0,gridColumnStart:!0,gridRow:!0,gridRowEnd:!0,gridRowStart:!0,lineHeight:!0,opacity:!0,order:!0,orphans:!0,widows:!0,zIndex:!0,zoom:!0},cssProps:{},style:function(e,t,n,r){if(e&&3!==e.nodeType&&8!==e.nodeType&&e.style){var i,o,a,s=X(t),u=Xe.test(t),l=e.style;if(u||(t=ze(s)),a=S.cssHooks[t]||S.cssHooks[s],void 0===n)return a&&"get"in a&&void 0!==(i=a.get(e,!1,r))?i:l[t];"string"===(o=typeof n)&&(i=te.exec(n))&&i[1]&&(n=se(e,t,i),o="number"),null!=n&&n==n&&("number"!==o||u||(n+=i&&i[3]||(S.cssNumber[s]?"":"px")),y.clearCloneStyle||""!==n||0!==t.indexOf("background")||(l[t]="inherit"),a&&"set"in a&&void 0===(n=a.set(e,n,r))||(u?l.setProperty(t,n):l[t]=n))}},css:function(e,t,n,r){var i,o,a,s=X(t);return Xe.test(t)||(t=ze(s)),(a=S.cssHooks[t]||S.cssHooks[s])&&"get"in a&&(i=a.get(e,!0,n)),void 0===i&&(i=We(e,t,r)),"normal"===i&&t in Ge&&(i=Ge[t]),""===n||n?(o=parseFloat(i),!0===n||isFinite(o)?o||0:i):i}}),S.each(["height","width"],function(e,u){S.cssHooks[u]={get:function(e,t,n){if(t)return!Ue.test(S.css(e,"display"))||e.getClientRects().length&&e.getBoundingClientRect().width?Je(e,u,n):Me(e,Ve,function(){return Je(e,u,n)})},set:function(e,t,n){var r,i=Re(e),o=!y.scrollboxSize()&&"absolute"===i.position,a=(o||n)&&"border-box"===S.css(e,"boxSizing",!1,i),s=n?Qe(e,u,n,a,i):0;return a&&o&&(s-=Math.ceil(e["offset"+u[0].toUpperCase()+u.slice(1)]-parseFloat(i[u])-Qe(e,u,"border",!1,i)-.5)),s&&(r=te.exec(t))&&"px"!==(r[3]||"px")&&(e.style[u]=t,t=S.css(e,u)),Ye(0,t,s)}}}),S.cssHooks.marginLeft=Fe(y.reliableMarginLeft,function(e,t){if(t)return(parseFloat(We(e,"marginLeft"))||e.getBoundingClientRect().left-Me(e,{marginLeft:0},function(){return e.getBoundingClientRect().left}))+"px"}),S.each({margin:"",padding:"",border:"Width"},function(i,o){S.cssHooks[i+o]={expand:function(e){for(var t=0,n={},r="string"==typeof e?e.split(" "):[e];t<4;t++)n[i+ne[t]+o]=r[t]||r[t-2]||r[0];return n}},"margin"!==i&&(S.cssHooks[i+o].set=Ye)}),S.fn.extend({css:function(e,t){return $(this,function(e,t,n){var r,i,o={},a=0;if(Array.isArray(t)){for(r=Re(e),i=t.length;a<i;a++)o[t[a]]=S.css(e,t[a],!1,r);return o}return void 0!==n?S.style(e,t,n):S.css(e,t)},e,t,1<arguments.length)}}),((S.Tween=Ke).prototype={constructor:Ke,init:function(e,t,n,r,i,o){this.elem=e,this.prop=n,this.easing=i||S.easing._default,this.options=t,this.start=this.now=this.cur(),this.end=r,this.unit=o||(S.cssNumber[n]?"":"px")},cur:function(){var e=Ke.propHooks[this.prop];return e&&e.get?e.get(this):Ke.propHooks._default.get(this)},run:function(e){var t,n=Ke.propHooks[this.prop];return this.options.duration?this.pos=t=S.easing[this.easing](e,this.options.duration*e,0,1,this.options.duration):this.pos=t=e,this.now=(this.end-this.start)*t+this.start,this.options.step&&this.options.step.call(this.elem,this.now,this),n&&n.set?n.set(this):Ke.propHooks._default.set(this),this}}).init.prototype=Ke.prototype,(Ke.propHooks={_default:{get:function(e){var t;return 1!==e.elem.nodeType||null!=e.elem[e.prop]&&null==e.elem.style[e.prop]?e.elem[e.prop]:(t=S.css(e.elem,e.prop,""))&&"auto"!==t?t:0},set:function(e){S.fx.step[e.prop]?S.fx.step[e.prop](e):1!==e.elem.nodeType||!S.cssHooks[e.prop]&&null==e.elem.style[ze(e.prop)]?e.elem[e.prop]=e.now:S.style(e.elem,e.prop,e.now+e.unit)}}}).scrollTop=Ke.propHooks.scrollLeft={set:function(e){e.elem.nodeType&&e.elem.parentNode&&(e.elem[e.prop]=e.now)}},S.easing={linear:function(e){return e},swing:function(e){return.5-Math.cos(e*Math.PI)/2},_default:"swing"},S.fx=Ke.prototype.init,S.fx.step={};var Ze,et,tt,nt,rt=/^(?:toggle|show|hide)$/,it=/queueHooks$/;function ot(){et&&(!1===E.hidden&&C.requestAnimationFrame?C.requestAnimationFrame(ot):C.setTimeout(ot,S.fx.interval),S.fx.tick())}function at(){return C.setTimeout(function(){Ze=void 0}),Ze=Date.now()}function st(e,t){var n,r=0,i={height:e};for(t=t?1:0;r<4;r+=2-t)i["margin"+(n=ne[r])]=i["padding"+n]=e;return t&&(i.opacity=i.width=e),i}function ut(e,t,n){for(var r,i=(lt.tweeners[t]||[]).concat(lt.tweeners["*"]),o=0,a=i.length;o<a;o++)if(r=i[o].call(n,t,e))return r}function lt(o,e,t){var n,a,r=0,i=lt.prefilters.length,s=S.Deferred().always(function(){delete u.elem}),u=function(){if(a)return!1;for(var e=Ze||at(),t=Math.max(0,l.startTime+l.duration-e),n=1-(t/l.duration||0),r=0,i=l.tweens.length;r<i;r++)l.tweens[r].run(n);return s.notifyWith(o,[l,n,t]),n<1&&i?t:(i||s.notifyWith(o,[l,1,0]),s.resolveWith(o,[l]),!1)},l=s.promise({elem:o,props:S.extend({},e),opts:S.extend(!0,{specialEasing:{},easing:S.easing._default},t),originalProperties:e,originalOptions:t,startTime:Ze||at(),duration:t.duration,tweens:[],createTween:function(e,t){var n=S.Tween(o,l.opts,e,t,l.opts.specialEasing[e]||l.opts.easing);return l.tweens.push(n),n},stop:function(e){var t=0,n=e?l.tweens.length:0;if(a)return this;for(a=!0;t<n;t++)l.tweens[t].run(1);return e?(s.notifyWith(o,[l,1,0]),s.resolveWith(o,[l,e])):s.rejectWith(o,[l,e]),this}}),c=l.props;for(!function(e,t){var n,r,i,o,a;for(n in e)if(i=t[r=X(n)],o=e[n],Array.isArray(o)&&(i=o[1],o=e[n]=o[0]),n!==r&&(e[r]=o,delete e[n]),(a=S.cssHooks[r])&&"expand"in a)for(n in o=a.expand(o),delete e[r],o)n in e||(e[n]=o[n],t[n]=i);else t[r]=i}(c,l.opts.specialEasing);r<i;r++)if(n=lt.prefilters[r].call(l,o,c,l.opts))return m(n.stop)&&(S._queueHooks(l.elem,l.opts.queue).stop=n.stop.bind(n)),n;return S.map(c,ut,l),m(l.opts.start)&&l.opts.start.call(o,l),l.progress(l.opts.progress).done(l.opts.done,l.opts.complete).fail(l.opts.fail).always(l.opts.always),S.fx.timer(S.extend(u,{elem:o,anim:l,queue:l.opts.queue})),l}S.Animation=S.extend(lt,{tweeners:{"*":[function(e,t){var n=this.createTween(e,t);return se(n.elem,e,te.exec(t),n),n}]},tweener:function(e,t){m(e)?(t=e,e=["*"]):e=e.match(P);for(var n,r=0,i=e.length;r<i;r++)n=e[r],lt.tweeners[n]=lt.tweeners[n]||[],lt.tweeners[n].unshift(t)},prefilters:[function(e,t,n){var r,i,o,a,s,u,l,c,f="width"in t||"height"in t,p=this,d={},h=e.style,g=e.nodeType&&ae(e),v=Y.get(e,"fxshow");for(r in n.queue||(null==(a=S._queueHooks(e,"fx")).unqueued&&(a.unqueued=0,s=a.empty.fire,a.empty.fire=function(){a.unqueued||s()}),a.unqueued++,p.always(function(){p.always(function(){a.unqueued--,S.queue(e,"fx").length||a.empty.fire()})})),t)if(i=t[r],rt.test(i)){if(delete t[r],o=o||"toggle"===i,i===(g?"hide":"show")){if("show"!==i||!v||void 0===v[r])continue;g=!0}d[r]=v&&v[r]||S.style(e,r)}if((u=!S.isEmptyObject(t))||!S.isEmptyObject(d))for(r in f&&1===e.nodeType&&(n.overflow=[h.overflow,h.overflowX,h.overflowY],null==(l=v&&v.display)&&(l=Y.get(e,"display")),"none"===(c=S.css(e,"display"))&&(l?c=l:(le([e],!0),l=e.style.display||l,c=S.css(e,"display"),le([e]))),("inline"===c||"inline-block"===c&&null!=l)&&"none"===S.css(e,"float")&&(u||(p.done(function(){h.display=l}),null==l&&(c=h.display,l="none"===c?"":c)),h.display="inline-block")),n.overflow&&(h.overflow="hidden",p.always(function(){h.overflow=n.overflow[0],h.overflowX=n.overflow[1],h.overflowY=n.overflow[2]})),u=!1,d)u||(v?"hidden"in v&&(g=v.hidden):v=Y.access(e,"fxshow",{display:l}),o&&(v.hidden=!g),g&&le([e],!0),p.done(function(){for(r in g||le([e]),Y.remove(e,"fxshow"),d)S.style(e,r,d[r])})),u=ut(g?v[r]:0,r,p),r in v||(v[r]=u.start,g&&(u.end=u.start,u.start=0))}],prefilter:function(e,t){t?lt.prefilters.unshift(e):lt.prefilters.push(e)}}),S.speed=function(e,t,n){var r=e&&"object"==typeof e?S.extend({},e):{complete:n||!n&&t||m(e)&&e,duration:e,easing:n&&t||t&&!m(t)&&t};return S.fx.off?r.duration=0:"number"!=typeof r.duration&&(r.duration in S.fx.speeds?r.duration=S.fx.speeds[r.duration]:r.duration=S.fx.speeds._default),null!=r.queue&&!0!==r.queue||(r.queue="fx"),r.old=r.complete,r.complete=function(){m(r.old)&&r.old.call(this),r.queue&&S.dequeue(this,r.queue)},r},S.fn.extend({fadeTo:function(e,t,n,r){return this.filter(ae).css("opacity",0).show().end().animate({opacity:t},e,n,r)},animate:function(t,e,n,r){var i=S.isEmptyObject(t),o=S.speed(e,n,r),a=function(){var e=lt(this,S.extend({},t),o);(i||Y.get(this,"finish"))&&e.stop(!0)};return a.finish=a,i||!1===o.queue?this.each(a):this.queue(o.queue,a)},stop:function(i,e,o){var a=function(e){var t=e.stop;delete e.stop,t(o)};return"string"!=typeof i&&(o=e,e=i,i=void 0),e&&this.queue(i||"fx",[]),this.each(function(){var e=!0,t=null!=i&&i+"queueHooks",n=S.timers,r=Y.get(this);if(t)r[t]&&r[t].stop&&a(r[t]);else for(t in r)r[t]&&r[t].stop&&it.test(t)&&a(r[t]);for(t=n.length;t--;)n[t].elem!==this||null!=i&&n[t].queue!==i||(n[t].anim.stop(o),e=!1,n.splice(t,1));!e&&o||S.dequeue(this,i)})},finish:function(a){return!1!==a&&(a=a||"fx"),this.each(function(){var e,t=Y.get(this),n=t[a+"queue"],r=t[a+"queueHooks"],i=S.timers,o=n?n.length:0;for(t.finish=!0,S.queue(this,a,[]),r&&r.stop&&r.stop.call(this,!0),e=i.length;e--;)i[e].elem===this&&i[e].queue===a&&(i[e].anim.stop(!0),i.splice(e,1));for(e=0;e<o;e++)n[e]&&n[e].finish&&n[e].finish.call(this);delete t.finish})}}),S.each(["toggle","show","hide"],function(e,r){var i=S.fn[r];S.fn[r]=function(e,t,n){return null==e||"boolean"==typeof e?i.apply(this,arguments):this.animate(st(r,!0),e,t,n)}}),S.each({slideDown:st("show"),slideUp:st("hide"),slideToggle:st("toggle"),fadeIn:{opacity:"show"},fadeOut:{opacity:"hide"},fadeToggle:{opacity:"toggle"}},function(e,r){S.fn[e]=function(e,t,n){return this.animate(r,e,t,n)}}),S.timers=[],S.fx.tick=function(){var e,t=0,n=S.timers;for(Ze=Date.now();t<n.length;t++)(e=n[t])()||n[t]!==e||n.splice(t--,1);n.length||S.fx.stop(),Ze=void 0},S.fx.timer=function(e){S.timers.push(e),S.fx.start()},S.fx.interval=13,S.fx.start=function(){et||(et=!0,ot())},S.fx.stop=function(){et=null},S.fx.speeds={slow:600,fast:200,_default:400},S.fn.delay=function(r,e){return r=S.fx&&S.fx.speeds[r]||r,e=e||"fx",this.queue(e,function(e,t){var n=C.setTimeout(e,r);t.stop=function(){C.clearTimeout(n)}})},tt=E.createElement("input"),nt=E.createElement("select").appendChild(E.createElement("option")),tt.type="checkbox",y.checkOn=""!==tt.value,y.optSelected=nt.selected,(tt=E.createElement("input")).value="t",tt.type="radio",y.radioValue="t"===tt.value;var ct,ft=S.expr.attrHandle;S.fn.extend({attr:function(e,t){return $(this,S.attr,e,t,1<arguments.length)},removeAttr:function(e){return this.each(function(){S.removeAttr(this,e)})}}),S.extend({attr:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return"undefined"==typeof e.getAttribute?S.prop(e,t,n):(1===o&&S.isXMLDoc(e)||(i=S.attrHooks[t.toLowerCase()]||(S.expr.match.bool.test(t)?ct:void 0)),void 0!==n?null===n?void S.removeAttr(e,t):i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:(e.setAttribute(t,n+""),n):i&&"get"in i&&null!==(r=i.get(e,t))?r:null==(r=S.find.attr(e,t))?void 0:r)},attrHooks:{type:{set:function(e,t){if(!y.radioValue&&"radio"===t&&A(e,"input")){var n=e.value;return e.setAttribute("type",t),n&&(e.value=n),t}}}},removeAttr:function(e,t){var n,r=0,i=t&&t.match(P);if(i&&1===e.nodeType)while(n=i[r++])e.removeAttribute(n)}}),ct={set:function(e,t,n){return!1===t?S.removeAttr(e,n):e.setAttribute(n,n),n}},S.each(S.expr.match.bool.source.match(/\w+/g),function(e,t){var a=ft[t]||S.find.attr;ft[t]=function(e,t,n){var r,i,o=t.toLowerCase();return n||(i=ft[o],ft[o]=r,r=null!=a(e,t,n)?o:null,ft[o]=i),r}});var pt=/^(?:input|select|textarea|button)$/i,dt=/^(?:a|area)$/i;function ht(e){return(e.match(P)||[]).join(" ")}function gt(e){return e.getAttribute&&e.getAttribute("class")||""}function vt(e){return Array.isArray(e)?e:"string"==typeof e&&e.match(P)||[]}S.fn.extend({prop:function(e,t){return $(this,S.prop,e,t,1<arguments.length)},removeProp:function(e){return this.each(function(){delete this[S.propFix[e]||e]})}}),S.extend({prop:function(e,t,n){var r,i,o=e.nodeType;if(3!==o&&8!==o&&2!==o)return 1===o&&S.isXMLDoc(e)||(t=S.propFix[t]||t,i=S.propHooks[t]),void 0!==n?i&&"set"in i&&void 0!==(r=i.set(e,n,t))?r:e[t]=n:i&&"get"in i&&null!==(r=i.get(e,t))?r:e[t]},propHooks:{tabIndex:{get:function(e){var t=S.find.attr(e,"tabindex");return t?parseInt(t,10):pt.test(e.nodeName)||dt.test(e.nodeName)&&e.href?0:-1}}},propFix:{"for":"htmlFor","class":"className"}}),y.optSelected||(S.propHooks.selected={get:function(e){var t=e.parentNode;return t&&t.parentNode&&t.parentNode.selectedIndex,null},set:function(e){var t=e.parentNode;t&&(t.selectedIndex,t.parentNode&&t.parentNode.selectedIndex)}}),S.each(["tabIndex","readOnly","maxLength","cellSpacing","cellPadding","rowSpan","colSpan","useMap","frameBorder","contentEditable"],function(){S.propFix[this.toLowerCase()]=this}),S.fn.extend({addClass:function(t){var e,n,r,i,o,a,s,u=0;if(m(t))return this.each(function(e){S(this).addClass(t.call(this,e,gt(this)))});if((e=vt(t)).length)while(n=this[u++])if(i=gt(n),r=1===n.nodeType&&" "+ht(i)+" "){a=0;while(o=e[a++])r.indexOf(" "+o+" ")<0&&(r+=o+" ");i!==(s=ht(r))&&n.setAttribute("class",s)}return this},removeClass:function(t){var e,n,r,i,o,a,s,u=0;if(m(t))return this.each(function(e){S(this).removeClass(t.call(this,e,gt(this)))});if(!arguments.length)return this.attr("class","");if((e=vt(t)).length)while(n=this[u++])if(i=gt(n),r=1===n.nodeType&&" "+ht(i)+" "){a=0;while(o=e[a++])while(-1<r.indexOf(" "+o+" "))r=r.replace(" "+o+" "," ");i!==(s=ht(r))&&n.setAttribute("class",s)}return this},toggleClass:function(i,t){var o=typeof i,a="string"===o||Array.isArray(i);return"boolean"==typeof t&&a?t?this.addClass(i):this.removeClass(i):m(i)?this.each(function(e){S(this).toggleClass(i.call(this,e,gt(this),t),t)}):this.each(function(){var e,t,n,r;if(a){t=0,n=S(this),r=vt(i);while(e=r[t++])n.hasClass(e)?n.removeClass(e):n.addClass(e)}else void 0!==i&&"boolean"!==o||((e=gt(this))&&Y.set(this,"__className__",e),this.setAttribute&&this.setAttribute("class",e||!1===i?"":Y.get(this,"__className__")||""))})},hasClass:function(e){var t,n,r=0;t=" "+e+" ";while(n=this[r++])if(1===n.nodeType&&-1<(" "+ht(gt(n))+" ").indexOf(t))return!0;return!1}});var yt=/\r/g;S.fn.extend({val:function(n){var r,e,i,t=this[0];return arguments.length?(i=m(n),this.each(function(e){var t;1===this.nodeType&&(null==(t=i?n.call(this,e,S(this).val()):n)?t="":"number"==typeof t?t+="":Array.isArray(t)&&(t=S.map(t,function(e){return null==e?"":e+""})),(r=S.valHooks[this.type]||S.valHooks[this.nodeName.toLowerCase()])&&"set"in r&&void 0!==r.set(this,t,"value")||(this.value=t))})):t?(r=S.valHooks[t.type]||S.valHooks[t.nodeName.toLowerCase()])&&"get"in r&&void 0!==(e=r.get(t,"value"))?e:"string"==typeof(e=t.value)?e.replace(yt,""):null==e?"":e:void 0}}),S.extend({valHooks:{option:{get:function(e){var t=S.find.attr(e,"value");return null!=t?t:ht(S.text(e))}},select:{get:function(e){var t,n,r,i=e.options,o=e.selectedIndex,a="select-one"===e.type,s=a?null:[],u=a?o+1:i.length;for(r=o<0?u:a?o:0;r<u;r++)if(((n=i[r]).selected||r===o)&&!n.disabled&&(!n.parentNode.disabled||!A(n.parentNode,"optgroup"))){if(t=S(n).val(),a)return t;s.push(t)}return s},set:function(e,t){var n,r,i=e.options,o=S.makeArray(t),a=i.length;while(a--)((r=i[a]).selected=-1<S.inArray(S.valHooks.option.get(r),o))&&(n=!0);return n||(e.selectedIndex=-1),o}}}}),S.each(["radio","checkbox"],function(){S.valHooks[this]={set:function(e,t){if(Array.isArray(t))return e.checked=-1<S.inArray(S(e).val(),t)}},y.checkOn||(S.valHooks[this].get=function(e){return null===e.getAttribute("value")?"on":e.value})}),y.focusin="onfocusin"in C;var mt=/^(?:focusinfocus|focusoutblur)$/,xt=function(e){e.stopPropagation()};S.extend(S.event,{trigger:function(e,t,n,r){var i,o,a,s,u,l,c,f,p=[n||E],d=v.call(e,"type")?e.type:e,h=v.call(e,"namespace")?e.namespace.split("."):[];if(o=f=a=n=n||E,3!==n.nodeType&&8!==n.nodeType&&!mt.test(d+S.event.triggered)&&(-1<d.indexOf(".")&&(d=(h=d.split(".")).shift(),h.sort()),u=d.indexOf(":")<0&&"on"+d,(e=e[S.expando]?e:new S.Event(d,"object"==typeof e&&e)).isTrigger=r?2:3,e.namespace=h.join("."),e.rnamespace=e.namespace?new RegExp("(^|\\.)"+h.join("\\.(?:.*\\.|)")+"(\\.|$)"):null,e.result=void 0,e.target||(e.target=n),t=null==t?[e]:S.makeArray(t,[e]),c=S.event.special[d]||{},r||!c.trigger||!1!==c.trigger.apply(n,t))){if(!r&&!c.noBubble&&!x(n)){for(s=c.delegateType||d,mt.test(s+d)||(o=o.parentNode);o;o=o.parentNode)p.push(o),a=o;a===(n.ownerDocument||E)&&p.push(a.defaultView||a.parentWindow||C)}i=0;while((o=p[i++])&&!e.isPropagationStopped())f=o,e.type=1<i?s:c.bindType||d,(l=(Y.get(o,"events")||Object.create(null))[e.type]&&Y.get(o,"handle"))&&l.apply(o,t),(l=u&&o[u])&&l.apply&&V(o)&&(e.result=l.apply(o,t),!1===e.result&&e.preventDefault());return e.type=d,r||e.isDefaultPrevented()||c._default&&!1!==c._default.apply(p.pop(),t)||!V(n)||u&&m(n[d])&&!x(n)&&((a=n[u])&&(n[u]=null),S.event.triggered=d,e.isPropagationStopped()&&f.addEventListener(d,xt),n[d](),e.isPropagationStopped()&&f.removeEventListener(d,xt),S.event.triggered=void 0,a&&(n[u]=a)),e.result}},simulate:function(e,t,n){var r=S.extend(new S.Event,n,{type:e,isSimulated:!0});S.event.trigger(r,null,t)}}),S.fn.extend({trigger:function(e,t){return this.each(function(){S.event.trigger(e,t,this)})},triggerHandler:function(e,t){var n=this[0];if(n)return S.event.trigger(e,t,n,!0)}}),y.focusin||S.each({focus:"focusin",blur:"focusout"},function(n,r){var i=function(e){S.event.simulate(r,e.target,S.event.fix(e))};S.event.special[r]={setup:function(){var e=this.ownerDocument||this.document||this,t=Y.access(e,r);t||e.addEventListener(n,i,!0),Y.access(e,r,(t||0)+1)},teardown:function(){var e=this.ownerDocument||this.document||this,t=Y.access(e,r)-1;t?Y.access(e,r,t):(e.removeEventListener(n,i,!0),Y.remove(e,r))}}});var bt=C.location,wt={guid:Date.now()},Tt=/\?/;S.parseXML=function(e){var t,n;if(!e||"string"!=typeof e)return null;try{t=(new C.DOMParser).parseFromString(e,"text/xml")}catch(e){}return n=t&&t.getElementsByTagName("parsererror")[0],t&&!n||S.error("Invalid XML: "+(n?S.map(n.childNodes,function(e){return e.textContent}).join("\n"):e)),t};var Ct=/\[\]$/,Et=/\r?\n/g,St=/^(?:submit|button|image|reset|file)$/i,kt=/^(?:input|select|textarea|keygen)/i;function At(n,e,r,i){var t;if(Array.isArray(e))S.each(e,function(e,t){r||Ct.test(n)?i(n,t):At(n+"["+("object"==typeof t&&null!=t?e:"")+"]",t,r,i)});else if(r||"object"!==w(e))i(n,e);else for(t in e)At(n+"["+t+"]",e[t],r,i)}S.param=function(e,t){var n,r=[],i=function(e,t){var n=m(t)?t():t;r[r.length]=encodeURIComponent(e)+"="+encodeURIComponent(null==n?"":n)};if(null==e)return"";if(Array.isArray(e)||e.jquery&&!S.isPlainObject(e))S.each(e,function(){i(this.name,this.value)});else for(n in e)At(n,e[n],t,i);return r.join("&")},S.fn.extend({serialize:function(){return S.param(this.serializeArray())},serializeArray:function(){return this.map(function(){var e=S.prop(this,"elements");return e?S.makeArray(e):this}).filter(function(){var e=this.type;return this.name&&!S(this).is(":disabled")&&kt.test(this.nodeName)&&!St.test(e)&&(this.checked||!pe.test(e))}).map(function(e,t){var n=S(this).val();return null==n?null:Array.isArray(n)?S.map(n,function(e){return{name:t.name,value:e.replace(Et,"\r\n")}}):{name:t.name,value:n.replace(Et,"\r\n")}}).get()}});var Nt=/%20/g,jt=/#.*$/,Dt=/([?&])_=[^&]*/,qt=/^(.*?):[ \t]*([^\r\n]*)$/gm,Lt=/^(?:GET|HEAD)$/,Ht=/^\/\//,Ot={},Pt={},Rt="*/".concat("*"),Mt=E.createElement("a");function It(o){return function(e,t){"string"!=typeof e&&(t=e,e="*");var n,r=0,i=e.toLowerCase().match(P)||[];if(m(t))while(n=i[r++])"+"===n[0]?(n=n.slice(1)||"*",(o[n]=o[n]||[]).unshift(t)):(o[n]=o[n]||[]).push(t)}}function Wt(t,i,o,a){var s={},u=t===Pt;function l(e){var r;return s[e]=!0,S.each(t[e]||[],function(e,t){var n=t(i,o,a);return"string"!=typeof n||u||s[n]?u?!(r=n):void 0:(i.dataTypes.unshift(n),l(n),!1)}),r}return l(i.dataTypes[0])||!s["*"]&&l("*")}function Ft(e,t){var n,r,i=S.ajaxSettings.flatOptions||{};for(n in t)void 0!==t[n]&&((i[n]?e:r||(r={}))[n]=t[n]);return r&&S.extend(!0,e,r),e}Mt.href=bt.href,S.extend({active:0,lastModified:{},etag:{},ajaxSettings:{url:bt.href,type:"GET",isLocal:/^(?:about|app|app-storage|.+-extension|file|res|widget):$/.test(bt.protocol),global:!0,processData:!0,async:!0,contentType:"application/x-www-form-urlencoded; charset=UTF-8",accepts:{"*":Rt,text:"text/plain",html:"text/html",xml:"application/xml, text/xml",json:"application/json, text/javascript"},contents:{xml:/\bxml\b/,html:/\bhtml/,json:/\bjson\b/},responseFields:{xml:"responseXML",text:"responseText",json:"responseJSON"},converters:{"* text":String,"text html":!0,"text json":JSON.parse,"text xml":S.parseXML},flatOptions:{url:!0,context:!0}},ajaxSetup:function(e,t){return t?Ft(Ft(e,S.ajaxSettings),t):Ft(S.ajaxSettings,e)},ajaxPrefilter:It(Ot),ajaxTransport:It(Pt),ajax:function(e,t){"object"==typeof e&&(t=e,e=void 0),t=t||{};var c,f,p,n,d,r,h,g,i,o,v=S.ajaxSetup({},t),y=v.context||v,m=v.context&&(y.nodeType||y.jquery)?S(y):S.event,x=S.Deferred(),b=S.Callbacks("once memory"),w=v.statusCode||{},a={},s={},u="canceled",T={readyState:0,getResponseHeader:function(e){var t;if(h){if(!n){n={};while(t=qt.exec(p))n[t[1].toLowerCase()+" "]=(n[t[1].toLowerCase()+" "]||[]).concat(t[2])}t=n[e.toLowerCase()+" "]}return null==t?null:t.join(", ")},getAllResponseHeaders:function(){return h?p:null},setRequestHeader:function(e,t){return null==h&&(e=s[e.toLowerCase()]=s[e.toLowerCase()]||e,a[e]=t),this},overrideMimeType:function(e){return null==h&&(v.mimeType=e),this},statusCode:function(e){var t;if(e)if(h)T.always(e[T.status]);else for(t in e)w[t]=[w[t],e[t]];return this},abort:function(e){var t=e||u;return c&&c.abort(t),l(0,t),this}};if(x.promise(T),v.url=((e||v.url||bt.href)+"").replace(Ht,bt.protocol+"//"),v.type=t.method||t.type||v.method||v.type,v.dataTypes=(v.dataType||"*").toLowerCase().match(P)||[""],null==v.crossDomain){r=E.createElement("a");try{r.href=v.url,r.href=r.href,v.crossDomain=Mt.protocol+"//"+Mt.host!=r.protocol+"//"+r.host}catch(e){v.crossDomain=!0}}if(v.data&&v.processData&&"string"!=typeof v.data&&(v.data=S.param(v.data,v.traditional)),Wt(Ot,v,t,T),h)return T;for(i in(g=S.event&&v.global)&&0==S.active++&&S.event.trigger("ajaxStart"),v.type=v.type.toUpperCase(),v.hasContent=!Lt.test(v.type),f=v.url.replace(jt,""),v.hasContent?v.data&&v.processData&&0===(v.contentType||"").indexOf("application/x-www-form-urlencoded")&&(v.data=v.data.replace(Nt,"+")):(o=v.url.slice(f.length),v.data&&(v.processData||"string"==typeof v.data)&&(f+=(Tt.test(f)?"&":"?")+v.data,delete v.data),!1===v.cache&&(f=f.replace(Dt,"$1"),o=(Tt.test(f)?"&":"?")+"_="+wt.guid+++o),v.url=f+o),v.ifModified&&(S.lastModified[f]&&T.setRequestHeader("If-Modified-Since",S.lastModified[f]),S.etag[f]&&T.setRequestHeader("If-None-Match",S.etag[f])),(v.data&&v.hasContent&&!1!==v.contentType||t.contentType)&&T.setRequestHeader("Content-Type",v.contentType),T.setRequestHeader("Accept",v.dataTypes[0]&&v.accepts[v.dataTypes[0]]?v.accepts[v.dataTypes[0]]+("*"!==v.dataTypes[0]?", "+Rt+"; q=0.01":""):v.accepts["*"]),v.headers)T.setRequestHeader(i,v.headers[i]);if(v.beforeSend&&(!1===v.beforeSend.call(y,T,v)||h))return T.abort();if(u="abort",b.add(v.complete),T.done(v.success),T.fail(v.error),c=Wt(Pt,v,t,T)){if(T.readyState=1,g&&m.trigger("ajaxSend",[T,v]),h)return T;v.async&&0<v.timeout&&(d=C.setTimeout(function(){T.abort("timeout")},v.timeout));try{h=!1,c.send(a,l)}catch(e){if(h)throw e;l(-1,e)}}else l(-1,"No Transport");function l(e,t,n,r){var i,o,a,s,u,l=t;h||(h=!0,d&&C.clearTimeout(d),c=void 0,p=r||"",T.readyState=0<e?4:0,i=200<=e&&e<300||304===e,n&&(s=function(e,t,n){var r,i,o,a,s=e.contents,u=e.dataTypes;while("*"===u[0])u.shift(),void 0===r&&(r=e.mimeType||t.getResponseHeader("Content-Type"));if(r)for(i in s)if(s[i]&&s[i].test(r)){u.unshift(i);break}if(u[0]in n)o=u[0];else{for(i in n){if(!u[0]||e.converters[i+" "+u[0]]){o=i;break}a||(a=i)}o=o||a}if(o)return o!==u[0]&&u.unshift(o),n[o]}(v,T,n)),!i&&-1<S.inArray("script",v.dataTypes)&&S.inArray("json",v.dataTypes)<0&&(v.converters["text script"]=function(){}),s=function(e,t,n,r){var i,o,a,s,u,l={},c=e.dataTypes.slice();if(c[1])for(a in e.converters)l[a.toLowerCase()]=e.converters[a];o=c.shift();while(o)if(e.responseFields[o]&&(n[e.responseFields[o]]=t),!u&&r&&e.dataFilter&&(t=e.dataFilter(t,e.dataType)),u=o,o=c.shift())if("*"===o)o=u;else if("*"!==u&&u!==o){if(!(a=l[u+" "+o]||l["* "+o]))for(i in l)if((s=i.split(" "))[1]===o&&(a=l[u+" "+s[0]]||l["* "+s[0]])){!0===a?a=l[i]:!0!==l[i]&&(o=s[0],c.unshift(s[1]));break}if(!0!==a)if(a&&e["throws"])t=a(t);else try{t=a(t)}catch(e){return{state:"parsererror",error:a?e:"No conversion from "+u+" to "+o}}}return{state:"success",data:t}}(v,s,T,i),i?(v.ifModified&&((u=T.getResponseHeader("Last-Modified"))&&(S.lastModified[f]=u),(u=T.getResponseHeader("etag"))&&(S.etag[f]=u)),204===e||"HEAD"===v.type?l="nocontent":304===e?l="notmodified":(l=s.state,o=s.data,i=!(a=s.error))):(a=l,!e&&l||(l="error",e<0&&(e=0))),T.status=e,T.statusText=(t||l)+"",i?x.resolveWith(y,[o,l,T]):x.rejectWith(y,[T,l,a]),T.statusCode(w),w=void 0,g&&m.trigger(i?"ajaxSuccess":"ajaxError",[T,v,i?o:a]),b.fireWith(y,[T,l]),g&&(m.trigger("ajaxComplete",[T,v]),--S.active||S.event.trigger("ajaxStop")))}return T},getJSON:function(e,t,n){return S.get(e,t,n,"json")},getScript:function(e,t){return S.get(e,void 0,t,"script")}}),S.each(["get","post"],function(e,i){S[i]=function(e,t,n,r){return m(t)&&(r=r||n,n=t,t=void 0),S.ajax(S.extend({url:e,type:i,dataType:r,data:t,success:n},S.isPlainObject(e)&&e))}}),S.ajaxPrefilter(function(e){var t;for(t in e.headers)"content-type"===t.toLowerCase()&&(e.contentType=e.headers[t]||"")}),S._evalUrl=function(e,t,n){return S.ajax({url:e,type:"GET",dataType:"script",cache:!0,async:!1,global:!1,converters:{"text script":function(){}},dataFilter:function(e){S.globalEval(e,t,n)}})},S.fn.extend({wrapAll:function(e){var t;return this[0]&&(m(e)&&(e=e.call(this[0])),t=S(e,this[0].ownerDocument).eq(0).clone(!0),this[0].parentNode&&t.insertBefore(this[0]),t.map(function(){var e=this;while(e.firstElementChild)e=e.firstElementChild;return e}).append(this)),this},wrapInner:function(n){return m(n)?this.each(function(e){S(this).wrapInner(n.call(this,e))}):this.each(function(){var e=S(this),t=e.contents();t.length?t.wrapAll(n):e.append(n)})},wrap:function(t){var n=m(t);return this.each(function(e){S(this).wrapAll(n?t.call(this,e):t)})},unwrap:function(e){return this.parent(e).not("body").each(function(){S(this).replaceWith(this.childNodes)}),this}}),S.expr.pseudos.hidden=function(e){return!S.expr.pseudos.visible(e)},S.expr.pseudos.visible=function(e){return!!(e.offsetWidth||e.offsetHeight||e.getClientRects().length)},S.ajaxSettings.xhr=function(){try{return new C.XMLHttpRequest}catch(e){}};var Bt={0:200,1223:204},$t=S.ajaxSettings.xhr();y.cors=!!$t&&"withCredentials"in $t,y.ajax=$t=!!$t,S.ajaxTransport(function(i){var o,a;if(y.cors||$t&&!i.crossDomain)return{send:function(e,t){var n,r=i.xhr();if(r.open(i.type,i.url,i.async,i.username,i.password),i.xhrFields)for(n in i.xhrFields)r[n]=i.xhrFields[n];for(n in i.mimeType&&r.overrideMimeType&&r.overrideMimeType(i.mimeType),i.crossDomain||e["X-Requested-With"]||(e["X-Requested-With"]="XMLHttpRequest"),e)r.setRequestHeader(n,e[n]);o=function(e){return function(){o&&(o=a=r.onload=r.onerror=r.onabort=r.ontimeout=r.onreadystatechange=null,"abort"===e?r.abort():"error"===e?"number"!=typeof r.status?t(0,"error"):t(r.status,r.statusText):t(Bt[r.status]||r.status,r.statusText,"text"!==(r.responseType||"text")||"string"!=typeof r.responseText?{binary:r.response}:{text:r.responseText},r.getAllResponseHeaders()))}},r.onload=o(),a=r.onerror=r.ontimeout=o("error"),void 0!==r.onabort?r.onabort=a:r.onreadystatechange=function(){4===r.readyState&&C.setTimeout(function(){o&&a()})},o=o("abort");try{r.send(i.hasContent&&i.data||null)}catch(e){if(o)throw e}},abort:function(){o&&o()}}}),S.ajaxPrefilter(function(e){e.crossDomain&&(e.contents.script=!1)}),S.ajaxSetup({accepts:{script:"text/javascript, application/javascript, application/ecmascript, application/x-ecmascript"},contents:{script:/\b(?:java|ecma)script\b/},converters:{"text script":function(e){return S.globalEval(e),e}}}),S.ajaxPrefilter("script",function(e){void 0===e.cache&&(e.cache=!1),e.crossDomain&&(e.type="GET")}),S.ajaxTransport("script",function(n){var r,i;if(n.crossDomain||n.scriptAttrs)return{send:function(e,t){r=S("<script>").attr(n.scriptAttrs||{}).prop({charset:n.scriptCharset,src:n.url}).on("load error",i=function(e){r.remove(),i=null,e&&t("error"===e.type?404:200,e.type)}),E.head.appendChild(r[0])},abort:function(){i&&i()}}});var _t,zt=[],Ut=/(=)\?(?=&|$)|\?\?/;S.ajaxSetup({jsonp:"callback",jsonpCallback:function(){var e=zt.pop()||S.expando+"_"+wt.guid++;return this[e]=!0,e}}),S.ajaxPrefilter("json jsonp",function(e,t,n){var r,i,o,a=!1!==e.jsonp&&(Ut.test(e.url)?"url":"string"==typeof e.data&&0===(e.contentType||"").indexOf("application/x-www-form-urlencoded")&&Ut.test(e.data)&&"data");if(a||"jsonp"===e.dataTypes[0])return r=e.jsonpCallback=m(e.jsonpCallback)?e.jsonpCallback():e.jsonpCallback,a?e[a]=e[a].replace(Ut,"$1"+r):!1!==e.jsonp&&(e.url+=(Tt.test(e.url)?"&":"?")+e.jsonp+"="+r),e.converters["script json"]=function(){return o||S.error(r+" was not called"),o[0]},e.dataTypes[0]="json",i=C[r],C[r]=function(){o=arguments},n.always(function(){void 0===i?S(C).removeProp(r):C[r]=i,e[r]&&(e.jsonpCallback=t.jsonpCallback,zt.push(r)),o&&m(i)&&i(o[0]),o=i=void 0}),"script"}),y.createHTMLDocument=((_t=E.implementation.createHTMLDocument("").body).innerHTML="<form></form><form></form>",2===_t.childNodes.length),S.parseHTML=function(e,t,n){return"string"!=typeof e?[]:("boolean"==typeof t&&(n=t,t=!1),t||(y.createHTMLDocument?((r=(t=E.implementation.createHTMLDocument("")).createElement("base")).href=E.location.href,t.head.appendChild(r)):t=E),o=!n&&[],(i=N.exec(e))?[t.createElement(i[1])]:(i=xe([e],t,o),o&&o.length&&S(o).remove(),S.merge([],i.childNodes)));var r,i,o},S.fn.load=function(e,t,n){var r,i,o,a=this,s=e.indexOf(" ");return-1<s&&(r=ht(e.slice(s)),e=e.slice(0,s)),m(t)?(n=t,t=void 0):t&&"object"==typeof t&&(i="POST"),0<a.length&&S.ajax({url:e,type:i||"GET",dataType:"html",data:t}).done(function(e){o=arguments,a.html(r?S("<div>").append(S.parseHTML(e)).find(r):e)}).always(n&&function(e,t){a.each(function(){n.apply(this,o||[e.responseText,t,e])})}),this},S.expr.pseudos.animated=function(t){return S.grep(S.timers,function(e){return t===e.elem}).length},S.offset={setOffset:function(e,t,n){var r,i,o,a,s,u,l=S.css(e,"position"),c=S(e),f={};"static"===l&&(e.style.position="relative"),s=c.offset(),o=S.css(e,"top"),u=S.css(e,"left"),("absolute"===l||"fixed"===l)&&-1<(o+u).indexOf("auto")?(a=(r=c.position()).top,i=r.left):(a=parseFloat(o)||0,i=parseFloat(u)||0),m(t)&&(t=t.call(e,n,S.extend({},s))),null!=t.top&&(f.top=t.top-s.top+a),null!=t.left&&(f.left=t.left-s.left+i),"using"in t?t.using.call(e,f):c.css(f)}},S.fn.extend({offset:function(t){if(arguments.length)return void 0===t?this:this.each(function(e){S.offset.setOffset(this,t,e)});var e,n,r=this[0];return r?r.getClientRects().length?(e=r.getBoundingClientRect(),n=r.ownerDocument.defaultView,{top:e.top+n.pageYOffset,left:e.left+n.pageXOffset}):{top:0,left:0}:void 0},position:function(){if(this[0]){var e,t,n,r=this[0],i={top:0,left:0};if("fixed"===S.css(r,"position"))t=r.getBoundingClientRect();else{t=this.offset(),n=r.ownerDocument,e=r.offsetParent||n.documentElement;while(e&&(e===n.body||e===n.documentElement)&&"static"===S.css(e,"position"))e=e.parentNode;e&&e!==r&&1===e.nodeType&&((i=S(e).offset()).top+=S.css(e,"borderTopWidth",!0),i.left+=S.css(e,"borderLeftWidth",!0))}return{top:t.top-i.top-S.css(r,"marginTop",!0),left:t.left-i.left-S.css(r,"marginLeft",!0)}}},offsetParent:function(){return this.map(function(){var e=this.offsetParent;while(e&&"static"===S.css(e,"position"))e=e.offsetParent;return e||re})}}),S.each({scrollLeft:"pageXOffset",scrollTop:"pageYOffset"},function(t,i){var o="pageYOffset"===i;S.fn[t]=function(e){return $(this,function(e,t,n){var r;if(x(e)?r=e:9===e.nodeType&&(r=e.defaultView),void 0===n)return r?r[i]:e[t];r?r.scrollTo(o?r.pageXOffset:n,o?n:r.pageYOffset):e[t]=n},t,e,arguments.length)}}),S.each(["top","left"],function(e,n){S.cssHooks[n]=Fe(y.pixelPosition,function(e,t){if(t)return t=We(e,n),Pe.test(t)?S(e).position()[n]+"px":t})}),S.each({Height:"height",Width:"width"},function(a,s){S.each({padding:"inner"+a,content:s,"":"outer"+a},function(r,o){S.fn[o]=function(e,t){var n=arguments.length&&(r||"boolean"!=typeof e),i=r||(!0===e||!0===t?"margin":"border");return $(this,function(e,t,n){var r;return x(e)?0===o.indexOf("outer")?e["inner"+a]:e.document.documentElement["client"+a]:9===e.nodeType?(r=e.documentElement,Math.max(e.body["scroll"+a],r["scroll"+a],e.body["offset"+a],r["offset"+a],r["client"+a])):void 0===n?S.css(e,t,i):S.style(e,t,n,i)},s,n?e:void 0,n)}})}),S.each(["ajaxStart","ajaxStop","ajaxComplete","ajaxError","ajaxSuccess","ajaxSend"],function(e,t){S.fn[t]=function(e){return this.on(t,e)}}),S.fn.extend({bind:function(e,t,n){return this.on(e,null,t,n)},unbind:function(e,t){return this.off(e,null,t)},delegate:function(e,t,n,r){return this.on(t,e,n,r)},undelegate:function(e,t,n){return 1===arguments.length?this.off(e,"**"):this.off(t,e||"**",n)},hover:function(e,t){return this.mouseenter(e).mouseleave(t||e)}}),S.each("blur focus focusin focusout resize scroll click dblclick mousedown mouseup mousemove mouseover mouseout mouseenter mouseleave change select submit keydown keypress keyup contextmenu".split(" "),function(e,n){S.fn[n]=function(e,t){return 0<arguments.length?this.on(n,null,e,t):this.trigger(n)}});var Xt=/^[\s\uFEFF\xA0]+|[\s\uFEFF\xA0]+$/g;S.proxy=function(e,t){var n,r,i;if("string"==typeof t&&(n=e[t],t=e,e=n),m(e))return r=s.call(arguments,2),(i=function(){return e.apply(t||this,r.concat(s.call(arguments)))}).guid=e.guid=e.guid||S.guid++,i},S.holdReady=function(e){e?S.readyWait++:S.ready(!0)},S.isArray=Array.isArray,S.parseJSON=JSON.parse,S.nodeName=A,S.isFunction=m,S.isWindow=x,S.camelCase=X,S.type=w,S.now=Date.now,S.isNumeric=function(e){var t=S.type(e);return("number"===t||"string"===t)&&!isNaN(e-parseFloat(e))},S.trim=function(e){return null==e?"":(e+"").replace(Xt,"")},"function"==typeof define&&define.amd&&define("jquery",[],function(){return S});var Vt=C.jQuery,Gt=C.$;return S.noConflict=function(e){return C.$===S&&(C.$=Gt),e&&C.jQuery===S&&(C.jQuery=Vt),S},"undefined"==typeof e&&(C.jQuery=C.$=S),S});
</script>
<meta name="viewport" content="width=device-width, initial-scale=1" />
<style type="text/css">html{font-family:sans-serif;-webkit-text-size-adjust:100%;-ms-text-size-adjust:100%}body{margin:0}article,aside,details,figcaption,figure,footer,header,hgroup,main,menu,nav,section,summary{display:block}audio,canvas,progress,video{display:inline-block;vertical-align:baseline}audio:not([controls]){display:none;height:0}[hidden],template{display:none}a{background-color:transparent}a:active,a:hover{outline:0}abbr[title]{border-bottom:1px dotted}b,strong{font-weight:700}dfn{font-style:italic}h1{margin:.67em 0;font-size:2em}mark{color:#000;background:#ff0}small{font-size:80%}sub,sup{position:relative;font-size:75%;line-height:0;vertical-align:baseline}sup{top:-.5em}sub{bottom:-.25em}img{border:0}svg:not(:root){overflow:hidden}figure{margin:1em 40px}hr{height:0;-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box}pre{overflow:auto}code,kbd,pre,samp{font-family:monospace,monospace;font-size:1em}button,input,optgroup,select,textarea{margin:0;font:inherit;color:inherit}button{overflow:visible}button,select{text-transform:none}button,html input[type=button],input[type=reset],input[type=submit]{-webkit-appearance:button;cursor:pointer}button[disabled],html input[disabled]{cursor:default}button::-moz-focus-inner,input::-moz-focus-inner{padding:0;border:0}input{line-height:normal}input[type=checkbox],input[type=radio]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box;padding:0}input[type=number]::-webkit-inner-spin-button,input[type=number]::-webkit-outer-spin-button{height:auto}input[type=search]{-webkit-box-sizing:content-box;-moz-box-sizing:content-box;box-sizing:content-box;-webkit-appearance:textfield}input[type=search]::-webkit-search-cancel-button,input[type=search]::-webkit-search-decoration{-webkit-appearance:none}fieldset{padding:.35em .625em .75em;margin:0 2px;border:1px solid silver}legend{padding:0;border:0}textarea{overflow:auto}optgroup{font-weight:700}table{border-spacing:0;border-collapse:collapse}td,th{padding:0}@media print{*,:after,:before{color:#000!important;text-shadow:none!important;background:0 0!important;-webkit-box-shadow:none!important;box-shadow:none!important}a,a:visited{text-decoration:underline}a[href]:after{content:" (" attr(href) ")"}abbr[title]:after{content:" (" attr(title) ")"}a[href^="javascript:"]:after,a[href^="#"]:after{content:""}blockquote,pre{border:1px solid #999;page-break-inside:avoid}thead{display:table-header-group}img,tr{page-break-inside:avoid}img{max-width:100%!important}h2,h3,p{orphans:3;widows:3}h2,h3{page-break-after:avoid}.navbar{display:none}.btn>.caret,.dropup>.btn>.caret{border-top-color:#000!important}.label{border:1px solid #000}.table{border-collapse:collapse!important}.table td,.table th{background-color:#fff!important}.table-bordered td,.table-bordered th{border:1px solid #ddd!important}}@font-face{font-family:'Glyphicons Halflings';src:url(data:application/vnd.ms-fontobject;base64,n04AAEFNAAACAAIABAAAAAAABQAAAAAAAAABAJABAAAEAExQAAAAAAAAAAIAAAAAAAAAAAEAAAAAAAAAJxJ/LAAAAAAAAAAAAAAAAAAAAAAAACgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAAAADgBSAGUAZwB1AGwAYQByAAAAeABWAGUAcgBzAGkAbwBuACAAMQAuADAAMAA5ADsAUABTACAAMAAwADEALgAwADAAOQA7AGgAbwB0AGMAbwBuAHYAIAAxAC4AMAAuADcAMAA7AG0AYQBrAGUAbwB0AGYALgBsAGkAYgAyAC4ANQAuADUAOAAzADIAOQAAADgARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzACAAUgBlAGcAdQBsAGEAcgAAAAAAQlNHUAAAAAAAAAAAAAAAAAAAAAADAKncAE0TAE0ZAEbuFM3pjM/SEdmjKHUbyow8ATBE40IvWA3vTu8LiABDQ+pexwUMcm1SMnNryctQSiI1K5ZnbOlXKmnVV5YvRe6RnNMFNCOs1KNVpn6yZhCJkRtVRNzEufeIq7HgSrcx4S8h/v4vnrrKc6oCNxmSk2uKlZQHBii6iKFoH0746ThvkO1kJHlxjrkxs+LWORaDQBEtiYJIR5IB9Bi1UyL4Rmr0BNigNkMzlKQmnofBHviqVzUxwdMb3NdCn69hy+pRYVKGVS/1tnsqv4LL7wCCPZZAZPT4aCShHjHJVNuXbmMrY5LeQaGnvAkXlVrJgKRAUdFjrWEah9XebPeQMj7KS7DIBAFt8ycgC5PLGUOHSE3ErGZCiViNLL5ZARfywnCoZaKQCu6NuFX42AEeKtKUGnr/Cm2Cy8tpFhBPMW5Fxi4Qm4TkDWh4IWFDClhU2hRWosUWqcKLlgyXB+lSHaWaHiWlBAR8SeSgSPCQxdVQgzUixWKSTrIQEbU94viDctkvX+VSjJuUmV8L4CXShI11esnp0pjWNZIyxKHS4wVQ2ime1P4RnhvGw0aDN1OLAXGERsB7buFpFGGBAre4QEQR0HOIO5oYH305G+KspT/FupEGGafCCwxSe6ZUa+073rXHnNdVXE6eWvibUS27XtRzkH838mYLMBmYysZTM0EM3A1fbpCBYFccN1B/EnCYu/TgCGmr7bMh8GfYL+BfcLvB0gRagC09w9elfldaIy/hNCBLRgBgtCC7jAF63wLSMAfbfAlEggYU0bUA7ACCJmTDpEmJtI78w4/BO7dN7JR7J7ZvbYaUbaILSQsRBiF3HGk5fEg6p9unwLvn98r+vnsV+372uf1xBLq4qU/45fTuqaAP+pssmCCCTF0mhEow8ZXZOS8D7Q85JsxZ+Azok7B7O/f6J8AzYBySZQB/QHYUSA+EeQhEWiS6AIQzgcsDiER4MjgMBAWDV4AgQ3g1eBgIdweCQmCjJEMkJ+PKRWyFHHmg1Wi/6xzUgA0LREoKJChwnQa9B+5RQZRB3IlBlkAnxyQNaANwHMowzlYSMCBgnbpzvqpl0iTJNCQidDI9ZrSYNIRBhHtUa5YHMHxyGEik9hDE0AKj72AbTCaxtHPUaKZdAZSnQTyjGqGLsmBStCejApUhg4uBMU6mATujEl+KdDPbI6Ag4vLr+hjY6lbjBeoLKnZl0UZgRX8gTySOeynZVz1wOq7e1hFGYIq+MhrGxDLak0PrwYzSXtcuyhXEhwOYofiW+EcI/jw8P6IY6ed+etAbuqKp5QIapT77LnAe505lMuqL79a0ut4rWexzFttsOsLDy7zvtQzcq3U1qabe7tB0wHWVXji+zDbo8x8HyIRUbXnwUcklFv51fvTymiV+MXLSmGH9d9+aXpD5X6lao41anWGig7IwIdnoBY2ht/pO9mClLo4NdXHAsefqWUKlXJkbqPOFhMoR4aiA1BXqhRNbB2Xwi+7u/jpAoOpKJ0UX24EsrzMfHXViakCNcKjBxuQX8BO0ZqjJ3xXzf+61t2VXOSgJ8xu65QKgtN6FibPmPYsXbJRHHqbgATcSZxBqGiDiU4NNNsYBsKD0MIP/OfKnlk/Lkaid/O2NbKeuQrwOB2Gq3YHyr6ALgzym5wIBnsdC1ZkoBFZSQXChZvlesPqvK2c5oHHT3Q65jYpNxnQcGF0EHbvYqoFw60WNlXIHQF2HQB7zD6lWjZ9rVqUKBXUT6hrkZOle0RFYII0V5ZYGl1JAP0Ud1fZZMvSomBzJ710j4Me8mjQDwEre5Uv2wQfk1ifDwb5ksuJQQ3xt423lbuQjvoIQByQrNDh1JxGFkOdlJvu/gFtuW0wR4cgd+ZKesSV7QkNE2kw6AV4hoIuC02LGmTomyf8PiO6CZzOTLTPQ+HW06H+tx+bQ8LmDYg1pTFrp2oJXgkZTyeRJZM0C8aE2LpFrNVDuhARsN543/FV6klQ6Tv1OoZGXLv0igKrl/CmJxRmX7JJbJ998VSIPQRyDBICzl4JJlYHbdql30NvYcOuZ7a10uWRrgoieOdgIm4rlq6vNOQBuqESLbXG5lzdJGHw2m0sDYmODXbYGTfSTGRKpssTO95fothJCjUGQgEL4yKoGAF/0SrpUDNn8CBgBcSDQByAeNkCXp4S4Ro2Xh4OeaGRgR66PVOsU8bc6TR5/xTcn4IVMLOkXSWiXxkZQCbvKfmoAvQaKjO3EDKwkwqHChCDEM5loQRPd5ACBki1TjF772oaQhQbQ5C0lcWXPFOzrfsDGUXGrpxasbG4iab6eByaQkQfm0VFlP0ZsDkvvqCL6QXMUwCjdMx1ZOyKhTJ7a1GWAdOUcJ8RSejxNVyGs31OKMyRyBVoZFjqIkmKlLQ5eHMeEL4MkUf23cQ/1SgRCJ1dk4UdBT7OoyuNgLs0oCd8RnrEIb6QdMxT2QjD4zMrJkfgx5aDMcA4orsTtKCqWb/Veyceqa5OGSmB28YwH4rFbkQaLoUN8OQQYnD3w2eXpI4ScQfbCUZiJ4yMOIKLyyTc7BQ4uXUw6Ee6/xM+4Y67ngNBknxIPwuppgIhFcwJyr6EIj+LzNj/mfR2vhhRlx0BILZoAYruF0caWQ7YxO66UmeguDREAFHYuC7HJviRgVO6ruJH59h/C/PkgSle8xNzZJULLWq9JMDTE2fjGE146a1Us6PZDGYle6ldWRqn/pdpgHKNGrGIdkRK+KPETT9nKT6kLyDI8xd9A1FgWmXWRAIHwZ37WyZHOVyCadJEmMVz0MadMjDrPho+EIochkVC2xgGiwwsQ6DMv2P7UXqT4x7CdcYGId2BJQQa85EQKmCmwcRejQ9Bm4oATENFPkxPXILHpMPUyWTI5rjNOsIlmEeMbcOCEqInpXACYQ9DDxmFo9vcmsDblcMtg4tqBerNngkIKaFJmrQAPnq1dEzsMXcwjcHdfdCibcAxxA+q/j9m3LM/O7WJka4tSidVCjsvo2lQ/2ewyoYyXwAYyr2PlRoR5MpgVmSUIrM3PQxXPbgjBOaDQFIyFMJvx3Pc5RSYj12ySVF9fwFPQu2e2KWVoL9q3Ayv3IzpGHUdvdPdrNUdicjsTQ2ISy7QU3DrEytIjvbzJnAkmANXjAFERA0MUoPF3/5KFmW14bBNOhwircYgMqoDpUMcDtCmBE82QM2YtdjVLB4kBuKho/bcwQdeboqfQartuU3CsCf+cXkgYAqp/0Ee3RorAZt0AvvOCSI4JICIlGlsV0bsSid/NIEALAAzb6HAgyWHBps6xAOwkJIGcB82CxRQq4sJf3FzA70A+TRqcqjEMETCoez3mkPcpnoALs0ugJY8kQwrC+JE5ik3w9rzrvDRjAQnqgEVvdGrNwlanR0SOKWzxOJOvLJhcd8Cl4AshACUkv9czdMkJCVQSQhp6kp7StAlpVRpK0t0SW6LHeBJnE2QchB5Ccu8kxRghZXGIgZIiSj7gEKMJDClcnX6hgoqJMwiQDigIXg3ioFLCgDgjPtYHYpsF5EiA4kcnN18MZtOrY866dEQAb0FB34OGKHGZQjwW/WDHA60cYFaI/PjpzquUqdaYGcIq+mLez3WLFFCtNBN2QJcrlcoELgiPku5R5dSlJFaCEqEZle1AQzAKC+1SotMcBNyQUFuRHRF6OlimSBgjZeTBCwLyc6A+P/oFRchXTz5ADknYJHxzrJ5pGuIKRQISU6WyKTBBjD8WozmVYWIsto1AS5rxzKlvJu4E/vwOiKxRtCWsDM+eTHUrmwrCK5BIfMzGkD+0Fk5LzBs0jMYXktNDblB06LMNJ09U8pzSLmo14MS0OMjcdrZ31pyQqxJJpRImlSvfYAK8inkYU52QY2FPEVsjoWewpwhRp5yAuNpkqhdb7ku9Seefl2D0B8SMTFD90xi4CSOwwZy9IKkpMtI3FmFUg3/kFutpQGNc3pCR7gvC4sgwbupDu3DyEN+W6YGLNM21jpB49irxy9BSlHrVDlnihGKHwPrbVFtc+h1rVQKZduxIyojccZIIcOCmhEnC7UkY68WXKQgLi2JCDQkQWJRQuk60hZp0D3rtCTINSeY9Ej2kIKYfGxwOs4j9qMM7fYZiipzgcf7TamnehqdhsiMiCawXnz4xAbyCkLAx5EGbo3Ax1u3dUIKnTxIaxwQTHehPl3V491H0+bC5zgpGz7Io+mjdhKlPJ01EeMpM7UsRJMi1nGjmJg35i6bQBAAxjO/ENJubU2mg3ONySEoWklCwdABETcs7ck3jgiuU9pcKKpbgn+3YlzV1FzIkB6pmEDOSSyDfPPlQskznctFji0kpgZjW5RZe6x9kYT4KJcXg0bNiCyif+pZACCyRMmYsfiKmN9tSO65F0R2OO6ytlEhY5Sj6uRKfFxw0ijJaAx/k3QgnAFSq27/2i4GEBA+UvTJKK/9eISNvG46Em5RZfjTYLdeD8kdXHyrwId/DQZUaMCY4gGbke2C8vfjgV/Y9kkRQOJIn/xM9INZSpiBnqX0Q9GlQPpPKAyO5y+W5NMPSRdBCUlmuxl40ZfMCnf2Cp044uI9WLFtCi4YVxKjuRCOBWIb4XbIsGdbo4qtMQnNOQz4XDSui7W/N6l54qOynCqD3DpWQ+mpD7C40D8BZEWGJX3tlAaZBMj1yjvDYKwCJBa201u6nBKE5UE+7QSEhCwrXfbRZylAaAkplhBWX50dumrElePyNMRYUrC99UmcSSNgImhFhDI4BXjMtiqkgizUGCrZ8iwFxU6fQ8GEHCFdLewwxYWxgScAYMdMLmcZR6b7rZl95eQVDGVoUKcRMM1ixXQtXNkBETZkVVPg8LoSrdetHzkuM7DjZRHP02tCxA1fmkXKF3VzfN1pc1cv/8lbTIkkYpqKM9VOhp65ktYk+Q46myFWBapDfyWUCnsnI00QTBQmuFjMZTcd0V2NQ768Fhpby04k2IzNR1wKabuGJqYWwSly6ocMFGTeeI+ejsWDYgEvr66QgqdcIbFYDNgsm0x9UHY6SCd5+7tpsLpKdvhahIDyYmEJQCqMqtCF6UlrE5GXRmbu+vtm3BFSxI6ND6UxIE7GsGMgWqghXxSnaRJuGFveTcK5ZVSPJyjUxe1dKgI6kNF7EZhIZs8y8FVqwEfbM0Xk2ltORVDKZZM40SD3qQoQe0orJEKwPfZwm3YPqwixhUMOndis6MhbmfvLBKjC8sKKIZKbJk8L11oNkCQzCgvjhyyEiQSuJcgCQSG4Mocfgc0Hkwcjal1UNgP0CBPikYqBIk9tONv4kLtBswH07vUCjEaHiFGlLf8MgXKzSgjp2HolRRccAOh0ILHz9qlGgIFkwAnzHJRjWFhlA7ROwINyB5HFj59PRZHFor6voq7l23EPNRwdWhgawqbivLSjRA4htEYUFkjESu67icTg5S0aW1sOkCiIysfJ9UnIWevOOLGpepcBxy1wEhd2WI3AZg7sr9WBmHWyasxMcvY/iOmsLtHSWNUWEGk9hScMPShasUA1AcHOtRZlqMeQ0OzYS9vQvYUjOLrzP07BUAFikcJNMi7gIxEw4pL1G54TcmmmoAQ5s7TGWErJZ2Io4yQ0ljRYhL8H5e62oDtLF8aDpnIvZ5R3GWJyAugdiiJW9hQAVTsnCBHhwu7rkBlBX6r3b7ejEY0k5GGeyKv66v+6dg7mcJTrWHbtMywbedYqCQ0FPwoytmSWsL8WTtChZCKKzEF7vP6De4x2BJkkniMgSdWhbeBSLtJZR9CTHetK1xb34AYIJ37OegYIoPVbXgJ/qDQK+bfCtxQRVKQu77WzOoM6SGL7MaZwCGJVk46aImai9fmam+WpHG+0BtQPWUgZ7RIAlPq6lkECUhZQ2gqWkMYKcYMYaIc4gYCDFHYa2d1nzp3+J1eCBay8IYZ0wQRKGAqvCuZ/UgbQPyllosq+XtfKIZOzmeJqRazpmmoP/76YfkjzV2NlXTDSBYB04SVlNQsFTbGPk1t/I4Jktu0XSgifO2ozFOiwd/0SssJDn0dn4xqk4GDTTKX73/wQyBLdqgJ+Wx6AQaba3BA9CKEzjtQYIfAsiYamapq80LAamYjinlKXUkxdpIDk0puXUEYzSalfRibAeDAKpNiqQ0FTwoxuGYzRnisyTotdVTclis1LHRQCy/qqL8oUaQzWRxilq5Mi0IJGtMY02cGLD69vGjkj3p6pGePKI8bkBv5evq8SjjyU04vJR2cQXQwSJyoinDsUJHCQ50jrFTT7yRdbdYQMB3MYCb6uBzJ9ewhXYPAIZSXfeEQBZZ3GPN3Nbhh/wkvAJLXnQMdi5NYYZ5GHE400GS5rXkOZSQsdZgIbzRnF9ueLnsfQ47wHAsirITnTlkCcuWWIUhJSbpM3wWhXNHvt2xUsKKMpdBSbJnBMcihkoDqAd1Zml/R4yrzow1Q2A5G+kzo/RhRxQS2lCSDRV8LlYLBOOoo1bF4jwJAwKMK1tWLHlu9i0j4Ig8qVm6wE1DxXwAwQwsaBWUg2pOOol2dHxyt6npwJEdLDDVYyRc2D0HbcbLUJQj8gPevQBUBOUHXPrsAPBERICpnYESeu2OHotpXQxRGlCCtLdIsu23MhZVEoJg8Qumj/UMMc34IBqTKLDTp76WzL/dMjCxK7MjhiGjeYAC/kj/jY/Rde7hpSM1xChrog6yZ7OWTuD56xBJnGFE+pT2ElSyCnJcwVzCjkqeNLfMEJqKW0G7OFIp0G+9mh50I9o8k1tpCY0xYqFNIALgIfc2me4n1bmJnRZ89oepgLPT0NTMLNZsvSCZAc3TXaNB07vail36/dBySis4m9/DR8izaLJW6bWCkVgm5T+ius3ZXq4xI+GnbveLbdRwF2mNtsrE0JjYc1AXknCOrLSu7Te/r4dPYMCl5qtiHNTn+TPbh1jCBHH+dMJNhwNgs3nT+OhQoQ0vYif56BMG6WowAcHR3DjQolxLzyVekHj00PBAaW7IIAF1EF+uRIWyXjQMAs2chdpaKPNaB+kSezYt0+CA04sOg5vx8Fr7Ofa9sUv87h7SLAUFSzbetCCZ9pmyLt6l6/TzoA1/ZBG9bIUVHLAbi/kdBFgYGyGwRQGBpkqCEg2ah9UD6EedEcEL3j4y0BQQCiExEnocA3SZboh+epgd3YsOkHskZwPuQ5OoyA0fTA5AXrHcUOQF+zkJHIA7PwCDk1gGVmGUZSSoPhNf+Tklauz98QofOlCIQ/tCD4dosHYPqtPCXB3agggQQIqQJsSkB+qn0rkQ1toJjON/OtCIB9RYv3PqRA4C4U68ZMlZn6BdgEvi2ziU+TQ6NIw3ej+AtDwMGEZk7e2IjxUWKdAxyaw9OCwSmeADTPPleyk6UhGDNXQb++W6Uk4q6F7/rg6WVTo82IoCxSIsFDrav4EPHphD3u4hR53WKVvYZUwNCCeM4PMBWzK+EfIthZOkuAwPo5C5jgoZgn6dUdvx5rIDmd58cXXdKNfw3l+wM2UjgrDJeQHhbD7HW2QDoZMCujgIUkk5Fg8VCsdyjOtnGRx8wgKRPZN5dR0zPUyfGZFVihbFRniXZFOZGKPnEQzU3AnD1KfR6weHW2XS6KbPJxUkOTZsAB9vTVp3Le1F8q5l+DMcLiIq78jxAImD2pGFw0VHfRatScGlK6SMu8leTmhUSMy8Uhdd6xBiH3Gdman4tjQGLboJfqz6fL2WKHTmrfsKZRYX6BTDjDldKMosaSTLdQS7oDisJNqAUhw1PfTlnacCO8vl8706Km1FROgLDmudzxg+EWTiArtHgLsRrAXYWdB0NmToNCJdKm0KWycZQqb+Mw76Qy29iQ5up/X7oyw8QZ75kP5F6iJAJz6KCmqxz8fEa/xnsMYcIO/vEkGRuMckhr4rIeLrKaXnmIzlNLxbFspOphkcnJdnz/Chp/Vlpj2P7jJQmQRwGnltkTV5dbF9fE3/fxoSqTROgq9wFUlbuYzYcasE0ouzBo+dDCDzxKAfhbAZYxQiHrLzV2iVexnDX/QnT1fsT/xuhu1ui5qIytgbGmRoQkeQooO8eJNNZsf0iALur8QxZFH0nCMnjerYQqG1pIfjyVZWxhVRznmmfLG00BcBWJE6hzQWRyFknuJnXuk8A5FRDCulwrWASSNoBtR+CtGdkPwYN2o7DOw/VGlCZPusRBFXODQdUM5zeHDIVuAJBLqbO/f9Qua+pDqEPk230Sob9lEZ8BHiCorjVghuI0lI4JDgHGRDD/prQ84B1pVGkIpVUAHCG+iz3Bn3qm2AVrYcYWhock4jso5+J7HfHVj4WMIQdGctq3psBCVVzupQOEioBGA2Bk+UILT7+VoX5mdxxA5fS42gISQVi/HTzrgMxu0fY6hE1ocUwwbsbWcezrY2n6S8/6cxXkOH4prpmPuFoikTzY7T85C4T2XYlbxLglSv2uLCgFv8Quk/wdesUdWPeHYIH0R729JIisN9Apdd4eB10aqwXrPt+Su9mA8k8n1sjMwnfsfF2j3jMUzXepSHmZ/BfqXvzgUNQQWOXO8YEuFBh4QTYCkOAPxywpYu1VxiDyJmKVcmJPGWk/gc3Pov02StyYDahwmzw3E1gYC9wkupyWfDqDSUMpCTH5e5N8B//lHiMuIkTNw4USHrJU67bjXGqNav6PBuQSoqTxc8avHoGmvqNtXzIaoyMIQIiiUHIM64cXieouplhNYln7qgc4wBVAYR104kO+CvKqsg4yIUlFNThVUAKZxZt1XA34h3TCUUiXVkZ0w8Hh2R0Z5L0b4LZvPd/p1gi/07h8qfwHrByuSxglc9cI4QIg2oqvC/qm0i7tjPLTgDhoWTAKDO2ONW5oe+/eKB9vZB8K6C25yCZ9RFVMnb6NRdRjyVK57CHHSkJBfnM2/j4ODUwRkqrtBBCrDsDpt8jhZdXoy/1BCqw3sSGhgGGy0a5Jw6BP/TExoCmNFYjZl248A0osgPyGEmRA+fAsqPVaNAfytu0vuQJ7rk3J4kTDTR2AlCHJ5cls26opZM4w3jMULh2YXKpcqGBtuleAlOZnaZGbD6DHzMd6i2oFeJ8z9XYmalg1Szd/ocZDc1C7Y6vcALJz2lYnTXiWEr2wawtoR4g3jvWUU2Ngjd1cewtFzEvM1NiHZPeLlIXFbBPawxNgMwwAlyNSuGF3zizVeOoC9bag1qRAQKQE/EZBWC2J8mnXAN2aTBboZ7HewnObE8CwROudZHmUM5oZ/Ugd/JZQK8lvAm43uDRAbyW8gZ+ZGq0EVerVGUKUSm/Idn8AQHdR4m7bue88WBwft9mSCeMOt1ncBwziOmJYI2ZR7ewNMPiCugmSsE4EyQ+QATJG6qORMGd4snEzc6B4shPIo4G1T7PgSm8PY5eUkPdF8JZ0VBtadbHXoJgnEhZQaODPj2gpODKJY5Yp4DOsLBFxWbvXN755KWylJm+oOd4zEL9Hpubuy2gyyfxh8oEfFutnYWdfB8PdESLWYvSqbElP9qo3u6KTmkhoacDauMNNjj0oy40DFV7Ql0aZj77xfGl7TJNHnIwgqOkenruYYNo6h724+zUQ7+vkCpZB+pGA562hYQiDxHVWOq0oDQl/QsoiY+cuI7iWq/ZIBtHcXJ7kks+h2fCNUPA82BzjnqktNts+RLdk1VSu+tqEn7QZCCsvEqk6FkfiOYkrsw092J8jsfIuEKypNjLxrKA9kiA19mxBD2suxQKCzwXGws7kEJvlhUiV9tArLIdZW0IORcxEzdzKmjtFhsjKy/44XYXdI5noQoRcvjZ1RMPACRqYg2V1+OwOepcOknRLLFdYgTkT5UApt/JhLM3jeFYprZV+Zow2g8fP+U68hkKFWJj2yBbKqsrp25xkZX1DAjUw52IMYWaOhab8Kp05VrdNftqwRrymWF4OQSjbdfzmRZirK8FMJELEgER2PHjEAN9pGfLhCUiTJFbd5LBkOBMaxLr/A1SY9dXFz4RjzoU9ExfJCmx/I9FKEGT3n2cmzl2X42L3Jh+AbQq6sA+Ss1kitoa4TAYgKHaoybHUDJ51oETdeI/9ThSmjWGkyLi5QAGWhL0BG1UsTyRGRJOldKBrYJeB8ljLJHfATWTEQBXBDnQexOHTB+Un44zExFE4vLytcu5NwpWrUxO/0ZICUGM7hGABXym0V6ZvDST0E370St9MIWQOTWngeoQHUTdCJUP04spMBMS8LSker9cReVQkULFDIZDFPrhTzBl6sed9wcZQTbL+BDqMyaN3RJPh/anbx+Iv+qgQdAa3M9Z5JmvYlh4qop+Ho1F1W5gbOE9YKLgAnWytXElU4G8GtW47lhgFE6gaSs+gs37sFvi0PPVvA5dnCBgILTwoKd/+DoL9F6inlM7H4rOTzD79KJgKlZO/Zgt22UsKhrAaXU5ZcLrAglTVKJEmNJvORGN1vqrcfSMizfpsgbIe9zno+gBoKVXgIL/VI8dB1O5o/R3Suez/gD7M781ShjKpIIORM/nxG+jjhhgPwsn2IoXsPGPqYHXA63zJ07M2GPEykQwJBYLK808qYxuIew4frk52nhCsnCYmXiR6CuapvE1IwRB4/QftDbEn+AucIr1oxrLabRj9q4ae0+fXkHnteAJwXRbVkR0mctVSwEbqhJiMSZUp9DNbEDMmjX22m3ABpkrPQQTP3S1sib5pD2VRKRd+eNAjLYyT0hGrdjWJZy24OYXRoWQAIhGBZRxuBFMjjZQhpgrWo8SiFYbojcHO8V5DyscJpLTHyx9Fimassyo5U6WNtquUMYgccaHY5amgR3PQzq3ToNM5ABnoB9kuxsebqmYZm0R9qxJbFXCQ1UPyFIbxoUraTJFDpCk0Wk9GaYJKz/6oHwEP0Q14lMtlddQsOAU9zlYdMVHiT7RQP3XCmWYDcHCGbVRHGnHuwzScA0BaSBOGkz3lM8CArjrBsyEoV6Ys4qgDK3ykQQPZ3hCRGNXQTNNXbEb6tDiTDLKOyMzRhCFT+mAUmiYbV3YQVqFVp9dorv+TsLeCykS2b5yyu8AV7IS9cxcL8z4Kfwp+xJyYLv1OsxQCZwTB4a8BZ/5EdxTBJthApqyfd9u3ifr/WILTqq5VqgwMT9SOxbSGWLQJUUWCVi4k9tho9nEsbUh7U6NUsLmkYFXOhZ0kmamaJLRNJzSj/qn4Mso6zb6iLLBXoaZ6AqeWCjHQm2lztnejYYM2eubnpBdKVLORZhudH3JF1waBJKA9+W8EhMj3Kzf0L4vi4k6RoHh3Z5YgmSZmk6ns4fjScjAoL8GoOECgqgYEBYUGFVO4FUv4/YtowhEmTs0vrvlD/CrisnoBNDAcUi/teY7OctFlmARQzjOItrrlKuPO6E2Ox93L4O/4DcgV/dZ7qR3VBwVQxP1GCieA4RIpweYJ5FoYrHxqRBdJjnqbsikA2Ictbb8vE1GYIo9dacK0REgDX4smy6GAkxlH1yCGGsk+tgiDhNKuKu3yNrMdxafmKTF632F8Vx4BNK57GvlFisrkjN9WDAtjsWA0ENT2e2nETUb/n7qwhvGnrHuf5bX6Vh/n3xffU3PeHdR+FA92i6ufT3AlyAREoNDh6chiMWTvjKjHDeRhOa9YkOQRq1vQXEMppAQVwHCuIcV2g5rBn6GmZZpTR7vnSD6ZmhdSl176gqKTXu5E+YbfL0adwNtHP7dT7t7b46DVZIkzaRJOM+S6KcrzYVg+T3wSRFRQashjfU18NutrKa/7PXbtuJvpIjbgPeqd+pjmRw6YKpnANFSQcpzTZgpSNJ6J7uiagAbir/8tNXJ/OsOnRh6iuIexxrmkIneAgz8QoLmiaJ8sLQrELVK2yn3wOHp57BAZJhDZjTBzyoRAuuZ4eoxHruY1pSb7qq79cIeAdOwin4GdgMeIMHeG+FZWYaiUQQyC5b50zKjYw97dFjAeY2I4Bnl105Iku1y0lMA1ZHolLx19uZnRdILcXKlZGQx/GdEqSsMRU1BIrFqRcV1qQOOHyxOLXEGcbRtAEsuAC2V4K3p5mFJ22IDWaEkk9ttf5Izb2LkD1MnrSwztXmmD/Qi/EmVEFBfiKGmftsPwVaIoZanlKndMZsIBOskFYpDOq3QUs9aSbAAtL5Dbokus2G4/asthNMK5UQKCOhU97oaOYNGsTah+jfCKsZnTRn5TbhFX8ghg8CBYt/BjeYYYUrtUZ5jVij/op7V5SsbA4mYTOwZ46hqdpbB6Qvq3AS2HHNkC15pTDIcDNGsMPXaBidXYPHc6PJAkRh29Vx8KcgX46LoUQBhRM+3SW6Opll/wgxxsPgKJKzr5QCmwkUxNbeg6Wj34SUnEzOemSuvS2OetRCO8Tyy+QbSKVJcqkia+GvDefFwMOmgnD7h81TUtMn+mRpyJJ349HhAnoWFTejhpYTL9G8N2nVg1qkXBeoS9Nw2fB27t7trm7d/QK7Cr4uoCeOQ7/8JfKT77KiDzLImESHw/0wf73QeHu74hxv7uihi4fTX+XEwAyQG3264dwv17aJ5N335Vt9sdrAXhPOAv8JFvzqyYXwfx8WYJaef1gMl98JRFyl5Mv5Uo/oVH5ww5OzLFsiTPDns7fS6EURSSWd/92BxMYQ8sBaH+j+wthQPdVgDGpTfi+JQIWMD8xKqULliRH01rTeyF8x8q/GBEEEBrAJMPf25UQwi0b8tmqRXY7kIvNkzrkvRWLnxoGYEJsz8u4oOyMp8cHyaybb1HdMCaLApUE+/7xLIZGP6H9xuSEXp1zLIdjk5nBaMuV/yTDRRP8Y2ww5RO6d2D94o+6ucWIqUAvgHIHXhZsmDhjVLczmZ3ca0Cb3PpKwt2UtHVQ0BgFJsqqTsnzZPlKahRUkEu4qmkJt+kqdae76ViWe3STan69yaF9+fESD2lcQshLHWVu4ovItXxO69bqC5p1nZLvI8NdQB9s9UNaJGlQ5mG947ipdDA0eTIw/A1zEdjWquIsQXXGIVEH0thC5M+W9pZe7IhAVnPJkYCCXN5a32HjN6nsvokEqRS44tGIs7s2LVTvcrHAF+RVmI8L4HUYk4x+67AxSMJKqCg8zrGOgvK9kNMdDrNiUtSWuHFpC8/p5qIQrEo/H+1l/0cAwQ2nKmpWxKcMIuHY44Y6DlkpO48tRuUGBWT0FyHwSKO72Ud+tJUfdaZ4CWNijzZtlRa8+CkmO/EwHYfPZFU/hzjFWH7vnzHRMo+aF9u8qHSAiEkA2HjoNQPEwHsDKOt6hOoK3Ce/+/9boMWDa44I6FrQhdgS7OnNaSzwxWKZMcyHi6LN4WC6sSj0qm2PSOGBTvDs/GWJS6SwEN/ULwpb4LQo9fYjUfSXRwZkynUazlSpvX9e+G2zor8l+YaMxSEomDdLHGcD6YVQPegTaA74H8+V4WvJkFUrjMLGLlvSZQWvi8/QA7yzQ8GPno//5SJHRP/OqKObPCo81s/+6WgLqykYpGAgQZhVDEBPXWgU/WzFZjKUhSFInufPRiMAUULC6T11yL45ZrRoB4DzOyJShKXaAJIBS9wzLYIoCEcJKQW8GVCx4fihqJ6mshBUXSw3wWVj3grrHQlGNGhIDNNzsxQ3M+GWn6ASobIWC+LbYOC6UpahVO13Zs2zOzZC8z7FmA05JhUGyBsF4tsG0drcggIFzgg/kpf3+CnAXKiMgIE8Jk/Mhpkc8DUJEUzDSnWlQFme3d0sHZDrg7LavtsEX3cHwjCYA17pMTfx8Ajw9hHscN67hyo+RJQ4458RmPywXykkVcW688oVUrQhahpPRvTWPnuI0B+SkQu7dCyvLRyFYlC1LG1gRCIvn3rwQeINzZQC2KXq31FaR9UmVV2QeGVqBHjmE+VMd3b1fhCynD0pQNhCG6/WCDbKPyE7NRQzL3BzQAJ0g09aUzcQA6mUp9iZFK6Sbp/YbHjo++7/Wj8S4YNa+ZdqAw1hDrKWFXv9+zaXpf8ZTDSbiqsxnwN/CzK5tPkOr4tRh2kY3Bn9JtalbIOI4b3F7F1vPQMfoDcdxMS8CW9m/NCW/HILTUVWQIPiD0j1A6bo8vsv6P1hCESl2abrSJWDrq5sSzUpwoxaCU9FtJyYH4QFMxDBpkkBR6kn0LMPO+5EJ7Z6bCiRoPedRZ/P0SSdii7ZnPAtVwwHUidcdyspwncz5uq6vvm4IEDbJVLUFCn/LvIHfooUBTkFO130FC7CmmcrKdgDJcid9mvVzsDSibOoXtIf9k6ABle3PmIxejodc4aob0QKS432srrCMndbfD454q52V01G4q913mC5HOsTzWF4h2No1av1VbcUgWAqyoZl+11PoFYnNv2HwAODeNRkHj+8SF1fcvVBu6MrehHAZK1Gm69ICcTKizykHgGFx7QdowTVAsYEF2tVc0Z6wLryz2FI1sc5By2znJAAmINndoJiB4sfPdPrTC8RnkW7KRCwxC6YvXg5ahMlQuMpoCSXjOlBy0Kij+bsCYPbGp8BdCBiLmLSAkEQRaieWo1SYvZIKJGj9Ur/eWHjiB7SOVdqMAVmpBvfRiebsFjger7DC+8kRFGtNrTrnnGD2GAJb8rQCWkUPYHhwXsjNBSkE6lGWUj5QNhK0DMNM2l+kXRZ0KLZaGsFSIdQz/HXDxf3/TE30+DgBKWGWdxElyLccJfEpjsnszECNoDGZpdwdRgCixeg9L4EPhH+RptvRMVRaahu4cySjS3P5wxAUCPkmn+rhyASpmiTaiDeggaIxYBmtLZDDhiWIJaBgzfCsAGUF1Q1SFZYyXDt9skCaxJsxK2Ms65dmdp5WAZyxik/zbrTQk5KmgxCg/f45L0jywebOWUYFJQAJia7XzCV0x89rpp/f3AVWhSPyTanqmik2SkD8A3Ml4NhIGLAjBXtPShwKYfi2eXtrDuKLk4QlSyTw1ftXgwqA2jUuopDl+5tfUWZNwBpEPXghzbBggYCw/dhy0ntds2yeHCDKkF/YxQjNIL/F/37jLPHCKBO9ibwYCmuxImIo0ijV2Wbg3kSN2psoe8IsABv3RNFaF9uMyCtCYtqcD+qNOhwMlfARQUdJ2tUX+MNJqOwIciWalZsmEjt07tfa8ma4cji9sqz+Q9hWfmMoKEbIHPOQORbhQRHIsrTYlnVTNvcq1imqmmPDdVDkJgRcTgB8Sb6epCQVmFZe+jGDiNJQLWnfx+drTKYjm0G8yH0ZAGMWzEJhUEQ4Maimgf/bkvo8PLVBsZl152y5S8+HRDfZIMCbYZ1WDp4yrdchOJw8k6R+/2pHmydK4NIK2PHdFPHtoLmHxRDwLFb7eB+M4zNZcB9NrAgjVyzLM7xyYSY13ykWfIEEd2n5/iYp3ZdrCf7fL+en+sIJu2W7E30MrAgZBD1rAAbZHPgeAMtKCg3NpSpYQUDWJu9bT3V7tOKv+NRiJc8JAKqqgCA/PNRBR7ChpiEulyQApMK1AyqcWnpSOmYh6yLiWkGJ2mklCSPIqN7UypWj3dGi5MvsHQ87MrB4VFgypJaFriaHivwcHIpmyi5LhNqtem4q0n8awM19Qk8BOS0EsqGscuuydYsIGsbT5GHnERUiMpKJl4ON7qjB4fEqlGN/hCky89232UQCiaeWpDYCJINXjT6xl4Gc7DxRCtgV0i1ma4RgWLsNtnEBRQFqZggCLiuyEydmFd7WlogpkCw5G1x4ft2psm3KAREwVwr1Gzl6RT7FDAqpVal34ewVm3VH4qn5mjGj+bYL1NgfLNeXDwtmYSpwzbruDKpTjOdgiIHDVQSb5/zBgSMbHLkxWWgghIh9QTFSDILixVwg0Eg1puooBiHAt7DzwJ7m8i8/i+jHvKf0QDnnHVkVTIqMvIQImOrzCJwhSR7qYB5gSwL6aWL9hERHCZc4G2+JrpgHNB8eCCmcIWIQ6rSdyPCyftXkDlErUkHafHRlkOIjxGbAktz75bnh50dU7YHk+Mz7wwstg6RFZb+TZuSOx1qqP5C66c0mptQmzIC2dlpte7vZrauAMm/7RfBYkGtXWGiaWTtwvAQiq2oD4YixPLXE2khB2FRaNRDTk+9sZ6K74Ia9VntCpN4BhJGJMT4Z5c5FhSepRCRWmBXqx+whVZC4me4saDs2iNqXMuCl6iAZflH8fscC1sTsy4PHeC+XYuqMBMUun5YezKbRKmEPwuK+CLzijPEQgfhahQswBBLfg/GBgBiI4QwAqzJkkyYAWtjzSg2ILgMAgqxYfwERRo3zruBL9WOryUArSD8sQOcD7fvIODJxKFS615KFPsb68USBEPPj1orNzFY2xoTtNBVTyzBhPbhFH0PI5AtlJBl2aSgNPYzxYLw7XTDBDinmVoENwiGzmngrMo8OmnRP0Z0i0Zrln9DDFcnmOoBZjABaQIbPOJYZGqX+RCMlDDbElcjaROLDoualmUIQ88Kekk3iM4OQrADcxi3rJguS4MOIBIgKgXrjd1WkbCdqxJk/4efRIFsavZA7KvvJQqp3Iid5Z0NFc5aiMRzGN3vrpBzaMy4JYde3wr96PjN90AYOIbyp6T4zj8LoE66OGcX1Ef4Z3KoWLAUF4BTg7ug/AbkG5UNQXAMkQezujSHeir2uTThgd3gpyzDrbnEdDRH2W7U6PeRvBX1ZFMP5RM+Zu6UUZZD8hDPHldVWntTCNk7To8IeOW9yn2wx0gmurwqC60AOde4r3ETi5pVMSDK8wxhoGAoEX9NLWHIR33VbrbMveii2jAJlrxwytTHbWNu8Y4N8vCCyZjAX/pcsfwXbLze2+D+u33OGBoJyAAL3jn3RuEcdp5If8O+a4NKWvxOTyDltG0IWoHhwVGe7dKkCWFT++tm+haBCikRUUMrMhYKZJKYoVuv/bsJzO8DwfVIInQq3g3BYypiz8baogH3r3GwqCwFtZnz4xMjAVOYnyOi5HWbFA8n0qz1OjSpHWFzpQOpvkNETZBGpxN8ybhtqV/DMUxd9uFZmBfKXMCn/SqkWJyKPnT6lq+4zBZni6fYRByJn6OK+OgPBGRAJluwGSk4wxjOOzyce/PKODwRlsgrVkdcsEiYrqYdXo0Er2GXi2GQZd0tNJT6c9pK1EEJG1zgDJBoTVuCXGAU8BKTvCO/cEQ1Wjk3Zzuy90JX4m3O5IlxVFhYkSUwuQB2up7jhvkm+bddRQu5F9s0XftGEJ9JSuSk+ZachCbdU45fEqbugzTIUokwoAKvpUQF/CvLbWW5BNQFqFkJg2f30E/48StNe5QwBg8zz3YAJ82FZoXBxXSv4QDooDo79NixyglO9AembuBcx5Re3CwOKTHebOPhkmFC7wNaWtoBhFuV4AkEuJ0J+1pT0tLkvFVZaNzfhs/Kd3+A9YsImlO4XK4vpCo/elHQi/9gkFg07xxnuXLt21unCIpDV+bbRxb7FC6nWYTsMFF8+1LUg4JFjVt3vqbuhHmDKbgQ4e+RGizRiO8ky05LQGMdL2IKLSNar0kNG7lHJMaXr5mLdG3nykgj6vB/KVijd1ARWkFEf3yiUw1v/WaQivVUpIDdSNrrKbjO5NPnxz6qTTGgYg03HgPhDrCFyYZTi3XQw3HXCva39mpLNFtz8AiEhxAJHpWX13gCTAwgm9YTvMeiqetdNQv6IU0hH0G+ZManTqDLPjyrOse7WiiwOJCG+J0pZYULhN8NILulmYYvmVcV2MjAfA39sGKqGdjpiPo86fecg65UPyXDIAOyOkCx5NQsLeD4gGVjTVDwOHWkbbBW0GeNjDkcSOn2Nq4cEssP54t9D749A7M1AIOBl0Fi0sSO5v3P7LCBrM6ZwFY6kp2FX6AcbGUdybnfChHPyu6WlRZ2Fwv9YM0RMI7kISRgR8HpQSJJOyTfXj/6gQKuihPtiUtlCQVPohUgzfezTg8o1b3n9pNZeco1QucaoXe40Fa5JYhqdTspFmxGtW9h5ezLFZs3j/N46f+S2rjYNC2JySXrnSAFhvAkz9a5L3pza8eYKHNoPrvBRESpxYPJdKVUxBE39nJ1chrAFpy4MMkf0qKgYALctGg1DQI1kIymyeS2AJNT4X240d3IFQb/0jQbaHJ2YRK8A+ls6WMhWmpCXYG5jqapGs5/eOJErxi2/2KWVHiPellTgh/fNl/2KYPKb7DUcAg+mCOPQFCiU9Mq/WLcU1xxC8aLePFZZlE+PCLzf7ey46INWRw2kcXySR9FDgByXzfxiNKwDFbUSMMhALPFSedyjEVM5442GZ4hTrsAEvZxIieSHGSgkwFh/nFNdrrFD4tBH4Il7fW6ur4J8Xaz7RW9jgtuPEXQsYk7gcMs2neu3zJwTyUerHKSh1iTBkj2YJh1SSOZL5pLuQbFFAvyO4k1Hxg2h99MTC6cTUkbONQIAnEfGsGkNFWRbuRyyaEZInM5pij73EA9rPIUfU4XoqQpHT9THZkW+oKFLvpyvTBMM69tN1Ydwv1LIEhHsC+ueVG+w+kyCPsvV3erRikcscHjZCkccx6VrBkBRusTDDd8847GA7p2Ucy0y0HdSRN6YIBciYa4vuXcAZbQAuSEmzw+H/AuOx+aH+tBL88H57D0MsqyiZxhOEQkF/8DR1d2hSPMj/sNOa5rxcUnBgH8ictv2J+cb4BA4v3MCShdZ2vtK30vAwkobnEWh7rsSyhmos3WC93Gn9C4nnAd/PjMMtQfyDNZsOPd6XcAsnBE/mRHtHEyJMzJfZFLE9OvQa0i9kUmToJ0ZxknTgdl/XPV8xoh0K7wNHHsnBdvFH3sv52lU7UFteseLG/VanIvcwycVA7+BE1Ulyb20BvwUWZcMTKhaCcmY3ROpvonVMV4N7yBXTL7IDtHzQ4CCcqF66LjF3xUqgErKzolLyCG6Kb7irP/MVTCCwGRxfrPGpMMGvPLgJ881PHMNMIO09T5ig7AzZTX/5PLlwnJLDAPfuHynSGhV4tPqR3gJ4kg4c06c/F1AcjGytKm2Yb5jwMotF7vro4YDLWlnMIpmPg36NgAZsGA0W1spfLSue4xxat0Gdwd0lqDBOgIaMANykwwDKejt5YaNtJYIkrSgu0KjIg0pznY0SCd1qlC6R19g97UrWDoYJGlrvCE05J/5wkjpkre727p5PTRX5FGrSBIfJqhJE/IS876PaHFkx9pGTH3oaY3jJRvLX9Iy3Edoar7cFvJqyUlOhAEiOSAyYgVEGkzHdug+oRHIEOXAExMiTSKU9A6nmRC8mp8iYhwWdP2U/5EkFAdPrZw03YA3gSyNUtMZeh7dDCu8pF5x0VORCTgKp07ehy7NZqKTpIC4UJJ89lnboyAfy5OyXzXtuDRbtAFjZRSyGFTpFrXwkpjSLIQIG3N0Vj4BtzK3wdlkBJrO18MNsgseR4BysJilI0wI6ZahLhBFA0XBmV8d4LUzEcNVb0xbLjLTETYN8OEVqNxkt10W614dd1FlFFVTIgB7/BQQp1sWlNolpIu4ekxUTBV7NmxOFKEBmmN+nA7pvF78/RII5ZHA09OAiE/66MF6HQ+qVEJCHxwymukkNvzqHEh52dULPbVasfQMgTDyBZzx4007YiKdBuUauQOt27Gmy8ISclPmEUCIcuLbkb1mzQSqIa3iE0PJh7UMYQbkpe+hXjTJKdldyt2mVPwywoODGJtBV1lJTgMsuSQBlDMwhEKIfrvsxGQjHPCEfNfMAY2oxvyKcKPUbQySkKG6tj9AQyEW3Q5rpaDJ5Sns9ScLKeizPRbvWYAw4bXkrZdmB7CQopCH8NAmqbuciZChHN8lVGaDbCnmddnqO1PQ4ieMYfcSiBE5zzMz+JV/4eyzrzTEShvqSGzgWimkNxLvUj86iAwcZuIkqdB0VaIB7wncLRmzHkiUQpPBIXbDDLHBlq7vp9xwuC9AiNkIptAYlG7Biyuk8ILdynuUM1cHWJgeB+K3wBP/ineogxkvBNNQ4AkW0hvpBOQGFfeptF2YTR75MexYDUy7Q/9uocGsx41O4IZhViw/2FvAEuGO5g2kyXBUijAggWM08bRhXg5ijgMwDJy40QeY/cQpUDZiIzmvskQpO5G1zyGZA8WByjIQU4jRoFJt56behxtHUUE/om7Rj2psYXGmq3llVOCgGYKNMo4pzwntITtapDqjvQtqpjaJwjHmDzSVGLxMt12gEXAdLi/caHSM3FPRGRf7dB7YC+cD2ho6oL2zGDCkjlf/DFoQVl8GS/56wur3rdV6ggtzZW60MRB3g+U1W8o8cvqIpMkctiGVMzXUFI7FacFLrgtdz4mTEr4aRAaQ2AFQaNeG7GX0yOJgMRYFziXdJf24kg/gBQIZMG/YcPEllRTVNoDYR6oSJ8wQNLuihfw81UpiKPm714bZX1KYjcXJdfclCUOOpvTxr9AAJevTY4HK/G7F3mUc3GOAKqh60zM0v34v+ELyhJZqhkaMA8UMMOU90f8RKEJFj7EqepBVwsRiLbwMo1J2zrE2UYJnsgIAscDmjPjnzI8a719Wxp757wqmSJBjXowhc46QN4RwKIxqEE6E5218OeK7RfcpGjWG1jD7qND+/GTk6M56Ig4yMsU6LUW1EWE+fIYycVV1thldSlbP6ltdC01y3KUfkobkt2q01YYMmxpKRvh1Z48uNKzP/IoRIZ/F6buOymSnW8gICitpJjKWBscSb9JJKaWkvEkqinAJ2kowKoqkqZftRqfRQlLtKoqvTRDi2vg/RrPD/d3a09J8JhGZlEkOM6znTsoMCsuvTmywxTCDhw5dd0GJOHCMPbsj3QLkTE3MInsZsimDQ3HkvthT7U9VA4s6G07sID0FW4SHJmRGwCl+Mu4xf0ezqeXD2PtPDnwMPo86sbwDV+9PWcgFcARUVYm3hrFQrHcgMElFGbSM2A1zUYA3baWfheJp2AINmTJLuoyYD/OwA4a6V0ChBN97E8YtDBerUECv0u0TlxR5yhJCXvJxgyM73Bb6pyq0jTFJDZ4p1Am1SA6sh8nADd1hAcGBMfq4d/UfwnmBqe0Jun1n1LzrgKuZMAnxA3NtCN7Klf4BH+14B7ibBmgt0TGUafVzI4uKlpF7v8NmgNjg90D6QE3tbx8AjSAC+OA1YJvclyPKgT27QpIEgVYpbPYGBsnyCNrGz9XUsCHkW1QAHgL2STZk12QGqmvAB0NFteERkvBIH7INDsNW9KKaAYyDMdBEMzJiWaJHZALqDxQDWRntumSDPcplyFiI1oDpT8wbwe01AHhW6+vAUUBoGhY3CT2tgwehdPqU/4Q7ZLYvhRl/ogOvR9O2+wkkPKW5vCTjD2fHRYXONCoIl4Jh1bZY0ZE1O94mMGn/dFSWBWzQ/VYk+Gezi46RgiDv3EshoTmMSlioUK6MQEN8qeyK6FRninyX8ZPeUWjjbMJChn0n/yJvrq5bh5UcCAcBYSafTFg7p0jDgrXo2QWLb3WpSOET/Hh4oSadBTvyDo10IufLzxiMLAnbZ1vcUmj3w7BQuIXjEZXifwukVxrGa9j+DXfpi12m1RbzYLg9J2wFergEwOxFyD0/JstNK06ZN2XdZSGWxcJODpQHOq4iKqjqkJUmPu1VczL5xTGUfCgLEYyNBCCbMBFT/cUP6pE/mujnHsSDeWxMbhrNilS5MyYR0nJyzanWXBeVcEQrRIhQeJA6Xt4f2eQESNeLwmC10WJVHqwx8SSyrtAAjpGjidcj1E2FYN0LObUcFQhafUKTiGmHWRHGsFCB+HEXgrzJEB5bp0QiF8ZHh11nFX8AboTD0PS4O1LqF8XBks2MpjsQnwKHF6HgaKCVLJtcr0XjqFMRGfKv8tmmykhLRzu+vqQ02+KpJBjaLt9ye1Ab+BbEBhy4EVdIJDrL2naV0o4wU8YZ2Lq04FG1mWCKC+UwkXOoAjneU/xHplMQo2cXUlrVNqJYczgYlaOEczVCs/OCgkyvLmTmdaBJc1iBLuKwmr6qtRnhowngsDxhzKFAi02tf8bmET8BO27ovJKF1plJwm3b0JpMh38+xsrXXg7U74QUM8ZCIMOpXujHntKdaRtsgyEZl5MClMVMMMZkZLNxH9+b8fH6+b8Lev30A9TuEVj9CqAdmwAAHBPbfOBFEATAPZ2CS0OH1Pj/0Q7PFUcC8hDrxESWdfgFRm+7vvWbkEppHB4T/1ApWnlTIqQwjcPl0VgS1yHSmD0OdsCVST8CQVwuiew1Y+g3QGFjNMzwRB2DSsAk26cmA8lp2wIU4p93AUBiUHFGOxOajAqD7Gm6NezNDjYzwLOaSXRBYcWipTSONHjUDXCY4mMI8XoVCR/Rrs/JLKXgEx+qkmeDlFOD1/yTQNDClRuiUyKYCllfMiQiyFkmuTz2vLsBNyRW+xz+5FElFxWB28VjYIGZ0Yd+5wIjkcoMaggxswbT0pCmckRAErbRlIlcOGdBo4djTNO8FAgQ+lT6vPS60BwTRSUAM3ddkEAZiwtEyArrkiDRnS7LJ+2hwbzd2YDQagSgACpsovmjil5wfPuXq3GuH0CyE7FK3M4FgRaFoIkaodORrPx1+JpI9psyNYIFuJogZa0/1AhOWdlHQxdAgbwacsHqPZo8u/ngAH2GmaTdhYnBfSDbBfh8CHq6Bx5bttP2+RdM+MAaYaZ0Y/ADkbNCZuAyAVQa2OcXOeICmDn9Q/eFkDeFQg5MgHEDXq/tVjj+jtd26nhaaolWxs1ixSUgOBwrDhRIGOLyOVk2/Bc0UxvseQCO2pQ2i+Krfhu/WeBovNb5dJxQtJRUDv2mCwYVpNl2efQM9xQHnK0JwLYt/U0Wf+phiA4uw8G91slC832pmOTCAoZXohg1fewCZqLBhkOUBofBWpMPsqg7XEXgPfAlDo2U5WXjtFdS87PIqClCK5nW6adCeXPkUiTGx0emOIDQqw1yFYGHEVx20xKjJVYe0O8iLmnQr3FA9nSIQilUKtJ4ZAdcTm7+ExseJauyqo30hs+1qSW211A1SFAOUgDlCGq7eTIcMAeyZkV1SQJ4j/e1Smbq4HcjqgFbLAGLyKxlMDMgZavK5NAYH19Olz3la/QCTiVelFnU6O/GCvykqS/wZJDhKN9gBtSOp/1SP5VRgJcoVj+kmf2wBgv4gjrgARBWiURYx8xENV3bEVUAAWWD3dYDKAIWk5opaCFCMR5ZjJExiCAw7gYiSZ2rkyTce4eNMY3lfGn+8p6+vBckGlKEXnA6Eota69OxDO9oOsJoy28BXOR0UoXNRaJD5ceKdlWMJlOFzDdZNpc05tkMGQtqeNF2lttZqNco1VtwXgRstLSQ6tSPChgqtGV5h2DcDReIQadaNRR6AsAYKL5gSFsCJMgfsaZ7DpKh8mg8Wz8V7H+gDnLuMxaWEIUPevIbClgap4dqmVWSrPgVYCzAoZHIa5z2Ocx1D/GvDOEqMOKLrMefWIbSWHZ6jbgA8qVBhYNHpx0P+jAgN5TB3haSifDcApp6yymEi6Ij/GsEpDYUgcHATJUYDUAmC1SCkJ4cuZXSAP2DEpQsGUjQmKJfJOvlC2x/pChkOyLW7KEoMYc5FDC4v2FGqSoRWiLsbPCiyg1U5yiHZVm1XLkHMMZL11/yxyw0UnGig3MFdZklN5FI/qiT65T+jOXOdO7XbgWurOAZR6Cv9uu1cm5LjkXX4xi6mWn5r5NjBS0gTliHhMZI2WNqSiSphEtiCAwnafS11JhseDGHYQ5+bqWiAYiAv6Jsf79/VUs4cIl+n6+WOjcgB/2l5TreoAV2717JzZbQIR0W1cl/dEqCy5kJ3ZSIHuU0vBoHooEpiHeQWVkkkOqRX27eD1FWw4BfO9CJDdKoSogQi3hAAwsPRFrN5RbX7bqLdBJ9JYMohWrgJKHSjVl1sy2xAG0E3sNyO0oCbSGOxCNBRRXTXenYKuwAoDLfnDcQaCwehUOIDiHAu5m5hMpKeKM4sIo3vxACakIxKoH2YWF2QM84e6F5C5hJU4g8uxuFOlAYnqtwxmHyNEawLW/PhoawJDrGAP0JYWHgAVUByo/bGdiv2T2EMg8gsS14/rAdzlOYazFE7w4OzxeKiWdm3nSOnQRRKXSlVo8HEAbBfyJMKqoq+SCcTSx5NDtbFwNlh8VhjGGDu7JG5/TAGAvniQSSUog0pNzTim8Owc6QTuSKSTXlQqwV3eiEnklS3LeSXYPXGK2VgeZBqNcHG6tZHvA3vTINhV0ELuQdp3t1y9+ogD8Kk/W7QoRN1UWPqM4+xdygkFDPLoTaumKReKiLWoPHOfY54m3qPx4c+4pgY3MRKKbljG8w4wvz8pxk3AqKsy4GMAkAtmRjRMsCxbb4Q2Ds0Ia9ci8cMT6DmsJG00XaHCIS+o3F8YVVeikw13w+OEDaCYYhC0ZE54kA4jpjruBr5STWeqQG6M74HHL6TZ3lXrd99ZX++7LhNatQaZosuxEf5yRA15S9gPeHskBIq3Gcw81AGb9/O53DYi/5CsQ51EmEh8Rkg4vOciClpy4d04eYsfr6fyQkBmtD+P8sNh6e+XYHJXT/lkXxT4KXU5F2sGxYyzfniMMQkb9OjDN2C8tRRgTyL7GwozH14PrEUZc6oz05Emne3Ts5EG7WolDmU8OB1LDG3VrpQxp+pT0KYV5dGtknU64JhabdqcVQbGZiAxQAnvN1u70y1AnmvOSPgLI6uB4AuDGhmAu3ATkJSw7OtS/2ToPjqkaq62/7WFG8advGlRRqxB9diP07JrXowKR9tpRa+jGJ91zxNTT1h8I2PcSfoUPtd7NejVoH03EUcqSBuFZPkMZhegHyo2ZAITovmm3zAIdGFWxoNNORiMRShgwdYwFzkPw5PA4a5MIIQpmq+nsp3YMuXt/GkXxLx/P6+ZJS0lFyz4MunC3eWSGE8xlCQrKvhKUPXr0hjpAN9ZK4PfEDrPMfMbGNWcHDzjA7ngMxTPnT7GMHar+gMQQ3NwHCv4zH4BIMYvzsdiERi6gebRmerTsVwZJTRsL8dkZgxgRxmpbgRcud+YlCIRpPwHShlUSwuipZnx9QCsEWziVazdDeKSYU5CF7UVPAhLer3CgJOQXl/zh575R5rsrmRnKAzq4POFdgbYBuEviM4+LVC15ssLNFghbTtHWerS1hDt5s4qkLUha/qpZXhWh1C6lTQAqCNQnaDjS7UGFBC6wTu8yFnKJnExCnAs3Ok9yj5KpfZESQ4lTy5pTGTnkAUpxI+yjEldJfSo4y0QhG4i4IwkRFGcjWY8+EzgYYJUK7BXQksLxAww/YYWBMhJILB9e8ePEJ4OP7z+4/wOQDl64iOYDp26DaONPxpKtBxq/aTzRGarm3VkPYTLJKx6Z/Mw2YbBGseJhPMwhhNswrIkyvV2BYzrvZbxLpKwcWJhYmFtVZ+lPEq91FzVp1HlQY1bZVLqeNR9SAUn6n0E28k/UuGkNpP1DBI5ch/EehZfjUQ9aE41NhETExoPT2gGQz0IhWJbEOvTQ4wgcXCHHFBhewYUiFHuhRSAUVmEHeCRQHQkXGFwkAgyzREJCVN7TRnTon36Zw3tPhx4EALwNdwDv+J41YSP4B2CQqz0EFgARZ4ESgBHQgROwAVn9GTI+HYexTUevLUeta4/DqKrbMVS+Yqb8hUwYCrlgKtmAq1YCrFgKrd4qpXiqZcKn1oqdWipjYKpWwVPVYqW6xUpVipKqFR3QKjagVEtAqHpxUMTitsnFaJOKx2cVhswq35RVpyiq9lFVNIKnOQVMkgqtYxVNxiqQjFS7GKlSIVIsQqPIhUWwioigFQ++KkN8VHr49HDw9Ebo9EDo9DTo9Crg9BDg9/Wx7gWx7YWwlobYrOGxWPNisAaAHEyALpkAVDIAeWAArsABVXACYuAD5cAF6wAKFQAQqgAbVAAsoAAlQAUaYAfkwAvogBWQACOgAD9AAHSAAKT4GUdMiOvFngBTwCn2AZ7Dv6B6k/90B8+yRnkV144AIBoAMTQATGgAjNAA4YABgwABZgB/mQCwyAVlwCguASlwCEuAQFwB4uAMlwBYuAJlQAUVAAhUD2KgdpUDaJgaRMDFJgX5MC1JgWJEAokQCWRAHxEAWkQBMRADpEAMkQAYROAEecC484DRpwBDTnwNOdw05tjTmiNOYwtswhYFwLA7BYG4LA2BYGOLAwRYFuLAsxYFQJAohIEyJAMwkAwiQC0JAJgkAeiQBkJAFokAPCQA0JABwcD4Dgc4cDdDgaYcDIDgYgUC6CgWgUClCgUYUAVBQBOFAEYMALgwAgDA9QYAdIn8AZzeBB2L5EcWrenUT1KXienEsuJJ7x5U8XlTjc1NVzUyXFTGb1LlpUtWlTDIjqwE4LsagowoCi2gJLKAkpoBgJQNpAIhNqaEoneI6kiiqQ6Go/n6j0cS+a2gEU8gIHJ+BwfgZX4GL+Bd/gW34FZ+BS/gUH4FN6BTegTvoEv6BJegRnYEF2A79gOvYDl2BdEjCkqkGtwXp0LNToIskOTXzh/F062yJ7AAAAEDAWAAABWhJ+KPEIJgBFxMVP7w2QJBGHASQnOBKXKFIdUK4igKA9IEaYJg);src:url(data:application/vnd.ms-fontobject;base64,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) format('embedded-opentype'),url(data:font/woff;base64,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) format('woff'),url(data:font/ttf;base64,AAEAAAAPAIAAAwBwRkZUTW0ql9wAAAD8AAAAHEdERUYBRAAEAAABGAAAACBPUy8yZ7lriQAAATgAAABgY21hcNqt44EAAAGYAAAGcmN2dCAAKAL4AAAIDAAAAARnYXNw//8AAwAACBAAAAAIZ2x5Zn1dwm8AAAgYAACUpGhlYWQFTS/YAACcvAAAADZoaGVhCkQEEQAAnPQAAAAkaG10eNLHIGAAAJ0YAAADdGxvY2Fv+5XOAACgjAAAAjBtYXhwAWoA2AAAorwAAAAgbmFtZbMsoJsAAKLcAAADonBvc3S6o+U1AACmgAAACtF3ZWJmwxhUUAAAsVQAAAAGAAAAAQAAAADMPaLPAAAAANB2gXUAAAAA0HZzlwABAAAADgAAABgAAAAAAAIAAQABARYAAQAEAAAAAgAAAAMEiwGQAAUABAMMAtAAAABaAwwC0AAAAaQAMgK4AAAAAAUAAAAAAAAAAAAAAAIAAAAAAAAAAAAAAFVLV04AQAAg//8DwP8QAAAFFAB7AAAAAQAAAAAAAAAAAAAAIAABAAAABQAAAAMAAAAsAAAACgAAAdwAAQAAAAAEaAADAAEAAAAsAAMACgAAAdwABAGwAAAAaABAAAUAKAAgACsAoAClIAogLyBfIKwgvSISIxsl/CYBJvonCScP4APgCeAZ4CngOeBJ4FngYOBp4HngieCX4QnhGeEp4TnhRuFJ4VnhaeF54YnhleGZ4gbiCeIW4hniIeIn4jniSeJZ4mD4////AAAAIAAqAKAApSAAIC8gXyCsIL0iEiMbJfwmASb6JwknD+AB4AXgEOAg4DDgQOBQ4GDgYuBw4IDgkOEB4RDhIOEw4UDhSOFQ4WDhcOGA4ZDhl+IA4gniEOIY4iHiI+Iw4kDiUOJg+P/////j/9r/Zv9i4Ajf5N+132nfWd4F3P3aHdoZ2SHZE9kOIB0gHCAWIBAgCiAEH/4f+B/3H/Ef6x/lH3wfdh9wH2ofZB9jH10fVx9RH0sfRR9EHt4e3B7WHtUezh7NHsUevx65HrMIFQABAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAADAAAAAACjAAAAAAAAAA1AAAAIAAAACAAAAADAAAAKgAAACsAAAAEAAAAoAAAAKAAAAAGAAAApQAAAKUAAAAHAAAgAAAAIAoAAAAIAAAgLwAAIC8AAAATAAAgXwAAIF8AAAAUAAAgrAAAIKwAAAAVAAAgvQAAIL0AAAAWAAAiEgAAIhIAAAAXAAAjGwAAIxsAAAAYAAAl/AAAJfwAAAAZAAAmAQAAJgEAAAAaAAAm+gAAJvoAAAAbAAAnCQAAJwkAAAAcAAAnDwAAJw8AAAAdAADgAQAA4AMAAAAeAADgBQAA4AkAAAAhAADgEAAA4BkAAAAmAADgIAAA4CkAAAAwAADgMAAA4DkAAAA6AADgQAAA4EkAAABEAADgUAAA4FkAAABOAADgYAAA4GAAAABYAADgYgAA4GkAAABZAADgcAAA4HkAAABhAADggAAA4IkAAABrAADgkAAA4JcAAAB1AADhAQAA4QkAAAB9AADhEAAA4RkAAACGAADhIAAA4SkAAACQAADhMAAA4TkAAACaAADhQAAA4UYAAACkAADhSAAA4UkAAACrAADhUAAA4VkAAACtAADhYAAA4WkAAAC3AADhcAAA4XkAAADBAADhgAAA4YkAAADLAADhkAAA4ZUAAADVAADhlwAA4ZkAAADbAADiAAAA4gYAAADeAADiCQAA4gkAAADlAADiEAAA4hYAAADmAADiGAAA4hkAAADtAADiIQAA4iEAAADvAADiIwAA4icAAADwAADiMAAA4jkAAAD1AADiQAAA4kkAAAD/AADiUAAA4lkAAAEJAADiYAAA4mAAAAETAAD4/wAA+P8AAAEUAAH1EQAB9REAAAEVAAH2qgAB9qoAAAEWAAYCCgAAAAABAAABAAAAAAAAAAAAAAAAAAAAAQACAAAAAAAAAAIAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAQAAAAAAAwAAAAAAAAAAAAAAAAAAAAAAAAAEAAUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAHAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAYAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAVAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAEUAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAAKAL4AAAAAf//AAIAAgAoAAABaAMgAAMABwAusQEALzyyBwQA7TKxBgXcPLIDAgDtMgCxAwAvPLIFBADtMrIHBgH8PLIBAgDtMjMRIRElMxEjKAFA/ujw8AMg/OAoAtAAAQBkAGQETARMAFsAAAEyFh8BHgEdATc+AR8BFgYPATMyFhcWFRQGDwEOASsBFx4BDwEGJi8BFRQGBwYjIiYvAS4BPQEHDgEvASY2PwEjIiYnJjU0Nj8BPgE7AScuAT8BNhYfATU0Njc2AlgPJgsLCg+eBxYIagcCB57gChECBgMCAQIRCuCeBwIHaggWB54PCikiDyYLCwoPngcWCGoHAgee4AoRAgYDAgECEQrgngcCB2oIFgeeDwopBEwDAgECEQrgngcCB2oIFgeeDwopIg8mCwsKD54HFghqBwIHnuAKEQIGAwIBAhEK4J4HAgdqCBYHng8KKSIPJgsLCg+eBxYIagcCB57gChECBgAAAAABAAAAAARMBEwAIwAAATMyFhURITIWHQEUBiMhERQGKwEiJjURISImPQE0NjMhETQ2AcLIFR0BXhUdHRX+oh0VyBUd/qIVHR0VAV4dBEwdFf6iHRXIFR3+ohUdHRUBXh0VyBUdAV4VHQAAAAABAHAAAARABEwARQAAATMyFgcBBgchMhYPAQ4BKwEVITIWDwEOASsBFRQGKwEiJj0BISImPwE+ATsBNSEiJj8BPgE7ASYnASY2OwEyHwEWMj8BNgM5+goFCP6UBgUBDAoGBngGGAp9ARMKBgZ4BhgKfQ8LlAsP/u0KBgZ4BhgKff7tCgYGeAYYCnYFBv6UCAUK+hkSpAgUCKQSBEwKCP6UBgwMCKAIDGQMCKAIDK4LDw8LrgwIoAgMZAwIoAgMDAYBbAgKEqQICKQSAAABAGQABQSMBK4AOwAAATIXFhcjNC4DIyIOAwchByEGFSEHIR4EMzI+AzUzBgcGIyInLgEnIzczNjcjNzM+ATc2AujycDwGtSM0QDkXEys4MjAPAXtk/tQGAZZk/tQJMDlCNBUWOUA0I64eYmunznYkQgzZZHABBdpkhhQ+H3UErr1oaS1LMCEPCx4uTzJkMjJkSnRCKw8PIjBKK6trdZ4wqndkLzVkV4UljQAAAgB7AAAETASwAD4ARwAAASEyHgUVHAEVFA4FKwEHITIWDwEOASsBFRQGKwEiJj0BISImPwE+ATsBNSEiJj8BPgE7ARE0NhcRMzI2NTQmIwGsAV5DakIwFgwBAQwWMEJqQ7ICASAKBgZ4BhgKigsKlQoP/vUKBgZ4BhgKdf71CgYGeAYYCnUPtstALS1ABLAaJD8yTyokCwsLJCpQMkAlGmQMCKAIDK8LDg8KrwwIoAgMZAwIoAgMAdsKD8j+1EJWVEAAAAEAyAGQBEwCvAAPAAATITIWHQEUBiMhIiY9ATQ2+gMgFR0dFfzgFR0dArwdFcgVHR0VyBUdAAAAAgDIAAAD6ASwACUAQQAAARUUBisBFRQGBx4BHQEzMhYdASE1NDY7ATU0NjcuAT0BIyImPQEXFRQWFx4BFAYHDgEdASE1NCYnLgE0Njc+AT0BA+gdFTJjUVFjMhUd/OAdFTJjUVFjMhUdyEE3HCAgHDdBAZBBNxwgIBw3QQSwlhUdZFuVIyOVW5YdFZaWFR2WW5UjI5VbZB0VlshkPGMYDDI8MgwYYzyWljxjGAwyPDIMGGM8ZAAAAAEAAAAAAAAAAAAAAAAxAAAB//IBLATCBEEAFgAAATIWFzYzMhYVFAYjISImNTQ2NyY1NDYB9261LCwueKqqeP0ST3FVQgLYBEF3YQ6teHmtclBFaw4MGZnXAAAAAgAAAGQEsASvABoAHgAAAB4BDwEBMzIWHQEhNTQ2OwEBJyY+ARYfATc2AyEnAwL2IAkKiAHTHhQe+1AeFB4B1IcKCSAkCm9wCXoBebbDBLMTIxC7/RYlFSoqFSUC6rcQJBQJEJSWEPwecAIWAAAAAAQAAABkBLAETAALABcAIwA3AAATITIWBwEGIicBJjYXARYUBwEGJjURNDYJATYWFREUBicBJjQHARYGIyEiJjcBNjIfARYyPwE2MhkEfgoFCP3MCBQI/cwIBQMBCAgI/vgICgoDjAEICAoKCP74CFwBbAgFCvuCCgUIAWwIFAikCBQIpAgUBEwKCP3JCAgCNwgK2v74CBQI/vgIBQoCJgoF/vABCAgFCv3aCgUIAQgIFID+lAgKCggBbAgIpAgIpAgAAAAD//D/8AS6BLoACQANABAAAAAyHwEWFA8BJzcTAScJAQUTA+AmDpkNDWPWXyL9mdYCZv4f/rNuBLoNmQ4mDlzWYP50/ZrWAmb8anABTwAAAAEAAAAABLAEsAAPAAABETMyFh0BITU0NjsBEQEhArz6FR384B0V+v4MBLACiv3aHRUyMhUdAiYCJgAAAAEADgAIBEwEnAAfAAABJTYWFREUBgcGLgE2NzYXEQURFAYHBi4BNjc2FxE0NgFwAoUnMFNGT4gkV09IQv2oWEFPiCRXT0hCHQP5ow8eIvzBN1EXGSltchkYEAIJm/2iKmAVGilucRoYEQJ/JioAAAACAAn/+AS7BKcAHQApAAAAMh4CFQcXFAcBFgYPAQYiJwEGIycHIi4CND4BBCIOARQeATI+ATQmAZDItoNOAQFOARMXARY7GikT/u13jgUCZLaDTk6DAXKwlFZWlLCUVlYEp06DtmQCBY15/u4aJRg6FBQBEk0BAU6Dtsi2g1tWlLCUVlaUsJQAAQBkAFgErwREABkAAAE+Ah4CFRQOAwcuBDU0PgIeAQKJMHt4dVg2Q3mEqD4+p4V4Qzhadnh5A7VESAUtU3ZAOXmAf7JVVbJ/gHk5QHZTLQVIAAAAAf/TAF4EewSUABgAAAETNjIXEyEyFgcFExYGJyUFBiY3EyUmNjMBl4MHFQeBAaUVBhH+qoIHDxH+qf6qEQ8Hgv6lEQYUAyABYRMT/p8RDPn+bxQLDPb3DAsUAZD7DBEAAv/TAF4EewSUABgAIgAAARM2MhcTITIWBwUTFgYnJQUGJjcTJSY2MwUjFwc3Fyc3IycBl4MHFQeBAaUVBhH+qoIHDxH+qf6qEQ8Hgv6lEQYUAfPwxUrBw0rA6k4DIAFhExP+nxEM+f5vFAsM9vcMCxQBkPsMEWSO4ouM5YzTAAABAAAAAASwBLAAJgAAATIWHQEUBiMVFBYXBR4BHQEUBiMhIiY9ATQ2NyU+AT0BIiY9ATQ2Alh8sD4mDAkBZgkMDwr7ggoPDAkBZgkMJj6wBLCwfPouaEsKFwbmBRcKXQoPDwpdChcF5gYXCktoLvp8sAAAAA0AAAAABLAETAAPABMAIwAnACsALwAzADcARwBLAE8AUwBXAAATITIWFREUBiMhIiY1ETQ2FxUzNSkBIgYVERQWMyEyNjURNCYzFTM1BRUzNSEVMzUFFTM1IRUzNQchIgYVERQWMyEyNjURNCYFFTM1IRUzNQUVMzUhFTM1GQR+Cg8PCvuCCg8PVWQCo/3aCg8PCgImCg8Pc2T8GGQDIGT8GGQDIGTh/doKDw8KAiYKDw/872QDIGT8GGQDIGQETA8K++YKDw8KBBoKD2RkZA8K/qIKDw8KAV4KD2RkyGRkZGTIZGRkZGQPCv6iCg8PCgFeCg9kZGRkZMhkZGRkAAAEAAAAAARMBEwADwAfAC8APwAAEyEyFhURFAYjISImNRE0NikBMhYVERQGIyEiJjURNDYBITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NjIBkBUdHRX+cBUdHQJtAZAVHR0V/nAVHR39vQGQFR0dFf5wFR0dAm0BkBUdHRX+cBUdHQRMHRX+cBUdHRUBkBUdHRX+cBUdHRUBkBUd/agdFf5wFR0dFQGQFR0dFf5wFR0dFQGQFR0AAAkAAAAABEwETAAPAB8ALwA/AE8AXwBvAH8AjwAAEzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2ATMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYhMzIWHQEUBisBIiY9ATQ2MsgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR389cgVHR0VyBUdHQGlyBUdHRXIFR0dAaXIFR0dFcgVHR0ETB0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHf5wHRXIFR0dFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUd/nAdFcgVHR0VyBUdHRXIFR0dFcgVHR0VyBUdHRXIFR0ABgAAAAAEsARMAA8AHwAvAD8ATwBfAAATMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYyyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHf6FyBUdHRXIFR0dAaUCvBUdHRX9RBUdHQRMHRXIFR0dFcgVHR0VyBUdHRXIFR3+cB0VyBUdHRXIFR0dFcgVHR0VyBUd/nAdFcgVHR0VyBUdHRXIFR0dFcgVHQAAAAABACYALAToBCAAFwAACQE2Mh8BFhQHAQYiJwEmND8BNjIfARYyAdECOwgUB7EICPzxBxUH/oAICLEHFAirBxYB3QI7CAixBxQI/PAICAGACBQHsQgIqwcAAQBuAG4EQgRCACMAAAEXFhQHCQEWFA8BBiInCQEGIi8BJjQ3CQEmND8BNjIXCQE2MgOIsggI/vUBCwgIsggVB/70/vQHFQiyCAgBC/71CAiyCBUHAQwBDAcVBDuzCBUH/vT+9AcVCLIICAEL/vUICLIIFQcBDAEMBxUIsggI/vUBDAcAAwAX/+sExQSZABkAJQBJAAAAMh4CFRQHARYUDwEGIicBBiMiLgI0PgEEIg4BFB4BMj4BNCYFMzIWHQEzMhYdARQGKwEVFAYrASImPQEjIiY9ATQ2OwE1NDYBmcSzgk1OASwICG0HFQj+1HeOYrSBTU2BAW+zmFhYmLOZWFj+vJYKD0sKDw8KSw8KlgoPSwoPDwpLDwSZTYKzYo15/tUIFQhsCAgBK01NgbTEs4JNWJmzmFhYmLOZIw8KSw8KlgoPSwoPDwpLDwqWCg9LCg8AAAMAF//rBMUEmQAZACUANQAAADIeAhUUBwEWFA8BBiInAQYjIi4CND4BBCIOARQeATI+ATQmBSEyFh0BFAYjISImPQE0NgGZxLOCTU4BLAgIbQcVCP7Ud45itIFNTYEBb7OYWFiYs5lYWP5YAV4KDw8K/qIKDw8EmU2Cs2KNef7VCBUIbAgIAStNTYG0xLOCTViZs5hYWJizmYcPCpYKDw8KlgoPAAAAAAIAFwAXBJkEsAAPAC0AAAEzMhYVERQGKwEiJjURNDYFNRYSFRQOAiIuAjU0EjcVDgEVFB4BMj4BNTQmAiZkFR0dFWQVHR0BD6fSW5vW6tabW9KnZ3xyxejFcnwEsB0V/nAVHR0VAZAVHeGmPv7ZuHXWm1tbm9Z1uAEnPqY3yHh0xXJyxXR4yAAEAGQAAASwBLAADwAfAC8APwAAATMyFhURFAYrASImNRE0NgEzMhYVERQGKwEiJjURNDYBMzIWFREUBisBIiY1ETQ2BTMyFh0BFAYrASImPQE0NgQBlgoPDwqWCg8P/t6WCg8PCpYKDw/+3pYKDw8KlgoPD/7elgoPDwqWCg8PBLAPCvuCCg8PCgR+Cg/+cA8K/RIKDw8KAu4KD/7UDwr+PgoPDwoBwgoPyA8K+goPDwr6Cg8AAAAAAgAaABsElgSWAEcATwAAATIfAhYfATcWFwcXFh8CFhUUDwIGDwEXBgcnBwYPAgYjIi8CJi8BByYnNycmLwImNTQ/AjY/ASc2Nxc3Nj8CNhIiBhQWMjY0AlghKSYFMS0Fhj0rUAMZDgGYBQWYAQ8YA1AwOIYFLDIFJisfISkmBTEtBYY8LFADGQ0ClwYGlwINGQNQLzqFBS0xBSYreLJ+frJ+BJYFmAEOGQJQMDmGBSwxBiYrHiIoJgYxLAWGPSxRAxkOApcFBZcCDhkDUTA5hgUtMAYmKiAhKCYGMC0Fhj0sUAIZDgGYBf6ZfrF+frEABwBkAAAEsAUUABMAFwAhACUAKQAtADEAAAEhMhYdASEyFh0BITU0NjMhNTQ2FxUhNQERFAYjISImNREXETMRMxEzETMRMxEzETMRAfQBLCk7ARMKD/u0DwoBEzspASwBLDsp/UQpO2RkZGRkZGRkBRQ7KWQPCktLCg9kKTtkZGT+1PzgKTs7KQMgZP1EArz9RAK8/UQCvP1EArwAAQAMAAAFCATRAB8AABMBNjIXARYGKwERFAYrASImNREhERQGKwEiJjURIyImEgJsCBUHAmAIBQqvDwr6Cg/+1A8K+goPrwoFAmoCYAcH/aAICv3BCg8PCgF3/okKDw8KAj8KAAIAZAAAA+gEsAARABcAAAERFBYzIREUBiMhIiY1ETQ2MwEjIiY9AQJYOykBLB0V/OAVHR0VA1L6FR0EsP5wKTv9dhUdHRUETBUd/nAdFfoAAwAXABcEmQSZAA8AGwAwAAAAMh4CFA4CIi4CND4BBCIOARQeATI+ATQmBTMyFhURMzIWHQEUBisBIiY1ETQ2AePq1ptbW5vW6tabW1ubAb/oxXJyxejFcnL+fDIKD68KDw8K+goPDwSZW5vW6tabW1ub1urWmztyxejFcnLF6MUNDwr+7Q8KMgoPDwoBXgoPAAAAAAL/nAAABRQEsAALAA8AACkBAyMDIQEzAzMDMwEDMwMFFP3mKfIp/eYBr9EVohTQ/p4b4BsBkP5wBLD+1AEs/nD+1AEsAAAAAAIAZAAABLAEsAAVAC8AAAEzMhYVETMyFgcBBiInASY2OwERNDYBMzIWFREUBiMhIiY1ETQ2OwEyFh0BITU0NgImyBUdvxQLDf65DSYN/rkNCxS/HQJUMgoPDwr75goPDwoyCg8DhA8EsB0V/j4XEP5wEBABkBAXAcIVHfzgDwr+ogoPDwoBXgoPDwqvrwoPAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgUzMhYVETMyFgcDBiInAyY2OwERNDYB4+rWm1tbm9bq1ptbW5sBv+jFcnLF6MVycv58lgoPiRUKDd8NJg3fDQoViQ8EmVub1urWm1tbm9bq1ps7csXoxXJyxejFDQ8K/u0XEP7tEBABExAXARMKDwAAAAMAFwAXBJkEmQAPABsAMQAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JiUTFgYrAREUBisBIiY1ESMiJjcTNjIB4+rWm1tbm9bq1ptbW5sBv+jFcnLF6MVycv7n3w0KFYkPCpYKD4kVCg3fDSYEmVub1urWm1tbm9bq1ps7csXoxXJyxejFAf7tEBf+7QoPDwoBExcQARMQAAAAAAIAAAAABLAEsAAZADkAABMhMhYXExYVERQGBwYjISImJyY1EzQ3Ez4BBSEiBgcDBhY7ATIWHwEeATsBMjY/AT4BOwEyNicDLgHhAu4KEwO6BwgFDBn7tAweAgYBB7kDEwKX/dQKEgJXAgwKlgoTAiYCEwr6ChMCJgITCpYKDAJXAhIEsA4K/XQYGf5XDB4CBggEDRkBqRkYAowKDsgOC/4+Cw4OCpgKDg4KmAoODgsBwgsOAAMAFwAXBJkEmQAPABsAJwAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgUXFhQPAQYmNRE0NgHj6tabW1ub1urWm1tbmwG/6MVycsXoxXJy/ov9ERH9EBgYBJlbm9bq1ptbW5vW6tabO3LF6MVycsXoxV2+DCQMvgwLFQGQFQsAAQAXABcEmQSwACgAAAE3NhYVERQGIyEiJj8BJiMiDgEUHgEyPgE1MxQOAiIuAjQ+AjMyA7OHBwsPCv6WCwQHhW2BdMVycsXoxXKWW5vW6tabW1ub1nXABCSHBwQL/pYKDwsHhUxyxejFcnLFdHXWm1tbm9bq1ptbAAAAAAIAFwABBJkEsAAaADUAAAE3NhYVERQGIyEiJj8BJiMiDgEVIzQ+AjMyEzMUDgIjIicHBiY1ETQ2MyEyFg8BFjMyPgEDs4cHCw8L/pcLBAeGboF0xXKWW5vWdcDrllub1nXAnIYHCw8LAWgKBQiFboJ0xXIEJIcHBAv+lwsPCweGS3LFdHXWm1v9v3XWm1t2hggFCgFoCw8LB4VMcsUAAAAKAGQAAASwBLAADwAfAC8APwBPAF8AbwB/AI8AnwAAEyEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0NgczMhYdARQGKwEiJj0BNDYzITIWHQEUBiMhIiY9ATQ2BzMyFh0BFAYrASImPQE0NjMhMhYdARQGIyEiJj0BNDYHMzIWHQEUBisBIiY9ATQ2MyEyFh0BFAYjISImPQE0Nn0EGgoPDwr75goPDwPA/K4KDw8KA1IKDw/9CDIKDw8KMgoPD9IBwgoPDwr+PgoPD74yCg8PCjIKDw/SAcIKDw8K/j4KDw++MgoPDwoyCg8P0gHCCg8PCv4+Cg8PvjIKDw8KMgoPD9IBwgoPDwr+PgoPDwSwDwr7ggoPDwoEfgoPyA8K/K4KDw8KA1IKD2QPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKD8gPCjIKDw8KMgoPDwoyCg8PCjIKDwAAAAACAAAAAARMBLAAGQAjAAABNTQmIyEiBh0BIyIGFREUFjMhMjY1ETQmIyE1NDY7ATIWHQEDhHVT/tRSdmQpOzspA4QpOzsp/ageFMgUHgMgyFN1dlLIOyn9qCk7OykCWCk7lhUdHRWWAAIAZAAABEwETAAJADcAABMzMhYVESMRNDYFMhcWFREUBw4DIyIuAScuAiMiBwYjIicmNRE+ATc2HgMXHgIzMjc2fTIKD2QPA8AEBRADIUNAMRwaPyonKSxHHlVLBwgGBQ4WeDsXKC4TOQQpLUUdZ1AHBEwPCvvNBDMKDzACBhH+WwYGO1AkDQ0ODg8PDzkFAwcPAbY3VwMCAwsGFAEODg5XCAAAAwAAAAAEsASXACEAMQBBAAAAMh4CFREUBisBIiY1ETQuASAOARURFAYrASImNRE0PgEDMzIWFREUBisBIiY1ETQ2ITMyFhURFAYrASImNRE0NgHk6N6jYw8KMgoPjeT++uSNDwoyCg9joyqgCAwMCKAIDAwCYKAIDAwIoAgMDASXY6PedP7UCg8PCgEsf9FyctF//tQKDw8KASx03qP9wAwI/jQIDAwIAcwIDAwI/jQIDAwIAcwIDAAAAAACAAAA0wRHA90AFQA5AAABJTYWFREUBiclJisBIiY1ETQ2OwEyBTc2Mh8BFhQPARcWFA8BBiIvAQcGIi8BJjQ/AScmND8BNjIXAUEBAgkMDAn+/hUZ+goPDwr6GQJYeAcUByIHB3h4BwciBxQHeHgHFAciBwd3dwcHIgcUBwMurAYHCv0SCgcGrA4PCgFeCg+EeAcHIgcUB3h4BxQHIgcHd3cHByIHFAd4eAcUByIICAAAAAACAAAA0wNyA90AFQAvAAABJTYWFREUBiclJisBIiY1ETQ2OwEyJTMWFxYVFAcGDwEiLwEuATc2NTQnJjY/ATYBQQECCQwMCf7+FRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcDLqwGBwr9EgoHBqwODwoBXgoPZAEJgaGafwkBAQYXBxMIZ36EaggUBxYFAAAAAAMAAADEBGID7AAbADEASwAAATMWFxYVFAYHBgcjIi8BLgE3NjU0JicmNj8BNgUlNhYVERQGJyUmKwEiJjURNDY7ATIlMxYXFhUUBwYPASIvAS4BNzY1NCcmNj8BNgPHAwsGh0RABwoDCQcqCAIGbzs3BgIJKgf9ggECCQwMCf7+FRn6Cg8PCvoZAdIECgZgWgYLAwkHHQcDBkhOBgMIHQcD7AEJs9lpy1QJAQYiBhQIlrJarEcJFAYhBb6sBgcK/RIKBwasDg8KAV4KD2QBCYGhmn8JAQEGFwcTCGd+hGoIFQYWBQAAAAANAAAAAASwBLAACQAVABkAHQAhACUALQA7AD8AQwBHAEsATwAAATMVIxUhFSMRIQEjFTMVIREjESM1IQURIREhESERBSM1MwUjNTMBMxEhETM1MwEzFSMVIzUjNTM1IzUhBREhEQcjNTMFIzUzASM1MwUhNSEB9GRk/nBkAfQCvMjI/tTIZAJY+7QBLAGQASz84GRkArxkZP1EyP4MyGQB9MhkyGRkyAEs/UQBLGRkZAOEZGT+DGRkAfT+1AEsA4RkZGQCWP4MZMgBLAEsyGT+1AEs/tQBLMhkZGT+DP4MAfRk/tRkZGRkyGTI/tQBLMhkZGT+1GRkZAAAAAAJAAAAAASwBLAAAwAHAAsADwATABcAGwAfACMAADcjETMTIxEzASMRMxMjETMBIxEzASE1IRcjNTMXIzUzBSM1M2RkZMhkZAGQyMjIZGQBLMjI/OD+1AEsyGRkyGRkASzIyMgD6PwYA+j8GAPo/BgD6PwYA+j7UGRkW1tbW1sAAAIAAAAKBKYEsAANABUAAAkBFhQHAQYiJwETNDYzBCYiBhQWMjYB9AKqCAj+MAgUCP1WAQ8KAUM7Uzs7UzsEsP1WCBQI/jAICAKqAdsKD807O1Q7OwAAAAADAAAACgXSBLAADQAZACEAAAkBFhQHAQYiJwETNDYzIQEWFAcBBiIvAQkBBCYiBhQWMjYB9AKqCAj+MAgUCP1WAQ8KAwYCqggI/jAIFAg4Aaj9RP7TO1M7O1M7BLD9VggUCP4wCAgCqgHbCg/9VggUCP4wCAg4AaoCvM07O1Q7OwAAAAABAGQAAASwBLAAJgAAASEyFREUDwEGJjURNCYjISIPAQYWMyEyFhURFAYjISImNRE0PwE2ASwDOUsSQAgKDwr9RBkSQAgFCgK8Cg8PCvyuCg8SixIEsEv8fBkSQAgFCgO2Cg8SQAgKDwr8SgoPDwoDzxkSixIAAAABAMj//wRMBLAACgAAEyEyFhURCQERNDb6AyAVHf4+/j4dBLAdFfuCAbz+QwR/FR0AAAAAAwAAAAAEsASwABUARQBVAAABISIGBwMGHwEeATMhMjY/ATYnAy4BASMiBg8BDgEjISImLwEuASsBIgYVERQWOwEyNj0BNDYzITIWHQEUFjsBMjY1ETQmASEiBg8BBhYzITI2LwEuAQM2/kQLEAFOBw45BhcKAcIKFwY+DgdTARABVpYKFgROBBYK/doKFgROBBYKlgoPDwqWCg8PCgLuCg8PCpYKDw/+sf4MChMCJgILCgJYCgsCJgITBLAPCv7TGBVsCQwMCWwVGAEtCg/+cA0JnAkNDQmcCQ0PCv12Cg8PCpYKDw8KlgoPDwoCigoP/agOCpgKDg4KmAoOAAAAAAQAAABkBLAETAAdACEAKQAxAAABMzIeAh8BMzIWFREUBiMhIiY1ETQ2OwE+BAEVMzUEIgYUFjI2NCQyFhQGIiY0AfTIOF00JAcGlik7Oyn8GCk7OymWAgknM10ByGT+z76Hh76H/u9WPDxWPARMKTs7FRQ7Kf2oKTs7KQJYKTsIG0U1K/7UZGRGh76Hh74IPFY8PFYAAAAAAgA1AAAEsASvACAAIwAACQEWFx4BHwEVITUyNi8BIQYHBh4CMxUhNTY3PgE/AQEDIQMCqQGBFCgSJQkK/l81LBFS/nk6IgsJKjIe/pM4HAwaBwcBj6wBVKIEr/waMioTFQECQkJXLd6RWSIuHAxCQhgcDCUNDQPu/VoByQAAAAADAGQAAAPwBLAAJwAyADsAAAEeBhUUDgMjITU+ATURNC4EJzUFMh4CFRQOAgclMzI2NTQuAisBETMyNjU0JisBAvEFEzUwOyodN1htbDD+DCk7AQYLFyEaAdc5dWM+Hy0tEP6Pi05pESpTPnbYUFJ9Xp8CgQEHGB0zOlIuQ3VONxpZBzMoAzsYFBwLEAkHRwEpSXNDM1s6KwkxYUopOzQb/K5lUFqBAAABAMgAAANvBLAAGQAAARcOAQcDBhYXFSE1NjcTNjQuBCcmJzUDbQJTQgeECSxK/gy6Dq0DAw8MHxUXDQYEsDkTNSj8uTEoBmFhEFIDQBEaExAJCwYHAwI5AAAAAAL/tQAABRQEsAAlAC8AAAEjNC4FKwERFBYfARUhNTI+AzURIyIOBRUjESEFIxEzByczESM3BRQyCAsZEyYYGcgyGRn+cAQOIhoWyBkYJhMZCwgyA+j7m0tLfX1LS30DhBUgFQ4IAwH8rhYZAQJkZAEFCRUOA1IBAwgOFSAVASzI/OCnpwMgpwACACH/tQSPBLAAJQAvAAABIzQuBSsBERQWHwEVITUyPgM1ESMiDgUVIxEhEwc1IRUnNxUhNQRMMggLGRMmGBnIMhkZ/nAEDiIaFsgZGCYTGQsIMgPoQ6f84KenAyADhBUgFQ4IAwH9dhYZAQJkZAEFCRUOAooBAwgOFSAVASz7gn1LS319S0sABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyAlgVHR0V/agVHR0VA+gVHR0V/BgVHR0VAyAVHR0V/OAVHR0VBEwVHR0V+7QVHR0ETB0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AABMhMhYdARQGIyEiJj0BNDYDITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NgMhMhYdARQGIyEiJj0BNDb6ArwVHR0V/UQVHR2zBEwVHR0V+7QVHR3dArwVHR0V/UQVHR2zBEwVHR0V+7QVHR0ETB0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR3+1B0VZBUdHRVkFR0ABAAAAAAEsARMAA8AHwAvAD8AAAE1NDYzITIWHQEUBiMhIiYBNTQ2MyEyFh0BFAYjISImEzU0NjMhMhYdARQGIyEiJgE1NDYzITIWHQEUBiMhIiYB9B0VAlgVHR0V/agVHf5wHRUD6BUdHRX8GBUdyB0VAyAVHR0V/OAVHf7UHRUETBUdHRX7tBUdA7ZkFR0dFWQVHR3+6WQVHR0VZBUdHf7pZBUdHRVkFR0d/ulkFR0dFWQVHR0AAAQAAAAABLAETAAPAB8ALwA/AAATITIWHQEUBiMhIiY9ATQ2EyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2MgRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dFQRMFR0dFfu0FR0dBEwdFWQVHR0VZBUd/tQdFWQVHR0VZBUd/tQdFWQVHR0VZBUd/tQdFWQVHR0VZBUdAAgAAAAABLAETAAPAB8ALwA/AE8AXwBvAH8AABMzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2ATMyFh0BFAYrASImPQE0NikBMhYdARQGIyEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2KQEyFh0BFAYjISImPQE0NgEzMhYdARQGKwEiJj0BNDYpATIWHQEUBiMhIiY9ATQ2MmQVHR0VZBUdHQFBAyAVHR0V/OAVHR3+6WQVHR0VZBUdHQFBAyAVHR0V/OAVHR3+6WQVHR0VZBUdHQFBAyAVHR0V/OAVHR3+6WQVHR0VZBUdHQFBAyAVHR0V/OAVHR0ETB0VZBUdHRVkFR0dFWQVHR0VZBUd/tQdFWQVHR0VZBUdHRVkFR0dFWQVHf7UHRVkFR0dFWQVHR0VZBUdHRVkFR3+1B0VZBUdHRVkFR0dFWQVHR0VZBUdAAAG/5wAAASwBEwAAwATACMAKgA6AEoAACEjETsCMhYdARQGKwEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2BQc1IzUzNQUhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2AZBkZJZkFR0dFWQVHR0VAfQVHR0V/gwVHR3++qfIyAHCASwVHR0V/tQVHR0VAlgVHR0V/agVHR0ETB0VZBUdHRVkFR3+1B0VZBUdHRVkFR36fUtkS68dFWQVHR0VZBUd/tQdFWQVHR0VZBUdAAAABgAAAAAFFARMAA8AEwAjACoAOgBKAAATMzIWHQEUBisBIiY9ATQ2ASMRMwEhMhYdARQGIyEiJj0BNDYFMxUjFSc3BSEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYyZBUdHRVkFR0dA2dkZPyuAfQVHR0V/gwVHR0EL8jIp6f75gEsFR0dFf7UFR0dFQJYFR0dFf2oFR0dBEwdFWQVHR0VZBUd+7QETP7UHRVkFR0dFWQVHchkS319rx0VZBUdHRVkFR3+1B0VZBUdHRVkFR0AAAAAAgAAAMgEsAPoAA8AEgAAEyEyFhURFAYjISImNRE0NgkCSwLuHywsH/0SHywsBIT+1AEsA+gsH/12HywsHwKKHyz9RAEsASwAAwAAAAAEsARMAA8AFwAfAAATITIWFREUBiMhIiY1ETQ2FxE3BScBExEEMhYUBiImNCwEWBIaGhL7qBIaGkr3ASpKASXs/NJwTk5wTgRMGhL8DBIaGhID9BIaZP0ftoOcAT7+4AH0dE5vT09vAAAAAAIA2wAFBDYEkQAWAB4AAAEyHgEVFAcOAQ8BLgQnJjU0PgIWIgYUFjI2NAKIdcZzRkWyNjYJIV5YbSk8RHOft7eCgreCBJF4ynVzj23pPz4IIWZomEiEdVijeUjDgriBgbgAAAACABcAFwSZBJkADwAXAAAAMh4CFA4CIi4CND4BAREiDgEUHgEB4+rWm1tbm9bq1ptbW5sBS3TFcnLFBJlbm9bq1ptbW5vW6tab/G8DVnLF6MVyAAACAHUAAwPfBQ8AGgA1AAABHgYVFA4DBy4DNTQ+BQMOAhceBBcWNj8BNiYnLgInJjc2IyYCKhVJT1dOPiUzVnB9P1SbfEokP0xXUEm8FykoAwEbITEcExUWAgYCCQkFEikMGiACCAgFD0iPdXdzdYdFR4BeRiYEBTpjl1lFh3ZzeHaQ/f4hS4I6JUEnIw4IBwwQIgoYBwQQQSlZtgsBAAAAAwAAAAAEywRsAAwAKgAvAAABNz4CHgEXHgEPAiUhMhcHISIGFREUFjMhMjY9ATcRFAYjISImNRE0NgkBBzcBA+hsAgYUFR0OFgoFBmz9BQGQMje7/pApOzspAfQpO8i7o/5wpbm5Azj+lqE3AWMD9XMBAgIEDw4WKgsKc8gNuzsp/gwpOzsptsj+tKW5uaUBkKW5/tf+ljKqAWMAAgAAAAAEkwRMABsANgAAASEGByMiBhURFBYzITI2NTcVFAYjISImNRE0NgUBFhQHAQYmJzUmDgMHPgY3NT4BAV4BaaQ0wyk7OykB9Ck7yLml/nClubkCfwFTCAj+rAcLARo5ZFRYGgouOUlARioTAQsETJI2Oyn+DCk7OymZZ6W5uaUBkKW5G/7TBxUH/s4GBAnLAQINFjAhO2JBNB0UBwHSCgUAAAAAAgAAAAAEnQRMAB0ANQAAASEyFwchIgYVERQWMyEyNj0BNxUUBiMhIiY1ETQ2CQE2Mh8BFhQHAQYiLwEmND8BNjIfARYyAV4BXjxDsv6jKTs7KQH0KTvIuaX+cKW5uQHKAYsHFQdlBwf97QcVB/gHB2UHFQdvCBQETBexOyn+DCk7OylFyNulubmlAZCluf4zAYsHB2UHFQf97AcH+AcVB2UHB28HAAAAAQAKAAoEpgSmADsAAAkBNjIXARYGKwEVMzU0NhcBFhQHAQYmPQEjFTMyFgcBBiInASY2OwE1IxUUBicBJjQ3ATYWHQEzNSMiJgE+AQgIFAgBBAcFCqrICggBCAgI/vgICsiqCgUH/vwIFAj++AgFCq/ICgj++AgIAQgICsivCgUDlgEICAj++AgKyK0KBAf+/AcVB/73BwQKrcgKCP74CAgBCAgKyK0KBAcBCQcVBwEEBwQKrcgKAAEAyAAAA4QETAAZAAATMzIWFREBNhYVERQGJwERFAYrASImNRE0NvpkFR0B0A8VFQ/+MB0VZBUdHQRMHRX+SgHFDggV/BgVCA4Bxf5KFR0dFQPoFR0AAAABAAAAAASwBEwAIwAAEzMyFhURATYWFREBNhYVERQGJwERFAYnAREUBisBIiY1ETQ2MmQVHQHQDxUB0A8VFQ/+MBUP/jAdFWQVHR0ETB0V/koBxQ4IFf5KAcUOCBX8GBUIDgHF/koVCA4Bxf5KFR0dFQPoFR0AAAABAJ0AGQSwBDMAFQAAAREUBicBERQGJwEmNDcBNhYVEQE2FgSwFQ/+MBUP/hQPDwHsDxUB0A8VBBr8GBUIDgHF/koVCA4B4A4qDgHgDggV/koBxQ4IAAAAAQDIABYEMwQ2AAsAABMBFhQHAQYmNRE0NvMDLhIS/NISGRkEMv4OCx4L/g4LDhUD6BUOAAIAyABkA4QD6AAPAB8AABMzMhYVERQGKwEiJjURNDYhMzIWFREUBisBIiY1ETQ2+sgVHR0VyBUdHQGlyBUdHRXIFR0dA+gdFfzgFR0dFQMgFR0dFfzgFR0dFQMgFR0AAAEAyABkBEwD6AAPAAABERQGIyEiJjURNDYzITIWBEwdFfzgFR0dFQMgFR0DtvzgFR0dFQMgFR0dAAAAAAEAAAAZBBMEMwAVAAABETQ2FwEWFAcBBiY1EQEGJjURNDYXAfQVDwHsDw/+FA8V/jAPFRUPAmQBthUIDv4gDioO/iAOCBUBtv47DggVA+gVCA4AAAH//gACBLMETwAjAAABNzIWFRMUBiMHIiY1AwEGJjUDAQYmNQM0NhcBAzQ2FwEDNDYEGGQUHgUdFWQVHQL+MQ4VAv4yDxUFFQ8B0gIVDwHSAh0ETgEdFfwYFR0BHRUBtf46DwkVAbX+OQ4JFAPoFQkP/j4BthQJDv49AbYVHQAAAQEsAAAD6ARMABkAAAEzMhYVERQGKwEiJjURAQYmNRE0NhcBETQ2A1JkFR0dFWQVHf4wDxUVDwHQHQRMHRX8GBUdHRUBtv47DggVA+gVCA7+OwG2FR0AAAIAZADIBLAESAALABsAAAkBFgYjISImNwE2MgEhMhYdARQGIyEiJj0BNDYCrgH1DwkW++4WCQ8B9Q8q/fcD6BUdHRX8GBUdHQQ5/eQPFhYPAhwP/UgdFWQVHR0VZBUdAAEAiP/8A3UESgAFAAAJAgcJAQN1/qABYMX92AIoA4T+n/6fxgIoAiYAAAAAAQE7//wEKARKAAUAAAkBJwkBNwQo/dnGAWH+n8YCI/3ZxgFhAWHGAAIAFwAXBJkEmQAPADMAAAAyHgIUDgIiLgI0PgEFIyIGHQEjIgYdARQWOwEVFBY7ATI2PQEzMjY9ATQmKwE1NCYB4+rWm1tbm9bq1ptbW5sBfWQVHZYVHR0Vlh0VZBUdlhUdHRWWHQSZW5vW6tabW1ub1urWm7odFZYdFWQVHZYVHR0Vlh0VZBUdlhUdAAAAAAIAFwAXBJkEmQAPAB8AAAAyHgIUDgIiLgI0PgEBISIGHQEUFjMhMjY9ATQmAePq1ptbW5vW6tabW1ubAkX+DBUdHRUB9BUdHQSZW5vW6tabW1ub1urWm/5+HRVkFR0dFWQVHQACABcAFwSZBJkADwAzAAAAMh4CFA4CIi4CND4BBCIPAScmIg8BBhQfAQcGFB8BFjI/ARcWMj8BNjQvATc2NC8BAePq1ptbW5vW6tabW1ubAeUZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0JCXh4CQmNBJlbm9bq1ptbW5vW6tabrQl4eAkJjQkZCXh4CRkJjQkJeHgJCY0JGQl4eAkZCY0AAgAXABcEmQSZAA8AJAAAADIeAhQOAiIuAjQ+AQEnJiIPAQYUHwEWMjcBNjQvASYiBwHj6tabW1ub1urWm1tbmwEVVAcVCIsHB/IHFQcBdwcHiwcVBwSZW5vW6tabW1ub1urWm/4xVQcHiwgUCPEICAF3BxUIiwcHAAAAAAMAFwAXBJkEmQAPADsASwAAADIeAhQOAiIuAjQ+AQUiDgMVFDsBFjc+ATMyFhUUBgciDgUHBhY7ATI+AzU0LgMTIyIGHQEUFjsBMjY9ATQmAePq1ptbW5vW6tabW1ubAT8dPEIyIRSDHgUGHR8UFw4TARkOGhITDAIBDQ6tBx4oIxgiM0Q8OpYKDw8KlgoPDwSZW5vW6tabW1ub1urWm5ELHi9PMhkFEBQQFRIXFgcIBw4UHCoZCBEQKDhcNi9IKhsJ/eMPCpYKDw8KlgoPAAADABcAFwSZBJkADwAfAD4AAAAyHgIUDgIiLgI0PgEFIyIGHQEUFjsBMjY9ATQmAyMiBh0BFBY7ARUjIgYdARQWMyEyNj0BNCYrARE0JgHj6tabW1ub1urWm1tbmwGWlgoPDwqWCg8PCvoKDw8KS0sKDw8KAV4KDw8KSw8EmVub1urWm1tbm9bq1ptWDwqWCg8PCpYKD/7UDwoyCg/IDwoyCg8PCjIKDwETCg8AAgAAAAAEsASwAC8AXwAAATMyFh0BHgEXMzIWHQEUBisBDgEHFRQGKwEiJj0BLgEnIyImPQE0NjsBPgE3NTQ2ExUUBisBIiY9AQ4BBzMyFh0BFAYrAR4BFzU0NjsBMhYdAT4BNyMiJj0BNDY7AS4BAg2WCg9nlxvCCg8PCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw+5DwqWCg9EZheoCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmBLAPCsIbl2cPCpYKD2eXG8IKDw8KwhuXZw8KlgoPZ5cbwgoP/s2oCg8PCqgXZkQPCpYKD0RmF6gKDw8KqBdmRA8KlgoPRGYAAwAXABcEmQSZAA8AGwA/AAAAMh4CFA4CIi4CND4BBCIOARQeATI+ATQmBxcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyAePq1ptbW5vW6tabW1ubAb/oxXJyxejFcnKaQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwdABxUHfHwHFQSZW5vW6tabW1ub1urWmztyxejFcnLF6MVaQAcVB3x8BxUHQAcHfHwHB0AHFQd8fAcVB0AHB3x8BwAAAAMAFwAXBJkEmQAPABsAMAAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgcXFhQHAQYiLwEmND8BNjIfATc2MgHj6tabW1ub1urWm1tbmwG/6MVycsXoxXJyg2oHB/7ACBQIyggIagcVB0/FBxUEmVub1urWm1tbm9bq1ps7csXoxXJyxejFfWoHFQf+vwcHywcVB2oICE/FBwAAAAMAFwAXBJkEmQAPABgAIQAAADIeAhQOAiIuAjQ+AQUiDgEVFBcBJhcBFjMyPgE1NAHj6tabW1ub1urWm1tbmwFLdMVyQQJLafX9uGhzdMVyBJlbm9bq1ptbW5vW6tabO3LFdHhpAktB0P24PnLFdHMAAAAAAQAXAFMEsAP5ABUAABMBNhYVESEyFh0BFAYjIREUBicBJjQnAgoQFwImFR0dFf3aFxD99hACRgGrDQoV/t0dFcgVHf7dFQoNAasNJgAAAAABAAAAUwSZA/kAFQAACQEWFAcBBiY1ESEiJj0BNDYzIRE0NgJ/AgoQEP32EBf92hUdHRUCJhcD8f5VDSYN/lUNChUBIx0VyBUdASMVCgAAAAEAtwAABF0EmQAVAAAJARYGIyERFAYrASImNREhIiY3ATYyAqoBqw0KFf7dHRXIFR3+3RUKDQGrDSYEif32EBf92hUdHRUCJhcQAgoQAAAAAQC3ABcEXQSwABUAAAEzMhYVESEyFgcBBiInASY2MyERNDYCJsgVHQEjFQoN/lUNJg3+VQ0KFQEjHQSwHRX92hcQ/fYQEAIKEBcCJhUdAAABAAAAtwSZBF0AFwAACQEWFAcBBiY1EQ4DBz4ENxE0NgJ/AgoQEP32EBdesKWBJAUsW4fHfhcEVf5VDSYN/lUNChUBIwIkRHVNabGdcUYHAQYVCgACAAAAAASwBLAAFQArAAABITIWFREUBi8BBwYiLwEmND8BJyY2ASEiJjURNDYfATc2Mh8BFhQPARcWBgNSASwVHRUOXvkIFAhqBwf5Xg4I/iH+1BUdFQ5e+QgUCGoHB/leDggEsB0V/tQVCA5e+QcHaggUCPleDhX7UB0VASwVCA5e+QcHaggUCPleDhUAAAACAEkASQRnBGcAFQArAAABFxYUDwEXFgYjISImNRE0Nh8BNzYyASEyFhURFAYvAQcGIi8BJjQ/AScmNgP2agcH+V4OCBX+1BUdFQ5e+QgU/QwBLBUdFQ5e+QgUCGoHB/leDggEYGoIFAj5Xg4VHRUBLBUIDl75B/3xHRX+1BUIDl75BwdqCBQI+V4OFQAAAAADABcAFwSZBJkADwAfAC8AAAAyHgIUDgIiLgI0PgEFIyIGFxMeATsBMjY3EzYmAyMiBh0BFBY7ATI2PQE0JgHj6tabW1ub1urWm1tbmwGz0BQYBDoEIxQ2FCMEOgQYMZYKDw8KlgoPDwSZW5vW6tabW1ub1urWm7odFP7SFB0dFAEuFB3+DA8KlgoPDwqWCg8AAAAABQAAAAAEsASwAEkAVQBhAGgAbwAAATIWHwEWHwEWFxY3Nj8BNjc2MzIWHwEWHwIeATsBMhYdARQGKwEiBh0BIREjESE1NCYrASImPQE0NjsBMjY1ND8BNjc+BAUHBhY7ATI2LwEuAQUnJgYPAQYWOwEyNhMhIiY1ESkBERQGIyERAQQJFAUFFhbEFQ8dCAsmxBYXERUXMA0NDgQZCAEPCj0KDw8KMgoP/nDI/nAPCjIKDw8KPQsOCRkFDgIGFRYfAp2mBwQK2woKAzMDEP41sQgQAzMDCgrnCwMe/okKDwGQAlgPCv6JBLAEAgIKDXYNCxUJDRZ2DQoHIREQFRh7LAkLDwoyCg8PCq8BLP7UrwoPDwoyCg8GBQQwgBkUAwgWEQ55ogcKDgqVCgSqnQcECo8KDgr8cg8KAXf+iQoPAZAAAAAAAgAAAAwErwSmACsASQAAATYWFQYCDgQuAScmByYOAQ8BBiY1NDc+ATc+AScuAT4BNz4GFyYGBw4BDwEOBAcOARY2Nz4CNz4DNz4BBI0IGgItQmxhi2KORDg9EQQRMxuZGhYqCFUYEyADCQIQOjEnUmFch3vAJQgdHyaiPT44XHRZUhcYDhItIRmKcVtGYWtbKRYEBKYDEwiy/t3IlVgxEQgLCwwBAQIbG5kYEyJAJghKFRE8Hzdff4U/M0o1JSMbL0QJGCYvcSEhHjZST2c1ODwEJygeW0AxJUBff1UyFAABAF0AHgRyBM8ATwAAAQ4BHgQXLgc+ATceAwYHDgQHBicmNzY3PgQuAScWDgMmJy4BJyY+BDcGHgM3PgEuAicmPgMCjScfCic4R0IgBBsKGAoQAwEJEg5gikggBhANPkpTPhZINx8SBgsNJysiCRZOQQoVNU1bYC9QZwICBAUWITsoCAYdJzIYHw8YIiYHDyJJYlkEz0OAZVxEOSQMBzgXOB42IzElKRIqg5Gnl0o3Z0c6IAYWCwYNAwQFIDhHXGF1OWiqb0sdBxUknF0XNTQ8PEUiNWNROBYJDS5AQVUhVZloUSkAAAAAA//cAGoE1ARGABsAPwBRAAAAMh4FFA4FIi4FND4EBSYGFxYVFAYiJjU0NzYmBwYHDgEXHgQyPgM3NiYnJgUHDgEXFhcWNj8BNiYnJicuAQIGpJ17bk85HBw6T257naKde25POhwcOU9uewIPDwYIGbD4sBcIBw5GWg0ECxYyWl+DiINfWjIWCwQMWv3/Iw8JCSU4EC0OIw4DDywtCyIERi1JXGJcSSpJXGJcSS0tSVxiXEkqSVxiXEncDwYTOT58sLB8OzcTBg9FcxAxEiRGXkQxMEVeRSQSMRF1HiQPLxJEMA0EDyIPJQ8sSRIEAAAABP/cAAAE1ASwABQAJwA7AEwAACEjNy4ENTQ+BTMyFzczEzceARUUDgMHNz4BNzYmJyYlBgcOARceBBc3LgE1NDc2JhcHDgEXFhcWNj8CJyYnLgECUJQfW6l2WSwcOU9ue51SPUEglCYvbIknUGqYUi5NdiYLBAw2/VFGWg0ECxIqSExoNSlrjxcIB3wjDwkJJTgQLQ4MFgMsLQsieBRhdHpiGxVJXGJcSS0Pef5StVXWNBpacm5jGq0xiD8SMRFGckVzEDESHjxRQTkNmhKnbjs3EwZwJA8vEkQwDQQPC1YELEkSBAAAAAP/ngAABRIEqwALABgAKAAAJwE2FhcBFgYjISImJSE1NDY7ATIWHQEhAQczMhYPAQ4BKwEiJi8BJjZaAoIUOBQCghUbJfryJRsBCgFZDwqWCg8BWf5DaNAUGAQ6BCMUNhQjBDoEGGQEKh8FIfvgIEdEhEsKDw8KSwLT3x0U/BQdHRT8FB0AAAABAGQAFQSwBLAAKAAAADIWFREBHgEdARQGJyURFh0BFAYvAQcGJj0BNDcRBQYmPQE0NjcBETQCTHxYAWsPFhgR/plkGhPNzRMaZP6ZERgWDwFrBLBYPv6t/rsOMRQpFA0M+f75XRRAFRAJgIAJEBVAFF0BB/kMDRQpFDEOAUUBUz4AAAARAAAAAARMBLAAHQAnACsALwAzADcAOwA/AEMARwBLAE8AUwBXAFsAXwBjAAABMzIWHQEzMhYdASE1NDY7ATU0NjsBMhYdASE1NDYBERQGIyEiJjURFxUzNTMVMzUzFTM1MxUzNTMVMzUFFTM1MxUzNTMVMzUzFTM1MxUzNQUVMzUzFTM1MxUzNTMVMzUzFTM1A1JkFR0yFR37tB0VMh0VZBUdAfQdAQ8dFfwYFR1kZGRkZGRkZGRk/HxkZGRkZGRkZGT8fGRkZGRkZGRkZASwHRUyHRWWlhUdMhUdHRUyMhUd/nD9EhUdHRUC7shkZGRkZGRkZGRkyGRkZGRkZGRkZGTIZGRkZGRkZGRkZAAAAAMAAAAZBXcElwAZACUANwAAARcWFA8BBiY9ASMBISImPQE0NjsBATM1NDYBBycjIiY9ATQ2MyEBFxYUDwEGJj0BIyc3FzM1NDYEb/kPD/kOFZ/9qP7dFR0dFdECWPEV/amNetEVHR0VASMDGvkPD/kOFfG1jXqfFQSN5g4qDuYOCBWW/agdFWQVHQJYlhUI/piNeh0VZBUd/k3mDioO5g4IFZa1jXqWFQgAAAABAAAAAASwBEwAEgAAEyEyFhURFAYjIQERIyImNRE0NmQD6Ck7Oyn9rP7QZCk7OwRMOyn9qCk7/tQBLDspAlgpOwAAAAMAZAAABEwEsAAJABMAPwAAEzMyFh0BITU0NiEzMhYdASE1NDYBERQOBSIuBTURIRUUFRwBHgYyPgYmNTQ9AZbIFR3+1B0C0cgVHf7UHQEPBhgoTGacwJxmTCgYBgEsAwcNFB8nNkI2Jx8TDwUFAQSwHRX6+hUdHRX6+hUd/nD+1ClJalZcPigoPlxWakkpASz6CRIVKyclIRsWEAgJEBccISUnKhURCPoAAAAB//8A1ARMA8IABQAAAQcJAScBBEzG/p/+n8UCJwGbxwFh/p/HAicAAQAAAO4ETQPcAAUAAAkCNwkBBE392v3ZxgFhAWEDFf3ZAifH/p8BYQAAAAAC/1EAZAVfA+gAFAApAAABITIWFREzMhYPAQYiLwEmNjsBESElFxYGKwERIRchIiY1ESMiJj8BNjIBlALqFR2WFQgO5g4qDuYOCBWW/oP+HOYOCBWWAYHX/RIVHZYVCA7mDioD6B0V/dkVDvkPD/kOFQGRuPkOFf5wyB0VAiYVDvkPAAABAAYAAASeBLAAMAAAEzMyFh8BITIWBwMOASMhFyEyFhQGKwEVFAYiJj0BIRUUBiImPQEjIiYvAQMjIiY0NjheERwEJgOAGB4FZAUsIf2HMAIXFR0dFTIdKh3+1B0qHR8SHQYFyTYUHh4EsBYQoiUY/iUVK8gdKh0yFR0dFTIyFR0dFTIUCQoDwR0qHQAAAAACAAAAAASwBEwACwAPAAABFSE1MzQ2MyEyFhUFIREhBLD7UMg7KQEsKTv9RASw+1AD6GRkKTs7Kcj84AACAAAAAAXcBEwADAAQAAATAxEzNDYzITIWFSEVBQEhAcjIyDspASwqOgH0ASz+1PtQASwDIP5wAlgpOzspyGT9RAK8AAEBRQAAA2sErwAbAAABFxYGKwERMzIWDwEGIi8BJjY7AREjIiY/ATYyAnvmDggVlpYVCA7mDioO5g4IFZaWFQgO5g4qBKD5DhX9pxUO+Q8P+Q4VAlkVDvkPAAAAAQABAUQErwNrABsAAAEXFhQPAQYmPQEhFRQGLwEmND8BNhYdASE1NDYDqPkODvkPFf2oFQ/5Dg75DxUCWBUDYOUPKQ/lDwkUl5cUCQ/lDykP5Q8JFZWVFQkAAAAEAAAAAASwBLAACQAZAB0AIQAAAQMuASMhIgYHAwUhIgYdARQWMyEyNj0BNCYFNTMVMzUzFQSRrAUkFP1gFCQFrAQt/BgpOzspA+gpOzv+q2RkZAGQAtwXLSgV/R1kOylkKTs7KWQpO8hkZGRkAAAAA/+cAGQEsARMAAsAIwAxAAAAMhYVERQGIiY1ETQDJSMTFgYjIisBIiYnAj0BNDU0PgE7ASUBFSIuAz0BND4CNwRpKh0dKh1k/V0mLwMRFQUCVBQdBDcCCwzIAqP8GAQOIhoWFR0dCwRMHRX8rhUdHRUDUhX8mcj+7BAIHBUBUQ76AgQQDw36/tT6AQsTKRwyGigUDAEAAAACAEoAAARmBLAALAA1AAABMzIWDwEeARcTFzMyFhQGBw4EIyIuBC8BLgE0NjsBNxM+ATcnJjYDFjMyNw4BIiYCKV4UEgYSU3oPP3YRExwaEggeZGqfTzl0XFU+LwwLEhocExF2Pw96UxIGEyQyNDUxDDdGOASwFRMlE39N/rmtHSkoBwQLHBYSCg4REg4FBAgoKR2tAUdNfhQgExr7vgYGMT09AAEAFAAUBJwEnAAXAAABNwcXBxcHFycHJwcnBzcnNyc3Jxc3FzcDIOBO6rS06k7gLZubLeBO6rS06k7gLZubA7JO4C2bmy3gTuq0tOpO4C2bmy3gTuq0tAADAAAAZASwBLAAIQAtAD0AAAEzMhYdAQchMhYdARQHAw4BKwEiJi8BIyImNRE0PwI+ARcPAREzFzMTNSE3NQEzMhYVERQGKwEiJjURNDYCijIoPBwBSCg8He4QLBf6B0YfHz0tNxSRYA0xG2SWZIjW+v4+Mv12ZBUdHRVkFR0dBLBRLJZ9USxkLR3+qBghMhkZJCcBkCQbxMYcKGTU1f6JZAF3feGv/tQdFf4MFR0dFQH0FR0AAAAAAwAAAAAEsARMACAAMAA8AAABMzIWFxMWHQEUBiMhFh0BFAYrASImLwImNRE0NjsBNgUzMhYVERQGKwEiJjURNDYhByMRHwEzNSchNQMCWPoXLBDuHTwo/rgcPCgyGzENYJEUNy09fP3pZBUdHRVkFR0dAl+IZJZkMjIBwvoETCEY/qgdLWQsUXYHlixRKBzGxBskAZAnJGRkHRX+DBUdHRUB9BUdZP6J1dSv4X0BdwADAAAAZAUOBE8AGwA3AEcAAAElNh8BHgEPASEyFhQGKwEDDgEjISImNRE0NjcXERchEz4BOwEyNiYjISoDLgQnJj8BJwUzMhYVERQGKwEiJjURNDYBZAFrHxZuDQEMVAEuVGxuVGqDBhsP/qoHphwOOmQBJYMGGw/LFRMSFv44AgoCCQMHAwUDAQwRklb9T2QVHR0VZBUdHQNp5hAWcA0mD3lMkE7+rRUoog0CDRElCkj+CVkBUxUoMjIBAgIDBQIZFrdT5B0V/gwVHR0VAfQVHQAAAAP/nABkBLAETwAdADYARgAAAQUeBBURFAYjISImJwMjIiY0NjMhJyY2PwE2BxcWBw4FKgIjIRUzMhYXEyE3ESUFMzIWFREUBisBIiY1ETQ2AdsBbgIIFBANrAf+qg8bBoNqVW1sVAEuVQsBDW4WSpIRDAIDBQMHAwkDCgH+Jd0PHAaCASZq/qoCUGQVHR0VZBUdHQRP5gEFEBEXC/3zDaIoFQFTTpBMeQ8mDXAWrrcWGQIFAwICAWQoFf6tWQH37OQdFf4MFR0dFQH0FR0AAAADAGEAAARMBQ4AGwA3AEcAAAAyFh0BBR4BFREUBiMhIiYvAQMmPwE+AR8BETQXNTQmBhURHAMOBAcGLwEHEyE3ESUuAQMhMhYdARQGIyEiJj0BNDYB3pBOAVMVKKIN/fMRJQoJ5hAWcA0mD3nGMjIBAgIDBQIZFrdT7AH3Wf6tFSiWAfQVHR0V/gwVHR0FDm5UaoMGGw/+qgemHA4OAWsfFm4NAQxUAS5U1ssVExIW/jgCCgIJAwcDBQMBDBGSVv6tZAElgwYb/QsdFWQVHR0VZBUdAAP//QAGA+gFFAAPAC0ASQAAASEyNj0BNCYjISIGHQEUFgEVFAYiJjURBwYmLwEmNxM+BDMhMhYVERQGBwEDFzc2Fx4FHAIVERQWNj0BNDY3JREnAV4B9BUdHRX+DBUdHQEPTpBMeQ8mDXAWEOYBBRARFwsCDQ2iKBX9iexTtxYZAgUDAgIBMjIoFQFTWQRMHRVkFR0dFWQVHfzmalRubFQBLlQMAQ1uFh8BawIIEw8Mpgf+qg8bBgHP/q1WkhEMAQMFAwcDCQIKAv44FhITFcsPGwaDASVkAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBJSYGHQEhIgYdARQWMyEVFBY3JTY0AeLs1ptbW5vW7NabW1ubAob+7RAX/u0KDw8KARMXEAETEASaW5vW7NabW1ub1uzWm/453w0KFYkPCpYKD4kVCg3fDSYAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgENAQYUFwUWNj0BITI2PQE0JiMhNTQmAeLs1ptbW5vW7NabW1ubASX+7RAQARMQFwETCg8PCv7tFwSaW5vW7NabW1ub1uzWm+jfDSYN3w0KFYkPCpYKD4kVCgAAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEBAyYiBwMGFjsBERQWOwEyNjURMzI2AeLs1ptbW5vW7NabW1ubAkvfDSYN3w0KFYkPCpYKD4kVCgSaW5vW7NabW1ub1uzWm/5AARMQEP7tEBf+7QoPDwoBExcAAAIAFgAWBJoEmgAPACUAAAAyHgIUDgIiLgI0PgEFIyIGFREjIgYXExYyNxM2JisBETQmAeLs1ptbW5vW7NabW1ubAZeWCg+JFQoN3w0mDd8NChWJDwSaW5vW7NabW1ub1uzWm7sPCv7tFxD+7RAQARMQFwETCg8AAAMAGAAYBJgEmAAPAJYApgAAADIeAhQOAiIuAjQ+ASUOAwcGJgcOAQcGFgcOAQcGFgcUFgcyHgEXHgIXHgI3Fg4BFx4CFxQGFBcWNz4CNy4BJy4BJyIOAgcGJyY2NS4BJzYuAQYHBicmNzY3HgIXHgMfAT4CJyY+ATc+AzcmNzIWMjY3LgMnND4CJiceAT8BNi4CJwYHFB4BFS4CJz4BNxYyPgEB5OjVm1xcm9Xo1ZtcXJsBZA8rHDoKDz0PFD8DAxMBAzEFCRwGIgEMFhkHECIvCxU/OR0HFBkDDRQjEwcFaHUeISQDDTAMD0UREi4oLBAzDwQBBikEAQMLGhIXExMLBhAGKBsGBxYVEwYFAgsFAwMNFwQGCQcYFgYQCCARFwkKKiFBCwQCAQMDHzcLDAUdLDgNEiEQEgg/KhADGgMKEgoRBJhcm9Xo1ZtcXJvV6NWbEQwRBwkCAwYFBycPCxcHInIWInYcCUcYChQECA4QBAkuHgQPJioRFRscBAcSCgwCch0kPiAIAQcHEAsBAgsLIxcBMQENCQIPHxkCFBkdHB4QBgEBBwoMGBENBAMMJSAQEhYXDQ4qFBkKEhIDCQsXJxQiBgEOCQwHAQ0DBAUcJAwSCwRnETIoAwEJCwsLJQcKDBEAAAAAAQAAAAIErwSFABYAAAE2FwUXNxYGBw4BJwEGIi8BJjQ3ASY2AvSkjv79kfsGUE08hjv9rA8rD28PDwJYIk8EhVxliuh+WYcrIgsW/awQEG4PKxACV2XJAAYAAABgBLAErAAPABMAIwAnADcAOwAAEyEyFh0BFAYjISImPQE0NgUjFTMFITIWHQEUBiMhIiY9ATQ2BSEVIQUhMhYdARQGIyEiJj0BNDYFIRUhZAPoKTs7KfwYKTs7BBHIyPwYA+gpOzsp/BgpOzsEEf4MAfT8GAPoKTs7KfwYKTs7BBH+1AEsBKw7KWQpOzspZCk7ZGTIOylkKTs7KWQpO2RkyDspZCk7OylkKTtkZAAAAAIAZAAABEwEsAALABEAABMhMhYUBiMhIiY0NgERBxEBIZYDhBUdHRX8fBUdHQI7yP6iA4QEsB0qHR0qHf1E/tTIAfQB9AAAAAMAAABkBLAEsAAXABsAJQAAATMyFh0BITIWFREhNSMVIRE0NjMhNTQ2FxUzNQEVFAYjISImPQEB9MgpOwEsKTv+DMj+DDspASw7KcgB9Dsp/BgpOwSwOylkOyn+cGRkAZApO2QpO2RkZP1EyCk7OynIAAAABAAAAAAEsASwABUAKwBBAFcAABMhMhYPARcWFA8BBiIvAQcGJjURNDYpATIWFREUBi8BBwYiLwEmND8BJyY2ARcWFA8BFxYGIyEiJjURNDYfATc2MgU3NhYVERQGIyEiJj8BJyY0PwE2MhcyASwVCA5exwcHaggUCMdeDhUdAzUBLBUdFQ5exwgUCGoHB8deDgj+L2oHB8deDggV/tQVHRUOXscIFALLXg4VHRX+1BUIDl7HBwdqCBQIBLAVDl7HCBQIagcHx14OCBUBLBUdHRX+1BUIDl7HBwdqCBQIx14OFf0maggUCMdeDhUdFQEsFQgOXscHzl4OCBX+1BUdFQ5exwgUCGoHBwAAAAYAAAAABKgEqAAPABsAIwA7AEMASwAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JiQyFhQGIiY0JDIWFAYjIicHFhUUBiImNTQ2PwImNTQEMhYUBiImNCQyFhQGIiY0Advy3Z9fX5/d8t2gXl6gAcbgv29vv+C/b2/+LS0gIC0gAUwtICAWDg83ETNIMykfegEJ/octICAtIAIdLSAgLSAEqF+f3fLdoF5eoN3y3Z9Xb7/gv29vv+C/BiAtISEtICAtIQqRFxwkMzMkIDEFfgEODhekIC0gIC0gIC0gIC0AAf/YAFoEuQS8AFsAACUBNjc2JicmIyIOAwcABw4EFx4BMzI3ATYnLgEjIgcGBwEOASY0NwA3PgEzMhceARcWBgcOBgcGIyImJyY2NwE2NzYzMhceARcWBgcBDgEnLgECIgHVWwgHdl8WGSJBMD8hIP6IDx4eLRMNBQlZN0ozAiQkEAcdEhoYDRr+qw8pHA4BRyIjQS4ODyw9DQ4YIwwod26La1YOOEBGdiIwGkQB/0coW2tQSE5nDxE4Qv4eDyoQEAOtAdZbZWKbEQQUGjIhH/6JDxsdNSg3HT5CMwIkJCcQFBcMGv6uDwEcKQ4BTSIjIQEINykvYyMLKnhuiWZMBxtAOU6+RAH/SBg3ISSGV121Qv4kDwIPDyYAAAACAGQAWASvBEQAGQBEAAABPgIeAhUUDgMHLgQ1ND4CHgEFIg4DIi4DIyIGFRQeAhcWFx4EMj4DNzY3PgQ1NCYCiTB7eHVYNkN5hKg+PqeFeEM4WnZ4eQEjIT8yLSohJyktPyJDbxtBMjMPBw86KzEhDSIzKUAMBAgrKT8dF2oDtURIBS1TdkA5eYB/slVVsn+AeTlAdlMtBUgtJjY1JiY1NiZvTRc4SjQxDwcOPCouGBgwKEALBAkpKkQqMhNPbQACADn/8gR3BL4AFwAuAAAAMh8BFhUUBg8BJi8BNycBFwcvASY0NwEDNxYfARYUBwEGIi8BJjQ/ARYfAQcXAQKru0KNQjgiHR8uEl/3/nvUaRONQkIBGxJpCgmNQkL+5UK6Qo1CQjcdLhJf9wGFBL5CjUJeKmsiHTUuEl/4/nvUahKNQrpCARv+RmkICY1CukL+5UJCjUK7Qjc3LxFf+AGFAAAAAAMAyAAAA+gEsAARABUAHQAAADIeAhURFAYjISImNRE0PgEHESERACIGFBYyNjQCBqqaZDo7Kf2oKTs8Zj4CWP7/Vj09Vj0EsB4uMhX8Ryk7OykDuRUzLar9RAK8/RY9Vj09VgABAAAAAASwBLAAFgAACQEWFAYiLwEBEScBBRMBJyEBJyY0NjIDhgEbDx0qDiT+6dT+zP7oywEz0gEsAQsjDx0qBKH+5g8qHQ8j/vX+1NL+zcsBGAE01AEXJA4qHQAAAAADAScAEQQJBOAAMgBAAEsAAAEVHgQXIy4DJxEXHgQVFAYHFSM1JicuASczHgEXEScuBDU0PgI3NRkBDgMVFB4DFxYXET4ENC4CArwmRVI8LAKfBA0dMydAIjxQNyiym2SWVygZA4sFV0obLkJOMCAyVWg6HSoqFQ4TJhkZCWgWKTEiGBkzNwTgTgUTLD9pQiQuLBsH/s0NBxMtPGQ+i6oMTU8QVyhrVk1iEAFPCA4ZLzlYNkZwSCoGTf4SARIEDh02Jh0rGRQIBgPQ/soCCRYgNEM0JRkAAAABAGQAZgOUBK0ASgAAATIeARUjNC4CIyIGBwYVFB4BFxYXMxUjFgYHBgc+ATM2FjMyNxcOAyMiLgEHDgEPASc+BTc+AScjNTMmJy4CPgE3NgIxVJlemSc8OxolVBQpGxoYBgPxxQgVFS02ImIWIIwiUzUyHzY4HCAXanQmJ1YYFzcEGAcTDBEJMAwk3aYXFQcKAg4tJGEErVCLTig/IhIdFSw5GkowKgkFZDKCHj4yCg8BIh6TExcIASIfBAMaDAuRAxAFDQsRCjePR2QvORQrREFMIVgAAAACABn//wSXBLAADwAfAAABMzIWDwEGIi8BJjY7AREzBRcWBisBESMRIyImPwE2MgGQlhUIDuYOKg7mDggVlsgCF+YOCBWWyJYVCA7mDioBLBYO+g8P+g4WA4QQ+Q4V/HwDhBUO+Q8AAAQAGf//A+gEsAAHABcAGwAlAAABIzUjFSMRIQEzMhYPAQYiLwEmNjsBETMFFTM1EwczFSE1NyM1IQPoZGRkASz9qJYVCA7mDioO5g4IFZbIAZFkY8jI/tTIyAEsArxkZAH0/HwWDvoPD/oOFgOEZMjI/RL6ZJb6ZAAAAAAEABn//wPoBLAADwAZACEAJQAAATMyFg8BBiIvASY2OwERMwUHMxUhNTcjNSERIzUjFSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAljIyP7UyMgBLGRkZAEsx2QBLBYO+g8P+g4WA4SW+mSW+mT7UGRkAfRkyMgAAAAEABn//wRMBLAADwAVABsAHwAAATMyFg8BBiIvASY2OwERMwEjESM1MxMjNSMRIQcVMzUBkJYVCA7mDioO5g4IFZbIAlhkZMhkZMgBLMdkASwWDvoPD/oOFgOE/gwBkGT7UGQBkGTIyAAAAAAEABn//wRMBLAADwAVABkAHwAAATMyFg8BBiIvASY2OwERMwEjNSMRIQcVMzUDIxEjNTMBkJYVCA7mDioO5g4IFZbIArxkyAEsx2QBZGTIASwWDvoPD/oOFgOE/gxkAZBkyMj7tAGQZAAAAAAFABn//wSwBLAADwATABcAGwAfAAABMzIWDwEGIi8BJjY7AREzBSM1MxMhNSETITUhEyE1IQGQlhUIDuYOKg7mDggVlsgB9MjIZP7UASxk/nABkGT+DAH0ASwWDvoPD/oOFgOEyMj+DMj+DMj+DMgABQAZ//8EsASwAA8AEwAXABsAHwAAATMyFg8BBiIvASY2OwERMwUhNSEDITUhAyE1IQMjNTMBkJYVCA7mDioO5g4IFZbIAyD+DAH0ZP5wAZBk/tQBLGTIyAEsFg76Dw/6DhYDhMjI/gzI/gzI/gzIAAIAAAAABEwETAAPAB8AAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmAV4BkKK8u6P+cKW5uQJn/gwpOzspAfQpOzsETLuj/nClubmlAZClucg7Kf4MKTs7KQH0KTsAAAAAAwAAAAAETARMAA8AHwArAAABITIWFREUBiMhIiY1ETQ2BSEiBhURFBYzITI2NRE0JgUXFhQPAQYmNRE0NgFeAZClubml/nCju7wCZP4MKTs7KQH0KTs7/m/9ERH9EBgYBEy5pf5wpbm5pQGQo7vIOyn+DCk7OykB9Ck7gr4MJAy+DAsVAZAVCwAAAAADAAAAAARMBEwADwAfACsAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFg8BBiIvASY2AV4BkKO7uaX+cKW5uQJn/gwpOzspAfQpOzv+FQGQFQsMvgwkDL4MCwRMvKL+cKW5uaUBkKO7yDsp/gwpOzspAfQpO8gYEP0REf0QGAAAAAMAAAAABEwETAAPAB8AKwAAASEyFhURFAYjISImNRE0NgUhIgYVERQWMyEyNjURNCYFFxYGIyEiJj8BNjIBXgGQpbm5pf5wo7u5Amf+DCk7OykB9Ck7O/77vgwLFf5wFQsMvgwkBEy5pf5wo7u8ogGQpbnIOyn+DCk7OykB9Ck7z/0QGBgQ/REAAAAAAgAAAAAFFARMAB8ANQAAASEyFhURFAYjISImPQE0NjMhMjY1ETQmIyEiJj0BNDYHARYUBwEGJj0BIyImPQE0NjsBNTQ2AiYBkKW5uaX+cBUdHRUBwik7Oyn+PhUdHb8BRBAQ/rwQFvoVHR0V+hYETLml/nCluR0VZBUdOykB9Ck7HRVkFR3p/uQOJg7+5A4KFZYdFcgVHZYVCgAAAQDZAAID1wSeACMAAAEXFgcGAgclMhYHIggBBwYrAScmNz4BPwEhIicmNzYANjc2MwMZCQgDA5gCASwYEQ4B/vf+8wQMDgkJCQUCUCcn/tIXCAoQSwENuwUJEASeCQoRC/5TBwEjEv7K/sUFDwgLFQnlbm4TFRRWAS/TBhAAAAACAAAAAAT+BEwAHwA1AAABITIWHQEUBiMhIgYVERQWMyEyFh0BFAYjISImNRE0NgUBFhQHAQYmPQEjIiY9ATQ2OwE1NDYBXgGQFR0dFf4+KTs7KQHCFR0dFf5wpbm5AvEBRBAQ/rwQFvoVHR0V+hYETB0VZBUdOyn+DCk7HRVkFR25pQGQpbnp/uQOJg7+5A4KFZYdFcgVHZYVCgACAAAAAASwBLAAFQAxAAABITIWFREUBi8BAQYiLwEmNDcBJyY2ASMiBhURFBYzITI2PQE3ERQGIyEiJjURNDYzIQLuAZAVHRUObf7IDykPjQ8PAThtDgj+75wpOzspAfQpO8i7o/5wpbm5pQEsBLAdFf5wFQgObf7IDw+NDykPAThtDhX+1Dsp/gwpOzsplMj+1qW5uaUBkKW5AAADAA4ADgSiBKIADwAbACMAAAAyHgIUDgIiLgI0PgEEIg4BFB4BMj4BNCYEMhYUBiImNAHh7tmdXV2d2e7ZnV1dnQHD5sJxccLmwnFx/nugcnKgcgSiXZ3Z7tmdXV2d2e7ZnUdxwubCcXHC5sJzcqBycqAAAAMAAAAABEwEsAAVAB8AIwAAATMyFhURMzIWBwEGIicBJjY7ARE0NgEhMhYdASE1NDYFFTM1AcLIFR31FAoO/oEOJw3+hQ0JFfod/oUD6BUd+7QdA2dkBLAdFf6iFg/+Vg8PAaoPFgFeFR38fB0V+voVHWQyMgAAAAMAAAAABEwErAAVAB8AIwAACQEWBisBFRQGKwEiJj0BIyImNwE+AQEhMhYdASE1NDYFFTM1AkcBeg4KFfQiFsgUGPoUCw4Bfw4n/fkD6BUd+7QdA2dkBJ7+TQ8g+hQeHRX6IQ8BrxAC/H8dFfr6FR1kMjIAAwAAAAAETARLABQAHgAiAAAJATYyHwEWFAcBBiInASY0PwE2MhcDITIWHQEhNTQ2BRUzNQGMAXEHFQeLBwf98wcVB/7cBweLCBUH1APoFR37tB0DZ2QC0wFxBweLCBUH/fMICAEjCBQIiwcH/dIdFfr6FR1kMjIABAAAAAAETASbAAkAGQAjACcAABM3NjIfAQcnJjQFNzYWFQMOASMFIiY/ASc3ASEyFh0BITU0NgUVMzWHjg4qDk3UTQ4CFtIOFQIBHRX9qxUIDtCa1P49A+gVHfu0HQNnZAP/jg4OTdRMDyqa0g4IFf2pFB4BFQ7Qm9T9Oh0V+voVHWQyMgAAAAQAAAAABEwEsAAPABkAIwAnAAABBR4BFRMUBi8BByc3JyY2EwcGIi8BJjQ/AQEhMhYdASE1NDYFFTM1AV4CVxQeARUO0JvUm9IOCMNMDyoOjg4OTf76A+gVHfu0HQNnZASwAgEdFf2rFQgO0JrUmtIOFf1QTQ4Ojg4qDk3+WB0V+voVHWQyMgACAAT/7ASwBK8ABQAIAAAlCQERIQkBFQEEsP4d/sb+cQSs/TMCq2cBFP5xAacDHPz55gO5AAAAAAIAAABkBEwEsAAVABkAAAERFAYrAREhESMiJjURNDY7AREhETMHIzUzBEwdFZb9RJYVHR0V+gH0ZMhkZAPo/K4VHQGQ/nAdFQPoFB7+1AEsyMgAAAMAAABFBN0EsAAWABoALwAAAQcBJyYiDwEhESMiJjURNDY7AREhETMHIzUzARcWFAcBBiIvASY0PwE2Mh8BATYyBEwC/tVfCRkJlf7IlhUdHRX6AfRkyGRkAbBqBwf+XAgUCMoICGoHFQdPASkHFQPolf7VXwkJk/5wHRUD6BQe/tQBLMjI/c5qBxUH/lsHB8sHFQdqCAhPASkHAAMAAAANBQcEsAAWABoAPgAAAREHJy4BBwEhESMiJjURNDY7AREhETMHIzUzARcWFA8BFxYUDwEGIi8BBwYiLwEmND8BJyY0PwE2Mh8BNzYyBExnhg8lEP72/reWFR0dFfoB9GTIZGQB9kYPD4ODDw9GDykPg4MPKQ9GDw+Dgw8PRg8pD4ODDykD6P7zZ4YPAw7+9v5wHRUD6BQe/tQBLMjI/YxGDykPg4MPKQ9GDw+Dgw8PRg8pD4ODDykPRg8Pg4MPAAADAAAAFQSXBLAAFQAZAC8AAAERISIGHQEhESMiJjURNDY7AREhETMHIzUzEzMyFh0BMzIWDwEGIi8BJjY7ATU0NgRM/qIVHf4MlhUdHRX6AfRkyGRklmQVHZYVCA7mDioO5g4IFZYdA+j+1B0Vlv5wHRUD6BQe/tQBLMjI/agdFfoVDuYODuYOFfoVHQAAAAADAAAAAASXBLAAFQAZAC8AAAERJyYiBwEhESMiJjURNDY7AREhETMHIzUzExcWBisBFRQGKwEiJj0BIyImPwE2MgRMpQ4qDv75/m6WFR0dFfoB9GTIZGTr5g4IFZYdFWQVHZYVCA7mDioD6P5wpQ8P/vf+cB0VA+gUHv7UASzIyP2F5Q8V+hQeHhT6FQ/lDwADAAAAyASwBEwACQATABcAABMhMhYdASE1NDYBERQGIyEiJjURExUhNTIETBUd+1AdBJMdFfu0FR1kAZAETB0VlpYVHf7U/doVHR0VAib+1MjIAAAGAAMAfQStBJcADwAZAB0ALQAxADsAAAEXFhQPAQYmPQEhNSE1NDYBIyImPQE0NjsBFyM1MwE3NhYdASEVIRUUBi8BJjQFIzU7AjIWHQEUBisBA6f4Dg74DhX+cAGQFf0vMhUdHRUyyGRk/oL3DhUBkP5wFQ73DwOBZGRkMxQdHRQzBI3mDioO5g4IFZbIlhUI/oUdFWQVHcjI/cvmDggVlsiWFQgO5g4qecgdFWQVHQAAAAACAGQAAASwBLAAFgBRAAABJTYWFREUBisBIiY1ES4ENRE0NiUyFh8BERQOAg8BERQGKwEiJjURLgQ1ETQ+AzMyFh8BETMRPAE+AjMyFh8BETMRND4DA14BFBklHRXIFR0EDiIaFiX+4RYZAgEVHR0LCh0VyBUdBA4iGhYBBwoTDRQZAgNkBQkVDxcZAQFkAQUJFQQxdBIUH/uuFR0dFQGNAQgbHzUeAWcfRJEZDA3+Phw/MSkLC/5BFR0dFQG/BA8uLkAcAcICBxENCxkMDf6iAV4CBxENCxkMDf6iAV4CBxENCwABAGQAAASwBEwAMwAAARUiDgMVERQWHwEVITUyNjURIREUFjMVITUyPgM1ETQmLwE1IRUiBhURIRE0JiM1BLAEDiIaFjIZGf5wSxn+DBlL/nAEDiIaFjIZGQGQSxkB9BlLBEw4AQUKFA78iBYZAQI4OA0lAYr+diUNODgBBQoUDgN4FhkBAjg4DSX+dgGKJQ04AAAABgAAAAAETARMAAwAHAAgACQAKAA0AAABITIWHQEjBTUnITchBSEyFhURFAYjISImNRE0NhcVITUBBTUlBRUhNQUVFAYjIQchJyE3MwKjAXcVHWn+2cj+cGQBd/4lASwpOzsp/tQpOzspASwCvP5wAZD8GAEsArwdFf6JZP6JZAGQyGkD6B0VlmJiyGTIOyn+DCk7OykB9Ck7ZMjI/veFo4XGyMhm+BUdZGTIAAEAEAAQBJ8EnwAmAAATNzYWHwEWBg8BHgEXNz4BHwEeAQ8BBiIuBicuBTcRohEuDosOBhF3ZvyNdxEzE8ATBxGjAw0uMUxPZWZ4O0p3RjITCwED76IRBhPCFDERdo78ZXYRBA6IDi8RogEECBUgNUNjO0qZfHNVQBAAAAACAAAAAASwBEwAIwBBAAAAMh4EHwEVFAYvAS4BPQEmIAcVFAYPAQYmPQE+BRIyHgIfARUBHgEdARQGIyEiJj0BNDY3ATU0PgIB/LimdWQ/LAkJHRTKFB2N/sKNHRTKFB0DDTE7ZnTKcFImFgEBAW0OFR0V+7QVHRUOAW0CFiYETBUhKCgiCgrIFRgDIgMiFZIYGJIVIgMiAxgVyAQNJyQrIP7kExwcCgoy/tEPMhTUFR0dFdQUMg8BLzIEDSEZAAADAAAAAASwBLAADQAdACcAAAEHIScRMxUzNTMVMzUzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYETMj9qMjIyMjIyPyuArwVHR0VDIn8SokMFR0dswRMFR37UB0CvMjIAfTIyMjI/OAdKh1kZB0qHf7UHRUyMhUdAAAAAwBkAAAEsARMAAkAEwAdAAABIyIGFREhETQmASMiBhURIRE0JgEhETQ2OwEyFhUCvGQpOwEsOwFnZCk7ASw7/Rv+1DspZCk7BEw7KfwYA+gpO/7UOyn9RAK8KTv84AGQKTs7KQAAAAAF/5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQURByMRMwcRMxHIArx8sLB8/UR8sLAYA4T+DMjI/tTIyAEsAZBkyMhkZARMsHz+DHywsHwB9HywyP1EArzIZP7UZGQBLGT+1GQB9GT+1AEsAAAABf+cAAAEsARMAA8AEwAfACUAKQAAEyEyFhURFAYjISImNRE0NhcRIREBIzUjFSMRMxUzNTMFEQcjETMHETMRyAK8fLCwfP1EfLCwGAOE/gxkZGRkZGQBkGTIyGRkBEywfP4MfLCwfAH0fLDI/UQCvP2oyMgB9MjIZP7UZAH0ZP7UASwABP+cAAAEsARMAA8AEwAbACMAABMhMhYVERQGIyEiJjURNDYXESERBSMRMxUhESEFIxEzFSERIcgCvHywsHz9RHywsBgDhP4MyMj+1AEsAZDIyP7UASwETLB8/gx8sLB8AfR8sMj9RAK8yP7UZAH0ZP7UZAH0AAAABP+cAAAEsARMAA8AEwAWABkAABMhMhYVERQGIyEiJjURNDYXESERAS0BDQERyAK8fLCwfP1EfLCwGAOE/gz+1AEsAZD+1ARMsHz+DHywsHwB9HywyP1EArz+DJaWlpYBLAAAAAX/nAAABLAETAAPABMAFwAgACkAABMhMhYVERQGIyEiJjURNDYXESERAyERIQcjIgYVFBY7AQERMzI2NTQmI8gCvHywsHz9RHywsBgDhGT9RAK8ZIImOTYpgv4Mgik2OSYETLB8/gx8sLB8AfR8sMj9RAK8/agB9GRWQUFUASz+1FRBQVYAAAAF/5wAAASwBEwADwATAB8AJQApAAATITIWFREUBiMhIiY1ETQ2FxEhEQUjFTMRITUzNSMRIQEjESM1MwMjNTPIArx8sLB8/UR8sLAYA4T+DMjI/tTIyAEsAZBkZMjIZGQETLB8/gx8sLB8AfR8sMj9RAK8yGT+1GRkASz+DAGQZP4MZAAG/5wAAASwBEwADwATABkAHwAjACcAABMhMhYVERQGIyEiJjURNDYXESERBTMRIREzASMRIzUzBRUzNQEjNTPIArx8sLB8/UR8sLAYA4T9RMj+1GQCWGRkyP2oZAEsZGQETLB8/gx8sLB8AfR8sMj9RAK8yP5wAfT+DAGQZMjIyP7UZAAF/5wAAASwBEwADwATABwAIgAmAAATITIWFREUBiMhIiY1ETQ2FxEhEQEHIzU3NSM1IQEjESM1MwMjNTPIArx8sLB8/UR8sLAYA4T+DMdkx8gBLAGQZGTIx2RkBEywfP4MfLCwfAH0fLDI/UQCvP5wyDLIlmT+DAGQZP4MZAAAAAMACQAJBKcEpwAPABsAJQAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgchFSEVISc1NyEB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWz+1AEs/tRkZAEsBKdentvw255eXp7b8NueTHHC5MJxccLkwtDIZGTIZAAAAAAEAAkACQSnBKcADwAbACcAKwAAADIeAhQOAiIuAjQ+AQQiDgEUHgEyPgE0JgcVBxcVIycjFSMRIQcVMzUB4PDbnl5entvw255eXp4BxeTCcXHC5MJxcWwyZGRklmQBLMjIBKdentvw255eXp7b8NueTHHC5MJxccLkwtBkMmQyZGQBkGRkZAAAAv/y/50EwgRBACAANgAAATIWFzYzMhYUBisBNTQmIyEiBh0BIyImNTQ2NyY1ND4BEzMyFhURMzIWDwEGIi8BJjY7ARE0NgH3brUsLC54qqp4gB0V/tQVHd5QcFZBAmKqepYKD4kVCg3fDSYN3w0KFYkPBEF3YQ6t8a36FR0dFfpzT0VrDhMSZKpi/bMPCv7tFxD0EBD0EBcBEwoPAAAAAAL/8v+cBMMEQQAcADMAAAEyFhc2MzIWFxQGBwEmIgcBIyImNTQ2NyY1ND4BExcWBisBERQGKwEiJjURIyImNzY3NjIB9m62LCsueaoBeFr+hg0lDf6DCU9xVkECYqnm3w0KFYkPCpYKD4kVCg3HGBMZBEF3YQ+teGOkHAFoEBD+k3NPRWsOExNkqWP9kuQQF/7tCg8PCgETFxDMGBMAAAABAGQAAARMBG0AGAAAJTUhATMBMwkBMwEzASEVIyIGHQEhNTQmIwK8AZD+8qr+8qr+1P7Uqv7yqv7yAZAyFR0BkB0VZGQBLAEsAU3+s/7U/tRkHRUyMhUdAAAAAAEAeQAABDcEmwAvAAABMhYXHgEVFAYHFhUUBiMiJxUyFh0BITU0NjM1BiMiJjU0Ny4BNTQ2MzIXNCY1NDYCWF6TGll7OzIJaUo3LRUd/tQdFS03SmkELzlpSgUSAqMEm3FZBoNaPWcfHRpKaR77HRUyMhUd+x5pShIUFVg1SmkCAhAFdKMAAAAGACcAFASJBJwAEQAqAEIASgBiAHsAAAEWEgIHDgEiJicmAhI3PgEyFgUiBw4BBwYWHwEWMzI3Njc2Nz4BLwEmJyYXIgcOAQcGFh8BFjMyNz4BNz4BLwEmJyYWJiIGFBYyNjciBw4BBw4BHwEWFxYzMjc+ATc2Ji8BJhciBwYHBgcOAR8BFhcWMzI3PgE3NiYvASYD8m9PT29T2dzZU29PT29T2dzZ/j0EBHmxIgQNDCQDBBcGG0dGYAsNAwkDCwccBAVQdRgEDA0iBAQWBhJROQwMAwkDCwf5Y4xjY4xjVhYGElE6CwwDCQMLBwgEBVB1GAQNDCIEjRcGG0dGYAsNAwkDCwcIBAR5sSIEDQwkAwPyb/7V/tVvU1dXU28BKwErb1NXVxwBIrF5DBYDCQEWYEZHGwMVDCMNBgSRAhh1UA0WAwkBFTpREgMVCyMMBwT6Y2OMY2MVFTpREQQVCyMMBwQCGHVQDRYDCQEkFmBGRxsDFQwjDQYEASKxeQwWAwkBAAAABQBkAAAD6ASwAAwADwAWABwAIgAAASERIzUhFSERNDYzIQEjNQMzByczNTMDISImNREFFRQGKwECvAEstP6s/oQPCgI/ASzIZKLU1KJktP51Cg8DhA8KwwMg/oTIyALzCg/+1Mj84NTUyP4MDwoBi8jDCg8AAAAABQBkAAAD6ASwAAkADAATABoAIQAAASERCQERNDYzIQEjNRMjFSM1IzcDISImPQEpARUUBisBNQK8ASz+ov3aDwoCPwEsyD6iZKLUqv6dCg8BfAIIDwqbAyD9+AFe/doERwoP/tTI/HzIyNT+ZA8KNzcKD1AAAAAAAwAAAAAEsAP0AAgAGQAfAAABIxUzFyERIzcFMzIeAhUhFSEDETM0PgIBMwMhASEEiqJkZP7UotT9EsgbGiEOASz9qMhkDiEaAnPw8PzgASwB9AMgyGQBLNTUBBErJGT+ogHCJCsRBP5w/nAB9AAAAAMAAAAABEwETAAZADIAOQAAATMyFh0BMzIWHQEUBiMhIiY9ATQ2OwE1NDYFNTIWFREUBiMhIic3ARE0NjMVFBYzITI2AQc1IzUzNQKKZBUdMhUdHRX+1BUdHRUyHQFzKTs7Kf2oARP2/ro7KVg+ASw+WP201MjIBEwdFTIdFWQVHR0VZBUdMhUd+pY7KfzgKTsE9gFGAUQpO5Y+WFj95tSiZKIAAwBkAAAEvARMABkANgA9AAABMzIWHQEzMhYdARQGIyEiJj0BNDY7ATU0NgU1MhYVESMRMxQOAiMhIiY1ETQ2MxUUFjMhMjYBBzUjNTM1AcJkFR0yFR0dFf7UFR0dFTIdAXMpO8jIDiEaG/2oKTs7KVg+ASw+WAGc1MjIBEwdFTIdFWQVHR0VZBUdMhUd+pY7Kf4M/tQkKxEEOykDICk7lj5YWP3m1KJkogAAAAP/ogAABRYE1AALABsAHwAACQEWBiMhIiY3ATYyEyMiBhcTHgE7ATI2NxM2JgMVMzUCkgJ9FyAs+wQsIBcCfRZARNAUGAQ6BCMUNhQjBDoEGODIBK37sCY3NyYEUCf+TB0U/tIUHR0UAS4UHf4MZGQAAAAACQAAAAAETARMAA8AHwAvAD8ATwBfAG8AfwCPAAABMzIWHQEUBisBIiY9ATQ2EzMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBMzIWHQEUBisBIiY9ATQ2ITMyFh0BFAYrASImPQE0NiEzMhYdARQGKwEiJj0BNDYBqfoKDw8K+goPDwr6Cg8PCvoKDw8BmvoKDw8K+goPD/zq+goPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K+goPD/zq+goPDwr6Cg8PAZr6Cg8PCvoKDw8BmvoKDw8K+goPDwRMDwqWCg8PCpYKD/7UDwqWCg8PCpYKDw8KlgoPDwqWCg/+1A8KlgoPDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKD/7UDwqWCg8PCpYKDw8KlgoPDwqWCg8PCpYKDw8KlgoPAAAAAwAAAAAEsAUUABkAKQAzAAABMxUjFSEyFg8BBgchJi8BJjYzITUjNTM1MwEhMhYUBisBFyE3IyImNDYDITIWHQEhNTQ2ArxkZAFePjEcQiko/PwoKUIcMT4BXmRkyP4+ArwVHR0VDIn8SooNFR0dswRMFR37UB0EsMhkTzeEUzMzU4Q3T2TIZPx8HSodZGQdKh3+1B0VMjIVHQAABAAAAAAEsAUUAAUAGQArADUAAAAyFhUjNAchFhUUByEyFg8BIScmNjMhJjU0AyEyFhQGKwEVBSElNSMiJjQ2AyEyFh0BITU0NgIwUDnCPAE6EgMBSCkHIq/9WrIiCikBSAOvArwVHR0VlgET/EoBE5YVHR2zBEwVHftQHQUUOykpjSUmCBEhFpGRFiERCCb+lR0qHcjIyMgdKh39qB0VMjIVHQAEAAAAAASwBJ0ABwAUACQALgAAADIWFAYiJjQTMzIWFRQXITY1NDYzASEyFhQGKwEXITcjIiY0NgMhMhYdASE1NDYCDZZqapZqty4iKyf+vCcrI/7NArwVHR0VDYr8SokMFR0dswRMFR37UB0EnWqWamqW/us5Okxra0w6Of5yHSodZGQdKh3+1B0VMjIVHQAEAAAAAASwBRQADwAcACwANgAAATIeARUUBiImNTQ3FzcnNhMzMhYVFBchNjU0NjMBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYL1szb5xvIpBvoyIfLiIrJ/68Jysj/s0CvBUdHRUNivxKiQwVHR2zBEwVHftQHQUUa4s2Tm9vTj5Rj2+jGv4KOTpMa2tMOjn+ch0qHWRkHSod/tQdFTIyFR0AAAADAAAAAASwBRIAEgAiACwAAAEFFSEUHgMXIS4BNTQ+AjcBITIWFAYrARchNyMiJjQ2AyEyFh0BITU0NgJYASz+1CU/P00T/e48PUJtj0r+ogK8FR0dFQ2K/EqJDBUdHbMETBUd+1AdBLChizlmUT9IGVO9VFShdksE/H4dKh1kZB0qHf7UHRUyMhUdAAIAyAAAA+gFFAAPACkAAAAyFh0BHgEdASE1NDY3NTQDITIWFyMVMxUjFTMVIxUzFAYjISImNRE0NgIvUjsuNv5wNi5kAZA2XBqsyMjIyMh1U/5wU3V1BRQ7KU4aXDYyMjZcGk4p/kc2LmRkZGRkU3V1UwGQU3UAAAMAZP//BEwETAAPAC8AMwAAEyEyFhURFAYjISImNRE0NgMhMhYdARQGIyEXFhQGIi8BIQcGIiY0PwEhIiY9ATQ2BQchJ5YDhBUdHRX8fBUdHQQDtgoPDwr+5eANGiUNWP30Vw0mGg3g/t8KDw8BqmQBRGQETB0V/gwVHR0VAfQVHf1EDwoyCg/gDSUbDVhYDRslDeAPCjIKD2RkZAAAAAAEAAAAAASwBEwAGQAjAC0ANwAAEyEyFh0BIzQmKwEiBhUjNCYrASIGFSM1NDYDITIWFREhETQ2ExUUBisBIiY9ASEVFAYrASImPQHIAyBTdWQ7KfopO2Q7KfopO2R1EQPoKTv7UDvxHRVkFR0D6B0VZBUdBEx1U8gpOzspKTs7KchTdf4MOyn+1AEsKTv+DDIVHR0VMjIVHR0VMgADAAEAAASpBKwADQARABsAAAkBFhQPASEBJjQ3ATYyCQMDITIWHQEhNTQ2AeACqh8fg/4f/fsgIAEnH1n+rAFWAS/+q6IDIBUd/HwdBI39VR9ZH4MCBh9ZHwEoH/5u/qoBMAFV/BsdFTIyFR0AAAAAAgCPAAAEIQSwABcALwAAAQMuASMhIgYHAwYWMyEVFBYyNj0BMzI2AyE1NDY7ATU0NjsBETMRMzIWHQEzMhYVBCG9CCcV/nAVJwi9CBMVAnEdKh19FROo/a0dFTIdFTDILxUdMhUdAocB+hMcHBP+BhMclhUdHRWWHP2MMhUdMhUdASz+1B0VMh0VAAAEAAAAAASwBLAADQAQAB8AIgAAASERFAYjIREBNTQ2MyEBIzUBIREUBiMhIiY1ETQ2MyEBIzUDhAEsDwr+if7UDwoBdwEsyP2oASwPCv12Cg8PCgF3ASzIAyD9wQoPAk8BLFQKD/7UyP4M/cEKDw8KA7YKD/7UyAAC/5wAZAUUBEcARgBWAAABMzIeAhcWFxY2NzYnJjc+ARYXFgcOASsBDgEPAQ4BKwEiJj8BBisBIicHDgErASImPwEmLwEuAT0BNDY7ATY3JyY2OwE2BSMiBh0BFBY7ATI2PQE0JgHkw0uOakkMEhEfQwoKGRMKBQ8XDCkCA1Y9Pgc4HCcDIhVkFRgDDDEqwxgpCwMiFWQVGAMaVCyfExwdFXwLLW8QBxXLdAFF+goPDwr6Cg8PBEdBa4pJDgYKISAiJRsQCAYIDCw9P1c3fCbqFB0dFEYOCEAUHR0UnUplNQcmFTIVHVdPXw4TZV8PCjIKDw8KMgoPAAb/nP/mBRQEfgAJACQANAA8AFIAYgAAASU2Fh8BFgYPASUzMhYfASEyFh0BFAYHBQYmJyYjISImPQE0NhcjIgYdARQ7ATI2NTQmJyYEIgYUFjI2NAE3PgEeARceAT8BFxYGDwEGJi8BJjYlBwYfAR4BPwE2Jy4BJy4BAoEBpxMuDiAOAxCL/CtqQ0geZgM3FR0cE/0fFyIJKjr+1D5YWLlQExIqhhALIAsSAYBALS1ALf4PmBIgHhMQHC0aPzANITNQL3wpgigJASlmHyElDR0RPRMFAhQHCxADhPcICxAmDyoNeMgiNtQdFTIVJgeEBBQPQ1g+yD5YrBwVODMQEAtEERzJLUAtLUD+24ITChESEyMgAwWzPUkrRSgJL5cvfRxYGyYrDwkLNRAhFEgJDAQAAAAAAwBkAAAEOQSwAFEAYABvAAABMzIWHQEeARcWDgIPATIeBRUUDgUjFRQGKwEiJj0BIxUUBisBIiY9ASMiJj0BNDY7AREjIiY9ATQ2OwE1NDY7ATIWHQEzNTQ2AxUhMj4CNTc0LgMjARUhMj4CNTc0LgMjAnGWCg9PaAEBIC4uEBEGEjQwOiodFyI2LUAjGg8KlgoPZA8KlgoPrwoPDwpLSwoPDwqvDwqWCg9kD9cBBxwpEwsBAQsTKRz++QFrHCkTCwEBCxMpHASwDwptIW1KLk0tHwYGAw8UKDJOLTtdPCoVCwJLCg8PCktLCg8PCksPCpYKDwJYDwqWCg9LCg8PCktLCg/+1MgVHR0LCgQOIhoW/nDIFR0dCwoEDiIaFgAAAwAEAAIEsASuABcAKQAsAAATITIWFREUBg8BDgEjISImJy4CNRE0NgQiDgQPARchNy4FAyMT1AMMVnokEhIdgVL9xFKCHAgYKHoCIIx9VkcrHQYGnAIwnAIIIClJVSGdwwSuelb+YDO3QkJXd3ZYHFrFMwGgVnqZFyYtLSUMDPPzBQ8sKDEj/sIBBQACAMgAAAOEBRQADwAZAAABMzIWFREUBiMhIiY1ETQ2ARUUBisBIiY9AQHblmesVCn+PilUrAFINhWWFTYFFKxn/gwpVFQpAfRnrPwY4RU2NhXhAAACAMgAAAOEBRQADwAZAAABMxQWMxEUBiMhIiY1ETQ2ARUUBisBIiY9AQHbYLOWVCn+PilUrAFINhWWFTYFFJaz/kIpVFQpAfRnrPwY4RU2NhXhAAACAAAAFAUOBBoAFAAaAAAJASUHFRcVJwc1NzU0Jj4CPwEnCQEFJTUFJQUO/YL+hk5klpZkAQEBBQQvkwKCAVz+ov6iAV4BXgL//uWqPOCWx5SVyJb6BA0GCgYDKEEBG/1ipqaTpaUAAAMAZAH0BLADIAAHAA8AFwAAEjIWFAYiJjQkMhYUBiImNCQyFhQGIiY0vHxYWHxYAeh8WFh8WAHofFhYfFgDIFh8WFh8WFh8WFh8WFh8WFh8AAAAAAMBkAAAArwETAAHAA8AFwAAADIWFAYiJjQSMhYUBiImNBIyFhQGIiY0Aeh8WFh8WFh8WFh8WFh8WFh8WARMWHxYWHz+yFh8WFh8/shYfFhYfAAAAAMAZABkBEwETAAPAB8ALwAAEyEyFh0BFAYjISImPQE0NhMhMhYdARQGIyEiJj0BNDYTITIWHQEUBiMhIiY9ATQ2fQO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PCgO2Cg8PCvxKCg8PBEwPCpYKDw8KlgoP/nAPCpYKDw8KlgoP/nAPCpYKDw8KlgoPAAAABAAAAAAEsASwAA8AHwAvADMAAAEhMhYVERQGIyEiJjURNDYFISIGFREUFjMhMjY1ETQmBSEyFhURFAYjISImNRE0NhcVITUBXgH0ory7o/4Mpbm5Asv9qCk7OykCWCk7O/2xAfQVHR0V/gwVHR1HAZAEsLuj/gylubmlAfSlucg7Kf2oKTs7KQJYKTtkHRX+1BUdHRUBLBUdZMjIAAAAAAEAZABkBLAETAA7AAATITIWFAYrARUzMhYUBisBFTMyFhQGKwEVMzIWFAYjISImNDY7ATUjIiY0NjsBNSMiJjQ2OwE1IyImNDaWA+gVHR0VMjIVHR0VMjIVHR0VMjIVHR0V/BgVHR0VMjIVHR0VMjIVHR0VMjIVHR0ETB0qHcgdKh3IHSodyB0qHR0qHcgdKh3IHSodyB0qHQAAAAYBLAAFA+gEowAHAA0AEwAZAB8AKgAAAR4BBgcuATYBMhYVIiYlFAYjNDYBMhYVIiYlFAYjNDYDFRQGIiY9ARYzMgKKVz8/V1c/P/75fLB8sAK8sHyw/cB8sHywArywfLCwHSodKAMRBKNDsrJCQrKy/sCwfLB8fLB8sP7UsHywfHywfLD+05AVHR0VjgQAAAH/tQDIBJQDgQBCAAABNzYXAR4BBw4BKwEyFRQOBCsBIhE0NyYiBxYVECsBIi4DNTQzIyImJyY2NwE2HwEeAQ4BLwEHIScHBi4BNgLpRRkUASoLCAYFGg8IAQQNGyc/KZK4ChRUFQu4jjBJJxkHAgcPGQYGCAsBKhQaTBQVCiMUM7YDe7YsFCMKFgNuEwYS/tkLHw8OEw0dNkY4MhwBIBgXBAQYF/7gKjxTQyMNEw4PHwoBKBIHEwUjKBYGDMHBDAUWKCMAAAAAAgAAAAAEsASwACUAQwAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjNC4DKwERFBYXMxUjNTI1ESMiDgMVIzUhBLAyCAsZEyYYGcgyGRn+cAQOIhoWyBkYJhMZCwgyA+j9RBkIChgQEWQZDQzIMmQREBgKCBkB9AOEFSAVDggDAfyuFhkBAmRkAQUJFQ4DUgEDCA4VIBUBLP0SDxMKBQH+VwsNATIyGQGpAQUKEw+WAAAAAAMAAAAABEwErgAdACAAMAAAATUiJy4BLwEBIwEGBw4BDwEVITUiJj8BIRcWBiMVARsBARUUBiMhIiY9ATQ2MyEyFgPoGR4OFgUE/t9F/tQSFQkfCwsBETE7EkUBJT0NISf+7IZ5AbEdFfwYFR0dFQPoFR0BLDIgDiIKCwLr/Q4jFQkTBQUyMisusKYiQTIBhwFW/qr942QVHR0VZBUdHQADAAAAAASwBLAADwBHAEoAABMhMhYVERQGIyEiJjURNDYFIyIHAQYHBgcGHQEUFjMhMjY9ATQmIyInJj8BIRcWBwYjIgYdARQWMyEyNj0BNCYnIicmJyMBJhMjEzIETBUdHRX7tBUdHQJGRg0F/tUREhImDAsJAREIDAwINxAKCj8BCjkLEQwYCAwMCAE5CAwLCBEZGQ8B/uAFDsVnBLAdFfu0FR0dFQRMFR1SDP0PIBMSEAUNMggMDAgyCAwXDhmjmR8YEQwIMggMDAgyBwwBGRskAuwM/gUBCAAABAAAAAAEsASwAAMAEwAjACcAAAEhNSEFITIWFREUBiMhIiY1ETQ2KQEyFhURFAYjISImNRE0NhcRIREEsPtQBLD7ggGQFR0dFf5wFR0dAm0BkBUdHRX+cBUdHUcBLARMZMgdFfx8FR0dFQOEFR0dFf5wFR0dFQGQFR1k/tQBLAAEAAAAAASwBLAADwAfACMAJwAAEyEyFhURFAYjISImNRE0NgEhMhYVERQGIyEiJjURNDYXESEREyE1ITIBkBUdHRX+cBUdHQJtAZAVHR0V/nAVHR1HASzI+1AEsASwHRX8fBUdHRUDhBUd/gwdFf5wFR0dFQGQFR1k/tQBLP2oZAAAAAACAAAAZASwA+gAJwArAAATITIWFREzNTQ2MyEyFh0BMxUjFRQGIyEiJj0BIxEUBiMhIiY1ETQ2AREhETIBkBUdZB0VAZAVHWRkHRX+cBUdZB0V/nAVHR0CnwEsA+gdFf6ilhUdHRWWZJYVHR0Vlv6iFR0dFQMgFR3+1P7UASwAAAQAAAAABLAEsAADABMAFwAnAAAzIxEzFyEyFhURFAYjISImNRE0NhcRIREBITIWFREUBiMhIiY1ETQ2ZGRklgGQFR0dFf5wFR0dRwEs/qIDhBUdHRX8fBUdHQSwZB0V/nAVHR0VAZAVHWT+1AEs/gwdFf5wFR0dFQGQFR0AAAAAAgBkAAAETASwACcAKwAAATMyFhURFAYrARUhMhYVERQGIyEiJjURNDYzITUjIiY1ETQ2OwE1MwcRIRECWJYVHR0VlgHCFR0dFfx8FR0dFQFelhUdHRWWZMgBLARMHRX+cBUdZB0V/nAVHR0VAZAVHWQdFQGQFR1kyP7UASwAAAAEAAAAAASwBLAAAwATABcAJwAAISMRMwUhMhYVERQGIyEiJjURNDYXESERASEyFhURFAYjISImNRE0NgSwZGT9dgGQFR0dFf5wFR0dRwEs/K4DhBUdHRX8fBUdHQSwZB0V/nAVHR0VAZAVHWT+1AEs/gwdFf5wFR0dFQGQFR0AAAEBLAAwA28EgAAPAAAJAQYjIiY1ETQ2MzIXARYUA2H+EhcSDhAQDhIXAe4OAjX+EhcbGQPoGRsX/hIOKgAAAAABAUEAMgOEBH4ACwAACQE2FhURFAYnASY0AU8B7h0qKh3+Eg4CewHuHREp/BgpER0B7g4qAAAAAAEAMgFBBH4DhAALAAATITIWBwEGIicBJjZkA+gpER3+Eg4qDv4SHREDhCod/hIODgHuHSoAAAAAAQAyASwEfgNvAAsAAAkBFgYjISImNwE2MgJ7Ae4dESn8GCkRHQHuDioDYf4SHSoqHQHuDgAAAAACAAgAAASwBCgABgAKAAABFQE1LQE1ASE1IQK8/UwBnf5jBKj84AMgAuW2/r3dwcHd+9jIAAAAAAIAAABkBLAEsAALADEAAAEjFTMVIREzNSM1IQEzND4FOwERFAYPARUhNSIuAzURMzIeBRUzESEEsMjI/tTIyAEs+1AyCAsZEyYYGWQyGRkBkAQOIhoWZBkYJhMZCwgy/OADhGRkASxkZP4MFSAVDggDAf3aFhkBAmRkAQUJFQ4CJgEDCA4VIBUBLAAAAgAAAAAETAPoACUAMQAAASM0LgUrAREUFh8BFSE1Mj4DNREjIg4FFSMRIQEjFTMVIREzNSM1IQMgMggLGRMmGBlkMhkZ/nAEDiIaFmQZGCYTGQsIMgMgASzIyP7UyMgBLAK8FSAVDggDAf3aFhkCAWRkAQUJFQ4CJgEDCA4VIBUBLPzgZGQBLGRkAAABAMgAZgNyBEoAEgAAATMyFgcJARYGKwEiJwEmNDcBNgK9oBAKDP4wAdAMChCgDQr+KQcHAdcKBEoWDP4w/jAMFgkB1wgUCAHXCQAAAQE+AGYD6ARKABIAAAEzMhcBFhQHAQYrASImNwkBJjYBU6ANCgHXBwf+KQoNoBAKDAHQ/jAMCgRKCf4pCBQI/ikJFgwB0AHQDBYAAAEAZgDIBEoDcgASAAAAFh0BFAcBBiInASY9ATQ2FwkBBDQWCf4pCBQI/ikJFgwB0AHQA3cKEKANCv4pBwcB1woNoBAKDP4wAdAAAAABAGYBPgRKA+gAEgAACQEWHQEUBicJAQYmPQE0NwE2MgJqAdcJFgz+MP4wDBYJAdcIFAPh/ikKDaAQCgwB0P4wDAoQoA0KAdcHAAAAAgDZ//kEPQSwAAUAOgAAARQGIzQ2BTMyFh8BNjc+Ah4EBgcOBgcGIiYjIgYiJy4DLwEuAT4EHgEXJyY2A+iwfLD+VmQVJgdPBQsiKFAzRyorDwURAQQSFyozTSwNOkkLDkc3EDlfNyYHBw8GDyUqPjdGMR+TDA0EsHywfLDIHBPCAQIGBwcFDx81S21DBxlLR1xKQhEFBQcHGWt0bCQjP2hJNyATBwMGBcASGAAAAAACAMgAFQOEBLAAFgAaAAATITIWFREUBisBEQcGJjURIyImNRE0NhcVITX6AlgVHR0Vlv8TGpYVHR2rASwEsB0V/nAVHf4MsgkQFQKKHRUBkBUdZGRkAAAAAgDIABkETASwAA4AEgAAEyEyFhURBRElIREjETQ2ARU3NfoC7ic9/UQCWP1EZB8BDWQEsFEs/Ft1A7Z9/BgEARc0/V1kFGQAAQAAAAECTW/DBF9fDzz1AB8EsAAAAADQdnOXAAAAANB2c5f/Uf+cBdwFFAAAAAgAAgAAAAAAAAABAAAFFP+FAAAFFP9R/tQF3AABAAAAAAAAAAAAAAAAAAAAowG4ACgAAAAAAZAAAASwAAAEsABkBLAAAASwAAAEsABwAooAAAUUAAACigAABRQAAAGxAAABRQAAANgAAADYAAAAogAAAQQAAABIAAABBAAAAUUAAASwAGQEsAB7BLAAyASwAMgB9AAABLD/8gSwAAAEsAAABLD/8ASwAAAEsAAOBLAACQSwAGQEsP/TBLD/0wSwAAAEsAAABLAAAASwAAAEsAAABLAAJgSwAG4EsAAXBLAAFwSwABcEsABkBLAAGgSwAGQEsAAMBLAAZASwABcEsP+cBLAAZASwABcEsAAXBLAAAASwABcEsAAXBLAAFwSwAGQEsAAABLAAZASwAAAEsAAABLAAAASwAAAEsAAABLAAAASwAAAEsAAABLAAZASwAMgEsAAABLAAAASwADUEsABkBLAAyASw/7UEsAAhBLAAAASwAAAEsAAABLAAAASwAAAEsP+cBLAAAASwAAAEsAAABLAA2wSwABcEsAB1BLAAAASwAAAEsAAABLAACgSwAMgEsAAABLAAnQSwAMgEsADIBLAAyASwAAAEsP/+BLABLASwAGQEsACIBLABOwSwABcEsAAXBLAAFwSwABcEsAAXBLAAFwSwAAAEsAAXBLAAFwSwABcEsAAXBLAAAASwALcEsAC3BLAAAASwAAAEsABJBLAAFwSwAAAEsAAABLAAXQSw/9wEsP/cBLD/nwSwAGQEsAAABLAAAASwAAAEsABkBLD//wSwAAAEsP9RBLAABgSwAAAEsAAABLABRQSwAAEEsAAABLD/nASwAEoEsAAUBLAAAASwAAAEsAAABLD/nASwAGEEsP/9BLAAFgSwABYEsAAWBLAAFgSwABgEsAAABMQAAASwAGQAAAAAAAD/2ABkADkAyAAAAScAZAAZABkAGQAZABkAGQAZAAAAAAAAAAAAAADZAAAAAAAOAAAAAAAAAAAAAAAEAAAAAAAAAAAAAAAAAAMAZABkAAAAEAAAAAAAZP+c/5z/nP+c/5z/nP+c/5wACQAJ//L/8gBkAHkAJwBkAGQAAAAAAGT/ogAAAAAAAAAAAAAAAADIAGQAAAABAI8AAP+c/5wAZAAEAMgAyAAAAGQBkABkAAAAZAEs/7UAAAAAAAAAAAAAAAAAAABkAAABLAFBADIAMgAIAAAAAADIAT4AZgBmANkAyADIAAAAKgAqACoAKgCyAOgA6AFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BTgFOAU4BpAIGAiICfgKGAqwC5ANGA24DjAPEBAgEMgRiBKIE3AVcBboGcgb0ByAHYgfKCB4IYgi+CTYJhAm2Cd4KKApMCpQK4gswC4oLygwIDFgNKg1eDbAODg5oDrQPKA+mD+YQEhBUEJAQqhEqEXYRthIKEjgSfBLAExoTdBPQFCoU1BU8FagVzBYEFjYWYBawFv4XUhemGAIYLhhqGJYYsBjgGP4ZKBloGZQZxBnaGe4aNhpoGrga9hteG7QcMhyUHOIdHB1EHWwdlB28HeYeLh52HsAfYh/SIEYgviEyIXYhuCJAIpYiuCMOIyIjOCN6I8Ij4CQCJDAkXiSWJOIlNCVgJbwmFCZ+JuYnUCe8J/goNChwKKwpoCnMKiYqSiqEKworeiwILGgsuizsLRwtiC30LiguZi6iLtgvDi9GL34vsi/4MD4whDDSMRIxYDGuMegyJDJeMpoy3jMiMz4zaDO2NBg0YDSoNNI1LDWeNeg2PjZ8Ntw3GjdON5I31DgQOEI4hjjIOQo5SjmIOcw6HDpsOpo63jugO9w8GDxQPKI8+D0yPew+Oj6MPtQ/KD9uP6o/+kBIQIBAxkECQX5CGEKoQu5DGENCQ3ZDoEPKRBBEYESuRPZFWkW2RgZGdEa0RvZHNkd2R7ZH9kgWSDJITkhqSIZIzEkSSThJXkmESapKAkouSlIAAQAAARcApwARAAAAAAACAAAAAQABAAAAQAAuAAAAAAAAABAAxgABAAAAAAATABIAAAADAAEECQAAAGoAEgADAAEECQABACgAfAADAAEECQACAA4ApAADAAEECQADAEwAsgADAAEECQAEADgA/gADAAEECQAFAHgBNgADAAEECQAGADYBrgADAAEECQAIABYB5AADAAEECQAJABYB+gADAAEECQALACQCEAADAAEECQAMACQCNAADAAEECQATACQCWAADAAEECQDIABYCfAADAAEECQDJADACkgADAAEECdkDABoCwnd3dy5nbHlwaGljb25zLmNvbQBDAG8AcAB5AHIAaQBnAGgAdAAgAKkAIAAyADAAMQA0ACAAYgB5ACAASgBhAG4AIABLAG8AdgBhAHIAaQBrAC4AIABBAGwAbAAgAHIAaQBnAGgAdABzACAAcgBlAHMAZQByAHYAZQBkAC4ARwBMAFkAUABIAEkAQwBPAE4AUwAgAEgAYQBsAGYAbABpAG4AZwBzAFIAZQBnAHUAbABhAHIAMQAuADAAMAA5ADsAVQBLAFcATgA7AEcATABZAFAASABJAEMATwBOAFMASABhAGwAZgBsAGkAbgBnAHMALQBSAGUAZwB1AGwAYQByAEcATABZAFAASABJAEMATwBOAFMAIABIAGEAbABmAGwAaQBuAGcAcwAgAFIAZQBnAHUAbABhAHIAVgBlAHIAcwBpAG8AbgAgADEALgAwADAAOQA7AFAAUwAgADAAMAAxAC4AMAAwADkAOwBoAG8AdABjAG8AbgB2ACAAMQAuADAALgA3ADAAOwBtAGEAawBlAG8AdABmAC4AbABpAGIAMgAuADUALgA1ADgAMwAyADkARwBMAFkAUABIAEkAQwBPAE4AUwBIAGEAbABmAGwAaQBuAGcAcwAtAFIAZQBnAHUAbABhAHIASgBhAG4AIABLAG8AdgBhAHIAaQBrAEoAYQBuACAASwBvAHYAYQByAGkAawB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQB3AHcAdwAuAGcAbAB5AHAAaABpAGMAbwBuAHMALgBjAG8AbQBXAGUAYgBmAG8AbgB0ACAAMQAuADAAVwBlAGQAIABPAGMAdAAgADIAOQAgADAANgA6ADMANgA6ADAANwAgADIAMAAxADQARgBvAG4AdAAgAFMAcQB1AGkAcgByAGUAbAAAAAIAAAAAAAD/tQAyAAAAAAAAAAAAAAAAAAAAAAAAAAABFwAAAQIBAwADAA0ADgEEAJYBBQEGAQcBCAEJAQoBCwEMAQ0BDgEPARABEQESARMA7wEUARUBFgEXARgBGQEaARsBHAEdAR4BHwEgASEBIgEjASQBJQEmAScBKAEpASoBKwEsAS0BLgEvATABMQEyATMBNAE1ATYBNwE4ATkBOgE7ATwBPQE+AT8BQAFBAUIBQwFEAUUBRgFHAUgBSQFKAUsBTAFNAU4BTwFQAVEBUgFTAVQBVQFWAVcBWAFZAVoBWwFcAV0BXgFfAWABYQFiAWMBZAFlAWYBZwFoAWkBagFrAWwBbQFuAW8BcAFxAXIBcwF0AXUBdgF3AXgBeQF6AXsBfAF9AX4BfwGAAYEBggGDAYQBhQGGAYcBiAGJAYoBiwGMAY0BjgGPAZABkQGSAZMBlAGVAZYBlwGYAZkBmgGbAZwBnQGeAZ8BoAGhAaIBowGkAaUBpgGnAagBqQGqAasBrAGtAa4BrwGwAbEBsgGzAbQBtQG2AbcBuAG5AboBuwG8Ab0BvgG/AcABwQHCAcMBxAHFAcYBxwHIAckBygHLAcwBzQHOAc8B0AHRAdIB0wHUAdUB1gHXAdgB2QHaAdsB3AHdAd4B3wHgAeEB4gHjAeQB5QHmAecB6AHpAeoB6wHsAe0B7gHvAfAB8QHyAfMB9AH1AfYB9wH4AfkB+gH7AfwB/QH+Af8CAAIBAgICAwIEAgUCBgIHAggCCQIKAgsCDAINAg4CDwIQAhECEgZnbHlwaDEGZ2x5cGgyB3VuaTAwQTAHdW5pMjAwMAd1bmkyMDAxB3VuaTIwMDIHdW5pMjAwMwd1bmkyMDA0B3VuaTIwMDUHdW5pMjAwNgd1bmkyMDA3B3VuaTIwMDgHdW5pMjAwOQd1bmkyMDBBB3VuaTIwMkYHdW5pMjA1RgRFdXJvB3VuaTIwQkQHdW5pMjMxQgd1bmkyNUZDB3VuaTI2MDEHdW5pMjZGQQd1bmkyNzA5B3VuaTI3MEYHdW5pRTAwMQd1bmlFMDAyB3VuaUUwMDMHdW5pRTAwNQd1bmlFMDA2B3VuaUUwMDcHdW5pRTAwOAd1bmlFMDA5B3VuaUUwMTAHdW5pRTAxMQd1bmlFMDEyB3VuaUUwMTMHdW5pRTAxNAd1bmlFMDE1B3VuaUUwMTYHdW5pRTAxNwd1bmlFMDE4B3VuaUUwMTkHdW5pRTAyMAd1bmlFMDIxB3VuaUUwMjIHdW5pRTAyMwd1bmlFMDI0B3VuaUUwMjUHdW5pRTAyNgd1bmlFMDI3B3VuaUUwMjgHdW5pRTAyOQd1bmlFMDMwB3VuaUUwMzEHdW5pRTAzMgd1bmlFMDMzB3VuaUUwMzQHdW5pRTAzNQd1bmlFMDM2B3VuaUUwMzcHdW5pRTAzOAd1bmlFMDM5B3VuaUUwNDAHdW5pRTA0MQd1bmlFMDQyB3VuaUUwNDMHdW5pRTA0NAd1bmlFMDQ1B3VuaUUwNDYHdW5pRTA0Nwd1bmlFMDQ4B3VuaUUwNDkHdW5pRTA1MAd1bmlFMDUxB3VuaUUwNTIHdW5pRTA1Mwd1bmlFMDU0B3VuaUUwNTUHdW5pRTA1Ngd1bmlFMDU3B3VuaUUwNTgHdW5pRTA1OQd1bmlFMDYwB3VuaUUwNjIHdW5pRTA2Mwd1bmlFMDY0B3VuaUUwNjUHdW5pRTA2Ngd1bmlFMDY3B3VuaUUwNjgHdW5pRTA2OQd1bmlFMDcwB3VuaUUwNzEHdW5pRTA3Mgd1bmlFMDczB3VuaUUwNzQHdW5pRTA3NQd1bmlFMDc2B3VuaUUwNzcHdW5pRTA3OAd1bmlFMDc5B3VuaUUwODAHdW5pRTA4MQd1bmlFMDgyB3VuaUUwODMHdW5pRTA4NAd1bmlFMDg1B3VuaUUwODYHdW5pRTA4Nwd1bmlFMDg4B3VuaUUwODkHdW5pRTA5MAd1bmlFMDkxB3VuaUUwOTIHdW5pRTA5Mwd1bmlFMDk0B3VuaUUwOTUHdW5pRTA5Ngd1bmlFMDk3B3VuaUUxMDEHdW5pRTEwMgd1bmlFMTAzB3VuaUUxMDQHdW5pRTEwNQd1bmlFMTA2B3VuaUUxMDcHdW5pRTEwOAd1bmlFMTA5B3VuaUUxMTAHdW5pRTExMQd1bmlFMTEyB3VuaUUxMTMHdW5pRTExNAd1bmlFMTE1B3VuaUUxMTYHdW5pRTExNwd1bmlFMTE4B3VuaUUxMTkHdW5pRTEyMAd1bmlFMTIxB3VuaUUxMjIHdW5pRTEyMwd1bmlFMTI0B3VuaUUxMjUHdW5pRTEyNgd1bmlFMTI3B3VuaUUxMjgHdW5pRTEyOQd1bmlFMTMwB3VuaUUxMzEHdW5pRTEzMgd1bmlFMTMzB3VuaUUxMzQHdW5pRTEzNQd1bmlFMTM2B3VuaUUxMzcHdW5pRTEzOAd1bmlFMTM5B3VuaUUxNDAHdW5pRTE0MQd1bmlFMTQyB3VuaUUxNDMHdW5pRTE0NAd1bmlFMTQ1B3VuaUUxNDYHdW5pRTE0OAd1bmlFMTQ5B3VuaUUxNTAHdW5pRTE1MQd1bmlFMTUyB3VuaUUxNTMHdW5pRTE1NAd1bmlFMTU1B3VuaUUxNTYHdW5pRTE1Nwd1bmlFMTU4B3VuaUUxNTkHdW5pRTE2MAd1bmlFMTYxB3VuaUUxNjIHdW5pRTE2Mwd1bmlFMTY0B3VuaUUxNjUHdW5pRTE2Ngd1bmlFMTY3B3VuaUUxNjgHdW5pRTE2OQd1bmlFMTcwB3VuaUUxNzEHdW5pRTE3Mgd1bmlFMTczB3VuaUUxNzQHdW5pRTE3NQd1bmlFMTc2B3VuaUUxNzcHdW5pRTE3OAd1bmlFMTc5B3VuaUUxODAHdW5pRTE4MQd1bmlFMTgyB3VuaUUxODMHdW5pRTE4NAd1bmlFMTg1B3VuaUUxODYHdW5pRTE4Nwd1bmlFMTg4B3VuaUUxODkHdW5pRTE5MAd1bmlFMTkxB3VuaUUxOTIHdW5pRTE5Mwd1bmlFMTk0B3VuaUUxOTUHdW5pRTE5Nwd1bmlFMTk4B3VuaUUxOTkHdW5pRTIwMAd1bmlFMjAxB3VuaUUyMDIHdW5pRTIwMwd1bmlFMjA0B3VuaUUyMDUHdW5pRTIwNgd1bmlFMjA5B3VuaUUyMTAHdW5pRTIxMQd1bmlFMjEyB3VuaUUyMTMHdW5pRTIxNAd1bmlFMjE1B3VuaUUyMTYHdW5pRTIxOAd1bmlFMjE5B3VuaUUyMjEHdW5pRTIyMwd1bmlFMjI0B3VuaUUyMjUHdW5pRTIyNgd1bmlFMjI3B3VuaUUyMzAHdW5pRTIzMQd1bmlFMjMyB3VuaUUyMzMHdW5pRTIzNAd1bmlFMjM1B3VuaUUyMzYHdW5pRTIzNwd1bmlFMjM4B3VuaUUyMzkHdW5pRTI0MAd1bmlFMjQxB3VuaUUyNDIHdW5pRTI0Mwd1bmlFMjQ0B3VuaUUyNDUHdW5pRTI0Ngd1bmlFMjQ3B3VuaUUyNDgHdW5pRTI0OQd1bmlFMjUwB3VuaUUyNTEHdW5pRTI1Mgd1bmlFMjUzB3VuaUUyNTQHdW5pRTI1NQd1bmlFMjU2B3VuaUUyNTcHdW5pRTI1OAd1bmlFMjU5B3VuaUUyNjAHdW5pRjhGRgZ1MUY1MTEGdTFGNkFBAAAAAAFUUMMXAAA=) format('truetype'),url(data:image/svg+xml;base64,<?xml version="1.0" standalone="no"?>
<!DOCTYPE svg PUBLIC "-//W3C//DTD SVG 1.1//EN" "http://www.w3.org/Graphics/SVG/1.1/DTD/svg11.dtd" >
<svg xmlns="http://www.w3.org/2000/svg">
<metadata></metadata>
<defs>
<font id="glyphicons_halflingsregular" horiz-adv-x="1200" >
<font-face units-per-em="1200" ascent="960" descent="-240" />
<missing-glyph horiz-adv-x="500" />
<glyph horiz-adv-x="0" />
<glyph horiz-adv-x="400" />
<glyph unicode=" " />
<glyph unicode="*" d="M600 1100q15 0 34 -1.5t30 -3.5l11 -1q10 -2 17.5 -10.5t7.5 -18.5v-224l158 158q7 7 18 8t19 -6l106 -106q7 -8 6 -19t-8 -18l-158 -158h224q10 0 18.5 -7.5t10.5 -17.5q6 -41 6 -75q0 -15 -1.5 -34t-3.5 -30l-1 -11q-2 -10 -10.5 -17.5t-18.5 -7.5h-224l158 -158 q7 -7 8 -18t-6 -19l-106 -106q-8 -7 -19 -6t-18 8l-158 158v-224q0 -10 -7.5 -18.5t-17.5 -10.5q-41 -6 -75 -6q-15 0 -34 1.5t-30 3.5l-11 1q-10 2 -17.5 10.5t-7.5 18.5v224l-158 -158q-7 -7 -18 -8t-19 6l-106 106q-7 8 -6 19t8 18l158 158h-224q-10 0 -18.5 7.5 t-10.5 17.5q-6 41 -6 75q0 15 1.5 34t3.5 30l1 11q2 10 10.5 17.5t18.5 7.5h224l-158 158q-7 7 -8 18t6 19l106 106q8 7 19 6t18 -8l158 -158v224q0 10 7.5 18.5t17.5 10.5q41 6 75 6z" />
<glyph unicode="+" d="M450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-350h350q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-350v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v350h-350q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5 h350v350q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xa0;" />
<glyph unicode="&#xa5;" d="M825 1100h250q10 0 12.5 -5t-5.5 -13l-364 -364q-6 -6 -11 -18h268q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-100h275q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-125v-174q0 -11 -7.5 -18.5t-18.5 -7.5h-148q-11 0 -18.5 7.5t-7.5 18.5v174 h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h125v100h-275q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h118q-5 12 -11 18l-364 364q-8 8 -5.5 13t12.5 5h250q25 0 43 -18l164 -164q8 -8 18 -8t18 8l164 164q18 18 43 18z" />
<glyph unicode="&#x2000;" horiz-adv-x="650" />
<glyph unicode="&#x2001;" horiz-adv-x="1300" />
<glyph unicode="&#x2002;" horiz-adv-x="650" />
<glyph unicode="&#x2003;" horiz-adv-x="1300" />
<glyph unicode="&#x2004;" horiz-adv-x="433" />
<glyph unicode="&#x2005;" horiz-adv-x="325" />
<glyph unicode="&#x2006;" horiz-adv-x="216" />
<glyph unicode="&#x2007;" horiz-adv-x="216" />
<glyph unicode="&#x2008;" horiz-adv-x="162" />
<glyph unicode="&#x2009;" horiz-adv-x="260" />
<glyph unicode="&#x200a;" horiz-adv-x="72" />
<glyph unicode="&#x202f;" horiz-adv-x="260" />
<glyph unicode="&#x205f;" horiz-adv-x="325" />
<glyph unicode="&#x20ac;" d="M744 1198q242 0 354 -189q60 -104 66 -209h-181q0 45 -17.5 82.5t-43.5 61.5t-58 40.5t-60.5 24t-51.5 7.5q-19 0 -40.5 -5.5t-49.5 -20.5t-53 -38t-49 -62.5t-39 -89.5h379l-100 -100h-300q-6 -50 -6 -100h406l-100 -100h-300q9 -74 33 -132t52.5 -91t61.5 -54.5t59 -29 t47 -7.5q22 0 50.5 7.5t60.5 24.5t58 41t43.5 61t17.5 80h174q-30 -171 -128 -278q-107 -117 -274 -117q-206 0 -324 158q-36 48 -69 133t-45 204h-217l100 100h112q1 47 6 100h-218l100 100h134q20 87 51 153.5t62 103.5q117 141 297 141z" />
<glyph unicode="&#x20bd;" d="M428 1200h350q67 0 120 -13t86 -31t57 -49.5t35 -56.5t17 -64.5t6.5 -60.5t0.5 -57v-16.5v-16.5q0 -36 -0.5 -57t-6.5 -61t-17 -65t-35 -57t-57 -50.5t-86 -31.5t-120 -13h-178l-2 -100h288q10 0 13 -6t-3 -14l-120 -160q-6 -8 -18 -14t-22 -6h-138v-175q0 -11 -5.5 -18 t-15.5 -7h-149q-10 0 -17.5 7.5t-7.5 17.5v175h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v100h-267q-10 0 -13 6t3 14l120 160q6 8 18 14t22 6h117v475q0 10 7.5 17.5t17.5 7.5zM600 1000v-300h203q64 0 86.5 33t22.5 119q0 84 -22.5 116t-86.5 32h-203z" />
<glyph unicode="&#x2212;" d="M250 700h800q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#x231b;" d="M1000 1200v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-50v-100q0 -91 -49.5 -165.5t-130.5 -109.5q81 -35 130.5 -109.5t49.5 -165.5v-150h50q21 0 35.5 -14.5t14.5 -35.5v-150h-800v150q0 21 14.5 35.5t35.5 14.5h50v150q0 91 49.5 165.5t130.5 109.5q-81 35 -130.5 109.5 t-49.5 165.5v100h-50q-21 0 -35.5 14.5t-14.5 35.5v150h800zM400 1000v-100q0 -60 32.5 -109.5t87.5 -73.5q28 -12 44 -37t16 -55t-16 -55t-44 -37q-55 -24 -87.5 -73.5t-32.5 -109.5v-150h400v150q0 60 -32.5 109.5t-87.5 73.5q-28 12 -44 37t-16 55t16 55t44 37 q55 24 87.5 73.5t32.5 109.5v100h-400z" />
<glyph unicode="&#x25fc;" horiz-adv-x="500" d="M0 0z" />
<glyph unicode="&#x2601;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -206.5q0 -121 -85 -207.5t-205 -86.5h-750q-79 0 -135.5 57t-56.5 137q0 69 42.5 122.5t108.5 67.5q-2 12 -2 37q0 153 108 260.5t260 107.5z" />
<glyph unicode="&#x26fa;" d="M774 1193.5q16 -9.5 20.5 -27t-5.5 -33.5l-136 -187l467 -746h30q20 0 35 -18.5t15 -39.5v-42h-1200v42q0 21 15 39.5t35 18.5h30l468 746l-135 183q-10 16 -5.5 34t20.5 28t34 5.5t28 -20.5l111 -148l112 150q9 16 27 20.5t34 -5zM600 200h377l-182 112l-195 534v-646z " />
<glyph unicode="&#x2709;" d="M25 1100h1150q10 0 12.5 -5t-5.5 -13l-564 -567q-8 -8 -18 -8t-18 8l-564 567q-8 8 -5.5 13t12.5 5zM18 882l264 -264q8 -8 8 -18t-8 -18l-264 -264q-8 -8 -13 -5.5t-5 12.5v550q0 10 5 12.5t13 -5.5zM918 618l264 264q8 8 13 5.5t5 -12.5v-550q0 -10 -5 -12.5t-13 5.5 l-264 264q-8 8 -8 18t8 18zM818 482l364 -364q8 -8 5.5 -13t-12.5 -5h-1150q-10 0 -12.5 5t5.5 13l364 364q8 8 18 8t18 -8l164 -164q8 -8 18 -8t18 8l164 164q8 8 18 8t18 -8z" />
<glyph unicode="&#x270f;" d="M1011 1210q19 0 33 -13l153 -153q13 -14 13 -33t-13 -33l-99 -92l-214 214l95 96q13 14 32 14zM1013 800l-615 -614l-214 214l614 614zM317 96l-333 -112l110 335z" />
<glyph unicode="&#xe001;" d="M700 650v-550h250q21 0 35.5 -14.5t14.5 -35.5v-50h-800v50q0 21 14.5 35.5t35.5 14.5h250v550l-500 550h1200z" />
<glyph unicode="&#xe002;" d="M368 1017l645 163q39 15 63 0t24 -49v-831q0 -55 -41.5 -95.5t-111.5 -63.5q-79 -25 -147 -4.5t-86 75t25.5 111.5t122.5 82q72 24 138 8v521l-600 -155v-606q0 -42 -44 -90t-109 -69q-79 -26 -147 -5.5t-86 75.5t25.5 111.5t122.5 82.5q72 24 138 7v639q0 38 14.5 59 t53.5 34z" />
<glyph unicode="&#xe003;" d="M500 1191q100 0 191 -39t156.5 -104.5t104.5 -156.5t39 -191l-1 -2l1 -5q0 -141 -78 -262l275 -274q23 -26 22.5 -44.5t-22.5 -42.5l-59 -58q-26 -20 -46.5 -20t-39.5 20l-275 274q-119 -77 -261 -77l-5 1l-2 -1q-100 0 -191 39t-156.5 104.5t-104.5 156.5t-39 191 t39 191t104.5 156.5t156.5 104.5t191 39zM500 1022q-88 0 -162 -43t-117 -117t-43 -162t43 -162t117 -117t162 -43t162 43t117 117t43 162t-43 162t-117 117t-162 43z" />
<glyph unicode="&#xe005;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104z" />
<glyph unicode="&#xe006;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429z" />
<glyph unicode="&#xe007;" d="M407 800l131 353q7 19 17.5 19t17.5 -19l129 -353h421q21 0 24 -8.5t-14 -20.5l-342 -249l130 -401q7 -20 -0.5 -25.5t-24.5 6.5l-343 246l-342 -247q-17 -12 -24.5 -6.5t-0.5 25.5l130 400l-347 251q-17 12 -14 20.5t23 8.5h429zM477 700h-240l197 -142l-74 -226 l193 139l195 -140l-74 229l192 140h-234l-78 211z" />
<glyph unicode="&#xe008;" d="M600 1200q124 0 212 -88t88 -212v-250q0 -46 -31 -98t-69 -52v-75q0 -10 6 -21.5t15 -17.5l358 -230q9 -5 15 -16.5t6 -21.5v-93q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v93q0 10 6 21.5t15 16.5l358 230q9 6 15 17.5t6 21.5v75q-38 0 -69 52 t-31 98v250q0 124 88 212t212 88z" />
<glyph unicode="&#xe009;" d="M25 1100h1150q10 0 17.5 -7.5t7.5 -17.5v-1050q0 -10 -7.5 -17.5t-17.5 -7.5h-1150q-10 0 -17.5 7.5t-7.5 17.5v1050q0 10 7.5 17.5t17.5 7.5zM100 1000v-100h100v100h-100zM875 1000h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5t17.5 -7.5h550 q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM1000 1000v-100h100v100h-100zM100 800v-100h100v100h-100zM1000 800v-100h100v100h-100zM100 600v-100h100v100h-100zM1000 600v-100h100v100h-100zM875 500h-550q-10 0 -17.5 -7.5t-7.5 -17.5v-350q0 -10 7.5 -17.5 t17.5 -7.5h550q10 0 17.5 7.5t7.5 17.5v350q0 10 -7.5 17.5t-17.5 7.5zM100 400v-100h100v100h-100zM1000 400v-100h100v100h-100zM100 200v-100h100v100h-100zM1000 200v-100h100v100h-100z" />
<glyph unicode="&#xe010;" d="M50 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM50 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM650 500h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe011;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM850 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 700h200q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h200 q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM850 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5 t35.5 14.5z" />
<glyph unicode="&#xe012;" d="M50 1100h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 1100h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200 q0 21 14.5 35.5t35.5 14.5zM50 700h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 700h700q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-700 q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM50 300h200q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5zM450 300h700q21 0 35.5 -14.5t14.5 -35.5v-200 q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe013;" d="M465 477l571 571q8 8 18 8t17 -8l177 -177q8 -7 8 -17t-8 -18l-783 -784q-7 -8 -17.5 -8t-17.5 8l-384 384q-8 8 -8 18t8 17l177 177q7 8 17 8t18 -8l171 -171q7 -7 18 -7t18 7z" />
<glyph unicode="&#xe014;" d="M904 1083l178 -179q8 -8 8 -18.5t-8 -17.5l-267 -268l267 -268q8 -7 8 -17.5t-8 -18.5l-178 -178q-8 -8 -18.5 -8t-17.5 8l-268 267l-268 -267q-7 -8 -17.5 -8t-18.5 8l-178 178q-8 8 -8 18.5t8 17.5l267 268l-267 268q-8 7 -8 17.5t8 18.5l178 178q8 8 18.5 8t17.5 -8 l268 -267l268 268q7 7 17.5 7t18.5 -7z" />
<glyph unicode="&#xe015;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM425 900h150q10 0 17.5 -7.5t7.5 -17.5v-75h75q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5 t-17.5 -7.5h-75v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-75q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v75q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe016;" d="M507 1177q98 0 187.5 -38.5t154.5 -103.5t103.5 -154.5t38.5 -187.5q0 -141 -78 -262l300 -299q8 -8 8 -18.5t-8 -18.5l-109 -108q-7 -8 -17.5 -8t-18.5 8l-300 299q-119 -77 -261 -77q-98 0 -188 38.5t-154.5 103t-103 154.5t-38.5 188t38.5 187.5t103 154.5 t154.5 103.5t188 38.5zM506.5 1023q-89.5 0 -165.5 -44t-120 -120.5t-44 -166t44 -165.5t120 -120t165.5 -44t166 44t120.5 120t44 165.5t-44 166t-120.5 120.5t-166 44zM325 800h350q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-350q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe017;" d="M550 1200h100q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM800 975v166q167 -62 272 -209.5t105 -331.5q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5 t-184.5 123t-123 184.5t-45.5 224q0 184 105 331.5t272 209.5v-166q-103 -55 -165 -155t-62 -220q0 -116 57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5q0 120 -62 220t-165 155z" />
<glyph unicode="&#xe018;" d="M1025 1200h150q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM725 800h150q10 0 17.5 -7.5t7.5 -17.5v-750q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v750 q0 10 7.5 17.5t17.5 7.5zM425 500h150q10 0 17.5 -7.5t7.5 -17.5v-450q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v450q0 10 7.5 17.5t17.5 7.5zM125 300h150q10 0 17.5 -7.5t7.5 -17.5v-250q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5 v250q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe019;" d="M600 1174q33 0 74 -5l38 -152l5 -1q49 -14 94 -39l5 -2l134 80q61 -48 104 -105l-80 -134l3 -5q25 -44 39 -93l1 -6l152 -38q5 -43 5 -73q0 -34 -5 -74l-152 -38l-1 -6q-15 -49 -39 -93l-3 -5l80 -134q-48 -61 -104 -105l-134 81l-5 -3q-44 -25 -94 -39l-5 -2l-38 -151 q-43 -5 -74 -5q-33 0 -74 5l-38 151l-5 2q-49 14 -94 39l-5 3l-134 -81q-60 48 -104 105l80 134l-3 5q-25 45 -38 93l-2 6l-151 38q-6 42 -6 74q0 33 6 73l151 38l2 6q13 48 38 93l3 5l-80 134q47 61 105 105l133 -80l5 2q45 25 94 39l5 1l38 152q43 5 74 5zM600 815 q-89 0 -152 -63t-63 -151.5t63 -151.5t152 -63t152 63t63 151.5t-63 151.5t-152 63z" />
<glyph unicode="&#xe020;" d="M500 1300h300q41 0 70.5 -29.5t29.5 -70.5v-100h275q10 0 17.5 -7.5t7.5 -17.5v-75h-1100v75q0 10 7.5 17.5t17.5 7.5h275v100q0 41 29.5 70.5t70.5 29.5zM500 1200v-100h300v100h-300zM1100 900v-800q0 -41 -29.5 -70.5t-70.5 -29.5h-700q-41 0 -70.5 29.5t-29.5 70.5 v800h900zM300 800v-700h100v700h-100zM500 800v-700h100v700h-100zM700 800v-700h100v700h-100zM900 800v-700h100v700h-100z" />
<glyph unicode="&#xe021;" d="M18 618l620 608q8 7 18.5 7t17.5 -7l608 -608q8 -8 5.5 -13t-12.5 -5h-175v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v375h-300v-375q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v575h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe022;" d="M600 1200v-400q0 -41 29.5 -70.5t70.5 -29.5h300v-650q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5h450zM1000 800h-250q-21 0 -35.5 14.5t-14.5 35.5v250z" />
<glyph unicode="&#xe023;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h50q10 0 17.5 -7.5t7.5 -17.5v-275h175q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe024;" d="M1300 0h-538l-41 400h-242l-41 -400h-538l431 1200h209l-21 -300h162l-20 300h208zM515 800l-27 -300h224l-27 300h-170z" />
<glyph unicode="&#xe025;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-450h191q20 0 25.5 -11.5t-7.5 -27.5l-327 -400q-13 -16 -32 -16t-32 16l-327 400q-13 16 -7.5 27.5t25.5 11.5h191v450q0 21 14.5 35.5t35.5 14.5zM1125 400h50q10 0 17.5 -7.5t7.5 -17.5v-350q0 -10 -7.5 -17.5t-17.5 -7.5 h-1050q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h50q10 0 17.5 -7.5t7.5 -17.5v-175h900v175q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe026;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM525 900h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -275q-13 -16 -32 -16t-32 16l-223 275q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z " />
<glyph unicode="&#xe027;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM632 914l223 -275q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5l223 275q13 16 32 16 t32 -16z" />
<glyph unicode="&#xe028;" d="M225 1200h750q10 0 19.5 -7t12.5 -17l186 -652q7 -24 7 -49v-425q0 -12 -4 -27t-9 -17q-12 -6 -37 -6h-1100q-12 0 -27 4t-17 8q-6 13 -6 38l1 425q0 25 7 49l185 652q3 10 12.5 17t19.5 7zM878 1000h-556q-10 0 -19 -7t-11 -18l-87 -450q-2 -11 4 -18t16 -7h150 q10 0 19.5 -7t11.5 -17l38 -152q2 -10 11.5 -17t19.5 -7h250q10 0 19.5 7t11.5 17l38 152q2 10 11.5 17t19.5 7h150q10 0 16 7t4 18l-87 450q-2 11 -11 18t-19 7z" />
<glyph unicode="&#xe029;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM540 820l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe030;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-362q0 -10 -7.5 -17.5t-17.5 -7.5h-362q-11 0 -13 5.5t5 12.5l133 133q-109 76 -238 76q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5h150q0 -117 -45.5 -224 t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117z" />
<glyph unicode="&#xe031;" d="M947 1060l135 135q7 7 12.5 5t5.5 -13v-361q0 -11 -7.5 -18.5t-18.5 -7.5h-361q-11 0 -13 5.5t5 12.5l134 134q-110 75 -239 75q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5h-150q0 117 45.5 224t123 184.5t184.5 123t224 45.5q192 0 347 -117zM1027 600h150 q0 -117 -45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5q-192 0 -348 118l-134 -134q-7 -8 -12.5 -5.5t-5.5 12.5v360q0 11 7.5 18.5t18.5 7.5h360q10 0 12.5 -5.5t-5.5 -12.5l-133 -133q110 -76 240 -76q116 0 214.5 57t155.5 155.5t57 214.5z" />
<glyph unicode="&#xe032;" d="M125 1200h1050q10 0 17.5 -7.5t7.5 -17.5v-1150q0 -10 -7.5 -17.5t-17.5 -7.5h-1050q-10 0 -17.5 7.5t-7.5 17.5v1150q0 10 7.5 17.5t17.5 7.5zM1075 1000h-850q-10 0 -17.5 -7.5t-7.5 -17.5v-850q0 -10 7.5 -17.5t17.5 -7.5h850q10 0 17.5 7.5t7.5 17.5v850 q0 10 -7.5 17.5t-17.5 7.5zM325 900h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 900h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 700h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 700h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 500h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 500h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5zM325 300h50q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM525 300h450q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-450q-10 0 -17.5 7.5t-7.5 17.5v50 q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe033;" d="M900 800v200q0 83 -58.5 141.5t-141.5 58.5h-300q-82 0 -141 -59t-59 -141v-200h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h900q41 0 70.5 29.5t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5h-100zM400 800v150q0 21 15 35.5t35 14.5h200 q20 0 35 -14.5t15 -35.5v-150h-300z" />
<glyph unicode="&#xe034;" d="M125 1100h50q10 0 17.5 -7.5t7.5 -17.5v-1075h-100v1075q0 10 7.5 17.5t17.5 7.5zM1075 1052q4 0 9 -2q16 -6 16 -23v-421q0 -6 -3 -12q-33 -59 -66.5 -99t-65.5 -58t-56.5 -24.5t-52.5 -6.5q-26 0 -57.5 6.5t-52.5 13.5t-60 21q-41 15 -63 22.5t-57.5 15t-65.5 7.5 q-85 0 -160 -57q-7 -5 -15 -5q-6 0 -11 3q-14 7 -14 22v438q22 55 82 98.5t119 46.5q23 2 43 0.5t43 -7t32.5 -8.5t38 -13t32.5 -11q41 -14 63.5 -21t57 -14t63.5 -7q103 0 183 87q7 8 18 8z" />
<glyph unicode="&#xe035;" d="M600 1175q116 0 227 -49.5t192.5 -131t131 -192.5t49.5 -227v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v300q0 127 -70.5 231.5t-184.5 161.5t-245 57t-245 -57t-184.5 -161.5t-70.5 -231.5v-300q0 -10 -7.5 -17.5t-17.5 -7.5h-50 q-10 0 -17.5 7.5t-7.5 17.5v300q0 116 49.5 227t131 192.5t192.5 131t227 49.5zM220 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460q0 8 6 14t14 6zM820 500h160q8 0 14 -6t6 -14v-460q0 -8 -6 -14t-14 -6h-160q-8 0 -14 6t-6 14v460 q0 8 6 14t14 6z" />
<glyph unicode="&#xe036;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM900 668l120 120q7 7 17 7t17 -7l34 -34q7 -7 7 -17t-7 -17l-120 -120l120 -120q7 -7 7 -17 t-7 -17l-34 -34q-7 -7 -17 -7t-17 7l-120 119l-120 -119q-7 -7 -17 -7t-17 7l-34 34q-7 7 -7 17t7 17l119 120l-119 120q-7 7 -7 17t7 17l34 34q7 8 17 8t17 -8z" />
<glyph unicode="&#xe037;" d="M321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6 l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238q-6 8 -4.5 18t9.5 17l29 22q7 5 15 5z" />
<glyph unicode="&#xe038;" d="M967 1004h3q11 -1 17 -10q135 -179 135 -396q0 -105 -34 -206.5t-98 -185.5q-7 -9 -17 -10h-3q-9 0 -16 6l-42 34q-8 6 -9 16t5 18q111 150 111 328q0 90 -29.5 176t-84.5 157q-6 9 -5 19t10 16l42 33q7 5 15 5zM321 814l258 172q9 6 15 2.5t6 -13.5v-750q0 -10 -6 -13.5 t-15 2.5l-258 172q-21 14 -46 14h-250q-10 0 -17.5 7.5t-7.5 17.5v350q0 10 7.5 17.5t17.5 7.5h250q25 0 46 14zM766 900h4q10 -1 16 -10q96 -129 96 -290q0 -154 -90 -281q-6 -9 -17 -10l-3 -1q-9 0 -16 6l-29 23q-7 7 -8.5 16.5t4.5 17.5q72 103 72 229q0 132 -78 238 q-6 8 -4.5 18.5t9.5 16.5l29 22q7 5 15 5z" />
<glyph unicode="&#xe039;" d="M500 900h100v-100h-100v-100h-400v-100h-100v600h500v-300zM1200 700h-200v-100h200v-200h-300v300h-200v300h-100v200h600v-500zM100 1100v-300h300v300h-300zM800 1100v-300h300v300h-300zM300 900h-100v100h100v-100zM1000 900h-100v100h100v-100zM300 500h200v-500 h-500v500h200v100h100v-100zM800 300h200v-100h-100v-100h-200v100h-100v100h100v200h-200v100h300v-300zM100 400v-300h300v300h-300zM300 200h-100v100h100v-100zM1200 200h-100v100h100v-100zM700 0h-100v100h100v-100zM1200 0h-300v100h300v-100z" />
<glyph unicode="&#xe040;" d="M100 200h-100v1000h100v-1000zM300 200h-100v1000h100v-1000zM700 200h-200v1000h200v-1000zM900 200h-100v1000h100v-1000zM1200 200h-200v1000h200v-1000zM400 0h-300v100h300v-100zM600 0h-100v91h100v-91zM800 0h-100v91h100v-91zM1100 0h-200v91h200v-91z" />
<glyph unicode="&#xe041;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe042;" d="M500 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-682 682l1 475q0 10 7.5 17.5t17.5 7.5h474zM800 1200l682 -682q8 -8 8 -18t-8 -18l-464 -464q-8 -8 -18 -8t-18 8l-56 56l424 426l-700 700h150zM319.5 1024.5q-29.5 29.5 -71 29.5t-71 -29.5 t-29.5 -71.5t29.5 -71.5t71 -29.5t71 29.5t29.5 71.5t-29.5 71.5z" />
<glyph unicode="&#xe043;" d="M300 1200h825q75 0 75 -75v-900q0 -25 -18 -43l-64 -64q-8 -8 -13 -5.5t-5 12.5v950q0 10 -7.5 17.5t-17.5 7.5h-700q-25 0 -43 -18l-64 -64q-8 -8 -5.5 -13t12.5 -5h700q10 0 17.5 -7.5t7.5 -17.5v-950q0 -10 -7.5 -17.5t-17.5 -7.5h-850q-10 0 -17.5 7.5t-7.5 17.5v975 q0 25 18 43l139 139q18 18 43 18z" />
<glyph unicode="&#xe044;" d="M250 1200h800q21 0 35.5 -14.5t14.5 -35.5v-1150l-450 444l-450 -445v1151q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe045;" d="M822 1200h-444q-11 0 -19 -7.5t-9 -17.5l-78 -301q-7 -24 7 -45l57 -108q6 -9 17.5 -15t21.5 -6h450q10 0 21.5 6t17.5 15l62 108q14 21 7 45l-83 301q-1 10 -9 17.5t-19 7.5zM1175 800h-150q-10 0 -21 -6.5t-15 -15.5l-78 -156q-4 -9 -15 -15.5t-21 -6.5h-550 q-10 0 -21 6.5t-15 15.5l-78 156q-4 9 -15 15.5t-21 6.5h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-650q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h750q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5 t7.5 17.5v650q0 10 -7.5 17.5t-17.5 7.5zM850 200h-500q-10 0 -19.5 -7t-11.5 -17l-38 -152q-2 -10 3.5 -17t15.5 -7h600q10 0 15.5 7t3.5 17l-38 152q-2 10 -11.5 17t-19.5 7z" />
<glyph unicode="&#xe046;" d="M500 1100h200q56 0 102.5 -20.5t72.5 -50t44 -59t25 -50.5l6 -20h150q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5h150q2 8 6.5 21.5t24 48t45 61t72 48t102.5 21.5zM900 800v-100 h100v100h-100zM600 730q-95 0 -162.5 -67.5t-67.5 -162.5t67.5 -162.5t162.5 -67.5t162.5 67.5t67.5 162.5t-67.5 162.5t-162.5 67.5zM600 603q43 0 73 -30t30 -73t-30 -73t-73 -30t-73 30t-30 73t30 73t73 30z" />
<glyph unicode="&#xe047;" d="M681 1199l385 -998q20 -50 60 -92q18 -19 36.5 -29.5t27.5 -11.5l10 -2v-66h-417v66q53 0 75 43.5t5 88.5l-82 222h-391q-58 -145 -92 -234q-11 -34 -6.5 -57t25.5 -37t46 -20t55 -6v-66h-365v66q56 24 84 52q12 12 25 30.5t20 31.5l7 13l399 1006h93zM416 521h340 l-162 457z" />
<glyph unicode="&#xe048;" d="M753 641q5 -1 14.5 -4.5t36 -15.5t50.5 -26.5t53.5 -40t50.5 -54.5t35.5 -70t14.5 -87q0 -67 -27.5 -125.5t-71.5 -97.5t-98.5 -66.5t-108.5 -40.5t-102 -13h-500v89q41 7 70.5 32.5t29.5 65.5v827q0 24 -0.5 34t-3.5 24t-8.5 19.5t-17 13.5t-28 12.5t-42.5 11.5v71 l471 -1q57 0 115.5 -20.5t108 -57t80.5 -94t31 -124.5q0 -51 -15.5 -96.5t-38 -74.5t-45 -50.5t-38.5 -30.5zM400 700h139q78 0 130.5 48.5t52.5 122.5q0 41 -8.5 70.5t-29.5 55.5t-62.5 39.5t-103.5 13.5h-118v-350zM400 200h216q80 0 121 50.5t41 130.5q0 90 -62.5 154.5 t-156.5 64.5h-159v-400z" />
<glyph unicode="&#xe049;" d="M877 1200l2 -57q-83 -19 -116 -45.5t-40 -66.5l-132 -839q-9 -49 13 -69t96 -26v-97h-500v97q186 16 200 98l173 832q3 17 3 30t-1.5 22.5t-9 17.5t-13.5 12.5t-21.5 10t-26 8.5t-33.5 10q-13 3 -19 5v57h425z" />
<glyph unicode="&#xe050;" d="M1300 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM175 1000h-75v-800h75l-125 -167l-125 167h75v800h-75l125 167z" />
<glyph unicode="&#xe051;" d="M1100 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-650q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v650h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM1167 50l-167 -125v75h-800v-75l-167 125l167 125v-75h800v75z" />
<glyph unicode="&#xe052;" d="M50 1100h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe053;" d="M250 1100h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM250 500h700q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-700q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe054;" d="M500 950v100q0 21 14.5 35.5t35.5 14.5h600q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5zM100 650v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000 q-21 0 -35.5 14.5t-14.5 35.5zM300 350v100q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5zM0 50v100q0 21 14.5 35.5t35.5 14.5h1100q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5z" />
<glyph unicode="&#xe055;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 800h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 500h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h1100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe056;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 1100h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 800h800q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 500h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 500h800q21 0 35.5 -14.5t14.5 -35.5v-100 q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM350 200h800 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe057;" d="M400 0h-100v1100h100v-1100zM550 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM267 550l-167 -125v75h-200v100h200v75zM550 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM550 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe058;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM900 0h-100v1100h100v-1100zM50 800h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM1100 600h200v-100h-200v-75l-167 125l167 125v-75zM50 500h300q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5zM50 200h600 q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-600q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe059;" d="M75 1000h750q31 0 53 -22t22 -53v-650q0 -31 -22 -53t-53 -22h-750q-31 0 -53 22t-22 53v650q0 31 22 53t53 22zM1200 300l-300 300l300 300v-600z" />
<glyph unicode="&#xe060;" d="M44 1100h1112q18 0 31 -13t13 -31v-1012q0 -18 -13 -31t-31 -13h-1112q-18 0 -31 13t-13 31v1012q0 18 13 31t31 13zM100 1000v-737l247 182l298 -131l-74 156l293 318l236 -288v500h-1000zM342 884q56 0 95 -39t39 -94.5t-39 -95t-95 -39.5t-95 39.5t-39 95t39 94.5 t95 39z" />
<glyph unicode="&#xe062;" d="M648 1169q117 0 216 -60t156.5 -161t57.5 -218q0 -115 -70 -258q-69 -109 -158 -225.5t-143 -179.5l-54 -62q-9 8 -25.5 24.5t-63.5 67.5t-91 103t-98.5 128t-95.5 148q-60 132 -60 249q0 88 34 169.5t91.5 142t137 96.5t166.5 36zM652.5 974q-91.5 0 -156.5 -65 t-65 -157t65 -156.5t156.5 -64.5t156.5 64.5t65 156.5t-65 157t-156.5 65z" />
<glyph unicode="&#xe063;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 173v854q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57z" />
<glyph unicode="&#xe064;" d="M554 1295q21 -72 57.5 -143.5t76 -130t83 -118t82.5 -117t70 -116t49.5 -126t18.5 -136.5q0 -71 -25.5 -135t-68.5 -111t-99 -82t-118.5 -54t-125.5 -23q-84 5 -161.5 34t-139.5 78.5t-99 125t-37 164.5q0 69 18 136.5t49.5 126.5t69.5 116.5t81.5 117.5t83.5 119 t76.5 131t58.5 143zM344 710q-23 -33 -43.5 -70.5t-40.5 -102.5t-17 -123q1 -37 14.5 -69.5t30 -52t41 -37t38.5 -24.5t33 -15q21 -7 32 -1t13 22l6 34q2 10 -2.5 22t-13.5 19q-5 4 -14 12t-29.5 40.5t-32.5 73.5q-26 89 6 271q2 11 -6 11q-8 1 -15 -10z" />
<glyph unicode="&#xe065;" d="M1000 1013l108 115q2 1 5 2t13 2t20.5 -1t25 -9.5t28.5 -21.5q22 -22 27 -43t0 -32l-6 -10l-108 -115zM350 1100h400q50 0 105 -13l-187 -187h-368q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v182l200 200v-332 q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM1009 803l-362 -362l-161 -50l55 170l355 355z" />
<glyph unicode="&#xe066;" d="M350 1100h361q-164 -146 -216 -200h-195q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5l200 153v-103q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M824 1073l339 -301q8 -7 8 -17.5t-8 -17.5l-340 -306q-7 -6 -12.5 -4t-6.5 11v203q-26 1 -54.5 0t-78.5 -7.5t-92 -17.5t-86 -35t-70 -57q10 59 33 108t51.5 81.5t65 58.5t68.5 40.5t67 24.5t56 13.5t40 4.5v210q1 10 6.5 12.5t13.5 -4.5z" />
<glyph unicode="&#xe067;" d="M350 1100h350q60 0 127 -23l-178 -177h-349q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v69l200 200v-219q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5z M643 639l395 395q7 7 17.5 7t17.5 -7l101 -101q7 -7 7 -17.5t-7 -17.5l-531 -532q-7 -7 -17.5 -7t-17.5 7l-248 248q-7 7 -7 17.5t7 17.5l101 101q7 7 17.5 7t17.5 -7l111 -111q8 -7 18 -7t18 7z" />
<glyph unicode="&#xe068;" d="M318 918l264 264q8 8 18 8t18 -8l260 -264q7 -8 4.5 -13t-12.5 -5h-170v-200h200v173q0 10 5 12t13 -5l264 -260q8 -7 8 -17.5t-8 -17.5l-264 -265q-8 -7 -13 -5t-5 12v173h-200v-200h170q10 0 12.5 -5t-4.5 -13l-260 -264q-8 -8 -18 -8t-18 8l-264 264q-8 8 -5.5 13 t12.5 5h175v200h-200v-173q0 -10 -5 -12t-13 5l-264 265q-8 7 -8 17.5t8 17.5l264 260q8 7 13 5t5 -12v-173h200v200h-175q-10 0 -12.5 5t5.5 13z" />
<glyph unicode="&#xe069;" d="M250 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe070;" d="M50 1100h100q21 0 35.5 -14.5t14.5 -35.5v-438l464 453q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5 t-14.5 35.5v1000q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe071;" d="M1200 1050v-1000q0 -21 -10.5 -25t-25.5 10l-464 453v-438q0 -21 -10.5 -25t-25.5 10l-492 480q-15 14 -15 35t15 35l492 480q15 14 25.5 10t10.5 -25v-438l464 453q15 14 25.5 10t10.5 -25z" />
<glyph unicode="&#xe072;" d="M243 1074l814 -498q18 -11 18 -26t-18 -26l-814 -498q-18 -11 -30.5 -4t-12.5 28v1000q0 21 12.5 28t30.5 -4z" />
<glyph unicode="&#xe073;" d="M250 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM650 1000h200q21 0 35.5 -14.5t14.5 -35.5v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v800 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe074;" d="M1100 950v-800q0 -21 -14.5 -35.5t-35.5 -14.5h-800q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5h800q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe075;" d="M500 612v438q0 21 10.5 25t25.5 -10l492 -480q15 -14 15 -35t-15 -35l-492 -480q-15 -14 -25.5 -10t-10.5 25v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10z" />
<glyph unicode="&#xe076;" d="M1048 1102l100 1q20 0 35 -14.5t15 -35.5l5 -1000q0 -21 -14.5 -35.5t-35.5 -14.5l-100 -1q-21 0 -35.5 14.5t-14.5 35.5l-2 437l-463 -454q-14 -15 -24.5 -10.5t-10.5 25.5l-2 437l-462 -455q-15 -14 -25.5 -9.5t-10.5 24.5l-5 1000q0 21 10.5 25.5t25.5 -10.5l466 -450 l-2 438q0 20 10.5 24.5t25.5 -9.5l466 -451l-2 438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe077;" d="M850 1100h100q21 0 35.5 -14.5t14.5 -35.5v-1000q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v438l-464 -453q-15 -14 -25.5 -10t-10.5 25v1000q0 21 10.5 25t25.5 -10l464 -453v438q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe078;" d="M686 1081l501 -540q15 -15 10.5 -26t-26.5 -11h-1042q-22 0 -26.5 11t10.5 26l501 540q15 15 36 15t36 -15zM150 400h1000q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe079;" d="M885 900l-352 -353l352 -353l-197 -198l-552 552l552 550z" />
<glyph unicode="&#xe080;" d="M1064 547l-551 -551l-198 198l353 353l-353 353l198 198z" />
<glyph unicode="&#xe081;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM650 900h-100q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-150 q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5h150v-150q0 -21 14.5 -35.5t35.5 -14.5h100q21 0 35.5 14.5t14.5 35.5v150h150q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-150v150q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe082;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM850 700h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5 t35.5 -14.5h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5z" />
<glyph unicode="&#xe083;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM741.5 913q-12.5 0 -21.5 -9l-120 -120l-120 120q-9 9 -21.5 9 t-21.5 -9l-141 -141q-9 -9 -9 -21.5t9 -21.5l120 -120l-120 -120q-9 -9 -9 -21.5t9 -21.5l141 -141q9 -9 21.5 -9t21.5 9l120 120l120 -120q9 -9 21.5 -9t21.5 9l141 141q9 9 9 21.5t-9 21.5l-120 120l120 120q9 9 9 21.5t-9 21.5l-141 141q-9 9 -21.5 9z" />
<glyph unicode="&#xe084;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM546 623l-84 85q-7 7 -17.5 7t-18.5 -7l-139 -139q-7 -8 -7 -18t7 -18 l242 -241q7 -8 17.5 -8t17.5 8l375 375q7 7 7 17.5t-7 18.5l-139 139q-7 7 -17.5 7t-17.5 -7z" />
<glyph unicode="&#xe085;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM588 941q-29 0 -59 -5.5t-63 -20.5t-58 -38.5t-41.5 -63t-16.5 -89.5 q0 -25 20 -25h131q30 -5 35 11q6 20 20.5 28t45.5 8q20 0 31.5 -10.5t11.5 -28.5q0 -23 -7 -34t-26 -18q-1 0 -13.5 -4t-19.5 -7.5t-20 -10.5t-22 -17t-18.5 -24t-15.5 -35t-8 -46q-1 -8 5.5 -16.5t20.5 -8.5h173q7 0 22 8t35 28t37.5 48t29.5 74t12 100q0 47 -17 83 t-42.5 57t-59.5 34.5t-64 18t-59 4.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe086;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM675 1000h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5 t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5zM675 700h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h75v-200h-75q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h350q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5 t-17.5 7.5h-75v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe087;" d="M525 1200h150q10 0 17.5 -7.5t7.5 -17.5v-194q103 -27 178.5 -102.5t102.5 -178.5h194q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-194q-27 -103 -102.5 -178.5t-178.5 -102.5v-194q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v194 q-103 27 -178.5 102.5t-102.5 178.5h-194q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h194q27 103 102.5 178.5t178.5 102.5v194q0 10 7.5 17.5t17.5 7.5zM700 893v-168q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v168q-68 -23 -119 -74 t-74 -119h168q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-168q23 -68 74 -119t119 -74v168q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-168q68 23 119 74t74 119h-168q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h168 q-23 68 -74 119t-119 74z" />
<glyph unicode="&#xe088;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM759 823l64 -64q7 -7 7 -17.5t-7 -17.5l-124 -124l124 -124q7 -7 7 -17.5t-7 -17.5l-64 -64q-7 -7 -17.5 -7t-17.5 7l-124 124l-124 -124q-7 -7 -17.5 -7t-17.5 7l-64 64 q-7 7 -7 17.5t7 17.5l124 124l-124 124q-7 7 -7 17.5t7 17.5l64 64q7 7 17.5 7t17.5 -7l124 -124l124 124q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe089;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5t57 -214.5 t155.5 -155.5t214.5 -57t214.5 57t155.5 155.5t57 214.5t-57 214.5t-155.5 155.5t-214.5 57zM782 788l106 -106q7 -7 7 -17.5t-7 -17.5l-320 -321q-8 -7 -18 -7t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l197 197q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe090;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM600 1027q-116 0 -214.5 -57t-155.5 -155.5t-57 -214.5q0 -120 65 -225 l587 587q-105 65 -225 65zM965 819l-584 -584q104 -62 219 -62q116 0 214.5 57t155.5 155.5t57 214.5q0 115 -62 219z" />
<glyph unicode="&#xe091;" d="M39 582l522 427q16 13 27.5 8t11.5 -26v-291h550q21 0 35.5 -14.5t14.5 -35.5v-200q0 -21 -14.5 -35.5t-35.5 -14.5h-550v-291q0 -21 -11.5 -26t-27.5 8l-522 427q-16 13 -16 32t16 32z" />
<glyph unicode="&#xe092;" d="M639 1009l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291h-550q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h550v291q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe093;" d="M682 1161l427 -522q13 -16 8 -27.5t-26 -11.5h-291v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v550h-291q-21 0 -26 11.5t8 27.5l427 522q13 16 32 16t32 -16z" />
<glyph unicode="&#xe094;" d="M550 1200h200q21 0 35.5 -14.5t14.5 -35.5v-550h291q21 0 26 -11.5t-8 -27.5l-427 -522q-13 -16 -32 -16t-32 16l-427 522q-13 16 -8 27.5t26 11.5h291v550q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe095;" d="M639 1109l522 -427q16 -13 16 -32t-16 -32l-522 -427q-16 -13 -27.5 -8t-11.5 26v291q-94 -2 -182 -20t-170.5 -52t-147 -92.5t-100.5 -135.5q5 105 27 193.5t67.5 167t113 135t167 91.5t225.5 42v262q0 21 11.5 26t27.5 -8z" />
<glyph unicode="&#xe096;" d="M850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5zM350 0h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249 q8 7 18 7t18 -7l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5z" />
<glyph unicode="&#xe097;" d="M1014 1120l106 -106q7 -8 7 -18t-7 -18l-249 -249l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l249 249q8 7 18 7t18 -7zM250 600h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-249 -249q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l249 249l-94 94q-14 14 -10 24.5t25 10.5z" />
<glyph unicode="&#xe101;" d="M600 1177q117 0 224 -45.5t184.5 -123t123 -184.5t45.5 -224t-45.5 -224t-123 -184.5t-184.5 -123t-224 -45.5t-224 45.5t-184.5 123t-123 184.5t-45.5 224t45.5 224t123 184.5t184.5 123t224 45.5zM704 900h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5 t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM675 400h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe102;" d="M260 1200q9 0 19 -2t15 -4l5 -2q22 -10 44 -23l196 -118q21 -13 36 -24q29 -21 37 -12q11 13 49 35l196 118q22 13 45 23q17 7 38 7q23 0 47 -16.5t37 -33.5l13 -16q14 -21 18 -45l25 -123l8 -44q1 -9 8.5 -14.5t17.5 -5.5h61q10 0 17.5 -7.5t7.5 -17.5v-50 q0 -10 -7.5 -17.5t-17.5 -7.5h-50q-10 0 -17.5 -7.5t-7.5 -17.5v-175h-400v300h-200v-300h-400v175q0 10 -7.5 17.5t-17.5 7.5h-50q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5h61q11 0 18 3t7 8q0 4 9 52l25 128q5 25 19 45q2 3 5 7t13.5 15t21.5 19.5t26.5 15.5 t29.5 7zM915 1079l-166 -162q-7 -7 -5 -12t12 -5h219q10 0 15 7t2 17l-51 149q-3 10 -11 12t-15 -6zM463 917l-177 157q-8 7 -16 5t-11 -12l-51 -143q-3 -10 2 -17t15 -7h231q11 0 12.5 5t-5.5 12zM500 0h-375q-10 0 -17.5 7.5t-7.5 17.5v375h400v-400zM1100 400v-375 q0 -10 -7.5 -17.5t-17.5 -7.5h-375v400h400z" />
<glyph unicode="&#xe103;" d="M1165 1190q8 3 21 -6.5t13 -17.5q-2 -178 -24.5 -323.5t-55.5 -245.5t-87 -174.5t-102.5 -118.5t-118 -68.5t-118.5 -33t-120 -4.5t-105 9.5t-90 16.5q-61 12 -78 11q-4 1 -12.5 0t-34 -14.5t-52.5 -40.5l-153 -153q-26 -24 -37 -14.5t-11 43.5q0 64 42 102q8 8 50.5 45 t66.5 58q19 17 35 47t13 61q-9 55 -10 102.5t7 111t37 130t78 129.5q39 51 80 88t89.5 63.5t94.5 45t113.5 36t129 31t157.5 37t182 47.5zM1116 1098q-8 9 -22.5 -3t-45.5 -50q-38 -47 -119 -103.5t-142 -89.5l-62 -33q-56 -30 -102 -57t-104 -68t-102.5 -80.5t-85.5 -91 t-64 -104.5q-24 -56 -31 -86t2 -32t31.5 17.5t55.5 59.5q25 30 94 75.5t125.5 77.5t147.5 81q70 37 118.5 69t102 79.5t99 111t86.5 148.5q22 50 24 60t-6 19z" />
<glyph unicode="&#xe104;" d="M653 1231q-39 -67 -54.5 -131t-10.5 -114.5t24.5 -96.5t47.5 -80t63.5 -62.5t68.5 -46.5t65 -30q-4 7 -17.5 35t-18.5 39.5t-17 39.5t-17 43t-13 42t-9.5 44.5t-2 42t4 43t13.5 39t23 38.5q96 -42 165 -107.5t105 -138t52 -156t13 -159t-19 -149.5q-13 -55 -44 -106.5 t-68 -87t-78.5 -64.5t-72.5 -45t-53 -22q-72 -22 -127 -11q-31 6 -13 19q6 3 17 7q13 5 32.5 21t41 44t38.5 63.5t21.5 81.5t-6.5 94.5t-50 107t-104 115.5q10 -104 -0.5 -189t-37 -140.5t-65 -93t-84 -52t-93.5 -11t-95 24.5q-80 36 -131.5 114t-53.5 171q-2 23 0 49.5 t4.5 52.5t13.5 56t27.5 60t46 64.5t69.5 68.5q-8 -53 -5 -102.5t17.5 -90t34 -68.5t44.5 -39t49 -2q31 13 38.5 36t-4.5 55t-29 64.5t-36 75t-26 75.5q-15 85 2 161.5t53.5 128.5t85.5 92.5t93.5 61t81.5 25.5z" />
<glyph unicode="&#xe105;" d="M600 1094q82 0 160.5 -22.5t140 -59t116.5 -82.5t94.5 -95t68 -95t42.5 -82.5t14 -57.5t-14 -57.5t-43 -82.5t-68.5 -95t-94.5 -95t-116.5 -82.5t-140 -59t-159.5 -22.5t-159.5 22.5t-140 59t-116.5 82.5t-94.5 95t-68.5 95t-43 82.5t-14 57.5t14 57.5t42.5 82.5t68 95 t94.5 95t116.5 82.5t140 59t160.5 22.5zM888 829q-15 15 -18 12t5 -22q25 -57 25 -119q0 -124 -88 -212t-212 -88t-212 88t-88 212q0 59 23 114q8 19 4.5 22t-17.5 -12q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q22 -36 47 -71t70 -82t92.5 -81t113 -58.5t133.5 -24.5 t133.5 24t113 58.5t92.5 81.5t70 81.5t47 70.5q11 18 9 42.5t-14 41.5q-90 117 -163 189zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l35 34q14 15 12.5 33.5t-16.5 33.5q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe106;" d="M592 0h-148l31 120q-91 20 -175.5 68.5t-143.5 106.5t-103.5 119t-66.5 110t-22 76q0 21 14 57.5t42.5 82.5t68 95t94.5 95t116.5 82.5t140 59t160.5 22.5q61 0 126 -15l32 121h148zM944 770l47 181q108 -85 176.5 -192t68.5 -159q0 -26 -19.5 -71t-59.5 -102t-93 -112 t-129 -104.5t-158 -75.5l46 173q77 49 136 117t97 131q11 18 9 42.5t-14 41.5q-54 70 -107 130zM310 824q-70 -69 -160 -184q-13 -16 -15 -40.5t9 -42.5q18 -30 39 -60t57 -70.5t74 -73t90 -61t105 -41.5l41 154q-107 18 -178.5 101.5t-71.5 193.5q0 59 23 114q8 19 4.5 22 t-17.5 -12zM448 727l-35 -36q-15 -15 -19.5 -38.5t4.5 -41.5q37 -68 93 -116q16 -13 38.5 -11t36.5 17l12 11l22 86l-3 4q-44 44 -89 117q-11 18 -28 20t-32 -12z" />
<glyph unicode="&#xe107;" d="M-90 100l642 1066q20 31 48 28.5t48 -35.5l642 -1056q21 -32 7.5 -67.5t-50.5 -35.5h-1294q-37 0 -50.5 34t7.5 66zM155 200h345v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h345l-445 723zM496 700h208q20 0 32 -14.5t8 -34.5l-58 -252 q-4 -20 -21.5 -34.5t-37.5 -14.5h-54q-20 0 -37.5 14.5t-21.5 34.5l-58 252q-4 20 8 34.5t32 14.5z" />
<glyph unicode="&#xe108;" d="M650 1200q62 0 106 -44t44 -106v-339l363 -325q15 -14 26 -38.5t11 -44.5v-41q0 -20 -12 -26.5t-29 5.5l-359 249v-263q100 -93 100 -113v-64q0 -21 -13 -29t-32 1l-205 128l-205 -128q-19 -9 -32 -1t-13 29v64q0 20 100 113v263l-359 -249q-17 -12 -29 -5.5t-12 26.5v41 q0 20 11 44.5t26 38.5l363 325v339q0 62 44 106t106 44z" />
<glyph unicode="&#xe109;" d="M850 1200h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-150h-1100v150q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5h100q21 0 35.5 -14.5t14.5 -35.5v-50h500v50q0 21 14.5 35.5t35.5 14.5zM1100 800v-750q0 -21 -14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v750h1100zM100 600v-100h100v100h-100zM300 600v-100h100v100h-100zM500 600v-100h100v100h-100zM700 600v-100h100v100h-100zM900 600v-100h100v100h-100zM100 400v-100h100v100h-100zM300 400v-100h100v100h-100zM500 400 v-100h100v100h-100zM700 400v-100h100v100h-100zM900 400v-100h100v100h-100zM100 200v-100h100v100h-100zM300 200v-100h100v100h-100zM500 200v-100h100v100h-100zM700 200v-100h100v100h-100zM900 200v-100h100v100h-100z" />
<glyph unicode="&#xe110;" d="M1135 1165l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-159l-600 -600h-291q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h209l600 600h241v150q0 21 10.5 25t24.5 -10zM522 819l-141 -141l-122 122h-209q-21 0 -35.5 14.5 t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h291zM1135 565l249 -230q15 -14 15 -35t-15 -35l-249 -230q-14 -14 -24.5 -10t-10.5 25v150h-241l-181 181l141 141l122 -122h159v150q0 21 10.5 25t24.5 -10z" />
<glyph unicode="&#xe111;" d="M100 1100h1000q41 0 70.5 -29.5t29.5 -70.5v-600q0 -41 -29.5 -70.5t-70.5 -29.5h-596l-304 -300v300h-100q-41 0 -70.5 29.5t-29.5 70.5v600q0 41 29.5 70.5t70.5 29.5z" />
<glyph unicode="&#xe112;" d="M150 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM850 1200h200q21 0 35.5 -14.5t14.5 -35.5v-250h-300v250q0 21 14.5 35.5t35.5 14.5zM1100 800v-300q0 -41 -3 -77.5t-15 -89.5t-32 -96t-58 -89t-89 -77t-129 -51t-174 -20t-174 20 t-129 51t-89 77t-58 89t-32 96t-15 89.5t-3 77.5v300h300v-250v-27v-42.5t1.5 -41t5 -38t10 -35t16.5 -30t25.5 -24.5t35 -19t46.5 -12t60 -4t60 4.5t46.5 12.5t35 19.5t25 25.5t17 30.5t10 35t5 38t2 40.5t-0.5 42v25v250h300z" />
<glyph unicode="&#xe113;" d="M1100 411l-198 -199l-353 353l-353 -353l-197 199l551 551z" />
<glyph unicode="&#xe114;" d="M1101 789l-550 -551l-551 551l198 199l353 -353l353 353z" />
<glyph unicode="&#xe115;" d="M404 1000h746q21 0 35.5 -14.5t14.5 -35.5v-551h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v401h-381zM135 984l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-400h385l215 -200h-750q-21 0 -35.5 14.5 t-14.5 35.5v550h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe116;" d="M56 1200h94q17 0 31 -11t18 -27l38 -162h896q24 0 39 -18.5t10 -42.5l-100 -475q-5 -21 -27 -42.5t-55 -21.5h-633l48 -200h535q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-50q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-300v-50 q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v50h-31q-18 0 -32.5 10t-20.5 19l-5 10l-201 961h-54q-20 0 -35 14.5t-15 35.5t15 35.5t35 14.5z" />
<glyph unicode="&#xe117;" d="M1200 1000v-100h-1200v100h200q0 41 29.5 70.5t70.5 29.5h300q41 0 70.5 -29.5t29.5 -70.5h500zM0 800h1200v-800h-1200v800z" />
<glyph unicode="&#xe118;" d="M200 800l-200 -400v600h200q0 41 29.5 70.5t70.5 29.5h300q42 0 71 -29.5t29 -70.5h500v-200h-1000zM1500 700l-300 -700h-1200l300 700h1200z" />
<glyph unicode="&#xe119;" d="M635 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-601h150q21 0 25 -10.5t-10 -24.5l-230 -249q-14 -15 -35 -15t-35 15l-230 249q-14 14 -10 24.5t25 10.5h150v601h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe120;" d="M936 864l249 -229q14 -15 14 -35.5t-14 -35.5l-249 -229q-15 -15 -25.5 -10.5t-10.5 24.5v151h-600v-151q0 -20 -10.5 -24.5t-25.5 10.5l-249 229q-14 15 -14 35.5t14 35.5l249 229q15 15 25.5 10.5t10.5 -25.5v-149h600v149q0 21 10.5 25.5t25.5 -10.5z" />
<glyph unicode="&#xe121;" d="M1169 400l-172 732q-5 23 -23 45.5t-38 22.5h-672q-20 0 -38 -20t-23 -41l-172 -739h1138zM1100 300h-1000q-41 0 -70.5 -29.5t-29.5 -70.5v-100q0 -41 29.5 -70.5t70.5 -29.5h1000q41 0 70.5 29.5t29.5 70.5v100q0 41 -29.5 70.5t-70.5 29.5zM800 100v100h100v-100h-100 zM1000 100v100h100v-100h-100z" />
<glyph unicode="&#xe122;" d="M1150 1100q21 0 35.5 -14.5t14.5 -35.5v-850q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v850q0 21 14.5 35.5t35.5 14.5zM1000 200l-675 200h-38l47 -276q3 -16 -5.5 -20t-29.5 -4h-7h-84q-20 0 -34.5 14t-18.5 35q-55 337 -55 351v250v6q0 16 1 23.5t6.5 14 t17.5 6.5h200l675 250v-850zM0 750v-250q-4 0 -11 0.5t-24 6t-30 15t-24 30t-11 48.5v50q0 26 10.5 46t25 30t29 16t25.5 7z" />
<glyph unicode="&#xe123;" d="M553 1200h94q20 0 29 -10.5t3 -29.5l-18 -37q83 -19 144 -82.5t76 -140.5l63 -327l118 -173h17q19 0 33 -14.5t14 -35t-13 -40.5t-31 -27q-8 -4 -23 -9.5t-65 -19.5t-103 -25t-132.5 -20t-158.5 -9q-57 0 -115 5t-104 12t-88.5 15.5t-73.5 17.5t-54.5 16t-35.5 12l-11 4 q-18 8 -31 28t-13 40.5t14 35t33 14.5h17l118 173l63 327q15 77 76 140t144 83l-18 32q-6 19 3.5 32t28.5 13zM498 110q50 -6 102 -6q53 0 102 6q-12 -49 -39.5 -79.5t-62.5 -30.5t-63 30.5t-39 79.5z" />
<glyph unicode="&#xe124;" d="M800 946l224 78l-78 -224l234 -45l-180 -155l180 -155l-234 -45l78 -224l-224 78l-45 -234l-155 180l-155 -180l-45 234l-224 -78l78 224l-234 45l180 155l-180 155l234 45l-78 224l224 -78l45 234l155 -180l155 180z" />
<glyph unicode="&#xe125;" d="M650 1200h50q40 0 70 -40.5t30 -84.5v-150l-28 -125h328q40 0 70 -40.5t30 -84.5v-100q0 -45 -29 -74l-238 -344q-16 -24 -38 -40.5t-45 -16.5h-250q-7 0 -42 25t-66 50l-31 25h-61q-45 0 -72.5 18t-27.5 57v400q0 36 20 63l145 196l96 198q13 28 37.5 48t51.5 20z M650 1100l-100 -212l-150 -213v-375h100l136 -100h214l250 375v125h-450l50 225v175h-50zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe126;" d="M600 1100h250q23 0 45 -16.5t38 -40.5l238 -344q29 -29 29 -74v-100q0 -44 -30 -84.5t-70 -40.5h-328q28 -118 28 -125v-150q0 -44 -30 -84.5t-70 -40.5h-50q-27 0 -51.5 20t-37.5 48l-96 198l-145 196q-20 27 -20 63v400q0 39 27.5 57t72.5 18h61q124 100 139 100z M50 1000h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM636 1000l-136 -100h-100v-375l150 -213l100 -212h50v175l-50 225h450v125l-250 375h-214z" />
<glyph unicode="&#xe127;" d="M356 873l363 230q31 16 53 -6l110 -112q13 -13 13.5 -32t-11.5 -34l-84 -121h302q84 0 138 -38t54 -110t-55 -111t-139 -39h-106l-131 -339q-6 -21 -19.5 -41t-28.5 -20h-342q-7 0 -90 81t-83 94v525q0 17 14 35.5t28 28.5zM400 792v-503l100 -89h293l131 339 q6 21 19.5 41t28.5 20h203q21 0 30.5 25t0.5 50t-31 25h-456h-7h-6h-5.5t-6 0.5t-5 1.5t-5 2t-4 2.5t-4 4t-2.5 4.5q-12 25 5 47l146 183l-86 83zM50 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v500 q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe128;" d="M475 1103l366 -230q2 -1 6 -3.5t14 -10.5t18 -16.5t14.5 -20t6.5 -22.5v-525q0 -13 -86 -94t-93 -81h-342q-15 0 -28.5 20t-19.5 41l-131 339h-106q-85 0 -139.5 39t-54.5 111t54 110t138 38h302l-85 121q-11 15 -10.5 34t13.5 32l110 112q22 22 53 6zM370 945l146 -183 q17 -22 5 -47q-2 -2 -3.5 -4.5t-4 -4t-4 -2.5t-5 -2t-5 -1.5t-6 -0.5h-6h-6.5h-6h-475v-100h221q15 0 29 -20t20 -41l130 -339h294l106 89v503l-342 236zM1050 800h100q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5 v500q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe129;" d="M550 1294q72 0 111 -55t39 -139v-106l339 -131q21 -6 41 -19.5t20 -28.5v-342q0 -7 -81 -90t-94 -83h-525q-17 0 -35.5 14t-28.5 28l-9 14l-230 363q-16 31 6 53l112 110q13 13 32 13.5t34 -11.5l121 -84v302q0 84 38 138t110 54zM600 972v203q0 21 -25 30.5t-50 0.5 t-25 -31v-456v-7v-6v-5.5t-0.5 -6t-1.5 -5t-2 -5t-2.5 -4t-4 -4t-4.5 -2.5q-25 -12 -47 5l-183 146l-83 -86l236 -339h503l89 100v293l-339 131q-21 6 -41 19.5t-20 28.5zM450 200h500q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-500 q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe130;" d="M350 1100h500q21 0 35.5 14.5t14.5 35.5v100q0 21 -14.5 35.5t-35.5 14.5h-500q-21 0 -35.5 -14.5t-14.5 -35.5v-100q0 -21 14.5 -35.5t35.5 -14.5zM600 306v-106q0 -84 -39 -139t-111 -55t-110 54t-38 138v302l-121 -84q-15 -12 -34 -11.5t-32 13.5l-112 110 q-22 22 -6 53l230 363q1 2 3.5 6t10.5 13.5t16.5 17t20 13.5t22.5 6h525q13 0 94 -83t81 -90v-342q0 -15 -20 -28.5t-41 -19.5zM308 900l-236 -339l83 -86l183 146q22 17 47 5q2 -1 4.5 -2.5t4 -4t2.5 -4t2 -5t1.5 -5t0.5 -6v-5.5v-6v-7v-456q0 -22 25 -31t50 0.5t25 30.5 v203q0 15 20 28.5t41 19.5l339 131v293l-89 100h-503z" />
<glyph unicode="&#xe131;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM914 632l-275 223q-16 13 -27.5 8t-11.5 -26v-137h-275 q-10 0 -17.5 -7.5t-7.5 -17.5v-150q0 -10 7.5 -17.5t17.5 -7.5h275v-137q0 -21 11.5 -26t27.5 8l275 223q16 13 16 32t-16 32z" />
<glyph unicode="&#xe132;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM561 855l-275 -223q-16 -13 -16 -32t16 -32l275 -223q16 -13 27.5 -8 t11.5 26v137h275q10 0 17.5 7.5t7.5 17.5v150q0 10 -7.5 17.5t-17.5 7.5h-275v137q0 21 -11.5 26t-27.5 -8z" />
<glyph unicode="&#xe133;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM855 639l-223 275q-13 16 -32 16t-32 -16l-223 -275q-13 -16 -8 -27.5 t26 -11.5h137v-275q0 -10 7.5 -17.5t17.5 -7.5h150q10 0 17.5 7.5t7.5 17.5v275h137q21 0 26 11.5t-8 27.5z" />
<glyph unicode="&#xe134;" d="M600 1178q118 0 225 -45.5t184.5 -123t123 -184.5t45.5 -225t-45.5 -225t-123 -184.5t-184.5 -123t-225 -45.5t-225 45.5t-184.5 123t-123 184.5t-45.5 225t45.5 225t123 184.5t184.5 123t225 45.5zM675 900h-150q-10 0 -17.5 -7.5t-7.5 -17.5v-275h-137q-21 0 -26 -11.5 t8 -27.5l223 -275q13 -16 32 -16t32 16l223 275q13 16 8 27.5t-26 11.5h-137v275q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe135;" d="M600 1176q116 0 222.5 -46t184 -123.5t123.5 -184t46 -222.5t-46 -222.5t-123.5 -184t-184 -123.5t-222.5 -46t-222.5 46t-184 123.5t-123.5 184t-46 222.5t46 222.5t123.5 184t184 123.5t222.5 46zM627 1101q-15 -12 -36.5 -20.5t-35.5 -12t-43 -8t-39 -6.5 q-15 -3 -45.5 0t-45.5 -2q-20 -7 -51.5 -26.5t-34.5 -34.5q-3 -11 6.5 -22.5t8.5 -18.5q-3 -34 -27.5 -91t-29.5 -79q-9 -34 5 -93t8 -87q0 -9 17 -44.5t16 -59.5q12 0 23 -5t23.5 -15t19.5 -14q16 -8 33 -15t40.5 -15t34.5 -12q21 -9 52.5 -32t60 -38t57.5 -11 q7 -15 -3 -34t-22.5 -40t-9.5 -38q13 -21 23 -34.5t27.5 -27.5t36.5 -18q0 -7 -3.5 -16t-3.5 -14t5 -17q104 -2 221 112q30 29 46.5 47t34.5 49t21 63q-13 8 -37 8.5t-36 7.5q-15 7 -49.5 15t-51.5 19q-18 0 -41 -0.5t-43 -1.5t-42 -6.5t-38 -16.5q-51 -35 -66 -12 q-4 1 -3.5 25.5t0.5 25.5q-6 13 -26.5 17.5t-24.5 6.5q1 15 -0.5 30.5t-7 28t-18.5 11.5t-31 -21q-23 -25 -42 4q-19 28 -8 58q6 16 22 22q6 -1 26 -1.5t33.5 -4t19.5 -13.5q7 -12 18 -24t21.5 -20.5t20 -15t15.5 -10.5l5 -3q2 12 7.5 30.5t8 34.5t-0.5 32q-3 18 3.5 29 t18 22.5t15.5 24.5q6 14 10.5 35t8 31t15.5 22.5t34 22.5q-6 18 10 36q8 0 24 -1.5t24.5 -1.5t20 4.5t20.5 15.5q-10 23 -31 42.5t-37.5 29.5t-49 27t-43.5 23q0 1 2 8t3 11.5t1.5 10.5t-1 9.5t-4.5 4.5q31 -13 58.5 -14.5t38.5 2.5l12 5q5 28 -9.5 46t-36.5 24t-50 15 t-41 20q-18 -4 -37 0zM613 994q0 -17 8 -42t17 -45t9 -23q-8 1 -39.5 5.5t-52.5 10t-37 16.5q3 11 16 29.5t16 25.5q10 -10 19 -10t14 6t13.5 14.5t16.5 12.5z" />
<glyph unicode="&#xe136;" d="M756 1157q164 92 306 -9l-259 -138l145 -232l251 126q6 -89 -34 -156.5t-117 -110.5q-60 -34 -127 -39.5t-126 16.5l-596 -596q-15 -16 -36.5 -16t-36.5 16l-111 110q-15 15 -15 36.5t15 37.5l600 599q-34 101 5.5 201.5t135.5 154.5z" />
<glyph unicode="&#xe137;" horiz-adv-x="1220" d="M100 1196h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 1096h-200v-100h200v100zM100 796h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 696h-500v-100h500v100zM100 396h1000q41 0 70.5 -29.5t29.5 -70.5v-100q0 -41 -29.5 -70.5t-70.5 -29.5h-1000q-41 0 -70.5 29.5t-29.5 70.5v100q0 41 29.5 70.5t70.5 29.5zM1100 296h-300v-100h300v100z " />
<glyph unicode="&#xe138;" d="M150 1200h900q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM700 500v-300l-200 -200v500l-350 500h900z" />
<glyph unicode="&#xe139;" d="M500 1200h200q41 0 70.5 -29.5t29.5 -70.5v-100h300q41 0 70.5 -29.5t29.5 -70.5v-400h-500v100h-200v-100h-500v400q0 41 29.5 70.5t70.5 29.5h300v100q0 41 29.5 70.5t70.5 29.5zM500 1100v-100h200v100h-200zM1200 400v-200q0 -41 -29.5 -70.5t-70.5 -29.5h-1000 q-41 0 -70.5 29.5t-29.5 70.5v200h1200z" />
<glyph unicode="&#xe140;" d="M50 1200h300q21 0 25 -10.5t-10 -24.5l-94 -94l199 -199q7 -8 7 -18t-7 -18l-106 -106q-8 -7 -18 -7t-18 7l-199 199l-94 -94q-14 -14 -24.5 -10t-10.5 25v300q0 21 14.5 35.5t35.5 14.5zM850 1200h300q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -10.5 -25t-24.5 10l-94 94 l-199 -199q-8 -7 -18 -7t-18 7l-106 106q-7 8 -7 18t7 18l199 199l-94 94q-14 14 -10 24.5t25 10.5zM364 470l106 -106q7 -8 7 -18t-7 -18l-199 -199l94 -94q14 -14 10 -24.5t-25 -10.5h-300q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 10.5 25t24.5 -10l94 -94l199 199 q8 7 18 7t18 -7zM1071 271l94 94q14 14 24.5 10t10.5 -25v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -25 10.5t10 24.5l94 94l-199 199q-7 8 -7 18t7 18l106 106q8 7 18 7t18 -7z" />
<glyph unicode="&#xe141;" d="M596 1192q121 0 231.5 -47.5t190 -127t127 -190t47.5 -231.5t-47.5 -231.5t-127 -190.5t-190 -127t-231.5 -47t-231.5 47t-190.5 127t-127 190.5t-47 231.5t47 231.5t127 190t190.5 127t231.5 47.5zM596 1010q-112 0 -207.5 -55.5t-151 -151t-55.5 -207.5t55.5 -207.5 t151 -151t207.5 -55.5t207.5 55.5t151 151t55.5 207.5t-55.5 207.5t-151 151t-207.5 55.5zM454.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38.5 -16.5t-38.5 16.5t-16 39t16 38.5t38.5 16zM754.5 905q22.5 0 38.5 -16t16 -38.5t-16 -39t-38 -16.5q-14 0 -29 10l-55 -145 q17 -23 17 -51q0 -36 -25.5 -61.5t-61.5 -25.5t-61.5 25.5t-25.5 61.5q0 32 20.5 56.5t51.5 29.5l122 126l1 1q-9 14 -9 28q0 23 16 39t38.5 16zM345.5 709q22.5 0 38.5 -16t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16zM854.5 709q22.5 0 38.5 -16 t16 -38.5t-16 -38.5t-38.5 -16t-38.5 16t-16 38.5t16 38.5t38.5 16z" />
<glyph unicode="&#xe142;" d="M546 173l469 470q91 91 99 192q7 98 -52 175.5t-154 94.5q-22 4 -47 4q-34 0 -66.5 -10t-56.5 -23t-55.5 -38t-48 -41.5t-48.5 -47.5q-376 -375 -391 -390q-30 -27 -45 -41.5t-37.5 -41t-32 -46.5t-16 -47.5t-1.5 -56.5q9 -62 53.5 -95t99.5 -33q74 0 125 51l548 548 q36 36 20 75q-7 16 -21.5 26t-32.5 10q-26 0 -50 -23q-13 -12 -39 -38l-341 -338q-15 -15 -35.5 -15.5t-34.5 13.5t-14 34.5t14 34.5q327 333 361 367q35 35 67.5 51.5t78.5 16.5q14 0 29 -1q44 -8 74.5 -35.5t43.5 -68.5q14 -47 2 -96.5t-47 -84.5q-12 -11 -32 -32 t-79.5 -81t-114.5 -115t-124.5 -123.5t-123 -119.5t-96.5 -89t-57 -45q-56 -27 -120 -27q-70 0 -129 32t-93 89q-48 78 -35 173t81 163l511 511q71 72 111 96q91 55 198 55q80 0 152 -33q78 -36 129.5 -103t66.5 -154q17 -93 -11 -183.5t-94 -156.5l-482 -476 q-15 -15 -36 -16t-37 14t-17.5 34t14.5 35z" />
<glyph unicode="&#xe143;" d="M649 949q48 68 109.5 104t121.5 38.5t118.5 -20t102.5 -64t71 -100.5t27 -123q0 -57 -33.5 -117.5t-94 -124.5t-126.5 -127.5t-150 -152.5t-146 -174q-62 85 -145.5 174t-150 152.5t-126.5 127.5t-93.5 124.5t-33.5 117.5q0 64 28 123t73 100.5t104 64t119 20 t120.5 -38.5t104.5 -104zM896 972q-33 0 -64.5 -19t-56.5 -46t-47.5 -53.5t-43.5 -45.5t-37.5 -19t-36 19t-40 45.5t-43 53.5t-54 46t-65.5 19q-67 0 -122.5 -55.5t-55.5 -132.5q0 -23 13.5 -51t46 -65t57.5 -63t76 -75l22 -22q15 -14 44 -44t50.5 -51t46 -44t41 -35t23 -12 t23.5 12t42.5 36t46 44t52.5 52t44 43q4 4 12 13q43 41 63.5 62t52 55t46 55t26 46t11.5 44q0 79 -53 133.5t-120 54.5z" />
<glyph unicode="&#xe144;" d="M776.5 1214q93.5 0 159.5 -66l141 -141q66 -66 66 -160q0 -42 -28 -95.5t-62 -87.5l-29 -29q-31 53 -77 99l-18 18l95 95l-247 248l-389 -389l212 -212l-105 -106l-19 18l-141 141q-66 66 -66 159t66 159l283 283q65 66 158.5 66zM600 706l105 105q10 -8 19 -17l141 -141 q66 -66 66 -159t-66 -159l-283 -283q-66 -66 -159 -66t-159 66l-141 141q-66 66 -66 159.5t66 159.5l55 55q29 -55 75 -102l18 -17l-95 -95l247 -248l389 389z" />
<glyph unicode="&#xe145;" d="M603 1200q85 0 162 -15t127 -38t79 -48t29 -46v-953q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-41 0 -70.5 29.5t-29.5 70.5v953q0 21 30 46.5t81 48t129 37.5t163 15zM300 1000v-700h600v700h-600zM600 254q-43 0 -73.5 -30.5t-30.5 -73.5t30.5 -73.5t73.5 -30.5t73.5 30.5 t30.5 73.5t-30.5 73.5t-73.5 30.5z" />
<glyph unicode="&#xe146;" d="M902 1185l283 -282q15 -15 15 -36t-14.5 -35.5t-35.5 -14.5t-35 15l-36 35l-279 -267v-300l-212 210l-308 -307l-280 -203l203 280l307 308l-210 212h300l267 279l-35 36q-15 14 -15 35t14.5 35.5t35.5 14.5t35 -15z" />
<glyph unicode="&#xe148;" d="M700 1248v-78q38 -5 72.5 -14.5t75.5 -31.5t71 -53.5t52 -84t24 -118.5h-159q-4 36 -10.5 59t-21 45t-40 35.5t-64.5 20.5v-307l64 -13q34 -7 64 -16.5t70 -32t67.5 -52.5t47.5 -80t20 -112q0 -139 -89 -224t-244 -97v-77h-100v79q-150 16 -237 103q-40 40 -52.5 93.5 t-15.5 139.5h139q5 -77 48.5 -126t117.5 -65v335l-27 8q-46 14 -79 26.5t-72 36t-63 52t-40 72.5t-16 98q0 70 25 126t67.5 92t94.5 57t110 27v77h100zM600 754v274q-29 -4 -50 -11t-42 -21.5t-31.5 -41.5t-10.5 -65q0 -29 7 -50.5t16.5 -34t28.5 -22.5t31.5 -14t37.5 -10 q9 -3 13 -4zM700 547v-310q22 2 42.5 6.5t45 15.5t41.5 27t29 42t12 59.5t-12.5 59.5t-38 44.5t-53 31t-66.5 24.5z" />
<glyph unicode="&#xe149;" d="M561 1197q84 0 160.5 -40t123.5 -109.5t47 -147.5h-153q0 40 -19.5 71.5t-49.5 48.5t-59.5 26t-55.5 9q-37 0 -79 -14.5t-62 -35.5q-41 -44 -41 -101q0 -26 13.5 -63t26.5 -61t37 -66q6 -9 9 -14h241v-100h-197q8 -50 -2.5 -115t-31.5 -95q-45 -62 -99 -112 q34 10 83 17.5t71 7.5q32 1 102 -16t104 -17q83 0 136 30l50 -147q-31 -19 -58 -30.5t-55 -15.5t-42 -4.5t-46 -0.5q-23 0 -76 17t-111 32.5t-96 11.5q-39 -3 -82 -16t-67 -25l-23 -11l-55 145q4 3 16 11t15.5 10.5t13 9t15.5 12t14.5 14t17.5 18.5q48 55 54 126.5 t-30 142.5h-221v100h166q-23 47 -44 104q-7 20 -12 41.5t-6 55.5t6 66.5t29.5 70.5t58.5 71q97 88 263 88z" />
<glyph unicode="&#xe150;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM935 1184l230 -249q14 -14 10 -24.5t-25 -10.5h-150v-900h-200v900h-150q-21 0 -25 10.5t10 24.5l230 249q14 15 35 15t35 -15z" />
<glyph unicode="&#xe151;" d="M1000 700h-100v100h-100v-100h-100v500h300v-500zM400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM801 1100v-200h100v200h-100zM1000 350l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150z " />
<glyph unicode="&#xe152;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 1050l-200 -250h200v-100h-300v150l200 250h-200v100h300v-150zM1000 0h-100v100h-100v-100h-100v500h300v-500zM801 400v-200h100v200h-100z " />
<glyph unicode="&#xe153;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1000 700h-100v400h-100v100h200v-500zM1100 0h-100v100h-200v400h300v-500zM901 400v-200h100v200h-100z" />
<glyph unicode="&#xe154;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1100 700h-100v100h-200v400h300v-500zM901 1100v-200h100v200h-100zM1000 0h-100v400h-100v100h200v-500z" />
<glyph unicode="&#xe155;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM900 1000h-200v200h200v-200zM1000 700h-300v200h300v-200zM1100 400h-400v200h400v-200zM1200 100h-500v200h500v-200z" />
<glyph unicode="&#xe156;" d="M400 300h150q21 0 25 -11t-10 -25l-230 -250q-14 -15 -35 -15t-35 15l-230 250q-14 14 -10 25t25 11h150v900h200v-900zM1200 1000h-500v200h500v-200zM1100 700h-400v200h400v-200zM1000 400h-300v200h300v-200zM900 100h-200v200h200v-200z" />
<glyph unicode="&#xe157;" d="M350 1100h400q162 0 256 -93.5t94 -256.5v-400q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5z" />
<glyph unicode="&#xe158;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-163 0 -256.5 92.5t-93.5 257.5v400q0 163 94 256.5t256 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM440 770l253 -190q17 -12 17 -30t-17 -30l-253 -190q-16 -12 -28 -6.5t-12 26.5v400q0 21 12 26.5t28 -6.5z" />
<glyph unicode="&#xe159;" d="M350 1100h400q163 0 256.5 -94t93.5 -256v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 163 92.5 256.5t257.5 93.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM350 700h400q21 0 26.5 -12t-6.5 -28l-190 -253q-12 -17 -30 -17t-30 17l-190 253q-12 16 -6.5 28t26.5 12z" />
<glyph unicode="&#xe160;" d="M350 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -163 -92.5 -256.5t-257.5 -93.5h-400q-163 0 -256.5 94t-93.5 256v400q0 165 92.5 257.5t257.5 92.5zM800 900h-500q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5 v500q0 41 -29.5 70.5t-70.5 29.5zM580 693l190 -253q12 -16 6.5 -28t-26.5 -12h-400q-21 0 -26.5 12t6.5 28l190 253q12 17 30 17t30 -17z" />
<glyph unicode="&#xe161;" d="M550 1100h400q165 0 257.5 -92.5t92.5 -257.5v-400q0 -165 -92.5 -257.5t-257.5 -92.5h-400q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h450q41 0 70.5 29.5t29.5 70.5v500q0 41 -29.5 70.5t-70.5 29.5h-450q-21 0 -35.5 14.5t-14.5 35.5v100 q0 21 14.5 35.5t35.5 14.5zM338 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe162;" d="M793 1182l9 -9q8 -10 5 -27q-3 -11 -79 -225.5t-78 -221.5l300 1q24 0 32.5 -17.5t-5.5 -35.5q-1 0 -133.5 -155t-267 -312.5t-138.5 -162.5q-12 -15 -26 -15h-9l-9 8q-9 11 -4 32q2 9 42 123.5t79 224.5l39 110h-302q-23 0 -31 19q-10 21 6 41q75 86 209.5 237.5 t228 257t98.5 111.5q9 16 25 16h9z" />
<glyph unicode="&#xe163;" d="M350 1100h400q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-450q-41 0 -70.5 -29.5t-29.5 -70.5v-500q0 -41 29.5 -70.5t70.5 -29.5h450q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400 q0 165 92.5 257.5t257.5 92.5zM938 867l324 -284q16 -14 16 -33t-16 -33l-324 -284q-16 -14 -27 -9t-11 26v150h-250q-21 0 -35.5 14.5t-14.5 35.5v200q0 21 14.5 35.5t35.5 14.5h250v150q0 21 11 26t27 -9z" />
<glyph unicode="&#xe164;" d="M750 1200h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -10.5 -25t-24.5 10l-109 109l-312 -312q-15 -15 -35.5 -15t-35.5 15l-141 141q-15 15 -15 35.5t15 35.5l312 312l-109 109q-14 14 -10 24.5t25 10.5zM456 900h-156q-41 0 -70.5 -29.5t-29.5 -70.5v-500 q0 -41 29.5 -70.5t70.5 -29.5h500q41 0 70.5 29.5t29.5 70.5v148l200 200v-298q0 -165 -93.5 -257.5t-256.5 -92.5h-400q-165 0 -257.5 92.5t-92.5 257.5v400q0 165 92.5 257.5t257.5 92.5h300z" />
<glyph unicode="&#xe165;" d="M600 1186q119 0 227.5 -46.5t187 -125t125 -187t46.5 -227.5t-46.5 -227.5t-125 -187t-187 -125t-227.5 -46.5t-227.5 46.5t-187 125t-125 187t-46.5 227.5t46.5 227.5t125 187t187 125t227.5 46.5zM600 1022q-115 0 -212 -56.5t-153.5 -153.5t-56.5 -212t56.5 -212 t153.5 -153.5t212 -56.5t212 56.5t153.5 153.5t56.5 212t-56.5 212t-153.5 153.5t-212 56.5zM600 794q80 0 137 -57t57 -137t-57 -137t-137 -57t-137 57t-57 137t57 137t137 57z" />
<glyph unicode="&#xe166;" d="M450 1200h200q21 0 35.5 -14.5t14.5 -35.5v-350h245q20 0 25 -11t-9 -26l-383 -426q-14 -15 -33.5 -15t-32.5 15l-379 426q-13 15 -8.5 26t25.5 11h250v350q0 21 14.5 35.5t35.5 14.5zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe167;" d="M583 1182l378 -435q14 -15 9 -31t-26 -16h-244v-250q0 -20 -17 -35t-39 -15h-200q-20 0 -32 14.5t-12 35.5v250h-250q-20 0 -25.5 16.5t8.5 31.5l383 431q14 16 33.5 17t33.5 -14zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5z M900 200v-50h100v50h-100z" />
<glyph unicode="&#xe168;" d="M396 723l369 369q7 7 17.5 7t17.5 -7l139 -139q7 -8 7 -18.5t-7 -17.5l-525 -525q-7 -8 -17.5 -8t-17.5 8l-292 291q-7 8 -7 18t7 18l139 139q8 7 18.5 7t17.5 -7zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50 h-100z" />
<glyph unicode="&#xe169;" d="M135 1023l142 142q14 14 35 14t35 -14l77 -77l-212 -212l-77 76q-14 15 -14 36t14 35zM655 855l210 210q14 14 24.5 10t10.5 -25l-2 -599q-1 -20 -15.5 -35t-35.5 -15l-597 -1q-21 0 -25 10.5t10 24.5l208 208l-154 155l212 212zM50 300h1000q21 0 35.5 -14.5t14.5 -35.5 v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe170;" d="M350 1200l599 -2q20 -1 35 -15.5t15 -35.5l1 -597q0 -21 -10.5 -25t-24.5 10l-208 208l-155 -154l-212 212l155 154l-210 210q-14 14 -10 24.5t25 10.5zM524 512l-76 -77q-15 -14 -36 -14t-35 14l-142 142q-14 14 -14 35t14 35l77 77zM50 300h1000q21 0 35.5 -14.5 t14.5 -35.5v-250h-1100v250q0 21 14.5 35.5t35.5 14.5zM900 200v-50h100v50h-100z" />
<glyph unicode="&#xe171;" d="M1200 103l-483 276l-314 -399v423h-399l1196 796v-1096zM483 424v-230l683 953z" />
<glyph unicode="&#xe172;" d="M1100 1000v-850q0 -21 -14.5 -35.5t-35.5 -14.5h-150v400h-700v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200z" />
<glyph unicode="&#xe173;" d="M1100 1000l-2 -149l-299 -299l-95 95q-9 9 -21.5 9t-21.5 -9l-149 -147h-312v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1132 638l106 -106q7 -7 7 -17.5t-7 -17.5l-420 -421q-8 -7 -18 -7 t-18 7l-202 203q-8 7 -8 17.5t8 17.5l106 106q7 8 17.5 8t17.5 -8l79 -79l297 297q7 7 17.5 7t17.5 -7z" />
<glyph unicode="&#xe174;" d="M1100 1000v-269l-103 -103l-134 134q-15 15 -33.5 16.5t-34.5 -12.5l-266 -266h-329v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM1202 572l70 -70q15 -15 15 -35.5t-15 -35.5l-131 -131 l131 -131q15 -15 15 -35.5t-15 -35.5l-70 -70q-15 -15 -35.5 -15t-35.5 15l-131 131l-131 -131q-15 -15 -35.5 -15t-35.5 15l-70 70q-15 15 -15 35.5t15 35.5l131 131l-131 131q-15 15 -15 35.5t15 35.5l70 70q15 15 35.5 15t35.5 -15l131 -131l131 131q15 15 35.5 15 t35.5 -15z" />
<glyph unicode="&#xe175;" d="M1100 1000v-300h-350q-21 0 -35.5 -14.5t-14.5 -35.5v-150h-500v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM850 600h100q21 0 35.5 -14.5t14.5 -35.5v-250h150q21 0 25 -10.5t-10 -24.5 l-230 -230q-14 -14 -35 -14t-35 14l-230 230q-14 14 -10 24.5t25 10.5h150v250q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe176;" d="M1100 1000v-400l-165 165q-14 15 -35 15t-35 -15l-263 -265h-402v-400h-150q-21 0 -35.5 14.5t-14.5 35.5v1000q0 20 14.5 35t35.5 15h250v-300h500v300h100zM700 1000h-100v200h100v-200zM935 565l230 -229q14 -15 10 -25.5t-25 -10.5h-150v-250q0 -20 -14.5 -35 t-35.5 -15h-100q-21 0 -35.5 15t-14.5 35v250h-150q-21 0 -25 10.5t10 25.5l230 229q14 15 35 15t35 -15z" />
<glyph unicode="&#xe177;" d="M50 1100h1100q21 0 35.5 -14.5t14.5 -35.5v-150h-1200v150q0 21 14.5 35.5t35.5 14.5zM1200 800v-550q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v550h1200zM100 500v-200h400v200h-400z" />
<glyph unicode="&#xe178;" d="M935 1165l248 -230q14 -14 14 -35t-14 -35l-248 -230q-14 -14 -24.5 -10t-10.5 25v150h-400v200h400v150q0 21 10.5 25t24.5 -10zM200 800h-50q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v-200zM400 800h-100v200h100v-200zM18 435l247 230 q14 14 24.5 10t10.5 -25v-150h400v-200h-400v-150q0 -21 -10.5 -25t-24.5 10l-247 230q-15 14 -15 35t15 35zM900 300h-100v200h100v-200zM1000 500h51q20 0 34.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-34.5 -14.5h-51v200z" />
<glyph unicode="&#xe179;" d="M862 1073l276 116q25 18 43.5 8t18.5 -41v-1106q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v397q-4 1 -11 5t-24 17.5t-30 29t-24 42t-11 56.5v359q0 31 18.5 65t43.5 52zM550 1200q22 0 34.5 -12.5t14.5 -24.5l1 -13v-450q0 -28 -10.5 -59.5 t-25 -56t-29 -45t-25.5 -31.5l-10 -11v-447q0 -21 -14.5 -35.5t-35.5 -14.5h-200q-21 0 -35.5 14.5t-14.5 35.5v447q-4 4 -11 11.5t-24 30.5t-30 46t-24 55t-11 60v450q0 2 0.5 5.5t4 12t8.5 15t14.5 12t22.5 5.5q20 0 32.5 -12.5t14.5 -24.5l3 -13v-350h100v350v5.5t2.5 12 t7 15t15 12t25.5 5.5q23 0 35.5 -12.5t13.5 -24.5l1 -13v-350h100v350q0 2 0.5 5.5t3 12t7 15t15 12t24.5 5.5z" />
<glyph unicode="&#xe180;" d="M1200 1100v-56q-4 0 -11 -0.5t-24 -3t-30 -7.5t-24 -15t-11 -24v-888q0 -22 25 -34.5t50 -13.5l25 -2v-56h-400v56q75 0 87.5 6.5t12.5 43.5v394h-500v-394q0 -37 12.5 -43.5t87.5 -6.5v-56h-400v56q4 0 11 0.5t24 3t30 7.5t24 15t11 24v888q0 22 -25 34.5t-50 13.5 l-25 2v56h400v-56q-75 0 -87.5 -6.5t-12.5 -43.5v-394h500v394q0 37 -12.5 43.5t-87.5 6.5v56h400z" />
<glyph unicode="&#xe181;" d="M675 1000h375q21 0 35.5 -14.5t14.5 -35.5v-150h-105l-295 -98v98l-200 200h-400l100 100h375zM100 900h300q41 0 70.5 -29.5t29.5 -70.5v-500q0 -41 -29.5 -70.5t-70.5 -29.5h-300q-41 0 -70.5 29.5t-29.5 70.5v500q0 41 29.5 70.5t70.5 29.5zM100 800v-200h300v200 h-300zM1100 535l-400 -133v163l400 133v-163zM100 500v-200h300v200h-300zM1100 398v-248q0 -21 -14.5 -35.5t-35.5 -14.5h-375l-100 -100h-375l-100 100h400l200 200h105z" />
<glyph unicode="&#xe182;" d="M17 1007l162 162q17 17 40 14t37 -22l139 -194q14 -20 11 -44.5t-20 -41.5l-119 -118q102 -142 228 -268t267 -227l119 118q17 17 42.5 19t44.5 -12l192 -136q19 -14 22.5 -37.5t-13.5 -40.5l-163 -162q-3 -1 -9.5 -1t-29.5 2t-47.5 6t-62.5 14.5t-77.5 26.5t-90 42.5 t-101.5 60t-111 83t-119 108.5q-74 74 -133.5 150.5t-94.5 138.5t-60 119.5t-34.5 100t-15 74.5t-4.5 48z" />
<glyph unicode="&#xe183;" d="M600 1100q92 0 175 -10.5t141.5 -27t108.5 -36.5t81.5 -40t53.5 -37t31 -27l9 -10v-200q0 -21 -14.5 -33t-34.5 -9l-202 34q-20 3 -34.5 20t-14.5 38v146q-141 24 -300 24t-300 -24v-146q0 -21 -14.5 -38t-34.5 -20l-202 -34q-20 -3 -34.5 9t-14.5 33v200q3 4 9.5 10.5 t31 26t54 37.5t80.5 39.5t109 37.5t141 26.5t175 10.5zM600 795q56 0 97 -9.5t60 -23.5t30 -28t12 -24l1 -10v-50l365 -303q14 -15 24.5 -40t10.5 -45v-212q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v212q0 20 10.5 45t24.5 40l365 303v50 q0 4 1 10.5t12 23t30 29t60 22.5t97 10z" />
<glyph unicode="&#xe184;" d="M1100 700l-200 -200h-600l-200 200v500h200v-200h200v200h200v-200h200v200h200v-500zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5 t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe185;" d="M700 1100h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-1000h300v1000q0 41 -29.5 70.5t-70.5 29.5zM1100 800h-100q-41 0 -70.5 -29.5t-29.5 -70.5v-700h300v700q0 41 -29.5 70.5t-70.5 29.5zM400 0h-300v400q0 41 29.5 70.5t70.5 29.5h100q41 0 70.5 -29.5t29.5 -70.5v-400z " />
<glyph unicode="&#xe186;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe187;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 300h-100v200h-100v-200h-100v500h100v-200h100v200h100v-500zM900 700v-300l-100 -100h-200v500h200z M700 700v-300h100v300h-100z" />
<glyph unicode="&#xe188;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-300h200v-100h-300v500h300v-100zM900 700h-200v-300h200v-100h-300v500h300v-100z" />
<glyph unicode="&#xe189;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 400l-300 150l300 150v-300zM900 550l-300 -150v300z" />
<glyph unicode="&#xe190;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM900 300h-700v500h700v-500zM800 700h-130q-38 0 -66.5 -43t-28.5 -108t27 -107t68 -42h130v300zM300 700v-300 h130q41 0 68 42t27 107t-28.5 108t-66.5 43h-130z" />
<glyph unicode="&#xe191;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 700h-200v-100h200v-300h-300v100h200v100h-200v300h300v-100zM900 300h-100v400h-100v100h200v-500z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe192;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM300 700h200v-400h-300v500h100v-100zM900 300h-100v400h-100v100h200v-500zM300 600v-200h100v200h-100z M700 300h-100v100h100v-100z" />
<glyph unicode="&#xe193;" d="M200 1100h700q124 0 212 -88t88 -212v-500q0 -124 -88 -212t-212 -88h-700q-124 0 -212 88t-88 212v500q0 124 88 212t212 88zM100 900v-700h900v700h-900zM500 500l-199 -200h-100v50l199 200v150h-200v100h300v-300zM900 300h-100v400h-100v100h200v-500zM701 300h-100 v100h100v-100z" />
<glyph unicode="&#xe194;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700h-300v-200h300v-100h-300l-100 100v200l100 100h300v-100z" />
<glyph unicode="&#xe195;" d="M600 1191q120 0 229.5 -47t188.5 -126t126 -188.5t47 -229.5t-47 -229.5t-126 -188.5t-188.5 -126t-229.5 -47t-229.5 47t-188.5 126t-126 188.5t-47 229.5t47 229.5t126 188.5t188.5 126t229.5 47zM600 1021q-114 0 -211 -56.5t-153.5 -153.5t-56.5 -211t56.5 -211 t153.5 -153.5t211 -56.5t211 56.5t153.5 153.5t56.5 211t-56.5 211t-153.5 153.5t-211 56.5zM800 700v-100l-50 -50l100 -100v-50h-100l-100 100h-150v-100h-100v400h300zM500 700v-100h200v100h-200z" />
<glyph unicode="&#xe197;" d="M503 1089q110 0 200.5 -59.5t134.5 -156.5q44 14 90 14q120 0 205 -86.5t85 -207t-85 -207t-205 -86.5h-128v250q0 21 -14.5 35.5t-35.5 14.5h-300q-21 0 -35.5 -14.5t-14.5 -35.5v-250h-222q-80 0 -136 57.5t-56 136.5q0 69 43 122.5t108 67.5q-2 19 -2 37q0 100 49 185 t134 134t185 49zM525 500h150q10 0 17.5 -7.5t7.5 -17.5v-275h137q21 0 26 -11.5t-8 -27.5l-223 -244q-13 -16 -32 -16t-32 16l-223 244q-13 16 -8 27.5t26 11.5h137v275q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe198;" d="M502 1089q110 0 201 -59.5t135 -156.5q43 15 89 15q121 0 206 -86.5t86 -206.5q0 -99 -60 -181t-150 -110l-378 360q-13 16 -31.5 16t-31.5 -16l-381 -365h-9q-79 0 -135.5 57.5t-56.5 136.5q0 69 43 122.5t108 67.5q-2 19 -2 38q0 100 49 184.5t133.5 134t184.5 49.5z M632 467l223 -228q13 -16 8 -27.5t-26 -11.5h-137v-275q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v275h-137q-21 0 -26 11.5t8 27.5q199 204 223 228q19 19 31.5 19t32.5 -19z" />
<glyph unicode="&#xe199;" d="M700 100v100h400l-270 300h170l-270 300h170l-300 333l-300 -333h170l-270 -300h170l-270 -300h400v-100h-50q-21 0 -35.5 -14.5t-14.5 -35.5v-50h400v50q0 21 -14.5 35.5t-35.5 14.5h-50z" />
<glyph unicode="&#xe200;" d="M600 1179q94 0 167.5 -56.5t99.5 -145.5q89 -6 150.5 -71.5t61.5 -155.5q0 -61 -29.5 -112.5t-79.5 -82.5q9 -29 9 -55q0 -74 -52.5 -126.5t-126.5 -52.5q-55 0 -100 30v-251q21 0 35.5 -14.5t14.5 -35.5v-50h-300v50q0 21 14.5 35.5t35.5 14.5v251q-45 -30 -100 -30 q-74 0 -126.5 52.5t-52.5 126.5q0 18 4 38q-47 21 -75.5 65t-28.5 97q0 74 52.5 126.5t126.5 52.5q5 0 23 -2q0 2 -1 10t-1 13q0 116 81.5 197.5t197.5 81.5z" />
<glyph unicode="&#xe201;" d="M1010 1010q111 -111 150.5 -260.5t0 -299t-150.5 -260.5q-83 -83 -191.5 -126.5t-218.5 -43.5t-218.5 43.5t-191.5 126.5q-111 111 -150.5 260.5t0 299t150.5 260.5q83 83 191.5 126.5t218.5 43.5t218.5 -43.5t191.5 -126.5zM476 1065q-4 0 -8 -1q-121 -34 -209.5 -122.5 t-122.5 -209.5q-4 -12 2.5 -23t18.5 -14l36 -9q3 -1 7 -1q23 0 29 22q27 96 98 166q70 71 166 98q11 3 17.5 13.5t3.5 22.5l-9 35q-3 13 -14 19q-7 4 -15 4zM512 920q-4 0 -9 -2q-80 -24 -138.5 -82.5t-82.5 -138.5q-4 -13 2 -24t19 -14l34 -9q4 -1 8 -1q22 0 28 21 q18 58 58.5 98.5t97.5 58.5q12 3 18 13.5t3 21.5l-9 35q-3 12 -14 19q-7 4 -15 4zM719.5 719.5q-49.5 49.5 -119.5 49.5t-119.5 -49.5t-49.5 -119.5t49.5 -119.5t119.5 -49.5t119.5 49.5t49.5 119.5t-49.5 119.5zM855 551q-22 0 -28 -21q-18 -58 -58.5 -98.5t-98.5 -57.5 q-11 -4 -17 -14.5t-3 -21.5l9 -35q3 -12 14 -19q7 -4 15 -4q4 0 9 2q80 24 138.5 82.5t82.5 138.5q4 13 -2.5 24t-18.5 14l-34 9q-4 1 -8 1zM1000 515q-23 0 -29 -22q-27 -96 -98 -166q-70 -71 -166 -98q-11 -3 -17.5 -13.5t-3.5 -22.5l9 -35q3 -13 14 -19q7 -4 15 -4 q4 0 8 1q121 34 209.5 122.5t122.5 209.5q4 12 -2.5 23t-18.5 14l-36 9q-3 1 -7 1z" />
<glyph unicode="&#xe202;" d="M700 800h300v-380h-180v200h-340v-200h-380v755q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM700 300h162l-212 -212l-212 212h162v200h100v-200zM520 0h-395q-10 0 -17.5 7.5t-7.5 17.5v395zM1000 220v-195q0 -10 -7.5 -17.5t-17.5 -7.5h-195z" />
<glyph unicode="&#xe203;" d="M700 800h300v-520l-350 350l-550 -550v1095q0 10 7.5 17.5t17.5 7.5h575v-400zM1000 900h-200v200zM862 200h-162v-200h-100v200h-162l212 212zM480 0h-355q-10 0 -17.5 7.5t-7.5 17.5v55h380v-80zM1000 80v-55q0 -10 -7.5 -17.5t-17.5 -7.5h-155v80h180z" />
<glyph unicode="&#xe204;" d="M1162 800h-162v-200h100l100 -100h-300v300h-162l212 212zM200 800h200q27 0 40 -2t29.5 -10.5t23.5 -30t7 -57.5h300v-100h-600l-200 -350v450h100q0 36 7 57.5t23.5 30t29.5 10.5t40 2zM800 400h240l-240 -400h-800l300 500h500v-100z" />
<glyph unicode="&#xe205;" d="M650 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM1000 850v150q41 0 70.5 -29.5t29.5 -70.5v-800 q0 -41 -29.5 -70.5t-70.5 -29.5h-600q-1 0 -20 4l246 246l-326 326v324q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM412 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe206;" d="M450 1100h100q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-300q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h50v50q0 21 14.5 35.5t35.5 14.5zM800 850v150q41 0 70.5 -29.5t29.5 -70.5v-500 h-200v-300h200q0 -36 -7 -57.5t-23.5 -30t-29.5 -10.5t-40 -2h-600q-41 0 -70.5 29.5t-29.5 70.5v800q0 41 29.5 70.5t70.5 29.5v-150q0 -62 44 -106t106 -44h300q62 0 106 44t44 106zM1212 250l-212 -212v162h-200v100h200v162z" />
<glyph unicode="&#xe209;" d="M658 1197l637 -1104q23 -38 7 -65.5t-60 -27.5h-1276q-44 0 -60 27.5t7 65.5l637 1104q22 39 54 39t54 -39zM704 800h-208q-20 0 -32 -14.5t-8 -34.5l58 -302q4 -20 21.5 -34.5t37.5 -14.5h54q20 0 37.5 14.5t21.5 34.5l58 302q4 20 -8 34.5t-32 14.5zM500 300v-100h200 v100h-200z" />
<glyph unicode="&#xe210;" d="M425 1100h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM825 800h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM25 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5zM425 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 500h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5 v150q0 10 7.5 17.5t17.5 7.5zM25 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM425 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5 t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM825 200h250q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-250q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe211;" d="M700 1200h100v-200h-100v-100h350q62 0 86.5 -39.5t-3.5 -94.5l-66 -132q-41 -83 -81 -134h-772q-40 51 -81 134l-66 132q-28 55 -3.5 94.5t86.5 39.5h350v100h-100v200h100v100h200v-100zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-12l137 -100 h-950l138 100h-13q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe212;" d="M600 1300q40 0 68.5 -29.5t28.5 -70.5h-194q0 41 28.5 70.5t68.5 29.5zM443 1100h314q18 -37 18 -75q0 -8 -3 -25h328q41 0 44.5 -16.5t-30.5 -38.5l-175 -145h-678l-178 145q-34 22 -29 38.5t46 16.5h328q-3 17 -3 25q0 38 18 75zM250 700h700q21 0 35.5 -14.5 t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-150v-200l275 -200h-950l275 200v200h-150q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe213;" d="M600 1181q75 0 128 -53t53 -128t-53 -128t-128 -53t-128 53t-53 128t53 128t128 53zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13 l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe214;" d="M600 1300q47 0 92.5 -53.5t71 -123t25.5 -123.5q0 -78 -55.5 -133.5t-133.5 -55.5t-133.5 55.5t-55.5 133.5q0 62 34 143l144 -143l111 111l-163 163q34 26 63 26zM602 798h46q34 0 55.5 -28.5t21.5 -86.5q0 -76 39 -183h-324q39 107 39 183q0 58 21.5 86.5t56.5 28.5h45 zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe215;" d="M600 1200l300 -161v-139h-300q0 -57 18.5 -108t50 -91.5t63 -72t70 -67.5t57.5 -61h-530q-60 83 -90.5 177.5t-30.5 178.5t33 164.5t87.5 139.5t126 96.5t145.5 41.5v-98zM250 400h700q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-13l138 -100h-950l137 100 h-12q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5zM50 100h1100q21 0 35.5 -14.5t14.5 -35.5v-50h-1200v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe216;" d="M600 1300q41 0 70.5 -29.5t29.5 -70.5v-78q46 -26 73 -72t27 -100v-50h-400v50q0 54 27 100t73 72v78q0 41 29.5 70.5t70.5 29.5zM400 800h400q54 0 100 -27t72 -73h-172v-100h200v-100h-200v-100h200v-100h-200v-100h200q0 -83 -58.5 -141.5t-141.5 -58.5h-400 q-83 0 -141.5 58.5t-58.5 141.5v400q0 83 58.5 141.5t141.5 58.5z" />
<glyph unicode="&#xe218;" d="M150 1100h900q21 0 35.5 -14.5t14.5 -35.5v-500q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v500q0 21 14.5 35.5t35.5 14.5zM125 400h950q10 0 17.5 -7.5t7.5 -17.5v-50q0 -10 -7.5 -17.5t-17.5 -7.5h-283l224 -224q13 -13 13 -31.5t-13 -32 t-31.5 -13.5t-31.5 13l-88 88h-524l-87 -88q-13 -13 -32 -13t-32 13.5t-13 32t13 31.5l224 224h-289q-10 0 -17.5 7.5t-7.5 17.5v50q0 10 7.5 17.5t17.5 7.5zM541 300l-100 -100h324l-100 100h-124z" />
<glyph unicode="&#xe219;" d="M200 1100h800q83 0 141.5 -58.5t58.5 -141.5v-200h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100q0 41 -29.5 70.5t-70.5 29.5h-250q-41 0 -70.5 -29.5t-29.5 -70.5h-100v200q0 83 58.5 141.5t141.5 58.5zM100 600h1000q41 0 70.5 -29.5 t29.5 -70.5v-300h-1200v300q0 41 29.5 70.5t70.5 29.5zM300 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200zM1100 100v-50q0 -21 -14.5 -35.5t-35.5 -14.5h-100q-21 0 -35.5 14.5t-14.5 35.5v50h200z" />
<glyph unicode="&#xe221;" d="M480 1165l682 -683q31 -31 31 -75.5t-31 -75.5l-131 -131h-481l-517 518q-32 31 -32 75.5t32 75.5l295 296q31 31 75.5 31t76.5 -31zM108 794l342 -342l303 304l-341 341zM250 100h800q21 0 35.5 -14.5t14.5 -35.5v-50h-900v50q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe223;" d="M1057 647l-189 506q-8 19 -27.5 33t-40.5 14h-400q-21 0 -40.5 -14t-27.5 -33l-189 -506q-8 -19 1.5 -33t30.5 -14h625v-150q0 -21 14.5 -35.5t35.5 -14.5t35.5 14.5t14.5 35.5v150h125q21 0 30.5 14t1.5 33zM897 0h-595v50q0 21 14.5 35.5t35.5 14.5h50v50 q0 21 14.5 35.5t35.5 14.5h48v300h200v-300h47q21 0 35.5 -14.5t14.5 -35.5v-50h50q21 0 35.5 -14.5t14.5 -35.5v-50z" />
<glyph unicode="&#xe224;" d="M900 800h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-375v591l-300 300v84q0 10 7.5 17.5t17.5 7.5h375v-400zM1200 900h-200v200zM400 600h300v-575q0 -10 -7.5 -17.5t-17.5 -7.5h-650q-10 0 -17.5 7.5t-7.5 17.5v950q0 10 7.5 17.5t17.5 7.5h375v-400zM700 700h-200v200z " />
<glyph unicode="&#xe225;" d="M484 1095h195q75 0 146 -32.5t124 -86t89.5 -122.5t48.5 -142q18 -14 35 -20q31 -10 64.5 6.5t43.5 48.5q10 34 -15 71q-19 27 -9 43q5 8 12.5 11t19 -1t23.5 -16q41 -44 39 -105q-3 -63 -46 -106.5t-104 -43.5h-62q-7 -55 -35 -117t-56 -100l-39 -234q-3 -20 -20 -34.5 t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l12 70q-49 -14 -91 -14h-195q-24 0 -65 8l-11 -64q-3 -20 -20 -34.5t-38 -14.5h-100q-21 0 -33 14.5t-9 34.5l26 157q-84 74 -128 175l-159 53q-19 7 -33 26t-14 40v50q0 21 14.5 35.5t35.5 14.5h124q11 87 56 166l-111 95 q-16 14 -12.5 23.5t24.5 9.5h203q116 101 250 101zM675 1000h-250q-10 0 -17.5 -7.5t-7.5 -17.5v-50q0 -10 7.5 -17.5t17.5 -7.5h250q10 0 17.5 7.5t7.5 17.5v50q0 10 -7.5 17.5t-17.5 7.5z" />
<glyph unicode="&#xe226;" d="M641 900l423 247q19 8 42 2.5t37 -21.5l32 -38q14 -15 12.5 -36t-17.5 -34l-139 -120h-390zM50 1100h106q67 0 103 -17t66 -71l102 -212h823q21 0 35.5 -14.5t14.5 -35.5v-50q0 -21 -14 -40t-33 -26l-737 -132q-23 -4 -40 6t-26 25q-42 67 -100 67h-300q-62 0 -106 44 t-44 106v200q0 62 44 106t106 44zM173 928h-80q-19 0 -28 -14t-9 -35v-56q0 -51 42 -51h134q16 0 21.5 8t5.5 24q0 11 -16 45t-27 51q-18 28 -43 28zM550 727q-32 0 -54.5 -22.5t-22.5 -54.5t22.5 -54.5t54.5 -22.5t54.5 22.5t22.5 54.5t-22.5 54.5t-54.5 22.5zM130 389 l152 130q18 19 34 24t31 -3.5t24.5 -17.5t25.5 -28q28 -35 50.5 -51t48.5 -13l63 5l48 -179q13 -61 -3.5 -97.5t-67.5 -79.5l-80 -69q-47 -40 -109 -35.5t-103 51.5l-130 151q-40 47 -35.5 109.5t51.5 102.5zM380 377l-102 -88q-31 -27 2 -65l37 -43q13 -15 27.5 -19.5 t31.5 6.5l61 53q19 16 14 49q-2 20 -12 56t-17 45q-11 12 -19 14t-23 -8z" />
<glyph unicode="&#xe227;" d="M625 1200h150q10 0 17.5 -7.5t7.5 -17.5v-109q79 -33 131 -87.5t53 -128.5q1 -46 -15 -84.5t-39 -61t-46 -38t-39 -21.5l-17 -6q6 0 15 -1.5t35 -9t50 -17.5t53 -30t50 -45t35.5 -64t14.5 -84q0 -59 -11.5 -105.5t-28.5 -76.5t-44 -51t-49.5 -31.5t-54.5 -16t-49.5 -6.5 t-43.5 -1v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-100v-75q0 -10 -7.5 -17.5t-17.5 -7.5h-150q-10 0 -17.5 7.5t-7.5 17.5v75h-175q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5h75v600h-75q-10 0 -17.5 7.5t-7.5 17.5v150 q0 10 7.5 17.5t17.5 7.5h175v75q0 10 7.5 17.5t17.5 7.5h150q10 0 17.5 -7.5t7.5 -17.5v-75h100v75q0 10 7.5 17.5t17.5 7.5zM400 900v-200h263q28 0 48.5 10.5t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-263zM400 500v-200h363q28 0 48.5 10.5 t30 25t15 29t5.5 25.5l1 10q0 4 -0.5 11t-6 24t-15 30t-30 24t-48.5 11h-363z" />
<glyph unicode="&#xe230;" d="M212 1198h780q86 0 147 -61t61 -147v-416q0 -51 -18 -142.5t-36 -157.5l-18 -66q-29 -87 -93.5 -146.5t-146.5 -59.5h-572q-82 0 -147 59t-93 147q-8 28 -20 73t-32 143.5t-20 149.5v416q0 86 61 147t147 61zM600 1045q-70 0 -132.5 -11.5t-105.5 -30.5t-78.5 -41.5 t-57 -45t-36 -41t-20.5 -30.5l-6 -12l156 -243h560l156 243q-2 5 -6 12.5t-20 29.5t-36.5 42t-57 44.5t-79 42t-105 29.5t-132.5 12zM762 703h-157l195 261z" />
<glyph unicode="&#xe231;" d="M475 1300h150q103 0 189 -86t86 -189v-500q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe232;" d="M475 1300h96q0 -150 89.5 -239.5t239.5 -89.5v-446q0 -41 -42 -83t-83 -42h-450q-41 0 -83 42t-42 83v500q0 103 86 189t189 86zM700 300v-225q0 -21 -27 -48t-48 -27h-150q-21 0 -48 27t-27 48v225h300z" />
<glyph unicode="&#xe233;" d="M1294 767l-638 -283l-378 170l-78 -60v-224l100 -150v-199l-150 148l-150 -149v200l100 150v250q0 4 -0.5 10.5t0 9.5t1 8t3 8t6.5 6l47 40l-147 65l642 283zM1000 380l-350 -166l-350 166v147l350 -165l350 165v-147z" />
<glyph unicode="&#xe234;" d="M250 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM650 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM1050 800q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe235;" d="M550 1100q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 700q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44zM550 300q62 0 106 -44t44 -106t-44 -106t-106 -44t-106 44t-44 106t44 106t106 44z" />
<glyph unicode="&#xe236;" d="M125 1100h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5zM125 700h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5 t17.5 7.5zM125 300h950q10 0 17.5 -7.5t7.5 -17.5v-150q0 -10 -7.5 -17.5t-17.5 -7.5h-950q-10 0 -17.5 7.5t-7.5 17.5v150q0 10 7.5 17.5t17.5 7.5z" />
<glyph unicode="&#xe237;" d="M350 1200h500q162 0 256 -93.5t94 -256.5v-500q0 -165 -93.5 -257.5t-256.5 -92.5h-500q-165 0 -257.5 92.5t-92.5 257.5v500q0 165 92.5 257.5t257.5 92.5zM900 1000h-600q-41 0 -70.5 -29.5t-29.5 -70.5v-600q0 -41 29.5 -70.5t70.5 -29.5h600q41 0 70.5 29.5 t29.5 70.5v600q0 41 -29.5 70.5t-70.5 29.5zM350 900h500q21 0 35.5 -14.5t14.5 -35.5v-300q0 -21 -14.5 -35.5t-35.5 -14.5h-500q-21 0 -35.5 14.5t-14.5 35.5v300q0 21 14.5 35.5t35.5 14.5zM400 800v-200h400v200h-400z" />
<glyph unicode="&#xe238;" d="M150 1100h1000q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5t-35.5 -14.5h-50v-200h50q21 0 35.5 -14.5t14.5 -35.5t-14.5 -35.5 t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5h50v200h-50q-21 0 -35.5 14.5t-14.5 35.5t14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe239;" d="M650 1187q87 -67 118.5 -156t0 -178t-118.5 -155q-87 66 -118.5 155t0 178t118.5 156zM300 800q124 0 212 -88t88 -212q-124 0 -212 88t-88 212zM1000 800q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM300 500q124 0 212 -88t88 -212q-124 0 -212 88t-88 212z M1000 500q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM700 199v-144q0 -21 -14.5 -35.5t-35.5 -14.5t-35.5 14.5t-14.5 35.5v142q40 -4 43 -4q17 0 57 6z" />
<glyph unicode="&#xe240;" d="M745 878l69 19q25 6 45 -12l298 -295q11 -11 15 -26.5t-2 -30.5q-5 -14 -18 -23.5t-28 -9.5h-8q1 0 1 -13q0 -29 -2 -56t-8.5 -62t-20 -63t-33 -53t-51 -39t-72.5 -14h-146q-184 0 -184 288q0 24 10 47q-20 4 -62 4t-63 -4q11 -24 11 -47q0 -288 -184 -288h-142 q-48 0 -84.5 21t-56 51t-32 71.5t-16 75t-3.5 68.5q0 13 2 13h-7q-15 0 -27.5 9.5t-18.5 23.5q-6 15 -2 30.5t15 25.5l298 296q20 18 46 11l76 -19q20 -5 30.5 -22.5t5.5 -37.5t-22.5 -31t-37.5 -5l-51 12l-182 -193h891l-182 193l-44 -12q-20 -5 -37.5 6t-22.5 31t6 37.5 t31 22.5z" />
<glyph unicode="&#xe241;" d="M1200 900h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-200v-850q0 -22 25 -34.5t50 -13.5l25 -2v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v850h-200q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h1000v-300zM500 450h-25q0 15 -4 24.5t-9 14.5t-17 7.5t-20 3t-25 0.5h-100v-425q0 -11 12.5 -17.5t25.5 -7.5h12v-50h-200v50q50 0 50 25v425h-100q-17 0 -25 -0.5t-20 -3t-17 -7.5t-9 -14.5t-4 -24.5h-25v150h500v-150z" />
<glyph unicode="&#xe242;" d="M1000 300v50q-25 0 -55 32q-14 14 -25 31t-16 27l-4 11l-289 747h-69l-300 -754q-18 -35 -39 -56q-9 -9 -24.5 -18.5t-26.5 -14.5l-11 -5v-50h273v50q-49 0 -78.5 21.5t-11.5 67.5l69 176h293l61 -166q13 -34 -3.5 -66.5t-55.5 -32.5v-50h312zM412 691l134 342l121 -342 h-255zM1100 150v-100q0 -21 -14.5 -35.5t-35.5 -14.5h-1000q-21 0 -35.5 14.5t-14.5 35.5v100q0 21 14.5 35.5t35.5 14.5h1000q21 0 35.5 -14.5t14.5 -35.5z" />
<glyph unicode="&#xe243;" d="M50 1200h1100q21 0 35.5 -14.5t14.5 -35.5v-1100q0 -21 -14.5 -35.5t-35.5 -14.5h-1100q-21 0 -35.5 14.5t-14.5 35.5v1100q0 21 14.5 35.5t35.5 14.5zM611 1118h-70q-13 0 -18 -12l-299 -753q-17 -32 -35 -51q-18 -18 -56 -34q-12 -5 -12 -18v-50q0 -8 5.5 -14t14.5 -6 h273q8 0 14 6t6 14v50q0 8 -6 14t-14 6q-55 0 -71 23q-10 14 0 39l63 163h266l57 -153q11 -31 -6 -55q-12 -17 -36 -17q-8 0 -14 -6t-6 -14v-50q0 -8 6 -14t14 -6h313q8 0 14 6t6 14v50q0 7 -5.5 13t-13.5 7q-17 0 -42 25q-25 27 -40 63h-1l-288 748q-5 12 -19 12zM639 611 h-197l103 264z" />
<glyph unicode="&#xe244;" d="M1200 1100h-1200v100h1200v-100zM50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 1000h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM700 900v-300h300v300h-300z" />
<glyph unicode="&#xe245;" d="M50 1200h400q21 0 35.5 -14.5t14.5 -35.5v-900q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v900q0 21 14.5 35.5t35.5 14.5zM650 700h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400 q0 21 14.5 35.5t35.5 14.5zM700 600v-300h300v300h-300zM1200 0h-1200v100h1200v-100z" />
<glyph unicode="&#xe246;" d="M50 1000h400q21 0 35.5 -14.5t14.5 -35.5v-350h100v150q0 21 14.5 35.5t35.5 14.5h400q21 0 35.5 -14.5t14.5 -35.5v-150h100v-100h-100v-150q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v150h-100v-350q0 -21 -14.5 -35.5t-35.5 -14.5h-400 q-21 0 -35.5 14.5t-14.5 35.5v800q0 21 14.5 35.5t35.5 14.5zM700 700v-300h300v300h-300z" />
<glyph unicode="&#xe247;" d="M100 0h-100v1200h100v-1200zM250 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM300 1000v-300h300v300h-300zM250 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe248;" d="M600 1100h150q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-100h450q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h350v100h-150q-21 0 -35.5 14.5 t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5h150v100h100v-100zM400 1000v-300h300v300h-300z" />
<glyph unicode="&#xe249;" d="M1200 0h-100v1200h100v-1200zM550 1100h400q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-400q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM600 1000v-300h300v300h-300zM50 500h900q21 0 35.5 -14.5t14.5 -35.5v-400 q0 -21 -14.5 -35.5t-35.5 -14.5h-900q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5z" />
<glyph unicode="&#xe250;" d="M865 565l-494 -494q-23 -23 -41 -23q-14 0 -22 13.5t-8 38.5v1000q0 25 8 38.5t22 13.5q18 0 41 -23l494 -494q14 -14 14 -35t-14 -35z" />
<glyph unicode="&#xe251;" d="M335 635l494 494q29 29 50 20.5t21 -49.5v-1000q0 -41 -21 -49.5t-50 20.5l-494 494q-14 14 -14 35t14 35z" />
<glyph unicode="&#xe252;" d="M100 900h1000q41 0 49.5 -21t-20.5 -50l-494 -494q-14 -14 -35 -14t-35 14l-494 494q-29 29 -20.5 50t49.5 21z" />
<glyph unicode="&#xe253;" d="M635 865l494 -494q29 -29 20.5 -50t-49.5 -21h-1000q-41 0 -49.5 21t20.5 50l494 494q14 14 35 14t35 -14z" />
<glyph unicode="&#xe254;" d="M700 741v-182l-692 -323v221l413 193l-413 193v221zM1200 0h-800v200h800v-200z" />
<glyph unicode="&#xe255;" d="M1200 900h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300zM0 700h50q0 21 4 37t9.5 26.5t18 17.5t22 11t28.5 5.5t31 2t37 0.5h100v-550q0 -22 -25 -34.5t-50 -13.5l-25 -2v-100h400v100q-4 0 -11 0.5t-24 3t-30 7t-24 15t-11 24.5v550h100q25 0 37 -0.5t31 -2 t28.5 -5.5t22 -11t18 -17.5t9.5 -26.5t4 -37h50v300h-800v-300z" />
<glyph unicode="&#xe256;" d="M800 700h-50q0 21 -4 37t-9.5 26.5t-18 17.5t-22 11t-28.5 5.5t-31 2t-37 0.5h-100v-550q0 -22 25 -34.5t50 -14.5l25 -1v-100h-400v100q4 0 11 0.5t24 3t30 7t24 15t11 24.5v550h-100q-25 0 -37 -0.5t-31 -2t-28.5 -5.5t-22 -11t-18 -17.5t-9.5 -26.5t-4 -37h-50v300 h800v-300zM1100 200h-200v-100h200v-100h-300v300h200v100h-200v100h300v-300z" />
<glyph unicode="&#xe257;" d="M701 1098h160q16 0 21 -11t-7 -23l-464 -464l464 -464q12 -12 7 -23t-21 -11h-160q-13 0 -23 9l-471 471q-7 8 -7 18t7 18l471 471q10 9 23 9z" />
<glyph unicode="&#xe258;" d="M339 1098h160q13 0 23 -9l471 -471q7 -8 7 -18t-7 -18l-471 -471q-10 -9 -23 -9h-160q-16 0 -21 11t7 23l464 464l-464 464q-12 12 -7 23t21 11z" />
<glyph unicode="&#xe259;" d="M1087 882q11 -5 11 -21v-160q0 -13 -9 -23l-471 -471q-8 -7 -18 -7t-18 7l-471 471q-9 10 -9 23v160q0 16 11 21t23 -7l464 -464l464 464q12 12 23 7z" />
<glyph unicode="&#xe260;" d="M618 993l471 -471q9 -10 9 -23v-160q0 -16 -11 -21t-23 7l-464 464l-464 -464q-12 -12 -23 -7t-11 21v160q0 13 9 23l471 471q8 7 18 7t18 -7z" />
<glyph unicode="&#xf8ff;" d="M1000 1200q0 -124 -88 -212t-212 -88q0 124 88 212t212 88zM450 1000h100q21 0 40 -14t26 -33l79 -194q5 1 16 3q34 6 54 9.5t60 7t65.5 1t61 -10t56.5 -23t42.5 -42t29 -64t5 -92t-19.5 -121.5q-1 -7 -3 -19.5t-11 -50t-20.5 -73t-32.5 -81.5t-46.5 -83t-64 -70 t-82.5 -50q-13 -5 -42 -5t-65.5 2.5t-47.5 2.5q-14 0 -49.5 -3.5t-63 -3.5t-43.5 7q-57 25 -104.5 78.5t-75 111.5t-46.5 112t-26 90l-7 35q-15 63 -18 115t4.5 88.5t26 64t39.5 43.5t52 25.5t58.5 13t62.5 2t59.5 -4.5t55.5 -8l-147 192q-12 18 -5.5 30t27.5 12z" />
<glyph unicode="&#x1f511;" d="M250 1200h600q21 0 35.5 -14.5t14.5 -35.5v-400q0 -21 -14.5 -35.5t-35.5 -14.5h-150v-500l-255 -178q-19 -9 -32 -1t-13 29v650h-150q-21 0 -35.5 14.5t-14.5 35.5v400q0 21 14.5 35.5t35.5 14.5zM400 1100v-100h300v100h-300z" />
<glyph unicode="&#x1f6aa;" d="M250 1200h750q39 0 69.5 -40.5t30.5 -84.5v-933l-700 -117v950l600 125h-700v-1000h-100v1025q0 23 15.5 49t34.5 26zM500 525v-100l100 20v100z" />
</font>
</defs></svg> ) format('svg')}.glyphicon{position:relative;top:1px;display:inline-block;font-family:'Glyphicons Halflings';font-style:normal;font-weight:400;line-height:1;-webkit-font-smoothing:antialiased;-moz-osx-font-smoothing:grayscale}.glyphicon-asterisk:before{content:"\2a"}.glyphicon-plus:before{content:"\2b"}.glyphicon-eur:before,.glyphicon-euro:before{content:"\20ac"}.glyphicon-minus:before{content:"\2212"}.glyphicon-cloud:before{content:"\2601"}.glyphicon-envelope:before{content:"\2709"}.glyphicon-pencil:before{content:"\270f"}.glyphicon-glass:before{content:"\e001"}.glyphicon-music:before{content:"\e002"}.glyphicon-search:before{content:"\e003"}.glyphicon-heart:before{content:"\e005"}.glyphicon-star:before{content:"\e006"}.glyphicon-star-empty:before{content:"\e007"}.glyphicon-user:before{content:"\e008"}.glyphicon-film:before{content:"\e009"}.glyphicon-th-large:before{content:"\e010"}.glyphicon-th:before{content:"\e011"}.glyphicon-th-list:before{content:"\e012"}.glyphicon-ok:before{content:"\e013"}.glyphicon-remove:before{content:"\e014"}.glyphicon-zoom-in:before{content:"\e015"}.glyphicon-zoom-out:before{content:"\e016"}.glyphicon-off:before{content:"\e017"}.glyphicon-signal:before{content:"\e018"}.glyphicon-cog:before{content:"\e019"}.glyphicon-trash:before{content:"\e020"}.glyphicon-home:before{content:"\e021"}.glyphicon-file:before{content:"\e022"}.glyphicon-time:before{content:"\e023"}.glyphicon-road:before{content:"\e024"}.glyphicon-download-alt:before{content:"\e025"}.glyphicon-download:before{content:"\e026"}.glyphicon-upload:before{content:"\e027"}.glyphicon-inbox:before{content:"\e028"}.glyphicon-play-circle:before{content:"\e029"}.glyphicon-repeat:before{content:"\e030"}.glyphicon-refresh:before{content:"\e031"}.glyphicon-list-alt:before{content:"\e032"}.glyphicon-lock:before{content:"\e033"}.glyphicon-flag:before{content:"\e034"}.glyphicon-headphones:before{content:"\e035"}.glyphicon-volume-off:before{content:"\e036"}.glyphicon-volume-down:before{content:"\e037"}.glyphicon-volume-up:before{content:"\e038"}.glyphicon-qrcode:before{content:"\e039"}.glyphicon-barcode:before{content:"\e040"}.glyphicon-tag:before{content:"\e041"}.glyphicon-tags:before{content:"\e042"}.glyphicon-book:before{content:"\e043"}.glyphicon-bookmark:before{content:"\e044"}.glyphicon-print:before{content:"\e045"}.glyphicon-camera:before{content:"\e046"}.glyphicon-font:before{content:"\e047"}.glyphicon-bold:before{content:"\e048"}.glyphicon-italic:before{content:"\e049"}.glyphicon-text-height:before{content:"\e050"}.glyphicon-text-width:before{content:"\e051"}.glyphicon-align-left:before{content:"\e052"}.glyphicon-align-center:before{content:"\e053"}.glyphicon-align-right:before{content:"\e054"}.glyphicon-align-justify:before{content:"\e055"}.glyphicon-list:before{content:"\e056"}.glyphicon-indent-left:before{content:"\e057"}.glyphicon-indent-right:before{content:"\e058"}.glyphicon-facetime-video:before{content:"\e059"}.glyphicon-picture:before{content:"\e060"}.glyphicon-map-marker:before{content:"\e062"}.glyphicon-adjust:before{content:"\e063"}.glyphicon-tint:before{content:"\e064"}.glyphicon-edit:before{content:"\e065"}.glyphicon-share:before{content:"\e066"}.glyphicon-check:before{content:"\e067"}.glyphicon-move:before{content:"\e068"}.glyphicon-step-backward:before{content:"\e069"}.glyphicon-fast-backward:before{content:"\e070"}.glyphicon-backward:before{content:"\e071"}.glyphicon-play:before{content:"\e072"}.glyphicon-pause:before{content:"\e073"}.glyphicon-stop:before{content:"\e074"}.glyphicon-forward:before{content:"\e075"}.glyphicon-fast-forward:before{content:"\e076"}.glyphicon-step-forward:before{content:"\e077"}.glyphicon-eject:before{content:"\e078"}.glyphicon-chevron-left:before{content:"\e079"}.glyphicon-chevron-right:before{content:"\e080"}.glyphicon-plus-sign:before{content:"\e081"}.glyphicon-minus-sign:before{content:"\e082"}.glyphicon-remove-sign:before{content:"\e083"}.glyphicon-ok-sign:before{content:"\e084"}.glyphicon-question-sign:before{content:"\e085"}.glyphicon-info-sign:before{content:"\e086"}.glyphicon-screenshot:before{content:"\e087"}.glyphicon-remove-circle:before{content:"\e088"}.glyphicon-ok-circle:before{content:"\e089"}.glyphicon-ban-circle:before{content:"\e090"}.glyphicon-arrow-left:before{content:"\e091"}.glyphicon-arrow-right:before{content:"\e092"}.glyphicon-arrow-up:before{content:"\e093"}.glyphicon-arrow-down:before{content:"\e094"}.glyphicon-share-alt:before{content:"\e095"}.glyphicon-resize-full:before{content:"\e096"}.glyphicon-resize-small:before{content:"\e097"}.glyphicon-exclamation-sign:before{content:"\e101"}.glyphicon-gift:before{content:"\e102"}.glyphicon-leaf:before{content:"\e103"}.glyphicon-fire:before{content:"\e104"}.glyphicon-eye-open:before{content:"\e105"}.glyphicon-eye-close:before{content:"\e106"}.glyphicon-warning-sign:before{content:"\e107"}.glyphicon-plane:before{content:"\e108"}.glyphicon-calendar:before{content:"\e109"}.glyphicon-random:before{content:"\e110"}.glyphicon-comment:before{content:"\e111"}.glyphicon-magnet:before{content:"\e112"}.glyphicon-chevron-up:before{content:"\e113"}.glyphicon-chevron-down:before{content:"\e114"}.glyphicon-retweet:before{content:"\e115"}.glyphicon-shopping-cart:before{content:"\e116"}.glyphicon-folder-close:before{content:"\e117"}.glyphicon-folder-open:before{content:"\e118"}.glyphicon-resize-vertical:before{content:"\e119"}.glyphicon-resize-horizontal:before{content:"\e120"}.glyphicon-hdd:before{content:"\e121"}.glyphicon-bullhorn:before{content:"\e122"}.glyphicon-bell:before{content:"\e123"}.glyphicon-certificate:before{content:"\e124"}.glyphicon-thumbs-up:before{content:"\e125"}.glyphicon-thumbs-down:before{content:"\e126"}.glyphicon-hand-right:before{content:"\e127"}.glyphicon-hand-left:before{content:"\e128"}.glyphicon-hand-up:before{content:"\e129"}.glyphicon-hand-down:before{content:"\e130"}.glyphicon-circle-arrow-right:before{content:"\e131"}.glyphicon-circle-arrow-left:before{content:"\e132"}.glyphicon-circle-arrow-up:before{content:"\e133"}.glyphicon-circle-arrow-down:before{content:"\e134"}.glyphicon-globe:before{content:"\e135"}.glyphicon-wrench:before{content:"\e136"}.glyphicon-tasks:before{content:"\e137"}.glyphicon-filter:before{content:"\e138"}.glyphicon-briefcase:before{content:"\e139"}.glyphicon-fullscreen:before{content:"\e140"}.glyphicon-dashboard:before{content:"\e141"}.glyphicon-paperclip:before{content:"\e142"}.glyphicon-heart-empty:before{content:"\e143"}.glyphicon-link:before{content:"\e144"}.glyphicon-phone:before{content:"\e145"}.glyphicon-pushpin:before{content:"\e146"}.glyphicon-usd:before{content:"\e148"}.glyphicon-gbp:before{content:"\e149"}.glyphicon-sort:before{content:"\e150"}.glyphicon-sort-by-alphabet:before{content:"\e151"}.glyphicon-sort-by-alphabet-alt:before{content:"\e152"}.glyphicon-sort-by-order:before{content:"\e153"}.glyphicon-sort-by-order-alt:before{content:"\e154"}.glyphicon-sort-by-attributes:before{content:"\e155"}.glyphicon-sort-by-attributes-alt:before{content:"\e156"}.glyphicon-unchecked:before{content:"\e157"}.glyphicon-expand:before{content:"\e158"}.glyphicon-collapse-down:before{content:"\e159"}.glyphicon-collapse-up:before{content:"\e160"}.glyphicon-log-in:before{content:"\e161"}.glyphicon-flash:before{content:"\e162"}.glyphicon-log-out:before{content:"\e163"}.glyphicon-new-window:before{content:"\e164"}.glyphicon-record:before{content:"\e165"}.glyphicon-save:before{content:"\e166"}.glyphicon-open:before{content:"\e167"}.glyphicon-saved:before{content:"\e168"}.glyphicon-import:before{content:"\e169"}.glyphicon-export:before{content:"\e170"}.glyphicon-send:before{content:"\e171"}.glyphicon-floppy-disk:before{content:"\e172"}.glyphicon-floppy-saved:before{content:"\e173"}.glyphicon-floppy-remove:before{content:"\e174"}.glyphicon-floppy-save:before{content:"\e175"}.glyphicon-floppy-open:before{content:"\e176"}.glyphicon-credit-card:before{content:"\e177"}.glyphicon-transfer:before{content:"\e178"}.glyphicon-cutlery:before{content:"\e179"}.glyphicon-header:before{content:"\e180"}.glyphicon-compressed:before{content:"\e181"}.glyphicon-earphone:before{content:"\e182"}.glyphicon-phone-alt:before{content:"\e183"}.glyphicon-tower:before{content:"\e184"}.glyphicon-stats:before{content:"\e185"}.glyphicon-sd-video:before{content:"\e186"}.glyphicon-hd-video:before{content:"\e187"}.glyphicon-subtitles:before{content:"\e188"}.glyphicon-sound-stereo:before{content:"\e189"}.glyphicon-sound-dolby:before{content:"\e190"}.glyphicon-sound-5-1:before{content:"\e191"}.glyphicon-sound-6-1:before{content:"\e192"}.glyphicon-sound-7-1:before{content:"\e193"}.glyphicon-copyright-mark:before{content:"\e194"}.glyphicon-registration-mark:before{content:"\e195"}.glyphicon-cloud-download:before{content:"\e197"}.glyphicon-cloud-upload:before{content:"\e198"}.glyphicon-tree-conifer:before{content:"\e199"}.glyphicon-tree-deciduous:before{content:"\e200"}.glyphicon-cd:before{content:"\e201"}.glyphicon-save-file:before{content:"\e202"}.glyphicon-open-file:before{content:"\e203"}.glyphicon-level-up:before{content:"\e204"}.glyphicon-copy:before{content:"\e205"}.glyphicon-paste:before{content:"\e206"}.glyphicon-alert:before{content:"\e209"}.glyphicon-equalizer:before{content:"\e210"}.glyphicon-king:before{content:"\e211"}.glyphicon-queen:before{content:"\e212"}.glyphicon-pawn:before{content:"\e213"}.glyphicon-bishop:before{content:"\e214"}.glyphicon-knight:before{content:"\e215"}.glyphicon-baby-formula:before{content:"\e216"}.glyphicon-tent:before{content:"\26fa"}.glyphicon-blackboard:before{content:"\e218"}.glyphicon-bed:before{content:"\e219"}.glyphicon-apple:before{content:"\f8ff"}.glyphicon-erase:before{content:"\e221"}.glyphicon-hourglass:before{content:"\231b"}.glyphicon-lamp:before{content:"\e223"}.glyphicon-duplicate:before{content:"\e224"}.glyphicon-piggy-bank:before{content:"\e225"}.glyphicon-scissors:before{content:"\e226"}.glyphicon-bitcoin:before{content:"\e227"}.glyphicon-btc:before{content:"\e227"}.glyphicon-xbt:before{content:"\e227"}.glyphicon-yen:before{content:"\00a5"}.glyphicon-jpy:before{content:"\00a5"}.glyphicon-ruble:before{content:"\20bd"}.glyphicon-rub:before{content:"\20bd"}.glyphicon-scale:before{content:"\e230"}.glyphicon-ice-lolly:before{content:"\e231"}.glyphicon-ice-lolly-tasted:before{content:"\e232"}.glyphicon-education:before{content:"\e233"}.glyphicon-option-horizontal:before{content:"\e234"}.glyphicon-option-vertical:before{content:"\e235"}.glyphicon-menu-hamburger:before{content:"\e236"}.glyphicon-modal-window:before{content:"\e237"}.glyphicon-oil:before{content:"\e238"}.glyphicon-grain:before{content:"\e239"}.glyphicon-sunglasses:before{content:"\e240"}.glyphicon-text-size:before{content:"\e241"}.glyphicon-text-color:before{content:"\e242"}.glyphicon-text-background:before{content:"\e243"}.glyphicon-object-align-top:before{content:"\e244"}.glyphicon-object-align-bottom:before{content:"\e245"}.glyphicon-object-align-horizontal:before{content:"\e246"}.glyphicon-object-align-left:before{content:"\e247"}.glyphicon-object-align-vertical:before{content:"\e248"}.glyphicon-object-align-right:before{content:"\e249"}.glyphicon-triangle-right:before{content:"\e250"}.glyphicon-triangle-left:before{content:"\e251"}.glyphicon-triangle-bottom:before{content:"\e252"}.glyphicon-triangle-top:before{content:"\e253"}.glyphicon-console:before{content:"\e254"}.glyphicon-superscript:before{content:"\e255"}.glyphicon-subscript:before{content:"\e256"}.glyphicon-menu-left:before{content:"\e257"}.glyphicon-menu-right:before{content:"\e258"}.glyphicon-menu-down:before{content:"\e259"}.glyphicon-menu-up:before{content:"\e260"}*{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}:after,:before{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}html{font-size:10px;-webkit-tap-highlight-color:rgba(0,0,0,0)}body{font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;line-height:1.42857143;color:#333;background-color:#fff}button,input,select,textarea{font-family:inherit;font-size:inherit;line-height:inherit}a{color:#337ab7;text-decoration:none}a:focus,a:hover{color:#23527c;text-decoration:underline}a:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}figure{margin:0}img{vertical-align:middle}.carousel-inner>.item>a>img,.carousel-inner>.item>img,.img-responsive,.thumbnail a>img,.thumbnail>img{display:block;max-width:100%;height:auto}.img-rounded{border-radius:6px}.img-thumbnail{display:inline-block;max-width:100%;height:auto;padding:4px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:all .2s ease-in-out;-o-transition:all .2s ease-in-out;transition:all .2s ease-in-out}.img-circle{border-radius:50%}hr{margin-top:20px;margin-bottom:20px;border:0;border-top:1px solid #eee}.sr-only{position:absolute;width:1px;height:1px;padding:0;margin:-1px;overflow:hidden;clip:rect(0,0,0,0);border:0}.sr-only-focusable:active,.sr-only-focusable:focus{position:static;width:auto;height:auto;margin:0;overflow:visible;clip:auto}[role=button]{cursor:pointer}.h1,.h2,.h3,.h4,.h5,.h6,h1,h2,h3,h4,h5,h6{font-family:inherit;font-weight:500;line-height:1.1;color:inherit}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-weight:400;line-height:1;color:#777}.h1,.h2,.h3,h1,h2,h3{margin-top:20px;margin-bottom:10px}.h1 .small,.h1 small,.h2 .small,.h2 small,.h3 .small,.h3 small,h1 .small,h1 small,h2 .small,h2 small,h3 .small,h3 small{font-size:65%}.h4,.h5,.h6,h4,h5,h6{margin-top:10px;margin-bottom:10px}.h4 .small,.h4 small,.h5 .small,.h5 small,.h6 .small,.h6 small,h4 .small,h4 small,h5 .small,h5 small,h6 .small,h6 small{font-size:75%}.h1,h1{font-size:36px}.h2,h2{font-size:30px}.h3,h3{font-size:24px}.h4,h4{font-size:18px}.h5,h5{font-size:14px}.h6,h6{font-size:12px}p{margin:0 0 10px}.lead{margin-bottom:20px;font-size:16px;font-weight:300;line-height:1.4}@media (min-width:768px){.lead{font-size:21px}}.small,small{font-size:85%}.mark,mark{padding:.2em;background-color:#fcf8e3}.text-left{text-align:left}.text-right{text-align:right}.text-center{text-align:center}.text-justify{text-align:justify}.text-nowrap{white-space:nowrap}.text-lowercase{text-transform:lowercase}.text-uppercase{text-transform:uppercase}.text-capitalize{text-transform:capitalize}.text-muted{color:#777}.text-primary{color:#337ab7}a.text-primary:focus,a.text-primary:hover{color:#286090}.text-success{color:#3c763d}a.text-success:focus,a.text-success:hover{color:#2b542c}.text-info{color:#31708f}a.text-info:focus,a.text-info:hover{color:#245269}.text-warning{color:#8a6d3b}a.text-warning:focus,a.text-warning:hover{color:#66512c}.text-danger{color:#a94442}a.text-danger:focus,a.text-danger:hover{color:#843534}.bg-primary{color:#fff;background-color:#337ab7}a.bg-primary:focus,a.bg-primary:hover{background-color:#286090}.bg-success{background-color:#dff0d8}a.bg-success:focus,a.bg-success:hover{background-color:#c1e2b3}.bg-info{background-color:#d9edf7}a.bg-info:focus,a.bg-info:hover{background-color:#afd9ee}.bg-warning{background-color:#fcf8e3}a.bg-warning:focus,a.bg-warning:hover{background-color:#f7ecb5}.bg-danger{background-color:#f2dede}a.bg-danger:focus,a.bg-danger:hover{background-color:#e4b9b9}.page-header{padding-bottom:9px;margin:40px 0 20px;border-bottom:1px solid #eee}ol,ul{margin-top:0;margin-bottom:10px}ol ol,ol ul,ul ol,ul ul{margin-bottom:0}.list-unstyled{padding-left:0;list-style:none}.list-inline{padding-left:0;margin-left:-5px;list-style:none}.list-inline>li{display:inline-block;padding-right:5px;padding-left:5px}dl{margin-top:0;margin-bottom:20px}dd,dt{line-height:1.42857143}dt{font-weight:700}dd{margin-left:0}@media (min-width:768px){.dl-horizontal dt{float:left;width:160px;overflow:hidden;clear:left;text-align:right;text-overflow:ellipsis;white-space:nowrap}.dl-horizontal dd{margin-left:180px}}abbr[data-original-title],abbr[title]{cursor:help;border-bottom:1px dotted #777}.initialism{font-size:90%;text-transform:uppercase}blockquote{padding:10px 20px;margin:0 0 20px;font-size:17.5px;border-left:5px solid #eee}blockquote ol:last-child,blockquote p:last-child,blockquote ul:last-child{margin-bottom:0}blockquote .small,blockquote footer,blockquote small{display:block;font-size:80%;line-height:1.42857143;color:#777}blockquote .small:before,blockquote footer:before,blockquote small:before{content:'\2014 \00A0'}.blockquote-reverse,blockquote.pull-right{padding-right:15px;padding-left:0;text-align:right;border-right:5px solid #eee;border-left:0}.blockquote-reverse .small:before,.blockquote-reverse footer:before,.blockquote-reverse small:before,blockquote.pull-right .small:before,blockquote.pull-right footer:before,blockquote.pull-right small:before{content:''}.blockquote-reverse .small:after,.blockquote-reverse footer:after,.blockquote-reverse small:after,blockquote.pull-right .small:after,blockquote.pull-right footer:after,blockquote.pull-right small:after{content:'\00A0 \2014'}address{margin-bottom:20px;font-style:normal;line-height:1.42857143}code,kbd,pre,samp{font-family:monospace}code{padding:2px 4px;font-size:90%;color:#c7254e;background-color:#f9f2f4;border-radius:4px}kbd{padding:2px 4px;font-size:90%;color:#fff;background-color:#333;border-radius:3px;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.25);box-shadow:inset 0 -1px 0 rgba(0,0,0,.25)}kbd kbd{padding:0;font-size:100%;font-weight:700;-webkit-box-shadow:none;box-shadow:none}pre{display:block;padding:9.5px;margin:0 0 10px;font-size:13px;line-height:1.42857143;color:#333;word-break:break-all;word-wrap:break-word;background-color:#f5f5f5;border:1px solid #ccc;border-radius:4px}pre code{padding:0;font-size:inherit;color:inherit;white-space:pre-wrap;background-color:transparent;border-radius:0}.pre-scrollable{max-height:340px;overflow-y:scroll}.container{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}@media (min-width:768px){.container{width:750px}}@media (min-width:992px){.container{width:970px}}@media (min-width:1200px){.container{width:1170px}}.container-fluid{padding-right:15px;padding-left:15px;margin-right:auto;margin-left:auto}.row{margin-right:-15px;margin-left:-15px}.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9,.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9,.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9,.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{position:relative;min-height:1px;padding-right:15px;padding-left:15px}.col-xs-1,.col-xs-10,.col-xs-11,.col-xs-12,.col-xs-2,.col-xs-3,.col-xs-4,.col-xs-5,.col-xs-6,.col-xs-7,.col-xs-8,.col-xs-9{float:left}.col-xs-12{width:100%}.col-xs-11{width:91.66666667%}.col-xs-10{width:83.33333333%}.col-xs-9{width:75%}.col-xs-8{width:66.66666667%}.col-xs-7{width:58.33333333%}.col-xs-6{width:50%}.col-xs-5{width:41.66666667%}.col-xs-4{width:33.33333333%}.col-xs-3{width:25%}.col-xs-2{width:16.66666667%}.col-xs-1{width:8.33333333%}.col-xs-pull-12{right:100%}.col-xs-pull-11{right:91.66666667%}.col-xs-pull-10{right:83.33333333%}.col-xs-pull-9{right:75%}.col-xs-pull-8{right:66.66666667%}.col-xs-pull-7{right:58.33333333%}.col-xs-pull-6{right:50%}.col-xs-pull-5{right:41.66666667%}.col-xs-pull-4{right:33.33333333%}.col-xs-pull-3{right:25%}.col-xs-pull-2{right:16.66666667%}.col-xs-pull-1{right:8.33333333%}.col-xs-pull-0{right:auto}.col-xs-push-12{left:100%}.col-xs-push-11{left:91.66666667%}.col-xs-push-10{left:83.33333333%}.col-xs-push-9{left:75%}.col-xs-push-8{left:66.66666667%}.col-xs-push-7{left:58.33333333%}.col-xs-push-6{left:50%}.col-xs-push-5{left:41.66666667%}.col-xs-push-4{left:33.33333333%}.col-xs-push-3{left:25%}.col-xs-push-2{left:16.66666667%}.col-xs-push-1{left:8.33333333%}.col-xs-push-0{left:auto}.col-xs-offset-12{margin-left:100%}.col-xs-offset-11{margin-left:91.66666667%}.col-xs-offset-10{margin-left:83.33333333%}.col-xs-offset-9{margin-left:75%}.col-xs-offset-8{margin-left:66.66666667%}.col-xs-offset-7{margin-left:58.33333333%}.col-xs-offset-6{margin-left:50%}.col-xs-offset-5{margin-left:41.66666667%}.col-xs-offset-4{margin-left:33.33333333%}.col-xs-offset-3{margin-left:25%}.col-xs-offset-2{margin-left:16.66666667%}.col-xs-offset-1{margin-left:8.33333333%}.col-xs-offset-0{margin-left:0}@media (min-width:768px){.col-sm-1,.col-sm-10,.col-sm-11,.col-sm-12,.col-sm-2,.col-sm-3,.col-sm-4,.col-sm-5,.col-sm-6,.col-sm-7,.col-sm-8,.col-sm-9{float:left}.col-sm-12{width:100%}.col-sm-11{width:91.66666667%}.col-sm-10{width:83.33333333%}.col-sm-9{width:75%}.col-sm-8{width:66.66666667%}.col-sm-7{width:58.33333333%}.col-sm-6{width:50%}.col-sm-5{width:41.66666667%}.col-sm-4{width:33.33333333%}.col-sm-3{width:25%}.col-sm-2{width:16.66666667%}.col-sm-1{width:8.33333333%}.col-sm-pull-12{right:100%}.col-sm-pull-11{right:91.66666667%}.col-sm-pull-10{right:83.33333333%}.col-sm-pull-9{right:75%}.col-sm-pull-8{right:66.66666667%}.col-sm-pull-7{right:58.33333333%}.col-sm-pull-6{right:50%}.col-sm-pull-5{right:41.66666667%}.col-sm-pull-4{right:33.33333333%}.col-sm-pull-3{right:25%}.col-sm-pull-2{right:16.66666667%}.col-sm-pull-1{right:8.33333333%}.col-sm-pull-0{right:auto}.col-sm-push-12{left:100%}.col-sm-push-11{left:91.66666667%}.col-sm-push-10{left:83.33333333%}.col-sm-push-9{left:75%}.col-sm-push-8{left:66.66666667%}.col-sm-push-7{left:58.33333333%}.col-sm-push-6{left:50%}.col-sm-push-5{left:41.66666667%}.col-sm-push-4{left:33.33333333%}.col-sm-push-3{left:25%}.col-sm-push-2{left:16.66666667%}.col-sm-push-1{left:8.33333333%}.col-sm-push-0{left:auto}.col-sm-offset-12{margin-left:100%}.col-sm-offset-11{margin-left:91.66666667%}.col-sm-offset-10{margin-left:83.33333333%}.col-sm-offset-9{margin-left:75%}.col-sm-offset-8{margin-left:66.66666667%}.col-sm-offset-7{margin-left:58.33333333%}.col-sm-offset-6{margin-left:50%}.col-sm-offset-5{margin-left:41.66666667%}.col-sm-offset-4{margin-left:33.33333333%}.col-sm-offset-3{margin-left:25%}.col-sm-offset-2{margin-left:16.66666667%}.col-sm-offset-1{margin-left:8.33333333%}.col-sm-offset-0{margin-left:0}}@media (min-width:992px){.col-md-1,.col-md-10,.col-md-11,.col-md-12,.col-md-2,.col-md-3,.col-md-4,.col-md-5,.col-md-6,.col-md-7,.col-md-8,.col-md-9{float:left}.col-md-12{width:100%}.col-md-11{width:91.66666667%}.col-md-10{width:83.33333333%}.col-md-9{width:75%}.col-md-8{width:66.66666667%}.col-md-7{width:58.33333333%}.col-md-6{width:50%}.col-md-5{width:41.66666667%}.col-md-4{width:33.33333333%}.col-md-3{width:25%}.col-md-2{width:16.66666667%}.col-md-1{width:8.33333333%}.col-md-pull-12{right:100%}.col-md-pull-11{right:91.66666667%}.col-md-pull-10{right:83.33333333%}.col-md-pull-9{right:75%}.col-md-pull-8{right:66.66666667%}.col-md-pull-7{right:58.33333333%}.col-md-pull-6{right:50%}.col-md-pull-5{right:41.66666667%}.col-md-pull-4{right:33.33333333%}.col-md-pull-3{right:25%}.col-md-pull-2{right:16.66666667%}.col-md-pull-1{right:8.33333333%}.col-md-pull-0{right:auto}.col-md-push-12{left:100%}.col-md-push-11{left:91.66666667%}.col-md-push-10{left:83.33333333%}.col-md-push-9{left:75%}.col-md-push-8{left:66.66666667%}.col-md-push-7{left:58.33333333%}.col-md-push-6{left:50%}.col-md-push-5{left:41.66666667%}.col-md-push-4{left:33.33333333%}.col-md-push-3{left:25%}.col-md-push-2{left:16.66666667%}.col-md-push-1{left:8.33333333%}.col-md-push-0{left:auto}.col-md-offset-12{margin-left:100%}.col-md-offset-11{margin-left:91.66666667%}.col-md-offset-10{margin-left:83.33333333%}.col-md-offset-9{margin-left:75%}.col-md-offset-8{margin-left:66.66666667%}.col-md-offset-7{margin-left:58.33333333%}.col-md-offset-6{margin-left:50%}.col-md-offset-5{margin-left:41.66666667%}.col-md-offset-4{margin-left:33.33333333%}.col-md-offset-3{margin-left:25%}.col-md-offset-2{margin-left:16.66666667%}.col-md-offset-1{margin-left:8.33333333%}.col-md-offset-0{margin-left:0}}@media (min-width:1200px){.col-lg-1,.col-lg-10,.col-lg-11,.col-lg-12,.col-lg-2,.col-lg-3,.col-lg-4,.col-lg-5,.col-lg-6,.col-lg-7,.col-lg-8,.col-lg-9{float:left}.col-lg-12{width:100%}.col-lg-11{width:91.66666667%}.col-lg-10{width:83.33333333%}.col-lg-9{width:75%}.col-lg-8{width:66.66666667%}.col-lg-7{width:58.33333333%}.col-lg-6{width:50%}.col-lg-5{width:41.66666667%}.col-lg-4{width:33.33333333%}.col-lg-3{width:25%}.col-lg-2{width:16.66666667%}.col-lg-1{width:8.33333333%}.col-lg-pull-12{right:100%}.col-lg-pull-11{right:91.66666667%}.col-lg-pull-10{right:83.33333333%}.col-lg-pull-9{right:75%}.col-lg-pull-8{right:66.66666667%}.col-lg-pull-7{right:58.33333333%}.col-lg-pull-6{right:50%}.col-lg-pull-5{right:41.66666667%}.col-lg-pull-4{right:33.33333333%}.col-lg-pull-3{right:25%}.col-lg-pull-2{right:16.66666667%}.col-lg-pull-1{right:8.33333333%}.col-lg-pull-0{right:auto}.col-lg-push-12{left:100%}.col-lg-push-11{left:91.66666667%}.col-lg-push-10{left:83.33333333%}.col-lg-push-9{left:75%}.col-lg-push-8{left:66.66666667%}.col-lg-push-7{left:58.33333333%}.col-lg-push-6{left:50%}.col-lg-push-5{left:41.66666667%}.col-lg-push-4{left:33.33333333%}.col-lg-push-3{left:25%}.col-lg-push-2{left:16.66666667%}.col-lg-push-1{left:8.33333333%}.col-lg-push-0{left:auto}.col-lg-offset-12{margin-left:100%}.col-lg-offset-11{margin-left:91.66666667%}.col-lg-offset-10{margin-left:83.33333333%}.col-lg-offset-9{margin-left:75%}.col-lg-offset-8{margin-left:66.66666667%}.col-lg-offset-7{margin-left:58.33333333%}.col-lg-offset-6{margin-left:50%}.col-lg-offset-5{margin-left:41.66666667%}.col-lg-offset-4{margin-left:33.33333333%}.col-lg-offset-3{margin-left:25%}.col-lg-offset-2{margin-left:16.66666667%}.col-lg-offset-1{margin-left:8.33333333%}.col-lg-offset-0{margin-left:0}}table{background-color:transparent}caption{padding-top:8px;padding-bottom:8px;color:#777;text-align:left}th{}.table{width:100%;max-width:100%;margin-bottom:20px}.table>tbody>tr>td,.table>tbody>tr>th,.table>tfoot>tr>td,.table>tfoot>tr>th,.table>thead>tr>td,.table>thead>tr>th{padding:8px;line-height:1.42857143;vertical-align:top;border-top:1px solid #ddd}.table>thead>tr>th{vertical-align:bottom;border-bottom:2px solid #ddd}.table>caption+thead>tr:first-child>td,.table>caption+thead>tr:first-child>th,.table>colgroup+thead>tr:first-child>td,.table>colgroup+thead>tr:first-child>th,.table>thead:first-child>tr:first-child>td,.table>thead:first-child>tr:first-child>th{border-top:0}.table>tbody+tbody{border-top:2px solid #ddd}.table .table{background-color:#fff}.table-condensed>tbody>tr>td,.table-condensed>tbody>tr>th,.table-condensed>tfoot>tr>td,.table-condensed>tfoot>tr>th,.table-condensed>thead>tr>td,.table-condensed>thead>tr>th{padding:5px}.table-bordered{border:1px solid #ddd}.table-bordered>tbody>tr>td,.table-bordered>tbody>tr>th,.table-bordered>tfoot>tr>td,.table-bordered>tfoot>tr>th,.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border:1px solid #ddd}.table-bordered>thead>tr>td,.table-bordered>thead>tr>th{border-bottom-width:2px}.table-striped>tbody>tr:nth-of-type(odd){background-color:#f9f9f9}.table-hover>tbody>tr:hover{background-color:#f5f5f5}table col[class*=col-]{position:static;display:table-column;float:none}table td[class*=col-],table th[class*=col-]{position:static;display:table-cell;float:none}.table>tbody>tr.active>td,.table>tbody>tr.active>th,.table>tbody>tr>td.active,.table>tbody>tr>th.active,.table>tfoot>tr.active>td,.table>tfoot>tr.active>th,.table>tfoot>tr>td.active,.table>tfoot>tr>th.active,.table>thead>tr.active>td,.table>thead>tr.active>th,.table>thead>tr>td.active,.table>thead>tr>th.active{background-color:#f5f5f5}.table-hover>tbody>tr.active:hover>td,.table-hover>tbody>tr.active:hover>th,.table-hover>tbody>tr:hover>.active,.table-hover>tbody>tr>td.active:hover,.table-hover>tbody>tr>th.active:hover{background-color:#e8e8e8}.table>tbody>tr.success>td,.table>tbody>tr.success>th,.table>tbody>tr>td.success,.table>tbody>tr>th.success,.table>tfoot>tr.success>td,.table>tfoot>tr.success>th,.table>tfoot>tr>td.success,.table>tfoot>tr>th.success,.table>thead>tr.success>td,.table>thead>tr.success>th,.table>thead>tr>td.success,.table>thead>tr>th.success{background-color:#dff0d8}.table-hover>tbody>tr.success:hover>td,.table-hover>tbody>tr.success:hover>th,.table-hover>tbody>tr:hover>.success,.table-hover>tbody>tr>td.success:hover,.table-hover>tbody>tr>th.success:hover{background-color:#d0e9c6}.table>tbody>tr.info>td,.table>tbody>tr.info>th,.table>tbody>tr>td.info,.table>tbody>tr>th.info,.table>tfoot>tr.info>td,.table>tfoot>tr.info>th,.table>tfoot>tr>td.info,.table>tfoot>tr>th.info,.table>thead>tr.info>td,.table>thead>tr.info>th,.table>thead>tr>td.info,.table>thead>tr>th.info{background-color:#d9edf7}.table-hover>tbody>tr.info:hover>td,.table-hover>tbody>tr.info:hover>th,.table-hover>tbody>tr:hover>.info,.table-hover>tbody>tr>td.info:hover,.table-hover>tbody>tr>th.info:hover{background-color:#c4e3f3}.table>tbody>tr.warning>td,.table>tbody>tr.warning>th,.table>tbody>tr>td.warning,.table>tbody>tr>th.warning,.table>tfoot>tr.warning>td,.table>tfoot>tr.warning>th,.table>tfoot>tr>td.warning,.table>tfoot>tr>th.warning,.table>thead>tr.warning>td,.table>thead>tr.warning>th,.table>thead>tr>td.warning,.table>thead>tr>th.warning{background-color:#fcf8e3}.table-hover>tbody>tr.warning:hover>td,.table-hover>tbody>tr.warning:hover>th,.table-hover>tbody>tr:hover>.warning,.table-hover>tbody>tr>td.warning:hover,.table-hover>tbody>tr>th.warning:hover{background-color:#faf2cc}.table>tbody>tr.danger>td,.table>tbody>tr.danger>th,.table>tbody>tr>td.danger,.table>tbody>tr>th.danger,.table>tfoot>tr.danger>td,.table>tfoot>tr.danger>th,.table>tfoot>tr>td.danger,.table>tfoot>tr>th.danger,.table>thead>tr.danger>td,.table>thead>tr.danger>th,.table>thead>tr>td.danger,.table>thead>tr>th.danger{background-color:#f2dede}.table-hover>tbody>tr.danger:hover>td,.table-hover>tbody>tr.danger:hover>th,.table-hover>tbody>tr:hover>.danger,.table-hover>tbody>tr>td.danger:hover,.table-hover>tbody>tr>th.danger:hover{background-color:#ebcccc}.table-responsive{min-height:.01%;overflow-x:auto}@media screen and (max-width:767px){.table-responsive{width:100%;margin-bottom:15px;overflow-y:hidden;-ms-overflow-style:-ms-autohiding-scrollbar;border:1px solid #ddd}.table-responsive>.table{margin-bottom:0}.table-responsive>.table>tbody>tr>td,.table-responsive>.table>tbody>tr>th,.table-responsive>.table>tfoot>tr>td,.table-responsive>.table>tfoot>tr>th,.table-responsive>.table>thead>tr>td,.table-responsive>.table>thead>tr>th{white-space:nowrap}.table-responsive>.table-bordered{border:0}.table-responsive>.table-bordered>tbody>tr>td:first-child,.table-responsive>.table-bordered>tbody>tr>th:first-child,.table-responsive>.table-bordered>tfoot>tr>td:first-child,.table-responsive>.table-bordered>tfoot>tr>th:first-child,.table-responsive>.table-bordered>thead>tr>td:first-child,.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.table-responsive>.table-bordered>tbody>tr>td:last-child,.table-responsive>.table-bordered>tbody>tr>th:last-child,.table-responsive>.table-bordered>tfoot>tr>td:last-child,.table-responsive>.table-bordered>tfoot>tr>th:last-child,.table-responsive>.table-bordered>thead>tr>td:last-child,.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.table-responsive>.table-bordered>tbody>tr:last-child>td,.table-responsive>.table-bordered>tbody>tr:last-child>th,.table-responsive>.table-bordered>tfoot>tr:last-child>td,.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}}fieldset{min-width:0;padding:0;margin:0;border:0}legend{display:block;width:100%;padding:0;margin-bottom:20px;font-size:21px;line-height:inherit;color:#333;border:0;border-bottom:1px solid #e5e5e5}label{display:inline-block;max-width:100%;margin-bottom:5px;font-weight:700}input[type=search]{-webkit-box-sizing:border-box;-moz-box-sizing:border-box;box-sizing:border-box}input[type=checkbox],input[type=radio]{margin:4px 0 0;margin-top:1px\9;line-height:normal}input[type=file]{display:block}input[type=range]{display:block;width:100%}select[multiple],select[size]{height:auto}input[type=file]:focus,input[type=checkbox]:focus,input[type=radio]:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}output{display:block;padding-top:7px;font-size:14px;line-height:1.42857143;color:#555}.form-control{display:block;width:100%;height:34px;padding:6px 12px;font-size:14px;line-height:1.42857143;color:#555;background-color:#fff;background-image:none;border:1px solid #ccc;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075);-webkit-transition:border-color ease-in-out .15s,-webkit-box-shadow ease-in-out .15s;-o-transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s;transition:border-color ease-in-out .15s,box-shadow ease-in-out .15s}.form-control:focus{border-color:#66afe9;outline:0;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6);box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 8px rgba(102,175,233,.6)}.form-control::-moz-placeholder{color:#999;opacity:1}.form-control:-ms-input-placeholder{color:#999}.form-control::-webkit-input-placeholder{color:#999}.form-control[disabled],.form-control[readonly],fieldset[disabled] .form-control{background-color:#eee;opacity:1}.form-control[disabled],fieldset[disabled] .form-control{cursor:not-allowed}textarea.form-control{height:auto}input[type=search]{-webkit-appearance:none}@media screen and (-webkit-min-device-pixel-ratio:0){input[type=date].form-control,input[type=time].form-control,input[type=datetime-local].form-control,input[type=month].form-control{line-height:34px}.input-group-sm input[type=date],.input-group-sm input[type=time],.input-group-sm input[type=datetime-local],.input-group-sm input[type=month],input[type=date].input-sm,input[type=time].input-sm,input[type=datetime-local].input-sm,input[type=month].input-sm{line-height:30px}.input-group-lg input[type=date],.input-group-lg input[type=time],.input-group-lg input[type=datetime-local],.input-group-lg input[type=month],input[type=date].input-lg,input[type=time].input-lg,input[type=datetime-local].input-lg,input[type=month].input-lg{line-height:46px}}.form-group{margin-bottom:15px}.checkbox,.radio{position:relative;display:block;margin-top:10px;margin-bottom:10px}.checkbox label,.radio label{min-height:20px;padding-left:20px;margin-bottom:0;font-weight:400;cursor:pointer}.checkbox input[type=checkbox],.checkbox-inline input[type=checkbox],.radio input[type=radio],.radio-inline input[type=radio]{position:absolute;margin-top:4px\9;margin-left:-20px}.checkbox+.checkbox,.radio+.radio{margin-top:-5px}.checkbox-inline,.radio-inline{position:relative;display:inline-block;padding-left:20px;margin-bottom:0;font-weight:400;vertical-align:middle;cursor:pointer}.checkbox-inline+.checkbox-inline,.radio-inline+.radio-inline{margin-top:0;margin-left:10px}fieldset[disabled] input[type=checkbox],fieldset[disabled] input[type=radio],input[type=checkbox].disabled,input[type=checkbox][disabled],input[type=radio].disabled,input[type=radio][disabled]{cursor:not-allowed}.checkbox-inline.disabled,.radio-inline.disabled,fieldset[disabled] .checkbox-inline,fieldset[disabled] .radio-inline{cursor:not-allowed}.checkbox.disabled label,.radio.disabled label,fieldset[disabled] .checkbox label,fieldset[disabled] .radio label{cursor:not-allowed}.form-control-static{min-height:34px;padding-top:7px;padding-bottom:7px;margin-bottom:0}.form-control-static.input-lg,.form-control-static.input-sm{padding-right:0;padding-left:0}.input-sm{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-sm{height:30px;line-height:30px}select[multiple].input-sm,textarea.input-sm{height:auto}.form-group-sm .form-control{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.form-group-sm select.form-control{height:30px;line-height:30px}.form-group-sm select[multiple].form-control,.form-group-sm textarea.form-control{height:auto}.form-group-sm .form-control-static{height:30px;min-height:32px;padding:6px 10px;font-size:12px;line-height:1.5}.input-lg{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-lg{height:46px;line-height:46px}select[multiple].input-lg,textarea.input-lg{height:auto}.form-group-lg .form-control{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.form-group-lg select.form-control{height:46px;line-height:46px}.form-group-lg select[multiple].form-control,.form-group-lg textarea.form-control{height:auto}.form-group-lg .form-control-static{height:46px;min-height:38px;padding:11px 16px;font-size:18px;line-height:1.3333333}.has-feedback{position:relative}.has-feedback .form-control{padding-right:42.5px}.form-control-feedback{position:absolute;top:0;right:0;z-index:2;display:block;width:34px;height:34px;line-height:34px;text-align:center;pointer-events:none}.form-group-lg .form-control+.form-control-feedback,.input-group-lg+.form-control-feedback,.input-lg+.form-control-feedback{width:46px;height:46px;line-height:46px}.form-group-sm .form-control+.form-control-feedback,.input-group-sm+.form-control-feedback,.input-sm+.form-control-feedback{width:30px;height:30px;line-height:30px}.has-success .checkbox,.has-success .checkbox-inline,.has-success .control-label,.has-success .help-block,.has-success .radio,.has-success .radio-inline,.has-success.checkbox label,.has-success.checkbox-inline label,.has-success.radio label,.has-success.radio-inline label{color:#3c763d}.has-success .form-control{border-color:#3c763d;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-success .form-control:focus{border-color:#2b542c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #67b168}.has-success .input-group-addon{color:#3c763d;background-color:#dff0d8;border-color:#3c763d}.has-success .form-control-feedback{color:#3c763d}.has-warning .checkbox,.has-warning .checkbox-inline,.has-warning .control-label,.has-warning .help-block,.has-warning .radio,.has-warning .radio-inline,.has-warning.checkbox label,.has-warning.checkbox-inline label,.has-warning.radio label,.has-warning.radio-inline label{color:#8a6d3b}.has-warning .form-control{border-color:#8a6d3b;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-warning .form-control:focus{border-color:#66512c;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #c0a16b}.has-warning .input-group-addon{color:#8a6d3b;background-color:#fcf8e3;border-color:#8a6d3b}.has-warning .form-control-feedback{color:#8a6d3b}.has-error .checkbox,.has-error .checkbox-inline,.has-error .control-label,.has-error .help-block,.has-error .radio,.has-error .radio-inline,.has-error.checkbox label,.has-error.checkbox-inline label,.has-error.radio label,.has-error.radio-inline label{color:#a94442}.has-error .form-control{border-color:#a94442;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075);box-shadow:inset 0 1px 1px rgba(0,0,0,.075)}.has-error .form-control:focus{border-color:#843534;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483;box-shadow:inset 0 1px 1px rgba(0,0,0,.075),0 0 6px #ce8483}.has-error .input-group-addon{color:#a94442;background-color:#f2dede;border-color:#a94442}.has-error .form-control-feedback{color:#a94442}.has-feedback label~.form-control-feedback{top:25px}.has-feedback label.sr-only~.form-control-feedback{top:0}.help-block{display:block;margin-top:5px;margin-bottom:10px;color:#737373}@media (min-width:768px){.form-inline .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.form-inline .form-control{display:inline-block;width:auto;vertical-align:middle}.form-inline .form-control-static{display:inline-block}.form-inline .input-group{display:inline-table;vertical-align:middle}.form-inline .input-group .form-control,.form-inline .input-group .input-group-addon,.form-inline .input-group .input-group-btn{width:auto}.form-inline .input-group>.form-control{width:100%}.form-inline .control-label{margin-bottom:0;vertical-align:middle}.form-inline .checkbox,.form-inline .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.form-inline .checkbox label,.form-inline .radio label{padding-left:0}.form-inline .checkbox input[type=checkbox],.form-inline .radio input[type=radio]{position:relative;margin-left:0}.form-inline .has-feedback .form-control-feedback{top:0}}.form-horizontal .checkbox,.form-horizontal .checkbox-inline,.form-horizontal .radio,.form-horizontal .radio-inline{padding-top:7px;margin-top:0;margin-bottom:0}.form-horizontal .checkbox,.form-horizontal .radio{min-height:27px}.form-horizontal .form-group{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.form-horizontal .control-label{padding-top:7px;margin-bottom:0;text-align:right}}.form-horizontal .has-feedback .form-control-feedback{right:15px}@media (min-width:768px){.form-horizontal .form-group-lg .control-label{padding-top:14.33px;font-size:18px}}@media (min-width:768px){.form-horizontal .form-group-sm .control-label{padding-top:6px;font-size:12px}}.btn{display:inline-block;padding:6px 12px;margin-bottom:0;font-size:14px;font-weight:400;line-height:1.42857143;text-align:center;white-space:nowrap;vertical-align:middle;-ms-touch-action:manipulation;touch-action:manipulation;cursor:pointer;-webkit-user-select:none;-moz-user-select:none;-ms-user-select:none;user-select:none;background-image:none;border:1px solid transparent;border-radius:4px}.btn.active.focus,.btn.active:focus,.btn.focus,.btn:active.focus,.btn:active:focus,.btn:focus{outline:thin dotted;outline:5px auto -webkit-focus-ring-color;outline-offset:-2px}.btn.focus,.btn:focus,.btn:hover{color:#333;text-decoration:none}.btn.active,.btn:active{background-image:none;outline:0;-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn.disabled,.btn[disabled],fieldset[disabled] .btn{cursor:not-allowed;filter:alpha(opacity=65);-webkit-box-shadow:none;box-shadow:none;opacity:.65}a.btn.disabled,fieldset[disabled] a.btn{pointer-events:none}.btn-default{color:#333;background-color:#fff;border-color:#ccc}.btn-default.focus,.btn-default:focus{color:#333;background-color:#e6e6e6;border-color:#8c8c8c}.btn-default:hover{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{color:#333;background-color:#e6e6e6;border-color:#adadad}.btn-default.active.focus,.btn-default.active:focus,.btn-default.active:hover,.btn-default:active.focus,.btn-default:active:focus,.btn-default:active:hover,.open>.dropdown-toggle.btn-default.focus,.open>.dropdown-toggle.btn-default:focus,.open>.dropdown-toggle.btn-default:hover{color:#333;background-color:#d4d4d4;border-color:#8c8c8c}.btn-default.active,.btn-default:active,.open>.dropdown-toggle.btn-default{background-image:none}.btn-default.disabled,.btn-default.disabled.active,.btn-default.disabled.focus,.btn-default.disabled:active,.btn-default.disabled:focus,.btn-default.disabled:hover,.btn-default[disabled],.btn-default[disabled].active,.btn-default[disabled].focus,.btn-default[disabled]:active,.btn-default[disabled]:focus,.btn-default[disabled]:hover,fieldset[disabled] .btn-default,fieldset[disabled] .btn-default.active,fieldset[disabled] .btn-default.focus,fieldset[disabled] .btn-default:active,fieldset[disabled] .btn-default:focus,fieldset[disabled] .btn-default:hover{background-color:#fff;border-color:#ccc}.btn-default .badge{color:#fff;background-color:#333}.btn-primary{color:#fff;background-color:#337ab7;border-color:#2e6da4}.btn-primary.focus,.btn-primary:focus{color:#fff;background-color:#286090;border-color:#122b40}.btn-primary:hover{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{color:#fff;background-color:#286090;border-color:#204d74}.btn-primary.active.focus,.btn-primary.active:focus,.btn-primary.active:hover,.btn-primary:active.focus,.btn-primary:active:focus,.btn-primary:active:hover,.open>.dropdown-toggle.btn-primary.focus,.open>.dropdown-toggle.btn-primary:focus,.open>.dropdown-toggle.btn-primary:hover{color:#fff;background-color:#204d74;border-color:#122b40}.btn-primary.active,.btn-primary:active,.open>.dropdown-toggle.btn-primary{background-image:none}.btn-primary.disabled,.btn-primary.disabled.active,.btn-primary.disabled.focus,.btn-primary.disabled:active,.btn-primary.disabled:focus,.btn-primary.disabled:hover,.btn-primary[disabled],.btn-primary[disabled].active,.btn-primary[disabled].focus,.btn-primary[disabled]:active,.btn-primary[disabled]:focus,.btn-primary[disabled]:hover,fieldset[disabled] .btn-primary,fieldset[disabled] .btn-primary.active,fieldset[disabled] .btn-primary.focus,fieldset[disabled] .btn-primary:active,fieldset[disabled] .btn-primary:focus,fieldset[disabled] .btn-primary:hover{background-color:#337ab7;border-color:#2e6da4}.btn-primary .badge{color:#337ab7;background-color:#fff}.btn-success{color:#fff;background-color:#5cb85c;border-color:#4cae4c}.btn-success.focus,.btn-success:focus{color:#fff;background-color:#449d44;border-color:#255625}.btn-success:hover{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{color:#fff;background-color:#449d44;border-color:#398439}.btn-success.active.focus,.btn-success.active:focus,.btn-success.active:hover,.btn-success:active.focus,.btn-success:active:focus,.btn-success:active:hover,.open>.dropdown-toggle.btn-success.focus,.open>.dropdown-toggle.btn-success:focus,.open>.dropdown-toggle.btn-success:hover{color:#fff;background-color:#398439;border-color:#255625}.btn-success.active,.btn-success:active,.open>.dropdown-toggle.btn-success{background-image:none}.btn-success.disabled,.btn-success.disabled.active,.btn-success.disabled.focus,.btn-success.disabled:active,.btn-success.disabled:focus,.btn-success.disabled:hover,.btn-success[disabled],.btn-success[disabled].active,.btn-success[disabled].focus,.btn-success[disabled]:active,.btn-success[disabled]:focus,.btn-success[disabled]:hover,fieldset[disabled] .btn-success,fieldset[disabled] .btn-success.active,fieldset[disabled] .btn-success.focus,fieldset[disabled] .btn-success:active,fieldset[disabled] .btn-success:focus,fieldset[disabled] .btn-success:hover{background-color:#5cb85c;border-color:#4cae4c}.btn-success .badge{color:#5cb85c;background-color:#fff}.btn-info{color:#fff;background-color:#5bc0de;border-color:#46b8da}.btn-info.focus,.btn-info:focus{color:#fff;background-color:#31b0d5;border-color:#1b6d85}.btn-info:hover{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{color:#fff;background-color:#31b0d5;border-color:#269abc}.btn-info.active.focus,.btn-info.active:focus,.btn-info.active:hover,.btn-info:active.focus,.btn-info:active:focus,.btn-info:active:hover,.open>.dropdown-toggle.btn-info.focus,.open>.dropdown-toggle.btn-info:focus,.open>.dropdown-toggle.btn-info:hover{color:#fff;background-color:#269abc;border-color:#1b6d85}.btn-info.active,.btn-info:active,.open>.dropdown-toggle.btn-info{background-image:none}.btn-info.disabled,.btn-info.disabled.active,.btn-info.disabled.focus,.btn-info.disabled:active,.btn-info.disabled:focus,.btn-info.disabled:hover,.btn-info[disabled],.btn-info[disabled].active,.btn-info[disabled].focus,.btn-info[disabled]:active,.btn-info[disabled]:focus,.btn-info[disabled]:hover,fieldset[disabled] .btn-info,fieldset[disabled] .btn-info.active,fieldset[disabled] .btn-info.focus,fieldset[disabled] .btn-info:active,fieldset[disabled] .btn-info:focus,fieldset[disabled] .btn-info:hover{background-color:#5bc0de;border-color:#46b8da}.btn-info .badge{color:#5bc0de;background-color:#fff}.btn-warning{color:#fff;background-color:#f0ad4e;border-color:#eea236}.btn-warning.focus,.btn-warning:focus{color:#fff;background-color:#ec971f;border-color:#985f0d}.btn-warning:hover{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{color:#fff;background-color:#ec971f;border-color:#d58512}.btn-warning.active.focus,.btn-warning.active:focus,.btn-warning.active:hover,.btn-warning:active.focus,.btn-warning:active:focus,.btn-warning:active:hover,.open>.dropdown-toggle.btn-warning.focus,.open>.dropdown-toggle.btn-warning:focus,.open>.dropdown-toggle.btn-warning:hover{color:#fff;background-color:#d58512;border-color:#985f0d}.btn-warning.active,.btn-warning:active,.open>.dropdown-toggle.btn-warning{background-image:none}.btn-warning.disabled,.btn-warning.disabled.active,.btn-warning.disabled.focus,.btn-warning.disabled:active,.btn-warning.disabled:focus,.btn-warning.disabled:hover,.btn-warning[disabled],.btn-warning[disabled].active,.btn-warning[disabled].focus,.btn-warning[disabled]:active,.btn-warning[disabled]:focus,.btn-warning[disabled]:hover,fieldset[disabled] .btn-warning,fieldset[disabled] .btn-warning.active,fieldset[disabled] .btn-warning.focus,fieldset[disabled] .btn-warning:active,fieldset[disabled] .btn-warning:focus,fieldset[disabled] .btn-warning:hover{background-color:#f0ad4e;border-color:#eea236}.btn-warning .badge{color:#f0ad4e;background-color:#fff}.btn-danger{color:#fff;background-color:#d9534f;border-color:#d43f3a}.btn-danger.focus,.btn-danger:focus{color:#fff;background-color:#c9302c;border-color:#761c19}.btn-danger:hover{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{color:#fff;background-color:#c9302c;border-color:#ac2925}.btn-danger.active.focus,.btn-danger.active:focus,.btn-danger.active:hover,.btn-danger:active.focus,.btn-danger:active:focus,.btn-danger:active:hover,.open>.dropdown-toggle.btn-danger.focus,.open>.dropdown-toggle.btn-danger:focus,.open>.dropdown-toggle.btn-danger:hover{color:#fff;background-color:#ac2925;border-color:#761c19}.btn-danger.active,.btn-danger:active,.open>.dropdown-toggle.btn-danger{background-image:none}.btn-danger.disabled,.btn-danger.disabled.active,.btn-danger.disabled.focus,.btn-danger.disabled:active,.btn-danger.disabled:focus,.btn-danger.disabled:hover,.btn-danger[disabled],.btn-danger[disabled].active,.btn-danger[disabled].focus,.btn-danger[disabled]:active,.btn-danger[disabled]:focus,.btn-danger[disabled]:hover,fieldset[disabled] .btn-danger,fieldset[disabled] .btn-danger.active,fieldset[disabled] .btn-danger.focus,fieldset[disabled] .btn-danger:active,fieldset[disabled] .btn-danger:focus,fieldset[disabled] .btn-danger:hover{background-color:#d9534f;border-color:#d43f3a}.btn-danger .badge{color:#d9534f;background-color:#fff}.btn-link{font-weight:400;color:#337ab7;border-radius:0}.btn-link,.btn-link.active,.btn-link:active,.btn-link[disabled],fieldset[disabled] .btn-link{background-color:transparent;-webkit-box-shadow:none;box-shadow:none}.btn-link,.btn-link:active,.btn-link:focus,.btn-link:hover{border-color:transparent}.btn-link:focus,.btn-link:hover{color:#23527c;text-decoration:underline;background-color:transparent}.btn-link[disabled]:focus,.btn-link[disabled]:hover,fieldset[disabled] .btn-link:focus,fieldset[disabled] .btn-link:hover{color:#777;text-decoration:none}.btn-group-lg>.btn,.btn-lg{padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}.btn-group-sm>.btn,.btn-sm{padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}.btn-group-xs>.btn,.btn-xs{padding:1px 5px;font-size:12px;line-height:1.5;border-radius:3px}.btn-block{display:block;width:100%}.btn-block+.btn-block{margin-top:5px}input[type=button].btn-block,input[type=reset].btn-block,input[type=submit].btn-block{width:100%}.fade{opacity:0;-webkit-transition:opacity .15s linear;-o-transition:opacity .15s linear;transition:opacity .15s linear}.fade.in{opacity:1}.collapse{display:none}.collapse.in{display:block}tr.collapse.in{display:table-row}tbody.collapse.in{display:table-row-group}.collapsing{position:relative;height:0;overflow:hidden;-webkit-transition-timing-function:ease;-o-transition-timing-function:ease;transition-timing-function:ease;-webkit-transition-duration:.35s;-o-transition-duration:.35s;transition-duration:.35s;-webkit-transition-property:height,visibility;-o-transition-property:height,visibility;transition-property:height,visibility}.caret{display:inline-block;width:0;height:0;margin-left:2px;vertical-align:middle;border-top:4px dashed;border-top:4px solid\9;border-right:4px solid transparent;border-left:4px solid transparent}.dropdown,.dropup{position:relative}.dropdown-toggle:focus{outline:0}.dropdown-menu{position:absolute;top:100%;left:0;z-index:1000;display:none;float:left;min-width:160px;padding:5px 0;margin:2px 0 0;font-size:14px;text-align:left;list-style:none;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.15);border-radius:4px;-webkit-box-shadow:0 6px 12px rgba(0,0,0,.175);box-shadow:0 6px 12px rgba(0,0,0,.175)}.dropdown-menu.pull-right{right:0;left:auto}.dropdown-menu .divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.dropdown-menu>li>a{display:block;padding:3px 20px;clear:both;font-weight:400;line-height:1.42857143;color:#333;white-space:nowrap}.dropdown-menu>li>a:focus,.dropdown-menu>li>a:hover{color:#262626;text-decoration:none;background-color:#f5f5f5}.dropdown-menu>.active>a,.dropdown-menu>.active>a:focus,.dropdown-menu>.active>a:hover{color:#fff;text-decoration:none;background-color:#337ab7;outline:0}.dropdown-menu>.disabled>a,.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{color:#777}.dropdown-menu>.disabled>a:focus,.dropdown-menu>.disabled>a:hover{text-decoration:none;cursor:not-allowed;background-color:transparent;background-image:none;filter:progid:DXImageTransform.Microsoft.gradient(enabled=false)}.open>.dropdown-menu{display:block}.open>a{outline:0}.dropdown-menu-right{right:0;left:auto}.dropdown-menu-left{right:auto;left:0}.dropdown-header{display:block;padding:3px 20px;font-size:12px;line-height:1.42857143;color:#777;white-space:nowrap}.dropdown-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:990}.pull-right>.dropdown-menu{right:0;left:auto}.dropup .caret,.navbar-fixed-bottom .dropdown .caret{content:"";border-top:0;border-bottom:4px dashed;border-bottom:4px solid\9}.dropup .dropdown-menu,.navbar-fixed-bottom .dropdown .dropdown-menu{top:auto;bottom:100%;margin-bottom:2px}@media (min-width:768px){.navbar-right .dropdown-menu{right:0;left:auto}.navbar-right .dropdown-menu-left{right:auto;left:0}}.btn-group,.btn-group-vertical{position:relative;display:inline-block;vertical-align:middle}.btn-group-vertical>.btn,.btn-group>.btn{position:relative;float:left}.btn-group-vertical>.btn.active,.btn-group-vertical>.btn:active,.btn-group-vertical>.btn:focus,.btn-group-vertical>.btn:hover,.btn-group>.btn.active,.btn-group>.btn:active,.btn-group>.btn:focus,.btn-group>.btn:hover{z-index:2}.btn-group .btn+.btn,.btn-group .btn+.btn-group,.btn-group .btn-group+.btn,.btn-group .btn-group+.btn-group{margin-left:-1px}.btn-toolbar{margin-left:-5px}.btn-toolbar .btn,.btn-toolbar .btn-group,.btn-toolbar .input-group{float:left}.btn-toolbar>.btn,.btn-toolbar>.btn-group,.btn-toolbar>.input-group{margin-left:5px}.btn-group>.btn:not(:first-child):not(:last-child):not(.dropdown-toggle){border-radius:0}.btn-group>.btn:first-child{margin-left:0}.btn-group>.btn:first-child:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn:last-child:not(:first-child),.btn-group>.dropdown-toggle:not(:first-child){border-top-left-radius:0;border-bottom-left-radius:0}.btn-group>.btn-group{float:left}.btn-group>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-top-right-radius:0;border-bottom-right-radius:0}.btn-group>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-bottom-left-radius:0}.btn-group .dropdown-toggle:active,.btn-group.open .dropdown-toggle{outline:0}.btn-group>.btn+.dropdown-toggle{padding-right:8px;padding-left:8px}.btn-group>.btn-lg+.dropdown-toggle{padding-right:12px;padding-left:12px}.btn-group.open .dropdown-toggle{-webkit-box-shadow:inset 0 3px 5px rgba(0,0,0,.125);box-shadow:inset 0 3px 5px rgba(0,0,0,.125)}.btn-group.open .dropdown-toggle.btn-link{-webkit-box-shadow:none;box-shadow:none}.btn .caret{margin-left:0}.btn-lg .caret{border-width:5px 5px 0;border-bottom-width:0}.dropup .btn-lg .caret{border-width:0 5px 5px}.btn-group-vertical>.btn,.btn-group-vertical>.btn-group,.btn-group-vertical>.btn-group>.btn{display:block;float:none;width:100%;max-width:100%}.btn-group-vertical>.btn-group>.btn{float:none}.btn-group-vertical>.btn+.btn,.btn-group-vertical>.btn+.btn-group,.btn-group-vertical>.btn-group+.btn,.btn-group-vertical>.btn-group+.btn-group{margin-top:-1px;margin-left:0}.btn-group-vertical>.btn:not(:first-child):not(:last-child){border-radius:0}.btn-group-vertical>.btn:first-child:not(:last-child){border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn:last-child:not(:first-child){border-top-left-radius:0;border-top-right-radius:0;border-bottom-left-radius:4px}.btn-group-vertical>.btn-group:not(:first-child):not(:last-child)>.btn{border-radius:0}.btn-group-vertical>.btn-group:first-child:not(:last-child)>.btn:last-child,.btn-group-vertical>.btn-group:first-child:not(:last-child)>.dropdown-toggle{border-bottom-right-radius:0;border-bottom-left-radius:0}.btn-group-vertical>.btn-group:last-child:not(:first-child)>.btn:first-child{border-top-left-radius:0;border-top-right-radius:0}.btn-group-justified{display:table;width:100%;table-layout:fixed;border-collapse:separate}.btn-group-justified>.btn,.btn-group-justified>.btn-group{display:table-cell;float:none;width:1%}.btn-group-justified>.btn-group .btn{width:100%}.btn-group-justified>.btn-group .dropdown-menu{left:auto}[data-toggle=buttons]>.btn input[type=checkbox],[data-toggle=buttons]>.btn input[type=radio],[data-toggle=buttons]>.btn-group>.btn input[type=checkbox],[data-toggle=buttons]>.btn-group>.btn input[type=radio]{position:absolute;clip:rect(0,0,0,0);pointer-events:none}.input-group{position:relative;display:table;border-collapse:separate}.input-group[class*=col-]{float:none;padding-right:0;padding-left:0}.input-group .form-control{position:relative;z-index:2;float:left;width:100%;margin-bottom:0}.input-group-lg>.form-control,.input-group-lg>.input-group-addon,.input-group-lg>.input-group-btn>.btn{height:46px;padding:10px 16px;font-size:18px;line-height:1.3333333;border-radius:6px}select.input-group-lg>.form-control,select.input-group-lg>.input-group-addon,select.input-group-lg>.input-group-btn>.btn{height:46px;line-height:46px}select[multiple].input-group-lg>.form-control,select[multiple].input-group-lg>.input-group-addon,select[multiple].input-group-lg>.input-group-btn>.btn,textarea.input-group-lg>.form-control,textarea.input-group-lg>.input-group-addon,textarea.input-group-lg>.input-group-btn>.btn{height:auto}.input-group-sm>.form-control,.input-group-sm>.input-group-addon,.input-group-sm>.input-group-btn>.btn{height:30px;padding:5px 10px;font-size:12px;line-height:1.5;border-radius:3px}select.input-group-sm>.form-control,select.input-group-sm>.input-group-addon,select.input-group-sm>.input-group-btn>.btn{height:30px;line-height:30px}select[multiple].input-group-sm>.form-control,select[multiple].input-group-sm>.input-group-addon,select[multiple].input-group-sm>.input-group-btn>.btn,textarea.input-group-sm>.form-control,textarea.input-group-sm>.input-group-addon,textarea.input-group-sm>.input-group-btn>.btn{height:auto}.input-group .form-control,.input-group-addon,.input-group-btn{display:table-cell}.input-group .form-control:not(:first-child):not(:last-child),.input-group-addon:not(:first-child):not(:last-child),.input-group-btn:not(:first-child):not(:last-child){border-radius:0}.input-group-addon,.input-group-btn{width:1%;white-space:nowrap;vertical-align:middle}.input-group-addon{padding:6px 12px;font-size:14px;font-weight:400;line-height:1;color:#555;text-align:center;background-color:#eee;border:1px solid #ccc;border-radius:4px}.input-group-addon.input-sm{padding:5px 10px;font-size:12px;border-radius:3px}.input-group-addon.input-lg{padding:10px 16px;font-size:18px;border-radius:6px}.input-group-addon input[type=checkbox],.input-group-addon input[type=radio]{margin-top:0}.input-group .form-control:first-child,.input-group-addon:first-child,.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group>.btn,.input-group-btn:first-child>.dropdown-toggle,.input-group-btn:last-child>.btn-group:not(:last-child)>.btn,.input-group-btn:last-child>.btn:not(:last-child):not(.dropdown-toggle){border-top-right-radius:0;border-bottom-right-radius:0}.input-group-addon:first-child{border-right:0}.input-group .form-control:last-child,.input-group-addon:last-child,.input-group-btn:first-child>.btn-group:not(:first-child)>.btn,.input-group-btn:first-child>.btn:not(:first-child),.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group>.btn,.input-group-btn:last-child>.dropdown-toggle{border-top-left-radius:0;border-bottom-left-radius:0}.input-group-addon:last-child{border-left:0}.input-group-btn{position:relative;font-size:0;white-space:nowrap}.input-group-btn>.btn{position:relative}.input-group-btn>.btn+.btn{margin-left:-1px}.input-group-btn>.btn:active,.input-group-btn>.btn:focus,.input-group-btn>.btn:hover{z-index:2}.input-group-btn:first-child>.btn,.input-group-btn:first-child>.btn-group{margin-right:-1px}.input-group-btn:last-child>.btn,.input-group-btn:last-child>.btn-group{z-index:2;margin-left:-1px}.nav{padding-left:0;margin-bottom:0;list-style:none}.nav>li{position:relative;display:block}.nav>li>a{position:relative;display:block;padding:10px 15px}.nav>li>a:focus,.nav>li>a:hover{text-decoration:none;background-color:#eee}.nav>li.disabled>a{color:#777}.nav>li.disabled>a:focus,.nav>li.disabled>a:hover{color:#777;text-decoration:none;cursor:not-allowed;background-color:transparent}.nav .open>a,.nav .open>a:focus,.nav .open>a:hover{background-color:#eee;border-color:#337ab7}.nav .nav-divider{height:1px;margin:9px 0;overflow:hidden;background-color:#e5e5e5}.nav>li>a>img{max-width:none}.nav-tabs{border-bottom:1px solid #ddd}.nav-tabs>li{float:left;margin-bottom:-1px}.nav-tabs>li>a{margin-right:2px;line-height:1.42857143;border:1px solid transparent;border-radius:4px 4px 0 0}.nav-tabs>li>a:hover{border-color:#eee #eee #ddd}.nav-tabs>li.active>a,.nav-tabs>li.active>a:focus,.nav-tabs>li.active>a:hover{color:#555;cursor:default;background-color:#fff;border:1px solid #ddd;border-bottom-color:transparent}.nav-tabs.nav-justified{width:100%;border-bottom:0}.nav-tabs.nav-justified>li{float:none}.nav-tabs.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-tabs.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-tabs.nav-justified>li{display:table-cell;width:1%}.nav-tabs.nav-justified>li>a{margin-bottom:0}}.nav-tabs.nav-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs.nav-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs.nav-justified>.active>a,.nav-tabs.nav-justified>.active>a:focus,.nav-tabs.nav-justified>.active>a:hover{border-bottom-color:#fff}}.nav-pills>li{float:left}.nav-pills>li>a{border-radius:4px}.nav-pills>li+li{margin-left:2px}.nav-pills>li.active>a,.nav-pills>li.active>a:focus,.nav-pills>li.active>a:hover{color:#fff;background-color:#337ab7}.nav-stacked>li{float:none}.nav-stacked>li+li{margin-top:2px;margin-left:0}.nav-justified{width:100%}.nav-justified>li{float:none}.nav-justified>li>a{margin-bottom:5px;text-align:center}.nav-justified>.dropdown .dropdown-menu{top:auto;left:auto}@media (min-width:768px){.nav-justified>li{display:table-cell;width:1%}.nav-justified>li>a{margin-bottom:0}}.nav-tabs-justified{border-bottom:0}.nav-tabs-justified>li>a{margin-right:0;border-radius:4px}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border:1px solid #ddd}@media (min-width:768px){.nav-tabs-justified>li>a{border-bottom:1px solid #ddd;border-radius:4px 4px 0 0}.nav-tabs-justified>.active>a,.nav-tabs-justified>.active>a:focus,.nav-tabs-justified>.active>a:hover{border-bottom-color:#fff}}.tab-content>.tab-pane{display:none}.tab-content>.active{display:block}.nav-tabs .dropdown-menu{margin-top:-1px;border-top-left-radius:0;border-top-right-radius:0}.navbar{position:relative;min-height:50px;margin-bottom:20px;border:1px solid transparent}@media (min-width:768px){.navbar{border-radius:4px}}@media (min-width:768px){.navbar-header{float:left}}.navbar-collapse{padding-right:15px;padding-left:15px;overflow-x:visible;-webkit-overflow-scrolling:touch;border-top:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1)}.navbar-collapse.in{overflow-y:auto}@media (min-width:768px){.navbar-collapse{width:auto;border-top:0;-webkit-box-shadow:none;box-shadow:none}.navbar-collapse.collapse{display:block!important;height:auto!important;padding-bottom:0;overflow:visible!important}.navbar-collapse.in{overflow-y:visible}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse,.navbar-static-top .navbar-collapse{padding-right:0;padding-left:0}}.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:340px}@media (max-device-width:480px) and (orientation:landscape){.navbar-fixed-bottom .navbar-collapse,.navbar-fixed-top .navbar-collapse{max-height:200px}}.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:-15px;margin-left:-15px}@media (min-width:768px){.container-fluid>.navbar-collapse,.container-fluid>.navbar-header,.container>.navbar-collapse,.container>.navbar-header{margin-right:0;margin-left:0}}.navbar-static-top{z-index:1000;border-width:0 0 1px}@media (min-width:768px){.navbar-static-top{border-radius:0}}.navbar-fixed-bottom,.navbar-fixed-top{position:fixed;right:0;left:0;z-index:1030}@media (min-width:768px){.navbar-fixed-bottom,.navbar-fixed-top{border-radius:0}}.navbar-fixed-top{top:0;border-width:0 0 1px}.navbar-fixed-bottom{bottom:0;margin-bottom:0;border-width:1px 0 0}.navbar-brand{float:left;height:50px;padding:15px 15px;font-size:18px;line-height:20px}.navbar-brand:focus,.navbar-brand:hover{text-decoration:none}.navbar-brand>img{display:block}@media (min-width:768px){.navbar>.container .navbar-brand,.navbar>.container-fluid .navbar-brand{margin-left:-15px}}.navbar-toggle{position:relative;float:right;padding:9px 10px;margin-top:8px;margin-right:15px;margin-bottom:8px;background-color:transparent;background-image:none;border:1px solid transparent;border-radius:4px}.navbar-toggle:focus{outline:0}.navbar-toggle .icon-bar{display:block;width:22px;height:2px;border-radius:1px}.navbar-toggle .icon-bar+.icon-bar{margin-top:4px}@media (min-width:768px){.navbar-toggle{display:none}}.navbar-nav{margin:7.5px -15px}.navbar-nav>li>a{padding-top:10px;padding-bottom:10px;line-height:20px}@media (max-width:767px){.navbar-nav .open .dropdown-menu{position:static;float:none;width:auto;margin-top:0;background-color:transparent;border:0;-webkit-box-shadow:none;box-shadow:none}.navbar-nav .open .dropdown-menu .dropdown-header,.navbar-nav .open .dropdown-menu>li>a{padding:5px 15px 5px 25px}.navbar-nav .open .dropdown-menu>li>a{line-height:20px}.navbar-nav .open .dropdown-menu>li>a:focus,.navbar-nav .open .dropdown-menu>li>a:hover{background-image:none}}@media (min-width:768px){.navbar-nav{float:left;margin:0}.navbar-nav>li{float:left}.navbar-nav>li>a{padding-top:15px;padding-bottom:15px}}.navbar-form{padding:10px 15px;margin-top:8px;margin-right:-15px;margin-bottom:8px;margin-left:-15px;border-top:1px solid transparent;border-bottom:1px solid transparent;-webkit-box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1);box-shadow:inset 0 1px 0 rgba(255,255,255,.1),0 1px 0 rgba(255,255,255,.1)}@media (min-width:768px){.navbar-form .form-group{display:inline-block;margin-bottom:0;vertical-align:middle}.navbar-form .form-control{display:inline-block;width:auto;vertical-align:middle}.navbar-form .form-control-static{display:inline-block}.navbar-form .input-group{display:inline-table;vertical-align:middle}.navbar-form .input-group .form-control,.navbar-form .input-group .input-group-addon,.navbar-form .input-group .input-group-btn{width:auto}.navbar-form .input-group>.form-control{width:100%}.navbar-form .control-label{margin-bottom:0;vertical-align:middle}.navbar-form .checkbox,.navbar-form .radio{display:inline-block;margin-top:0;margin-bottom:0;vertical-align:middle}.navbar-form .checkbox label,.navbar-form .radio label{padding-left:0}.navbar-form .checkbox input[type=checkbox],.navbar-form .radio input[type=radio]{position:relative;margin-left:0}.navbar-form .has-feedback .form-control-feedback{top:0}}@media (max-width:767px){.navbar-form .form-group{margin-bottom:5px}.navbar-form .form-group:last-child{margin-bottom:0}}@media (min-width:768px){.navbar-form{width:auto;padding-top:0;padding-bottom:0;margin-right:0;margin-left:0;border:0;-webkit-box-shadow:none;box-shadow:none}}.navbar-nav>li>.dropdown-menu{margin-top:0;border-top-left-radius:0;border-top-right-radius:0}.navbar-fixed-bottom .navbar-nav>li>.dropdown-menu{margin-bottom:0;border-top-left-radius:4px;border-top-right-radius:4px;border-bottom-right-radius:0;border-bottom-left-radius:0}.navbar-btn{margin-top:8px;margin-bottom:8px}.navbar-btn.btn-sm{margin-top:10px;margin-bottom:10px}.navbar-btn.btn-xs{margin-top:14px;margin-bottom:14px}.navbar-text{margin-top:15px;margin-bottom:15px}@media (min-width:768px){.navbar-text{float:left;margin-right:15px;margin-left:15px}}@media (min-width:768px){.navbar-left{float:left!important}.navbar-right{float:right!important;margin-right:-15px}.navbar-right~.navbar-right{margin-right:0}}.navbar-default{background-color:#f8f8f8;border-color:#e7e7e7}.navbar-default .navbar-brand{color:#777}.navbar-default .navbar-brand:focus,.navbar-default .navbar-brand:hover{color:#5e5e5e;background-color:transparent}.navbar-default .navbar-text{color:#777}.navbar-default .navbar-nav>li>a{color:#777}.navbar-default .navbar-nav>li>a:focus,.navbar-default .navbar-nav>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav>.active>a,.navbar-default .navbar-nav>.active>a:focus,.navbar-default .navbar-nav>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav>.disabled>a,.navbar-default .navbar-nav>.disabled>a:focus,.navbar-default .navbar-nav>.disabled>a:hover{color:#ccc;background-color:transparent}.navbar-default .navbar-toggle{border-color:#ddd}.navbar-default .navbar-toggle:focus,.navbar-default .navbar-toggle:hover{background-color:#ddd}.navbar-default .navbar-toggle .icon-bar{background-color:#888}.navbar-default .navbar-collapse,.navbar-default .navbar-form{border-color:#e7e7e7}.navbar-default .navbar-nav>.open>a,.navbar-default .navbar-nav>.open>a:focus,.navbar-default .navbar-nav>.open>a:hover{color:#555;background-color:#e7e7e7}@media (max-width:767px){.navbar-default .navbar-nav .open .dropdown-menu>li>a{color:#777}.navbar-default .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>li>a:hover{color:#333;background-color:transparent}.navbar-default .navbar-nav .open .dropdown-menu>.active>a,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.active>a:hover{color:#555;background-color:#e7e7e7}.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-default .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#ccc;background-color:transparent}}.navbar-default .navbar-link{color:#777}.navbar-default .navbar-link:hover{color:#333}.navbar-default .btn-link{color:#777}.navbar-default .btn-link:focus,.navbar-default .btn-link:hover{color:#333}.navbar-default .btn-link[disabled]:focus,.navbar-default .btn-link[disabled]:hover,fieldset[disabled] .navbar-default .btn-link:focus,fieldset[disabled] .navbar-default .btn-link:hover{color:#ccc}.navbar-inverse{background-color:#222;border-color:#080808}.navbar-inverse .navbar-brand{color:#9d9d9d}.navbar-inverse .navbar-brand:focus,.navbar-inverse .navbar-brand:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-text{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav>li>a:focus,.navbar-inverse .navbar-nav>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav>.active>a,.navbar-inverse .navbar-nav>.active>a:focus,.navbar-inverse .navbar-nav>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav>.disabled>a,.navbar-inverse .navbar-nav>.disabled>a:focus,.navbar-inverse .navbar-nav>.disabled>a:hover{color:#444;background-color:transparent}.navbar-inverse .navbar-toggle{border-color:#333}.navbar-inverse .navbar-toggle:focus,.navbar-inverse .navbar-toggle:hover{background-color:#333}.navbar-inverse .navbar-toggle .icon-bar{background-color:#fff}.navbar-inverse .navbar-collapse,.navbar-inverse .navbar-form{border-color:#101010}.navbar-inverse .navbar-nav>.open>a,.navbar-inverse .navbar-nav>.open>a:focus,.navbar-inverse .navbar-nav>.open>a:hover{color:#fff;background-color:#080808}@media (max-width:767px){.navbar-inverse .navbar-nav .open .dropdown-menu>.dropdown-header{border-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu .divider{background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a{color:#9d9d9d}.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>li>a:hover{color:#fff;background-color:transparent}.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.active>a:hover{color:#fff;background-color:#080808}.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:focus,.navbar-inverse .navbar-nav .open .dropdown-menu>.disabled>a:hover{color:#444;background-color:transparent}}.navbar-inverse .navbar-link{color:#9d9d9d}.navbar-inverse .navbar-link:hover{color:#fff}.navbar-inverse .btn-link{color:#9d9d9d}.navbar-inverse .btn-link:focus,.navbar-inverse .btn-link:hover{color:#fff}.navbar-inverse .btn-link[disabled]:focus,.navbar-inverse .btn-link[disabled]:hover,fieldset[disabled] .navbar-inverse .btn-link:focus,fieldset[disabled] .navbar-inverse .btn-link:hover{color:#444}.breadcrumb{padding:8px 15px;margin-bottom:20px;list-style:none;background-color:#f5f5f5;border-radius:4px}.breadcrumb>li{display:inline-block}.breadcrumb>li+li:before{padding:0 5px;color:#ccc;content:"/\00a0"}.breadcrumb>.active{color:#777}.pagination{display:inline-block;padding-left:0;margin:20px 0;border-radius:4px}.pagination>li{display:inline}.pagination>li>a,.pagination>li>span{position:relative;float:left;padding:6px 12px;margin-left:-1px;line-height:1.42857143;color:#337ab7;text-decoration:none;background-color:#fff;border:1px solid #ddd}.pagination>li:first-child>a,.pagination>li:first-child>span{margin-left:0;border-top-left-radius:4px;border-bottom-left-radius:4px}.pagination>li:last-child>a,.pagination>li:last-child>span{border-top-right-radius:4px;border-bottom-right-radius:4px}.pagination>li>a:focus,.pagination>li>a:hover,.pagination>li>span:focus,.pagination>li>span:hover{z-index:3;color:#23527c;background-color:#eee;border-color:#ddd}.pagination>.active>a,.pagination>.active>a:focus,.pagination>.active>a:hover,.pagination>.active>span,.pagination>.active>span:focus,.pagination>.active>span:hover{z-index:2;color:#fff;cursor:default;background-color:#337ab7;border-color:#337ab7}.pagination>.disabled>a,.pagination>.disabled>a:focus,.pagination>.disabled>a:hover,.pagination>.disabled>span,.pagination>.disabled>span:focus,.pagination>.disabled>span:hover{color:#777;cursor:not-allowed;background-color:#fff;border-color:#ddd}.pagination-lg>li>a,.pagination-lg>li>span{padding:10px 16px;font-size:18px;line-height:1.3333333}.pagination-lg>li:first-child>a,.pagination-lg>li:first-child>span{border-top-left-radius:6px;border-bottom-left-radius:6px}.pagination-lg>li:last-child>a,.pagination-lg>li:last-child>span{border-top-right-radius:6px;border-bottom-right-radius:6px}.pagination-sm>li>a,.pagination-sm>li>span{padding:5px 10px;font-size:12px;line-height:1.5}.pagination-sm>li:first-child>a,.pagination-sm>li:first-child>span{border-top-left-radius:3px;border-bottom-left-radius:3px}.pagination-sm>li:last-child>a,.pagination-sm>li:last-child>span{border-top-right-radius:3px;border-bottom-right-radius:3px}.pager{padding-left:0;margin:20px 0;text-align:center;list-style:none}.pager li{display:inline}.pager li>a,.pager li>span{display:inline-block;padding:5px 14px;background-color:#fff;border:1px solid #ddd;border-radius:15px}.pager li>a:focus,.pager li>a:hover{text-decoration:none;background-color:#eee}.pager .next>a,.pager .next>span{float:right}.pager .previous>a,.pager .previous>span{float:left}.pager .disabled>a,.pager .disabled>a:focus,.pager .disabled>a:hover,.pager .disabled>span{color:#777;cursor:not-allowed;background-color:#fff}.label{display:inline;padding:.2em .6em .3em;font-size:75%;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:baseline;border-radius:.25em}a.label:focus,a.label:hover{color:#fff;text-decoration:none;cursor:pointer}.label:empty{display:none}.btn .label{position:relative;top:-1px}.label-default{background-color:#777}.label-default[href]:focus,.label-default[href]:hover{background-color:#5e5e5e}.label-primary{background-color:#337ab7}.label-primary[href]:focus,.label-primary[href]:hover{background-color:#286090}.label-success{background-color:#5cb85c}.label-success[href]:focus,.label-success[href]:hover{background-color:#449d44}.label-info{background-color:#5bc0de}.label-info[href]:focus,.label-info[href]:hover{background-color:#31b0d5}.label-warning{background-color:#f0ad4e}.label-warning[href]:focus,.label-warning[href]:hover{background-color:#ec971f}.label-danger{background-color:#d9534f}.label-danger[href]:focus,.label-danger[href]:hover{background-color:#c9302c}.badge{display:inline-block;min-width:10px;padding:3px 7px;font-size:12px;font-weight:700;line-height:1;color:#fff;text-align:center;white-space:nowrap;vertical-align:middle;background-color:#777;border-radius:10px}.badge:empty{display:none}.btn .badge{position:relative;top:-1px}.btn-group-xs>.btn .badge,.btn-xs .badge{top:0;padding:1px 5px}a.badge:focus,a.badge:hover{color:#fff;text-decoration:none;cursor:pointer}.list-group-item.active>.badge,.nav-pills>.active>a>.badge{color:#337ab7;background-color:#fff}.list-group-item>.badge{float:right}.list-group-item>.badge+.badge{margin-right:5px}.nav-pills>li>a>.badge{margin-left:3px}.jumbotron{padding-top:30px;padding-bottom:30px;margin-bottom:30px;color:inherit;background-color:#eee}.jumbotron .h1,.jumbotron h1{color:inherit}.jumbotron p{margin-bottom:15px;font-size:21px;font-weight:200}.jumbotron>hr{border-top-color:#d5d5d5}.container .jumbotron,.container-fluid .jumbotron{border-radius:6px}.jumbotron .container{max-width:100%}@media screen and (min-width:768px){.jumbotron{padding-top:48px;padding-bottom:48px}.container .jumbotron,.container-fluid .jumbotron{padding-right:60px;padding-left:60px}.jumbotron .h1,.jumbotron h1{font-size:63px}}.thumbnail{display:block;padding:4px;margin-bottom:20px;line-height:1.42857143;background-color:#fff;border:1px solid #ddd;border-radius:4px;-webkit-transition:border .2s ease-in-out;-o-transition:border .2s ease-in-out;transition:border .2s ease-in-out}.thumbnail a>img,.thumbnail>img{margin-right:auto;margin-left:auto}a.thumbnail.active,a.thumbnail:focus,a.thumbnail:hover{border-color:#337ab7}.thumbnail .caption{padding:9px;color:#333}.alert{padding:15px;margin-bottom:20px;border:1px solid transparent;border-radius:4px}.alert h4{margin-top:0;color:inherit}.alert .alert-link{font-weight:700}.alert>p,.alert>ul{margin-bottom:0}.alert>p+p{margin-top:5px}.alert-dismissable,.alert-dismissible{padding-right:35px}.alert-dismissable .close,.alert-dismissible .close{position:relative;top:-2px;right:-21px;color:inherit}.alert-success{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.alert-success hr{border-top-color:#c9e2b3}.alert-success .alert-link{color:#2b542c}.alert-info{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.alert-info hr{border-top-color:#a6e1ec}.alert-info .alert-link{color:#245269}.alert-warning{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.alert-warning hr{border-top-color:#f7e1b5}.alert-warning .alert-link{color:#66512c}.alert-danger{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.alert-danger hr{border-top-color:#e4b9c0}.alert-danger .alert-link{color:#843534}@-webkit-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@-o-keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}@keyframes progress-bar-stripes{from{background-position:40px 0}to{background-position:0 0}}.progress{height:20px;margin-bottom:20px;overflow:hidden;background-color:#f5f5f5;border-radius:4px;-webkit-box-shadow:inset 0 1px 2px rgba(0,0,0,.1);box-shadow:inset 0 1px 2px rgba(0,0,0,.1)}.progress-bar{float:left;width:0;height:100%;font-size:12px;line-height:20px;color:#fff;text-align:center;background-color:#337ab7;-webkit-box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);box-shadow:inset 0 -1px 0 rgba(0,0,0,.15);-webkit-transition:width .6s ease;-o-transition:width .6s ease;transition:width .6s ease}.progress-bar-striped,.progress-striped .progress-bar{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);-webkit-background-size:40px 40px;background-size:40px 40px}.progress-bar.active,.progress.active .progress-bar{-webkit-animation:progress-bar-stripes 2s linear infinite;-o-animation:progress-bar-stripes 2s linear infinite;animation:progress-bar-stripes 2s linear infinite}.progress-bar-success{background-color:#5cb85c}.progress-striped .progress-bar-success{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-info{background-color:#5bc0de}.progress-striped .progress-bar-info{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-warning{background-color:#f0ad4e}.progress-striped .progress-bar-warning{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.progress-bar-danger{background-color:#d9534f}.progress-striped .progress-bar-danger{background-image:-webkit-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:-o-linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent);background-image:linear-gradient(45deg,rgba(255,255,255,.15) 25%,transparent 25%,transparent 50%,rgba(255,255,255,.15) 50%,rgba(255,255,255,.15) 75%,transparent 75%,transparent)}.media{margin-top:15px}.media:first-child{margin-top:0}.media,.media-body{overflow:hidden;zoom:1}.media-body{width:10000px}.media-object{display:block}.media-object.img-thumbnail{max-width:none}.media-right,.media>.pull-right{padding-left:10px}.media-left,.media>.pull-left{padding-right:10px}.media-body,.media-left,.media-right{display:table-cell;vertical-align:top}.media-middle{vertical-align:middle}.media-bottom{vertical-align:bottom}.media-heading{margin-top:0;margin-bottom:5px}.media-list{padding-left:0;list-style:none}.list-group{padding-left:0;margin-bottom:20px}.list-group-item{position:relative;display:block;padding:10px 15px;margin-bottom:-1px;background-color:#fff;border:1px solid #ddd}.list-group-item:first-child{border-top-left-radius:4px;border-top-right-radius:4px}.list-group-item:last-child{margin-bottom:0;border-bottom-right-radius:4px;border-bottom-left-radius:4px}a.list-group-item,button.list-group-item{color:#555}a.list-group-item .list-group-item-heading,button.list-group-item .list-group-item-heading{color:#333}a.list-group-item:focus,a.list-group-item:hover,button.list-group-item:focus,button.list-group-item:hover{color:#555;text-decoration:none;background-color:#f5f5f5}button.list-group-item{width:100%;text-align:left}.list-group-item.disabled,.list-group-item.disabled:focus,.list-group-item.disabled:hover{color:#777;cursor:not-allowed;background-color:#eee}.list-group-item.disabled .list-group-item-heading,.list-group-item.disabled:focus .list-group-item-heading,.list-group-item.disabled:hover .list-group-item-heading{color:inherit}.list-group-item.disabled .list-group-item-text,.list-group-item.disabled:focus .list-group-item-text,.list-group-item.disabled:hover .list-group-item-text{color:#777}.list-group-item.active,.list-group-item.active:focus,.list-group-item.active:hover{z-index:2;color:#fff;background-color:#337ab7;border-color:#337ab7}.list-group-item.active .list-group-item-heading,.list-group-item.active .list-group-item-heading>.small,.list-group-item.active .list-group-item-heading>small,.list-group-item.active:focus .list-group-item-heading,.list-group-item.active:focus .list-group-item-heading>.small,.list-group-item.active:focus .list-group-item-heading>small,.list-group-item.active:hover .list-group-item-heading,.list-group-item.active:hover .list-group-item-heading>.small,.list-group-item.active:hover .list-group-item-heading>small{color:inherit}.list-group-item.active .list-group-item-text,.list-group-item.active:focus .list-group-item-text,.list-group-item.active:hover .list-group-item-text{color:#c7ddef}.list-group-item-success{color:#3c763d;background-color:#dff0d8}a.list-group-item-success,button.list-group-item-success{color:#3c763d}a.list-group-item-success .list-group-item-heading,button.list-group-item-success .list-group-item-heading{color:inherit}a.list-group-item-success:focus,a.list-group-item-success:hover,button.list-group-item-success:focus,button.list-group-item-success:hover{color:#3c763d;background-color:#d0e9c6}a.list-group-item-success.active,a.list-group-item-success.active:focus,a.list-group-item-success.active:hover,button.list-group-item-success.active,button.list-group-item-success.active:focus,button.list-group-item-success.active:hover{color:#fff;background-color:#3c763d;border-color:#3c763d}.list-group-item-info{color:#31708f;background-color:#d9edf7}a.list-group-item-info,button.list-group-item-info{color:#31708f}a.list-group-item-info .list-group-item-heading,button.list-group-item-info .list-group-item-heading{color:inherit}a.list-group-item-info:focus,a.list-group-item-info:hover,button.list-group-item-info:focus,button.list-group-item-info:hover{color:#31708f;background-color:#c4e3f3}a.list-group-item-info.active,a.list-group-item-info.active:focus,a.list-group-item-info.active:hover,button.list-group-item-info.active,button.list-group-item-info.active:focus,button.list-group-item-info.active:hover{color:#fff;background-color:#31708f;border-color:#31708f}.list-group-item-warning{color:#8a6d3b;background-color:#fcf8e3}a.list-group-item-warning,button.list-group-item-warning{color:#8a6d3b}a.list-group-item-warning .list-group-item-heading,button.list-group-item-warning .list-group-item-heading{color:inherit}a.list-group-item-warning:focus,a.list-group-item-warning:hover,button.list-group-item-warning:focus,button.list-group-item-warning:hover{color:#8a6d3b;background-color:#faf2cc}a.list-group-item-warning.active,a.list-group-item-warning.active:focus,a.list-group-item-warning.active:hover,button.list-group-item-warning.active,button.list-group-item-warning.active:focus,button.list-group-item-warning.active:hover{color:#fff;background-color:#8a6d3b;border-color:#8a6d3b}.list-group-item-danger{color:#a94442;background-color:#f2dede}a.list-group-item-danger,button.list-group-item-danger{color:#a94442}a.list-group-item-danger .list-group-item-heading,button.list-group-item-danger .list-group-item-heading{color:inherit}a.list-group-item-danger:focus,a.list-group-item-danger:hover,button.list-group-item-danger:focus,button.list-group-item-danger:hover{color:#a94442;background-color:#ebcccc}a.list-group-item-danger.active,a.list-group-item-danger.active:focus,a.list-group-item-danger.active:hover,button.list-group-item-danger.active,button.list-group-item-danger.active:focus,button.list-group-item-danger.active:hover{color:#fff;background-color:#a94442;border-color:#a94442}.list-group-item-heading{margin-top:0;margin-bottom:5px}.list-group-item-text{margin-bottom:0;line-height:1.3}.panel{margin-bottom:20px;background-color:#fff;border:1px solid transparent;border-radius:4px;-webkit-box-shadow:0 1px 1px rgba(0,0,0,.05);box-shadow:0 1px 1px rgba(0,0,0,.05)}.panel-body{padding:15px}.panel-heading{padding:10px 15px;border-bottom:1px solid transparent;border-top-left-radius:3px;border-top-right-radius:3px}.panel-heading>.dropdown .dropdown-toggle{color:inherit}.panel-title{margin-top:0;margin-bottom:0;font-size:16px;color:inherit}.panel-title>.small,.panel-title>.small>a,.panel-title>a,.panel-title>small,.panel-title>small>a{color:inherit}.panel-footer{padding:10px 15px;background-color:#f5f5f5;border-top:1px solid #ddd;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.list-group,.panel>.panel-collapse>.list-group{margin-bottom:0}.panel>.list-group .list-group-item,.panel>.panel-collapse>.list-group .list-group-item{border-width:1px 0;border-radius:0}.panel>.list-group:first-child .list-group-item:first-child,.panel>.panel-collapse>.list-group:first-child .list-group-item:first-child{border-top:0;border-top-left-radius:3px;border-top-right-radius:3px}.panel>.list-group:last-child .list-group-item:last-child,.panel>.panel-collapse>.list-group:last-child .list-group-item:last-child{border-bottom:0;border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.panel-heading+.panel-collapse>.list-group .list-group-item:first-child{border-top-left-radius:0;border-top-right-radius:0}.panel-heading+.list-group .list-group-item:first-child{border-top-width:0}.list-group+.panel-footer{border-top-width:0}.panel>.panel-collapse>.table,.panel>.table,.panel>.table-responsive>.table{margin-bottom:0}.panel>.panel-collapse>.table caption,.panel>.table caption,.panel>.table-responsive>.table caption{padding-right:15px;padding-left:15px}.panel>.table-responsive:first-child>.table:first-child,.panel>.table:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child,.panel>.table:first-child>thead:first-child>tr:first-child{border-top-left-radius:3px;border-top-right-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:first-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:first-child,.panel>.table:first-child>thead:first-child>tr:first-child td:first-child,.panel>.table:first-child>thead:first-child>tr:first-child th:first-child{border-top-left-radius:3px}.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table-responsive:first-child>.table:first-child>thead:first-child>tr:first-child th:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child td:last-child,.panel>.table:first-child>tbody:first-child>tr:first-child th:last-child,.panel>.table:first-child>thead:first-child>tr:first-child td:last-child,.panel>.table:first-child>thead:first-child>tr:first-child th:last-child{border-top-right-radius:3px}.panel>.table-responsive:last-child>.table:last-child,.panel>.table:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child{border-bottom-right-radius:3px;border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:first-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:first-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:first-child{border-bottom-left-radius:3px}.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table-responsive:last-child>.table:last-child>tfoot:last-child>tr:last-child th:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child td:last-child,.panel>.table:last-child>tbody:last-child>tr:last-child th:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child td:last-child,.panel>.table:last-child>tfoot:last-child>tr:last-child th:last-child{border-bottom-right-radius:3px}.panel>.panel-body+.table,.panel>.panel-body+.table-responsive,.panel>.table+.panel-body,.panel>.table-responsive+.panel-body{border-top:1px solid #ddd}.panel>.table>tbody:first-child>tr:first-child td,.panel>.table>tbody:first-child>tr:first-child th{border-top:0}.panel>.table-bordered,.panel>.table-responsive>.table-bordered{border:0}.panel>.table-bordered>tbody>tr>td:first-child,.panel>.table-bordered>tbody>tr>th:first-child,.panel>.table-bordered>tfoot>tr>td:first-child,.panel>.table-bordered>tfoot>tr>th:first-child,.panel>.table-bordered>thead>tr>td:first-child,.panel>.table-bordered>thead>tr>th:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:first-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:first-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:first-child,.panel>.table-responsive>.table-bordered>thead>tr>td:first-child,.panel>.table-responsive>.table-bordered>thead>tr>th:first-child{border-left:0}.panel>.table-bordered>tbody>tr>td:last-child,.panel>.table-bordered>tbody>tr>th:last-child,.panel>.table-bordered>tfoot>tr>td:last-child,.panel>.table-bordered>tfoot>tr>th:last-child,.panel>.table-bordered>thead>tr>td:last-child,.panel>.table-bordered>thead>tr>th:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>td:last-child,.panel>.table-responsive>.table-bordered>tbody>tr>th:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>td:last-child,.panel>.table-responsive>.table-bordered>tfoot>tr>th:last-child,.panel>.table-responsive>.table-bordered>thead>tr>td:last-child,.panel>.table-responsive>.table-bordered>thead>tr>th:last-child{border-right:0}.panel>.table-bordered>tbody>tr:first-child>td,.panel>.table-bordered>tbody>tr:first-child>th,.panel>.table-bordered>thead>tr:first-child>td,.panel>.table-bordered>thead>tr:first-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:first-child>th,.panel>.table-responsive>.table-bordered>thead>tr:first-child>td,.panel>.table-responsive>.table-bordered>thead>tr:first-child>th{border-bottom:0}.panel>.table-bordered>tbody>tr:last-child>td,.panel>.table-bordered>tbody>tr:last-child>th,.panel>.table-bordered>tfoot>tr:last-child>td,.panel>.table-bordered>tfoot>tr:last-child>th,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>td,.panel>.table-responsive>.table-bordered>tbody>tr:last-child>th,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>td,.panel>.table-responsive>.table-bordered>tfoot>tr:last-child>th{border-bottom:0}.panel>.table-responsive{margin-bottom:0;border:0}.panel-group{margin-bottom:20px}.panel-group .panel{margin-bottom:0;border-radius:4px}.panel-group .panel+.panel{margin-top:5px}.panel-group .panel-heading{border-bottom:0}.panel-group .panel-heading+.panel-collapse>.list-group,.panel-group .panel-heading+.panel-collapse>.panel-body{border-top:1px solid #ddd}.panel-group .panel-footer{border-top:0}.panel-group .panel-footer+.panel-collapse .panel-body{border-bottom:1px solid #ddd}.panel-default{border-color:#ddd}.panel-default>.panel-heading{color:#333;background-color:#f5f5f5;border-color:#ddd}.panel-default>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ddd}.panel-default>.panel-heading .badge{color:#f5f5f5;background-color:#333}.panel-default>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ddd}.panel-primary{border-color:#337ab7}.panel-primary>.panel-heading{color:#fff;background-color:#337ab7;border-color:#337ab7}.panel-primary>.panel-heading+.panel-collapse>.panel-body{border-top-color:#337ab7}.panel-primary>.panel-heading .badge{color:#337ab7;background-color:#fff}.panel-primary>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#337ab7}.panel-success{border-color:#d6e9c6}.panel-success>.panel-heading{color:#3c763d;background-color:#dff0d8;border-color:#d6e9c6}.panel-success>.panel-heading+.panel-collapse>.panel-body{border-top-color:#d6e9c6}.panel-success>.panel-heading .badge{color:#dff0d8;background-color:#3c763d}.panel-success>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#d6e9c6}.panel-info{border-color:#bce8f1}.panel-info>.panel-heading{color:#31708f;background-color:#d9edf7;border-color:#bce8f1}.panel-info>.panel-heading+.panel-collapse>.panel-body{border-top-color:#bce8f1}.panel-info>.panel-heading .badge{color:#d9edf7;background-color:#31708f}.panel-info>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#bce8f1}.panel-warning{border-color:#faebcc}.panel-warning>.panel-heading{color:#8a6d3b;background-color:#fcf8e3;border-color:#faebcc}.panel-warning>.panel-heading+.panel-collapse>.panel-body{border-top-color:#faebcc}.panel-warning>.panel-heading .badge{color:#fcf8e3;background-color:#8a6d3b}.panel-warning>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#faebcc}.panel-danger{border-color:#ebccd1}.panel-danger>.panel-heading{color:#a94442;background-color:#f2dede;border-color:#ebccd1}.panel-danger>.panel-heading+.panel-collapse>.panel-body{border-top-color:#ebccd1}.panel-danger>.panel-heading .badge{color:#f2dede;background-color:#a94442}.panel-danger>.panel-footer+.panel-collapse>.panel-body{border-bottom-color:#ebccd1}.embed-responsive{position:relative;display:block;height:0;padding:0;overflow:hidden}.embed-responsive .embed-responsive-item,.embed-responsive embed,.embed-responsive iframe,.embed-responsive object,.embed-responsive video{position:absolute;top:0;bottom:0;left:0;width:100%;height:100%;border:0}.embed-responsive-16by9{padding-bottom:56.25%}.embed-responsive-4by3{padding-bottom:75%}.well{min-height:20px;padding:19px;margin-bottom:20px;background-color:#f5f5f5;border:1px solid #e3e3e3;border-radius:4px;-webkit-box-shadow:inset 0 1px 1px rgba(0,0,0,.05);box-shadow:inset 0 1px 1px rgba(0,0,0,.05)}.well blockquote{border-color:#ddd;border-color:rgba(0,0,0,.15)}.well-lg{padding:24px;border-radius:6px}.well-sm{padding:9px;border-radius:3px}.close{float:right;font-size:21px;font-weight:700;line-height:1;color:#000;text-shadow:0 1px 0 #fff;filter:alpha(opacity=20);opacity:.2}.close:focus,.close:hover{color:#000;text-decoration:none;cursor:pointer;filter:alpha(opacity=50);opacity:.5}button.close{-webkit-appearance:none;padding:0;cursor:pointer;background:0 0;border:0}.modal-open{overflow:hidden}.modal{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1050;display:none;overflow:hidden;-webkit-overflow-scrolling:touch;outline:0}.modal.fade .modal-dialog{-webkit-transition:-webkit-transform .3s ease-out;-o-transition:-o-transform .3s ease-out;transition:transform .3s ease-out;-webkit-transform:translate(0,-25%);-ms-transform:translate(0,-25%);-o-transform:translate(0,-25%);transform:translate(0,-25%)}.modal.in .modal-dialog{-webkit-transform:translate(0,0);-ms-transform:translate(0,0);-o-transform:translate(0,0);transform:translate(0,0)}.modal-open .modal{overflow-x:hidden;overflow-y:auto}.modal-dialog{position:relative;width:auto;margin:10px}.modal-content{position:relative;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #999;border:1px solid rgba(0,0,0,.2);border-radius:6px;outline:0;-webkit-box-shadow:0 3px 9px rgba(0,0,0,.5);box-shadow:0 3px 9px rgba(0,0,0,.5)}.modal-backdrop{position:fixed;top:0;right:0;bottom:0;left:0;z-index:1040;background-color:#000}.modal-backdrop.fade{filter:alpha(opacity=0);opacity:0}.modal-backdrop.in{filter:alpha(opacity=50);opacity:.5}.modal-header{min-height:16.43px;padding:15px;border-bottom:1px solid #e5e5e5}.modal-header .close{margin-top:-2px}.modal-title{margin:0;line-height:1.42857143}.modal-body{position:relative;padding:15px}.modal-footer{padding:15px;text-align:right;border-top:1px solid #e5e5e5}.modal-footer .btn+.btn{margin-bottom:0;margin-left:5px}.modal-footer .btn-group .btn+.btn{margin-left:-1px}.modal-footer .btn-block+.btn-block{margin-left:0}.modal-scrollbar-measure{position:absolute;top:-9999px;width:50px;height:50px;overflow:scroll}@media (min-width:768px){.modal-dialog{width:600px;margin:30px auto}.modal-content{-webkit-box-shadow:0 5px 15px rgba(0,0,0,.5);box-shadow:0 5px 15px rgba(0,0,0,.5)}.modal-sm{width:300px}}@media (min-width:992px){.modal-lg{width:900px}}.tooltip{position:absolute;z-index:1070;display:block;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:12px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;filter:alpha(opacity=0);opacity:0;line-break:auto}.tooltip.in{filter:alpha(opacity=90);opacity:.9}.tooltip.top{padding:5px 0;margin-top:-3px}.tooltip.right{padding:0 5px;margin-left:3px}.tooltip.bottom{padding:5px 0;margin-top:3px}.tooltip.left{padding:0 5px;margin-left:-3px}.tooltip-inner{max-width:200px;padding:3px 8px;color:#fff;text-align:center;background-color:#000;border-radius:4px}.tooltip-arrow{position:absolute;width:0;height:0;border-color:transparent;border-style:solid}.tooltip.top .tooltip-arrow{bottom:0;left:50%;margin-left:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-left .tooltip-arrow{right:5px;bottom:0;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.top-right .tooltip-arrow{bottom:0;left:5px;margin-bottom:-5px;border-width:5px 5px 0;border-top-color:#000}.tooltip.right .tooltip-arrow{top:50%;left:0;margin-top:-5px;border-width:5px 5px 5px 0;border-right-color:#000}.tooltip.left .tooltip-arrow{top:50%;right:0;margin-top:-5px;border-width:5px 0 5px 5px;border-left-color:#000}.tooltip.bottom .tooltip-arrow{top:0;left:50%;margin-left:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-left .tooltip-arrow{top:0;right:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.tooltip.bottom-right .tooltip-arrow{top:0;left:5px;margin-top:-5px;border-width:0 5px 5px;border-bottom-color:#000}.popover{position:absolute;top:0;left:0;z-index:1060;display:none;max-width:276px;padding:1px;font-family:"Helvetica Neue",Helvetica,Arial,sans-serif;font-size:14px;font-style:normal;font-weight:400;line-height:1.42857143;text-align:left;text-align:start;text-decoration:none;text-shadow:none;text-transform:none;letter-spacing:normal;word-break:normal;word-spacing:normal;word-wrap:normal;white-space:normal;background-color:#fff;-webkit-background-clip:padding-box;background-clip:padding-box;border:1px solid #ccc;border:1px solid rgba(0,0,0,.2);border-radius:6px;-webkit-box-shadow:0 5px 10px rgba(0,0,0,.2);box-shadow:0 5px 10px rgba(0,0,0,.2);line-break:auto}.popover.top{margin-top:-10px}.popover.right{margin-left:10px}.popover.bottom{margin-top:10px}.popover.left{margin-left:-10px}.popover-title{padding:8px 14px;margin:0;font-size:14px;background-color:#f7f7f7;border-bottom:1px solid #ebebeb;border-radius:5px 5px 0 0}.popover-content{padding:9px 14px}.popover>.arrow,.popover>.arrow:after{position:absolute;display:block;width:0;height:0;border-color:transparent;border-style:solid}.popover>.arrow{border-width:11px}.popover>.arrow:after{content:"";border-width:10px}.popover.top>.arrow{bottom:-11px;left:50%;margin-left:-11px;border-top-color:#999;border-top-color:rgba(0,0,0,.25);border-bottom-width:0}.popover.top>.arrow:after{bottom:1px;margin-left:-10px;content:" ";border-top-color:#fff;border-bottom-width:0}.popover.right>.arrow{top:50%;left:-11px;margin-top:-11px;border-right-color:#999;border-right-color:rgba(0,0,0,.25);border-left-width:0}.popover.right>.arrow:after{bottom:-10px;left:1px;content:" ";border-right-color:#fff;border-left-width:0}.popover.bottom>.arrow{top:-11px;left:50%;margin-left:-11px;border-top-width:0;border-bottom-color:#999;border-bottom-color:rgba(0,0,0,.25)}.popover.bottom>.arrow:after{top:1px;margin-left:-10px;content:" ";border-top-width:0;border-bottom-color:#fff}.popover.left>.arrow{top:50%;right:-11px;margin-top:-11px;border-right-width:0;border-left-color:#999;border-left-color:rgba(0,0,0,.25)}.popover.left>.arrow:after{right:1px;bottom:-10px;content:" ";border-right-width:0;border-left-color:#fff}.carousel{position:relative}.carousel-inner{position:relative;width:100%;overflow:hidden}.carousel-inner>.item{position:relative;display:none;-webkit-transition:.6s ease-in-out left;-o-transition:.6s ease-in-out left;transition:.6s ease-in-out left}.carousel-inner>.item>a>img,.carousel-inner>.item>img{line-height:1}@media all and (transform-3d),(-webkit-transform-3d){.carousel-inner>.item{-webkit-transition:-webkit-transform .6s ease-in-out;-o-transition:-o-transform .6s ease-in-out;transition:transform .6s ease-in-out;-webkit-backface-visibility:hidden;backface-visibility:hidden;-webkit-perspective:1000px;perspective:1000px}.carousel-inner>.item.active.right,.carousel-inner>.item.next{left:0;-webkit-transform:translate3d(100%,0,0);transform:translate3d(100%,0,0)}.carousel-inner>.item.active.left,.carousel-inner>.item.prev{left:0;-webkit-transform:translate3d(-100%,0,0);transform:translate3d(-100%,0,0)}.carousel-inner>.item.active,.carousel-inner>.item.next.left,.carousel-inner>.item.prev.right{left:0;-webkit-transform:translate3d(0,0,0);transform:translate3d(0,0,0)}}.carousel-inner>.active,.carousel-inner>.next,.carousel-inner>.prev{display:block}.carousel-inner>.active{left:0}.carousel-inner>.next,.carousel-inner>.prev{position:absolute;top:0;width:100%}.carousel-inner>.next{left:100%}.carousel-inner>.prev{left:-100%}.carousel-inner>.next.left,.carousel-inner>.prev.right{left:0}.carousel-inner>.active.left{left:-100%}.carousel-inner>.active.right{left:100%}.carousel-control{position:absolute;top:0;bottom:0;left:0;width:15%;font-size:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6);filter:alpha(opacity=50);opacity:.5}.carousel-control.left{background-image:-webkit-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.5)),to(rgba(0,0,0,.0001)));background-image:linear-gradient(to right,rgba(0,0,0,.5) 0,rgba(0,0,0,.0001) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#80000000', endColorstr='#00000000', GradientType=1);background-repeat:repeat-x}.carousel-control.right{right:0;left:auto;background-image:-webkit-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-o-linear-gradient(left,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);background-image:-webkit-gradient(linear,left top,right top,from(rgba(0,0,0,.0001)),to(rgba(0,0,0,.5)));background-image:linear-gradient(to right,rgba(0,0,0,.0001) 0,rgba(0,0,0,.5) 100%);filter:progid:DXImageTransform.Microsoft.gradient(startColorstr='#00000000', endColorstr='#80000000', GradientType=1);background-repeat:repeat-x}.carousel-control:focus,.carousel-control:hover{color:#fff;text-decoration:none;filter:alpha(opacity=90);outline:0;opacity:.9}.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{position:absolute;top:50%;z-index:5;display:inline-block;margin-top:-10px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{left:50%;margin-left:-10px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{right:50%;margin-right:-10px}.carousel-control .icon-next,.carousel-control .icon-prev{width:20px;height:20px;font-family:serif;line-height:1}.carousel-control .icon-prev:before{content:'\2039'}.carousel-control .icon-next:before{content:'\203a'}.carousel-indicators{position:absolute;bottom:10px;left:50%;z-index:15;width:60%;padding-left:0;margin-left:-30%;text-align:center;list-style:none}.carousel-indicators li{display:inline-block;width:10px;height:10px;margin:1px;text-indent:-999px;cursor:pointer;background-color:#000\9;background-color:rgba(0,0,0,0);border:1px solid #fff;border-radius:10px}.carousel-indicators .active{width:12px;height:12px;margin:0;background-color:#fff}.carousel-caption{position:absolute;right:15%;bottom:20px;left:15%;z-index:10;padding-top:20px;padding-bottom:20px;color:#fff;text-align:center;text-shadow:0 1px 2px rgba(0,0,0,.6)}.carousel-caption .btn{text-shadow:none}@media screen and (min-width:768px){.carousel-control .glyphicon-chevron-left,.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next,.carousel-control .icon-prev{width:30px;height:30px;margin-top:-15px;font-size:30px}.carousel-control .glyphicon-chevron-left,.carousel-control .icon-prev{margin-left:-15px}.carousel-control .glyphicon-chevron-right,.carousel-control .icon-next{margin-right:-15px}.carousel-caption{right:20%;left:20%;padding-bottom:30px}.carousel-indicators{bottom:20px}}.btn-group-vertical>.btn-group:after,.btn-group-vertical>.btn-group:before,.btn-toolbar:after,.btn-toolbar:before,.clearfix:after,.clearfix:before,.container-fluid:after,.container-fluid:before,.container:after,.container:before,.dl-horizontal dd:after,.dl-horizontal dd:before,.form-horizontal .form-group:after,.form-horizontal .form-group:before,.modal-footer:after,.modal-footer:before,.nav:after,.nav:before,.navbar-collapse:after,.navbar-collapse:before,.navbar-header:after,.navbar-header:before,.navbar:after,.navbar:before,.pager:after,.pager:before,.panel-body:after,.panel-body:before,.row:after,.row:before{display:table;content:" "}.btn-group-vertical>.btn-group:after,.btn-toolbar:after,.clearfix:after,.container-fluid:after,.container:after,.dl-horizontal dd:after,.form-horizontal .form-group:after,.modal-footer:after,.nav:after,.navbar-collapse:after,.navbar-header:after,.navbar:after,.pager:after,.panel-body:after,.row:after{clear:both}.center-block{display:block;margin-right:auto;margin-left:auto}.pull-right{float:right!important}.pull-left{float:left!important}.hide{display:none!important}.show{display:block!important}.invisible{visibility:hidden}.text-hide{font:0/0 a;color:transparent;text-shadow:none;background-color:transparent;border:0}.hidden{display:none!important}.affix{position:fixed}@-ms-viewport{width:device-width}.visible-lg,.visible-md,.visible-sm,.visible-xs{display:none!important}.visible-lg-block,.visible-lg-inline,.visible-lg-inline-block,.visible-md-block,.visible-md-inline,.visible-md-inline-block,.visible-sm-block,.visible-sm-inline,.visible-sm-inline-block,.visible-xs-block,.visible-xs-inline,.visible-xs-inline-block{display:none!important}@media (max-width:767px){.visible-xs{display:block!important}table.visible-xs{display:table!important}tr.visible-xs{display:table-row!important}td.visible-xs,th.visible-xs{display:table-cell!important}}@media (max-width:767px){.visible-xs-block{display:block!important}}@media (max-width:767px){.visible-xs-inline{display:inline!important}}@media (max-width:767px){.visible-xs-inline-block{display:inline-block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm{display:block!important}table.visible-sm{display:table!important}tr.visible-sm{display:table-row!important}td.visible-sm,th.visible-sm{display:table-cell!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-block{display:block!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline{display:inline!important}}@media (min-width:768px) and (max-width:991px){.visible-sm-inline-block{display:inline-block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md{display:block!important}table.visible-md{display:table!important}tr.visible-md{display:table-row!important}td.visible-md,th.visible-md{display:table-cell!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-block{display:block!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline{display:inline!important}}@media (min-width:992px) and (max-width:1199px){.visible-md-inline-block{display:inline-block!important}}@media (min-width:1200px){.visible-lg{display:block!important}table.visible-lg{display:table!important}tr.visible-lg{display:table-row!important}td.visible-lg,th.visible-lg{display:table-cell!important}}@media (min-width:1200px){.visible-lg-block{display:block!important}}@media (min-width:1200px){.visible-lg-inline{display:inline!important}}@media (min-width:1200px){.visible-lg-inline-block{display:inline-block!important}}@media (max-width:767px){.hidden-xs{display:none!important}}@media (min-width:768px) and (max-width:991px){.hidden-sm{display:none!important}}@media (min-width:992px) and (max-width:1199px){.hidden-md{display:none!important}}@media (min-width:1200px){.hidden-lg{display:none!important}}.visible-print{display:none!important}@media print{.visible-print{display:block!important}table.visible-print{display:table!important}tr.visible-print{display:table-row!important}td.visible-print,th.visible-print{display:table-cell!important}}.visible-print-block{display:none!important}@media print{.visible-print-block{display:block!important}}.visible-print-inline{display:none!important}@media print{.visible-print-inline{display:inline!important}}.visible-print-inline-block{display:none!important}@media print{.visible-print-inline-block{display:inline-block!important}}@media print{.hidden-print{display:none!important}}
</style>
<script>/*!
 * Bootstrap v3.3.5 (http://getbootstrap.com)
 * Copyright 2011-2015 Twitter, Inc.
 * Licensed under the MIT license
 */
if("undefined"==typeof jQuery)throw new Error("Bootstrap's JavaScript requires jQuery");+function(a){"use strict";var b=a.fn.jquery.split(" ")[0].split(".");if(b[0]<2&&b[1]<9||1==b[0]&&9==b[1]&&b[2]<1)throw new Error("Bootstrap's JavaScript requires jQuery version 1.9.1 or higher")}(jQuery),+function(a){"use strict";function b(){var a=document.createElement("bootstrap"),b={WebkitTransition:"webkitTransitionEnd",MozTransition:"transitionend",OTransition:"oTransitionEnd otransitionend",transition:"transitionend"};for(var c in b)if(void 0!==a.style[c])return{end:b[c]};return!1}a.fn.emulateTransitionEnd=function(b){var c=!1,d=this;a(this).one("bsTransitionEnd",function(){c=!0});var e=function(){c||a(d).trigger(a.support.transition.end)};return setTimeout(e,b),this},a(function(){a.support.transition=b(),a.support.transition&&(a.event.special.bsTransitionEnd={bindType:a.support.transition.end,delegateType:a.support.transition.end,handle:function(b){return a(b.target).is(this)?b.handleObj.handler.apply(this,arguments):void 0}})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var c=a(this),e=c.data("bs.alert");e||c.data("bs.alert",e=new d(this)),"string"==typeof b&&e[b].call(c)})}var c='[data-dismiss="alert"]',d=function(b){a(b).on("click",c,this.close)};d.VERSION="3.3.5",d.TRANSITION_DURATION=150,d.prototype.close=function(b){function c(){g.detach().trigger("closed.bs.alert").remove()}var e=a(this),f=e.attr("data-target");f||(f=e.attr("href"),f=f&&f.replace(/.*(?=#[^\s]*$)/,""));var g=a(f);b&&b.preventDefault(),g.length||(g=e.closest(".alert")),g.trigger(b=a.Event("close.bs.alert")),b.isDefaultPrevented()||(g.removeClass("in"),a.support.transition&&g.hasClass("fade")?g.one("bsTransitionEnd",c).emulateTransitionEnd(d.TRANSITION_DURATION):c())};var e=a.fn.alert;a.fn.alert=b,a.fn.alert.Constructor=d,a.fn.alert.noConflict=function(){return a.fn.alert=e,this},a(document).on("click.bs.alert.data-api",c,d.prototype.close)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.button"),f="object"==typeof b&&b;e||d.data("bs.button",e=new c(this,f)),"toggle"==b?e.toggle():b&&e.setState(b)})}var c=function(b,d){this.$element=a(b),this.options=a.extend({},c.DEFAULTS,d),this.isLoading=!1};c.VERSION="3.3.5",c.DEFAULTS={loadingText:"loading..."},c.prototype.setState=function(b){var c="disabled",d=this.$element,e=d.is("input")?"val":"html",f=d.data();b+="Text",null==f.resetText&&d.data("resetText",d[e]()),setTimeout(a.proxy(function(){d[e](null==f[b]?this.options[b]:f[b]),"loadingText"==b?(this.isLoading=!0,d.addClass(c).attr(c,c)):this.isLoading&&(this.isLoading=!1,d.removeClass(c).removeAttr(c))},this),0)},c.prototype.toggle=function(){var a=!0,b=this.$element.closest('[data-toggle="buttons"]');if(b.length){var c=this.$element.find("input");"radio"==c.prop("type")?(c.prop("checked")&&(a=!1),b.find(".active").removeClass("active"),this.$element.addClass("active")):"checkbox"==c.prop("type")&&(c.prop("checked")!==this.$element.hasClass("active")&&(a=!1),this.$element.toggleClass("active")),c.prop("checked",this.$element.hasClass("active")),a&&c.trigger("change")}else this.$element.attr("aria-pressed",!this.$element.hasClass("active")),this.$element.toggleClass("active")};var d=a.fn.button;a.fn.button=b,a.fn.button.Constructor=c,a.fn.button.noConflict=function(){return a.fn.button=d,this},a(document).on("click.bs.button.data-api",'[data-toggle^="button"]',function(c){var d=a(c.target);d.hasClass("btn")||(d=d.closest(".btn")),b.call(d,"toggle"),a(c.target).is('input[type="radio"]')||a(c.target).is('input[type="checkbox"]')||c.preventDefault()}).on("focus.bs.button.data-api blur.bs.button.data-api",'[data-toggle^="button"]',function(b){a(b.target).closest(".btn").toggleClass("focus",/^focus(in)?$/.test(b.type))})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.carousel"),f=a.extend({},c.DEFAULTS,d.data(),"object"==typeof b&&b),g="string"==typeof b?b:f.slide;e||d.data("bs.carousel",e=new c(this,f)),"number"==typeof b?e.to(b):g?e[g]():f.interval&&e.pause().cycle()})}var c=function(b,c){this.$element=a(b),this.$indicators=this.$element.find(".carousel-indicators"),this.options=c,this.paused=null,this.sliding=null,this.interval=null,this.$active=null,this.$items=null,this.options.keyboard&&this.$element.on("keydown.bs.carousel",a.proxy(this.keydown,this)),"hover"==this.options.pause&&!("ontouchstart"in document.documentElement)&&this.$element.on("mouseenter.bs.carousel",a.proxy(this.pause,this)).on("mouseleave.bs.carousel",a.proxy(this.cycle,this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=600,c.DEFAULTS={interval:5e3,pause:"hover",wrap:!0,keyboard:!0},c.prototype.keydown=function(a){if(!/input|textarea/i.test(a.target.tagName)){switch(a.which){case 37:this.prev();break;case 39:this.next();break;default:return}a.preventDefault()}},c.prototype.cycle=function(b){return b||(this.paused=!1),this.interval&&clearInterval(this.interval),this.options.interval&&!this.paused&&(this.interval=setInterval(a.proxy(this.next,this),this.options.interval)),this},c.prototype.getItemIndex=function(a){return this.$items=a.parent().children(".item"),this.$items.index(a||this.$active)},c.prototype.getItemForDirection=function(a,b){var c=this.getItemIndex(b),d="prev"==a&&0===c||"next"==a&&c==this.$items.length-1;if(d&&!this.options.wrap)return b;var e="prev"==a?-1:1,f=(c+e)%this.$items.length;return this.$items.eq(f)},c.prototype.to=function(a){var b=this,c=this.getItemIndex(this.$active=this.$element.find(".item.active"));return a>this.$items.length-1||0>a?void 0:this.sliding?this.$element.one("slid.bs.carousel",function(){b.to(a)}):c==a?this.pause().cycle():this.slide(a>c?"next":"prev",this.$items.eq(a))},c.prototype.pause=function(b){return b||(this.paused=!0),this.$element.find(".next, .prev").length&&a.support.transition&&(this.$element.trigger(a.support.transition.end),this.cycle(!0)),this.interval=clearInterval(this.interval),this},c.prototype.next=function(){return this.sliding?void 0:this.slide("next")},c.prototype.prev=function(){return this.sliding?void 0:this.slide("prev")},c.prototype.slide=function(b,d){var e=this.$element.find(".item.active"),f=d||this.getItemForDirection(b,e),g=this.interval,h="next"==b?"left":"right",i=this;if(f.hasClass("active"))return this.sliding=!1;var j=f[0],k=a.Event("slide.bs.carousel",{relatedTarget:j,direction:h});if(this.$element.trigger(k),!k.isDefaultPrevented()){if(this.sliding=!0,g&&this.pause(),this.$indicators.length){this.$indicators.find(".active").removeClass("active");var l=a(this.$indicators.children()[this.getItemIndex(f)]);l&&l.addClass("active")}var m=a.Event("slid.bs.carousel",{relatedTarget:j,direction:h});return a.support.transition&&this.$element.hasClass("slide")?(f.addClass(b),f[0].offsetWidth,e.addClass(h),f.addClass(h),e.one("bsTransitionEnd",function(){f.removeClass([b,h].join(" ")).addClass("active"),e.removeClass(["active",h].join(" ")),i.sliding=!1,setTimeout(function(){i.$element.trigger(m)},0)}).emulateTransitionEnd(c.TRANSITION_DURATION)):(e.removeClass("active"),f.addClass("active"),this.sliding=!1,this.$element.trigger(m)),g&&this.cycle(),this}};var d=a.fn.carousel;a.fn.carousel=b,a.fn.carousel.Constructor=c,a.fn.carousel.noConflict=function(){return a.fn.carousel=d,this};var e=function(c){var d,e=a(this),f=a(e.attr("data-target")||(d=e.attr("href"))&&d.replace(/.*(?=#[^\s]+$)/,""));if(f.hasClass("carousel")){var g=a.extend({},f.data(),e.data()),h=e.attr("data-slide-to");h&&(g.interval=!1),b.call(f,g),h&&f.data("bs.carousel").to(h),c.preventDefault()}};a(document).on("click.bs.carousel.data-api","[data-slide]",e).on("click.bs.carousel.data-api","[data-slide-to]",e),a(window).on("load",function(){a('[data-ride="carousel"]').each(function(){var c=a(this);b.call(c,c.data())})})}(jQuery),+function(a){"use strict";function b(b){var c,d=b.attr("data-target")||(c=b.attr("href"))&&c.replace(/.*(?=#[^\s]+$)/,"");return a(d)}function c(b){return this.each(function(){var c=a(this),e=c.data("bs.collapse"),f=a.extend({},d.DEFAULTS,c.data(),"object"==typeof b&&b);!e&&f.toggle&&/show|hide/.test(b)&&(f.toggle=!1),e||c.data("bs.collapse",e=new d(this,f)),"string"==typeof b&&e[b]()})}var d=function(b,c){this.$element=a(b),this.options=a.extend({},d.DEFAULTS,c),this.$trigger=a('[data-toggle="collapse"][href="#'+b.id+'"],[data-toggle="collapse"][data-target="#'+b.id+'"]'),this.transitioning=null,this.options.parent?this.$parent=this.getParent():this.addAriaAndCollapsedClass(this.$element,this.$trigger),this.options.toggle&&this.toggle()};d.VERSION="3.3.5",d.TRANSITION_DURATION=350,d.DEFAULTS={toggle:!0},d.prototype.dimension=function(){var a=this.$element.hasClass("width");return a?"width":"height"},d.prototype.show=function(){if(!this.transitioning&&!this.$element.hasClass("in")){var b,e=this.$parent&&this.$parent.children(".panel").children(".in, .collapsing");if(!(e&&e.length&&(b=e.data("bs.collapse"),b&&b.transitioning))){var f=a.Event("show.bs.collapse");if(this.$element.trigger(f),!f.isDefaultPrevented()){e&&e.length&&(c.call(e,"hide"),b||e.data("bs.collapse",null));var g=this.dimension();this.$element.removeClass("collapse").addClass("collapsing")[g](0).attr("aria-expanded",!0),this.$trigger.removeClass("collapsed").attr("aria-expanded",!0),this.transitioning=1;var h=function(){this.$element.removeClass("collapsing").addClass("collapse in")[g](""),this.transitioning=0,this.$element.trigger("shown.bs.collapse")};if(!a.support.transition)return h.call(this);var i=a.camelCase(["scroll",g].join("-"));this.$element.one("bsTransitionEnd",a.proxy(h,this)).emulateTransitionEnd(d.TRANSITION_DURATION)[g](this.$element[0][i])}}}},d.prototype.hide=function(){if(!this.transitioning&&this.$element.hasClass("in")){var b=a.Event("hide.bs.collapse");if(this.$element.trigger(b),!b.isDefaultPrevented()){var c=this.dimension();this.$element[c](this.$element[c]())[0].offsetHeight,this.$element.addClass("collapsing").removeClass("collapse in").attr("aria-expanded",!1),this.$trigger.addClass("collapsed").attr("aria-expanded",!1),this.transitioning=1;var e=function(){this.transitioning=0,this.$element.removeClass("collapsing").addClass("collapse").trigger("hidden.bs.collapse")};return a.support.transition?void this.$element[c](0).one("bsTransitionEnd",a.proxy(e,this)).emulateTransitionEnd(d.TRANSITION_DURATION):e.call(this)}}},d.prototype.toggle=function(){this[this.$element.hasClass("in")?"hide":"show"]()},d.prototype.getParent=function(){return a(this.options.parent).find('[data-toggle="collapse"][data-parent="'+this.options.parent+'"]').each(a.proxy(function(c,d){var e=a(d);this.addAriaAndCollapsedClass(b(e),e)},this)).end()},d.prototype.addAriaAndCollapsedClass=function(a,b){var c=a.hasClass("in");a.attr("aria-expanded",c),b.toggleClass("collapsed",!c).attr("aria-expanded",c)};var e=a.fn.collapse;a.fn.collapse=c,a.fn.collapse.Constructor=d,a.fn.collapse.noConflict=function(){return a.fn.collapse=e,this},a(document).on("click.bs.collapse.data-api",'[data-toggle="collapse"]',function(d){var e=a(this);e.attr("data-target")||d.preventDefault();var f=b(e),g=f.data("bs.collapse"),h=g?"toggle":e.data();c.call(f,h)})}(jQuery),+function(a){"use strict";function b(b){var c=b.attr("data-target");c||(c=b.attr("href"),c=c&&/#[A-Za-z]/.test(c)&&c.replace(/.*(?=#[^\s]*$)/,""));var d=c&&a(c);return d&&d.length?d:b.parent()}function c(c){c&&3===c.which||(a(e).remove(),a(f).each(function(){var d=a(this),e=b(d),f={relatedTarget:this};e.hasClass("open")&&(c&&"click"==c.type&&/input|textarea/i.test(c.target.tagName)&&a.contains(e[0],c.target)||(e.trigger(c=a.Event("hide.bs.dropdown",f)),c.isDefaultPrevented()||(d.attr("aria-expanded","false"),e.removeClass("open").trigger("hidden.bs.dropdown",f))))}))}function d(b){return this.each(function(){var c=a(this),d=c.data("bs.dropdown");d||c.data("bs.dropdown",d=new g(this)),"string"==typeof b&&d[b].call(c)})}var e=".dropdown-backdrop",f='[data-toggle="dropdown"]',g=function(b){a(b).on("click.bs.dropdown",this.toggle)};g.VERSION="3.3.5",g.prototype.toggle=function(d){var e=a(this);if(!e.is(".disabled, :disabled")){var f=b(e),g=f.hasClass("open");if(c(),!g){"ontouchstart"in document.documentElement&&!f.closest(".navbar-nav").length&&a(document.createElement("div")).addClass("dropdown-backdrop").insertAfter(a(this)).on("click",c);var h={relatedTarget:this};if(f.trigger(d=a.Event("show.bs.dropdown",h)),d.isDefaultPrevented())return;e.trigger("focus").attr("aria-expanded","true"),f.toggleClass("open").trigger("shown.bs.dropdown",h)}return!1}},g.prototype.keydown=function(c){if(/(38|40|27|32)/.test(c.which)&&!/input|textarea/i.test(c.target.tagName)){var d=a(this);if(c.preventDefault(),c.stopPropagation(),!d.is(".disabled, :disabled")){var e=b(d),g=e.hasClass("open");if(!g&&27!=c.which||g&&27==c.which)return 27==c.which&&e.find(f).trigger("focus"),d.trigger("click");var h=" li:not(.disabled):visible a",i=e.find(".dropdown-menu"+h);if(i.length){var j=i.index(c.target);38==c.which&&j>0&&j--,40==c.which&&j<i.length-1&&j++,~j||(j=0),i.eq(j).trigger("focus")}}}};var h=a.fn.dropdown;a.fn.dropdown=d,a.fn.dropdown.Constructor=g,a.fn.dropdown.noConflict=function(){return a.fn.dropdown=h,this},a(document).on("click.bs.dropdown.data-api",c).on("click.bs.dropdown.data-api",".dropdown form",function(a){a.stopPropagation()}).on("click.bs.dropdown.data-api",f,g.prototype.toggle).on("keydown.bs.dropdown.data-api",f,g.prototype.keydown).on("keydown.bs.dropdown.data-api",".dropdown-menu",g.prototype.keydown)}(jQuery),+function(a){"use strict";function b(b,d){return this.each(function(){var e=a(this),f=e.data("bs.modal"),g=a.extend({},c.DEFAULTS,e.data(),"object"==typeof b&&b);f||e.data("bs.modal",f=new c(this,g)),"string"==typeof b?f[b](d):g.show&&f.show(d)})}var c=function(b,c){this.options=c,this.$body=a(document.body),this.$element=a(b),this.$dialog=this.$element.find(".modal-dialog"),this.$backdrop=null,this.isShown=null,this.originalBodyPad=null,this.scrollbarWidth=0,this.ignoreBackdropClick=!1,this.options.remote&&this.$element.find(".modal-content").load(this.options.remote,a.proxy(function(){this.$element.trigger("loaded.bs.modal")},this))};c.VERSION="3.3.5",c.TRANSITION_DURATION=300,c.BACKDROP_TRANSITION_DURATION=150,c.DEFAULTS={backdrop:!0,keyboard:!0,show:!0},c.prototype.toggle=function(a){return this.isShown?this.hide():this.show(a)},c.prototype.show=function(b){var d=this,e=a.Event("show.bs.modal",{relatedTarget:b});this.$element.trigger(e),this.isShown||e.isDefaultPrevented()||(this.isShown=!0,this.checkScrollbar(),this.setScrollbar(),this.$body.addClass("modal-open"),this.escape(),this.resize(),this.$element.on("click.dismiss.bs.modal",'[data-dismiss="modal"]',a.proxy(this.hide,this)),this.$dialog.on("mousedown.dismiss.bs.modal",function(){d.$element.one("mouseup.dismiss.bs.modal",function(b){a(b.target).is(d.$element)&&(d.ignoreBackdropClick=!0)})}),this.backdrop(function(){var e=a.support.transition&&d.$element.hasClass("fade");d.$element.parent().length||d.$element.appendTo(d.$body),d.$element.show().scrollTop(0),d.adjustDialog(),e&&d.$element[0].offsetWidth,d.$element.addClass("in"),d.enforceFocus();var f=a.Event("shown.bs.modal",{relatedTarget:b});e?d.$dialog.one("bsTransitionEnd",function(){d.$element.trigger("focus").trigger(f)}).emulateTransitionEnd(c.TRANSITION_DURATION):d.$element.trigger("focus").trigger(f)}))},c.prototype.hide=function(b){b&&b.preventDefault(),b=a.Event("hide.bs.modal"),this.$element.trigger(b),this.isShown&&!b.isDefaultPrevented()&&(this.isShown=!1,this.escape(),this.resize(),a(document).off("focusin.bs.modal"),this.$element.removeClass("in").off("click.dismiss.bs.modal").off("mouseup.dismiss.bs.modal"),this.$dialog.off("mousedown.dismiss.bs.modal"),a.support.transition&&this.$element.hasClass("fade")?this.$element.one("bsTransitionEnd",a.proxy(this.hideModal,this)).emulateTransitionEnd(c.TRANSITION_DURATION):this.hideModal())},c.prototype.enforceFocus=function(){a(document).off("focusin.bs.modal").on("focusin.bs.modal",a.proxy(function(a){this.$element[0]===a.target||this.$element.has(a.target).length||this.$element.trigger("focus")},this))},c.prototype.escape=function(){this.isShown&&this.options.keyboard?this.$element.on("keydown.dismiss.bs.modal",a.proxy(function(a){27==a.which&&this.hide()},this)):this.isShown||this.$element.off("keydown.dismiss.bs.modal")},c.prototype.resize=function(){this.isShown?a(window).on("resize.bs.modal",a.proxy(this.handleUpdate,this)):a(window).off("resize.bs.modal")},c.prototype.hideModal=function(){var a=this;this.$element.hide(),this.backdrop(function(){a.$body.removeClass("modal-open"),a.resetAdjustments(),a.resetScrollbar(),a.$element.trigger("hidden.bs.modal")})},c.prototype.removeBackdrop=function(){this.$backdrop&&this.$backdrop.remove(),this.$backdrop=null},c.prototype.backdrop=function(b){var d=this,e=this.$element.hasClass("fade")?"fade":"";if(this.isShown&&this.options.backdrop){var f=a.support.transition&&e;if(this.$backdrop=a(document.createElement("div")).addClass("modal-backdrop "+e).appendTo(this.$body),this.$element.on("click.dismiss.bs.modal",a.proxy(function(a){return this.ignoreBackdropClick?void(this.ignoreBackdropClick=!1):void(a.target===a.currentTarget&&("static"==this.options.backdrop?this.$element[0].focus():this.hide()))},this)),f&&this.$backdrop[0].offsetWidth,this.$backdrop.addClass("in"),!b)return;f?this.$backdrop.one("bsTransitionEnd",b).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):b()}else if(!this.isShown&&this.$backdrop){this.$backdrop.removeClass("in");var g=function(){d.removeBackdrop(),b&&b()};a.support.transition&&this.$element.hasClass("fade")?this.$backdrop.one("bsTransitionEnd",g).emulateTransitionEnd(c.BACKDROP_TRANSITION_DURATION):g()}else b&&b()},c.prototype.handleUpdate=function(){this.adjustDialog()},c.prototype.adjustDialog=function(){var a=this.$element[0].scrollHeight>document.documentElement.clientHeight;this.$element.css({paddingLeft:!this.bodyIsOverflowing&&a?this.scrollbarWidth:"",paddingRight:this.bodyIsOverflowing&&!a?this.scrollbarWidth:""})},c.prototype.resetAdjustments=function(){this.$element.css({paddingLeft:"",paddingRight:""})},c.prototype.checkScrollbar=function(){var a=window.innerWidth;if(!a){var b=document.documentElement.getBoundingClientRect();a=b.right-Math.abs(b.left)}this.bodyIsOverflowing=document.body.clientWidth<a,this.scrollbarWidth=this.measureScrollbar()},c.prototype.setScrollbar=function(){var a=parseInt(this.$body.css("padding-right")||0,10);this.originalBodyPad=document.body.style.paddingRight||"",this.bodyIsOverflowing&&this.$body.css("padding-right",a+this.scrollbarWidth)},c.prototype.resetScrollbar=function(){this.$body.css("padding-right",this.originalBodyPad)},c.prototype.measureScrollbar=function(){var a=document.createElement("div");a.className="modal-scrollbar-measure",this.$body.append(a);var b=a.offsetWidth-a.clientWidth;return this.$body[0].removeChild(a),b};var d=a.fn.modal;a.fn.modal=b,a.fn.modal.Constructor=c,a.fn.modal.noConflict=function(){return a.fn.modal=d,this},a(document).on("click.bs.modal.data-api",'[data-toggle="modal"]',function(c){var d=a(this),e=d.attr("href"),f=a(d.attr("data-target")||e&&e.replace(/.*(?=#[^\s]+$)/,"")),g=f.data("bs.modal")?"toggle":a.extend({remote:!/#/.test(e)&&e},f.data(),d.data());d.is("a")&&c.preventDefault(),f.one("show.bs.modal",function(a){a.isDefaultPrevented()||f.one("hidden.bs.modal",function(){d.is(":visible")&&d.trigger("focus")})}),b.call(f,g,this)})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tooltip"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.tooltip",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.type=null,this.options=null,this.enabled=null,this.timeout=null,this.hoverState=null,this.$element=null,this.inState=null,this.init("tooltip",a,b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.DEFAULTS={animation:!0,placement:"top",selector:!1,template:'<div class="tooltip" role="tooltip"><div class="tooltip-arrow"></div><div class="tooltip-inner"></div></div>',trigger:"hover focus",title:"",delay:0,html:!1,container:!1,viewport:{selector:"body",padding:0}},c.prototype.init=function(b,c,d){if(this.enabled=!0,this.type=b,this.$element=a(c),this.options=this.getOptions(d),this.$viewport=this.options.viewport&&a(a.isFunction(this.options.viewport)?this.options.viewport.call(this,this.$element):this.options.viewport.selector||this.options.viewport),this.inState={click:!1,hover:!1,focus:!1},this.$element[0]instanceof document.constructor&&!this.options.selector)throw new Error("`selector` option must be specified when initializing "+this.type+" on the window.document object!");for(var e=this.options.trigger.split(" "),f=e.length;f--;){var g=e[f];if("click"==g)this.$element.on("click."+this.type,this.options.selector,a.proxy(this.toggle,this));else if("manual"!=g){var h="hover"==g?"mouseenter":"focusin",i="hover"==g?"mouseleave":"focusout";this.$element.on(h+"."+this.type,this.options.selector,a.proxy(this.enter,this)),this.$element.on(i+"."+this.type,this.options.selector,a.proxy(this.leave,this))}}this.options.selector?this._options=a.extend({},this.options,{trigger:"manual",selector:""}):this.fixTitle()},c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.getOptions=function(b){return b=a.extend({},this.getDefaults(),this.$element.data(),b),b.delay&&"number"==typeof b.delay&&(b.delay={show:b.delay,hide:b.delay}),b},c.prototype.getDelegateOptions=function(){var b={},c=this.getDefaults();return this._options&&a.each(this._options,function(a,d){c[a]!=d&&(b[a]=d)}),b},c.prototype.enter=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusin"==b.type?"focus":"hover"]=!0),c.tip().hasClass("in")||"in"==c.hoverState?void(c.hoverState="in"):(clearTimeout(c.timeout),c.hoverState="in",c.options.delay&&c.options.delay.show?void(c.timeout=setTimeout(function(){"in"==c.hoverState&&c.show()},c.options.delay.show)):c.show())},c.prototype.isInStateTrue=function(){for(var a in this.inState)if(this.inState[a])return!0;return!1},c.prototype.leave=function(b){var c=b instanceof this.constructor?b:a(b.currentTarget).data("bs."+this.type);return c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c)),b instanceof a.Event&&(c.inState["focusout"==b.type?"focus":"hover"]=!1),c.isInStateTrue()?void 0:(clearTimeout(c.timeout),c.hoverState="out",c.options.delay&&c.options.delay.hide?void(c.timeout=setTimeout(function(){"out"==c.hoverState&&c.hide()},c.options.delay.hide)):c.hide())},c.prototype.show=function(){var b=a.Event("show.bs."+this.type);if(this.hasContent()&&this.enabled){this.$element.trigger(b);var d=a.contains(this.$element[0].ownerDocument.documentElement,this.$element[0]);if(b.isDefaultPrevented()||!d)return;var e=this,f=this.tip(),g=this.getUID(this.type);this.setContent(),f.attr("id",g),this.$element.attr("aria-describedby",g),this.options.animation&&f.addClass("fade");var h="function"==typeof this.options.placement?this.options.placement.call(this,f[0],this.$element[0]):this.options.placement,i=/\s?auto?\s?/i,j=i.test(h);j&&(h=h.replace(i,"")||"top"),f.detach().css({top:0,left:0,display:"block"}).addClass(h).data("bs."+this.type,this),this.options.container?f.appendTo(this.options.container):f.insertAfter(this.$element),this.$element.trigger("inserted.bs."+this.type);var k=this.getPosition(),l=f[0].offsetWidth,m=f[0].offsetHeight;if(j){var n=h,o=this.getPosition(this.$viewport);h="bottom"==h&&k.bottom+m>o.bottom?"top":"top"==h&&k.top-m<o.top?"bottom":"right"==h&&k.right+l>o.width?"left":"left"==h&&k.left-l<o.left?"right":h,f.removeClass(n).addClass(h)}var p=this.getCalculatedOffset(h,k,l,m);this.applyPlacement(p,h);var q=function(){var a=e.hoverState;e.$element.trigger("shown.bs."+e.type),e.hoverState=null,"out"==a&&e.leave(e)};a.support.transition&&this.$tip.hasClass("fade")?f.one("bsTransitionEnd",q).emulateTransitionEnd(c.TRANSITION_DURATION):q()}},c.prototype.applyPlacement=function(b,c){var d=this.tip(),e=d[0].offsetWidth,f=d[0].offsetHeight,g=parseInt(d.css("margin-top"),10),h=parseInt(d.css("margin-left"),10);isNaN(g)&&(g=0),isNaN(h)&&(h=0),b.top+=g,b.left+=h,a.offset.setOffset(d[0],a.extend({using:function(a){d.css({top:Math.round(a.top),left:Math.round(a.left)})}},b),0),d.addClass("in");var i=d[0].offsetWidth,j=d[0].offsetHeight;"top"==c&&j!=f&&(b.top=b.top+f-j);var k=this.getViewportAdjustedDelta(c,b,i,j);k.left?b.left+=k.left:b.top+=k.top;var l=/top|bottom/.test(c),m=l?2*k.left-e+i:2*k.top-f+j,n=l?"offsetWidth":"offsetHeight";d.offset(b),this.replaceArrow(m,d[0][n],l)},c.prototype.replaceArrow=function(a,b,c){this.arrow().css(c?"left":"top",50*(1-a/b)+"%").css(c?"top":"left","")},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle();a.find(".tooltip-inner")[this.options.html?"html":"text"](b),a.removeClass("fade in top bottom left right")},c.prototype.hide=function(b){function d(){"in"!=e.hoverState&&f.detach(),e.$element.removeAttr("aria-describedby").trigger("hidden.bs."+e.type),b&&b()}var e=this,f=a(this.$tip),g=a.Event("hide.bs."+this.type);return this.$element.trigger(g),g.isDefaultPrevented()?void 0:(f.removeClass("in"),a.support.transition&&f.hasClass("fade")?f.one("bsTransitionEnd",d).emulateTransitionEnd(c.TRANSITION_DURATION):d(),this.hoverState=null,this)},c.prototype.fixTitle=function(){var a=this.$element;(a.attr("title")||"string"!=typeof a.attr("data-original-title"))&&a.attr("data-original-title",a.attr("title")||"").attr("title","")},c.prototype.hasContent=function(){return this.getTitle()},c.prototype.getPosition=function(b){b=b||this.$element;var c=b[0],d="BODY"==c.tagName,e=c.getBoundingClientRect();null==e.width&&(e=a.extend({},e,{width:e.right-e.left,height:e.bottom-e.top}));var f=d?{top:0,left:0}:b.offset(),g={scroll:d?document.documentElement.scrollTop||document.body.scrollTop:b.scrollTop()},h=d?{width:a(window).width(),height:a(window).height()}:null;return a.extend({},e,g,h,f)},c.prototype.getCalculatedOffset=function(a,b,c,d){return"bottom"==a?{top:b.top+b.height,left:b.left+b.width/2-c/2}:"top"==a?{top:b.top-d,left:b.left+b.width/2-c/2}:"left"==a?{top:b.top+b.height/2-d/2,left:b.left-c}:{top:b.top+b.height/2-d/2,left:b.left+b.width}},c.prototype.getViewportAdjustedDelta=function(a,b,c,d){var e={top:0,left:0};if(!this.$viewport)return e;var f=this.options.viewport&&this.options.viewport.padding||0,g=this.getPosition(this.$viewport);if(/right|left/.test(a)){var h=b.top-f-g.scroll,i=b.top+f-g.scroll+d;h<g.top?e.top=g.top-h:i>g.top+g.height&&(e.top=g.top+g.height-i)}else{var j=b.left-f,k=b.left+f+c;j<g.left?e.left=g.left-j:k>g.right&&(e.left=g.left+g.width-k)}return e},c.prototype.getTitle=function(){var a,b=this.$element,c=this.options;return a=b.attr("data-original-title")||("function"==typeof c.title?c.title.call(b[0]):c.title)},c.prototype.getUID=function(a){do a+=~~(1e6*Math.random());while(document.getElementById(a));return a},c.prototype.tip=function(){if(!this.$tip&&(this.$tip=a(this.options.template),1!=this.$tip.length))throw new Error(this.type+" `template` option must consist of exactly 1 top-level element!");return this.$tip},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".tooltip-arrow")},c.prototype.enable=function(){this.enabled=!0},c.prototype.disable=function(){this.enabled=!1},c.prototype.toggleEnabled=function(){this.enabled=!this.enabled},c.prototype.toggle=function(b){var c=this;b&&(c=a(b.currentTarget).data("bs."+this.type),c||(c=new this.constructor(b.currentTarget,this.getDelegateOptions()),a(b.currentTarget).data("bs."+this.type,c))),b?(c.inState.click=!c.inState.click,c.isInStateTrue()?c.enter(c):c.leave(c)):c.tip().hasClass("in")?c.leave(c):c.enter(c)},c.prototype.destroy=function(){var a=this;clearTimeout(this.timeout),this.hide(function(){a.$element.off("."+a.type).removeData("bs."+a.type),a.$tip&&a.$tip.detach(),a.$tip=null,a.$arrow=null,a.$viewport=null})};var d=a.fn.tooltip;a.fn.tooltip=b,a.fn.tooltip.Constructor=c,a.fn.tooltip.noConflict=function(){return a.fn.tooltip=d,this}}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.popover"),f="object"==typeof b&&b;(e||!/destroy|hide/.test(b))&&(e||d.data("bs.popover",e=new c(this,f)),"string"==typeof b&&e[b]())})}var c=function(a,b){this.init("popover",a,b)};if(!a.fn.tooltip)throw new Error("Popover requires tooltip.js");c.VERSION="3.3.5",c.DEFAULTS=a.extend({},a.fn.tooltip.Constructor.DEFAULTS,{placement:"right",trigger:"click",content:"",template:'<div class="popover" role="tooltip"><div class="arrow"></div><h3 class="popover-title"></h3><div class="popover-content"></div></div>'}),c.prototype=a.extend({},a.fn.tooltip.Constructor.prototype),c.prototype.constructor=c,c.prototype.getDefaults=function(){return c.DEFAULTS},c.prototype.setContent=function(){var a=this.tip(),b=this.getTitle(),c=this.getContent();a.find(".popover-title")[this.options.html?"html":"text"](b),a.find(".popover-content").children().detach().end()[this.options.html?"string"==typeof c?"html":"append":"text"](c),a.removeClass("fade top bottom left right in"),a.find(".popover-title").html()||a.find(".popover-title").hide()},c.prototype.hasContent=function(){return this.getTitle()||this.getContent()},c.prototype.getContent=function(){var a=this.$element,b=this.options;return a.attr("data-content")||("function"==typeof b.content?b.content.call(a[0]):b.content)},c.prototype.arrow=function(){return this.$arrow=this.$arrow||this.tip().find(".arrow")};var d=a.fn.popover;a.fn.popover=b,a.fn.popover.Constructor=c,a.fn.popover.noConflict=function(){return a.fn.popover=d,this}}(jQuery),+function(a){"use strict";function b(c,d){this.$body=a(document.body),this.$scrollElement=a(a(c).is(document.body)?window:c),this.options=a.extend({},b.DEFAULTS,d),this.selector=(this.options.target||"")+" .nav li > a",this.offsets=[],this.targets=[],this.activeTarget=null,this.scrollHeight=0,this.$scrollElement.on("scroll.bs.scrollspy",a.proxy(this.process,this)),this.refresh(),this.process()}function c(c){return this.each(function(){var d=a(this),e=d.data("bs.scrollspy"),f="object"==typeof c&&c;e||d.data("bs.scrollspy",e=new b(this,f)),"string"==typeof c&&e[c]()})}b.VERSION="3.3.5",b.DEFAULTS={offset:10},b.prototype.getScrollHeight=function(){return this.$scrollElement[0].scrollHeight||Math.max(this.$body[0].scrollHeight,document.documentElement.scrollHeight)},b.prototype.refresh=function(){var b=this,c="offset",d=0;this.offsets=[],this.targets=[],this.scrollHeight=this.getScrollHeight(),a.isWindow(this.$scrollElement[0])||(c="position",d=this.$scrollElement.scrollTop()),this.$body.find(this.selector).map(function(){var b=a(this),e=b.data("target")||b.attr("href"),f=/^#./.test(e)&&a(e);return f&&f.length&&f.is(":visible")&&[[f[c]().top+d,e]]||null}).sort(function(a,b){return a[0]-b[0]}).each(function(){b.offsets.push(this[0]),b.targets.push(this[1])})},b.prototype.process=function(){var a,b=this.$scrollElement.scrollTop()+this.options.offset,c=this.getScrollHeight(),d=this.options.offset+c-this.$scrollElement.height(),e=this.offsets,f=this.targets,g=this.activeTarget;if(this.scrollHeight!=c&&this.refresh(),b>=d)return g!=(a=f[f.length-1])&&this.activate(a);if(g&&b<e[0])return this.activeTarget=null,this.clear();for(a=e.length;a--;)g!=f[a]&&b>=e[a]&&(void 0===e[a+1]||b<e[a+1])&&this.activate(f[a])},b.prototype.activate=function(b){this.activeTarget=b,this.clear();var c=this.selector+'[data-target="'+b+'"],'+this.selector+'[href="'+b+'"]',d=a(c).parents("li").addClass("active");d.parent(".dropdown-menu").length&&(d=d.closest("li.dropdown").addClass("active")),
d.trigger("activate.bs.scrollspy")},b.prototype.clear=function(){a(this.selector).parentsUntil(this.options.target,".active").removeClass("active")};var d=a.fn.scrollspy;a.fn.scrollspy=c,a.fn.scrollspy.Constructor=b,a.fn.scrollspy.noConflict=function(){return a.fn.scrollspy=d,this},a(window).on("load.bs.scrollspy.data-api",function(){a('[data-spy="scroll"]').each(function(){var b=a(this);c.call(b,b.data())})})}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.tab");e||d.data("bs.tab",e=new c(this)),"string"==typeof b&&e[b]()})}var c=function(b){this.element=a(b)};c.VERSION="3.3.5",c.TRANSITION_DURATION=150,c.prototype.show=function(){var b=this.element,c=b.closest("ul:not(.dropdown-menu)"),d=b.data("target");if(d||(d=b.attr("href"),d=d&&d.replace(/.*(?=#[^\s]*$)/,"")),!b.parent("li").hasClass("active")){var e=c.find(".active:last a"),f=a.Event("hide.bs.tab",{relatedTarget:b[0]}),g=a.Event("show.bs.tab",{relatedTarget:e[0]});if(e.trigger(f),b.trigger(g),!g.isDefaultPrevented()&&!f.isDefaultPrevented()){var h=a(d);this.activate(b.closest("li"),c),this.activate(h,h.parent(),function(){e.trigger({type:"hidden.bs.tab",relatedTarget:b[0]}),b.trigger({type:"shown.bs.tab",relatedTarget:e[0]})})}}},c.prototype.activate=function(b,d,e){function f(){g.removeClass("active").find("> .dropdown-menu > .active").removeClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!1),b.addClass("active").find('[data-toggle="tab"]').attr("aria-expanded",!0),h?(b[0].offsetWidth,b.addClass("in")):b.removeClass("fade"),b.parent(".dropdown-menu").length&&b.closest("li.dropdown").addClass("active").end().find('[data-toggle="tab"]').attr("aria-expanded",!0),e&&e()}var g=d.find("> .active"),h=e&&a.support.transition&&(g.length&&g.hasClass("fade")||!!d.find("> .fade").length);g.length&&h?g.one("bsTransitionEnd",f).emulateTransitionEnd(c.TRANSITION_DURATION):f(),g.removeClass("in")};var d=a.fn.tab;a.fn.tab=b,a.fn.tab.Constructor=c,a.fn.tab.noConflict=function(){return a.fn.tab=d,this};var e=function(c){c.preventDefault(),b.call(a(this),"show")};a(document).on("click.bs.tab.data-api",'[data-toggle="tab"]',e).on("click.bs.tab.data-api",'[data-toggle="pill"]',e)}(jQuery),+function(a){"use strict";function b(b){return this.each(function(){var d=a(this),e=d.data("bs.affix"),f="object"==typeof b&&b;e||d.data("bs.affix",e=new c(this,f)),"string"==typeof b&&e[b]()})}var c=function(b,d){this.options=a.extend({},c.DEFAULTS,d),this.$target=a(this.options.target).on("scroll.bs.affix.data-api",a.proxy(this.checkPosition,this)).on("click.bs.affix.data-api",a.proxy(this.checkPositionWithEventLoop,this)),this.$element=a(b),this.affixed=null,this.unpin=null,this.pinnedOffset=null,this.checkPosition()};c.VERSION="3.3.5",c.RESET="affix affix-top affix-bottom",c.DEFAULTS={offset:0,target:window},c.prototype.getState=function(a,b,c,d){var e=this.$target.scrollTop(),f=this.$element.offset(),g=this.$target.height();if(null!=c&&"top"==this.affixed)return c>e?"top":!1;if("bottom"==this.affixed)return null!=c?e+this.unpin<=f.top?!1:"bottom":a-d>=e+g?!1:"bottom";var h=null==this.affixed,i=h?e:f.top,j=h?g:b;return null!=c&&c>=e?"top":null!=d&&i+j>=a-d?"bottom":!1},c.prototype.getPinnedOffset=function(){if(this.pinnedOffset)return this.pinnedOffset;this.$element.removeClass(c.RESET).addClass("affix");var a=this.$target.scrollTop(),b=this.$element.offset();return this.pinnedOffset=b.top-a},c.prototype.checkPositionWithEventLoop=function(){setTimeout(a.proxy(this.checkPosition,this),1)},c.prototype.checkPosition=function(){if(this.$element.is(":visible")){var b=this.$element.height(),d=this.options.offset,e=d.top,f=d.bottom,g=Math.max(a(document).height(),a(document.body).height());"object"!=typeof d&&(f=e=d),"function"==typeof e&&(e=d.top(this.$element)),"function"==typeof f&&(f=d.bottom(this.$element));var h=this.getState(g,b,e,f);if(this.affixed!=h){null!=this.unpin&&this.$element.css("top","");var i="affix"+(h?"-"+h:""),j=a.Event(i+".bs.affix");if(this.$element.trigger(j),j.isDefaultPrevented())return;this.affixed=h,this.unpin="bottom"==h?this.getPinnedOffset():null,this.$element.removeClass(c.RESET).addClass(i).trigger(i.replace("affix","affixed")+".bs.affix")}"bottom"==h&&this.$element.offset({top:g-b-f})}};var d=a.fn.affix;a.fn.affix=b,a.fn.affix.Constructor=c,a.fn.affix.noConflict=function(){return a.fn.affix=d,this},a(window).on("load",function(){a('[data-spy="affix"]').each(function(){var c=a(this),d=c.data();d.offset=d.offset||{},null!=d.offsetBottom&&(d.offset.bottom=d.offsetBottom),null!=d.offsetTop&&(d.offset.top=d.offsetTop),b.call(c,d)})})}(jQuery);</script>
<script>/**
* @preserve HTML5 Shiv 3.7.2 | @afarkas @jdalton @jon_neal @rem | MIT/GPL2 Licensed
*/
// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a,b){function c(a,b){var c=a.createElement("p"),d=a.getElementsByTagName("head")[0]||a.documentElement;return c.innerHTML="x<style>"+b+"</style>",d.insertBefore(c.lastChild,d.firstChild)}function d(){var a=t.elements;return"string"==typeof a?a.split(" "):a}function e(a,b){var c=t.elements;"string"!=typeof c&&(c=c.join(" ")),"string"!=typeof a&&(a=a.join(" ")),t.elements=c+" "+a,j(b)}function f(a){var b=s[a[q]];return b||(b={},r++,a[q]=r,s[r]=b),b}function g(a,c,d){if(c||(c=b),l)return c.createElement(a);d||(d=f(c));var e;return e=d.cache[a]?d.cache[a].cloneNode():p.test(a)?(d.cache[a]=d.createElem(a)).cloneNode():d.createElem(a),!e.canHaveChildren||o.test(a)||e.tagUrn?e:d.frag.appendChild(e)}function h(a,c){if(a||(a=b),l)return a.createDocumentFragment();c=c||f(a);for(var e=c.frag.cloneNode(),g=0,h=d(),i=h.length;i>g;g++)e.createElement(h[g]);return e}function i(a,b){b.cache||(b.cache={},b.createElem=a.createElement,b.createFrag=a.createDocumentFragment,b.frag=b.createFrag()),a.createElement=function(c){return t.shivMethods?g(c,a,b):b.createElem(c)},a.createDocumentFragment=Function("h,f","return function(){var n=f.cloneNode(),c=n.createElement;h.shivMethods&&("+d().join().replace(/[\w\-:]+/g,function(a){return b.createElem(a),b.frag.createElement(a),'c("'+a+'")'})+");return n}")(t,b.frag)}function j(a){a||(a=b);var d=f(a);return!t.shivCSS||k||d.hasCSS||(d.hasCSS=!!c(a,"article,aside,dialog,figcaption,figure,footer,header,hgroup,main,nav,section{display:block}mark{background:#FF0;color:#000}template{display:none}")),l||i(a,d),a}var k,l,m="3.7.2",n=a.html5||{},o=/^<|^(?:button|map|select|textarea|object|iframe|option|optgroup)$/i,p=/^(?:a|b|code|div|fieldset|h1|h2|h3|h4|h5|h6|i|label|li|ol|p|q|span|strong|style|table|tbody|td|th|tr|ul)$/i,q="_html5shiv",r=0,s={};!function(){try{var a=b.createElement("a");a.innerHTML="<xyz></xyz>",k="hidden"in a,l=1==a.childNodes.length||function(){b.createElement("a");var a=b.createDocumentFragment();return"undefined"==typeof a.cloneNode||"undefined"==typeof a.createDocumentFragment||"undefined"==typeof a.createElement}()}catch(c){k=!0,l=!0}}();var t={elements:n.elements||"abbr article aside audio bdi canvas data datalist details dialog figcaption figure footer header hgroup main mark meter nav output picture progress section summary template time video",version:m,shivCSS:n.shivCSS!==!1,supportsUnknownElements:l,shivMethods:n.shivMethods!==!1,type:"default",shivDocument:j,createElement:g,createDocumentFragment:h,addElements:e};a.html5=t,j(b)}(this,document);
};
</script>
<script>/*! Respond.js v1.4.2: min/max-width media query polyfill * Copyright 2013 Scott Jehl
 * Licensed under https://github.com/scottjehl/Respond/blob/master/LICENSE-MIT
 *  */

// Only run this code in IE 8
if (!!window.navigator.userAgent.match("MSIE 8")) {
!function(a){"use strict";a.matchMedia=a.matchMedia||function(a){var b,c=a.documentElement,d=c.firstElementChild||c.firstChild,e=a.createElement("body"),f=a.createElement("div");return f.id="mq-test-1",f.style.cssText="position:absolute;top:-100em",e.style.background="none",e.appendChild(f),function(a){return f.innerHTML='&shy;<style media="'+a+'"> #mq-test-1 { width: 42px; }</style>',c.insertBefore(e,d),b=42===f.offsetWidth,c.removeChild(e),{matches:b,media:a}}}(a.document)}(this),function(a){"use strict";function b(){u(!0)}var c={};a.respond=c,c.update=function(){};var d=[],e=function(){var b=!1;try{b=new a.XMLHttpRequest}catch(c){b=new a.ActiveXObject("Microsoft.XMLHTTP")}return function(){return b}}(),f=function(a,b){var c=e();c&&(c.open("GET",a,!0),c.onreadystatechange=function(){4!==c.readyState||200!==c.status&&304!==c.status||b(c.responseText)},4!==c.readyState&&c.send(null))};if(c.ajax=f,c.queue=d,c.regex={media:/@media[^\{]+\{([^\{\}]*\{[^\}\{]*\})+/gi,keyframes:/@(?:\-(?:o|moz|webkit)\-)?keyframes[^\{]+\{(?:[^\{\}]*\{[^\}\{]*\})+[^\}]*\}/gi,urls:/(url\()['"]?([^\/\)'"][^:\)'"]+)['"]?(\))/g,findStyles:/@media *([^\{]+)\{([\S\s]+?)$/,only:/(only\s+)?([a-zA-Z]+)\s?/,minw:/\([\s]*min\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/,maxw:/\([\s]*max\-width\s*:[\s]*([\s]*[0-9\.]+)(px|em)[\s]*\)/},c.mediaQueriesSupported=a.matchMedia&&null!==a.matchMedia("only all")&&a.matchMedia("only all").matches,!c.mediaQueriesSupported){var g,h,i,j=a.document,k=j.documentElement,l=[],m=[],n=[],o={},p=30,q=j.getElementsByTagName("head")[0]||k,r=j.getElementsByTagName("base")[0],s=q.getElementsByTagName("link"),t=function(){var a,b=j.createElement("div"),c=j.body,d=k.style.fontSize,e=c&&c.style.fontSize,f=!1;return b.style.cssText="position:absolute;font-size:1em;width:1em",c||(c=f=j.createElement("body"),c.style.background="none"),k.style.fontSize="100%",c.style.fontSize="100%",c.appendChild(b),f&&k.insertBefore(c,k.firstChild),a=b.offsetWidth,f?k.removeChild(c):c.removeChild(b),k.style.fontSize=d,e&&(c.style.fontSize=e),a=i=parseFloat(a)},u=function(b){var c="clientWidth",d=k[c],e="CSS1Compat"===j.compatMode&&d||j.body[c]||d,f={},o=s[s.length-1],r=(new Date).getTime();if(b&&g&&p>r-g)return a.clearTimeout(h),h=a.setTimeout(u,p),void 0;g=r;for(var v in l)if(l.hasOwnProperty(v)){var w=l[v],x=w.minw,y=w.maxw,z=null===x,A=null===y,B="em";x&&(x=parseFloat(x)*(x.indexOf(B)>-1?i||t():1)),y&&(y=parseFloat(y)*(y.indexOf(B)>-1?i||t():1)),w.hasquery&&(z&&A||!(z||e>=x)||!(A||y>=e))||(f[w.media]||(f[w.media]=[]),f[w.media].push(m[w.rules]))}for(var C in n)n.hasOwnProperty(C)&&n[C]&&n[C].parentNode===q&&q.removeChild(n[C]);n.length=0;for(var D in f)if(f.hasOwnProperty(D)){var E=j.createElement("style"),F=f[D].join("\n");E.type="text/css",E.media=D,q.insertBefore(E,o.nextSibling),E.styleSheet?E.styleSheet.cssText=F:E.appendChild(j.createTextNode(F)),n.push(E)}},v=function(a,b,d){var e=a.replace(c.regex.keyframes,"").match(c.regex.media),f=e&&e.length||0;b=b.substring(0,b.lastIndexOf("/"));var g=function(a){return a.replace(c.regex.urls,"$1"+b+"$2$3")},h=!f&&d;b.length&&(b+="/"),h&&(f=1);for(var i=0;f>i;i++){var j,k,n,o;h?(j=d,m.push(g(a))):(j=e[i].match(c.regex.findStyles)&&RegExp.$1,m.push(RegExp.$2&&g(RegExp.$2))),n=j.split(","),o=n.length;for(var p=0;o>p;p++)k=n[p],l.push({media:k.split("(")[0].match(c.regex.only)&&RegExp.$2||"all",rules:m.length-1,hasquery:k.indexOf("(")>-1,minw:k.match(c.regex.minw)&&parseFloat(RegExp.$1)+(RegExp.$2||""),maxw:k.match(c.regex.maxw)&&parseFloat(RegExp.$1)+(RegExp.$2||"")})}u()},w=function(){if(d.length){var b=d.shift();f(b.href,function(c){v(c,b.href,b.media),o[b.href]=!0,a.setTimeout(function(){w()},0)})}},x=function(){for(var b=0;b<s.length;b++){var c=s[b],e=c.href,f=c.media,g=c.rel&&"stylesheet"===c.rel.toLowerCase();e&&g&&!o[e]&&(c.styleSheet&&c.styleSheet.rawCssText?(v(c.styleSheet.rawCssText,e,f),o[e]=!0):(!/^([a-zA-Z:]*\/\/)/.test(e)&&!r||e.replace(RegExp.$1,"").split("/")[0]===a.location.host)&&("//"===e.substring(0,2)&&(e=a.location.protocol+e),d.push({href:e,media:f})))}w()};x(),c.update=x,c.getEmValue=t,a.addEventListener?a.addEventListener("resize",b,!1):a.attachEvent&&a.attachEvent("onresize",b)}}(this);
};
</script>
<style>h1 {font-size: 34px;}
h1.title {font-size: 38px;}
h2 {font-size: 30px;}
h3 {font-size: 24px;}
h4 {font-size: 18px;}
h5 {font-size: 16px;}
h6 {font-size: 12px;}
code {color: inherit; background-color: rgba(0, 0, 0, 0.04);}
pre:not([class]) { background-color: white }</style>
<script>

/**
 * jQuery Plugin: Sticky Tabs
 *
 * @author Aidan Lister <aidan@php.net>
 * adapted by Ruben Arslan to activate parent tabs too
 * http://www.aidanlister.com/2014/03/persisting-the-tab-state-in-bootstrap/
 */
(function($) {
  "use strict";
  $.fn.rmarkdownStickyTabs = function() {
    var context = this;
    // Show the tab corresponding with the hash in the URL, or the first tab
    var showStuffFromHash = function() {
      var hash = window.location.hash;
      var selector = hash ? 'a[href="' + hash + '"]' : 'li.active > a';
      var $selector = $(selector, context);
      if($selector.data('toggle') === "tab") {
        $selector.tab('show');
        // walk up the ancestors of this element, show any hidden tabs
        $selector.parents('.section.tabset').each(function(i, elm) {
          var link = $('a[href="#' + $(elm).attr('id') + '"]');
          if(link.data('toggle') === "tab") {
            link.tab("show");
          }
        });
      }
    };


    // Set the correct tab when the page loads
    showStuffFromHash(context);

    // Set the correct tab when a user uses their back/forward button
    $(window).on('hashchange', function() {
      showStuffFromHash(context);
    });

    // Change the URL when tabs are clicked
    $('a', context).on('click', function(e) {
      history.pushState(null, null, this.href);
      showStuffFromHash(context);
    });

    return this;
  };
}(jQuery));

window.buildTabsets = function(tocID) {

  // build a tabset from a section div with the .tabset class
  function buildTabset(tabset) {

    // check for fade and pills options
    var fade = tabset.hasClass("tabset-fade");
    var pills = tabset.hasClass("tabset-pills");
    var navClass = pills ? "nav-pills" : "nav-tabs";

    // determine the heading level of the tabset and tabs
    var match = tabset.attr('class').match(/level(\d) /);
    if (match === null)
      return;
    var tabsetLevel = Number(match[1]);
    var tabLevel = tabsetLevel + 1;

    // find all subheadings immediately below
    var tabs = tabset.find("div.section.level" + tabLevel);
    if (!tabs.length)
      return;

    // create tablist and tab-content elements
    var tabList = $('<ul class="nav ' + navClass + '" role="tablist"></ul>');
    $(tabs[0]).before(tabList);
    var tabContent = $('<div class="tab-content"></div>');
    $(tabs[0]).before(tabContent);

    // build the tabset
    var activeTab = 0;
    tabs.each(function(i) {

      // get the tab div
      var tab = $(tabs[i]);

      // get the id then sanitize it for use with bootstrap tabs
      var id = tab.attr('id');

      // see if this is marked as the active tab
      if (tab.hasClass('active'))
        activeTab = i;

      // remove any table of contents entries associated with
      // this ID (since we'll be removing the heading element)
      $("div#" + tocID + " li a[href='#" + id + "']").parent().remove();

      // sanitize the id for use with bootstrap tabs
      id = id.replace(/[.\/?&!#<>]/g, '').replace(/\s/g, '_');
      tab.attr('id', id);

      // get the heading element within it, grab it's text, then remove it
      var heading = tab.find('h' + tabLevel + ':first');
      var headingText = heading.html();
      heading.remove();

      // build and append the tab list item
      var a = $('<a role="tab" data-toggle="tab">' + headingText + '</a>');
      a.attr('href', '#' + id);
      a.attr('aria-controls', id);
      var li = $('<li role="presentation"></li>');
      li.append(a);
      tabList.append(li);

      // set it's attributes
      tab.attr('role', 'tabpanel');
      tab.addClass('tab-pane');
      tab.addClass('tabbed-pane');
      if (fade)
        tab.addClass('fade');

      // move it into the tab content div
      tab.detach().appendTo(tabContent);
    });

    // set active tab
    $(tabList.children('li')[activeTab]).addClass('active');
    var active = $(tabContent.children('div.section')[activeTab]);
    active.addClass('active');
    if (fade)
      active.addClass('in');

    if (tabset.hasClass("tabset-sticky"))
      tabset.rmarkdownStickyTabs();
  }

  // convert section divs with the .tabset class to tabsets
  var tabsets = $("div.section.tabset");
  tabsets.each(function(i) {
    buildTabset($(tabsets[i]));
  });
};

</script>
<style type="text/css">.hljs-literal {
color: #990073;
}
.hljs-number {
color: #099;
}
.hljs-comment {
color: #998;
font-style: italic;
}
.hljs-keyword {
color: #900;
font-weight: bold;
}
.hljs-string {
color: #d14;
}
</style>
<script src="data:application/javascript;base64,/*! highlight.js v9.12.0 | BSD3 License | git.io/hljslicense */
!function(e){var n="object"==typeof window&&window||"object"==typeof self&&self;"undefined"!=typeof exports?e(exports):n&&(n.hljs=e({}),"function"==typeof define&&define.amd&&define([],function(){return n.hljs}))}(function(e){function n(e){return e.replace(/&/g,"&amp;").replace(/</g,"&lt;").replace(/>/g,"&gt;")}function t(e){return e.nodeName.toLowerCase()}function r(e,n){var t=e&&e.exec(n);return t&&0===t.index}function a(e){return k.test(e)}function i(e){var n,t,r,i,o=e.className+" ";if(o+=e.parentNode?e.parentNode.className:"",t=B.exec(o))return w(t[1])?t[1]:"no-highlight";for(o=o.split(/\s+/),n=0,r=o.length;r>n;n++)if(i=o[n],a(i)||w(i))return i}function o(e){var n,t={},r=Array.prototype.slice.call(arguments,1);for(n in e)t[n]=e[n];return r.forEach(function(e){for(n in e)t[n]=e[n]}),t}function u(e){var n=[];return function r(e,a){for(var i=e.firstChild;i;i=i.nextSibling)3===i.nodeType?a+=i.nodeValue.length:1===i.nodeType&&(n.push({event:"start",offset:a,node:i}),a=r(i,a),t(i).match(/br|hr|img|input/)||n.push({event:"stop",offset:a,node:i}));return a}(e,0),n}function c(e,r,a){function i(){return e.length&&r.length?e[0].offset!==r[0].offset?e[0].offset<r[0].offset?e:r:"start"===r[0].event?e:r:e.length?e:r}function o(e){function r(e){return" "+e.nodeName+'="'+n(e.value).replace('"',"&quot;")+'"'}s+="<"+t(e)+E.map.call(e.attributes,r).join("")+">"}function u(e){s+="</"+t(e)+">"}function c(e){("start"===e.event?o:u)(e.node)}for(var l=0,s="",f=[];e.length||r.length;){var g=i();if(s+=n(a.substring(l,g[0].offset)),l=g[0].offset,g===e){f.reverse().forEach(u);do c(g.splice(0,1)[0]),g=i();while(g===e&&g.length&&g[0].offset===l);f.reverse().forEach(o)}else"start"===g[0].event?f.push(g[0].node):f.pop(),c(g.splice(0,1)[0])}return s+n(a.substr(l))}function l(e){return e.v&&!e.cached_variants&&(e.cached_variants=e.v.map(function(n){return o(e,{v:null},n)})),e.cached_variants||e.eW&&[o(e)]||[e]}function s(e){function n(e){return e&&e.source||e}function t(t,r){return new RegExp(n(t),"m"+(e.cI?"i":"")+(r?"g":""))}function r(a,i){if(!a.compiled){if(a.compiled=!0,a.k=a.k||a.bK,a.k){var o={},u=function(n,t){e.cI&&(t=t.toLowerCase()),t.split(" ").forEach(function(e){var t=e.split("|");o[t[0]]=[n,t[1]?Number(t[1]):1]})};"string"==typeof a.k?u("keyword",a.k):x(a.k).forEach(function(e){u(e,a.k[e])}),a.k=o}a.lR=t(a.l||/\w+/,!0),i&&(a.bK&&(a.b="\\b("+a.bK.split(" ").join("|")+")\\b"),a.b||(a.b=/\B|\b/),a.bR=t(a.b),a.e||a.eW||(a.e=/\B|\b/),a.e&&(a.eR=t(a.e)),a.tE=n(a.e)||"",a.eW&&i.tE&&(a.tE+=(a.e?"|":"")+i.tE)),a.i&&(a.iR=t(a.i)),null==a.r&&(a.r=1),a.c||(a.c=[]),a.c=Array.prototype.concat.apply([],a.c.map(function(e){return l("self"===e?a:e)})),a.c.forEach(function(e){r(e,a)}),a.starts&&r(a.starts,i);var c=a.c.map(function(e){return e.bK?"\\.?("+e.b+")\\.?":e.b}).concat([a.tE,a.i]).map(n).filter(Boolean);a.t=c.length?t(c.join("|"),!0):{exec:function(){return null}}}}r(e)}function f(e,t,a,i){function o(e,n){var t,a;for(t=0,a=n.c.length;a>t;t++)if(r(n.c[t].bR,e))return n.c[t]}function u(e,n){if(r(e.eR,n)){for(;e.endsParent&&e.parent;)e=e.parent;return e}return e.eW?u(e.parent,n):void 0}function c(e,n){return!a&&r(n.iR,e)}function l(e,n){var t=N.cI?n[0].toLowerCase():n[0];return e.k.hasOwnProperty(t)&&e.k[t]}function p(e,n,t,r){var a=r?"":I.classPrefix,i='<span class="'+a,o=t?"":C;return i+=e+'">',i+n+o}function h(){var e,t,r,a;if(!E.k)return n(k);for(a="",t=0,E.lR.lastIndex=0,r=E.lR.exec(k);r;)a+=n(k.substring(t,r.index)),e=l(E,r),e?(B+=e[1],a+=p(e[0],n(r[0]))):a+=n(r[0]),t=E.lR.lastIndex,r=E.lR.exec(k);return a+n(k.substr(t))}function d(){var e="string"==typeof E.sL;if(e&&!y[E.sL])return n(k);var t=e?f(E.sL,k,!0,x[E.sL]):g(k,E.sL.length?E.sL:void 0);return E.r>0&&(B+=t.r),e&&(x[E.sL]=t.top),p(t.language,t.value,!1,!0)}function b(){L+=null!=E.sL?d():h(),k=""}function v(e){L+=e.cN?p(e.cN,"",!0):"",E=Object.create(e,{parent:{value:E}})}function m(e,n){if(k+=e,null==n)return b(),0;var t=o(n,E);if(t)return t.skip?k+=n:(t.eB&&(k+=n),b(),t.rB||t.eB||(k=n)),v(t,n),t.rB?0:n.length;var r=u(E,n);if(r){var a=E;a.skip?k+=n:(a.rE||a.eE||(k+=n),b(),a.eE&&(k=n));do E.cN&&(L+=C),E.skip||(B+=E.r),E=E.parent;while(E!==r.parent);return r.starts&&v(r.starts,""),a.rE?0:n.length}if(c(n,E))throw new Error('Illegal lexeme "'+n+'" for mode "'+(E.cN||"<unnamed>")+'"');return k+=n,n.length||1}var N=w(e);if(!N)throw new Error('Unknown language: "'+e+'"');s(N);var R,E=i||N,x={},L="";for(R=E;R!==N;R=R.parent)R.cN&&(L=p(R.cN,"",!0)+L);var k="",B=0;try{for(var M,j,O=0;;){if(E.t.lastIndex=O,M=E.t.exec(t),!M)break;j=m(t.substring(O,M.index),M[0]),O=M.index+j}for(m(t.substr(O)),R=E;R.parent;R=R.parent)R.cN&&(L+=C);return{r:B,value:L,language:e,top:E}}catch(T){if(T.message&&-1!==T.message.indexOf("Illegal"))return{r:0,value:n(t)};throw T}}function g(e,t){t=t||I.languages||x(y);var r={r:0,value:n(e)},a=r;return t.filter(w).forEach(function(n){var t=f(n,e,!1);t.language=n,t.r>a.r&&(a=t),t.r>r.r&&(a=r,r=t)}),a.language&&(r.second_best=a),r}function p(e){return I.tabReplace||I.useBR?e.replace(M,function(e,n){return I.useBR&&"\n"===e?"<br>":I.tabReplace?n.replace(/\t/g,I.tabReplace):""}):e}function h(e,n,t){var r=n?L[n]:t,a=[e.trim()];return e.match(/\bhljs\b/)||a.push("hljs"),-1===e.indexOf(r)&&a.push(r),a.join(" ").trim()}function d(e){var n,t,r,o,l,s=i(e);a(s)||(I.useBR?(n=document.createElementNS("http://www.w3.org/1999/xhtml","div"),n.innerHTML=e.innerHTML.replace(/\n/g,"").replace(/<br[ \/]*>/g,"\n")):n=e,l=n.textContent,r=s?f(s,l,!0):g(l),t=u(n),t.length&&(o=document.createElementNS("http://www.w3.org/1999/xhtml","div"),o.innerHTML=r.value,r.value=c(t,u(o),l)),r.value=p(r.value),e.innerHTML=r.value,e.className=h(e.className,s,r.language),e.result={language:r.language,re:r.r},r.second_best&&(e.second_best={language:r.second_best.language,re:r.second_best.r}))}function b(e){I=o(I,e)}function v(){if(!v.called){v.called=!0;var e=document.querySelectorAll("pre code");E.forEach.call(e,d)}}function m(){addEventListener("DOMContentLoaded",v,!1),addEventListener("load",v,!1)}function N(n,t){var r=y[n]=t(e);r.aliases&&r.aliases.forEach(function(e){L[e]=n})}function R(){return x(y)}function w(e){return e=(e||"").toLowerCase(),y[e]||y[L[e]]}var E=[],x=Object.keys,y={},L={},k=/^(no-?highlight|plain|text)$/i,B=/\blang(?:uage)?-([\w-]+)\b/i,M=/((^(<[^>]+>|\t|)+|(?:\n)))/gm,C="</span>",I={classPrefix:"hljs-",tabReplace:null,useBR:!1,languages:void 0};return e.highlight=f,e.highlightAuto=g,e.fixMarkup=p,e.highlightBlock=d,e.configure=b,e.initHighlighting=v,e.initHighlightingOnLoad=m,e.registerLanguage=N,e.listLanguages=R,e.getLanguage=w,e.inherit=o,e.IR="[a-zA-Z]\\w*",e.UIR="[a-zA-Z_]\\w*",e.NR="\\b\\d+(\\.\\d+)?",e.CNR="(-?)(\\b0[xX][a-fA-F0-9]+|(\\b\\d+(\\.\\d*)?|\\.\\d+)([eE][-+]?\\d+)?)",e.BNR="\\b(0b[01]+)",e.RSR="!|!=|!==|%|%=|&|&&|&=|\\*|\\*=|\\+|\\+=|,|-|-=|/=|/|:|;|<<|<<=|<=|<|===|==|=|>>>=|>>=|>=|>>>|>>|>|\\?|\\[|\\{|\\(|\\^|\\^=|\\||\\|=|\\|\\||~",e.BE={b:"\\\\[\\s\\S]",r:0},e.ASM={cN:"string",b:"'",e:"'",i:"\\n",c:[e.BE]},e.QSM={cN:"string",b:'"',e:'"',i:"\\n",c:[e.BE]},e.PWM={b:/\b(a|an|the|are|I'm|isn't|don't|doesn't|won't|but|just|should|pretty|simply|enough|gonna|going|wtf|so|such|will|you|your|they|like|more)\b/},e.C=function(n,t,r){var a=e.inherit({cN:"comment",b:n,e:t,c:[]},r||{});return a.c.push(e.PWM),a.c.push({cN:"doctag",b:"(?:TODO|FIXME|NOTE|BUG|XXX):",r:0}),a},e.CLCM=e.C("//","$"),e.CBCM=e.C("/\\*","\\*/"),e.HCM=e.C("#","$"),e.NM={cN:"number",b:e.NR,r:0},e.CNM={cN:"number",b:e.CNR,r:0},e.BNM={cN:"number",b:e.BNR,r:0},e.CSSNM={cN:"number",b:e.NR+"(%|em|ex|ch|rem|vw|vh|vmin|vmax|cm|mm|in|pt|pc|px|deg|grad|rad|turn|s|ms|Hz|kHz|dpi|dpcm|dppx)?",r:0},e.RM={cN:"regexp",b:/\//,e:/\/[gimuy]*/,i:/\n/,c:[e.BE,{b:/\[/,e:/\]/,r:0,c:[e.BE]}]},e.TM={cN:"title",b:e.IR,r:0},e.UTM={cN:"title",b:e.UIR,r:0},e.METHOD_GUARD={b:"\\.\\s*"+e.UIR,r:0},e});hljs.registerLanguage("sql",function(e){var t=e.C("--","$");return{cI:!0,i:/[<>{}*#]/,c:[{bK:"begin end start commit rollback savepoint lock alter create drop rename call delete do handler insert load replace select truncate update set show pragma grant merge describe use explain help declare prepare execute deallocate release unlock purge reset change stop analyze cache flush optimize repair kill install uninstall checksum restore check backup revoke comment",e:/;/,eW:!0,l:/[\w\.]+/,k:{keyword:"abort abs absolute acc acce accep accept access accessed accessible account acos action activate add addtime admin administer advanced advise aes_decrypt aes_encrypt after agent aggregate ali alia alias allocate allow alter always analyze ancillary and any anydata anydataset anyschema anytype apply archive archived archivelog are as asc ascii asin assembly assertion associate asynchronous at atan atn2 attr attri attrib attribu attribut attribute attributes audit authenticated authentication authid authors auto autoallocate autodblink autoextend automatic availability avg backup badfile basicfile before begin beginning benchmark between bfile bfile_base big bigfile bin binary_double binary_float binlog bit_and bit_count bit_length bit_or bit_xor bitmap blob_base block blocksize body both bound buffer_cache buffer_pool build bulk by byte byteordermark bytes cache caching call calling cancel capacity cascade cascaded case cast catalog category ceil ceiling chain change changed char_base char_length character_length characters characterset charindex charset charsetform charsetid check checksum checksum_agg child choose chr chunk class cleanup clear client clob clob_base clone close cluster_id cluster_probability cluster_set clustering coalesce coercibility col collate collation collect colu colum column column_value columns columns_updated comment commit compact compatibility compiled complete composite_limit compound compress compute concat concat_ws concurrent confirm conn connec connect connect_by_iscycle connect_by_isleaf connect_by_root connect_time connection consider consistent constant constraint constraints constructor container content contents context contributors controlfile conv convert convert_tz corr corr_k corr_s corresponding corruption cos cost count count_big counted covar_pop covar_samp cpu_per_call cpu_per_session crc32 create creation critical cross cube cume_dist curdate current current_date current_time current_timestamp current_user cursor curtime customdatum cycle data database databases datafile datafiles datalength date_add date_cache date_format date_sub dateadd datediff datefromparts datename datepart datetime2fromparts day day_to_second dayname dayofmonth dayofweek dayofyear days db_role_change dbtimezone ddl deallocate declare decode decompose decrement decrypt deduplicate def defa defau defaul default defaults deferred defi defin define degrees delayed delegate delete delete_all delimited demand dense_rank depth dequeue des_decrypt des_encrypt des_key_file desc descr descri describ describe descriptor deterministic diagnostics difference dimension direct_load directory disable disable_all disallow disassociate discardfile disconnect diskgroup distinct distinctrow distribute distributed div do document domain dotnet double downgrade drop dumpfile duplicate duration each edition editionable editions element ellipsis else elsif elt empty enable enable_all enclosed encode encoding encrypt end end-exec endian enforced engine engines enqueue enterprise entityescaping eomonth error errors escaped evalname evaluate event eventdata events except exception exceptions exchange exclude excluding execu execut execute exempt exists exit exp expire explain export export_set extended extent external external_1 external_2 externally extract failed failed_login_attempts failover failure far fast feature_set feature_value fetch field fields file file_name_convert filesystem_like_logging final finish first first_value fixed flash_cache flashback floor flush following follows for forall force form forma format found found_rows freelist freelists freepools fresh from from_base64 from_days ftp full function general generated get get_format get_lock getdate getutcdate global global_name globally go goto grant grants greatest group group_concat group_id grouping grouping_id groups gtid_subtract guarantee guard handler hash hashkeys having hea head headi headin heading heap help hex hierarchy high high_priority hosts hour http id ident_current ident_incr ident_seed identified identity idle_time if ifnull ignore iif ilike ilm immediate import in include including increment index indexes indexing indextype indicator indices inet6_aton inet6_ntoa inet_aton inet_ntoa infile initial initialized initially initrans inmemory inner innodb input insert install instance instantiable instr interface interleaved intersect into invalidate invisible is is_free_lock is_ipv4 is_ipv4_compat is_not is_not_null is_used_lock isdate isnull isolation iterate java join json json_exists keep keep_duplicates key keys kill language large last last_day last_insert_id last_value lax lcase lead leading least leaves left len lenght length less level levels library like like2 like4 likec limit lines link list listagg little ln load load_file lob lobs local localtime localtimestamp locate locator lock locked log log10 log2 logfile logfiles logging logical logical_reads_per_call logoff logon logs long loop low low_priority lower lpad lrtrim ltrim main make_set makedate maketime managed management manual map mapping mask master master_pos_wait match matched materialized max maxextents maximize maxinstances maxlen maxlogfiles maxloghistory maxlogmembers maxsize maxtrans md5 measures median medium member memcompress memory merge microsecond mid migration min minextents minimum mining minus minute minvalue missing mod mode model modification modify module monitoring month months mount move movement multiset mutex name name_const names nan national native natural nav nchar nclob nested never new newline next nextval no no_write_to_binlog noarchivelog noaudit nobadfile nocheck nocompress nocopy nocycle nodelay nodiscardfile noentityescaping noguarantee nokeep nologfile nomapping nomaxvalue nominimize nominvalue nomonitoring none noneditionable nonschema noorder nopr nopro noprom nopromp noprompt norely noresetlogs noreverse normal norowdependencies noschemacheck noswitch not nothing notice notrim novalidate now nowait nth_value nullif nulls num numb numbe nvarchar nvarchar2 object ocicoll ocidate ocidatetime ociduration ociinterval ociloblocator ocinumber ociref ocirefcursor ocirowid ocistring ocitype oct octet_length of off offline offset oid oidindex old on online only opaque open operations operator optimal optimize option optionally or oracle oracle_date oradata ord ordaudio orddicom orddoc order ordimage ordinality ordvideo organization orlany orlvary out outer outfile outline output over overflow overriding package pad parallel parallel_enable parameters parent parse partial partition partitions pascal passing password password_grace_time password_lock_time password_reuse_max password_reuse_time password_verify_function patch path patindex pctincrease pctthreshold pctused pctversion percent percent_rank percentile_cont percentile_disc performance period period_add period_diff permanent physical pi pipe pipelined pivot pluggable plugin policy position post_transaction pow power pragma prebuilt precedes preceding precision prediction prediction_cost prediction_details prediction_probability prediction_set prepare present preserve prior priority private private_sga privileges procedural procedure procedure_analyze processlist profiles project prompt protection public publishingservername purge quarter query quick quiesce quota quotename radians raise rand range rank raw read reads readsize rebuild record records recover recovery recursive recycle redo reduced ref reference referenced references referencing refresh regexp_like register regr_avgx regr_avgy regr_count regr_intercept regr_r2 regr_slope regr_sxx regr_sxy reject rekey relational relative relaylog release release_lock relies_on relocate rely rem remainder rename repair repeat replace replicate replication required reset resetlogs resize resource respect restore restricted result result_cache resumable resume retention return returning returns reuse reverse revoke right rlike role roles rollback rolling rollup round row row_count rowdependencies rowid rownum rows rtrim rules safe salt sample save savepoint sb1 sb2 sb4 scan schema schemacheck scn scope scroll sdo_georaster sdo_topo_geometry search sec_to_time second section securefile security seed segment select self sequence sequential serializable server servererror session session_user sessions_per_user set sets settings sha sha1 sha2 share shared shared_pool short show shrink shutdown si_averagecolor si_colorhistogram si_featurelist si_positionalcolor si_stillimage si_texture siblings sid sign sin size size_t sizes skip slave sleep smalldatetimefromparts smallfile snapshot some soname sort soundex source space sparse spfile split sql sql_big_result sql_buffer_result sql_cache sql_calc_found_rows sql_small_result sql_variant_property sqlcode sqldata sqlerror sqlname sqlstate sqrt square standalone standby start starting startup statement static statistics stats_binomial_test stats_crosstab stats_ks_test stats_mode stats_mw_test stats_one_way_anova stats_t_test_ stats_t_test_indep stats_t_test_one stats_t_test_paired stats_wsr_test status std stddev stddev_pop stddev_samp stdev stop storage store stored str str_to_date straight_join strcmp strict string struct stuff style subdate subpartition subpartitions substitutable substr substring subtime subtring_index subtype success sum suspend switch switchoffset switchover sync synchronous synonym sys sys_xmlagg sysasm sysaux sysdate sysdatetimeoffset sysdba sysoper system system_user sysutcdatetime table tables tablespace tan tdo template temporary terminated tertiary_weights test than then thread through tier ties time time_format time_zone timediff timefromparts timeout timestamp timestampadd timestampdiff timezone_abbr timezone_minute timezone_region to to_base64 to_date to_days to_seconds todatetimeoffset trace tracking transaction transactional translate translation treat trigger trigger_nestlevel triggers trim truncate try_cast try_convert try_parse type ub1 ub2 ub4 ucase unarchived unbounded uncompress under undo unhex unicode uniform uninstall union unique unix_timestamp unknown unlimited unlock unpivot unrecoverable unsafe unsigned until untrusted unusable unused update updated upgrade upped upper upsert url urowid usable usage use use_stored_outlines user user_data user_resources users using utc_date utc_timestamp uuid uuid_short validate validate_password_strength validation valist value values var var_samp varcharc vari varia variab variabl variable variables variance varp varraw varrawc varray verify version versions view virtual visible void wait wallet warning warnings week weekday weekofyear wellformed when whene whenev wheneve whenever where while whitespace with within without work wrapped xdb xml xmlagg xmlattributes xmlcast xmlcolattval xmlelement xmlexists xmlforest xmlindex xmlnamespaces xmlpi xmlquery xmlroot xmlschema xmlserialize xmltable xmltype xor year year_to_month years yearweek",literal:"true false null",built_in:"array bigint binary bit blob boolean char character date dec decimal float int int8 integer interval number numeric real record serial serial8 smallint text varchar varying void"},c:[{cN:"string",b:"'",e:"'",c:[e.BE,{b:"''"}]},{cN:"string",b:'"',e:'"',c:[e.BE,{b:'""'}]},{cN:"string",b:"`",e:"`",c:[e.BE]},e.CNM,e.CBCM,t]},e.CBCM,t]}});hljs.registerLanguage("r",function(e){var r="([a-zA-Z]|\\.[a-zA-Z.])[a-zA-Z0-9._]*";return{c:[e.HCM,{b:r,l:r,k:{keyword:"function if in break next repeat else for return switch while try tryCatch stop warning require library attach detach source setMethod setGeneric setGroupGeneric setClass ...",literal:"NULL NA TRUE FALSE T F Inf NaN NA_integer_|10 NA_real_|10 NA_character_|10 NA_complex_|10"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{b:"`",e:"`",r:0},{cN:"string",c:[e.BE],v:[{b:'"',e:'"'},{b:"'",e:"'"}]}]}});hljs.registerLanguage("perl",function(e){var t="getpwent getservent quotemeta msgrcv scalar kill dbmclose undef lc ma syswrite tr send umask sysopen shmwrite vec qx utime local oct semctl localtime readpipe do return format read sprintf dbmopen pop getpgrp not getpwnam rewinddir qqfileno qw endprotoent wait sethostent bless s|0 opendir continue each sleep endgrent shutdown dump chomp connect getsockname die socketpair close flock exists index shmgetsub for endpwent redo lstat msgctl setpgrp abs exit select print ref gethostbyaddr unshift fcntl syscall goto getnetbyaddr join gmtime symlink semget splice x|0 getpeername recv log setsockopt cos last reverse gethostbyname getgrnam study formline endhostent times chop length gethostent getnetent pack getprotoent getservbyname rand mkdir pos chmod y|0 substr endnetent printf next open msgsnd readdir use unlink getsockopt getpriority rindex wantarray hex system getservbyport endservent int chr untie rmdir prototype tell listen fork shmread ucfirst setprotoent else sysseek link getgrgid shmctl waitpid unpack getnetbyname reset chdir grep split require caller lcfirst until warn while values shift telldir getpwuid my getprotobynumber delete and sort uc defined srand accept package seekdir getprotobyname semop our rename seek if q|0 chroot sysread setpwent no crypt getc chown sqrt write setnetent setpriority foreach tie sin msgget map stat getlogin unless elsif truncate exec keys glob tied closedirioctl socket readlink eval xor readline binmode setservent eof ord bind alarm pipe atan2 getgrent exp time push setgrent gt lt or ne m|0 break given say state when",r={cN:"subst",b:"[$@]\\{",e:"\\}",k:t},s={b:"->{",e:"}"},n={v:[{b:/\$\d/},{b:/[\$%@](\^\w\b|#\w+(::\w+)*|{\w+}|\w+(::\w*)*)/},{b:/[\$%@][^\s\w{]/,r:0}]},i=[e.BE,r,n],o=[n,e.HCM,e.C("^\\=\\w","\\=cut",{eW:!0}),s,{cN:"string",c:i,v:[{b:"q[qwxr]?\\s*\\(",e:"\\)",r:5},{b:"q[qwxr]?\\s*\\[",e:"\\]",r:5},{b:"q[qwxr]?\\s*\\{",e:"\\}",r:5},{b:"q[qwxr]?\\s*\\|",e:"\\|",r:5},{b:"q[qwxr]?\\s*\\<",e:"\\>",r:5},{b:"qw\\s+q",e:"q",r:5},{b:"'",e:"'",c:[e.BE]},{b:'"',e:'"'},{b:"`",e:"`",c:[e.BE]},{b:"{\\w+}",c:[],r:0},{b:"-?\\w+\\s*\\=\\>",c:[],r:0}]},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\/\\/|"+e.RSR+"|\\b(split|return|print|reverse|grep)\\b)\\s*",k:"split return print reverse grep",r:0,c:[e.HCM,{cN:"regexp",b:"(s|tr|y)/(\\\\.|[^/])*/(\\\\.|[^/])*/[a-z]*",r:10},{cN:"regexp",b:"(m|qr)?/",e:"/[a-z]*",c:[e.BE],r:0}]},{cN:"function",bK:"sub",e:"(\\s*\\(.*?\\))?[;{]",eE:!0,r:5,c:[e.TM]},{b:"-\\w\\b",r:0},{b:"^__DATA__$",e:"^__END__$",sL:"mojolicious",c:[{b:"^@@.*",e:"$",cN:"comment"}]}];return r.c=o,s.c=o,{aliases:["pl","pm"],l:/[\w\.]+/,k:t,c:o}});hljs.registerLanguage("ini",function(e){var b={cN:"string",c:[e.BE],v:[{b:"'''",e:"'''",r:10},{b:'"""',e:'"""',r:10},{b:'"',e:'"'},{b:"'",e:"'"}]};return{aliases:["toml"],cI:!0,i:/\S/,c:[e.C(";","$"),e.HCM,{cN:"section",b:/^\s*\[+/,e:/\]+/},{b:/^[a-z0-9\[\]_-]+\s*=\s*/,e:"$",rB:!0,c:[{cN:"attr",b:/[a-z0-9\[\]_-]+/},{b:/=/,eW:!0,r:0,c:[{cN:"literal",b:/\bon|off|true|false|yes|no\b/},{cN:"variable",v:[{b:/\$[\w\d"][\w\d_]*/},{b:/\$\{(.*?)}/}]},b,{cN:"number",b:/([\+\-]+)?[\d]+_[\d_]+/},e.NM]}]}]}});hljs.registerLanguage("diff",function(e){return{aliases:["patch"],c:[{cN:"meta",r:10,v:[{b:/^@@ +\-\d+,\d+ +\+\d+,\d+ +@@$/},{b:/^\*\*\* +\d+,\d+ +\*\*\*\*$/},{b:/^\-\-\- +\d+,\d+ +\-\-\-\-$/}]},{cN:"comment",v:[{b:/Index: /,e:/$/},{b:/={3,}/,e:/$/},{b:/^\-{3}/,e:/$/},{b:/^\*{3} /,e:/$/},{b:/^\+{3}/,e:/$/},{b:/\*{5}/,e:/\*{5}$/}]},{cN:"addition",b:"^\\+",e:"$"},{cN:"deletion",b:"^\\-",e:"$"},{cN:"addition",b:"^\\!",e:"$"}]}});hljs.registerLanguage("go",function(e){var t={keyword:"break default func interface select case map struct chan else goto package switch const fallthrough if range type continue for import return var go defer bool byte complex64 complex128 float32 float64 int8 int16 int32 int64 string uint8 uint16 uint32 uint64 int uint uintptr rune",literal:"true false iota nil",built_in:"append cap close complex copy imag len make new panic print println real recover delete"};return{aliases:["golang"],k:t,i:"</",c:[e.CLCM,e.CBCM,{cN:"string",v:[e.QSM,{b:"'",e:"[^\\\\]'"},{b:"`",e:"`"}]},{cN:"number",v:[{b:e.CNR+"[dflsi]",r:1},e.CNM]},{b:/:=/},{cN:"function",bK:"func",e:/\s*\{/,eE:!0,c:[e.TM,{cN:"params",b:/\(/,e:/\)/,k:t,i:/["']/}]}]}});hljs.registerLanguage("bash",function(e){var t={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},s={cN:"string",b:/"/,e:/"/,c:[e.BE,t,{cN:"variable",b:/\$\(/,e:/\)/,c:[e.BE]}]},a={cN:"string",b:/'/,e:/'/};return{aliases:["sh","zsh"],l:/\b-?[a-z\._]+\b/,k:{keyword:"if then else elif fi for while in do done case esac function",literal:"true false",built_in:"break cd continue eval exec exit export getopts hash pwd readonly return shift test times trap umask unset alias bind builtin caller command declare echo enable help let local logout mapfile printf read readarray source type typeset ulimit unalias set shopt autoload bg bindkey bye cap chdir clone comparguments compcall compctl compdescribe compfiles compgroups compquote comptags comptry compvalues dirs disable disown echotc echoti emulate fc fg float functions getcap getln history integer jobs kill limit log noglob popd print pushd pushln rehash sched setcap setopt stat suspend ttyctl unfunction unhash unlimit unsetopt vared wait whence where which zcompile zformat zftp zle zmodload zparseopts zprof zpty zregexparse zsocket zstyle ztcp",_:"-ne -eq -lt -gt -f -d -e -s -l -a"},c:[{cN:"meta",b:/^#![^\n]+sh\s*$/,r:10},{cN:"function",b:/\w[\w\d_]*\s*\(\s*\)\s*\{/,rB:!0,c:[e.inherit(e.TM,{b:/\w[\w\d_]*/})],r:0},e.HCM,s,a,t]}});hljs.registerLanguage("python",function(e){var r={keyword:"and elif is global as in if from raise for except finally print import pass return exec else break not with class assert yield try while continue del or def lambda async await nonlocal|10 None True False",built_in:"Ellipsis NotImplemented"},b={cN:"meta",b:/^(>>>|\.\.\.) /},c={cN:"subst",b:/\{/,e:/\}/,k:r,i:/#/},a={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,c:[b],r:10},{b:/(u|b)?r?"""/,e:/"""/,c:[b],r:10},{b:/(fr|rf|f)'''/,e:/'''/,c:[b,c]},{b:/(fr|rf|f)"""/,e:/"""/,c:[b,c]},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},{b:/(fr|rf|f)'/,e:/'/,c:[c]},{b:/(fr|rf|f)"/,e:/"/,c:[c]},e.ASM,e.QSM]},s={cN:"number",r:0,v:[{b:e.BNR+"[lLjJ]?"},{b:"\\b(0o[0-7]+)[lLjJ]?"},{b:e.CNR+"[lLjJ]?"}]},i={cN:"params",b:/\(/,e:/\)/,c:["self",b,s,a]};return c.c=[a,s,b],{aliases:["py","gyp"],k:r,i:/(<\/|->|\?)|=>/,c:[b,s,a,e.HCM,{v:[{cN:"function",bK:"def"},{cN:"class",bK:"class"}],e:/:/,i:/[${=;\n,]/,c:[e.UTM,i,{b:/->/,eW:!0,k:"None"}]},{cN:"meta",b:/^[\t ]*@/,e:/$/},{b:/\b(print|exec)\(/}]}});hljs.registerLanguage("julia",function(e){var r={keyword:"in isa where baremodule begin break catch ccall const continue do else elseif end export false finally for function global if import importall let local macro module quote return true try using while type immutable abstract bitstype typealias ",literal:"true false ARGS C_NULL DevNull ENDIAN_BOM ENV I Inf Inf16 Inf32 Inf64 InsertionSort JULIA_HOME LOAD_PATH MergeSort NaN NaN16 NaN32 NaN64 PROGRAM_FILE QuickSort RoundDown RoundFromZero RoundNearest RoundNearestTiesAway RoundNearestTiesUp RoundToZero RoundUp STDERR STDIN STDOUT VERSION catalan e|0 eu|0 eulergamma golden im nothing pi γ π φ ",built_in:"ANY AbstractArray AbstractChannel AbstractFloat AbstractMatrix AbstractRNG AbstractSerializer AbstractSet AbstractSparseArray AbstractSparseMatrix AbstractSparseVector AbstractString AbstractUnitRange AbstractVecOrMat AbstractVector Any ArgumentError Array AssertionError Associative Base64DecodePipe Base64EncodePipe Bidiagonal BigFloat BigInt BitArray BitMatrix BitVector Bool BoundsError BufferStream CachingPool CapturedException CartesianIndex CartesianRange Cchar Cdouble Cfloat Channel Char Cint Cintmax_t Clong Clonglong ClusterManager Cmd CodeInfo Colon Complex Complex128 Complex32 Complex64 CompositeException Condition ConjArray ConjMatrix ConjVector Cptrdiff_t Cshort Csize_t Cssize_t Cstring Cuchar Cuint Cuintmax_t Culong Culonglong Cushort Cwchar_t Cwstring DataType Date DateFormat DateTime DenseArray DenseMatrix DenseVecOrMat DenseVector Diagonal Dict DimensionMismatch Dims DirectIndexString Display DivideError DomainError EOFError EachLine Enum Enumerate ErrorException Exception ExponentialBackOff Expr Factorization FileMonitor Float16 Float32 Float64 Function Future GlobalRef GotoNode HTML Hermitian IO IOBuffer IOContext IOStream IPAddr IPv4 IPv6 IndexCartesian IndexLinear IndexStyle InexactError InitError Int Int128 Int16 Int32 Int64 Int8 IntSet Integer InterruptException InvalidStateException Irrational KeyError LabelNode LinSpace LineNumberNode LoadError LowerTriangular MIME Matrix MersenneTwister Method MethodError MethodTable Module NTuple NewvarNode NullException Nullable Number ObjectIdDict OrdinalRange OutOfMemoryError OverflowError Pair ParseError PartialQuickSort PermutedDimsArray Pipe PollingFileWatcher ProcessExitedException Ptr QuoteNode RandomDevice Range RangeIndex Rational RawFD ReadOnlyMemoryError Real ReentrantLock Ref Regex RegexMatch RemoteChannel RemoteException RevString RoundingMode RowVector SSAValue SegmentationFault SerializationState Set SharedArray SharedMatrix SharedVector Signed SimpleVector Slot SlotNumber SparseMatrixCSC SparseVector StackFrame StackOverflowError StackTrace StepRange StepRangeLen StridedArray StridedMatrix StridedVecOrMat StridedVector String SubArray SubString SymTridiagonal Symbol Symmetric SystemError TCPSocket Task Text TextDisplay Timer Tridiagonal Tuple Type TypeError TypeMapEntry TypeMapLevel TypeName TypeVar TypedSlot UDPSocket UInt UInt128 UInt16 UInt32 UInt64 UInt8 UndefRefError UndefVarError UnicodeError UniformScaling Union UnionAll UnitRange Unsigned UpperTriangular Val Vararg VecElement VecOrMat Vector VersionNumber Void WeakKeyDict WeakRef WorkerConfig WorkerPool "},t="[A-Za-z_\\u00A1-\\uFFFF][A-Za-z_0-9\\u00A1-\\uFFFF]*",a={l:t,k:r,i:/<\//},n={cN:"number",b:/(\b0x[\d_]*(\.[\d_]*)?|0x\.\d[\d_]*)p[-+]?\d+|\b0[box][a-fA-F0-9][a-fA-F0-9_]*|(\b\d[\d_]*(\.[\d_]*)?|\.\d[\d_]*)([eEfF][-+]?\d+)?/,r:0},o={cN:"string",b:/'(.|\\[xXuU][a-zA-Z0-9]+)'/},i={cN:"subst",b:/\$\(/,e:/\)/,k:r},l={cN:"variable",b:"\\$"+t},c={cN:"string",c:[e.BE,i,l],v:[{b:/\w*"""/,e:/"""\w*/,r:10},{b:/\w*"/,e:/"\w*/}]},s={cN:"string",c:[e.BE,i,l],b:"`",e:"`"},d={cN:"meta",b:"@"+t},u={cN:"comment",v:[{b:"#=",e:"=#",r:10},{b:"#",e:"$"}]};return a.c=[n,o,c,s,d,u,e.HCM,{cN:"keyword",b:"\\b(((abstract|primitive)\\s+)type|(mutable\\s+)?struct)\\b"},{b:/<:/}],i.c=a.c,a});hljs.registerLanguage("coffeescript",function(e){var c={keyword:"in if for while finally new do return else break catch instanceof throw try this switch continue typeof delete debugger super yield import export from as default await then unless until loop of by when and or is isnt not",literal:"true false null undefined yes no on off",built_in:"npm require console print module global window document"},n="[A-Za-z$_][0-9A-Za-z$_]*",r={cN:"subst",b:/#\{/,e:/}/,k:c},i=[e.BNM,e.inherit(e.CNM,{starts:{e:"(\\s*/)?",r:0}}),{cN:"string",v:[{b:/'''/,e:/'''/,c:[e.BE]},{b:/'/,e:/'/,c:[e.BE]},{b:/"""/,e:/"""/,c:[e.BE,r]},{b:/"/,e:/"/,c:[e.BE,r]}]},{cN:"regexp",v:[{b:"///",e:"///",c:[r,e.HCM]},{b:"//[gim]*",r:0},{b:/\/(?![ *])(\\\/|.)*?\/[gim]*(?=\W|$)/}]},{b:"@"+n},{sL:"javascript",eB:!0,eE:!0,v:[{b:"```",e:"```"},{b:"`",e:"`"}]}];r.c=i;var s=e.inherit(e.TM,{b:n}),t="(\\(.*\\))?\\s*\\B[-=]>",o={cN:"params",b:"\\([^\\(]",rB:!0,c:[{b:/\(/,e:/\)/,k:c,c:["self"].concat(i)}]};return{aliases:["coffee","cson","iced"],k:c,i:/\/\*/,c:i.concat([e.C("###","###"),e.HCM,{cN:"function",b:"^\\s*"+n+"\\s*=\\s*"+t,e:"[-=]>",rB:!0,c:[s,o]},{b:/[:\(,=]\s*/,r:0,c:[{cN:"function",b:t,e:"[-=]>",rB:!0,c:[o]}]},{cN:"class",bK:"class",e:"$",i:/[:="\[\]]/,c:[{bK:"extends",eW:!0,i:/[:="\[\]]/,c:[s]},s]},{b:n+":",e:":",rB:!0,rE:!0,r:0}])}});hljs.registerLanguage("cpp",function(t){var e={cN:"keyword",b:"\\b[a-z\\d_]*_t\\b"},r={cN:"string",v:[{b:'(u8?|U)?L?"',e:'"',i:"\\n",c:[t.BE]},{b:'(u8?|U)?R"',e:'"',c:[t.BE]},{b:"'\\\\?.",e:"'",i:"."}]},s={cN:"number",v:[{b:"\\b(0b[01']+)"},{b:"(-?)\\b([\\d']+(\\.[\\d']*)?|\\.[\\d']+)(u|U|l|L|ul|UL|f|F|b|B)"},{b:"(-?)(\\b0[xX][a-fA-F0-9']+|(\\b[\\d']+(\\.[\\d']*)?|\\.[\\d']+)([eE][-+]?[\\d']+)?)"}],r:0},i={cN:"meta",b:/#\s*[a-z]+\b/,e:/$/,k:{"meta-keyword":"if else elif endif define undef warning error line pragma ifdef ifndef include"},c:[{b:/\\\n/,r:0},t.inherit(r,{cN:"meta-string"}),{cN:"meta-string",b:/<[^\n>]*>/,e:/$/,i:"\\n"},t.CLCM,t.CBCM]},a=t.IR+"\\s*\\(",c={keyword:"int float while private char catch import module export virtual operator sizeof dynamic_cast|10 typedef const_cast|10 const for static_cast|10 union namespace unsigned long volatile static protected bool template mutable if public friend do goto auto void enum else break extern using asm case typeid short reinterpret_cast|10 default double register explicit signed typename try this switch continue inline delete alignof constexpr decltype noexcept static_assert thread_local restrict _Bool complex _Complex _Imaginary atomic_bool atomic_char atomic_schar atomic_uchar atomic_short atomic_ushort atomic_int atomic_uint atomic_long atomic_ulong atomic_llong atomic_ullong new throw return and or not",built_in:"std string cin cout cerr clog stdin stdout stderr stringstream istringstream ostringstream auto_ptr deque list queue stack vector map set bitset multiset multimap unordered_set unordered_map unordered_multiset unordered_multimap array shared_ptr abort abs acos asin atan2 atan calloc ceil cosh cos exit exp fabs floor fmod fprintf fputs free frexp fscanf isalnum isalpha iscntrl isdigit isgraph islower isprint ispunct isspace isupper isxdigit tolower toupper labs ldexp log10 log malloc realloc memchr memcmp memcpy memset modf pow printf putchar puts scanf sinh sin snprintf sprintf sqrt sscanf strcat strchr strcmp strcpy strcspn strlen strncat strncmp strncpy strpbrk strrchr strspn strstr tanh tan vfprintf vprintf vsprintf endl initializer_list unique_ptr",literal:"true false nullptr NULL"},n=[e,t.CLCM,t.CBCM,s,r];return{aliases:["c","cc","h","c++","h++","hpp"],k:c,i:"</",c:n.concat([i,{b:"\\b(deque|list|queue|stack|vector|map|set|bitset|multiset|multimap|unordered_map|unordered_set|unordered_multiset|unordered_multimap|array)\\s*<",e:">",k:c,c:["self",e]},{b:t.IR+"::",k:c},{v:[{b:/=/,e:/;/},{b:/\(/,e:/\)/},{bK:"new throw return else",e:/;/}],k:c,c:n.concat([{b:/\(/,e:/\)/,k:c,c:n.concat(["self"]),r:0}]),r:0},{cN:"function",b:"("+t.IR+"[\\*&\\s]+)+"+a,rB:!0,e:/[{;=]/,eE:!0,k:c,i:/[^\w\s\*&]/,c:[{b:a,rB:!0,c:[t.TM],r:0},{cN:"params",b:/\(/,e:/\)/,k:c,r:0,c:[t.CLCM,t.CBCM,r,s,e]},t.CLCM,t.CBCM,i]},{cN:"class",bK:"class struct",e:/[{;:]/,c:[{b:/</,e:/>/,c:["self"]},t.TM]}]),exports:{preprocessor:i,strings:r,k:c}}});hljs.registerLanguage("ruby",function(e){var b="[a-zA-Z_]\\w*[!?=]?|[-+~]\\@|<<|>>|=~|===?|<=>|[<>]=?|\\*\\*|[-/+%^&*~`|]|\\[\\]=?",r={keyword:"and then defined module in return redo if BEGIN retry end for self when next until do begin unless END rescue else break undef not super class case require yield alias while ensure elsif or include attr_reader attr_writer attr_accessor",literal:"true false nil"},c={cN:"doctag",b:"@[A-Za-z]+"},a={b:"#<",e:">"},s=[e.C("#","$",{c:[c]}),e.C("^\\=begin","^\\=end",{c:[c],r:10}),e.C("^__END__","\\n$")],n={cN:"subst",b:"#\\{",e:"}",k:r},t={cN:"string",c:[e.BE,n],v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/`/,e:/`/},{b:"%[qQwWx]?\\(",e:"\\)"},{b:"%[qQwWx]?\\[",e:"\\]"},{b:"%[qQwWx]?{",e:"}"},{b:"%[qQwWx]?<",e:">"},{b:"%[qQwWx]?/",e:"/"},{b:"%[qQwWx]?%",e:"%"},{b:"%[qQwWx]?-",e:"-"},{b:"%[qQwWx]?\\|",e:"\\|"},{b:/\B\?(\\\d{1,3}|\\x[A-Fa-f0-9]{1,2}|\\u[A-Fa-f0-9]{4}|\\?\S)\b/},{b:/<<(-?)\w+$/,e:/^\s*\w+$/}]},i={cN:"params",b:"\\(",e:"\\)",endsParent:!0,k:r},d=[t,a,{cN:"class",bK:"class module",e:"$|;",i:/=/,c:[e.inherit(e.TM,{b:"[A-Za-z_]\\w*(::\\w+)*(\\?|\\!)?"}),{b:"<\\s*",c:[{b:"("+e.IR+"::)?"+e.IR}]}].concat(s)},{cN:"function",bK:"def",e:"$|;",c:[e.inherit(e.TM,{b:b}),i].concat(s)},{b:e.IR+"::"},{cN:"symbol",b:e.UIR+"(\\!|\\?)?:",r:0},{cN:"symbol",b:":(?!\\s)",c:[t,{b:b}],r:0},{cN:"number",b:"(\\b0[0-7_]+)|(\\b0x[0-9a-fA-F_]+)|(\\b[1-9][0-9_]*(\\.[0-9_]+)?)|[0_]\\b",r:0},{b:"(\\$\\W)|((\\$|\\@\\@?)(\\w+))"},{cN:"params",b:/\|/,e:/\|/,k:r},{b:"("+e.RSR+"|unless)\\s*",k:"unless",c:[a,{cN:"regexp",c:[e.BE,n],i:/\n/,v:[{b:"/",e:"/[a-z]*"},{b:"%r{",e:"}[a-z]*"},{b:"%r\\(",e:"\\)[a-z]*"},{b:"%r!",e:"![a-z]*"},{b:"%r\\[",e:"\\][a-z]*"}]}].concat(s),r:0}].concat(s);n.c=d,i.c=d;var l="[>?]>",o="[\\w#]+\\(\\w+\\):\\d+:\\d+>",u="(\\w+-)?\\d+\\.\\d+\\.\\d(p\\d+)?[^>]+>",w=[{b:/^\s*=>/,starts:{e:"$",c:d}},{cN:"meta",b:"^("+l+"|"+o+"|"+u+")",starts:{e:"$",c:d}}];return{aliases:["rb","gemspec","podspec","thor","irb"],k:r,i:/\/\*/,c:s.concat(w).concat(d)}});hljs.registerLanguage("yaml",function(e){var b="true false yes no null",a="^[ \\-]*",r="[a-zA-Z_][\\w\\-]*",t={cN:"attr",v:[{b:a+r+":"},{b:a+'"'+r+'":'},{b:a+"'"+r+"':"}]},c={cN:"template-variable",v:[{b:"{{",e:"}}"},{b:"%{",e:"}"}]},l={cN:"string",r:0,v:[{b:/'/,e:/'/},{b:/"/,e:/"/},{b:/\S+/}],c:[e.BE,c]};return{cI:!0,aliases:["yml","YAML","yaml"],c:[t,{cN:"meta",b:"^---s*$",r:10},{cN:"string",b:"[\\|>] *$",rE:!0,c:l.c,e:t.v[0].b},{b:"<%[%=-]?",e:"[%-]?%>",sL:"ruby",eB:!0,eE:!0,r:0},{cN:"type",b:"!!"+e.UIR},{cN:"meta",b:"&"+e.UIR+"$"},{cN:"meta",b:"\\*"+e.UIR+"$"},{cN:"bullet",b:"^ *-",r:0},e.HCM,{bK:b,k:{literal:b}},e.CNM,l]}});hljs.registerLanguage("css",function(e){var c="[a-zA-Z-][a-zA-Z0-9_-]*",t={b:/[A-Z\_\.\-]+\s*:/,rB:!0,e:";",eW:!0,c:[{cN:"attribute",b:/\S/,e:":",eE:!0,starts:{eW:!0,eE:!0,c:[{b:/[\w-]+\(/,rB:!0,c:[{cN:"built_in",b:/[\w-]+/},{b:/\(/,e:/\)/,c:[e.ASM,e.QSM]}]},e.CSSNM,e.QSM,e.ASM,e.CBCM,{cN:"number",b:"#[0-9A-Fa-f]+"},{cN:"meta",b:"!important"}]}}]};return{cI:!0,i:/[=\/|'\$]/,c:[e.CBCM,{cN:"selector-id",b:/#[A-Za-z0-9_-]+/},{cN:"selector-class",b:/\.[A-Za-z0-9_-]+/},{cN:"selector-attr",b:/\[/,e:/\]/,i:"$"},{cN:"selector-pseudo",b:/:(:)?[a-zA-Z0-9\_\-\+\(\)"'.]+/},{b:"@(font-face|page)",l:"[a-z-]+",k:"font-face page"},{b:"@",e:"[{;]",i:/:/,c:[{cN:"keyword",b:/\w+/},{b:/\s/,eW:!0,eE:!0,r:0,c:[e.ASM,e.QSM,e.CSSNM]}]},{cN:"selector-tag",b:c,r:0},{b:"{",e:"}",i:/\S/,c:[e.CBCM,t]}]}});hljs.registerLanguage("fortran",function(e){var t={cN:"params",b:"\\(",e:"\\)"},n={literal:".False. .True.",keyword:"kind do while private call intrinsic where elsewhere type endtype endmodule endselect endinterface end enddo endif if forall endforall only contains default return stop then public subroutine|10 function program .and. .or. .not. .le. .eq. .ge. .gt. .lt. goto save else use module select case access blank direct exist file fmt form formatted iostat name named nextrec number opened rec recl sequential status unformatted unit continue format pause cycle exit c_null_char c_alert c_backspace c_form_feed flush wait decimal round iomsg synchronous nopass non_overridable pass protected volatile abstract extends import non_intrinsic value deferred generic final enumerator class associate bind enum c_int c_short c_long c_long_long c_signed_char c_size_t c_int8_t c_int16_t c_int32_t c_int64_t c_int_least8_t c_int_least16_t c_int_least32_t c_int_least64_t c_int_fast8_t c_int_fast16_t c_int_fast32_t c_int_fast64_t c_intmax_t C_intptr_t c_float c_double c_long_double c_float_complex c_double_complex c_long_double_complex c_bool c_char c_null_ptr c_null_funptr c_new_line c_carriage_return c_horizontal_tab c_vertical_tab iso_c_binding c_loc c_funloc c_associated  c_f_pointer c_ptr c_funptr iso_fortran_env character_storage_size error_unit file_storage_size input_unit iostat_end iostat_eor numeric_storage_size output_unit c_f_procpointer ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode newunit contiguous recursive pad position action delim readwrite eor advance nml interface procedure namelist include sequence elemental pure integer real character complex logical dimension allocatable|10 parameter external implicit|10 none double precision assign intent optional pointer target in out common equivalence data",built_in:"alog alog10 amax0 amax1 amin0 amin1 amod cabs ccos cexp clog csin csqrt dabs dacos dasin datan datan2 dcos dcosh ddim dexp dint dlog dlog10 dmax1 dmin1 dmod dnint dsign dsin dsinh dsqrt dtan dtanh float iabs idim idint idnint ifix isign max0 max1 min0 min1 sngl algama cdabs cdcos cdexp cdlog cdsin cdsqrt cqabs cqcos cqexp cqlog cqsin cqsqrt dcmplx dconjg derf derfc dfloat dgamma dimag dlgama iqint qabs qacos qasin qatan qatan2 qcmplx qconjg qcos qcosh qdim qerf qerfc qexp qgamma qimag qlgama qlog qlog10 qmax1 qmin1 qmod qnint qsign qsin qsinh qsqrt qtan qtanh abs acos aimag aint anint asin atan atan2 char cmplx conjg cos cosh exp ichar index int log log10 max min nint sign sin sinh sqrt tan tanh print write dim lge lgt lle llt mod nullify allocate deallocate adjustl adjustr all allocated any associated bit_size btest ceiling count cshift date_and_time digits dot_product eoshift epsilon exponent floor fraction huge iand ibclr ibits ibset ieor ior ishft ishftc lbound len_trim matmul maxexponent maxloc maxval merge minexponent minloc minval modulo mvbits nearest pack present product radix random_number random_seed range repeat reshape rrspacing scale scan selected_int_kind selected_real_kind set_exponent shape size spacing spread sum system_clock tiny transpose trim ubound unpack verify achar iachar transfer dble entry dprod cpu_time command_argument_count get_command get_command_argument get_environment_variable is_iostat_end ieee_arithmetic ieee_support_underflow_control ieee_get_underflow_mode ieee_set_underflow_mode is_iostat_eor move_alloc new_line selected_char_kind same_type_as extends_type_ofacosh asinh atanh bessel_j0 bessel_j1 bessel_jn bessel_y0 bessel_y1 bessel_yn erf erfc erfc_scaled gamma log_gamma hypot norm2 atomic_define atomic_ref execute_command_line leadz trailz storage_size merge_bits bge bgt ble blt dshiftl dshiftr findloc iall iany iparity image_index lcobound ucobound maskl maskr num_images parity popcnt poppar shifta shiftl shiftr this_image"};return{cI:!0,aliases:["f90","f95"],k:n,i:/\/\*/,c:[e.inherit(e.ASM,{cN:"string",r:0}),e.inherit(e.QSM,{cN:"string",r:0}),{cN:"function",bK:"subroutine function program",i:"[${=\\n]",c:[e.UTM,t]},e.C("!","$",{r:0}),{cN:"number",b:"(?=\\b|\\+|\\-|\\.)(?=\\.\\d|\\d)(?:\\d+)?(?:\\.?\\d*)(?:[de][+-]?\\d+)?\\b\\.?",r:0}]}});hljs.registerLanguage("awk",function(e){var r={cN:"variable",v:[{b:/\$[\w\d#@][\w\d_]*/},{b:/\$\{(.*?)}/}]},b="BEGIN END if else while do for in break continue delete next nextfile function func exit|10",n={cN:"string",c:[e.BE],v:[{b:/(u|b)?r?'''/,e:/'''/,r:10},{b:/(u|b)?r?"""/,e:/"""/,r:10},{b:/(u|r|ur)'/,e:/'/,r:10},{b:/(u|r|ur)"/,e:/"/,r:10},{b:/(b|br)'/,e:/'/},{b:/(b|br)"/,e:/"/},e.ASM,e.QSM]};return{k:{keyword:b},c:[r,n,e.RM,e.HCM,e.NM]}});hljs.registerLanguage("makefile",function(e){var i={cN:"variable",v:[{b:"\\$\\("+e.UIR+"\\)",c:[e.BE]},{b:/\$[@%<?\^\+\*]/}]},r={cN:"string",b:/"/,e:/"/,c:[e.BE,i]},a={cN:"variable",b:/\$\([\w-]+\s/,e:/\)/,k:{built_in:"subst patsubst strip findstring filter filter-out sort word wordlist firstword lastword dir notdir suffix basename addsuffix addprefix join wildcard realpath abspath error warning shell origin flavor foreach if or and call eval file value"},c:[i]},n={b:"^"+e.UIR+"\\s*[:+?]?=",i:"\\n",rB:!0,c:[{b:"^"+e.UIR,e:"[:+?]?=",eE:!0}]},t={cN:"meta",b:/^\.PHONY:/,e:/$/,k:{"meta-keyword":".PHONY"},l:/[\.\w]+/},l={cN:"section",b:/^[^\s]+:/,e:/$/,c:[i]};return{aliases:["mk","mak"],k:"define endef undefine ifdef ifndef ifeq ifneq else endif include -include sinclude override export unexport private vpath",l:/[\w-]+/,c:[e.HCM,i,r,a,n,t,l]}});hljs.registerLanguage("java",function(e){var a="[À-ʸa-zA-Z_$][À-ʸa-zA-Z_$0-9]*",t=a+"(<"+a+"(\\s*,\\s*"+a+")*>)?",r="false synchronized int abstract float private char boolean static null if const for true while long strictfp finally protected import native final void enum else break transient catch instanceof byte super volatile case assert short package default double public try this switch continue throws protected public private module requires exports do",s="\\b(0[bB]([01]+[01_]+[01]+|[01]+)|0[xX]([a-fA-F0-9]+[a-fA-F0-9_]+[a-fA-F0-9]+|[a-fA-F0-9]+)|(([\\d]+[\\d_]+[\\d]+|[\\d]+)(\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))?|\\.([\\d]+[\\d_]+[\\d]+|[\\d]+))([eE][-+]?\\d+)?)[lLfF]?",c={cN:"number",b:s,r:0};return{aliases:["jsp"],k:r,i:/<\/|#/,c:[e.C("/\\*\\*","\\*/",{r:0,c:[{b:/\w+@/,r:0},{cN:"doctag",b:"@[A-Za-z]+"}]}),e.CLCM,e.CBCM,e.ASM,e.QSM,{cN:"class",bK:"class interface",e:/[{;=]/,eE:!0,k:"class interface",i:/[:"\[\]]/,c:[{bK:"extends implements"},e.UTM]},{bK:"new throw return else",r:0},{cN:"function",b:"("+t+"\\s+)+"+e.UIR+"\\s*\\(",rB:!0,e:/[{;=]/,eE:!0,k:r,c:[{b:e.UIR+"\\s*\\(",rB:!0,r:0,c:[e.UTM]},{cN:"params",b:/\(/,e:/\)/,k:r,r:0,c:[e.ASM,e.QSM,e.CNM,e.CBCM]},e.CLCM,e.CBCM]},c,{cN:"meta",b:"@[A-Za-z]+"}]}});hljs.registerLanguage("stan",function(e){return{c:[e.HCM,e.CLCM,e.CBCM,{b:e.UIR,l:e.UIR,k:{name:"for in while repeat until if then else",symbol:"bernoulli bernoulli_logit binomial binomial_logit beta_binomial hypergeometric categorical categorical_logit ordered_logistic neg_binomial neg_binomial_2 neg_binomial_2_log poisson poisson_log multinomial normal exp_mod_normal skew_normal student_t cauchy double_exponential logistic gumbel lognormal chi_square inv_chi_square scaled_inv_chi_square exponential inv_gamma weibull frechet rayleigh wiener pareto pareto_type_2 von_mises uniform multi_normal multi_normal_prec multi_normal_cholesky multi_gp multi_gp_cholesky multi_student_t gaussian_dlm_obs dirichlet lkj_corr lkj_corr_cholesky wishart inv_wishart","selector-tag":"int real vector simplex unit_vector ordered positive_ordered row_vector matrix cholesky_factor_corr cholesky_factor_cov corr_matrix cov_matrix",title:"functions model data parameters quantities transformed generated",literal:"true false"},r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"0[xX][0-9a-fA-F]+[Li]?\\b",r:0},{cN:"number",b:"\\d+(?:[eE][+\\-]?\\d*)?L\\b",r:0},{cN:"number",b:"\\d+\\.(?!\\d)(?:i\\b)?",r:0},{cN:"number",b:"\\d+(?:\\.\\d*)?(?:[eE][+\\-]?\\d*)?i?\\b",r:0},{cN:"number",b:"\\.\\d+(?:[eE][+\\-]?\\d*)?i?\\b",r:0}]}});hljs.registerLanguage("javascript",function(e){var r="[A-Za-z$_][0-9A-Za-z$_]*",t={keyword:"in of if for while finally var new function do return void else break catch instanceof with throw case default try this switch continue typeof delete let yield const export super debugger as async await static import from as",literal:"true false null undefined NaN Infinity",built_in:"eval isFinite isNaN parseFloat parseInt decodeURI decodeURIComponent encodeURI encodeURIComponent escape unescape Object Function Boolean Error EvalError InternalError RangeError ReferenceError StopIteration SyntaxError TypeError URIError Number Math Date String RegExp Array Float32Array Float64Array Int16Array Int32Array Int8Array Uint16Array Uint32Array Uint8Array Uint8ClampedArray ArrayBuffer DataView JSON Intl arguments require module console window document Symbol Set Map WeakSet WeakMap Proxy Reflect Promise"},a={cN:"number",v:[{b:"\\b(0[bB][01]+)"},{b:"\\b(0[oO][0-7]+)"},{b:e.CNR}],r:0},n={cN:"subst",b:"\\$\\{",e:"\\}",k:t,c:[]},c={cN:"string",b:"`",e:"`",c:[e.BE,n]};n.c=[e.ASM,e.QSM,c,a,e.RM];var s=n.c.concat([e.CBCM,e.CLCM]);return{aliases:["js","jsx"],k:t,c:[{cN:"meta",r:10,b:/^\s*['"]use (strict|asm)['"]/},{cN:"meta",b:/^#!/,e:/$/},e.ASM,e.QSM,c,e.CLCM,e.CBCM,a,{b:/[{,]\s*/,r:0,c:[{b:r+"\\s*:",rB:!0,r:0,c:[{cN:"attr",b:r,r:0}]}]},{b:"("+e.RSR+"|\\b(case|return|throw)\\b)\\s*",k:"return throw case",c:[e.CLCM,e.CBCM,e.RM,{cN:"function",b:"(\\(.*?\\)|"+r+")\\s*=>",rB:!0,e:"\\s*=>",c:[{cN:"params",v:[{b:r},{b:/\(\s*\)/},{b:/\(/,e:/\)/,eB:!0,eE:!0,k:t,c:s}]}]},{b:/</,e:/(\/\w+|\w+\/)>/,sL:"xml",c:[{b:/<\w+\s*\/>/,skip:!0},{b:/<\w+/,e:/(\/\w+|\w+\/)>/,skip:!0,c:[{b:/<\w+\s*\/>/,skip:!0},"self"]}]}],r:0},{cN:"function",bK:"function",e:/\{/,eE:!0,c:[e.inherit(e.TM,{b:r}),{cN:"params",b:/\(/,e:/\)/,eB:!0,eE:!0,c:s}],i:/\[|%/},{b:/\$[(.]/},e.METHOD_GUARD,{cN:"class",bK:"class",e:/[{;=]/,eE:!0,i:/[:"\[\]]/,c:[{bK:"extends"},e.UTM]},{bK:"constructor",e:/\{/,eE:!0}],i:/#(?!!)/}});hljs.registerLanguage("tex",function(c){var e={cN:"tag",b:/\\/,r:0,c:[{cN:"name",v:[{b:/[a-zA-Zа-яА-я]+[*]?/},{b:/[^a-zA-Zа-яА-я0-9]/}],starts:{eW:!0,r:0,c:[{cN:"string",v:[{b:/\[/,e:/\]/},{b:/\{/,e:/\}/}]},{b:/\s*=\s*/,eW:!0,r:0,c:[{cN:"number",b:/-?\d*\.?\d+(pt|pc|mm|cm|in|dd|cc|ex|em)?/}]}]}}]};return{c:[e,{cN:"formula",c:[e],r:0,v:[{b:/\$\$/,e:/\$\$/},{b:/\$/,e:/\$/}]},c.C("%","$",{r:0})]}});hljs.registerLanguage("xml",function(s){var e="[A-Za-z0-9\\._:-]+",t={eW:!0,i:/</,r:0,c:[{cN:"attr",b:e,r:0},{b:/=\s*/,r:0,c:[{cN:"string",endsParent:!0,v:[{b:/"/,e:/"/},{b:/'/,e:/'/},{b:/[^\s"'=<>`]+/}]}]}]};return{aliases:["html","xhtml","rss","atom","xjb","xsd","xsl","plist"],cI:!0,c:[{cN:"meta",b:"<!DOCTYPE",e:">",r:10,c:[{b:"\\[",e:"\\]"}]},s.C("<!--","-->",{r:10}),{b:"<\\!\\[CDATA\\[",e:"\\]\\]>",r:10},{b:/<\?(php)?/,e:/\?>/,sL:"php",c:[{b:"/\\*",e:"\\*/",skip:!0}]},{cN:"tag",b:"<style(?=\\s|>|$)",e:">",k:{name:"style"},c:[t],starts:{e:"</style>",rE:!0,sL:["css","xml"]}},{cN:"tag",b:"<script(?=\\s|>|$)",e:">",k:{name:"script"},c:[t],starts:{e:"</script>",rE:!0,sL:["actionscript","javascript","handlebars","xml"]}},{cN:"meta",v:[{b:/<\?xml/,e:/\?>/,r:10},{b:/<\?\w+/,e:/\?>/}]},{cN:"tag",b:"</?",e:"/?>",c:[{cN:"name",b:/[^\/><\s]+/,r:0},t]}]}});hljs.registerLanguage("markdown",function(e){return{aliases:["md","mkdown","mkd"],c:[{cN:"section",v:[{b:"^#{1,6}",e:"$"},{b:"^.+?\\n[=-]{2,}$"}]},{b:"<",e:">",sL:"xml",r:0},{cN:"bullet",b:"^([*+-]|(\\d+\\.))\\s+"},{cN:"strong",b:"[*_]{2}.+?[*_]{2}"},{cN:"emphasis",v:[{b:"\\*.+?\\*"},{b:"_.+?_",r:0}]},{cN:"quote",b:"^>\\s+",e:"$"},{cN:"code",v:[{b:"^```w*s*$",e:"^```s*$"},{b:"`.+?`"},{b:"^( {4}|	)",e:"$",r:0}]},{b:"^[-\\*]{3,}",e:"$"},{b:"\\[.+?\\][\\(\\[].*?[\\)\\]]",rB:!0,c:[{cN:"string",b:"\\[",e:"\\]",eB:!0,rE:!0,r:0},{cN:"link",b:"\\]\\(",e:"\\)",eB:!0,eE:!0},{cN:"symbol",b:"\\]\\[",e:"\\]",eB:!0,eE:!0}],r:10},{b:/^\[[^\n]+\]:/,rB:!0,c:[{cN:"symbol",b:/\[/,e:/\]/,eB:!0,eE:!0},{cN:"link",b:/:\s*/,e:/$/,eB:!0}]}]}});hljs.registerLanguage("json",function(e){var i={literal:"true false null"},n=[e.QSM,e.CNM],r={e:",",eW:!0,eE:!0,c:n,k:i},t={b:"{",e:"}",c:[{cN:"attr",b:/"/,e:/"/,c:[e.BE],i:"\\n"},e.inherit(r,{b:/:/})],i:"\\S"},c={b:"\\[",e:"\\]",c:[e.inherit(r)],i:"\\S"};return n.splice(n.length,0,t,c),{c:n,k:i,i:"\\S"}});"></script>
<style type="text/css">.pagedtable {
overflow: auto;
padding-left: 8px;
padding-right: 8px;
}
.pagedtable-wrapper {
border: 1px solid #ccc;
border-radius: 4px;
margin-bottom: 10px;
}
.pagedtable table {
width: 100%;
max-width: 100%;
margin: 0;
}
.pagedtable th {
padding: 0 5px 0 5px;
border: none;
border-bottom: 2px solid #dddddd;
min-width: 45px;
}
.pagedtable-empty th {
display: none;
}
.pagedtable td {
padding: 0 4px 0 4px;
}
.pagedtable .even {
background-color: rgba(140, 140, 140, 0.1);
}
.pagedtable-padding-col {
display: none;
}
.pagedtable a {
-webkit-touch-callout: none;
-webkit-user-select: none;
-khtml-user-select: none;
-moz-user-select: none;
-ms-user-select: none;
user-select: none;
}
.pagedtable-index-nav {
cursor: pointer;
padding: 0 5px 0 5px;
float: right;
border: 0;
}
.pagedtable-index-nav-disabled {
cursor: default;
text-decoration: none;
color: #999;
}
a.pagedtable-index-nav-disabled:hover {
text-decoration: none;
color: #999;
}
.pagedtable-indexes {
cursor: pointer;
float: right;
border: 0;
}
.pagedtable-index-current {
cursor: default;
text-decoration: none;
font-weight: bold;
color: #333;
border: 0;
}
a.pagedtable-index-current:hover {
text-decoration: none;
font-weight: bold;
color: #333;
}
.pagedtable-index {
width: 30px;
display: inline-block;
text-align: center;
border: 0;
}
.pagedtable-index-separator-left {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 0 0 0;
cursor: default;
}
.pagedtable-index-separator-right {
display: inline-block;
color: #333;
font-size: 9px;
padding: 0 4px 0 0;
cursor: default;
}
.pagedtable-footer {
padding-top: 4px;
padding-bottom: 5px;
}
.pagedtable-not-empty .pagedtable-footer {
border-top: 2px solid #dddddd;
}
.pagedtable-info {
overflow: hidden;
color: #999;
white-space: nowrap;
text-overflow: ellipsis;
}
.pagedtable-header-name {
overflow: hidden;
text-overflow: ellipsis;
}
.pagedtable-header-type {
color: #999;
font-weight: 400;
}
.pagedtable-na-cell {
font-style: italic;
opacity: 0.3;
}
</style>
<script>// Production steps of ECMA-262, Edition 5, 15.4.4.18
// Reference: http://es5.github.io/#x15.4.4.18
if (!Array.prototype.forEach) {

  Array.prototype.forEach = function(callback, thisArg) {

    var T, k;

    if (this === null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling toObject() passing the
    // |this| value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get() internal
    // method of O with the argument "length".
    // 3. Let len be toUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If isCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== "function") {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let
    // T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let k be 0
    k = 0;

    // 7. Repeat, while k < len
    while (k < len) {

      var kValue;

      // a. Let Pk be ToString(k).
      //    This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty
      //    internal method of O with argument Pk.
      //    This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        // method of O with argument Pk.
        kValue = O[k];

        // ii. Call the Call internal method of callback with T as
        // the this value and argument list containing kValue, k, and O.
        callback.call(T, kValue, k, O);
      }
      // d. Increase k by 1.
      k++;
    }
    // 8. return undefined
  };
}

// Production steps of ECMA-262, Edition 5, 15.4.4.19
// Reference: http://es5.github.io/#x15.4.4.19
if (!Array.prototype.map) {

  Array.prototype.map = function(callback, thisArg) {

    var T, A, k;

    if (this == null) {
      throw new TypeError(' this is null or not defined');
    }

    // 1. Let O be the result of calling ToObject passing the |this|
    //    value as the argument.
    var O = Object(this);

    // 2. Let lenValue be the result of calling the Get internal
    //    method of O with the argument "length".
    // 3. Let len be ToUint32(lenValue).
    var len = O.length >>> 0;

    // 4. If IsCallable(callback) is false, throw a TypeError exception.
    // See: http://es5.github.com/#x9.11
    if (typeof callback !== 'function') {
      throw new TypeError(callback + ' is not a function');
    }

    // 5. If thisArg was supplied, let T be thisArg; else let T be undefined.
    if (arguments.length > 1) {
      T = thisArg;
    }

    // 6. Let A be a new array created as if by the expression new Array(len)
    //    where Array is the standard built-in constructor with that name and
    //    len is the value of len.
    A = new Array(len);

    // 7. Let k be 0
    k = 0;

    // 8. Repeat, while k < len
    while (k < len) {

      var kValue, mappedValue;

      // a. Let Pk be ToString(k).
      //   This is implicit for LHS operands of the in operator
      // b. Let kPresent be the result of calling the HasProperty internal
      //    method of O with argument Pk.
      //   This step can be combined with c
      // c. If kPresent is true, then
      if (k in O) {

        // i. Let kValue be the result of calling the Get internal
        //    method of O with argument Pk.
        kValue = O[k];

        // ii. Let mappedValue be the result of calling the Call internal
        //     method of callback with T as the this value and argument
        //     list containing kValue, k, and O.
        mappedValue = callback.call(T, kValue, k, O);

        // iii. Call the DefineOwnProperty internal method of A with arguments
        // Pk, Property Descriptor
        // { Value: mappedValue,
        //   Writable: true,
        //   Enumerable: true,
        //   Configurable: true },
        // and false.

        // In browsers that support Object.defineProperty, use the following:
        // Object.defineProperty(A, k, {
        //   value: mappedValue,
        //   writable: true,
        //   enumerable: true,
        //   configurable: true
        // });

        // For best browser support, use the following:
        A[k] = mappedValue;
      }
      // d. Increase k by 1.
      k++;
    }

    // 9. return A
    return A;
  };
}

var PagedTable = function (pagedTable) {
  var me = this;

  var source = function(pagedTable) {
    var sourceElems = [].slice.call(pagedTable.children).filter(function(e) {
      return e.hasAttribute("data-pagedtable-source");
    });

    if (sourceElems === null || sourceElems.length !== 1) {
      throw("A single data-pagedtable-source was not found");
    }

    return JSON.parse(sourceElems[0].innerHTML);
  }(pagedTable);

  var options = function(source) {
    var options = typeof(source.options) !== "undefined" &&
      source.options !== null ? source.options : {};

    var columns = typeof(options.columns) !== "undefined" ? options.columns : {};
    var rows = typeof(options.rows) !== "undefined" ? options.rows : {};

    var positiveIntOrNull = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : null;
    };

    return {
      pages: positiveIntOrNull(options.pages),
      rows: {
        min: positiveIntOrNull(rows.min),
        max: positiveIntOrNull(rows.max),
        total: positiveIntOrNull(rows.total)
      },
      columns: {
        min: positiveIntOrNull(columns.min),
        max: positiveIntOrNull(columns.max),
        total: positiveIntOrNull(columns.total)
      }
    };
  }(source);

  var Measurer = function() {

    // set some default initial values that will get adjusted in runtime
    me.measures = {
      padding: 12,
      character: 8,
      height: 15,
      defaults: true
    };

    me.calculate = function(measuresCell) {
      if (!me.measures.defaults)
        return;

      var measuresCellStyle = window.getComputedStyle(measuresCell, null);

      var newPadding = parsePadding(measuresCellStyle.paddingLeft) +
            parsePadding(measuresCellStyle.paddingRight);

      var sampleString = "ABCDEFGHIJ0123456789";
      var newCharacter = Math.ceil(measuresCell.clientWidth / sampleString.length);

      if (newPadding <= 0 || newCharacter <= 0)
        return;

      me.measures.padding = newPadding;
      me.measures.character = newCharacter;
      me.measures.height = measuresCell.clientHeight;
      me.measures.defaults = false;
    };

    return me;
  };

  var Page = function(data, options) {
    var me = this;

    var defaults = {
      max: 7,
      rows: 10
    };

    var totalPages = function() {
      return Math.ceil(data.length / me.rows);
    };

    me.number = 0;
    me.max = options.pages !== null ? options.pages : defaults.max;
    me.visible = me.max;
    me.rows = options.rows.min !== null ? options.rows.min : defaults.rows;
    me.total = totalPages();

    me.setRows = function(newRows) {
      me.rows = newRows;
      me.total = totalPages();
    };

    me.setPageNumber = function(newPageNumber) {
      if (newPageNumber < 0) newPageNumber = 0;
      if (newPageNumber >= me.total) newPageNumber = me.total - 1;

      me.number = newPageNumber;
    };

    me.setVisiblePages = function(visiblePages) {
      me.visible = Math.min(me.max, visiblePages);
      me.setPageNumber(me.number);
    };

    me.getVisiblePageRange = function() {
      var start = me.number - Math.max(Math.floor((me.visible - 1) / 2), 0);
      var end = me.number + Math.floor(me.visible / 2) + 1;
      var pageCount = me.total;

      if (start < 0) {
        var diffToStart = 0 - start;
        start += diffToStart;
        end += diffToStart;
      }

      if (end > pageCount) {
        var diffToEnd = end - pageCount;
        start -= diffToEnd;
        end -= diffToEnd;
      }

      start = start < 0 ? 0 : start;
      end = end >= pageCount ? pageCount : end;

      var first = false;
      var last = false;

      if (start > 0 && me.visible > 1) {
        start = start + 1;
        first = true;
      }

      if (end < pageCount && me.visible > 2) {
        end = end - 1;
        last = true;
      }

      return {
        first: first,
        start: start,
        end: end,
        last: last
      };
    };

    me.getRowStart = function() {
      var rowStart = page.number * page.rows;
      if (rowStart < 0)
        rowStart = 0;

      return rowStart;
    };

    me.getRowEnd = function() {
      var rowStart = me.getRowStart();
      return Math.min(rowStart + me.rows, data.length);
    };

    me.getPaddingRows = function() {
      var rowStart = me.getRowStart();
      var rowEnd = me.getRowEnd();
      return data.length > me.rows ? me.rows - (rowEnd - rowStart) : 0;
    };
  };

  var Columns = function(data, columns, options) {
    var me = this;

    me.defaults = {
      min: 5
    };

    me.number = 0;
    me.visible = 0;
    me.total = columns.length;
    me.subset = [];
    me.padding = 0;
    me.min = options.columns.min !== null ? options.columns.min : me.defaults.min;
    me.max = options.columns.max !== null ? options.columns.max : null;
    me.widths = {};

    var widthsLookAhead = Math.max(100, options.rows.min);
    var paddingColChars = 10;

    me.emptyNames = function() {
      columns.forEach(function(column) {
        if (columns.label !== null && columns.label !== "")
          return false;
      });

      return true;
    };

    var parsePadding = function(value) {
      return parseInt(value) >= 0 ? parseInt(value) : 0;
    };

    me.calculateWidths = function(measures) {
      columns.forEach(function(column) {
        var maxChars = Math.max(
          column.label.toString().length,
          column.type.toString().length
        );

        for (var idxRow = 0; idxRow < Math.min(widthsLookAhead, data.length); idxRow++) {
          maxChars = Math.max(maxChars, data[idxRow][column.name.toString()].length);
        }

        me.widths[column.name] = {
          // width in characters
          chars: maxChars,
          // width for the inner html columns
          inner: maxChars * measures.character,
          // width adding outer styles like padding
          outer: maxChars * measures.character + measures.padding
        };
      });
    };

    me.getWidth = function() {
      var widthOuter = 0;
      for (var idxCol = 0; idxCol < me.subset.length; idxCol++) {
        var columnName = me.subset[idxCol].name;
        widthOuter = widthOuter + me.widths[columnName].outer;
      }

      widthOuter = widthOuter + me.padding * paddingColChars * measurer.measures.character;

      if (me.hasMoreLeftColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      if (me.hasMoreRightColumns()) {
        widthOuter = widthOuter + columnNavigationWidthPX + measurer.measures.padding;
      }

      return widthOuter;
    };

    me.updateSlice = function() {
      if (me.number + me.visible >= me.total)
        me.number = me.total - me.visible;

      if (me.number < 0) me.number = 0;

      me.subset = columns.slice(me.number, Math.min(me.number + me.visible, me.total));

      me.subset = me.subset.map(function(column) {
        Object.keys(column).forEach(function(colKey) {
          column[colKey] = column[colKey] === null ? "" : column[colKey].toString();
        });

        column.width = null;
        return column;
      });
    };

    me.setVisibleColumns = function(columnNumber, newVisibleColumns, paddingCount) {
      me.number = columnNumber;
      me.visible = newVisibleColumns;
      me.padding = paddingCount;

      me.updateSlice();
    };

    me.incColumnNumber = function(increment) {
      me.number = me.number + increment;
    };

    me.setColumnNumber = function(newNumber) {
      me.number = newNumber;
    };

    me.setPaddingCount = function(newPadding) {
      me.padding = newPadding;
    };

    me.getPaddingCount = function() {
      return me.padding;
    };

    me.hasMoreLeftColumns = function() {
      return me.number > 0;
    };

    me.hasMoreRightColumns = function() {
      return me.number + me.visible < me.total;
    };

    me.updateSlice(0);
    return me;
  };

  var data = source.data;
  var page = new Page(data, options);
  var measurer = new Measurer(data, options);
  var columns = new Columns(data, source.columns, options);

  var table = null;
  var tableDiv = null;
  var header = null;
  var footer = null;
  var tbody = null;

  // Caches pagedTable.clientWidth, specially for webkit
  var cachedPagedTableClientWidth = null;

  var onChangeCallbacks = [];

  var clearSelection = function() {
    if(document.selection && document.selection.empty) {
      document.selection.empty();
    } else if(window.getSelection) {
      var sel = window.getSelection();
      sel.removeAllRanges();
    }
  };

  var columnNavigationWidthPX = 5;

  var renderColumnNavigation = function(increment, backwards) {
    var arrow = document.createElement("div");
    arrow.setAttribute("style",
      "border-top: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-bottom: " + columnNavigationWidthPX + "px solid transparent;" +
      "border-" + (backwards ? "right" : "left") + ": " + columnNavigationWidthPX + "px solid;");

    var header = document.createElement("th");
    header.appendChild(arrow);
    header.setAttribute("style",
      "cursor: pointer;" +
      "vertical-align: middle;" +
      "min-width: " + columnNavigationWidthPX + "px;" +
      "width: " + columnNavigationWidthPX + "px;");

    header.onclick = function() {
      columns.incColumnNumber(backwards ? -1 : increment);

      me.animateColumns(backwards);
      renderFooter();

      clearSelection();
      triggerOnChange();
    };

    return header;
  };

  var maxColumnWidth = function(width) {
    var padding = 80;
    var columnMax = Math.max(cachedPagedTableClientWidth - padding, 0);

    return parseInt(width) > 0 ?
      Math.min(columnMax, parseInt(width)) + "px" :
      columnMax + "px";
  };

  var clearHeader = function() {
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.innerHTML = "";
  };

  var renderHeader = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth;

    var fragment = document.createDocumentFragment();

    header = document.createElement("tr");
    fragment.appendChild(header);

    if (columns.number > 0)
      header.appendChild(renderColumnNavigation(-columns.visible, true));

    columns.subset = columns.subset.map(function(columnData) {
      var column = document.createElement("th");
      column.setAttribute("align", columnData.align);
      column.style.textAlign = columnData.align;

      column.style.maxWidth = maxColumnWidth(null);
      if (columnData.width) {
        column.style.minWidth =
          column.style.maxWidth = maxColumnWidth(columnData.width);
      }

      var columnName = document.createElement("div");
      columnName.setAttribute("class", "pagedtable-header-name");
      if (columnData.label === "") {
        columnName.innerHTML = "&nbsp;";
      }
      else {
        columnName.appendChild(document.createTextNode(columnData.label));
      }
      column.appendChild(columnName);

      var columnType = document.createElement("div");
      columnType.setAttribute("class", "pagedtable-header-type");
      if (columnData.type === "") {
        columnType.innerHTML = "&nbsp;";
      }
      else {
        columnType.appendChild(document.createTextNode("<" + columnData.type + ">"));
      }
      column.appendChild(columnType);

      header.appendChild(column);

      columnData.element = column;

      return columnData;
    });

    for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
      var paddingCol = document.createElement("th");
      paddingCol.setAttribute("class", "pagedtable-padding-col");
      header.appendChild(paddingCol);
    }

    if (columns.number + columns.visible < columns.total)
      header.appendChild(renderColumnNavigation(columns.visible, false));

    if (typeof(clear) == "undefined" || clear) clearHeader();
    var thead = pagedTable.querySelectorAll("thead")[0];
    thead.appendChild(fragment);
  };

  me.animateColumns = function(backwards) {
    var thead = pagedTable.querySelectorAll("thead")[0];

    var headerOld = thead.querySelectorAll("tr")[0];
    var tbodyOld = table.querySelectorAll("tbody")[0];

    me.fitColumns(backwards);

    renderHeader(false);

    header.style.opacity = "0";
    header.style.transform = backwards ? "translateX(-30px)" : "translateX(30px)";
    header.style.transition = "transform 200ms linear, opacity 200ms";
    header.style.transitionDelay = "0";

    renderBody(false);

    if (headerOld) {
      headerOld.style.position = "absolute";
      headerOld.style.transform = "translateX(0px)";
      headerOld.style.opacity = "1";
      headerOld.style.transition = "transform 100ms linear, opacity 100ms";
      headerOld.setAttribute("class", "pagedtable-remove-head");
      if (headerOld.style.transitionEnd) {
        headerOld.addEventListener("transitionend", function() {
          var headerOldByClass = thead.querySelector(".pagedtable-remove-head");
          if (headerOldByClass) thead.removeChild(headerOldByClass);
        });
      }
      else {
        thead.removeChild(headerOld);
      }
    }

    if (tbodyOld) table.removeChild(tbodyOld);

    tbody.style.opacity = "0";
    tbody.style.transition = "transform 200ms linear, opacity 200ms";
    tbody.style.transitionDelay = "0ms";

    // force relayout
    window.getComputedStyle(header).opacity;
    window.getComputedStyle(tbody).opacity;

    if (headerOld) {
      headerOld.style.transform = backwards ? "translateX(20px)" : "translateX(-30px)";
      headerOld.style.opacity = "0";
    }

    header.style.transform = "translateX(0px)";
    header.style.opacity = "1";

    tbody.style.opacity = "1";
  }

  me.onChange = function(callback) {
    onChangeCallbacks.push(callback);
  };

  var triggerOnChange = function() {
    onChangeCallbacks.forEach(function(onChange) {
      onChange();
    });
  };

  var clearBody = function() {
    if (tbody) {
      table.removeChild(tbody);
      tbody = null;
    }
  };

  var renderBody = function(clear) {
    cachedPagedTableClientWidth = pagedTable.clientWidth

    var fragment = document.createDocumentFragment();

    var pageData = data.slice(page.getRowStart(), page.getRowEnd());

    pageData.forEach(function(dataRow, idxRow) {
      var htmlRow = document.createElement("tr");
      htmlRow.setAttribute("class", (idxRow % 2 !==0) ? "even" : "odd");

      if (columns.hasMoreLeftColumns())
        htmlRow.appendChild(document.createElement("td"));

      columns.subset.forEach(function(columnData) {
        var cellName = columnData.name;
        var dataCell = dataRow[cellName];
        var htmlCell = document.createElement("td");

        if (dataCell === "NA") htmlCell.setAttribute("class", "pagedtable-na-cell");
        if (dataCell === "__NA__") dataCell = "NA";

        var cellText = document.createTextNode(dataCell);
        htmlCell.appendChild(cellText);
        if (dataCell.length > 50) {
          htmlCell.setAttribute("title", dataCell);
        }
        htmlCell.setAttribute("align", columnData.align);
        htmlCell.style.textAlign = columnData.align;
        htmlCell.style.maxWidth = maxColumnWidth(null);
        if (columnData.width) {
          htmlCell.style.minWidth = htmlCell.style.maxWidth = maxColumnWidth(columnData.width);
        }
        htmlRow.appendChild(htmlCell);
      });

      for (var idx = 0; idx < columns.getPaddingCount(); idx++) {
        var paddingCol = document.createElement("td");
        paddingCol.setAttribute("class", "pagedtable-padding-col");
        htmlRow.appendChild(paddingCol);
      }

      if (columns.hasMoreRightColumns())
        htmlRow.appendChild(document.createElement("td"));

      fragment.appendChild(htmlRow);
    });

    for (var idxPadding = 0; idxPadding < page.getPaddingRows(); idxPadding++) {
      var paddingRow = document.createElement("tr");

      var paddingCellRow = document.createElement("td");
      paddingCellRow.innerHTML = "&nbsp;";
      paddingCellRow.setAttribute("colspan", "100%");
      paddingRow.appendChild(paddingCellRow);

      fragment.appendChild(paddingRow);
    }

    if (typeof(clear) == "undefined" || clear) clearBody();
    tbody = document.createElement("tbody");
    tbody.appendChild(fragment);

    table.appendChild(tbody);
  };

  var getLabelInfo = function() {
    var pageStart = page.getRowStart();
    var pageEnd = page.getRowEnd();
    var totalRows = data.length;

    var totalRowsLabel = options.rows.total ? options.rows.total : totalRows;
    var totalRowsLabelFormat = totalRowsLabel.toString().replace(/(\d)(?=(\d\d\d)+(?!\d))/g, '$1,');

    var infoText = (pageStart + 1) + "-" + pageEnd + " of " + totalRowsLabelFormat + " rows";
    if (totalRows < page.rows) {
      infoText = totalRowsLabel + " row" + (totalRows != 1 ? "s" : "");
    }
    if (columns.total > columns.visible) {
      var totalColumnsLabel = options.columns.total ? options.columns.total : columns.total;

      infoText = infoText + " | " + (columns.number + 1) + "-" +
        (Math.min(columns.number + columns.visible, columns.total)) +
        " of " + totalColumnsLabel + " columns";
    }

    return infoText;
  };

  var clearFooter = function() {
    footer = pagedTable.querySelectorAll("div.pagedtable-footer")[0];
    footer.innerHTML = "";

    return footer;
  };

  var createPageLink = function(idxPage) {
    var pageLink = document.createElement("a");
    pageLinkClass = idxPage === page.number ? "pagedtable-index pagedtable-index-current" : "pagedtable-index";
    pageLink.setAttribute("class", pageLinkClass);
    pageLink.setAttribute("data-page-index", idxPage);
    pageLink.onclick = function() {
      page.setPageNumber(parseInt(this.getAttribute("data-page-index")));
      renderBody();
      renderFooter();

      triggerOnChange();
    };

    pageLink.appendChild(document.createTextNode(idxPage + 1));

    return pageLink;
  }

  var renderFooter = function() {
    footer = clearFooter();

    var next = document.createElement("a");
    next.appendChild(document.createTextNode("Next"));
    next.onclick = function() {
      page.setPageNumber(page.number + 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(next);

    var pageNumbers = document.createElement("div");
    pageNumbers.setAttribute("class", "pagedtable-indexes");

    var pageRange = page.getVisiblePageRange();

    if (pageRange.first) {
      var pageLink = createPageLink(0);
      pageNumbers.appendChild(pageLink);

      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-left");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);
    }

    for (var idxPage = pageRange.start; idxPage < pageRange.end; idxPage++) {
      var pageLink = createPageLink(idxPage);

      pageNumbers.appendChild(pageLink);
    }

    if (pageRange.last) {
      var pageSeparator = document.createElement("div");
      pageSeparator.setAttribute("class", "pagedtable-index-separator-right");
      pageSeparator.appendChild(document.createTextNode("..."))
      pageNumbers.appendChild(pageSeparator);

      var pageLink = createPageLink(page.total - 1);
      pageNumbers.appendChild(pageLink);
    }

    if (data.length > page.rows) footer.appendChild(pageNumbers);

    var previous = document.createElement("a");
    previous.appendChild(document.createTextNode("Previous"));
    previous.onclick = function() {
      page.setPageNumber(page.number - 1);
      renderBody();
      renderFooter();

      triggerOnChange();
    };
    if (data.length > page.rows) footer.appendChild(previous);

    var infoLabel = document.createElement("div");
    infoLabel.setAttribute("class", "pagedtable-info");
    infoLabel.setAttribute("title", getLabelInfo());
    infoLabel.appendChild(document.createTextNode(getLabelInfo()));
    footer.appendChild(infoLabel);

    var enabledClass = "pagedtable-index-nav";
    var disabledClass = "pagedtable-index-nav pagedtable-index-nav-disabled";
    previous.setAttribute("class", page.number <= 0 ? disabledClass : enabledClass);
    next.setAttribute("class", (page.number + 1) * page.rows >= data.length ? disabledClass : enabledClass);
  };

  var measuresCell = null;

  var renderMeasures = function() {
    var measuresTable = document.createElement("table");
    measuresTable.style.visibility = "hidden";
    measuresTable.style.position = "absolute";
    measuresTable.style.whiteSpace = "nowrap";
    measuresTable.style.height = "auto";
    measuresTable.style.width = "auto";

    var measuresRow = document.createElement("tr");
    measuresTable.appendChild(measuresRow);

    measuresCell = document.createElement("td");
    var sampleString = "ABCDEFGHIJ0123456789";
    measuresCell.appendChild(document.createTextNode(sampleString));

    measuresRow.appendChild(measuresCell);

    tableDiv.appendChild(measuresTable);
  }

  me.init = function() {
    tableDiv = document.createElement("div");
    pagedTable.appendChild(tableDiv);
    var pagedTableClass = data.length > 0 ?
      "pagedtable pagedtable-not-empty" :
      "pagedtable pagedtable-empty";

    if (columns.total == 0 || (columns.emptyNames() && data.length == 0)) {
      pagedTableClass = pagedTableClass + " pagedtable-empty-columns";
    }

    tableDiv.setAttribute("class", pagedTableClass);

    renderMeasures();
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    table = document.createElement("table");
    table.setAttribute("cellspacing", "0");
    table.setAttribute("class", "table table-condensed");
    tableDiv.appendChild(table);

    table.appendChild(document.createElement("thead"));

    var footerDiv = document.createElement("div");
    footerDiv.setAttribute("class", "pagedtable-footer");
    tableDiv.appendChild(footerDiv);

    // if the host has not yet provided horizontal space, render hidden
    if (tableDiv.clientWidth <= 0) {
      tableDiv.style.opacity = "0";
    }

    me.render();

    // retry seizing columns later if the host has not provided space
    function retryFit() {
      if (tableDiv.clientWidth <= 0) {
        setTimeout(retryFit, 100);
      } else {
        me.render();
        triggerOnChange();
      }
    }
    if (tableDiv.clientWidth <= 0) {
      retryFit();
    }
  };

  var registerWidths = function() {
    columns.subset = columns.subset.map(function(column) {
      column.width = columns.widths[column.name].inner;
      return column;
    });
  };

  var parsePadding = function(value) {
    return parseInt(value) >= 0 ? parseInt(value) : 0;
  };

  me.fixedHeight = function() {
    return options.rows.max != null;
  }

  me.fitRows = function() {
    if (me.fixedHeight())
      return;

    measurer.calculate(measuresCell);

    var rows = options.rows.min !== null ? options.rows.min : 0;
    var headerHeight = header !== null && header.offsetHeight > 0 ? header.offsetHeight : 0;
    var footerHeight = footer !== null && footer.offsetHeight > 0 ? footer.offsetHeight : 0;

    if (pagedTable.offsetHeight > 0) {
      var availableHeight = pagedTable.offsetHeight - headerHeight - footerHeight;
      rows = Math.floor((availableHeight) / measurer.measures.height);
    }

    rows = options.rows.min !== null ? Math.max(options.rows.min, rows) : rows;

    page.setRows(rows);
  }

  // The goal of this function is to add as many columns as possible
  // starting from left-to-right, when the right most limit is reached
  // it tries to add columns from the left as well.
  //
  // When startBackwards is true columns are added from right-to-left
  me.fitColumns = function(startBackwards) {
    measurer.calculate(measuresCell);
    columns.calculateWidths(measurer.measures);

    if (tableDiv.clientWidth > 0) {
      tableDiv.style.opacity = 1;
    }

    var visibleColumns = tableDiv.clientWidth <= 0 ? Math.max(columns.min, 1) : 1;
    var columnNumber = columns.number;
    var paddingCount = 0;

    // track a list of added columns as we build the visible ones to allow us
    // to remove columns when they don't fit anymore.
    var columnHistory = [];

    var lastTableHeight = 0;
    var backwards = startBackwards;

    var tableDivStyle = window.getComputedStyle(tableDiv, null);
    var tableDivPadding = parsePadding(tableDivStyle.paddingLeft) +
      parsePadding(tableDivStyle.paddingRight);

    var addPaddingCol = false;
    var currentWidth = 0;

    while (true) {
      columns.setVisibleColumns(columnNumber, visibleColumns, paddingCount);
      currentWidth = columns.getWidth();

      if (tableDiv.clientWidth - tableDivPadding < currentWidth) {
        break;
      }

      columnHistory.push({
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
      });

      if (columnHistory.length > 100) {
        console.error("More than 100 tries to fit columns, aborting");
        break;
      }

      if (columns.max !== null &&
        columns.visible + columns.getPaddingCount() >= columns.max) {
        break;
      }

      // if we run out of right-columns
      if (!backwards && columnNumber + columns.visible >= columns.total) {
        // if we started adding right-columns, try adding left-columns
        if (!startBackwards && columnNumber > 0) {
          backwards = true;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // if we run out of left-columns
      if (backwards && columnNumber == 0) {
        // if we started adding left-columns, try adding right-columns
        if (startBackwards && columnNumber + columns.visible < columns.total) {
          backwards = false;
        }
        else if (columns.min === null || visibleColumns + columns.getPaddingCount() >= columns.min) {
          break;
        }
        else {
          paddingCount = paddingCount + 1;
        }
      }

      // when moving backwards try fitting left columns first
      if (backwards && columnNumber > 0) {
        columnNumber = columnNumber - 1;
      }

      if (columnNumber + visibleColumns < columns.total) {
        visibleColumns = visibleColumns + 1;
      }
    }

    var lastRenderableColumn = {
        columnNumber: columnNumber,
        visibleColumns: visibleColumns,
        paddingCount: paddingCount
    };

    if (columnHistory.length > 0) {
      lastRenderableColumn = columnHistory[columnHistory.length - 1];
    }

    columns.setVisibleColumns(
      lastRenderableColumn.columnNumber,
      lastRenderableColumn.visibleColumns,
      lastRenderableColumn.paddingCount);

    if (pagedTable.offsetWidth > 0) {
      page.setVisiblePages(Math.max(Math.ceil(1.0 * (pagedTable.offsetWidth - 250) / 40), 2));
    }

    registerWidths();
  };

  me.fit = function(startBackwards) {
    me.fitRows();
    me.fitColumns(startBackwards);
  }

  me.render = function() {
    me.fitColumns(false);

    // render header/footer to measure height accurately
    renderHeader();
    renderFooter();

    me.fitRows();
    renderBody();

    // re-render footer to match new rows
    renderFooter();
  }

  var resizeLastWidth = -1;
  var resizeLastHeight = -1;
  var resizeNewWidth = -1;
  var resizeNewHeight = -1;
  var resizePending = false;

  me.resize = function(newWidth, newHeight) {

    function resizeDelayed() {
      resizePending = false;

      if (
        (resizeNewWidth !== resizeLastWidth) ||
        (!me.fixedHeight() && resizeNewHeight !== resizeLastHeight)
      ) {
        resizeLastWidth = resizeNewWidth;
        resizeLastHeight = resizeNewHeight;

        setTimeout(resizeDelayed, 200);
        resizePending = true;
      } else {
        me.render();
        triggerOnChange();

        resizeLastWidth = -1;
        resizeLastHeight = -1;
      }
    }

    resizeNewWidth = newWidth;
    resizeNewHeight = newHeight;

    if (!resizePending) resizeDelayed();
  };
};

var PagedTableDoc;
(function (PagedTableDoc) {
  var allPagedTables = [];

  PagedTableDoc.initAll = function() {
    allPagedTables = [];

    var pagedTables = [].slice.call(document.querySelectorAll('[data-pagedtable="false"],[data-pagedtable=""]'));
    pagedTables.forEach(function(pagedTable, idx) {
      pagedTable.setAttribute("data-pagedtable", "true");
      pagedTable.setAttribute("pagedtable-page", 0);
      pagedTable.setAttribute("class", "pagedtable-wrapper");

      var pagedTableInstance = new PagedTable(pagedTable);
      pagedTableInstance.init();

      allPagedTables.push(pagedTableInstance);
    });
  };

  PagedTableDoc.resizeAll = function() {
    allPagedTables.forEach(function(pagedTable) {
      pagedTable.render();
    });
  };

  window.addEventListener("resize", PagedTableDoc.resizeAll);

  return PagedTableDoc;
})(PagedTableDoc || (PagedTableDoc = {}));

window.onload = function() {
  PagedTableDoc.initAll();
};
</script>

<style type="text/css">
code{white-space: pre-wrap;}
span.smallcaps{font-variant: small-caps;}
span.underline{text-decoration: underline;}
div.column{display: inline-block; vertical-align: top; width: 50%;}
div.hanging-indent{margin-left: 1.5em; text-indent: -1.5em;}
ul.task-list{list-style: none;}
</style>

<style type="text/css">code{white-space: pre;}</style>
<script type="text/javascript">
if (window.hljs) {
  hljs.configure({languages: []});
  hljs.initHighlightingOnLoad();
  if (document.readyState && document.readyState === "complete") {
    window.setTimeout(function() { hljs.initHighlighting(); }, 0);
  }
}
</script>









<style type="text/css">
.main-container {
max-width: 940px;
margin-left: auto;
margin-right: auto;
}
img {
max-width:100%;
}
.tabbed-pane {
padding-top: 12px;
}
.html-widget {
margin-bottom: 20px;
}
button.code-folding-btn:focus {
outline: none;
}
summary {
display: list-item;
}
details > summary > p:only-child {
display: inline;
}
pre code {
padding: 0;
}
</style>



<!-- tabsets -->

<style type="text/css">
.tabset-dropdown > .nav-tabs {
display: inline-table;
max-height: 500px;
min-height: 44px;
overflow-y: auto;
border: 1px solid #ddd;
border-radius: 4px;
}
.tabset-dropdown > .nav-tabs > li.active:before, .tabset-dropdown > .nav-tabs.nav-tabs-open:before {
content: "\e259";
font-family: 'Glyphicons Halflings';
display: inline-block;
padding: 10px;
border-right: 1px solid #ddd;
}
.tabset-dropdown > .nav-tabs.nav-tabs-open > li.active:before {
content: "\e258";
font-family: 'Glyphicons Halflings';
border: none;
}
.tabset-dropdown > .nav-tabs > li.active {
display: block;
}
.tabset-dropdown > .nav-tabs > li > a,
.tabset-dropdown > .nav-tabs > li > a:focus,
.tabset-dropdown > .nav-tabs > li > a:hover {
border: none;
display: inline-block;
border-radius: 4px;
background-color: transparent;
}
.tabset-dropdown > .nav-tabs.nav-tabs-open > li {
display: block;
float: none;
}
.tabset-dropdown > .nav-tabs > li {
display: none;
}
</style>

<!-- code folding -->




</head>

<body>


<div class="container-fluid main-container">




<div id="header">



<h1 class="title toc-ignore">Lab 06 - Regular Expressions and Web
Scraping</h1>

</div>


<div id="learning-goals" class="section level1">
<h1>Learning goals</h1>
<ul>
<li>Use a real world API to make queries and process the data.</li>
<li>Use regular expressions to parse the information.</li>
<li>Practice your GitHub skills.</li>
</ul>
</div>
<div id="lab-description" class="section level1">
<h1>Lab description</h1>
<p>In this lab, we will be working with the <a href="https://www.ncbi.nlm.nih.gov/home/develop/api/">NCBI API</a> to
make queries and extract information using XML and regular expressions.
For this lab, we will be using the <code>httr</code>, <code>xml2</code>,
and <code>stringr</code> R packages.</p>
<p>This markdown document should be rendered using
<code>github_document</code> document ONLY and pushed to your
<em>JSC370-labs</em> repository in <code>lab06/README.md</code>.</p>
<div id="question-1-how-many-sars-cov-2-papers" class="section level2">
<h2>Question 1: How many sars-cov-2 papers?</h2>
<p>Build an automatic counter of sars-cov-2 papers using PubMed. You
will need to apply XPath as we did during the lecture to extract the
number of results returned by PubMed in the following web address:</p>
<pre><code>https://pubmed.ncbi.nlm.nih.gov/?term=sars-cov-2</code></pre>
<p>Complete the lines of code:</p>
<pre class="r"><code>url &lt;- &quot;https://pubmed.ncbi.nlm.nih.gov/?term=sars-cov-2&quot;
# Downloading the website
website &lt;- xml2::read_html(url)
# Finding the counts
counts &lt;- xml2::xml_find_first(website, &quot;/html/body/main/div[9]/div[2]/div[2]/div[1]/div[1]/span&quot;)
# Turning it into text
counts &lt;- as.character(counts)
# Extracting the data using regex
stringr::str_extract(counts, &quot;[\\d,]+&quot;)</code></pre>
<pre><code>## [1] &quot;192,677&quot;</code></pre>
<ul>
<li>How many sars-cov-2 papers are there?</li>
</ul>
<p>There are 192,677 sars-cov-2 papers</p>
<p>Dont forget to commit your work!</p>
</div>
<div id="question-2-academic-publications-on-covid19-and-hawaii" class="section level2">
<h2>Question 2: Academic publications on COVID19 and Hawaii</h2>
<p>Use the function <code>httr::GET()</code> to make the following
query:</p>
<ol style="list-style-type: decimal">
<li><p>Baseline URL: <a href="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi" class="uri">https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi</a></p></li>
<li><p>Query parameters:</p>
<ul>
<li>db: pubmed</li>
<li>term: covid19 hawaii</li>
<li>retmax: 1000</li>
</ul></li>
</ol>
<p>The parameters passed to the query are documented <a href="https://www.ncbi.nlm.nih.gov/books/NBK25499/">here</a>.</p>
<pre class="r"><code>library(httr)
baseurl &lt;-&quot;https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esearch.fcgi&quot;
query_ids &lt;- GET(
  url   = baseurl,
  query = list(db = &quot;pubmed&quot;,
               term = &quot;covid19 hawaii&quot;,
               retmax = 1000)
)
# Extracting the content of the response of GET
ids &lt;- httr::content(query_ids)</code></pre>
<p>The query will return an XML object, we can turn it into a character
list to analyze the text directly with <code>as.character()</code>.
Another way of processing the data could be using lists with the
function <code>xml2::as_list()</code>. We will skip the latter for
now.</p>
<p>Take a look at the data, and continue with the next question (dont
forget to commit and push your results to your GitHub repo!).</p>
</div>
<div id="question-3-get-details-about-the-articles" class="section level2">
<h2>Question 3: Get details about the articles</h2>
<p>The Ids are wrapped around text in the following way:
<code>&lt;Id&gt;... id number ...&lt;/Id&gt;</code>. we can use a
regular expression that extract that information. Fill out the following
lines of code:</p>
<pre class="r"><code># Turn the result into a character vector
ids &lt;- as.character(ids)
# Find all the ids 
ids &lt;- stringr::str_extract_all(ids, &quot;&lt;Id&gt;[\\d]+&lt;/Id&gt;&quot;)[[1]]
# Remove all the leading and trailing &lt;Id&gt; &lt;/Id&gt;. Make use of &quot;|&quot;
ids &lt;- stringr::str_remove_all(ids, &quot;&lt;Id&gt;|&lt;/Id&gt;&quot;)</code></pre>
<p>With the ids in hand, we can now try to get the abstracts of the
papers. As before, we will need to coerce the contents (results) to a
list using:</p>
<ol style="list-style-type: decimal">
<li><p>Baseline url: <a href="https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi" class="uri">https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi</a></p></li>
<li><p>Query parameters:</p>
<ul>
<li>db: pubmed</li>
<li>id: A character with all the ids separated by comma, e.g.,
1232131,546464,13131</li>
<li>retmax: 1000</li>
<li>rettype: abstract</li>
</ul></li>
</ol>
<p><strong>Pro-tip</strong>: If you want <code>GET()</code> to take some
element literal, wrap it around <code>I()</code> (as you would do in a
formula in R). For example, the text <code>&quot;123,456&quot;</code> is replaced
with <code>&quot;123%2C456&quot;</code>. If you dont want that behavior, you
would need to do the following <code>I(&quot;123,456&quot;)</code>.</p>
<pre class="r"><code>baseurl2 = &quot;https://eutils.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi&quot;
publications &lt;- GET(
  url   = baseurl2,
  query = list(
    db=&quot;pubmed&quot;,
    id= paste(ids, collapse = &quot;,&quot;),
    retmax=1000,
    rettype=&quot;abstract&quot;
    )
)
# Turning the output into character vector
publications &lt;- httr::content(publications)
publications_txt &lt;- as.character(publications)</code></pre>
<p>With this in hand, we can now analyze the data. This is also a good
time for committing and pushing your work!</p>
</div>
<div id="question-4-distribution-of-universities-schools-and-departments" class="section level2">
<h2>Question 4: Distribution of universities, schools, and
departments</h2>
<p>Using the function <code>stringr::str_extract_all()</code> applied on
<code>publications_txt</code>, capture all the terms of the form:</p>
<ol style="list-style-type: decimal">
<li>University of </li>
<li> Institute of </li>
</ol>
<p>Write a regular expression that captures all such instances</p>
<pre class="r"><code>institution &lt;- stringr::str_extract_all(
  publications_txt,
  &quot;University of [[:alnum:]]+ | [[:alnum:]]+ Institute of [[:alnum:]]+&quot;
  ) 
institution &lt;- unlist(institution)
as.data.frame(table(institution))</code></pre>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["institution"],"name":[1],"type":["fct"],"align":["left"]},{"label":["Freq"],"name":[2],"type":["int"],"align":["right"]}],"data":[{"1":"Army Institute of Research","2":"1"},{"1":"Beijing Institute of Pharmacology","2":"2"},{"1":"Berlin Institute of Health","2":"4"},{"1":"Breadfruit Institute of the","2":"1"},{"1":"Cancer Institute of Emory","2":"2"},{"1":"Cancer Institute of New","2":"1"},{"1":"Davis Institute of Health","2":"8"},{"1":"Graduate Institute of Rehabilitation","2":"3"},{"1":"Health Institute of Montpellier","2":"1"},{"1":"Higher Institute of Health","2":"1"},{"1":"Medanta Institute of Education","2":"1"},{"1":"Mediterranean Institute of Oceanography","2":"1"},{"1":"MGM Institute of Health","2":"1"},{"1":"Monterrey Institute of Technology","2":"1"},{"1":"National Institute of Allergy","2":"2"},{"1":"National Institute of Biostructures","2":"1"},{"1":"National Institute of Infectious","2":"1"},{"1":"National Institute of Public","2":"1"},{"1":"National Institute of Technology","2":"1"},{"1":"Research Institute of New","2":"4"},{"1":"Research Institute of Tuberculosis","2":"2"},{"1":"the Institute of Biomedical","2":"1"},{"1":"the Institute of Medicine","2":"1"},{"1":"University of Applied","2":"4"},{"1":"University of Arizona","2":"2"},{"1":"University of Arkansas","2":"24"},{"1":"University of Benin","2":"1"},{"1":"University of British","2":"4"},{"1":"University of California","2":"28"},{"1":"University of Campinas","2":"3"},{"1":"University of Chicago","2":"5"},{"1":"University of Chinese","2":"1"},{"1":"University of Cincinnati","2":"4"},{"1":"University of Colorado","2":"4"},{"1":"University of Dayton","2":"1"},{"1":"University of Education","2":"1"},{"1":"University of Hawai","2":"8"},{"1":"University of Hawaii","2":"1"},{"1":"University of Hawaii","2":"295"},{"1":"University of Hawai","2":"2"},{"1":"University of Hawai","2":"1"},{"1":"University of Health","2":"12"},{"1":"University of Hong","2":"4"},{"1":"University of Honolulu","2":"3"},{"1":"University of Illinois","2":"6"},{"1":"University of Information","2":"2"},{"1":"University of Juiz","2":"4"},{"1":"University of Kansas","2":"2"},{"1":"University of Kentucky","2":"1"},{"1":"University of Korea","2":"1"},{"1":"University of Maryland","2":"13"},{"1":"University of Massachusetts","2":"24"},{"1":"University of Medical","2":"3"},{"1":"University of Medicine","2":"2"},{"1":"University of Miami","2":"1"},{"1":"University of Michigan","2":"2"},{"1":"University of Minas","2":"1"},{"1":"University of Minnesota","2":"3"},{"1":"University of Mount","2":"1"},{"1":"University of Nebraska","2":"5"},{"1":"University of New","2":"20"},{"1":"University of North","2":"9"},{"1":"University of Ohio","2":"1"},{"1":"University of Ontario","2":"1"},{"1":"University of Pennsylvania","2":"27"},{"1":"University of Pittsburgh","2":"7"},{"1":"University of Puerto","2":"3"},{"1":"University of Queensland","2":"1"},{"1":"University of Rhode","2":"3"},{"1":"University of Rio","2":"1"},{"1":"University of Rochester","2":"4"},{"1":"University of Sao","2":"2"},{"1":"University of So","2":"4"},{"1":"University of Science","2":"34"},{"1":"University of Sergipe","2":"1"},{"1":"University of South","2":"4"},{"1":"University of Southern","2":"27"},{"1":"University of Technology","2":"3"},{"1":"University of Texas","2":"11"},{"1":"University of the","2":"244"},{"1":"University of Thessalonica","2":"1"},{"1":"University of Utah","2":"3"},{"1":"University of Washington","2":"4"},{"1":"University of West","2":"1"},{"1":"University of Western","2":"1"},{"1":"University of Wisconsin","2":"4"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
<p>Repeat the exercise and this time focus on schools and departments in
the form of</p>
<ol style="list-style-type: decimal">
<li>School of </li>
<li>Department of </li>
</ol>
<p>And tabulate the results</p>
<pre class="r"><code>schools_and_deps &lt;- stringr::str_extract_all(
  publications_txt,
  &quot;School of [[:alnum:]]+| Department of [[:alnum:]]+&quot;
  )
as.data.frame(table(schools_and_deps))</code></pre>
<div data-pagedtable="false">
<script data-pagedtable-source type="application/json">
{"columns":[{"label":["schools_and_deps"],"name":[1],"type":["fct"],"align":["left"]},{"label":["Freq"],"name":[2],"type":["int"],"align":["right"]}],"data":[{"1":"Department of Agriculture","2":"8"},{"1":"Department of Anatomy","2":"12"},{"1":"Department of Anesthesiology","2":"10"},{"1":"Department of Atmospheric","2":"3"},{"1":"Department of Behavioral","2":"3"},{"1":"Department of Bioethics","2":"1"},{"1":"Department of Biology","2":"5"},{"1":"Department of Biophysics","2":"1"},{"1":"Department of Biostatistics","2":"3"},{"1":"Department of Business","2":"31"},{"1":"Department of Chemistry","2":"1"},{"1":"Department of Commerce","2":"4"},{"1":"Department of Communication","2":"1"},{"1":"Department of Community","2":"2"},{"1":"Department of Computational","2":"1"},{"1":"Department of Critical","2":"11"},{"1":"Department of Defense","2":"19"},{"1":"Department of Dermatology","2":"1"},{"1":"Department of Economic","2":"5"},{"1":"Department of Economics","2":"9"},{"1":"Department of Education","2":"8"},{"1":"Department of Emergency","2":"3"},{"1":"Department of Environmental","2":"1"},{"1":"Department of Epidemiology","2":"1"},{"1":"Department of Family","2":"1"},{"1":"Department of Fish","2":"1"},{"1":"Department of General","2":"1"},{"1":"Department of Geography","2":"2"},{"1":"Department of Health","2":"224"},{"1":"Department of Home","2":"1"},{"1":"Department of Homeland","2":"1"},{"1":"Department of Infectious","2":"4"},{"1":"Department of Information","2":"1"},{"1":"Department of Internal","2":"26"},{"1":"Department of Labor","2":"1"},{"1":"Department of Mathematics","2":"5"},{"1":"Department of Medical","2":"1"},{"1":"Department of Medicine","2":"76"},{"1":"Department of Natural","2":"5"},{"1":"Department of Obstetrics","2":"7"},{"1":"Department of Occupational","2":"1"},{"1":"Department of Orthopaedic","2":"4"},{"1":"Department of Otolaryngology","2":"1"},{"1":"Department of Parliamentary","2":"1"},{"1":"Department of Pathology","2":"8"},{"1":"Department of Pediatric","2":"1"},{"1":"Department of Pediatrics","2":"11"},{"1":"Department of Physical","2":"1"},{"1":"Department of Physiology","2":"4"},{"1":"Department of Population","2":"6"},{"1":"Department of Preventive","2":"164"},{"1":"Department of Psychiatry","2":"3"},{"1":"Department of Psychology","2":"1"},{"1":"Department of Public","2":"8"},{"1":"Department of Quantitative","2":"2"},{"1":"Department of Rehabilitation","2":"1"},{"1":"Department of Research","2":"7"},{"1":"Department of Science","2":"1"},{"1":"Department of Social","2":"1"},{"1":"Department of Sociology","2":"1"},{"1":"Department of State","2":"3"},{"1":"Department of Surgery","2":"32"},{"1":"Department of Taxation","2":"2"},{"1":"Department of the","2":"1"},{"1":"Department of Transportation","2":"1"},{"1":"Department of Tropical","2":"2"},{"1":"Department of Veterans","2":"18"},{"1":"Department of Veterinary","2":"1"},{"1":"Department of Virus","2":"1"},{"1":"Department of Zoology","2":"1"},{"1":"School of Aerospace","2":"7"},{"1":"School of Agriculture","2":"1"},{"1":"School of Applied","2":"1"},{"1":"School of Aquatic","2":"1"},{"1":"School of Biological","2":"4"},{"1":"School of Biomedical","2":"3"},{"1":"School of Brown","2":"2"},{"1":"School of Business","2":"5"},{"1":"School of Chemical","2":"1"},{"1":"School of Clinical","2":"1"},{"1":"School of Communication","2":"2"},{"1":"School of Economics","2":"1"},{"1":"School of Education","2":"3"},{"1":"School of Electronic","2":"1"},{"1":"School of Energy","2":"2"},{"1":"School of Engineering","2":"1"},{"1":"School of Environmental","2":"2"},{"1":"School of Epidemiology","2":"6"},{"1":"School of Forest","2":"1"},{"1":"School of Forestry","2":"4"},{"1":"School of Government","2":"1"},{"1":"School of Hawaiian","2":"2"},{"1":"School of Health","2":"14"},{"1":"School of Hygiene","2":"2"},{"1":"School of Immunology","2":"1"},{"1":"School of Law","2":"1"},{"1":"School of Life","2":"3"},{"1":"School of Medicine","2":"688"},{"1":"School of Natural","2":"4"},{"1":"School of Nursing","2":"72"},{"1":"School of Ocean","2":"1"},{"1":"School of Pacific","2":"1"},{"1":"School of Pharmacy","2":"2"},{"1":"School of Physical","2":"6"},{"1":"School of Physiotherapy","2":"1"},{"1":"School of Population","2":"2"},{"1":"School of Public","2":"104"},{"1":"School of Sciences","2":"4"},{"1":"School of Social","2":"69"},{"1":"School of the","2":"1"},{"1":"School of Transportation","2":"1"},{"1":"School of Veterinary","2":"1"}],"options":{"columns":{"min":{},"max":[10]},"rows":{"min":[10],"max":[10]},"pages":{}}}
  </script>
</div>
</div>
<div id="question-5-form-a-database" class="section level2">
<h2>Question 5: Form a database</h2>
<p>We want to build a dataset which includes the title and the abstract
of the paper. The title of all records is enclosed by the HTML tag
<code>ArticleTitle</code>, and the abstract by
<code>Abstract</code>.</p>
<p>Before applying the functions to extract text directly, it will help
to process the XML a bit. We will use the
<code>xml2::xml_children()</code> function to keep one element per id.
This way, if a paper is missing the abstract, or something else, we will
be able to properly match PUBMED IDS with their corresponding
records.</p>
<pre class="r"><code>pub_char_list &lt;- xml2::xml_children(publications)
pub_char_list &lt;- sapply(pub_char_list, as.character)</code></pre>
<p>Now, extract the abstract and article title for each one of the
elements of <code>pub_char_list</code>. You can either use
<code>sapply()</code> as we just did, or simply take advantage of
vectorization of <code>stringr::str_extract</code></p>
<pre class="r"><code>abstracts &lt;- stringr::str_extract(pub_char_list, &quot;&lt;Abstract&gt;(\\n|.)+&lt;/Abstract&gt;&quot;)
abstracts &lt;- stringr::str_remove_all(abstracts, &quot;&lt;/[:alnum:]+&gt;|&lt;[:alnum:]+&gt;&quot;)
abstracts &lt;- stringr::str_replace_all(abstracts, &quot;\\s+&quot;,&quot; &quot;)
abstracts &lt;- stringr::str_remove_all(abstracts, &quot;\\n&quot;)
table(is.na(abstracts))</code></pre>
<pre><code>## 
## FALSE  TRUE 
##   285    53</code></pre>
<ul>
<li>How many of these dont have an abstract?</li>
</ul>
<p>53 of them have no abstract</p>
<p>Now, the title</p>
<pre class="r"><code>titles &lt;- stringr::str_extract(pub_char_list, &quot;&lt;Title&gt;(\\n|.)+&lt;/Title&gt;&quot;)
titles &lt;- stringr::str_remove_all(titles, &quot;&lt;/[:alnum:]+&gt;|&lt;[:alnum:]+&gt;&quot;)
table(is.na(titles))</code></pre>
<pre><code>## 
## FALSE 
##   338</code></pre>
<ul>
<li>How many of these dont have a title ?</li>
</ul>
<p>All of them have title</p>
<p>Finally, put everything together into a single
<code>data.frame</code> and use <code>knitr::kable</code> to print the
results</p>
<pre class="r"><code>database &lt;- data.frame(
  ids, titles, abstracts
)
knitr::kable(database)</code></pre>
<table>
<colgroup>
<col width="0%" />
<col width="70%" />
<col width="29%" />
</colgroup>
<thead>
<tr class="header">
<th align="left">ids</th>
<th align="left">titles</th>
<th align="left">abstracts</th>
</tr>
</thead>
<tbody>
<tr class="odd">
<td align="left">36757946</td>
<td align="left">PloS one</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Accurate
COVID-19 prognosis is a critical aspect of acute and long-term clinical
management. We identified discrete clusters of early stage-symptoms
which may delineate groups with distinct disease severity phenotypes,
including risk of developing long-term symptoms and associated
inflammatory profiles.
<AbstractText Label="METHODS" NlmCategory="METHODS">1,273 SARS-CoV-2
positive U.S. Military Health System beneficiaries with quantitative
symptom scores (FLU-PRO Plus) were included in this analysis. We
employed machine-learning approaches to identify symptom clusters and
compared risk of hospitalization, long-term symptoms, as well as peak
CRP and IL-6 concentrations.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">We identified three
distinct clusters of participants based on their FLU-PRO Plus symptoms:
cluster 1 (Nasal cluster) is highly correlated with reporting
runny/stuffy nose and sneezing, cluster 2 (Sensory cluster) is highly
correlated with loss of smell or taste, and cluster 3
(Respiratory/Systemic cluster) is highly correlated with the
respiratory (cough, trouble breathing, among others) and systemic (body
aches, chills, among others) domain symptoms. Participants in the
Respiratory/Systemic cluster were twice as likely as those in the Nasal
cluster to have been hospitalized, and 1.5 times as likely to report
that they had not returned-to-activities, which remained significant
after controlling for confounding covariates (P &lt; 0.01).
Respiratory/Systemic and Sensory clusters were more likely to have
symptoms at six-months post-symptom-onset (P = 0.03). We observed higher
peak CRP and IL-6 in the Respiratory/Systemic cluster (P &lt; 0.01).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">We
identified early symptom profiles potentially associated with
hospitalization, return-to-activities, long-term symptoms, and
inflammatory profiles. These findings may assist in patient prognosis,
including prediction of long COVID risk. Copyright: This is an open
access article, free of all copyright, and may be freely reproduced,
distributed, transmitted, modified, built upon, or otherwise used by
anyone for any lawful purpose. The work is made available under the
Creative Commons CC0 public domain dedication.</td>
</tr>
<tr class="even">
<td align="left">36743999</td>
<td align="left">The chronicle of mentoring &amp; coaching</td>
<td align="left">Critical career milestones for faculty (e.g., tenure,
securing grant funding) relate to career advancement, job satisfaction,
service/leadership, scholarship/research, clinical or teaching
activities, professionalism, compensation, and work-life balance.
However, barriers and challenges to these milestones encountered by
junior faculty have been inadequately studied, particularly those
affecting underrepresented minorities in science (URM-S). Additionally,
little is known about how barriers and challenges to career milestones
have changed during the COVID-19 pandemic for URM-S and non-URM faculty
mentees in science. In this study, we conducted semi-structured
interviews with 31 faculty mentees from four academic institutions
(located in New Mexico, Arizona, Idaho, and Hawaii), including 22 URM-S
(women or racial/ethnic). Respondents were given examples of critical
career milestones and were asked to identify and discuss barriers and
challenges that they have encountered or expect to encounter while
working toward achieving these milestones. We performed thematic
descriptive analysis using NVivo software in an iterative, team-based
process. Our preliminary analysis identified five key themes that
illustrate barriers and challenges encountered: Job and career
development, Discrimination and a lack of workplace diversity; Lack of
interpersonal relationships and inadequate social support at the
workplace; Personal and family matters; and Unique COVID-19-related
issues. COVID-19 barriers and challenges were related to online
curriculum creation and administration, interpersonal relationship
development, inadequate training/service/conference opportunities, and
disruptions in childcare and schooling. Although COVID-19 helped create
new barriers and challenges for junior faculty mentees, traditional
barriers and challenges for critical career milestones continue to be
reported among our respondents. URM-S respondents also identified
discrimination and diversity-related barriers and challenges. Subsequent
interviews will focus on 12-month and 24-month follow-ups and provide
additional insight into the unique challenges and barriers to critical
career milestones that URM and non-URM faculty in science have
encountered during the unique historical context of the COVID-19
pandemic.</td>
</tr>
<tr class="odd">
<td align="left">36721521</td>
<td align="left">Global health, epidemiology and genomics</td>
<td align="left"><AbstractText Label="INTRODUCTION">Whilst the
coronavirus disease 2019 (COVID-19) vaccination rollout is well
underway, there is a concern in Africa where less than 2% of global
vaccinations have occurred. In the absence of herd immunity, health
promotion remains essential. YouTube has been widely utilised as a
source of medical information in previous outbreaks and pandemics. There
are limited data on COVID-19 information on YouTube videos, especially
in languages widely spoken in Africa. This study investigated the
quality and reliability of such videos.
<AbstractText Label="METHODS">Medical information related to COVID-19
was analysed in 11 languages (English, isiZulu, isiXhosa, Afrikaans,
Nigerian Pidgin, Hausa, Twi, Arabic, Amharic, French, and Swahili).
Cohens Kappa was used to measure inter-rater reliability. A total of
562 videos were analysed. Viewer interaction metrics and video
characteristics, source, and content type were collected. Quality was
evaluated using the Medical Information Content Index (MICI) scale and
reliability was evaluated by the modified DISCERN tool.
<AbstractText Label="RESULTS">Kappa coefficient of agreement for all
languages was p &lt; 0.01. Informative videos (471/562, 83.8%) accounted
for the majority, whilst misleading videos (12/562, 2.13%) were minimal.
Independent users (246/562, 43.8%) were the predominant source type.
Transmission of information (477/562 videos, 84.9%) was most prevalent,
whilst content covering screening or testing was reported in less than a
third of all videos. The mean total MICI score was 5.75/5 (SD 4.25) and
the mean total DISCERN score was 3.01/5 (SD 1.11).
<AbstractText Label="CONCLUSION">YouTube is an invaluable, easily
accessible resource for information dissemination during health
emergencies. Misleading videos are often a concern; however, our study
found a negligible proportion. Whilst most videos were fairly reliable,
the quality of videos was poor, especially noting a dearth of
information covering screening or testing. Governments, academic
institutions, and healthcare workers must harness the capability of
digital platforms, such as YouTube to contain the spread of
misinformation. Copyright  2023 Kapil Narain et al.</td>
</tr>
<tr class="even">
<td align="left">36715070</td>
<td align="left">Journal of the Pediatric Infectious Diseases
Society</td>
<td align="left">In a 1:1 matched test-negative design among
5-11-year-olds in the Kaiser Permanente Southern California health
system (n=3984), BNT162b2 effectiveness against omicron-related
emergency department or urgent care encounters was 60% [95%CI: 47-69]
&lt;3 months post-dose-two and 28% [8-43] after 3 months. A booster
improved protection to 77% [53-88].  The Author(s) 2023. Published by
Oxford University Press on behalf of The Journal of the Pediatric
Infectious Diseases Society.</td>
</tr>
<tr class="odd">
<td align="left">36685780</td>
<td align="left">Hawaii journal of health &amp; social welfare</td>
<td align="left">This study explored how undergraduate students at the
University of Hawaii at Manoa sought and consumed information about the
virus that causes COVID-19. This study also examined student perceptions
of the severity of and their susceptibility to the virus and their main
concerns about it. Four hundred fifty-six students completed online
surveys between October and early December of 2020 and 2021. Students
reported low to moderate levels of information seeking across four
domains: (1) knowledge about COVID-19 and its symptoms; (2) preventing
the spread of the virus; (3) the current state of the pandemic in
Hawaii; and (4) the likely future of the pandemic in Hawaii. Overall,
websites, television, and Instagram were the top 3 channels used by
students to seek information for these domains. Students reported
primarily paying attention to information from government and news
organizations as sources. However, students preferred channels and
sources varied with the type of information they sought. Students also
reported believing that COVID-19 is severe and that they are susceptible
to being infected with it. The more time students reported seeking
information, the greater their perceptions of COVID-19s severity across
all domains. Students primary concerns about COVID-19 centered on state
regulations/policies, vaccines, tourism/travel, the economy, and
pandemic/post-pandemic life. These findings can help public health
practitioners in Hawaii determine how best to reach an undergraduate
student population with information related to COVID-19. Copyright 2023
by University Health Partners of Hawaii (UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">36662525</td>
<td align="left">JAMA network open</td>
<td align="left"><AbstractText Label="IMPORTANCE" NlmCategory="UNASSIGNED">Immunocompromised
individuals are at increased risk for severe outcomes due to SARS-CoV-2
infection. Given the varying and complex nature of COVID-19 vaccination
recommendations, it is important to understand COVID-19 vaccine uptake
in this vulnerable population.
<AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">To assess mRNA
COVID-19 vaccine uptake and factors associated with uptake among
immunocompromised individuals from December 14, 2020, through August 6,
2022.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS" NlmCategory="UNASSIGNED">This
cohort study was conducted with patients of Kaiser Permanente Southern
California (KPSC), an integrated health care system in the US. The study
included patients aged 18 years or older who were immunocompromised
(individuals with an immunocompromising condition or patients who
received immunosuppressive medications in the year prior to December 14,
2020) and still met criteria for being immunocompromised 1 year later.
<AbstractText Label="EXPOSURES" NlmCategory="UNASSIGNED">Age, sex,
self-identified race and ethnicity, prior positive COVID-19 test result,
immunocompromising condition, immunomodulating medication,
comorbidities, health care utilization, and neighborhood median income.
<AbstractText Label="MAIN OUTCOMES AND MEASURES" NlmCategory="UNASSIGNED">Outcomes
were the number of doses of mRNA COVID-19 vaccine received and the
factors associated with receipt of at least 4 doses, estimated by hazard
ratios (HRs) and 95% Wald CIs via Cox proportional hazards regression.
Statistical analyses were conducted between August 9 and 23, 2022.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Overall, 42 697
immunocompromised individuals met the study eligibility criteria. Among
these, 18 789 (44.0%) were aged 65 years or older; 20 061 (47.0%) were
women and 22 635 (53.0%) were men. With regard to race and ethnicity,
4295 participants (10.1%) identified as Asian or Pacific Islander, 5174
(12.1%) as Black, 14 289 (33.5%) as Hispanic, and 17 902 (41.9%) as
White. As of the end of the study period and after accounting for
participant censoring due to death or disenrollment from the KPSC health
plan, 78.0% of immunocompromised individuals had received a third dose
of mRNA COVID-19 vaccine. Only 41.0% had received a fourth dose, which
corresponds to a primary series and a monovalent booster dose for
immunocompromised individuals. Uptake of a fifth dose was only 0.9%
following the US Centers for Disease Control and Prevention (CDC)
recommendation to receive a second monovalent booster (ie, fifth dose).
Adults aged 65 years or older (HR, 3.95 [95% CI, 3.70-4.22]) were more
likely to receive at least 4 doses compared with those aged 18 to 44
years or 45 to 64 years (2.52 [2.36-2.69]). Hispanic and non-Hispanic
Black adults (HR, 0.77 [95% CI, 0.74-0.80] and 0.82 [0.78-0.87],
respectively, compared with non-Hispanic White adults), individuals with
prior documented SARS-CoV-2 infection (0.71 [0.62-0.81] compared with
those without), and individuals receiving high-dose corticosteroids
(0.88 [0.81-0.95] compared with those who were not) were less likely to
receive at least 4 doses.
<AbstractText Label="CONCLUSIONS AND RELEVANCE" NlmCategory="UNASSIGNED">These
findings suggest that adherence to CDC mRNA monovalent COVID-19 booster
dose recommendations among immunocompromised individuals was low. Given
the increased risk for severe COVID-19 in this vulnerable population and
the well-established additional protection afforded by booster doses,
targeted and tailored efforts to ensure that immunocompromised
individuals remain up to date with COVID-19 booster dose recommendations
are warranted.</td>
</tr>
<tr class="odd">
<td align="left">36652247</td>
<td align="left">JAMA network open</td>
<td align="left"><AbstractText Label="IMPORTANCE">Understanding the
factors associated with post-COVID conditions is important for
prevention. <AbstractText Label="OBJECTIVE">To identify characteristics
associated with persistent post-COVID-19 symptoms and to describe
post-COVID-19 medical encounters.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This cohort
study used data from the Epidemiology, Immunology, and Clinical
Characteristics of Emerging Infectious Diseases With Pandemic Potential
(EPICC) study implemented in the US military health system (MHS); MHS
beneficiaries aged 18 years or older who tested positive for SARS-CoV-2
from February 28, 2020, through December 31, 2021, were analyzed, with
1-year follow-up. <AbstractText Label="EXPOSURES">SARS-CoV-2 infection.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">The outcomes analyzed
included survey-reported symptoms through 6 months after SARS-CoV-2
infection and International Statistical Classification of Diseases and
Related Health Problems, Tenth Revision diagnosis categories reported in
medical records 6 months following SARS-CoV-2 infection vs 3 months
before infection. <AbstractText Label="RESULTS">More than half of the
1832 participants in these analyses were aged 18 to 44 years (1226
[66.9%]; mean [SD] age, 40.5 [13.7] years), were male (1118 [61.0%]),
were unvaccinated at the time of their infection (1413 [77.1%]), and had
no comorbidities (1290 [70.4%]). A total of 728 participants (39.7%) had
illness that lasted 28 days or longer (28-89 days: 364 [19.9%]; 90
days: 364 [19.9%]). Participants who were unvaccinated prior to
infection (risk ratio [RR], 1.39; 95% CI, 1.04-1.85), reported moderate
(RR, 1.80; 95% CI, 1.47-2.22) or severe (RR, 2.25; 95% CI, 1.80-2.81)
initial illnesses, had more hospitalized days (RR per each day of
hospitalization, 1.02; 95% CI, 1.00-1.03), and had a Charlson
Comorbidity Index score of 5 or greater (RR, 1.55; 95% CI, 1.01-2.37)
were more likely to report 28 or more days of symptoms. Among
unvaccinated participants, postinfection vaccination was associated with
a 41% lower risk of reporting symptoms at 6 months (RR, 0.59; 95% CI,
0.40-0.89). Participants had higher risk of pulmonary (RR, 2.00; 95% CI,
1.40-2.84), diabetes (RR, 1.46; 95% CI, 1.00-2.13), neurological (RR,
1.29; 95% CI, 1.02-1.64), and mental health-related medical encounters
(RR, 1.28; 95% CI, 1.01-1.62) at 6 months after symptom onset than at
baseline (before SARS-CoV-2 infection).
<AbstractText Label="CONCLUSIONS AND RELEVANCE">In this cohort study,
more severe acute illness, a higher Charlson Comorbidity Index score,
and being unvaccinated were associated with a higher risk of reporting
COVID-19 symptoms lasting 28 days or more. Participants with COVID-19
were more likely to seek medical care for diabetes, pulmonary,
neurological, and mental health-related illness for at least 6 months
after onset compared with their pre-COVID baseline health care use
patterns. These findings may inform the risk-benefit ratio of COVID-19
vaccination policy.</td>
</tr>
<tr class="even">
<td align="left">36619744</td>
<td align="left">Frontiers in cellular and infection microbiology</td>
<td align="left">Native Hawaiians and Pacific Islanders (NHPIs) suffer
from higher prevalence of and mortality to type 2 diabetes mellitus
(T2DM) than any other major race/ethnic group in Hawaii. Health
inequities in this indigenous population was further exacerbated by the
SARS-CoV-2 pandemic. T2DM progression and medical complications
exacerbated by COVID-19 are partially regulated by the gut microbiome.
However, there is limited understanding of the role of gut bacteria in
the context of inflammation-related diseases of health disparities
including T2DM and obesity. To address these gaps, we used a
community-based research approach from a cohort enriched with NHPI
residents on the island of Oahu, Hawaii (N=138). Gut microbiome
profiling was achieved via 16s rDNA metagenomic sequencing analysis from
stool DNA. Gut bacterial capacity for butyrate-kinase (BUK)-mediated
fiber metabolism was assessed using quantitative PCR to measure the
abundance of BUK DNA and RNA relative to total bacterial load per stool
sample. In our cohort, age positively correlated with hemoglobin A1c (%;
R=0.39; P&lt;0.001) and body mass index (BMI; R=0.28; P&lt;0.001). The
relative abundance of major gut bacterial phyla significantly varied
across age groups, including Bacteroidetes (P&lt;0.001), Actinobacteria
(P=0.007), and Proteobacteria (P=0.008). A1c was negatively correlated
with the relative levels of BUK DNA copy number (R=-0.17; P=0.071) and
gene expression (R=-0.33; P=0.003). Interestingly, we identified
specific genera of gut bacteria potentially mediating the effects of
diet on metabolic health in this cohort. Additionally, -diversity among
gut bacterial genera significantly varied across T2DM and BMI
categories. Together, these results provide insight into age-related
differences in gut bacteria that may influence T2DM and obesity in
NHPIs. Furthermore, we observed overlapping patterns between gut
bacteria and T2DM risk factors, indicating more nuanced, interdependent
interactions among these factors as partial determinants of health
outcomes. This study adds to the paucity of NHPI-specific data to
further elucidate the biological characteristics associated with
pre-existing health inequities in this racial/ethnic group that is
significantly underrepresented in biomedical research. Copyright  2022
Wells, Kunihiro, Phankitnirundorn, Peres, McCracken, Umeda, Lee, Kim,
Juarez and Maunakea.</td>
</tr>
<tr class="odd">
<td align="left">36602072</td>
<td align="left">Clinical toxicology (Philadelphia, Pa.)</td>
<td align="left"><AbstractText Label="ABSTRACTINTRODUCTION" NlmCategory="UNASSIGNED">This
is the 39th Annual Report of Americas Poison Centers National Poison
Data System (NPDS). As of 1 January, 2021, all 55 of the nations poison
centers (PCs) uploaded case data automatically to NPDS. The upload
interval was 4.87 [4.38, 8.62] (median [25%, 75%]) minutes, effectuating
a near real-time national exposure and information database and
surveillance system.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We analyzed the
case data tabulating specific indices from NPDS. The methodology was
similar to that of previous years. Where changes were introduced, the
differences are identified. Cases with medical outcomes of death were
evaluated by a team of medical and clinical toxicologist reviewers using
an ordinal scale of 1-6 to assess the Relative Contribution to Fatality
(RCF) of the exposure.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">In 2021,
2,851,166 closed encounters were logged by NPDS: 2,080,917 human
exposures, 62,189 animal exposures, 703,086 information requests, 4,920
human confirmed nonexposures, and 54 animal confirmed nonexposures.
Total encounters showed a 14.0% decrease from 2020, and human exposure
cases decreased by 2.22%, while health care facility (HCF) human
exposure cases increased by 7.20%. All information requests decreased by
37.0%, medication identification (Drug ID) requests decreased by 20.8%,
and medical information requests showed a 61.1% decrease, although these
remain about 13-fold higher than before the COVID-19 pandemic. Drug
Information requests showed a 146% increase, reflecting COVID-19 vaccine
calls to PCs. Human exposures with less serious outcomes have decreased
1.80% per year since 2008, while those with more serious outcomes
(moderate, major or death) have increased 4.56% per year since
2000.Consistent with the previous year, the top 5 substance classes most
frequently involved in all human exposures were analgesics (11.2%),
household cleaning substances (7.49%), cosmetics/personal care products
(5.88%), antidepressants (5.61%), and sedatives/hypnotics/antipsychotics
(4.73%). As a class, antidepressant exposures increased most rapidly, by
1,663 cases/year (5.30%/year) over the past 10 years for cases with more
serious outcomes.The top 5 most common exposures in children age 5 years
or less were cosmetics/personal care products (10.8%), household
cleaning substances (10.7%), analgesics (8.16%), dietary
supplements/herbals/homeopathic (7.00%), and foreign
bodies/toys/miscellaneous (6.51%). Drug identification requests
comprised 3.64% of all information contacts. NPDS documented 4,497 human
exposures resulting in death; 3,809 (84.7%) of these were judged as
related (RCF of 1-Undoubtedly responsible, 2-Probably responsible, or
3-Contributory).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">These data
support the continued value of PC expertise and the need for specialized
medical toxicology information to manage more serious exposures.
Unintentional and intentional exposures continue to be a significant
cause of morbidity and mortality in the US. The near real-time status of
NPDS represents a national public health resource to collect and monitor
US exposure cases and information contacts. The continuing mission of
NPDS is to provide a nationwide infrastructure for surveillance for all
types of exposures (e.g., foreign body, infectious, venomous, chemical
agent, or commercial product), and the identification and tracking of
significant public health events. NPDS is a model system for the near
real-time surveillance of national and global public health.</td>
</tr>
<tr class="even">
<td align="left">36591237</td>
<td align="left">Frontiers in immunology</td>
<td align="left"><AbstractText Label="BACKGROUND">Low-density
granulocytes (LDGs) are a distinct subset of neutrophils whose increased
abundance is associated with the severity of COVID-19. However, the
long-term effects of severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) infection on LDG levels and phenotypic alteration remain
unexplored. <AbstractText Label="METHODS">Using participants nave to
SARS-CoV-2 (NP), infected with SARS-CoV-2 with no residual symptoms
(NRS), and infected with SARS-CoV-2 with chronic pulmonary symptoms
(PPASC), we compared LDG levels and their phenotype by measuring the
expression of markers for activation, maturation, and neutrophil
extracellular trap (NET) formation using flow cytometry.
<AbstractText Label="RESULTS">The number of LDGs was elevated in PPASC
compared to NP. Individuals infected with SARS-CoV-2 (NRS and PPASC)
demonstrated increased CD10+ and CD16hi subset counts of LDGs compared
to NP group. Further characterization of LDGs demonstrated that LDGs
from COVID-19 convalescents (PPASC and NRS) displayed increased markers
of NET forming ability and aggregation with platelets compared to LDGs
from NP, but no differences were observed between PPASC and NRS.
<AbstractText Label="CONCLUSIONS">Our data from a small cohort study
demonstrates that mature neutrophils with a heightened activation
phenotype remain in circulation long after initial SARS-CoV-2 infection.
Persistent elevation of markers for neutrophil activation and NET
formation on LDGs, as well as an enhanced proclivity for
platelet-neutrophil aggregation (PNA) formation in COVID-19 convalescent
individuals may be associated with PPASC prognosis and development.
Copyright  2022 Dean, Devendra, Jiyarom, Subia, Tallquist, Nerurkar,
Chang, Chow, Shikuma and Park.</td>
</tr>
<tr class="odd">
<td align="left">36582496</td>
<td align="left">Federal practitioner : for the health care
professionals of the VA, DoD, and PHS</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">During
the initial phase of the COVID-19 pandemic, facilities transformed some
medical care to virtual appointments. There was a subsequent decline in
chronic disease screening and management, as well as cancer screening
rates.
<AbstractText Label="OBSERVATIONS" NlmCategory="UNASSIGNED">COVID-19
vaccine events offered an opportunity to provide face-to-face preventive
care to veterans, and mobile vaccine events enabled us to reach rural
veterans. In this quality improvement project, we partnered with state
and community organizations to reach veterans at large vaccine events,
as well as in rural sites and homeless housing. The program resulted in
the successful provision of preventive care to 115 veterans at these
events, with high follow-up for recommended medical care. In all, 404
clinical reminders were completed and 10 new veterans were enrolled for
health care. Important clinical findings included an invasive colorectal
cancer, positive HIV point-of-care test, diabetic retinal disease,
uncontrolled hypertension, and depression.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Vaccine
events offer a venue for chronic disease screening, referral, and cancer
screening. Copyright  2022 Frontline Medical Communications Inc.,
Parsippany, NJ, USA.</td>
</tr>
<tr class="even">
<td align="left">36572233</td>
<td align="left">The Journal of arthroplasty</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
COVID-19 pandemic caused a surge of same-day discharge (SDD) for total
joint arthroplasty. However, SDD may not be beneficial for all patients.
Therefore, continued investigation into the safety of SDD is necessary
as well as risk stratification for improved patient outcomes.
<AbstractText Label="METHODS" NlmCategory="METHODS">This retrospective
cohort study examined 31,851 elective SDD hip and knee arthroplasties
from 2016 to 2020 in a large national database. Logistic regression
models were used to identify patient variables and preoperative
comorbidities that contribute to postoperative complication or
readmission with SDD. Adjusted odds ratios (AOR) and 95% confidence
intervals (CI) were calculated.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">SDD increased from
1.4% in 2016 to 14.6% in 2020. SDD is associated with lower odds of
readmission (AOR: 0.994, CI: 0.992-0.996) and postoperative
complications (AOR: 0.998, CI: 0.997-1.000). Patients who have
preoperative dyspnea (AOR: 1.03, CI: 1.02-1.04, P &lt; .001), chronic
obstructive pulmonary disease (AOR: 1.02, CI: 1.01-1.03, P = .002), and
hypoalbuminemia (AOR: 1.02, CI: 1.00-1.03, P &lt; .001), had higher odds
of postoperative complications. Patients who had preoperative dyspnea
(AOR: 1.02, CI: 1.01-1.03), hypertension (AOR: 1.01, CI: 1.01-1.03, P =
.003), chronic corticosteroid use (AOR: 1.02, CI: 1.01-1.03, P &lt;
.001), bleeding disorder (AOR: 1.02; CI: 1.01-1.03, P &lt; .001), and
hypoalbuminemia (AOR: 1.01, CI: 1.00-1.02, P = .038), had higher odds of
readmission.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">SDD is safe
with certain comorbidities. Preoperative screening for cardiopulmonary
comorbidities (eg, dyspnea, hypertension, and chronic obstructive
pulmonary disease), chronic corticosteroid use, bleeding disorder, and
hypoalbuminemia may improve SDD outcomes. Copyright  2022 Elsevier
Inc.All rights reserved.</td>
</tr>
<tr class="odd">
<td align="left">36560974</td>
<td align="left">Proceedings of the  Annual Hawaii International
Conference on System Sciences. Annual Hawaii International Conference on
System Sciences</td>
<td align="left">Our collaboration seeks to demonstrate shared
interrogation by exploring the ethics of machine learning benchmarks
from a socio-technical management perspective with insight from public
health and ethnic studies. Benchmarks, such as ImageNet, are annotated
open data sets for training algorithms. The COVID-19 pandemic reinforced
the practical need for ethical information infrastructures to analyze
digital and social media, especially related to medicine and race.
Social media analysis that obscures Black teen mental health and ignores
anti-Asian hate fails as information infrastructure. Despite
inadequately handling non-dominant voices, machine learning benchmarks
are the basis for analysis in operational systems. Turning to the
management literature, we interrogate cross-cutting problems of
benchmarks through the lens of coupling, or mutual interdependence
between people, technologies, and environments. Uncoupling inequality
from machine learning benchmarks may require conceptualizing the social
dependencies that build structural barriers to inclusion.</td>
</tr>
<tr class="even">
<td align="left">36555339</td>
<td align="left">International journal of molecular sciences</td>
<td align="left">Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) is a highly contagious and pathogenic coronavirus that
emerged in late 2019 and caused a pandemic of respiratory illness termed
as coronavirus disease 2019 (COVID-19). Cancer patients are more
susceptible to SARS-CoV-2 infection. The treatment of cancer patients
infected with SARS-CoV-2 is more complicated, and the patients are at
risk of poor prognosis compared to other populations. Patients infected
with SARS-CoV-2 are prone to rapid development of acute respiratory
distress syndrome (ARDS) of which pulmonary fibrosis (PF) is considered
a sequelae. Both ARDS and PF are factors that contribute to poor
prognosis in COVID-19 patients. However, the molecular mechanisms among
COVID-19, ARDS and PF in COVID-19 patients with cancer are not
well-understood. In this study, the common differentially expressed
genes (DEGs) between COVID-19 patients with and without cancer were
identified. Based on the common DEGs, a series of analyses were
performed, including Gene Ontology (GO) and pathway analysis,
protein-protein interaction (PPI) network construction and hub gene
extraction, transcription factor (TF)-DEG regulatory network
construction, TF-DEG-miRNA coregulatory network construction and drug
molecule identification. The candidate drug molecules (e.g.,
Tamibarotene CTD 00002527) obtained by this study might be helpful for
effective therapeutic targets in COVID-19 patients with cancer. In
addition, the common DEGs among ARDS, PF and COVID-19 patients with and
without cancer are TNFSF10 and IFITM2. These two genes may serve as
potential therapeutic targets in the treatment of COVID-19 patients with
cancer. Changes in the expression levels of TNFSF10 and IFITM2 in
CD14+/CD16+ monocytes may affect the immune response of COVID-19
patients. Specifically, changes in the expression level of TNFSF10 in
monocytes can be considered as an immune signature in COVID-19 patients
with hematologic cancer. Targeting N6-methyladenosine (m6A) pathways
(e.g., METTL3/SERPINA1 axis) to restrict SARS-CoV-2 reproduction has
therapeutic potential for COVID-19 patients.</td>
</tr>
<tr class="odd">
<td align="left">36554713</td>
<td align="left">International journal of environmental research and
public health</td>
<td align="left">Limited information exists about social network
variation and health information sharing during COVID-19, especially for
Native Hawaiians (NH), Other Pacific Islanders (OPI), and Filipinos, who
experienced COVID-19 inequities. Hawaii residents aged 18-35 completed
an online survey regarding social media sources of COVID-19 information
and social network health information measured by how many people
participants: (1) talked to and (2) listened to about health. Regression
models were fit with age, gender, race/ethnicity, chronic disease
status, pandemic perceptions, and health literacy as predictors of
information sources (logistic) and social network size (Poisson).
Respondents were 68% female; 41% NH, OPI, or Filipino; and 73% conducted
a recent COVID-19 digital search for themselves or others. Respondents
listened to others or discussed their own health with ~2-3 people.
Respondents who talked with more people about their health were more
likely to have larger networks for listening to others. In regression
models, those who perceived greater risk of acquiring COVID-19 discussed
their health with more people; in discussing others health, women and
those with chronic diseases listened to a greater number. Understanding
young adults social networks and information sources is important for
health literacy and designing effective health communications,
especially to reach populations experiencing health inequities.</td>
</tr>
<tr class="even">
<td align="left">36536782</td>
<td align="left">Lancet regional health. Americas</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The
impact of the COVID-19 vaccination campaign in the US has been hampered
by a substantial geographical heterogeneity of the vaccination coverage.
Several studies have proposed vaccination hesitancy as a key driver of
the vaccination uptake disparities. However, the impact of other
important structural determinants such as local disparities in
healthcare capacity is virtually unknown.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this
cross-sectional study, we conducted causal inference and geospatial
analyses to assess the impact of healthcare capacity on the vaccination
coverage disparity in the US. We evaluated the causal relationship
between the healthcare system capacity of 2417 US counties and their
COVID-19 vaccination rate. We also conducted geospatial analyses using
spatial scan statistics to identify areas with low vaccination rates.
<AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">We found a
causal effect of the constraints in the healthcare capacity of a county
and its low-vaccination uptake. Counties with higher constraints in
their healthcare capacity were more probable to have COVID-19
vaccination rates 50, with 35% higher constraints in low-vaccinated
areas (vaccination rates  50) compared to high-vaccinated areas
(vaccination rates &gt; 50). We also found that COVID-19 vaccination in
the US exhibits a distinct spatial structure with defined vaccination
coldspots.
<AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">We found
that the healthcare capacity of a county is an important determinant of
low vaccine uptake. Our study highlights that even in high-income
nations, internal disparities in healthcare capacity play an important
role in the health outcomes of the nation. Therefore, strengthening the
funding and infrastructure of the healthcare system, particularly in
rural underserved areas, should be intensified to help vulnerable
communities.
<AbstractText Label="FUNDING" NlmCategory="UNASSIGNED">None.  2022 The
Authors.</td>
</tr>
<tr class="odd">
<td align="left">36485021</td>
<td align="left">JMIR cancer</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Telehealth
visits increase patients access to care and are often rated as just as
good as face-to-face visits by oncology patients. Telehealth visits
have become increasingly more common in the care of patients with cancer
since the advent of the COVID-19 pandemic. Asians and Pacific Islanders
are two of the fastest growing racial groups in the United States, but
there are few studies assessing patient satisfaction with telemedicine
among these two racial groups.
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our objective
was to compare satisfaction with communication during telehealth visits
versus face-to-face visits among oncology patients, with a specific
focus on Asian patients and Native Hawaiian and other Pacific Islander
(NHOPI) patients. <AbstractText Label="METHODS" NlmCategory="METHODS">We
surveyed a racially diverse group of patients who were treated at
community cancer centers in Hawaii and had recently experienced a
face-to-face visit or telehealth visit. Questions for assessing
satisfaction with patient-physician communication were adapted from a
previously published study of cancer survivors. Variables that impact
communication, including age, sex, household income, education level,
and cancer type and stage, were captured. Multivariable logistic models
for patient satisfaction were created, with adjustments for
sociodemographic factors.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Participants who
attended a face-to-face visit reported higher levels of satisfaction in
all communication measures than those reported by participants who
underwent a telehealth encounter. The univariate analysis revealed lower
levels of satisfaction during telehealth visits among Asian participants
and NHOPI participants compared to those among White participants for
all measures of communication (eg, when asked to what degree [y]our
physician listened carefully to you). Asian patients and NHOPI patients
were significantly less likely than White patients to strongly agree
with the statement (P&lt;.004 and P&lt;.007, respectively). Racial
differences in satisfaction with communication persisted in the
multivariate analysis even after adjusting for sociodemographic factors.
There were no significant racial differences in communication during
face-to-face visits.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Asian
patients and NHOPI patients were significantly less content with
patient-physician communication during telehealth visits when compared
to White patients. This difference among racial groups was not seen in
face-to-face visits. The observation that telehealth increases racial
disparities in health care satisfaction should prompt further
exploration. Jared D Acoba, Chelsea Yin, Michael Meno, Justin Abe, Ian
Pagano, Sharon Tamashiro, Kristy Fujinaga, Christa Braun-Inglis, Jami
Fukui. Originally published in JMIR Cancer (<a href="https://cancer.jmir.org" class="uri">https://cancer.jmir.org</a>),
09.12.2022.</td>
</tr>
<tr class="even">
<td align="left">36473671</td>
<td align="left">Virus research</td>
<td align="left"><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Rapid
transmission and reproduction of RNA viruses prepare conducive
conditions to have a high rate of mutations in their genetic sequence.
The viral mutations make adapt the severe acute respiratory syndrome
coronavirus 2 in the host environment and help the evolution of the
virus then also caused a high mortality rate by the virus that threatens
worldwide health. Mutations and adaptation help the virus to escape
confrontations that are done against it.
<AbstractText Label="METHODS" NlmCategory="METHODS">In the present
study, we analyzed 6,510,947 sequences of non-structural protein 1 as
one of the conserved regions of the virus to find out frequent mutations
and substitute amino acids in comparison with the wild type. NSP1
mutations rate divided into continents were different.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Based on this
continental categorization, E87D in global vision and also in Europe
notably increased. The E87D mutation has signed up to January 2022 as
the first frequent mutation observed. The remarkable mutations, H110Y
and R24C have the second and third frequencies, respectively.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">According to
the important role of non-structural protein 1 on the host mRNA
translation, developing drug design against the protein could be so
hopeful to find more effective ways the control and then treatment of
the global pandemic coronavirus disease 2019. Published by Elsevier
B.V.</td>
</tr>
<tr class="odd">
<td align="left">36454775</td>
<td align="left">PloS one</td>
<td align="left">Using genomics, bioinformatics and statistics, herein
we demonstrate the effect of statewide and nationwide quarantine on the
introduction of SARS-CoV-2 variants of concern (VOC) in Hawaii. To
define the origins of introduced VOC, we analyzed 260 VOC sequences from
Hawaii, and 301,646 VOC sequences worldwide, deposited in the GenBank
and global initiative on sharing all influenza data (GISAID), and
constructed phylogenetic trees. The trees define the most recent common
ancestor as the origin. Further, the multiple sequence alignment used to
generate the phylogenetic trees identified the consensus single
nucleotide polymorphisms in the VOC genomes. These consensus sequences
allow for VOC comparison and identification of mutations of interest in
relation to viral immune evasion and host immune activation. Of note is
the P71L substitution within the E protein, the protein sensed by TLR2
to produce cytokines, found in the B.1.351 VOC may diminish the efficacy
of some vaccines. Based on the phylogenetic trees, the B.1.1.7, B.1.351,
B.1.427, and B.1.429 VOC have been introduced in Hawaii multiple times
since December 2020 from several definable geographic regions. From the
first worldwide report of VOC in GenBank and GISAID, to the first
arrival of VOC in Hawaii, averages 320 days with quarantine, and 132
days without quarantine. As such, the effect of quarantine is shown to
significantly affect the time to arrival of VOC in Hawaii. Further, the
collective 2020 quarantine of 43-states in the United States
demonstrates a profound impact in delaying the arrival of VOC in states
that did not practice quarantine, such as Utah. Our data demonstrates
that at least 76% of all definable SARS-CoV-2 VOC have entered Hawaii
from California, with the B.1.351 variant in Hawaii originating
exclusively from the United Kingdom. These data provide a foundation for
policy-makers and public-health officials to apply precision public
health genomics to real-world policies such as mandatory screening and
quarantine. Copyright:  2022 Maison et al.This is an open access
article distributed under the terms of the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction
in any medium, provided the original author and source are
credited.</td>
</tr>
<tr class="even">
<td align="left">36454600</td>
<td align="left">Health security</td>
<td align="left">Local health jurisdictions have struggled to protect
their communities during the pandemic, and successes are few. The Kauai
District Health Office (KDHO) of the Hawaii Department of Health serves
a rural island community of 73,000 residents. As a state agency, KDHO
works closely with the county mayor and administration. Kauai has
experienced comparatively low COVID-19 case and case-fatality rates
while maintaining strong community and leadership cohesion. Kauais
response was highly rated by residents in a recent Community Assessment
for Public Health Emergency Response survey. In this article, we
describe examples of local response efforts in the areas of (1) policy
and regulations, (2) health-directed isolation and quarantine, (3) case
investigation and contact tracing, (4) testing availability, (5) vaccine
rollout and availability, and (6) public information, as well as the
factors that have contributed to Kauais successes. KDHO regularly
prioritizes agencywide initiatives that cross program silos; staff have
experience using the incident command system in real-world situations;
the community health worker team is multicultural, multilingual, and
well established; and staff are integral members of the community they
serve. Preexisting partnerships were strong, including those with county
agencies, healthcare partners, and nongovernmental organizations, which
facilitated early and effective collaboration. Response successes
include implementation of unified command, coordinated public messaging,
early protective measures, effective disease control and outbreak
response, attention to secondary impacts of the pandemic, free community
testing, mass vaccination, and mobile vaccinations and testing. The
value of local health departments engaging regularly and authentically
with partners and communities cannot be overstated. It has saved lives
on Kauai. Local health jurisdictions should focus on all-hazards and
all-staff endeavors to enhance their disaster response
effectiveness.</td>
</tr>
<tr class="odd">
<td align="left">36443734</td>
<td align="left">BMC public health</td>
<td align="left"><AbstractText Label="BACKGROUND">Racial disparities in
psychological distress associated with COVID-19 remain unclear in the
U.S. This study aims to investigate the associations between social
determinants of health and COVID-19-related psychological distress
across different racial/ethnic groups in the US (i.e., non-Hispanic
Whites, Hispanic, non-Hispanic Asians, and non-Hispanic African
Americans). <AbstractText Label="METHODS">This study used
cross-sectional data from the 2020 California Health Interview Survey
Adult Data Files (N = 21,280). Adjusting for covariates-including age,
gender, COVID-19 pandemic challenges, and risk of severe illness from
COVID-19-four sets of weighted binary logistic regressions were
conducted. <AbstractText Label="RESULTS">The rates of moderate/severe
psychological distress significantly varied across four racial/ethnic
groups (p &lt; 0.001), with the highest rate found in the Hispanic
group. Across the five domains of social determinants of health, we
found that unemployment, food insecurity, housing instability, high
educational attainment, usual source of health care, delayed medical
care, and low neighborhood social cohesion and safety were associated
with high levels of psychological distress in at least one racial/ethnic
group (p &lt; 0.05). <AbstractText Label="CONCLUSION">Our study suggests
that Hispanic adults face more adverse social determinants of health and
are disproportionately impacted by the pandemic. Public health practice
and policy should highlight social determinants of heath that are
associated with different racial/ethnic groups and develop tailored
programs to reduce psychological distress.  2022. The Author(s).</td>
</tr>
<tr class="even">
<td align="left">36425114</td>
<td align="left">Frontiers in medicine</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Evidence
highlighted the likelihood of unmet mental health needs (UMHNs) among
LGBTQ+ than non-LGBTQ+ populations during COVID-19. However, there lacks
evidence to accurately answer to what extent the gap was in UMHN between
LGBTQ+ and non-LGBTQ+ populations. We aim to evaluate the difference in
UMHN between LGBTQ+ and non-LGBTQ+ during COVID-19.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Cross-sectional
data from Household Pulse Survey between 21 July 2021 and 9 May 2022
were analyzed. LGBTQ+ was defined based on self-reported sex at birth,
gender, and sexual orientation identity. UMHN was assessed by a
self-reported question. Multivariable logistic regressions generated
adjusted odds ratios (AODs) of UMHN, both on overall and subgroups,
controlling for a variety of socio-demographic and
economic-affordability confounders.
<AbstractText Label="FINDINGS" NlmCategory="UNASSIGNED">81267 LGBTQ+ and
722638 non-LGBTQ+ were studied. The difference in UMHN between LGBTQ+
and non-LGBTQ+ (as reference) varied from 4.9% (95% CI 1.2-8.7%) in
Hawaii to 16.0% (95% CI 12.2-19.7%) in Utah. In multivariable models,
compared with non-LGBTQ+ populations, LGBTQ+ had a higher likelihood to
report UMHN (AOR = 2.27, 95% CI 2.18-2.39), with the highest likelihood
identified in transgender (AOR = 3.63, 95% CI 2.97-4.39); compared with
LGBTQ+ aged 65+, LGBTQ+ aged 18-25 had a higher likelihood to report
UMHN (AOR = 1.34, 95% CI 1.03-1.75); compared with White LGBTQ+
populations, Black and Hispanic LGBTQ+ had a lower likelihood to report
UMHN (AOR = 0.72, 95% CI 0.63-0.82; AOR = 0.85, 95% CI 0.75-0.97,
respectively).
<AbstractText Label="INTERPRETATION" NlmCategory="UNASSIGNED">During the
COVID-19, LGBTQ+ had a substantial additional risk of UMHN than
non-LGBTQ+. Disparities among age groups, subtypes of LGBTQ+, and
geographic variance were also identified. Copyright  2022 Chen, Wang,
She, Qin and Ming.</td>
</tr>
<tr class="odd">
<td align="left">36399438</td>
<td align="left">PloS one</td>
<td align="left">Using bargaining agreement data from the Federal
Mediation Conciliation Services, we found that the median national
resident COVID-19 mortality percentage (as of April 24, 2022) of
unionized nursing homes and that of nonunionized ones were not
statically different (10.2% vs.10.7%; P = 0.32). The median nursing
home resident COVID-19 mortality percentage varied from 0% in Hawaii to
above 16% in Rhode Island (16.6%). Unionized nursing homes had a
statistically significant lower median mortality percentage than
nonunionized nursing homes (P &lt; 0.1) in Missouri, and had a higher
median mortality percentage than nonunionized nursing homes (P &lt;
0.05) in Alabama and Tennessee. Higher average resident age, lower
percentage of Medicare residents, small size, for-profit ownership, and
chain organization affiliation were associated with higher resident
COVID-19 mortality percentage. Overall, no evidence was found that
nursing home resident COVID-19 mortality percentage differed between
unionized nursing homes and nonunionized nursing homes in the U.S.
Copyright:  2022 Olson et al.This is an open access article
distributed under the terms of the Creative Commons Attribution License,
which permits unrestricted use, distribution, and reproduction in any
medium, provided the original author and source are credited.</td>
</tr>
<tr class="even">
<td align="left">36399335</td>
<td align="left">JAMA</td>
<td align="left">NA</td>
</tr>
<tr class="odd">
<td align="left">36395004</td>
<td align="left">Preventing chronic disease</td>
<td align="left"><AbstractText Label="INTRODUCTION">The true extent of
racial and ethnic disparities in COVID-19 hospitalizations may be hidden
by misclassification of race and ethnicity. This study aimed to quantify
this inaccuracy in a hospitals electronic medical record (EMR) against
the gold standard of self-identification and then project data onto
state-level COVID-19 hospitalizations by self-identified race and
ethnicity. <AbstractText Label="METHODS">To identify misclassification
of race and ethnicity in the EMRs of a hospital in Honolulu, Hawaii,
research and quality improvement staff members surveyed all available
patients (N = 847) in 5 cohorts in 2007, 2008, 2010, 2013, and 2020 at
randomly selected hospital and ambulatory units. The survey asked
patients to self-identify up to 12 races and ethnicities. We compared
these data with data from EMRs. We then estimated the number of COVID-19
hospitalizations by projecting racial misclassifications onto publicly
available data. We determined significant differences via
simulation-constructed medians and 95% CIs.
<AbstractText Label="RESULTS">EMR-based and self-identified race and
ethnicity were the same in 86.5% of the sample. Native Hawaiians (79.2%)
were significantly less likely than non-Native Hawaiians (89.4%) to be
correctly classified on initial analysis; this difference was driven by
Native Hawaiians being more likely than non-Native Hawaiians to be
multiracial (93.4% vs 30.3%). When restricted to multiracial patients
only, we found no significant difference in accuracy (P = .32). The
number of COVID-19-related hospitalizations was 8.7% higher among Native
Hawaiians and 3.9% higher among Pacific Islanders when we projected
self-identified race and ethnicity rather than using EMR data.
<AbstractText Label="CONCLUSION">Using self-identified rather than
hospital EMR data on race and ethnicity may uncover further disparities
in COVID-19 hospitalizations.</td>
</tr>
<tr class="even">
<td align="left">36382733</td>
<td align="left">Eastern Mediterranean health journal = La revue de
sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq
al-mutawassit</td>
<td align="left"><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Since
winter 2020, excess deaths due to COVID-19 have been higher in Eastern
Europe than most of Western Europe, partly because regulatory
enforcement was poor.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This paper
analysed data from 50 countries in the WHO European Region, in addition
to data from USA and Canada. Excess mMortality and vaccination data were
retrieved from Our World In Data and regulation implementation was
assessed using standard methods. Multiple linear regression was used to
assess the association between mortality and each covariate.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Excess mortality
increased by 4.1 per 100 000 (P = 0.038) for every percentage decrease
in vaccination rate and with 6/100 000 (p=0.011) for every decreased
unit in the regulatory implementation score a country achieved in the
Rule of Law Index.
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Degree of
regulation enforcement, likely including public health measure
enforcement, may be an important factor in controlling COVID-19s
deleterious health impacts. Copyright  Authors 2022; licensee World
Health Organization. EMHJ is an open access journal. This paper is
available under the Creative Commons Attribution Non-Commercial
ShareAlike 3.0 IGO licence (CC BY-NC-SA 3.0 IGO; <a href="https://creativecommons.org/licenses/by-nc-sa/3.0/igo" class="uri">https://creativecommons.org/licenses/by-nc-sa/3.0/igo</a>).</td>
</tr>
<tr class="odd">
<td align="left">36381259</td>
<td align="left">Hawaii journal of health &amp; social welfare</td>
<td align="left">The COVID-19 pandemic increased stress and worry among
faculty and staff members at universities across the US. To assess the
well-being of university faculty and staff, a survey was administered at
a medical school in the state of Hawaii during early fall 2020. The
purpose of the exploratory study was to assess and gauge faculty and
staff members well-being regarding the schools response to COVID-19.
Participants in this study represented a convenience sample of
compensated teaching, research, and administrative faculty and staff
members. A total of 80 faculty and 73 staff members participated.
Overall, faculty and staff reported relatively low levels of worries and
stress. Staff members reported greater levels of worry and stress than
faculty members in 8 of the 11 questions. Statistical differences were
detected in 3 questions, with staff reporting higher levels of worry and
stress in their health and well-being of themselves (P &lt; .001),
paying bills (P &lt; .001), and losing their jobs (P &lt; .001). Both
faculty and staff reported good overall satisfaction on the timeliness
and clarity of messages that they received, support from leadership and
the school, and support to adjust to changes in response to COVID-19.
For both faculty and staff, the greatest worry or concern for the
open-ended question on worry and stress was related to financial and
economic issues. Data from this survey and can contribute to an
understanding of medical school employee well-being during a major
operational disruption and may help develop policies and programs to
assist employees in different employment categories during future
disruptions. Copyright 2022 by University Health Partners of Hawaii
(UHP Hawaii).</td>
</tr>
<tr class="even">
<td align="left">36377347</td>
<td align="left">Child: care, health and development</td>
<td align="left"></td>
</tr>
</tbody>
</table>
<pre><code>    Child Care Health Dev
  
  A review of state regulations for child care: Preventing, recognizing and reporting child maltreatment.
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1111/cch.13080
  
    &lt;AbstractText Label=&quot;BACKGROUND&quot; NlmCategory=&quot;BACKGROUND&quot;&gt;Prior to the COVID-19 pandemic, nearly 60% of children under 5years of age were cared for in out-of-home child care arrangements in the United States. Thus, child care provides an opportunity to identify and address potential child maltreatment. However, during the pandemic, rates of reporting child maltreatment decreased-likely because children spent less time in the presence of mandated reporters. As children return to child care, states must have regulations in place to help child care providers prevent, recognize and report child maltreatment. However, little is known about the extent to which state regulations address child maltreatment. Therefore, the purpose of this cross-sectional study was to assess state regulations related to child maltreatment and compare them to national standards.
    &lt;AbstractText Label=&quot;METHOD&quot; NlmCategory=&quot;METHODS&quot;&gt;We reviewed state regulations for all 50 states and the District of Columbia for child care centres (&#39;centres&#39;) and family child care homes (&#39;homes&#39;) through 31 July 2021 and compared these regulations to eight national health and safety standards on child maltreatment. We coded regulations as either not meeting, partially meeting or fully meeting each standard.
    &lt;AbstractText Label=&quot;RESULTS&quot; NlmCategory=&quot;RESULTS&quot;&gt;Three states (Colorado, Utah and Washington) had regulations for centres, and one state (Washington) had regulations for homes that at least partially met all eight national standards. Nearly all states had regulations consistent with the standards requiring that caregivers and teachers are mandated reporters of child maltreatment and requiring that they be trained in preventing, recognizing and reporting child maltreatment. One state (Hawaii) did not have regulations consistent with any of the national standards for either centres or homes.
    &lt;AbstractText Label=&quot;CONCLUSIONS&quot; NlmCategory=&quot;CONCLUSIONS&quot;&gt;Generally, states lacked regulations related to the prevention, recognition and reporting of child maltreatment for both centres and homes. Encouraging states to adopt regulations that meet national standards and further exploring their impact on child welfare are important next steps.
     2022 John Wiley &amp;amp; Sons Ltd.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Grossman
      Elyse R
      ER
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0003-1444-5804
      
        Department of Health, Behavior and Society, John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      McClendon
      Jasmine E
      JE
      
        University of California Davis Medical Center, Sacramento, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Gielen
      Andrea C
      AC
      
        Department of Health, Behavior and Society, John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      McDonald
      Eileen M
      EM
      
        Department of Health, Behavior and Society, John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Benjamin-Neelon
      Sara E
      SE
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0003-4643-2397
      
        Department of Health, Behavior and Society, John Hopkins Bloomberg School of Public Health, Baltimore, Maryland, USA.
      
    
  
  eng
  &lt;GrantList CompleteYN=&quot;Y&quot;&gt;
    
      1R49CE002466
      CC
      CDC HHS
      United States
    
    
      1R49CE002466
      CC
      CDC HHS
      United States
    
  
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2022
    11
    14
  


  England
  Child Care Health Dev
  7602632
  0305-1862

IM
&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;child care
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;child maltreatment
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;mandatory reporting
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;state regulations




  &lt;PubMedPubDate PubStatus=&quot;revised&quot;&gt;
    2022
    9
    23
  
  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2021
    12
    10
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2022
    11
    5
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2022
    11
    16
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2022
    11
    16
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2022
    11
    15
    3
    2
  

aheadofprint

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;36377347
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1111/cch.13080


  REFERENCES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |&lt;AbstractText Label=&quot;BACKGROUND&quot; NlmCategory=&quot;BACKGROUND&quot;&gt;Prior to the COVID-19 pandemic, nearly 60% of children under 5 years of age were cared for in out-of-home child care arrangements in the United States. Thus, child care provides an opportunity to identify and address potential child maltreatment. However, during the pandemic, rates of reporting child maltreatment decreased-likely because children spent less time in the presence of mandated reporters. As children return to child care, states must have regulations in place to help child care providers prevent, recognize and report child maltreatment. However, little is known about the extent to which state regulations address child maltreatment. Therefore, the purpose of this cross-sectional study was to assess state regulations related to child maltreatment and compare them to national standards. &lt;AbstractText Label=&quot;METHOD&quot; NlmCategory=&quot;METHODS&quot;&gt;We reviewed state regulations for all 50 states and the District of Columbia for child care centres (&#39;centres&#39;) and family child care homes (&#39;homes&#39;) through 31 July 2021 and compared these regulations to eight national health and safety standards on child maltreatment. We coded regulations as either not meeting, partially meeting or fully meeting each standard. &lt;AbstractText Label=&quot;RESULTS&quot; NlmCategory=&quot;RESULTS&quot;&gt;Three states (Colorado, Utah and Washington) had regulations for centres, and one state (Washington) had regulations for homes that at least partially met all eight national standards. Nearly all states had regulations consistent with the standards requiring that caregivers and teachers are mandated reporters of child maltreatment and requiring that they be trained in preventing, recognizing and reporting child maltreatment. One state (Hawaii) did not have regulations consistent with any of the national standards for either centres or homes. &lt;AbstractText Label=&quot;CONCLUSIONS&quot; NlmCategory=&quot;CONCLUSIONS&quot;&gt;Generally, states lacked regulations related to the prevention, recognition and reporting of child maltreatment for both centres and homes. Encouraging states to adopt regulations that meet national standards and further exploring their impact on child welfare are important next steps.  2022 John Wiley &amp;amp; Sons Ltd.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                               |</code></pre>
<p>|36371370 |Vaccine |Monitoring COVID-19 vaccine hesitancy helps
design and implement strategies to increase vaccine uptake. Utilizing
the large scale cross-sectional Household Pulse Survey data collected
between July 21 and October 11 in 2021, this study aims to construct
measures of COVID-19 vaccine hesitancy and identify demographic
disparities among U.S. adults (18y+). Factor analysis identified three
factors of vaccine hesitancy: safety concerns (prevalence: 70.1 %).
trust issues (53.5 %), and not seen as necessary (33.8 %). Among those
who did not show willingness to receive COVID-19 vaccine, females were
more likely to have safety concerns (73.7 %) compared to males (66.7 %),
but less likely to have trust issues (female: 49.7 %; male: 57.1 %) or
not seen as necessary (female: 23.8 %; male 43.4 %). Higher education
was associated with higher prevalence of not seen as necessary. Younger
adults and Whites had higher prevalence of having trust issues and not
seen as necessary compared to their counter parts. Copyright  2022
Elsevier Ltd.All rights reserved. | |36367993 |Journal of perinatal
medicine J Perinat Med</p>
<pre><code>  Maternal telehealth: innovations and Hawai&#39;i perspectives.
  
    69
    82
    69-82
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1515/jpm-2022-0394
  
    Access to maternal-fetal medicine (MFM) subspecialty services is a critical part of a healthcare system that optimizes pregnancy outcomes for women with complex medical and obstetrical disorders. Healthcare services in the State of Hawai&#39;i consist of a complicated patchwork of independently run community health clinics and hospital systems which are difficult for many pregnant patients to navigate. Maternal telehealth services have been identified as a solution to increase access to subspecialty prenatal services for women in rural communities or neighboring islands, especially during the COVID-19 pandemic. Telehealth innovations have been rapidly developing in the areas of remote ultrasound, hypertension management, diabetes management, and fetal monitoring. This report describes how telehealth innovations are being introduced by MFM specialists to optimize care for a unique population of high-risk patients in a remote area of the world such as Hawai&#39;i, as well as review currently available telemedicine technologies and future innovations.
     2022 Walter de Gruyter GmbH, Berlin/Boston.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Sullivan
      Cathlyn
      C
      
        Department of OB/GYN and Women&#39;s Health, Division of Maternal Fetal Medicine, University of Hawai&#39;i, John A. Burns School of Medicine, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Cazin
      Marguerite
      M
      
        Occidental College, Los Angeles, CA, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Higa
      Christina
      C
      
        Social Science Research Institute, University of Hawai&#39;i, College of Social Sciences, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Zalud
      Ivica
      I
      
        Department of OB/GYN and Women&#39;s Health, Division of Maternal Fetal Medicine, University of Hawai&#39;i, John A. Burns School of Medicine, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Lee
      Men-Jean
      MJ
      
        Department of OB/GYN and Women&#39;s Health, Division of Maternal Fetal Medicine, University of Hawai&#39;i, John A. Burns School of Medicine, Honolulu, HI, USA.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
    &lt;PublicationType UI=&quot;D016454&quot;&gt;Review
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2022
    11
    14
  


  Germany
  J Perinat Med
  0361031
  0300-5577

IM

  
    &lt;DescriptorName UI=&quot;D011247&quot; MajorTopicYN=&quot;N&quot;&gt;Pregnancy
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D005260&quot; MajorTopicYN=&quot;N&quot;&gt;Female
  
  
    &lt;DescriptorName UI=&quot;D006254&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;Hawaii
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D058873&quot; MajorTopicYN=&quot;N&quot;&gt;Pandemics
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;Y&quot;&gt;COVID-19
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D017216&quot; MajorTopicYN=&quot;Y&quot;&gt;Telemedicine
  
  
    &lt;DescriptorName UI=&quot;D012424&quot; MajorTopicYN=&quot;N&quot;&gt;Rural Population
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;Hawaii
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;maternal health
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;obstetrics
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;remote fetal monitoring
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;rural health
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;telehealth




  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2022
    8
    15
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2022
    10
    27
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2022
    11
    12
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2023
    1
    17
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2022
    11
    11
    15
    52
  

epublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;36367993
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1515/jpm-2022-0394
  &lt;ArticleId IdType=&quot;pii&quot;&gt;jpm-2022-0394


  References                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |Access to maternal-fetal medicine (MFM) subspecialty services is a critical part of a healthcare system that optimizes pregnancy outcomes for women with complex medical and obstetrical disorders. Healthcare services in the State of Hawai&#39;i consist of a complicated patchwork of independently run community health clinics and hospital systems which are difficult for many pregnant patients to navigate. Maternal telehealth services have been identified as a solution to increase access to subspecialty prenatal services for women in rural communities or neighboring islands, especially during the COVID-19 pandemic. Telehealth innovations have been rapidly developing in the areas of remote ultrasound, hypertension management, diabetes management, and fetal monitoring. This report describes how telehealth innovations are being introduced by MFM specialists to optimize care for a unique population of high-risk patients in a remote area of the world such as Hawai&#39;i, as well as review currently available telemedicine technologies and future innovations.  2022 Walter de Gruyter GmbH, Berlin/Boston.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                      |</code></pre>
<p>|36349436 |Birth defects research
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Remdesivir is
an antiviral drug approved for the treatment of COVID-19, whose
developmental toxicity remains unclear. More information about the
safety of remdesivir is urgently needed for people of childbearing
potential, who are affected by the ongoing pandemic. Morphogenetic
embryoid bodies (MEBs) are three-dimensional (3D) aggregates of
pluripotent stem cells that recapitulate embryonic body patterning in
vitro, and have been used as effective embryo models to detect the
developmental toxicity of chemical exposures specifically and
sensitively. <AbstractText Label="METHODS" NlmCategory="METHODS">MEBs
were generated from mouse P19C5 and human H9 pluripotent stem cells, and
used to examine the effects of remdesivir. The morphological effects
were assessed by analyzing the morphometric parameters of MEBs after
exposure to varying concentrations of remdesivir. The molecular impact
of remdesivir was evaluated by measuring the transcript levels of
developmental regulator genes.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The mouse MEB
morphogenesis was impaired by remdesivir at 1-8 M. Remdesivir affected
MEBs in a manner dependent on metabolic conversion, and its potency was
higher than GS-441524 and GS-621763, presumptive anti-COVID-19 drugs
that act similarly to remdesivir. The expressions of developmental
regulator genes, particularly those involved in axial and somite
patterning, were dysregulated by remdesivir. The early stage of MEB
development was more vulnerable to remdesivir exposure than the later
stage. The morphogenesis and gene expression profiles of human MEBs were
also impaired by remdesivir at 1-8 M.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Remdesivir
impaired mouse and human MEBs at concentrations that are comparable to
the therapeutic plasma levels in humans, urging further investigation
into the potential impact of remdesivir on developing embryos.  2022
The Authors. Birth Defects Research published by Wiley Periodicals LLC.
| |36347663 |American journal of preventive medicine
|<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Shelter-in-place
orders altered facilitators and barriers to tobacco use (e.g., outlet
closures, restricted social gatherings). This study examined whether the
duration of time in shelter in place and compliance with different
shelter-in-place orders influenced adolescent cigarette and E-cigarette
use and how the use may differ by demographic characteristics.
<AbstractText Label="METHODS" NlmCategory="METHODS">Shelter-in-place
policy data obtained from government websites were merged with
cross-sectional 2020 survey data on adolescents in California. Treatment
variables included the proportion of time in shelter in place and
self-reported compliance with shelter-in-place orders (for essential
businesses and retail spaces and social and outdoor contexts).
Multilevel logit models for dichotomous past 6-month cigarette and
E-cigarette use and multilevel negative binomial regression models for
past 6-month frequency of use were used. Moderation analyses were
conducted on demographic measures. The sample included 1,196 adolescents
(mean age=15.8 years, age range=13-19 years, 49.2% female, 50.0% White).
Analyses were conducted in 2022.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">No associations were
found between the proportion of time in shelter in place and outcomes.
Shelter-in-place compliance with essential business and retail space
orders was associated with lower odds of using cigarettes and
E-cigarettes in the past 6 months. Compliance with social and outdoor
context-related orders were associated with lower odds of using
E-cigarettes and fewer days using cigarettes and E-cigarettes. Being
aged 18 years moderated the associations between essential
business/retail space and social/outdoor context-related
shelter-in-place compliance orders and past 6-month frequency of
cigarette smoking.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Findings
support tailored interventions for less compliant and older adolescents
for future pandemic mitigation measures. Copyright  2022 American
Journal of Preventive Medicine. Published by Elsevier Inc.All rights
reserved. | |36317584 |Anatomia, histologia, embryologia Anat Histol
Embryol</p>
<pre><code>  Extended reality veterinary medicine case studies for diagnostic veterinary imaging instruction: Assessing student perceptions and examination performance.
  
    101
    114
    101-114
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1111/ahe.12879
  
    Educational technologies in veterinary medicine aim to train veterinarians faster and improve clinical outcomes. COVID-19 pandemic, shifted face-to-face teaching to online, thus, the need to provide effective education remotely was exacerbated. Among recent technology advances for veterinary medical education, extended reality (XR) is a promising teaching tool. This study aimed to develop a case resolution approach for radiographic anatomy studies using XR technology and assess students&#39; achievement of differential diagnostic skills. Learning objectives based on Bloom&#39;s taxonomy keywords were used to develop four clinical cases (3 dogs/1 cat) of spinal injuries utilizing CT scans and XR models and presented to 22 third-year veterinary medicine students. Quantitative assessment (ASMT) of 7 questions probing &#39;memorization&#39;, &#39;understanding and application&#39;, &#39;analysis&#39; and &#39;evaluation&#39; was given before and after contact with XR technology as well as qualitative feedback via a survey. Mean ASMT scores increased during case resolution (pre 51.6% (37%)/post 60.1% (34%); p&amp;lt;0.01), but without significant difference between cases (Kruskal-Wallis H=2.18, NS). Learning objectives were examined for six questions (Q1-Q6) across cases (C1-4): Memorization improved sequentially (Q1, 2 8/8), while Understanding and Application (Q3,4) showed the greatest improvement (26.7%-76.9%). Evaluation and Analysis (Q5,6) was somewhat mixed, improving (5/8), no change (3/8) and declining (1/8).Positive student perceptions suggest that case studies&#39; online delivery was well received stimulating learning in diagnostic imaging and anatomy while developing visual-spatial skills that aid understanding cross-sectional images. Therefore, XR technology could be a useful approach to complement radiological instruction in veterinary medicine.
     2022 Wiley-VCH GmbH.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Guaran
      Julia B
      JB
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-6964-0589
      
        Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of So Paulo (USP), So Paulo, Brazil.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Ayta
      Gne
      G
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0003-4902-2844
      
        Department of Anatomy, Biochemistry &amp;amp; Physiology, John A. Burns School of Medicine, University of Hawaii (UH), Honolulu, Hawaii, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Mller
      Alois F
      AF
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-4053-9161
      
        Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of So Paulo (USP), So Paulo, Brazil.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Thompson
      Jesse
      J
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0003-0639-033X
      
        Department of Anatomy, Biochemistry &amp;amp; Physiology, John A. Burns School of Medicine, University of Hawaii (UH), Honolulu, Hawaii, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Freitas
      Silvio H
      SH
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0001-7595-0367
      
        Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of So Paulo (USP), So Paulo, Brazil.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Lee
      U-Young
      UY
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-8990-1213
      
        Department of Anatomy, College of Medicine, The Catholic University of Korea (CUK), Seoul, South Korea.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Lozanoff
      Scott
      S
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0001-9089-3153
      
        Department of Anatomy, Biochemistry &amp;amp; Physiology, John A. Burns School of Medicine, University of Hawaii (UH), Honolulu, Hawaii, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Ferrante
      Bruno
      B
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0001-9783-7744
      
        Department of Veterinary Medicine, Faculty of Animal Science and Food Engineering, University of So Paulo (USP), So Paulo, Brazil.
      
      
        Veterinary Clinical and Surgery Department of Veterinary School, Federal University of Minas Gerais (UFMG), Belo Horizonte, Minas Gerais, Brazil.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2022
    11
    01
  


  Germany
  Anat Histol Embryol
  7704218
  0340-2096

IM

  
    &lt;DescriptorName UI=&quot;D000818&quot; MajorTopicYN=&quot;N&quot;&gt;Animals
  
  
    &lt;DescriptorName UI=&quot;D004285&quot; MajorTopicYN=&quot;N&quot;&gt;Dogs
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;N&quot;&gt;COVID-19
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D004283&quot; MajorTopicYN=&quot;Y&quot;&gt;Dog Diseases
    &lt;QualifierName UI=&quot;Q000000981&quot; MajorTopicYN=&quot;N&quot;&gt;diagnostic imaging
  
  
    &lt;DescriptorName UI=&quot;D007858&quot; MajorTopicYN=&quot;N&quot;&gt;Learning
  
  
    &lt;DescriptorName UI=&quot;D058873&quot; MajorTopicYN=&quot;N&quot;&gt;Pandemics
  
  
    &lt;DescriptorName UI=&quot;D014057&quot; MajorTopicYN=&quot;N&quot;&gt;Tomography, X-Ray Computed
    &lt;QualifierName UI=&quot;Q000662&quot; MajorTopicYN=&quot;N&quot;&gt;veterinary
  
  
    &lt;DescriptorName UI=&quot;D002371&quot; MajorTopicYN=&quot;Y&quot;&gt;Cat Diseases
    &lt;QualifierName UI=&quot;Q000000981&quot; MajorTopicYN=&quot;N&quot;&gt;diagnostic imaging
  
  
    &lt;DescriptorName UI=&quot;D004520&quot; MajorTopicYN=&quot;Y&quot;&gt;Education, Veterinary
    &lt;QualifierName UI=&quot;Q000458&quot; MajorTopicYN=&quot;N&quot;&gt;organization &amp;amp; administration
  
  
    &lt;DescriptorName UI=&quot;D013337&quot; MajorTopicYN=&quot;Y&quot;&gt;Students, Medical
    &lt;QualifierName UI=&quot;Q000523&quot; MajorTopicYN=&quot;N&quot;&gt;psychology
  
  
    &lt;DescriptorName UI=&quot;D020375&quot; MajorTopicYN=&quot;Y&quot;&gt;Education, Distance
    &lt;QualifierName UI=&quot;Q000458&quot; MajorTopicYN=&quot;N&quot;&gt;organization &amp;amp; administration
  
  
    &lt;DescriptorName UI=&quot;D004521&quot; MajorTopicYN=&quot;N&quot;&gt;Educational Measurement
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;distance learning
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;extended reality
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;radiological anatomy
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;visual-spatial learning




  &lt;PubMedPubDate PubStatus=&quot;revised&quot;&gt;
    2022
    8
    7
  
  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2022
    6
    30
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2022
    8
    31
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2022
    11
    2
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2023
    1
    19
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2022
    11
    1
    5
    53
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;36317584
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1111/ahe.12879


  REFERENCES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |Educational technologies in veterinary medicine aim to train veterinarians faster and improve clinical outcomes. COVID-19 pandemic, shifted face-to-face teaching to online, thus, the need to provide effective education remotely was exacerbated. Among recent technology advances for veterinary medical education, extended reality (XR) is a promising teaching tool. This study aimed to develop a case resolution approach for radiographic anatomy studies using XR technology and assess students&#39; achievement of differential diagnostic skills. Learning objectives based on Bloom&#39;s taxonomy keywords were used to develop four clinical cases (3 dogs/1 cat) of spinal injuries utilizing CT scans and XR models and presented to 22 third-year veterinary medicine students. Quantitative assessment (ASMT) of 7 questions probing &#39;memorization&#39;, &#39;understanding and application&#39;, &#39;analysis&#39; and &#39;evaluation&#39; was given before and after contact with XR technology as well as qualitative feedback via a survey. Mean ASMT scores increased during case resolution (pre 51.6% (37%)/post 60.1% ( 34%); p &amp;lt; 0.01), but without significant difference between cases (Kruskal-Wallis H = 2.18, NS). Learning objectives were examined for six questions (Q1-Q6) across cases (C1-4): Memorization improved sequentially (Q1, 2 8/8), while Understanding and Application (Q3,4) showed the greatest improvement (26.7%-76.9%). Evaluation and Analysis (Q5,6) was somewhat mixed, improving (5/8), no change (3/8) and declining (1/8).Positive student perceptions suggest that case studies&#39; online delivery was well received stimulating learning in diagnostic imaging and anatomy while developing visual-spatial skills that aid understanding cross-sectional images. Therefore, XR technology could be a useful approach to complement radiological instruction in veterinary medicine.  2022 Wiley-VCH GmbH.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |</code></pre>
<p>|36306800 |The Lancet. Infectious diseases |NA | |36299999 |iScience
|The MetaSUB Consortium, founded in 2015, is a global consortium with an
interdisciplinary team of clinicians, scientists, bioinformaticians,
engineers, and designers, with members from more than 100 countries
across the globe. This network has continually collected samples from
urban and rural sites including subways and transit systems, sewage
systems, hospitals, and other environmental sampling. These collections
have been ongoing since 2015 and have continued when possible, even
throughout the COVID-19 pandemic. The consortium has optimized their
workflow for the collection, isolation, and sequencing of DNA and RNA
collected from these various sites and processing them for metagenomics
analysis, including the identification of SARS-CoV-2 and its variants.
Here, the Consortium describes its foundations, and its ongoing work to
expand on this network and to focus its scope on the mapping,
annotation, and prediction of emerging pathogens, mapping microbial
evolution and antibiotic resistance, and the discovery of novel
organisms and biosynthetic gene clusters.  2022 The Authors. |
|36284135 |Nature communications |Genes with moderate to low expression
heritability may explain a large proportion of complex trait etiology,
but such genes cannot be sufficiently captured in conventional
transcriptome-wide association studies (TWASs), partly due to the
relatively small available reference datasets for developing expression
genetic prediction models to capture the moderate to low genetically
regulated components of gene expression. Here, we introduce a method,
the Summary-level Unified Method for Modeling Integrated Transcriptome
(SUMMIT), to improve the expression prediction model accuracy and the
power of TWAS by using a large expression quantitative trait loci (eQTL)
summary-level dataset. We apply SUMMIT to the eQTL summary-level data
provided by the eQTLGen consortium. Through simulation studies and
analyses of genome-wide association study summary statistics for 24
complex traits, we show that SUMMIT improves the accuracy of expression
prediction in blood, successfully builds expression prediction models
for genes with low expression heritability, and achieves higher
statistical power than several benchmark methods. Finally, we conduct a
case study of COVID-19 severity with SUMMIT and identify 11 likely
causal genes associated with COVID-19 severity.  2022. The Author(s). |
|36279491 |Clinical nurse specialist CNS
|<AbstractText Label="PURPOSE/AIMS" NlmCategory="OBJECTIVE">To gain
insights in how women use technology to address health information needs
during the prenatal and postpartum time frame.
<AbstractText Label="DESIGN" NlmCategory="METHODS">An exploratory
qualitative study recruited pregnant and recent postpartum women to
share their perspectives on information they needed and how they
obtained it. <AbstractText Label="METHODS" NlmCategory="METHODS">Women
who were pregnant or &lt;90 days postpartum (n = 26) were recruited via
social media and invited to share their experiences. Design thinking
methodology was used to develop questions to understand information
needs in the perinatal period as well as in context of the COVID-19
pandemic. Verbatim transcripts were coded by the research team according
to Braun and Clarkes reflexive thematic analysis.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Five themes explain
the experience of seeking information to support the perinatal period.
Women explained the need for the following: (1) information and
relationships are inseparable, (2) current practices leave needs unmet,
(3) the pandemic exposes vulnerability in prenatal care, (4) left to
figure it out alone, and (5) bridging the gap through technology.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Aggregated
findings suggest how usual care can be modified to improve support for
women through personalized care, improved information support, and use
of technology. The study findings inform innovative strategies using
current technologies to improve health promotion in a dynamic health
environment. Copyright  2022 Wolters Kluwer Health, Inc.All rights
reserved. | |36265162 |JMIR public health and surveillance
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The Covid-19
pandemic had many unprecedented secondary outcomes resulting in various
mental health issues leading to substance use coping behaviors. The
extent of substance use changes in a US sample by nativity have not been
previously described.
<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Our aim was to
design an online survey to assess the social distancing and isolation
issues exacerbated by the Covid-19 pandemic to describe substance use as
coping behaviors by comparing substance use changes prior to and during
the pandemic. <AbstractText Label="METHODS" NlmCategory="METHODS">A
comprehensive 116-item survey to understand the impact of Covid-19 and
social distancing on physical and psychosocial mental health and chronic
diseases was designed. Approximately 10,000 online surveys were
distributed by Qualtrics LLC between 13 May 2021 and 09 January 2022
across the US (i.e., continental US, Hawaii, Alaska, and territories) to
adults 18 and older. We oversampled low income and rural adults among
non-Hispanic White, non-Hispanic Black, Hispanic/Latino adults, and
foreign-born participants. Of the 5,938 surveys returned, 5,413 surveys
were used after Qualtrics proprietary expert review fraud detection, and
detailed assessments of completion rate and timing to complete the
survey. Participant demographics, substance use coping behaviors, and
substance use prior to and during the pandemic are described by the
overall US resident sample, followed by US born and foreign-born
self-report. Substance use included tobacco use, e-cigarettes/vaping,
alcohol use, marijuana use, and other illicit substance use. Marginal
homogeneity based on Stuart-Maxwell test was used to assess changes in
self-reported substance use prior to and during the pandemic.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The sample was
mostly White (2182/5413, 40.3%), women (3369/5406, 62.3%) that
identified as straight/heterosexual (4805/5406, 89.3%), reported making
$75,000 (1405/5355, 26.2%) and had vocational/technical training
(1746/5404, 32.3%). Significant changes were found in alcohol use
self-reports the overall sample. Significant changes were also observed
among US born and foreign-born samples. Similarities were observed
between US born and foreign-born participants on increased alcohol use
from: (1) no alcohol use prior to the pandemic to using alcohol once to
several times a month; and (2) once to several times per week to
everyday to several times per day. While significant changes were
observed from no prior alcohol use to some level of increased use, the
inverse was observed as well and more pronounced among foreign-born
participants. That is, there was a 5.1% overall change in some level of
alcohol use prior to the pandemic to no alcohol use during the pandemic
among foreign born, compared to the 4.3% change among US born.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">To better
prepare for the inadvertent effects of public health policies meant to
protect individuals, we must understand the mental health burdens that
can precipitate into substance use coping mechanisms that not only have
a deleterious effect on physical and mental health but exacerbate
morbidity and mortality to disease like Covid-19. | |36247032 |Earth
systems and environment |The unprecedented outbreak of Coronavirus
Disease 2019 (COVID-19) has impacted the whole world in every aspect
including health, social life, economic activity, education, and the
environment. The pandemic has led to an improvement in air quality all
around the world, including in Malaysia. Lockdowns have resulted in
industry shutting down and road travel decreasing which can reduce the
emission of Greenhouse Gases (GHG) and air pollution. This research
assesses the impact of the COVID-19 lockdown on emissions using the Air
Pollution Index (API), aerosols, and GHG which is Nitrogen Dioxide (NO2)
in Malaysia. The data used is from Sentinel-5p and Sentinel-2A which
monitor the air quality based on Ozone (O3) and NO2 concentration. Using
an interpolated API Index Map comparing 2019, before the implementation
of a Movement Control Order (MCO), and 2020, after the MCO period we
examine the impact on pollution during and after the COVID-19 lockdown.
Data used Sentinel-5p, Sentinel-2A, and Air Pollution Index of Malaysia
(APIMS) to monitor the air quality that contains NO2 concentration. The
result has shown the recovery in air quality during the MCO
implementation which indirectly shows anthropogenic activities towards
the environmental condition. The study will help to enhance and support
the policy and scope for air pollution management strategies as well as
raise public awareness of the main causes that contribute to air
pollution.  King Abdulaziz University and Springer Nature Switzerland
AG 2022, Springer Nature or its licensor holds exclusive rights to this
article under a publishing agreement with the author(s) or other
rightsholder(s); author self-archiving of the accepted manuscript
version of this article is solely governed by the terms of such
publishing agreement and applicable law. | |36227851 |Preventing chronic
disease |<AbstractText Label="INTRODUCTION">Forgone health care, defined
as not using health care despite perceiving a need for it, is associated
with poor health outcomes, especially among people with chronic
conditions. The objective of our study was to examine how the pandemic
affected forgone health care during 3 stages of the pandemic.
<AbstractText Label="METHODS">We used the Medicare Current Beneficiary
Survey COVID-19 Rapid Response Questionnaire administered in summer
2020, fall 2020, and winter 2021 to examine sociodemographic
characteristics, chronic diseases, COVID-19 vaccination status, and
telehealth availability in relation to beneficiary reports of forgone
health care. <AbstractText Label="RESULTS">Of the 3 periods studied, the
overall rate of forgone health care was highest in summer 2020 (20.8%),
followed by fall 2020 (7.8%) and winter 2021 (6.5%). COVID-19
vaccination status, age, sex, race and ethnicity, US region,
availability of primary care telehealth appointments, and chronic
conditions (heart disease, arthritis, depression, osteoporosis or a
broken hip, and diabetes or high blood glucose) were significantly
related to forgone care. <AbstractText Label="CONCLUSION">High rates of
forgone care among Medicare participants varied over time and were
significantly related to beneficiary characteristics. Our findings
highlight the need for health care reform and changes in policy to
address the issue of access to care for people with chronic conditions
during a pandemic or other public health emergency. | |36217024
|Communications biology |SARS-CoV-2 worldwide spread and evolution has
resulted in variants containing mutations resulting in immune evasive
epitopes that decrease vaccine efficacy. We acquired SARS-CoV-2 positive
clinical samples and compared the worldwide emerged spike mutations from
Variants of Concern/Interest, and developed an algorithm for monitoring
the evolution of SARS-CoV-2 in the context of vaccines and monoclonal
antibodies. The algorithm partitions logarithmic-transformed prevalence
data monthly and Pearsons correlation determines exponential emergence
of amino acid substitutions (AAS) and lineages. The SARS-CoV-2 genome
evaluation indicated 49 mutations, with 44 resulting in AAS. Nine of the
ten most worldwide prevalent (&gt;70%) spike protein changes have
Pearsons coefficient r &gt; 0.9. The tenth, D614G, has a prevalence
&gt;99% and r-value of 0.67. The resulting algorithm is based on the
patterns these ten substitutions elucidated. The strong positive
correlation of the emerged spike protein changes and algorithmic
predictive value can be harnessed in designing vaccines with relevant
immunogenic epitopes. Monitoring, next-generation vaccine design, and
mAb clinical efficacy must keep up with SARS-CoV-2 evolution, as the
virus is predicted to remain endemic.  2022. The Author(s). | |36216013
|The Lancet. Respiratory medicine
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The
SARS-CoV-2 omicron (B.1.1.529 BA.1) lineage was first detected in
November, 2021, and is associated with reduced vaccine effectiveness. By
March, 2022, BA.1 had been replaced by sub-lineage BA.2 in the USA. As
new variants evolve, vaccine performance must be continually assessed.
We aimed to evaluate the effectiveness and durability of BNT162b2
(Pfizer-BioNTech) against hospital and emergency department admissions
for BA.1 and BA.2.
<AbstractText Label="METHODS" NlmCategory="METHODS">In this
test-negative, case-control study, we sourced data from the electronic
health records of adult (aged 18 years) members of Kaiser Permanente
Southern California (KPSC), which is a health-care system in the USA,
who were admitted to one of 15 KPSC hospitals or emergency departments
(without subsequent hospitalisation) between Dec 27, 2021, and June 4,
2022, with an acute respiratory infection and were tested for SARS-CoV-2
by RT-PCR. Omicron sub-lineage was determined by use of sequencing,
spike gene target failure, and the predominance of variants in certain
time periods. Our main outcome was the effectiveness of two or three
doses of BNT162b2 in preventing emergency department or hospital
admission. Variant-specific vaccine effectiveness was evaluated by
comparing the odds ratios from logistic regression models of vaccination
between test-positive cases and test-negative controls, adjusting for
the month of admission, age, sex, race and ethnicity, body-mass index,
Charlson Comorbidity Index, previous influenza or pneumococcal vaccines,
and previous SARS-CoV-2 infection. We also assessed effectiveness by the
time since vaccination. This study is registered at ClinicalTrials.gov,
NCT04848584, and is ongoing.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Of 65 813 total
admissions during the study period, we included 16 994 in our analyses,
of which 7435 were due to BA.1, 1056 were due to BA.2, and 8503 were not
due to SARS-CoV-2. In adjusted analyses, two-dose vaccine effectiveness
was 40% (95% CI 27 to 50) for hospitalisation and 29% (18 to 38) for
emergency department admission against BA.1 and 56% (31 to 72) for
hospitalisation and 16% (-5 to 33) for emergency department admission
against BA.2. Three-dose vaccine effectiveness was 79% (74 to 83) for
hospitalisation and 72% (67 to 77) for emergency department admission
against BA.1 and 71% (55 to 81) for hospitalisation and 21% (1 to 37)
for emergency department admission against BA.2. Less than 3 months
after the third dose, vaccine effectiveness was 80% (74 to 84) for
hospitalisation and 74% (69 to 78) for emergency department admission
against BA.1. Vaccine effectiveness 3 months or more after the third
dose was 76% (69 to 82) against BA.1-related hospitalisation and 65% (56
to 73) against BA.1-related emergency department admission. Against
BA.2, vaccine effectiveness was 74% (47 to 87) for hospitalisation and
59% (40 to 72) for emergency department admission at less than 3 months
after the third dose and 70% (53 to 81) for hospitalisation and 5% (-21
to 25) for emergency department admission at 3 months or more after the
third dose.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Two doses
of BNT162b2 provided only partial protection against BA.1-related and
BA.2-related hospital and emergency department admission, which
underscores the need for booster doses against omicron. Although three
doses offered high levels of protection (70%) against hospitalisation,
variant-adapted vaccines are probably needed to improve protection
against less severe endpoints, like emergency department admission,
especially for BA.2.
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">Pfizer. Copyright
 2023 Elsevier Ltd.All rights reserved. | |36212220 |Hawaii journal
of health &amp; social welfare |Increasing numbers of medical students
participate in international electives. However, this recent trend has
yet to be examined in non-Western high-income countries such as Japan.
The aim of this study is to assess recent trends in Japan, and to
suggest ways in which those trends might be influenced. A retrospective
cross-sectional analysis of responses to an 8-item questionnaire sent in
August 2019 to 82 medical schools in Japan is reported. The responses
were received in September 2019. Narrative responses were obtained
regarding rationales for exchange programs, participant feedback, and
challenges encountered. Responses were translated into English and
categorized into themes. Of 82 Japanese medical schools, 56 (68%)
responded to the questionnaire. Both the number of incoming and outgoing
exchange students had increased steadily over the preceding 3-year
period. The leading destinations for Japanese students were the United
States (30%), other Asian (36%), and European countries (24%). Narrative
responses reveal different rationales from those reported by medical
schools in Western high-income countries. Only a few Japanese students
chose low or middle-income countries as their destinations, as opposed
to the trend seen in Western high-income countries. The reported
challenges encountered by the exchange programs may provide insights for
improvement. Exchanges have been greatly affected by the coronavirus
disease 2019 pandemic. The results can serve as pre-pandemic baseline
data and should promote further international collaboration for medical
education under current circumstances. Copyright 2022 by University
Health Partners of Hawaii (UHP Hawaii). | |36196777 |Epilepsia
Epilepsia</p>
<pre><code>  Fenfluramine provides clinically meaningful reduction in frequency of drop seizures in patients with Lennox-Gastaut syndrome: Interim analysis of an open-label extension study.
  
    139
    151
    139-151
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1111/epi.17431
  
    &lt;AbstractText Label=&quot;OBJECTIVE&quot; NlmCategory=&quot;OBJECTIVE&quot;&gt;This study was undertaken to evaluate the long-term safety and effectiveness of fenfluramine in patients with Lennox-Gastaut syndrome (LGS).
    &lt;AbstractText Label=&quot;METHODS&quot; NlmCategory=&quot;METHODS&quot;&gt;Eligible patients with LGS who completed a 14-week phase 3 randomized clinical trial enrolled in an open-label extension (OLE; NCT03355209). All patients were initially started on .2mg/kg/day fenfluramine and after 1month were titrated by effectiveness and tolerability, which were assessed at 3-month intervals. The protocol-specified treatment duration was 12months, but COVID-19-related delays resulted in 142 patients completing their final visit after 12months.
    &lt;AbstractText Label=&quot;RESULTS&quot; NlmCategory=&quot;RESULTS&quot;&gt;As of October 19, 2020, 247 patients were enrolled in the OLE. Mean age was 14.37.6years (79 [32%] adults) and median fenfluramine treatment duration was 364days; 88.3% of patients received 2-4 concomitant antiseizure medications. Median percentage change in monthly drop seizure frequency was -28.6% over the entire OLE (n=241) and -50.5% at Month 15 (n=142, p&amp;lt;.0001); 75 of 241 patients (31.1%) experienced 50% reduction in drop seizure frequency. Median percentage change in nondrop seizure frequency was -45.9% (n=192, p=.0038). Generalized tonic-clonic seizures (GTCS) and tonic seizures were most responsive to treatment, with median reductions over the entire OLE of 48.8% (p&amp;lt;.0001, n=106) and 35.8% (p&amp;lt;.0001, n=186), respectively. A total of 37.6% (95% confidence interval [CI]=31.4%-44.1%, n=237) of investigators and 35.2% of caregivers (95% CI=29.1%-41.8%, n=230) rated patients as Much Improved/Very Much Improved on the Clinical Global Impression of Improvement scale. The most frequent treatment-emergent adverse events were decreased appetite (16.2%) and fatigue (13.4%). No cases of valvular heart disease (VHD) or pulmonary arterial hypertension (PAH) were observed.
    &lt;AbstractText Label=&quot;SIGNIFICANCE&quot; NlmCategory=&quot;CONCLUSIONS&quot;&gt;Patients with LGS experienced sustained reductions in drop seizure frequency on fenfluramine treatment, with a particularly robust reduction in frequency of GTCS, the key risk factor for sudden unexpected death in epilepsy. Fenfluramine was generally well tolerated; VHD or PAH was not observed long-term. Fenfluramine may provide an important long-term treatment option for LGS.
     2022 UCB and The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Knupp
      Kelly G
      KG
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-1967-0827
      
        University of Colorado, Children&#39;s Hospital Colorado, Aurora, Colorado, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Scheffer
      Ingrid E
      IE
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-2311-2174
      
        University of Melbourne, Austin Hospital and Royal Children&#39;s Hospital, Melbourne, Victoria, Australia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Ceulemans
      Berten
      B
      
        Department of Pediatric Neurology, Antwerp University Hospital, Antwerp, Belgium.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Sullivan
      Joseph
      J
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0003-2081-8988
      
        University of California, San Francisco Weill Institute for Neurosciences, Benioff Children&#39;s Hospital, San Francisco, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Nickels
      Katherine C
      KC
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-6579-3035
      
        Department of Neurology, Mayo Clinic, Rochester, Minnesota, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Lagae
      Lieven
      L
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-7118-0139
      
        Member of the European Reference Network EpiCARE, Department of Pediatric Neurology, University of Leuven, Leuven, Belgium.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Guerrini
      Renzo
      R
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-7272-7079
      
        Pediatric Neurology and Neurogenetics Unit, Anna Meyer Children&#39;s Hospital, University of Florence, Florence, Italy.
      
      
        Stella Maris Foundation, Scientific Institute for Research and Health Care, Pisa, Italy.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Zuberi
      Sameer M
      SM
      
        Paediatric Neurosciences Research Group, Royal Hospital for Children, Glasgow, UK.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Nabbout
      Rima
      R
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0001-5877-4074
      
        Reference Center for Rare Epilepsies, Necker-Sick Children University Hospital, Public Hospital Network of Paris, member of EpiCARE, Imagine Institute, Paris Cit University, Paris, France.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Riney
      Kate
      K
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-1122-3555
      
        Neuroscience Unit, Queensland Children&#39;s Hospital, South Brisbane, Queensland, Australia.
      
      
        School of Clinical Medicine, University of Queensland, St Lucia, Queensland, Australia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Agarwal
      Anupam
      A
      
        Zogenix (now a part of UCB), Emeryville, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Lock
      Michael
      M
      
        Independent Consultant, Zogenix (now a part of UCB), Haiku, Hawaii, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Dai
      David
      D
      
        Syneos Health, Morrisville, North Carolina, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Farfel
      Gail M
      GM
      
        Zogenix (now a part of UCB), Emeryville, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Galer
      Bradley S
      BS
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-4735-3327
      
        Zogenix (now a part of UCB), Emeryville, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Gammaitoni
      Arnold R
      AR
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-4775-2862
      
        Zogenix (now a part of UCB), Emeryville, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Polega
      Shikha
      S
      
        Zogenix (now a part of UCB), Emeryville, California, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Davis
      Ronald
      R
      
        Neurology and Epilepsy Research Center, Orlando, Florida, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Gil-Nagel
      Antonio
      A
      
        Ruber International Hospital, Madrid, Spain.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016449&quot;&gt;Randomized Controlled Trial
    &lt;PublicationType UI=&quot;D017428&quot;&gt;Clinical Trial, Phase III
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2022
    11
    09
  


  United States
  Epilepsia
  2983306R
  0013-9580


  
    0
    &lt;NameOfSubstance UI=&quot;D000927&quot;&gt;Anticonvulsants
  
  
    2DS058H2CF
    &lt;NameOfSubstance UI=&quot;D005277&quot;&gt;Fenfluramine
  

IM

  
    &lt;DescriptorName UI=&quot;D000328&quot; MajorTopicYN=&quot;N&quot;&gt;Adult
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D002648&quot; MajorTopicYN=&quot;N&quot;&gt;Child
  
  
    &lt;DescriptorName UI=&quot;D000293&quot; MajorTopicYN=&quot;N&quot;&gt;Adolescent
  
  
    &lt;DescriptorName UI=&quot;D055815&quot; MajorTopicYN=&quot;N&quot;&gt;Young Adult
  
  
    &lt;DescriptorName UI=&quot;D065768&quot; MajorTopicYN=&quot;Y&quot;&gt;Lennox Gastaut Syndrome
    &lt;QualifierName UI=&quot;Q000188&quot; MajorTopicYN=&quot;N&quot;&gt;drug therapy
  
  
    &lt;DescriptorName UI=&quot;D000927&quot; MajorTopicYN=&quot;N&quot;&gt;Anticonvulsants
    &lt;QualifierName UI=&quot;Q000627&quot; MajorTopicYN=&quot;N&quot;&gt;therapeutic use
  
  
    &lt;DescriptorName UI=&quot;D005277&quot; MajorTopicYN=&quot;N&quot;&gt;Fenfluramine
    &lt;QualifierName UI=&quot;Q000627&quot; MajorTopicYN=&quot;N&quot;&gt;therapeutic use
  
  
    &lt;DescriptorName UI=&quot;D016896&quot; MajorTopicYN=&quot;N&quot;&gt;Treatment Outcome
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;Y&quot;&gt;COVID-19
  
  
    &lt;DescriptorName UI=&quot;D012640&quot; MajorTopicYN=&quot;N&quot;&gt;Seizures
    &lt;QualifierName UI=&quot;Q000188&quot; MajorTopicYN=&quot;N&quot;&gt;drug therapy
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;Lennox-Gastaut syndrome
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;developmental and epileptic encephalopathies
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;fenfluramine
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;long-term open-label extension




  &lt;PubMedPubDate PubStatus=&quot;revised&quot;&gt;
    2022
    9
    30
  
  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2022
    6
    15
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2022
    10
    3
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2022
    10
    6
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2023
    1
    21
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2022
    10
    5
    5
    43
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;36196777
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1111/epi.17431


  REFERENCES |&lt;AbstractText Label=&quot;OBJECTIVE&quot; NlmCategory=&quot;OBJECTIVE&quot;&gt;This study was undertaken to evaluate the long-term safety and effectiveness of fenfluramine in patients with Lennox-Gastaut syndrome (LGS). &lt;AbstractText Label=&quot;METHODS&quot; NlmCategory=&quot;METHODS&quot;&gt;Eligible patients with LGS who completed a 14-week phase 3 randomized clinical trial enrolled in an open-label extension (OLE; NCT03355209). All patients were initially started on .2 mg/kg/day fenfluramine and after 1 month were titrated by effectiveness and tolerability, which were assessed at 3-month intervals. The protocol-specified treatment duration was 12 months, but COVID-19-related delays resulted in 142 patients completing their final visit after 12 months. &lt;AbstractText Label=&quot;RESULTS&quot; NlmCategory=&quot;RESULTS&quot;&gt;As of October 19, 2020, 247 patients were enrolled in the OLE. Mean age was 14.3  7.6 years (79 [32%] adults) and median fenfluramine treatment duration was 364 days; 88.3% of patients received 2-4 concomitant antiseizure medications. Median percentage change in monthly drop seizure frequency was -28.6% over the entire OLE (n = 241) and -50.5% at Month 15 (n = 142, p &amp;lt; .0001); 75 of 241 patients (31.1%) experienced 50% reduction in drop seizure frequency. Median percentage change in nondrop seizure frequency was -45.9% (n = 192, p = .0038). Generalized tonic-clonic seizures (GTCS) and tonic seizures were most responsive to treatment, with median reductions over the entire OLE of 48.8% (p &amp;lt; .0001, n = 106) and 35.8% (p &amp;lt; .0001, n = 186), respectively. A total of 37.6% (95% confidence interval [CI] = 31.4%-44.1%, n = 237) of investigators and 35.2% of caregivers (95% CI = 29.1%-41.8%, n = 230) rated patients as Much Improved/Very Much Improved on the Clinical Global Impression of Improvement scale. The most frequent treatment-emergent adverse events were decreased appetite (16.2%) and fatigue (13.4%). No cases of valvular heart disease (VHD) or pulmonary arterial hypertension (PAH) were observed. &lt;AbstractText Label=&quot;SIGNIFICANCE&quot; NlmCategory=&quot;CONCLUSIONS&quot;&gt;Patients with LGS experienced sustained reductions in drop seizure frequency on fenfluramine treatment, with a particularly robust reduction in frequency of GTCS, the key risk factor for sudden unexpected death in epilepsy. Fenfluramine was generally well tolerated; VHD or PAH was not observed long-term. Fenfluramine may provide an important long-term treatment option for LGS.  2022 UCB and The Authors. Epilepsia published by Wiley Periodicals LLC on behalf of International League Against Epilepsy.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |</code></pre>
<p>|36186620 |Health equity
|<AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">COVID-19
disproportionately affects racial/ethnic minorities and vaccine can help
mitigate infection and transition, decrease rate of hospitalization,
lower mortality rate, and control the pandemic. This study aims to
examine disparities in COVID-19 vaccination rate by age among Whites,
Hispanics, Blacks, and Asian Americans, and the modification effects by
gender and education.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">We used seven
waves of biweekly surveys from the Household Pulse Survey collected
between July 21, 2021, and October 11, 2021.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Asians reported
the highest, Blacks reported the lowest vaccination rate, and gender
differences were minimal. Increasing age was associated with higher
vaccination rate except for the oldest age group. The decline was from
84.4% (70-79 years) to 41.1% (80-88 years: 41.1%) among Hispanics and
92.8% to 69.6% among Asians. Educational effect was the most salient
among younger adults with the largest gaps observed in Blacks. Among
18-29-year Black participants, the vaccination rates were 31.1%
(confidence interval [95% CI]: 25.7-37.1) for high school or lower,
58.9% (95% CI: 54.2-63.5) for some college or associate degree, and
74.2% (95% CI: 69.4-78.5) for bachelor or higher degrees, leaving a
43.1% gap between the lowest and the highest education levels. The gaps
in this age group were 33.7% among Whites, 32.1% among Hispanics, and
20.5% among Asian Americans.
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Our study
advances the existing literature on COVID-19 vaccination by providing
empirical evidence on the dynamic race/ethnic-age-education differences
across racial/ethnic groups. The findings from our study provide
scientific foundation for the development of more strategies to improve
vaccination rate for the minority populations.  Wei Zhang et al., 2022;
Published by Mary Ann Liebert, Inc.| |36178690 |JAMA network open |NA |
|36173983 |PloS one |<AbstractText Label="BACKGROUND">Results from
observational studies and randomized clinical trials (RCTs) have led to
the consensus that hydroxychloroquine (HCQ) and chloroquine (CQ) are not
effective for COVID-19 prevention or treatment. Pooling individual
participant data, including unanalyzed data from trials terminated
early, enables more detailed investigation of the efficacy and safety of
HCQ/CQ among subgroups of hospitalized patients.
<AbstractText Label="METHODS">We searched ClinicalTrials.gov in May and
June 2020 for US-based RCTs evaluating HCQ/CQ in hospitalized COVID-19
patients in which the outcomes defined in this study were recorded or
could be extrapolated. The primary outcome was a 7-point ordinal scale
measured between day 28 and 35 post enrollment; comparisons used
proportional odds ratios. Harmonized de-identified data were collected
via a common template spreadsheet sent to each principal investigator.
The data were analyzed by fitting a prespecified Bayesian ordinal
regression model and standardizing the resulting predictions.
<AbstractText Label="RESULTS">Eight of 19 trials met eligibility
criteria and agreed to participate. Patient-level data were available
from 770 participants (412 HCQ/CQ vs 358 control). Baseline
characteristics were similar between groups. We did not find evidence of
a difference in COVID-19 ordinal scores between days 28 and 35
post-enrollment in the pooled patient population (odds ratio, 0.97; 95%
credible interval, 0.76-1.24; higher favors HCQ/CQ), and found no
convincing evidence of meaningful treatment effect heterogeneity among
prespecified subgroups. Adverse event and serious adverse event rates
were numerically higher with HCQ/CQ vs control (0.39 vs 0.29 and 0.13 vs
0.09 per patient, respectively). <AbstractText Label="CONCLUSIONS">The
findings of this individual participant data meta-analysis reinforce
those of individual RCTs that HCQ/CQ is not efficacious for treatment of
COVID-19 in hospitalized patients. | |36152041 |Intensive care medicine
|<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">Sepsis is a
heterogeneous syndrome and identification of sub-phenotypes is
essential. This study used trajectories of vital signs to develop and
validate sub-phenotypes and investigated the interaction of
sub-phenotypes with treatment using randomized controlled trial data.
<AbstractText Label="METHODS" NlmCategory="METHODS">All patients with
suspected infection admitted to four academic hospitals in Emory
Healthcare between 2014-2017 (training cohort) and 2018-2019 (validation
cohort) were included. Group-based trajectory modeling was applied to
vital signs from the first 8 h of hospitalization to develop and
validate vitals trajectory sub-phenotypes. The associations between
sub-phenotypes and outcomes were evaluated in patients with sepsis. The
interaction between sub-phenotype and treatment with balanced
crystalloids versus saline was tested in a secondary analysis of SMART
(Isotonic Solutions and Major Adverse Renal Events Trial).
<AbstractText Label="RESULTS" NlmCategory="RESULTS">There were 12,473
patients with suspected infection in training and 8256 patients in
validation cohorts, and 4 vitals trajectory sub-phenotypes were found.
Group A (N = 3483, 28%) were hyperthermic, tachycardic, tachypneic, and
hypotensive. Group B (N = 1578, 13%) were hyperthermic, tachycardic,
tachypneic (not as pronounced as Group A) and hypertensive. Groups C (N
= 4044, 32%) and D (N = 3368, 27%) had lower temperatures, heart rates,
and respiratory rates, with Group C normotensive and Group D
hypotensive. In the 6,919 patients with sepsis, Groups A and B were
younger while Groups C and D were older. Group A had the lowest
prevalence of congestive heart failure, hypertension, diabetes mellitus,
and chronic kidney disease, while Group B had the highest prevalence.
Groups A and D had the highest vasopressor use (p &lt; 0.001 for all
analyses above). In logistic regression, 30-day mortality was
significantly higher in Groups A and D (p &lt; 0.001 and p = 0.03,
respectively). In the SMART trial, sub-phenotype significantly modified
treatment effect (p = 0.03). Group D had significantly lower odds of
mortality with balanced crystalloids compared to saline (odds ratio (OR)
0.39, 95% confidence interval (CI) 0.23-0.67, p &lt; 0.001).
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Sepsis
sub-phenotypes based on vital sign trajectory were consistent across
cohorts, had distinct outcomes, and different responses to treatment
with balanced crystalloids versus saline.  2022. Springer-Verlag GmbH
Germany, part of Springer Nature. | |36146513 |Vaccines |Vaccine
hesitancy remains a significant barrier to achieving herd immunity and
preventing the further spread of COVID-19. Understanding contributors to
vaccine hesitancy and how they change over time may improve COVID-19
mitigation strategies and public health policies. To date, no mechanism
explains how trust in and consumption of different sources of
information affect vaccine uptake. A total of 1594 adults enrolled in
our COVID-19 testing program completed standardized surveys on
demographics, vaccination status, use, reliance, and trust in sources of
COVID-19 information, from September to October 2021, during the
COVID-19 Delta wave. Of those, 802 individuals (50.3%) completed a
follow-up survey, from January to February 2022, during the
Omicron-wave. Regression analyses were performed to understand
contributors to vaccine and booster uptake over time. Individuals
vaccinated within two months of eligibility (early vaccinees) tended to
have more years of schooling, with greater trust in and consumption of
official sources of COVID-19 information, compared to those who waited
3-6 months (late vaccinees), or those who remained unvaccinated at 6
months post-eligibility (non-vaccinees). Most (70.1%) early vaccinees
took the booster shot, compared to only 30.5% of late vaccinees, with
the latter group gaining trust and consumption of official information
after four months. These data provide the foundation for a mechanism
based on the level of trust in and consumption of official information
sources, where those who increased their level of trust in and
consumption of official information sources were more likely to receive
a booster. This study shows that social factors, including education and
individual-level degree of trust in (and consumption of) sources of
COVID-19 information, interact and change over time to be associated
with vaccine and booster uptakes. These results are critical for the
development of effective public health policies and offer insights into
hesitancy over the course of the COVID-19 vaccine and booster rollout. |
|36128780 |The Journal of school nursing : the official publication of
the National Association of School Nurses |This mixed-method study
examined school nurses experiences during the Coronavirus Disease 2019
pandemic related to role change, psychological feelings, and
coping/resiliency in the State of Hawaii. A total of 30 school nurses
completed a Brief Resilience Coping Scale plus a series of open-ended
questions in January 2022. On the coping scale, over 40% of participants
scored high, 52% scored medium, and 7% scored a low resilient/coping
level. We did not identify any association between coping level and
participant characteristics. Three qualitative themes emerged: 1) school
nurses experience chronic negative emotions related to the pandemic, 2)
school nurses demonstrate attributes of resilience, and 3) school nurses
utilize positive coping techniques. The pandemic created significant
stresses and negative emotions among school nurses. Yet, school nurses
reported effective coping strategies and demonstrated
strength/resilience. Support and open communication between school
nurses, their employers, and other school-based stakeholders is needed
to provide continued support for school nurses. | |36126272 |Medical
care |<AbstractText Label="BACKGROUND">Since the onset of the COVID-19
pandemic, telehealth has been an option for Veterans receiving urgent
care through Veterans Health Administration Community Care (CC).
<AbstractText Label="OBJECTIVE">We assessed use, arrangements, Veteran
decision-making, and experiences with CC urgent care delivered via
telehealth. <AbstractText Label="DESIGN">Convergent parallel mixed
methods, combining multivariable regression analyses of claims data with
semistructured Veteran interviews.
<AbstractText Label="SUBJECTS">Veterans residing in the Western United
States and Hawaii, with CC urgent care claims March 1 to September 30,
2020. <AbstractText Label="KEY RESULTS">In comparison to having
in-person only visits, having a telehealth-only visit was more likely
for Veterans who were non-Hispanic Black, were urban-dwelling, lived
further from the clinic used, had a COVID-related visit, and did not
require an in-person procedure. Predictors of having both telehealth and
in-person (compared with in-person only) visits were other (non-White,
non-Black) non-Hispanic race/ethnicity, urban-dwelling status, living
further from the clinic used, and having had a COVID-related visit. Care
arrangements varied widely; telephone-only care was common. Veteran
decisions about using telehealth were driven by limitations in in-person
care availability and COVID-related concerns. Veterans receiving care
via telehealth generally reported high satisfaction.
<AbstractText Label="CONCLUSIONS">CC urgent care via telehealth played
an important role in providing Veterans with care access early in the
COVID-19 pandemic. Use of telehealth differed by Veteran
characteristics; lack of in-person care availability was a driver.
Future work should assess for changes in telehealth use with pandemic
progression, geographic differences, and impact on care quality, care
coordination, outcomes, and costs to ensure Veterans optimal and
equitable access to care. | |36113145 |Public health reports
(Washington, D.C. : 1974)
|<AbstractText Label="OBJECTIVES" NlmCategory="UNASSIGNED">Minimal
research has assessed COVID-19s unique impact on the Native
Hawaiian/Pacific Islander (NH/PI) population-an Indigenous-colonized
racial group with social and health disparities that increase their risk
for COVID-19 morbidity and mortality. To address this gap, we explored
the scope of COVID-19 outcomes, vaccination status, and health in
diverse NH/PI communities.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">NH/PI staff at
partner organizations collected survey data from April through November
2021 from 319 community-dwelling NH/PI adults in 5 states with large
NH/PI populations: Arkansas, California, Oregon, Utah, and Washington.
Data were analyzed with descriptive statistics, Pearson 2 tests,
independent and paired t tests, and linear and logistic regression
analyses. <AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During
the COVID-19 pandemic, 30% of survey participants had contracted
COVID-19, 16% had a close family member who died of the disease, and 64%
reported COVID-19 vaccine uptake. Thirty percent reported fair/poor
health, 21% currently smoked cigarettes, and 58% reported obesity.
Survey participants reported heightened COVID-19-related psychosocial
distress (mean score = 4.9 on 10-point scale), which was more likely
when health outcomes (general health, sleep, obesity) were poor or a
family member had died of COVID-19. Logistic regression indicated that
age, experiencing COVID-19 distress, and past-year use of influenza
vaccines were associated with higher odds of COVID-19 vaccine uptake
(1.06, 1.18, and 7.58 times, respectively).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Our empirical
findings highlight the acute and understudied negative impact of
COVID-19 on NH/PI communities in the United States and suggest new
avenues for improving NH/PI community health, vaccination, and recovery
from COVID-19. | |36108254 |American journal of public health |Native
Hawaiians and other Pacific Islanders (NHPIs) across the country have
experienced significant disparities because of the COVID-19 pandemic.
The Pacific Alliance Against COVID-19 used a community-based
participatory approach involving academic and community partners to
expand sustainable COVID-19 testing capacity and mitigate the severe
consequences among NHPI communities in Hawaii. We describe the approach
of this one-year study, some of the results, and how the data are being
used to inform next steps for the communities. Clinical Trials.gov
identifier: NCT04766333. (Am J Public Health. 2022;112(S9):S896-S899. <a href="https://doi.org/10.2105/AJPH.2022.306973" class="uri">https://doi.org/10.2105/AJPH.2022.306973</a>). | |36091468
|CABI agriculture and bioscience
|<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The COVID-19
pandemic is interrupting domestic and global food supply chains
resulting in reduced access to healthy diverse diets. Hawaii has been
described as a model social-ecological system and it has been suggested
that indigenous agro-ecosystems have the potential to be highly
productive and resilient under changing land-use and climate change
disturbance. However, little research has yet been conducted exploring
the disruption and resilience of agro-ecosystems in Hawaii caused by
the COVID-19 pandemic. The breadfruit tree (Artocarpus altilis;
Moraceae) is a signature, multi-purpose-tree of the complex perennial
agro-ecosystems systems in Oceania.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This case study
explores the ways in which the breadfruit agro-ecosystems of Hawaii
have shown resilience during the COVID-19 pandemic.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Our study
suggests that breadfruit has increased its value as a subsistence crop
during the COVID-19 pandemic, even in a developed economy like Hawaii,
and that resilience of Hawaiian breadfruit agroe-cosystems during a
crisis can be supported through cooperatives and food-hubs.
<AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The
online version contains supplementary material available at
10.1186/s43170-022-00125-3.  The Author(s) 2022. | |36081413
|Orthopaedic journal of sports medicine
|<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Health and
safety concerns surrounding the coronavirus 2019 (COVID-19) pandemic led
the National Basketball Association (NBA) to condense and accelerate the
2020 season. Although prior literature has suggested that inadequate
rest may lead to an increased injury risk, the unique circumstances
surrounding this season offer a unique opportunity to evaluate player
safety in the setting of reduced interval rest.
<AbstractText Label="HYPOTHESIS" NlmCategory="UNASSIGNED">We
hypothesized that the condensed 2020 NBA season resulted in an increased
overall injury risk as compared with the 2015 to 2018 seasons.
<AbstractText Label="STUDY DESIGN" NlmCategory="UNASSIGNED">Descriptive
epidemiology study.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A publicly
available database, Pro Sports Transactions, was queried for injuries
that forced players to miss 1 game between the 2015 and 2020 seasons.
Data from the 2019 season were omitted given the abrupt suspension of
the league year. All injury incidences were calculated per 1000
game-exposures (GEs). The primary outcome was the overall injury
proportion ratio (IPR) between the 2020 season and previous seasons.
Secondary measures included injury incidences stratified by type,
severity, age, position, and minutes per game.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 4346
injuries occurred over a 5-season span among 2572 unique player-seasons.
The overall incidence of injury during the 2020 season was 48.20 per
1000 GEs but decreased to 39.97 per 1000 GEs when excluding COVID-19.
Despite this exclusion, the overall injury rate in 2020 remained
significantly greater (IPR, 1.42 [95% CI, 1.32-1.52]) than that of the
2015 to 2018 seasons (28.20 per 1000 GEs). On closer evaluation, the
most notable increases seen in the 2020 season occurred within minor
injuries requiring only a 1-game absence (IPR, 1.53 [95% CI, 1.37-1.70])
and in players who were aged 25 to 29 years (IPR, 1.57 [95% CI,
1.40-2.63]), averaging 30.0 minutes per game (IPR, 1.67 [95% CI,
1.47-1.90]), and playing the point guard position (IPR, 1.67 [95%
1.44-1.95]).
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">Players in the
condensed 2020 NBA season had a significantly higher incidence of
injuries when compared with the prior 4 seasons, even when excluding
COVID-19-related absences. This rise is consistent with the other
congested NBA seasons of 1998 and 2011. These findings suggest that
condensing the NBA schedule is associated with an increased risk to
player health and safety.  The Author(s) 2022. | |36065487 |Journal of
traumatic stress |Trauma-exposed veterans receiving mental health care
may have an elevated risk of experiencing COVID-19-related difficulties.
Using data from several ongoing clinical trials (N = 458), this study
examined exposure to COVID-19-related stressors and their associations
with key sociodemographic factors and mental health outcomes. The
results showed that exposure to COVID-19-related stressors was common,
higher among veterans who were racial/ethnic minorities d = 0.32, and
associated with elevated posttraumatic stress disorder (PTSD), r = .288,
and depressive symptom severity, r = .246. Women veterans experienced
more difficulty accessing social support, d = 0.31, and higher levels of
COVID-19-related distress, d = 0.31, than men. Qualitative data were
consistent with survey findings and highlighted the broader societal
context in veterans experience of COVID-19-related distress. These
findings may inform future research on the impact of the pandemic on
veterans, particularly those who are women and members of minoritized
racial/ethnic groups, as well as mental health treatment planning for
this population.  2022 International Society for Traumatic Stress
Studies. | |36051401 |The journal of education in perioperative medicine
: JEPM |<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">This
studys primary aim was to determine how training programs use
simulation-based medical education (SBME), because SBME is linked to
superior clinical performance.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">An anonymous
10-question survey was distributed to anesthesiology residency program
directors across the United States. The survey aimed to assess where and
how SBME takes place, which resources are available, frequency of and
barriers to its use, and perceived utility of a dedicated departmental
education laboratory.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The survey
response rate was 30.4% (45/148). SBME typically occurred at shared
on-campus laboratories, with residents typically participating in SBME 1
to 4 times per year. Frequently practiced skills included airway
management, trauma scenarios, nontechnical skills, and ultrasound
techniques (all  77.8%). Frequently cited logistical barriers to
simulation laboratory use included COVID-19 precautions (75.6%),
scheduling (57.8%), and lack of trainers (48.9%). Several respondents
also acknowledged financial barriers. Most respondents believed a
dedicated departmental education laboratory would be a useful or very
useful resource (77.8%).
<AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">SBME is a
widely incorporated activity but may be impeded by barriers that our
survey helped identify. Barriers can be addressed by departmental
education laboratories. We discuss how such laboratories increase
capabilities to support structured SBME events and how costs can be
offset. Other academic departments may also benefit from establishing
such laboratories. | |36043851 |The journal of physical chemistry
letters |Pulmonary surfactant has been attempted as a supportive therapy
to treat COVID-19. Although it is mechanistically accepted that the
fusion peptide in the S2 subunit of the S protein plays a predominant
role in mediating viral fusion with the host cell membrane, it is still
unknown how the S2 subunit interacts with the natural surfactant film.
Using combined bio-physicochemical assays and atomic force microscopy
imaging, it was found that the S2 subunit inhibited the biophysical
properties of the surfactant and induced microdomain fusion in the
surfactant monolayer. The surfactant inhibition has been attributed to
membrane fluidization caused by insertion of the S2 subunit mediated by
its fusion peptide. These findings may provide novel insight into the
understanding of bio-physicochemical mechanisms responsible for
surfactant interactions with SARS-CoV-2 and may have translational
implications in the further development of surfactant replacement
therapy for COVID-19 patients. | |36018589 |JAMA network open
|<AbstractText Label="IMPORTANCE">Widespread distribution of rapid
antigen tests is integral to the US strategy to address COVID-19;
however, it is estimated that few rapid antigen test results are
reported to local departments of health.
<AbstractText Label="OBJECTIVE">To characterize how often individuals in
6 communities throughout the United States used a digital assistant to
log rapid antigen test results and report them to their local
departments of health.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This prospective
cohort study is based on anonymously collected data from the
beneficiaries of the Say Yes! Covid Test program, which distributed more
than 3 000 000 rapid antigen tests at no cost to residents of 6
communities (Louisville, Kentucky; Indianapolis, Indiana; Fulton County,
Georgia; Oahu, Hawaii; Ann Arbor and Ypsilanti, Michigan; and
Chattanooga, Tennessee) between April and October 2021. A descriptive
evaluation of beneficiary use of a digital assistant for logging and
reporting their rapid antigen test results was performed.
<AbstractText Label="INTERVENTIONS">Widespread community distribution of
rapid antigen tests.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Number and proportion
of tests logged and reported to the local department of health through
the digital assistant. <AbstractText Label="RESULTS">A total of 313 000
test kits were distributed, including 178 785 test kits that were
ordered using the digital assistant. Among all distributed kits, 14 398
households (4.6%) used the digital assistant, but beneficiaries reported
three-quarters of their rapid antigen test results to their state public
health departments (30 965 tests reported of 41 465 total test results
[75.0%]). The reporting behavior varied by community and was
significantly higher among communities that were incentivized for
reporting test results vs those that were not incentivized or partially
incentivized (90.5% [95% CI, 89.9%-91.2%] vs 70.5%; [95% CI,
70.0%-71.0%]). In all communities, positive tests were less frequently
reported than negative tests (60.4% [95% CI, 58.1%-62.8%] vs 75.5% [95%
CI, 75.1%-76.0%]). <AbstractText Label="CONCLUSIONS AND RELEVANCE">These
results suggest that application-based reporting with incentives may be
associated with increased reporting of rapid tests for COVID-19.
However, increasing the adoption of the digital assistant may be a
critical first step. | |35997977 |JAMA network open
|<AbstractText Label="IMPORTANCE">The 2 primary efforts of Medicare to
advance value-based care are Medicare Advantage (MA) and the
fee-for-service-based Medicare Shared Savings Program (MSSP). It is
unknown how spending differs between the 2 programs after accounting for
differences in patient clinical risk. <AbstractText Label="OBJECTIVE">To
examine how spending and utilization differ between MA and MSSP
beneficiaries after accounting for differences in clinical risk using
data from administrative claims and electronic health records.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This
retrospective economic evaluation used data from 15 763 propensity
score-matched beneficiaries who were continuously enrolled in MA or MSSP
from January 1, 2014, to December 31, 2018, with diabetes, congestive
heart failure (CHF), chronic kidney disease (CKD), or hypertension.
Participants received care at a large nonprofit academic health system
in the southern United States that bears risk for Medicare beneficiaries
through both the MA and MSSP programs. Differences in beneficiary risk
were mitigated by propensity score matching using validated clinical
criteria based on data from administrative claims and electronic health
records. Data were analyzed from January 2019 to May 2022.
<AbstractText Label="EXPOSURES">Enrollment in MA or attribution to an
accountable care organization in the MSSP program.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Per-beneficiary annual
total spending and subcomponents, including inpatient hospital,
outpatient hospital, skilled nursing facility, emergency department,
primary care, and specialist spending. <AbstractText Label="RESULTS">The
sample of 15 763 participants included 12 720 (81%) MA and 3043 (19%)
MSSP beneficiaries. MA beneficiaries, compared with MSSP beneficiaries,
were more likely to be older (median [IQR] age, 75.0 [69.9-81.8] years
vs 73.1 [68.3-79.8] years), male (5515 [43%] vs 1119 [37%]), and White
(9644 [76%] vs 2046 [69%]) and less likely to live in low-income zip
codes (2338 [19%] vs 750 [25%]). The mean unadjusted per-member per-year
spending difference between MSSP and MA disease-specific subcohorts was
$2159 in diabetes, $4074 in CHF, $2560 in CKD, and $2330 in
hypertension. After matching on clinical risk and demographic factors,
MSSP spending was higher for patients with diabetes (mean per-member
per-year spending difference in 2015: $2454; 95% CI, $1431-$3574), CHF
($3699; 95% CI, $1235-$6523), CKD ($2478; 95% CI, $1172-$3920), and
hypertension ($2258; 95% CI, $1616-2,939). Higher MSSP spending among
matched beneficiaries was consistent over time. In the matched cohort in
2018, MSSP total spending ranged from 23% (CHF) to 30% (CKD) higher than
MA. Adjusting for differential trends in coding intensity did not affect
these results. Higher outpatient hospital spending among MSSP
beneficiaries contributed most to spending differences between MSSP and
MA, representing 49% to 62% of spending differences across disease
cohorts. <AbstractText Label="CONCLUSIONS AND RELEVANCE">In this study,
utilization and spending were consistently higher for MSSP than MA
beneficiaries within the same health system even after adjusting for
granular metrics of clinical risk. Nonclinical factors likely contribute
to the large differences in MA vs MSSP spending, which may create
challenges for health systems participating in MSSP relative to their
participation in MA. | |35969382 |JAMA neurology |NA | |35954726
|International journal of environmental research and public health |In
response to the second surge of COVID-19 cases in Hawaii in the fall of
2020, the Hawaii State Department of Health Behavioral Health
Administration led and contracted a coalition of agencies to plan and
implement an isolation and quarantine facility placement service that
included food, testing, and transportation assistance for a state
capitol and major urban center. The goal of the program was to provide
safe isolation and quarantine options for individual residents at risk
of not being able to comply with isolation and quarantine mandates.
Drawing upon historical lived experiences in planning and implementing
the system for isolation and quarantine facilities, this qualitative
public health case study report applies the plan-do-study-act (PDSA)
improvement model and framework to review and summarize the
implementation of this system. This case study also offers lessons for a
unique opportunity for collaboration led by a public behavioral health
leadership that expands upon traditionally narrow infectious disease
control, by developing a continuum of care that not only addresses
immediate COVID-19 concerns but also longer-term supports and services
including housing, access to mental health services, and other social
services. This case study highlights the role of a state agency in
building a coalition of agencies, including a public university, to
respond to the pandemic. The case study also discusses how continuous
learning was executed to improve delivery of care. | |35953887 |Drug and
alcohol review |<AbstractText Label="INTRODUCTION">Before COVID-19,
Native Hawaiians/Pacific Islanders (NH/PI) endured a heavy burden of
alcohol, tobacco and other drug (ATOD) use in prior US data. Responding
to reports that many NH/PI communities experienced severe COVID-19
disparities that could exacerbate their ATOD burden, we partnered with
NH/PI communities to assess the substance use patterns and treatment
needs of diverse NH/PIs during COVID-19.
<AbstractText Label="METHODS">Collaborating with NH/PI community
organisations across five states with large NH/PI populations, we
conducted a large-scale investigation of NH/PI ATOD use, mental health
and treatment need during COVID-19. Between April and November 2021,
NH/PI-heritage research staff from our community partners collected data
involving 306 NH/PI adults using several community-based recruitment
methods (e-mail, telephone, in-person) and two survey approaches: online
and paper-and-pencil. Multivariate regressions were conducted to examine
potential predictors of NH/PI alcohol use disorder and need for
behavioural health treatment. <AbstractText Label="RESULTS">During
COVID-19, 47% and 22% of NH/PI adults reported current alcohol and
cigarette use, while 35% reported lifetime illicit substance use (e.g.,
cannabis, opioid). Depression and anxiety were high, and alcohol use
disorder, major depression and generalised anxiety disorder prevalence
were 27%, 27% and 19%, respectively. One-third of participants reported
past-year treatment need with lifetime illicit substance use, COVID-19
distress and major depression respectively associating with 3.0, 1.2,
and 5.3 times greater adjusted odds for needing treatment.
<AbstractText Label="CONCLUSIONS">NH/PI adults reported heavy ATOD use,
depression, anxiety and treatment need during COVID-19. Targeted
research and treatment services may be warranted to mitigate COVID-19s
negative behavioural health impact on NH/PI communities.  2022 The
Authors. Drug and Alcohol Review published by John Wiley &amp; Sons
Australia, Ltd on behalf of Australasian Professional Society on Alcohol
and other Drugs. | |35951232 |Medical journal (Fort Sam Houston, Tex.)
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Since March
of 2020, thousands of National Guard service members have played a key
role in the domestic response to COVID-19, ranging from medical support,
health screening, decontamination, personal protective equipment (PPE)
training, and more. As a result of these missions, there was a
hypothesized potential increase in COVID-19 exposure risk.
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">Assess COVID-19
transmission rates and mortality rates in the US population compared to
the National Guard.
<AbstractText Label="METHODS" NlmCategory="METHODS">Six months of
retrospective data were assessed with analysis of a snapshot in time for
pandemic data on 29 July 2020. Potential relationships between National
Guard COVID-19 response personnel, cumulative US COVID-19 cases,
National Guard COVID-19 cases, and National Guard COVID-19 fatalities
were assessed. <AbstractText Label="RESULTS" NlmCategory="RESULTS">No
evidence of correlations exist between the number of National Guard
personnel supporting the COVID-19 response and the number of deaths in
the National Guard due to COVID-19 (p=0.547), and the number of National
Guard COVID-19 cases and the number of deaths in the National Guard due
to COVID-19 (p=0.214). The number of COVID-19 cases in the US was
positively correlated to the number of deaths in the US due to COVID-19
(rs=0.947, p is less than.001).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Though much
of the data could not be reported due to operational security (OPSEC)
and capabilities, activities, limitations, and intentions (CALI)
concerns, the data herein demonstrate National Guard service members are
significantly less likely to suffer COVID-19 related mortality compared
to US civilians. Since the National Guard adheres the same medical and
physical fitness standards as set by their parent service (Army and Air
Force), it follows overall levels of medical readiness and fitness
should start with a higher baseline. Age, medical screening, PPE, and
physical fitness requirements have likely contributed to this
phenomenon. These results should empower National Guard service members
to feel more confident in their roles as they continue to support the
COVID-19 response efforts. | |35947596 |PloS one
|<AbstractText Label="BACKGROUND">Venous phlebotomy performed by trained
personnel is critical for patient diagnosis and monitoring of chronic
disease, but has limitations in resource-constrained settings, and
represents an infection control challenge during outbreaks.
Self-collection devices have the potential to shift phlebotomy closer to
the point of care, supporting telemedicine strategies and virtual
clinical trials. Here we assess a capillary blood micro-sampling device,
the Tasso Serum Separator Tube (SST), for measuring blood protein levels
in healthy subjects and non-hospitalized COVID-19 patients.
<AbstractText Label="METHODS">57 healthy controls and 56 participants
with mild/moderate COVID-19 were recruited at two U.S. military
healthcare facilities. Healthy controls donated Tasso SST capillary
serum, venous plasma and venous serum samples at multiple time points,
while COVID-19 patients donated a single Tasso SST serum sample at
enrolment. Concentrations of 17 protein inflammatory biomarkers were
measured in all biospecimens by Ella multi-analyte immune-assay.
<AbstractText Label="RESULTS">Tasso SST serum protein measurements in
healthy control subjects were highly reproducible, but their agreements
with matched venous samples varied. Most of the selected proteins,
including CRP, Ferritin, IL-6 and PCT, were well-correlated between
Tasso SST and venous serum with little sample type bias, but
concentrations of D-dimer, IL-1B and IL-1Ra were not. Self-collection at
home with delayed sample processing was associated with significant
concentrations differences for several analytes compared to supervised,
in-clinic collection with rapid processing. Finally, Tasso SST serum
protein concentrations were significantly elevated in in
non-hospitalized COVID-19 patients compared with healthy controls.
<AbstractText Label="CONCLUSIONS">Self-collection of capillary blood
with micro-sampling devices provides an attractive alternative to
routine phlebotomy. However, concentrations of certain analytes may
differ significantly from those in venous samples, and factors including
user proficiency, temperature control and time lags between specimen
collection and processing need to be considered for their effect on
sample quality and reproducibility. | |35942481 |Fisheries management
and ecology |The COVID-19 pandemic transformed social and economic
systems globally, including fisheries systems. Decreases in seafood
demand, supply chain disruptions, and public safety regulations required
numerous adaptations to maintain the livelihoods and social resilience
of fishing communities. Surveys, interviews, and focus groups were
undertaken to assess impacts from and adaptive responses to the pandemic
in commercial fisheries in five U.S. regions: the Northeast, California,
Alaska, the U.S. Caribbean, and the Pacific Islands. Fishery adaptation
strategies were categorized using the Resist-Accept-Direct (RAD)
framework, a novel application to understand social transformation in a
social-ecological system in response to a disturbance. A number of
innovations emerged, or were facilitated, that could improve the
fisheries resilience to future disruptions. Fishers with diversified
options and strategic flexibility generally fared better, i.e., had
fewer disruptions to their livelihoods. Using the RAD framework to
identify adaptation strategies from fishery system actors highlights
opportunities for improving resilience of fisheries social-ecological
systems to future stressors.  2022 The Authors. Fisheries Management
and Ecology published by John Wiley &amp; Sons Ltd.| |35923385 |Hawaii
journal of health &amp; social welfare |NA | |35922730 |Internal and
emergency medicine |Colorectal cancer (CRC) is one of the leading causes
of cancer death worldwide. Many communities remain under the 80% CRC
screening goal. We aimed to identify factors associated with
non-adherence to CRC screening and to describe the effect of the
COVID-19 pandemic in CRC screening patterns. A retrospective review of
patients aged 50-75 years seen at the Griffin Faculty Physicians primary
care offices between January 2019 and December 2020 was performed.
Logistic regression models were used to identify factors associated with
CRC screening non-adherence. Of 12,189 patients, 66.2% had an updated
CRC screen. On univariable logistic regression, factors associated with
CRC screening non-adherence included age  55 years [odds ratio (OR)
2.267, p &lt; 0.001], White/Caucasian race (OR 0.858, p = 0.030),
Medicaid insurance (OR 2.097, p &lt; 0.001), morbid obesity (OR 1.436, p
&lt; 0.001), current cigarette smoking (OR 1.849, p &lt; 0.001), and
elevated HbA1c (OR 1.178, p = 0.004). Age, Medicaid insurance, morbid
obesity, current smoking, and HbA1c  6.5% remained significant in the
final multivariable model. Compared to 2019, there was an 18.2% decrease
in the total number of CRC screening tests in 2020. The proportion of
colonoscopy procedures was lower in 2020 compared to the proportion of
colonoscopy procedures conducted in 2019 (65.9% vs 81.7%, p &lt; 0.001),
with a concurrent increase in stool-based tests. CRC screening rates in
our population are comparable to national statistics but below the 80%
goal. COVID-19 affected CRC screening. Our results underscore the need
to identify patient groups most vulnerable to missing CRC screening and
highlight the importance of stool-based testing to bridge screening
gaps.  2022. The Author(s), under exclusive licence to Societ Italiana
di Medicina Interna (SIMI). | |35921109 |JAMA network open
|<AbstractText Label="IMPORTANCE">Data about the duration of protection
of 2 and 3 doses of BNT162b2 in children and adolescents are needed to
help inform recommendations for boosters in this age group.
<AbstractText Label="OBJECTIVE">To evaluate vaccine effectiveness (VE)
and durability associated with 2 doses of BNT162b2 against Delta- and
Omicron-related emergency department (ED) and urgent care (UC)
encounters among adolescents aged 12 to 17 years and to estimate VE
associated with 3 doses against these same outcomes.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This
test-negative case-control study was conducted at Kaiser Permanente
Southern California, an integrated health care system using electronic
health records in the US. Participants included Kaiser Permanente
Southern California members ages 12 to 17 years with an ED or UC
encounter from November 1, 2021, through March 18, 2022, for acute
respiratory infection who were tested for SARS-CoV-2 via a reverse
transction-polymerase chain reaction test. Analyses were conducted from
March 21 to June 22, 2022. <AbstractText Label="EXPOSURES">BNT162b2
vaccination status ascertained from electronic health records and state
registry data. <AbstractText Label="MAIN OUTCOMES AND MEASURES">The main
outcome was VE associated with BNT162b2 against ED and UC encounters
related to Delta or Omicron variant SARS-CoV-2 infection.
<AbstractText Label="RESULTS">Analyses were conducted among 3168
adolescents, including 1004 with ED visits and 2164 with UC visits.
Median (IQR) age was 15 (13-16) years, and 1461 (46.1%) were boys. In
adjusted analyses, VE associated with 2 doses of BNT162b2 against ED or
UC encounters was highest within the first 2 months for both Delta (89%
[95% CI, 69% to 96%]) and Omicron (73% [95% CI, 54% to 84%]) variants
but waned to 49% (95% CI, 27% to 65%) for the Delta variant and 16% (95%
CI, -7% to 34%) for the Omicron variant at 6 months and beyond. A third
dose of BNT162b2 was associated with improved protection against the
Omicron variant (87% [95% CI, 72% to 94%]) after a median (IQR) of 19
(9-32) days after dose 3.
<AbstractText Label="CONCLUSIONS AND RELEVANCE">These findings suggest
that 2 doses of the BNT162b2 COVID-19 vaccine were associated with high
levels of protection against ED and UC encounters related to the Delta
and Omicron variants of SARS-CoV-2 in the first few months after
vaccination. However, effectiveness waned over time, especially against
Omicron. A third dose of BNT162b2 was associated with improved
protection against Omicron beyond that seen initially after 2 doses,
underscoring the importance of boosters for adolescents aged 12 to 17
years. | |35916603 |Cancer epidemiology, biomarkers &amp; prevention : a
publication of the American Association for Cancer Research, cosponsored
by the American Society of Preventive Oncology
|<AbstractText Label="BACKGROUND">Cancer screening is a complex process
involving multiple steps and levels of influence (e.g., patient,
provider, facility, health care system, community, or neighborhood). We
describe the design, methods, and research agenda of the
Population-based Research to Optimize the Screening Process (PROSPR II)
consortium. PROSPR II Research Centers (PRC), and the Coordinating
Center aim to identify opportunities to improve screening processes and
reduce disparities through investigation of factors affecting cervical,
colorectal, and lung cancer screening in U.S. community health care
settings. <AbstractText Label="METHODS">We collected multilevel,
longitudinal cervical, colorectal, and lung cancer screening process
data from clinical and administrative sources on &amp;gt;9 million
racially and ethnically diverse individuals across 10 heterogeneous
health care systems with cohorts beginning January 1, 2010. To
facilitate comparisons across organ types and highlight data breadth, we
calculated frequencies of multilevel characteristics and volumes of
screening and diagnostic tests/procedures and abnormalities.
<AbstractText Label="RESULTS">Variations in patient, provider, and
facility characteristics reflected the PROSPR II health care systems and
differing target populations. PRCs identified incident diagnoses of
invasive cancers, in situ cancers, and precancers (invasive: 372
cervical, 24,131 colorectal, 11,205 lung; in situ: 911 colorectal, 32
lung; precancers: 13,838 cervical, 554,499 colorectal).
<AbstractText Label="CONCLUSIONS">PROSPR IIs research agenda aims to
advance: (i) conceptualization and measurement of the cancer screening
process, its multilevel factors, and quality; (ii) knowledge of cancer
disparities; and (iii) evaluation of the COVID-19 pandemics initial
impacts on cancer screening. We invite researchers to collaborate with
PROSPR II investigators. <AbstractText Label="IMPACT">PROSPR II is a
valuable data resource for cancer screening researchers. 2022 American
Association for Cancer Research. | |35899278 |Open forum infectious
diseases
|<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">There is
limited information on the functional consequences of coronavirus
disease 2019 (COVID-19) vaccine side effects. To support patient
counseling and public health messaging, we describe the risk and
correlates of COVID-19 vaccine side effects sufficient to prevent work
or usual activities and/or lead to medical care (severe side effects).
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The EPICC study
is a longitudinal cohort study of Military Healthcare System
beneficiaries including active duty service members, dependents, and
retirees. We studied 2789 adults who were vaccinated between December
2020 and December 2021.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Severe side
effects were most common with the Ad26.COV2.S (Janssen/Johnson and
Johnson) vaccine, followed by mRNA-1273 (Moderna) then BNT162b2
(Pfizer/BioNTech). Severe side effects were more common after the second
than first dose (11% vs 4%; P &lt; .001). First (but not second) dose
side effects were more common in those with vs without prior severe
acute respiratory syndrome coronavirus 2 infection (9% vs 2%; adjusted
odds ratio [aOR], 5.84; 95% CI, 3.8-9.1), particularly if the prior
illness was severe or critical (13% vs 2%; aOR, 10.57; 95% CI, 5.5-20.1)
or resulted in inpatient care (17% vs 2%; aOR, 19.3; 95% CI, 5.1-72.5).
Side effects were more common in women than men but not otherwise
related to demographic factors.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Vaccine side
effects sufficient to prevent usual activities were more common after
the second than first dose and varied by vaccine type. First dose side
effects were more likely in those with a history of
COVID-19-particularly if that prior illness was severe or associated
with inpatient care. These findings may assist clinicians and patients
by providing a real-world evaluation of the likelihood of experiencing
impactful postvaccine symptoms. Published by Oxford University Press on
behalf of Infectious Diseases Society of America 2022.This work is
written by (a) US Government employee(s) and is in the public domain in
the US. | |35873301 |Open forum infectious diseases
|<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">Patient-reported
outcomes of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection are an important measure of the full burden of coronavirus
disease (COVID). Here, we examine how (1) infecting genotype and
COVID-19 vaccination correlate with inFLUenza Patient-Reported Outcome
(FLU-PRO) Plus score, including by symptom domains, and (2) FLU-PRO Plus
scores predict return to usual activities and health.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">The epidemiology,
immunology, and clinical characteristics of pandemic infectious diseases
(EPICC) study was implemented to describe the short- and long-term
consequences of SARS-CoV-2 infection in a longitudinal, observational
cohort. Multivariable linear regression models were run with FLU-PRO
Plus scores as the outcome variable, and multivariable Cox proportional
hazards models evaluated effects of FLU-PRO Plus scores on return to
usual health or activities.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Among the 764
participants included in this analysis, 63% were 18-44 years old, 40%
were female, and 51% were White. Being fully vaccinated was associated
with lower total scores ( = -0.39; 95% CI, -0.57 to -0.21). The Delta
variant was associated with higher total scores ( = 0.25; 95% CI, 0.05
to 0.45). Participants with higher FLU-PRO Plus scores were less likely
to report returning to usual health and activities (health: hazard ratio
[HR], 0.46; 95% CI, 0.37 to 0.57; activities: HR, 0.56; 95% CI, 0.47 to
0.67). Fully vaccinated participants were more likely to report
returning to usual activities (HR, 1.24; 95% CI, 1.04 to 1.48).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Full
SARS-CoV-2 vaccination is associated with decreased severity of
patient-reported symptoms across multiple domains, which in turn is
likely to be associated with earlier return to usual activities. In
addition, infection with the Delta variant was associated with higher
FLU-PRO Plus scores than previous variants, even after controlling for
vaccination status. Published by Oxford University Press on behalf of
the Infectious Diseases Society of America 2022. | |35873076 |Current
dermatology reports
|<AbstractText Label="PURPOSE OF REVIEW" NlmCategory="UNASSIGNED">Neutrophilic
dermatoses are a heterogeneous group of disorders with significant
overlap in associated conditions, clinical presentation, and
histopathologic features. This review provides a structural overview of
neutrophilic dermatoses that may present in the inpatient setting along
with diagnostic work-up and management strategies.
<AbstractText Label="RECENT FINDINGS" NlmCategory="UNASSIGNED">Sweets
syndrome has been found in patients with coronavirus disease 2019
(COVID-19). Pyoderma gangrenosum (PG) has been shown to be equally
associated with ulcerative colitis and Crohns disease. A clinical trial
shows that cyclosporine is equally effective as prednisone in treating
PG. Neutrophilic eccrine hidradenitis has been found in the setting of
newer antineoplastic medications, such as BRAF inhibitors, as well as in
the setting of malignancy without chemotherapy exposure.
<AbstractText Label="SUMMARY" NlmCategory="UNASSIGNED">Neutrophilic
dermatoses are a rare and complex group of dermatoses with varying and
overlapping clinical presentations. Physicians should be aware of the
growing list of associated diseases in order to build a better
differential diagnosis or to potentially investigate for co-existing
disease.  The Author(s), under exclusive licence to Springer
Science+Business Media, LLC, part of Springer Nature 2022. | |35833192
|International journal of endocrinology |[This corrects the article DOI:
10.1155/2022/9322332.]. Copyright  2022 Yuanyuan Fu et al.| |35821668
|Hawaii journal of health &amp; social welfare |The Next Gen Hawaii
social media project was initiated in the fall of 2020 to address
ongoing public health concerns and the need for accessible and reliable
information across Hawaiis diverse communities by strategically
amplifying the voices of Hawaiis youth in their Native languages. The
collaborative effort arose from conversations within the Hawaiis
Native Hawaiian &amp; Pacific Islander COVID-19 Response, Recovery, and
Resilience Team, composed of diverse public and private organizations
involved in statewide COVID-19 response efforts for Native Hawaiian and
Pacific Islander communities. Next Gen Hawaiis focus was on Native
Hawaiian, Pacific Islander, Filipino, and other populations
disproportionately suffering from COVID-19. Five social media platforms
were developed to spread messaging to youth and young adults about
COVID-19. Public Health Ambassadors (from high school to young adults)
were recruited and engaged to create culturally and linguistically
rooted messaging to promote public health and prevention-based social
norms. This strength-based approach recognized youth as important
community leaders and ambassadors for change and empowered them to
create content for dissemination on platforms with national and global
reach. Messaging was designed to build individual, community, and
digital health literacy while integrating core cultural values and
strengths of Native Hawaiian, Pacific Islander, and Filipino
communities. Over 250 messages have been delivered across Next Gen
Hawaii social media channels on topics including vaccine information,
mask-wearing, staying together over distances, mental health, and
in-languages resources in Chuukese, Chamorro, Marshallese, Samoan,
Hawaiian, Ilocano, Tagalog, and other Pacific-basin languages. Reach has
included more than 75 000 views from various social media channels,
media features, successful webinars, and relevant conference
presentations. This Public Health Insights article provides an overview
of Next Gen Hawaiis activities and achievements as well as lessons
learned for other youth-focused public health social media campaigns and
organizations. Copyright 2022 by University Health Partners of Hawaii
(UHP Hawaii). | |35818366 |Open forum infectious diseases
|<AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">As the number
of coronavirus disease 2019 (COVID-19) cases continue to surge worldwide
and new variants emerge, additional accurate, rapid, and noninvasive
screening methods to detect severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) are needed. The number of COVID-19 cases
reported globally is &gt;455 million, and deaths have surpassed 6
million. Current diagnostic methods are expensive, invasive, and produce
delayed results. While COVID-19 vaccinations are proven to help slow the
spread of infection and prevent serious illness, they are not equitably
available worldwide. Almost 40% of the worlds population remains
unvaccinated. Evidence suggests that SARS-CoV-2 virus-associated
volatile organic compounds found in the breath, urine, and sweat of
infected individuals can be detected by canine olfaction. Medical
detection dogs may be a feasible, accurate, and affordable SARS-CoV-2
screening method.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">In this
double-blinded, case-control, validation study, we obtained sweat
samples from inpatients and outpatients tested for SARS-CoV-2 by a
polymerase chain reaction test. Medical detection dogs were trained to
distinguish SARS-CoV-2-positive samples from SARS-CoV-2-negative samples
using reward-based reinforcement.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Samples were
obtained from 584 individuals (6-97 years of age; 24% positive
SARS-CoV-2 samples and 76% negative SARS-CoV-2 samples). In the testing
phase, all dogs performed with high accuracy in detecting SARS-CoV-2.
The overall diagnostic sensitivity was 98%, and specificity was 92%. In
a follow-up phase, 1 dog screened 153 patients for SARS-CoV-2 in a
hospital setting with 96% diagnostic sensitivity and 100% specificity.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Canine
olfaction is an accurate and feasible method for diagnosis of
SARS-CoV-2, including asymptomatic and presymptomatic infected
individuals.  The Author(s) 2022. Published by Oxford University Press
on behalf of Infectious Diseases Society of America. | |35801366
|Journal of cosmetic dermatology
|<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">While there are
literature reporting increased incidence of hair loss in COVID-19
patients, insufficient evidence exists on the topic to date. This review
aims to identify the existing evidence and clinical characteristics of
hair loss with COVID-19 infection.
<AbstractText Label="METHODS" NlmCategory="METHODS">Following the PRISMA
Extension for Scoping Reviews, MEDLINE and EMBASE were searched for all
peer-reviewed articles with relevant keywords including Alopecia,
Telogen Effluvium (TE), and COVID-19 from their inception to
November 20, 2021. <AbstractText Label="RESULTS" NlmCategory="RESULTS">A
total of 26 articles, with 9 observational studies and 17 case reports
or series (a total of 58 cases), were included. Most studies dealt with
TE. There were no clear trends between COVID-19 severity and the extent
of hair loss. Analysis of the 58 cases also found similar results with
most of the cases being female (82.8%), the median onset of hair loss of
2.0 months, and the median time to recovery of hair loss of 5.0 months
with a resolution rate of 95%.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">While this
systematic review revealed uncertainty and a lack of strong evidence
regarding the association of COVID-19 and hair loss, hair loss in
COVID-19 may mainly include TE and be reversible in nature. Future
studies are warranted to determine the detailed pathophysiology and risk
factors of hair loss in COVID-19, including possible roles of estrogen,
progesterone, and pro-inflammatory cytokines.  2022 Wiley Periodicals
LLC. | |35775002 |Frontiers in medicine
|<AbstractText Label="OBJECTIVE" NlmCategory="UNASSIGNED">The US
recently suffered the fourth and most severe wave of the COVID-19
pandemic. This wave was driven by the SARS-CoV-2 Omicron, a highly
transmissible variant that infected even vaccinated people. Vaccination
coverage disparities have played an important role in shaping the
epidemic dynamics. Analyzing the epidemiological impact of this uneven
vaccination coverage is essential to understand local differences in the
spread and outcomes of the Omicron wave. Therefore, the objective of
this study was to quantify the impact of vaccination coverage disparity
in the US in the dynamics of the COVID-19 pandemic during the third and
fourth waves of the pandemic driven by the Delta and Omicron variants.
<AbstractText Label="METHODS" NlmCategory="UNASSIGNED">This
cross-sectional study used COVID-19 cases, deaths, and vaccination
coverage from 2,417 counties. The main outcomes of the study were new
COVID-19 cases (incidence rate per 100,000 people) and new COVID-19
related deaths (mortality rate per 100,000 people) at county level and
the main exposure variable was COVID-19 vaccination rate at county
level. Geospatial and data visualization analyses were used to estimate
the association between vaccination rate and COVID-19 incidence and
mortality rates for the Delta and Omicron waves.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">During the
Omicron wave, areas with high vaccination rates (&gt;60%) experienced
1.4 (95% confidence interval [CI] 1.3-1.7) times higher COVID-19
incidence rate compared to areas with low vaccination rates (&lt;40%).
However, mortality rate was 1.6 (95% CI 1.5-1.7) higher in these
low-vaccinated areas compared to areas with vaccination rates higher
than 60%. As a result, areas with low vaccination rate had a 2.2 (95% CI
2.1-2.2) times higher case-fatality ratio. Geospatial clustering
analysis showed a more defined spatial structure during the Delta wave
with clusters with low vaccination rates and high incidence and
mortality located in southern states.
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">Despite the
emergence of new virus variants with differential transmission
potential, the protective effect of vaccines keeps generating marked
differences in the distribution of critical health outcomes, with low
vaccinated areas having the largest COVID-19 related mortality during
the Delta and Omicron waves in the US. Vulnerable communities residing
in low vaccinated areas, which are mostly rural, are suffering the
highest burden of the COVID-19 pandemic during the vaccination era.
Copyright  2022 Cuadros, Moreno, Musuka, Miller, Coule and MacKinnon. |
|35746577 |Vaccines |Native Hawaiians and other Pacific Islanders
(NHPIs) were disproportionately impacted by COVID-19 and remain
significantly under-vaccinated against SARS-CoV-2. To understand vaccine
hesitancy, we surveyed 1124 adults residing in a region with one of the
lowest vaccination rates in Hawaii during our COVID-19 testing program.
Probit regression analysis revealed that race/ethnicity was not directly
associated with the probability of vaccine uptake. Instead, a higher
degree of trust in official sources of COVID-19 information increased
the probability of vaccination by 20.68%, whereas a higher trust in
unofficial sources decreased the probability of vaccination by 12.49%
per unit of trust. These results revealed a dual and opposing role of
trust on vaccine uptake. Interestingly, NHPIs were the only
racial/ethnic group to exhibit a significant positive association
between trust in and consumption of unofficial sources of COVID-19
information, which explained the vaccine hesitancy observed in this
indigenous population. These results offer novel insight relevant to
COVID-19 mitigation efforts in minority populations. | |35742804
|International journal of molecular sciences |The receptor of advanced
glycation end products (RAGE) is a receptor that is thought to be a key
driver of inflammation in pregnancy, SARS-CoV-2, and also in the
comorbidities that are known to aggravate these afflictions. In addition
to this, vulnerable populations are particularly susceptible to the
negative health outcomes when these afflictions are experienced in
concert. RAGE binds a number of ligands produced by tissue damage and
cellular stress, and its activation triggers the proinflammatory
transcription factor Nuclear Factor Kappa B (NF-B), with the subsequent
generation of key proinflammatory cytokines. While this is important for
fetal membrane weakening, RAGE is also activated at the end of pregnancy
in the uterus, placenta, and cervix. The comorbidities of hypertension,
cardiovascular disease, diabetes, and obesity are known to lead to poor
pregnancy outcomes, and particularly in populations such as Native
Hawaiians and Pacific Islanders. They have also been linked to RAGE
activation when individuals are infected with SARS-CoV-2. Therefore, we
propose that increasing our understanding of this receptor system will
help us to understand how these various afflictions converge, how forms
of RAGE could be used as a biomarker, and if its manipulation could be
used to develop future therapeutic targets to help those at risk. |
|35716737 |The Science of the total environment |Methane (CH4) is a
potent greenhouse gas and also plays a significant role in tropospheric
chemistry. High-frequency (sub-hourly) measurements of CH4 and carbon
isotopic ratio (13CH4) have been conducted at Pune (18.53N, 73.80E),
an urban environment in India, during 2018-2020. High CH4 concentrations
were observed, with a mean of 2100  196 ppb (1844-2749 ppb), relative
to marine background concentrations. The 13CH4 varied between -45.11
and -50.03  for the entire study period with an average of -47.41 
0.94 . The diurnal variability of CH4 typically showed maximum values
in the morning (08:00-09:00 local time) and minimum in the afternoon
(15:00 local time). The deepest diurnal amplitude of ~500 ppb was
observed during winter (December-February), which was reduced to less
than half, ~200 ppb, during the summer (March-May). CH4 concentration at
Pune showed a strong seasonality (470 ppb), much higher than that at
Mauna Loa, Hawaii. On the other hand, 13CH4 records did not show
distinct seasonality at Pune. The 13CH4 values revealed that the
significant sources of CH4 in Pune were from the waste sector (enhanced
during the monsoon season; signature of depleted 13CH4), followed by
the natural gas sector with a signature of enriched 13CH4. Our analysis
of Covid-19 lockdown (April to May 2020) effect on the CH4 variability
showed no signal in the CH4 variability; however, the isotopic analysis
indicated a transient shift in the CH4 source to the waste sector (early
summer of 2020). Copyright  2022 Elsevier B.V. All rights reserved. |
|35710669 |Journal of general internal medicine
|<AbstractText Label="BACKGROUND">Animation in medical education has
boomed over the past two decades, and demand for distance learning
technologies will likely continue in the context of the COVID-19
pandemic. However, experimental data guiding best practices for
animation in medical education are scarce.
<AbstractText Label="OBJECTIVE">To compare the efficacy of two animated
video styles in a diabetes pharmacotherapy curriculum for internal
medicine residents. <AbstractText Label="DESIGN">Learners were
randomized to receive one of two versions of the same multimodal
didactic curriculum. They received identical lectures, group activities,
and quizzes, but were randomized to either digital chalk talk (DCT)
videos or Sugar-Coated Science (SCS). SCS is an animated series using
anthropomorphic characters, stories, and mnemonics to communicate
knowledge. <AbstractText Label="PARTICIPANTS">Ninety-two internal
medicine residents at a single academic medical center received the
curriculum within ambulatory medicine didactics.
<AbstractText Label="MAIN MEASURES">Knowledge was measured at multiple
time points, as was residents self-reported comfort using each
medication class covered. Surveys assessed video acceptability and
telepresence. Key themes were identified from open-ended feedback.
<AbstractText Label="KEY RESULTS">Baseline knowledge was low, consistent
with prior needs assessments. On immediate posttest, mean scores were
higher with SCS than DCT (74.8% versus 68.4%), but the difference was
not statistically significant, p = 0.10. Subgroup analyses revealed
increased knowledge in the SCS group for specific medication classes.
Delayed posttest showed significant knowledge gains averaging 17.6%
across all participants (p &lt; 0.05); these gains were similar between
animation types. SCS achieved significantly higher telepresence,
entertainment, and acceptability scores than DCT. Qualitative data
suggested that residents prioritize well-designed, multimodal curricula
over specific animation characteristics.
<AbstractText Label="CONCLUSION">SCS and DCTs both led to learning
within a multimodal curriculum, but SCS significantly enhanced learner
experience. Animation techniques exemplified by both SCS and DCTs have
roles in the medical educator toolkit. Selection between them should
incorporate context, learner factors, and production resources.  2022.
The Author(s), under exclusive licence to Society of General Internal
Medicine. | |35700997 |CMAJ open |<AbstractText Label="BACKGROUND">Asian
Canadians have experienced increased cases of racialized discrimination
after the first emergence of SARS-CoV-2 in China. This study examined
how the COVID-19 pandemic has affected Asian Canadians sense of safety
and belonging in their Canadian (i.e., geographical) communities.
<AbstractText Label="METHODS">We applied a qualitative description study
design in which semistructured interviews were conducted from Mar.23 to
May 27, 2021. Purposive and snowball sampling methods were used to
recruit Asian Canadians diverse in region, gender and age. Interviews
were conducted through Zoom videoconference or telephone, and
independent qualitative thematic analysis in duplicate was used to
derive primary themes and subthemes.
<AbstractText Label="RESULTS">Thirty-two Asian Canadians (median age 35
[interquartile range 24-46] yr, 56% female, 44% East Asian) participated
in the study. We identified 5 predominant themes associated with how the
COVID-19 pandemic affected the participants sense of security and
belonging to their communities: relation between socioeconomic status
(SES) and exposure to discrimination (i.e., how SES insulates or exposes
individuals to increased discrimination); politics, media and the
COVID-19 pandemic (i.e., the key role that politicians and media played
in enabling spread of discrimination against and fear of Asian people);
effect of discrimination on mental and social health (i.e., peoples
ability to interact and form meaningful relationships with others);
coping with the impact of discrimination (i.e., the way people appraise
and move forward in identity-threatening situations); and implications
for sense of safety and sense of belonging (i.e., people feeling unable
to safely use public spaces in person, including the need to remain
alert in anticipation of harm, leading to distress and exhaustion).
<AbstractText Label="INTERPRETATION">During the COVID-19 pandemic, Asian
Canadians in our study felt unsafe owing to the uncertain, unexpected
and unpredictable nature of discrimination, but also felt a strong sense
of belonging to Canadian society and felt well connected to their Asian
Canadian communities. Future work should seek to explore the influence
of social media on treatment of and attitudes toward Asian Canadians. 
2022 CMA Impact Inc.or its licensors. | |35678989 |Journal of general
internal medicine |NA | |35673364 |Hawaii journal of health &amp;
social welfare |NA | |35661139 |Ecology |Managing wildlife populations
in the face of global change requires regular data on the abundance and
distribution of wild animals, but acquiring these over appropriate
spatial scales in a sustainable way has proven challenging. Here we
present the data from Snapshot USA 2020, a second annual national mammal
survey of the USA. This project involved 152 scientists setting camera
traps in a standardized protocol at 1485 locations across 103 arrays in
43 states for a total of 52,710 trap-nights of survey effort. Most (58)
of these arrays were also sampled during the same months (September and
October) in 2019, providing a direct comparison of animal populations in
2 years that includes data from both during and before the COVID-19
pandemic. All data were managed by the eMammal system, with all species
identifications checked by at least two reviewers. In total, we recorded
117,415 detections of 78 species of wild mammals, 9236 detections of at
least 43 species of birds, 15,851 detections of six domestic animals and
23,825 detections of humans or their vehicles. Spatial differences
across arrays explained more variation in the relative abundance than
temporal variation across years for all 38 species modeled, although
there are examples of significant site-level differences among years for
many species. Temporal results show how species allocate their time and
can be used to study species interactions, including between humans and
wildlife. These data provide a snapshot of the mammal community of the
USA for 2020 and will be useful for exploring the drivers of spatial and
temporal changes in relative abundance and distribution, and the impacts
of species interactions on daily activity patterns. There are no
copyright restrictions, and please cite this paper when using these
data, or a subset of these data, for publication.  2022 The Authors.
Ecology  2022 The Ecological Society of America. | |35636901
|Infectious disease clinics of North America |The violence and
victimization brought by colonization and slavery and justified for over
a century by race-based science have resulted in enduring inequities for
black, Indigenous and people of color (BIPOC) across the United States.
This is particularly true if BIPOC individuals have other intersecting
devalued identities. We highlight how such longstanding inequities paved
the way for the disproportionate burdens of coronavirus disease 2019
(COVID-19) among the BIPOC populations across the country and provide
recommendations on how to improve COVID-19 mitigation strategies with
the goal of eliminating disparities. Copyright  2022 Elsevier Inc.All
rights reserved. | |35632529 |Vaccines |Having been affected by the
highest increase in COVID-19 cases since the start of the pandemic,
Honolulu and Maui counties in Hawaii implemented vaccine passport
mandates for select industries in September 2021. However, the degree to
which such mandates impacted COVID-19 mitigation efforts and economics
remains poorly understood. Herein, we describe the effects of these
mandates on changes in three areas using difference-in-difference
regression models: (1) business foot traffic; (2) number of COVID-19
cases per 100,000 individuals, and (3) COVID-19 vaccination rates across
counties affected or unaffected by the mandates. We observed that
although businesses affected by mandates experienced a 6.7% decrease in
foot traffic over the 14 weeks after the mandates were implemented, the
number of COVID-19 cases decreased by 19.0%. Notably, the vaccination
rate increased by 1.41% in counties that implemented mandates. In
addition, towards the end of the studied period, the level of foot
traffic at impacted businesses converged towards the level of that of
non-impacted businesses. As such, the trade-off in temporary losses at
businesses was met with significant gains in public health and safety. |
|35627656 |International journal of environmental research and public
health |In the face of great uncertainty and a global crisis from
COVID-19, mathematical and epidemiologic COVID-19 models proliferated
during the pandemic. Yet, many models were not created with the explicit
audience of policymakers, the intention of informing specific scenarios,
or explicit communication of assumptions, limitations, and complexities.
This study presents a case study of the roles, uses, and approaches to
COVID-19 modeling and forecasting in one state jurisdiction in the
United States. Based on an account of the historical real-world events
through lived experiences, we first examine the specific modeling
considerations used to inform policy decisions. Then, we review the
real-world policy use cases and key decisions that were informed by
modeling during the pandemic including the role of modeling in informing
planning for hospital capacity, isolation and quarantine facilities, and
broad public communication. Key lessons are examined through the
real-world application of modeling, noting the importance of locally
tailored models, the role of a scientific and technical advisory group,
and the challenges of communicating technical considerations to a public
audience. | |35608504 |Clinical infectious diseases : an official
publication of the Infectious Diseases Society of America
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Comparison of
humoral responses in severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) vaccinees, those with SARS-CoV-2 infection, or combinations
of vaccine/ infection (hybrid immunity) may clarify predictors of
vaccine immunogenicity.
<AbstractText Label="METHODS" NlmCategory="METHODS">We studied 2660 US
Military Health System beneficiaries with a history of SARS-CoV-2
infection-alone (n = 705), vaccination-alone (n = 932),
vaccine-after-infection (n = 869), and vaccine-breakthrough-infection (n
= 154). Peak anti-spike-immunoglobulin G (IgG) responses through 183
days were compared, with adjustment for vaccine product, demography, and
comorbidities. We excluded those with evidence of clinical or
subclinical SARS-CoV-2 reinfection from all groups.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Multivariable
regression results indicated that vaccine-after-infection anti-spike-IgG
responses were higher than infection-alone (P &lt; .01), regardless of
prior infection severity. An increased time between infection and
vaccination was associated with greater post-vaccination IgG response (P
&lt; .01). Vaccination-alone elicited a greater IgG response but more
rapid waning of IgG (P &lt; .01) compared with infection-alone (P &lt;
.01). BNT162b2 and mRNA-1273 vaccine-receipt was associated with greater
IgG responses compared with JNJ-78436735 vaccine-receipt (P &lt; .01),
regardless of infection history. Those with vaccine-after-infection or
vaccine-breakthrough-infection had a more durable anti-spike-IgG
response compared to infection-alone (P &lt; .01).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Vaccine-receipt
elicited higher anti-spike-IgG responses than infection-alone, although
IgG levels waned faster in those vaccinated (compared to
infection-alone). Vaccine-after-infection elicits a greater humoral
response compared with vaccine or infection alone; and the timing, but
not disease severity, of prior infection predicted these
post-vaccination IgG responses. While differences between groups were
small in magnitude, these results offer insights into vaccine
immunogenicity variations that may help inform vaccination timing
strategies.  The Author(s) 2022. Published by Oxford University Press
on behalf of the Infectious Diseases Society of America. All rights
reserved. For permissions, please e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>. | |35605700
|Reproductive toxicology (Elmsford, N.Y.) |Remdesivir (RDV) is the first
antiviral drug to be approved by the US Food and Drug Administration for
the treatment of COVID-19. While the general safety of RDV has been
studied, its reproductive risk, including embryotoxicity, is largely
unknown. Here, to gain insights into its embryotoxic potential, we
investigated the effects of RDV on mouse preimplantation embryos
cultured in vitro at the concentrations comparable to the therapeutic
plasma levels. Exposure to RDV (2-8 M) did not affect the initiation of
blastocyst formation, although the maintenance of the cavity failed at 8
M due to increased cell death. While exposure to 2-4 M permitted the
cavity maintenance, expressions of developmental regulator genes
associated with the inner cell mass (ICM) lineage were significantly
diminished. Adverse effects of RDV depended on the duration and timing
of exposure, as treatment between the 8-cell to early blastocyst stage
most sensitively affected cavity expansion, gene expressions, and cell
proliferation, particularly of the ICM than the trophectoderm lineage.
GS-441524, a major metabolite of RDV, did not impair blastocyst
formation or cavity expansion, although it altered gene expressions in a
manner differently from RDV. Additionally, RDV reduced the viability of
human embryonic stem cells, which were used as a model for the human ICM
lineage, more potently than GS-441524. These findings suggest that RDV
is potentially embryotoxic to impair the pluripotent lineage, and will
be useful for designing and interpreting further in vitro and in vivo
studies on the reproductive toxicity of RDV. Copyright  2022 Elsevier
Inc.All rights reserved. | |35605371 |Journal of clinical virology :
the official publication of the Pan American Society for Clinical
Virology |NA | |35600422 |British journal of educational technology :
journal of the Council for Educational Technology |The annual
instructional virtual team Project X brings together professors and
students from across the globe to engage in client projects. The 2020
project was challenged by the global disruption of the COVID-19
pandemic. This paper draws on a quantitative dataset from a post-project
survey among 500 participating students and a qualitative narrative
inquiry of personal experiences of the faculty members. The findings
reveal how innovative use of a variety of collaboration and
communication technologies helped students and their professors in
building emotional connection and compassion to support each other in
the midst of the crisis, and to accomplish the project despite
connectivity disruptions. The results suggest that the role of an
instructor changed to a coach and mentor, and technology was used to
create a greater sense of inclusion and co-presence in student-faculty
interactions. Ultimately, the paper highlights the role of technology to
help the participants navigate sudden crisis affecting a global online
instructional team project. The adaptive instructional teaching
strategies and technologies depicted in this study offer transformative
potential for future developments in higher education.  2022 British
Educational Research Association. | |35594688 |Asian journal of
psychiatry
|<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">While the
coronavirus disease 2019 (COVID-19) pandemic has led to increased
burnout among frontline healthcare workers (HCWs), little research has
been done regarding the potential psychological burden among public
health officials who have worked tirelessly to tackle the pandemic from
an administrative perspective. This study aimed to determine the
prevalence of burnout, depression, and job-related stress in Japanese
public health officers amid the COVID-19 pandemic.
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted an
anonymous, self-administered web-based cross-sectional survey including
basic demographics, work-related questions, the Maslach Burnout
Inventory, Patient Health Questionnaire-9, Utrecht Work Engagement
Scale-3, and Brief Job Stress Questionnaire. 100 public health officers
working in the public health centers (PHCs) in Okayama, Japan, answered
the survey in December 2021 when the 5th surge in the number of COVID-19
was over. <AbstractText Label="RESULTS" NlmCategory="RESULTS">The
prevalence of burnout, depression, and job-related stress was 27%, 43%,
and 62%, respectively. The multivariate logistic analysis demonstrated
that females, public health nurses, and those who suffered from a lack
of support from their workplaces were significantly associated with
psychological distress.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">While we
tend to focus on mitigation plans to help alleviate burnout of frontline
HCWs, more focus is needed to help public health officers, and public
health nurses, in particular, to alleviate their psychological distress
and job-related stress to prevent further staff shortages and secure
sustainable health systems. Copyright  2022 Elsevier B.V. All rights
reserved. | |35584085 |PloS one |<AbstractText Label="BACKGROUND">It is
critical to capture data and modeling from the COVID-19 pandemic to
understand as much as possible and prepare for future epidemics and
possible pandemics. The Hawaiian Islands provide a unique opportunity to
study heterogeneity and demographics in a controlled environment due to
the geographically closed borders and mostly uniform pandemic-induced
governmental controls and restrictions.
<AbstractText Label="OBJECTIVE">The goal of the paper is to quantify the
differences and similarities in the spread of COVID-19 among different
Hawaiian islands as well as several other archipelago and islands, which
could potentially help us better understand the effect of differences in
social behavior and various mitigation measures. The approach should be
robust with respect to the unavoidable differences in time, as the
arrival of the virus and promptness of mitigation measures may vary
significantly among the chosen locations. At the same time, the
comparison should be able to capture differences in the overall pandemic
experience. <AbstractText Label="METHODS">We examine available data on
the daily cases, positivity rates, mobility, and employ a
compartmentalized model fitted to the daily cases to develop appropriate
comparison approaches. In particular, we focus on merge trees for the
daily cases, normalized positivity rates, and baseline transmission
rates of the models. <AbstractText Label="RESULTS">We observe noticeable
differences among different Hawaiian counties and interesting
similarities between some Hawaiian counties and other geographic
locations. The results suggest that mitigation measures should be more
localized, that is, targeting the county level rather than the state
level if the counties are reasonably insulated from one another. We also
notice that the spread of the disease is very sensitive to unexpected
events and certain changes in mitigation measures.
<AbstractText Label="CONCLUSIONS">Despite being a part of the same
archipelago and having similar protocols for mitigation measures,
different Hawaiian counties exhibit quantifiably different dynamics of
the spread of the disease. One potential explanation is that not
sufficiently targeted mitigation measures are incapable of handling
unexpected, localized outbreak events. At a larger-scale view of the
general spread of the disease on the Hawaiian island counties, we find
very interesting similarities between individual Hawaiian islands and
other archipelago and islands. | |35570918 |Frontiers in public health
|Service-learning is a high-impact educational practice at the core of
the undergraduate public health degree at the University of Hawaii at
Mnoa (UHM). This practice provides an invaluable learning experience
and professional opportunity for students to collaborate with community
partners and make significant contributions in the field. The COVID-19
pandemic halted or disrupted service-learning experiences as community
partners adapted to shifting mandates and emergency orders. Surveying
the rapidly evolving landscape of partner organizations to support
service-learning is a challenge. Assessing changes to the program
mentorship or satisfaction is the first step to developing protocols to
ensure standardization of service-learning during times of crisis. This
study will address if and how the pandemic impacted students
satisfaction with required service-learning experiences. Furthermore,
authors hope to create a comprehensive list of practicum partnering
organizations, both focused on pandemic response and, more generally, of
the service-learning students at UHM, with the intent to increase
students and community partners in local service-learning. Assessments
were conducted to assess the impact of COVID-19 on undergraduate
students experiences with service-learning through use of a program
exit survey. The authors hypothesized pandemic-related adjustments would
not affect student satisfaction or skill development. Despite challenges
associated with the pandemic and emergency online transitions, students
persisted in personal and professional growth associated with
service-learning. This developed resilience supports students as they
graduate and enter a workforce adapting to remote work demands and
community needs. Copyright  2022 Kehl, Patil, Tagorda and
Nelson-Hurwitz. | |35528753 |Hawaii journal of health &amp; social
welfare |The coronavirus disease (COVID-19) pandemic has placed
extraordinary strain on health care systems. This has led to increased
stress among health care workers, and nurses in particular, which has
had a negative impact on their physical and psychosocial wellbeing. This
is likely to negatively impact the nursing workforce at the state and
national levels as the pandemic continues. The purpose of this study was
to assess whether nurses licensed in Hawaii have considered leaving the
workforce. A cross-sectional online survey was conducted among Hawaii
nurses at all levels of licensure, with 421 responding. Of these nurses,
97 (23.0%) reported considering leaving the workforce, with safety
(39.2%) and family/caregiver strain (32.0%) being the most common
reasons. Reconsidering whether they should stay employed in their
current roles (Odds ratio [OR] 2.05; 95% CI 1.56 - 2.69) and fear to
continue providing direct patient care (OR 1.97; 95% CI 1.54 - 2.54)
were associated with increased odds of having considered leaving the
workforce. Based on these results, the State of Hawaii and local health
care organizations need to adjust their nursing workforce estimates and
address how to alleviate nurses stressors and safety concerns to
mitigate a potential workforce shortage. Research is needed to develop
interventions to support and empower nurses in their current roles but
also address future emergency preparedness. Copyright 2022 by
University Health Partners of Hawaii (UHP Hawaii). | |35528751
|Hawaii journal of health &amp; social welfare |NA | |35503921
|International journal of dermatology
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although
there is literature reporting correlations between varicella zoster
virus (VZV) infections and COVID-19, insufficient evidence exists in
this regard. This scoping review aims to identify the existing evidence
regarding clinical characteristics of primary VZV infection or
reactivation in COVID-19.
<AbstractText Label="METHODS" NlmCategory="METHODS">Following the PRISMA
Extension for Scoping Reviews, MEDLINE and EMBASE were searched for all
peer-reviewed articles with relevant keywords including Zoster,
Herpes, and COVID-19 from their inception to November 20, 2021.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 19
articles with three observational studies and 16 case reports or series
were included. Primary VZV infections or reactivation were observed in
25 patients. Forty-eight percent of the patients had disseminated VZV
infection. The median time of VZV-related rash after the onset of
respiratory symptoms was 7.0 days (interquartile range: 0-18.8). Those
with COVID-19 and primary VZV infection or reactivation had low
lymphocyte counts with a median of 0.67  103 /l.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">This scoping
review identified uncertainty and a lack of strong evidence to see the
association between primary VZV infection or reactivation and COVID-19.
However, those with COVID-19 may be more likely to have disseminated
VZV, which poses an additional challenge from an infection prevention
standpoint. Future studies are warranted to determine the association
between primary VZV infection or reactivation and long-term consequences
related to COVID-19.  2022 the International Society of Dermatology. |
|35502304 |Advances in virology
|<AbstractText Label="PURPOSE" NlmCategory="UNASSIGNED">Septic shock is
a severe complication of COVID-19 patients. We aim to identify risk
factors associated with septic shock and mortality among COVID-19
patients. <AbstractText Label="METHODS" NlmCategory="UNASSIGNED">A total
of 212 COVID-19 confirmed patients in Wuhan were included in this
retrospective study. Clinical outcomes were designated as nonseptic
shock and septic shock. Log-rank test was conducted to determine any
association with clinical progression. A prediction model was
established using random forest.
<AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">The mortality of
septic shock and nonshock patients with COVID-19 was 96.7% (29/30) and
3.8% (7/182). Patients taking hypnotics had a much lower chance to
develop septic shock (HR = 0.096, p=0.0014). By univariate logistic
regression analysis, 40 risk factors were significantly associated with
septic shock. Based on multiple regression analysis, eight risk factors
were shown to be independent risk factors and these factors were then
selected to build a model to predict septic shock with AUC = 0.956.
These eight factors included disease severity (HR = 15, p &lt; 0.001),
age &gt; 65 years (HR = 2.6, p=0.012), temperature &gt; 39.1C (HR =
2.9, p=0.047), white blood cell count &gt; 10  10 (HR = 6.9, p &lt;
0.001), neutrophil count &gt; 75  10 (HR = 2.4, p=0.022), creatine
kinase &gt; 5 U/L (HR = 1.8, p=0.042), glucose &gt; 6.1 mmol/L (HR = 7,
p &lt; 0.001), and lactate &gt; 2 mmol/L (HR = 22, p &lt; 0.001).
<AbstractText Label="CONCLUSIONS" NlmCategory="UNASSIGNED">We found 40
risk factors were significantly associated with septic shock. The model
contained eight independent factors that can accurately predict septic
shock. The administration of hypnotics could potentially reduce the
incidence of septic shock in COVID-19 patients. Copyright  2022 Shaoqiu
Chen et al.| |35495071 |Hawaii journal of health &amp; social welfare
|The Hawaii Physician Workforce project, launched in 2010, investigates
state physician workforce trends. Over the past decade, workforce
demands have continued to climb as the state struggles to maintain the
physician supply. This article describes the current state of the
physician workforce, the physician age landscape, past trends, as well
as initial changes to the physician supply with the COVID-19 pandemic.
Data on practice location, full time equivalency of time spent providing
patient care in Hawaii, and specialty of non-military physicians were
clarified and informed via survey, internet search, and direct calling
methodologies. A proprietary microsimulation modeling methodology was
used to assess physician demand. The current estimated physician
shortage is between 710 and 1,008 full time equivalents, the largest
shortage in a decade. The unmet demand for numbers of additional
physicians is greatest on the largely urban island of Oahu, however
Oahus neighboring islands have the largest shortages by percentage of
demand. In fact, Hawaii island has over a 50% shortage of physicians
for the first time since the supply has been calculated starting in
2010. Primary care has the greatest demand with a statewide shortage of
412 full time equivalents. The average age of physicians in Hawaii is
54 compared to the national average of 52. The authors estimate that
more than 52% of providers are utilizing telehealth and that 10% of
providers have retired or closed their practices since the start of the
COVID-19 pandemic. Hawaii is now in an urgent state of need for
recruitment and retention of physicians. Copyright 2022 by University
Health Partners of Hawaii (UHP Hawaii). | |35455823 |Healthcare
(Basel, Switzerland) |Since the onset of the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) pandemic, various potential targeted
therapies for SARS-CoV-2 infection have been proposed. The protective
effects of mineralocorticoid receptor antagonists (MRA) against tissue
fibrosis, pulmonary and systemic vasoconstriction, and inflammation have
been implicated in potentially attenuating the severity of SARS-CoV-2
infection by inhibiting the deleterious effects of aldosterone.
Furthermore, spironolactone, a type of MRA, has been suggested to have a
beneficial effect on SARS-CoV-2 outcomes through its dual action as an
MRA and antiandrogen, resulting in reduced transmembrane protease
receptor serine type 2 (TMPRSS2)-related viral entry to host cells. In
this study, we sought to investigate the association between MRA
antagonist therapy and mortality in SARS-CoV-2 patients via systematic
review and meta-analysis. The systematic review was performed according
to the Preferred Reporting Items for Systematic Reviews and
Meta-Analyses (PRISMA) guidelines. MEDLINE and EMBASE databases were
searched for studies that reported the incidence of mortality in
patients on MRA with SARS-CoV-2 infection. Pooled odds ratio (OR) and
95% confidence interval (CI) of the outcome were obtained using the
random-effects model. Five studies with a total of 1,388,178 subjects
(80,903 subjects receiving MRA therapy) met the inclusion criteria. We
included studies with all types of MRA therapy including spironolactone
and canrenone and found no association between MRA therapy and mortality
in SARS-CoV-2 infection (OR = 0.387, 95% CI: 0.134-1.117, p = 0.079). |
|35415617 |Hawaii journal of health &amp; social welfare |A
mixed-methods study was performed to identify the physical and emotional
needs of
Hawai<code>i health care workers during the COVID-19 pandemic, and the degree to which these needs are being met by their clinic or hospital. Qualitative interviews and demographic surveys were conducted with two cohorts of health care workers. Cohort 1 (N=15) was interviewed between July 20 - August 7, 2020, and Cohort 2 (N=16) between September 28 - October 9, 2020. A thematic analysis of the interview data was then performed. Participants&#39; primary concern was contracting the illness at work and transmitting it to their families. Solo practitioners working in outpatient clinics reported more financial challenges and greater difficulty obtaining PPE than those employed by hospitals or group practices. While telehealth visits increased for both inpatient and out-patient settings, the new visit type introduced new barriers to entry for patients. The study findings may serve to better understand the effect of COVID-19 on health care workers and support the development of hospital and clinic procedures. Further research into the impacts of COVID-19 on nurses in Hawai</code>i
is recommended. Copyright 2022 by University Health Partners of Hawaii
(UHP Hawaii). | |35405638 |The American journal of tropical medicine
and hygiene |Severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2)-associated pancytopenia is a known but rare complication of
COVID-19 syndrome that is not well described in literature. Severe acute
respiratory syndrome coronavirus 2 has shown the potential to affect any
organ including the bone marrow, which then results in a decrease in all
three blood cell lines. These cases usually resolve with the passage of
time and treatment of underlying risk factors. As COVID pneumonia rates
continue to increase worldwide, it is crucial to be able to recognize
this complication. Additionally, deeper investigation into patients
response to COVID infection can be complicated by unexpected underlying
disease. We report a case of a symptomatic 24-year-old active duty male
in Hawaii with post-COVID pancytopenia that was found to have previously
undiagnosed pernicious anemia and his response to standard treatment. |
|35399704 |Marine policy |The human response to the COVID-19 pandemic
set in motion an unprecedented shift in human activity with unknown
long-term effects. The impacts in marine systems are expected to be
highly dynamic at local and global scales. However, in comparison to
terrestrial ecosystems, we are not well-prepared to document these
changes in marine and coastal environments. The problems are two-fold:
1) manual and siloed data collection and processing, and 2) reliance on
marine professionals for observation and analysis. These problems are
relevant beyond the pandemic and are a barrier to understanding rapidly
evolving blue economies, the impacts of climate change, and the many
other changes our modern-day oceans are undergoing. The Our Ocean in
COVID-19 project, which aims to track human-ocean interactions
throughout the pandemic, uses the new eOceans platform (eOceans.app) to
overcome these barriers. Working at local scales, a global network of
ocean scientists and citizen scientists are collaborating to monitor the
ocean in near real-time. The purpose of this paper is to bring this
project to the attention of the marine conservation community,
researchers, and the public wanting to track changes in their area. As
our team continues to grow, this project will provide important
baselines and temporal patterns for ocean conservation, policy, and
innovation as society transitions towards a new normal. It may also
provide a proof-of-concept for real-time, collaborative ocean monitoring
that breaks down silos between academia, government, and at-sea
stakeholders to create a stronger and more democratic blue economy with
communities more resilient to ocean and global change.  2022 Elsevier
Ltd.All rights reserved. | |35382257 |Climate dynamics
|<AbstractText Label="UNLABELLED">Anthropogenic emissions decreased
dramatically during the COVID-19 pandemic, but its possible effect on
monsoon is unclear. Based on coupled models participating in the COVID
Model Intercomparison Project (COVID-MIP), we show modeling evidence
that the East Asian summer monsoon (EASM) is enhanced by 2.2% in terms
of precipitation and by 5.4% in terms of the southerly wind at lower
troposphere, and the amplitude of the forced response reaches about 1/3
of the standard deviation for interannual variability. The enhanced EASM
during COVID-19 pandemic is a fast response to reduced aerosols, which
is confirmed by the simulated response to the removal of all
anthropogenic aerosols. The observational evidence, i.e., the
anomalously strong EASM observed in 2020 and 2021, also supports the
simulated enhancement of EASM. The essential mechanism for the enhanced
EASM in response to COVID-19 is the enhanced zonal thermal contrast
between Asian continent and the western North Pacific in the
troposphere, due to the reduced aerosol concentration over Asian
continent and the associated latent heating feedback. As the enhancement
of EASM is a fast response to the reduction in aerosols, the effect of
COVID-19 on EASM dampens soon after the rebound of emissions based on
the models participating in COVID-MIP.
<AbstractText Label="SUPPLEMENTARY INFORMATION" NlmCategory="UNASSIGNED">The
online version contains supplementary material available at
10.1007/s00382-022-06247-8.  The Author(s), under exclusive licence to
Springer-Verlag GmbH Germany, part of Springer Nature 2022. | |35382073
|Innovations in clinical neuroscience |The authors explore the impact of
cumulative stress on United States (US) military service members (SM),
including soldiers and medical personnel, deployed to serve in New York
City (NYC) communities. Their mission was to assist in establishing
emergency field hospitals during the COVID-19 pandemic. Causative
biopsychosocial factors are presented, as well as the impact of wellness
checks, which were utilized to monitor the mood and morale of frontline
healthcare providers, military personnel, and infected patients in a
2,500-bed emergency field hospital and a 1,000-bed Naval hospital ship
operating in the metropolitan NYC area. The authors introduce a
self-care and wellness tool, which assesses five core domains (physical,
mental, emotional, social, and spiritual) for the purpose of assessing
and improving individual overall well-being during periods of heightened
stress. This instrument could aid attending medical personnel in
identifying patients at risk of suicide. Likewise, the utility of this
self-care tool is applicable to both military SM and civilians, and
includes soldiers and medical personnel. Copyright  2022. Matrix
Medical Communications. All rights reserved. | |35379351 |Womens
midlife health
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The COVID-19
pandemic presented challenges that disproportionately impacted women.
Household roles typically performed by women (such as resource
acquisition and caretaking) became more difficult due to financial
strain, fear of infection, and limited childcare options among other
concerns. This research draws from an on-going study of hot flashes and
brown adipose tissue to examine the health-related effects of the
COVID-19 pandemic among 162 women aged 45-55 living in western
Massachusetts. <AbstractText Label="METHODS" NlmCategory="METHODS">We
compared women who participated in the study pre- and early pandemic
with women who participated mid-pandemic and later-pandemic (when
vaccines became widely available). We collected self-reported symptom
frequencies (e.g., aches/stiffness in joints, irritability), and
assessments of stress, depression, and physical activity through
questionnaires as well as measures of adiposity (BMI and percent body
fat). Additionally, we asked open-ended questions about how the pandemic
influenced womens health and experience of menopause. Comparisons
across pre-/early, mid-, and later pandemic categories were carried out
using ANOVA and Chi-square analyses as appropriate. The Levene test for
homogeneity of variances was examined prior to each ANOVA. Open-ended
questions were analyzed for yes/no responses and general themes.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Contrary to our
hypothesis that women would suffer negative health-related consequences
during the COVID-19 pandemic, we found no significant differences in
womens health-related measures or physical activity across the
pandemic. However, our analysis of open-ended responses revealed a
bi-modal distribution of answers that sheds light on our unexpected
findings. While some women reported higher levels of stress and anxiety
and lower levels of physical activity, other women reported benefitting
from the remote life that the pandemic imposed and described having more
time to spend on physical activity or in quality time with their
families. <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">In
this cross-sectional comparison of women during the pre-/early, mid-,
and later-pandemic, we found no significant differences across means in
multiple health-related variables. However, open-ended questions
revealed that while some women suffered health-related effects during
the pandemic, others experienced conditions that improved their health
and well-being. The differential results of this study highlight a need
for more nuanced and intersectional research on risk, vulnerabilities,
and coping among mid-life women.  2022. The Author(s). | |35370509
|American journal of lifestyle medicine |Chronic health conditions
related to diet are linked with increased risk for COVID-19 infection,
complications, and mortality. Adherence to a healthy diet pattern can be
protective, but a major barrier to healthy eating is the high cost of
healthy foods. Access to healthy foods is especially limited in
households that experience food insecurity, not having enough food or
resources to get food. Individuals who live in these households are also
at increased risk for a number of health conditions. Addressing food
insecurity within lifestyle medicine practice is needed to achieve
optimal nutrition status. Emerging food as medicine and other food
access programs are promising but coverage of such programs is lacking
through healthcare insurers. Medicaid waivers are a potential solution
and have been utilized in a handful of states. Copyright  2022 The
Author(s). | |35358349 |Public health nursing (Boston, Mass.)
|<AbstractText Label="OBJECTIVE">The COVID-19 pandemic has resulted in
major disruption to economic, health, education, and social systems.
Families with preschool children experienced extraordinary strain during
this time. This paper describes a qualitative study examining the
experience of parents of preschool children in Hawaii during the
COVID-19 pandemic. <AbstractText Label="SAMPLE">Thirteen (N = 13)
parents of preschool children living on the island of Oahu, Hawaii,
participated in small group discussions occurring in February and March
2021, approximately 1 year after the start of the pandemic in the state.
Discussion transcripts were coded and sorted into themes.
<AbstractText Label="RESULTS">Four themes emerged: stressors due to the
COVID-19 pandemic, family coping and resources, meaning of the COVID-19
crisis to the family, and family adaptation patterns. Themes mapped to
the Family Adjustment and Adaptation Response model.
<AbstractText Label="CONCLUSION">Families relied on various resources to
cope with stressors experienced due to the COVID-19 pandemic, and
adopted new patterns related to seeking healthcare and household
emergency preparedness. Findings may inform policies and interventions
to support families during the ongoing COVID-19 pandemic and future
public health emergencies.  2022 Wiley Periodicals LLC. | |35320122
|Academic medicine : journal of the Association of American Medical
Colleges |Asian American, Native Hawaiian, and Pacific Islander (AANHPI)
populations are growing rapidly in the United States, yet AANHPIs remain
understudied, overlooked, and misunderstood. During the COVID-19
pandemic, themes from the tragic history of anti-Asian bias and
marginalization have resurfaced in a surge of renewed bigotry and
xenophobic violence against AANHPIs. In this commentary, the authors
discuss the role of medical schools in combating anti-Asian sentiment as
an important step toward achieving health equity. Based on their
collective expertise in health disparities research, medical education,
and policy, they offer suggestions about how to disrupt the pattern of
invisibility and exclusion faced by AANHPI populations. They consider
ways that representative data, leadership in medical education, research
funding, national policies, and broad partnerships can help address
AANHPI health disparities. Copyright  2022 by the Association of
American Medical Colleges. | |35311911 |JAMA internal medicine
|<AbstractText Label="IMPORTANCE">Screening for medication abortion
eligibility typically includes ultrasonography or pelvic examination. To
reduce physical contact during the COVID-19 pandemic, many clinicians
stopped requiring tests before medication abortion and instead screened
patients for pregnancy duration and ectopic pregnancy risk by history
alone. However, few US-based studies have been conducted on the outcomes
and safety of this novel model of care.
<AbstractText Label="OBJECTIVE">To evaluate the outcomes and safety of a
history-based screening, no-test approach to medication abortion care.
<AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">This
retrospective cohort study included patients obtaining a medication
abortion without preabortion ultrasonography or pelvic examination
between February 1, 2020, and January 31, 2021, at 14 independent,
Planned Parenthood, academic-affiliated, and online-only clinics
throughout the US. <AbstractText Label="EXPOSURES">Medications for
abortion provided without preabortion ultrasonography or pelvic
examination and dispensed to patients in person or by mail.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Effectiveness, defined
as complete abortion after 200 g of mifepristone and up to 1600 g of
misoprostol without additional intervention, and major abortion-related
adverse events, defined as hospital admission, major surgery, or blood
transfusion. <AbstractText Label="RESULTS">The study included data on
3779 patients with eligible abortions. The study participants were
racially and ethnically diverse and included 870 (23.0%) Black patients,
533 (14.1%) Latinx/Hispanic patients, 1623 (42.9%) White patients, and
327 (8.7%) who identified as multiracial or with other racial or ethnic
groups. For most (2626 [69.5%]), it was their first medication abortion.
Patients lived in 34 states, and 2785 (73.7%) lived in urban areas. In
2511 (66.4%) abortions, the medications were dispensed in person; in the
other 1268 (33.6%), they were mailed to the patient. Follow-up data were
obtained for 2825 abortions (74.8%), and multiple imputation was used to
account for missing data. Across the sample, 12 abortions (0.54%; 95%
CI, 0.18%-0.90%) were followed by major abortion-related adverse events,
and 4 patients (0.22%; 95% CI, 0.00%-0.45%) were treated for ectopic
pregnancies. Follow-up identified 9 (0.40%; 95% CI, 0.00%-0.84%)
patients who had pregnancy durations of greater than 70 days on the date
the mifepristone was dispensed that were not identified at screening.
The adjusted effectiveness rate was 94.8% (95% CI, 93.6%-95.9%).
Effectiveness was similar when medications were dispensed in person
(95.4%; 95% CI, 94.1%-96.7%) or mailed (93.3%; 95% CI, 90.7%-95.9%).
<AbstractText Label="CONCLUSIONS AND RELEVANCE">In this cohort study,
screening for medication abortion eligibility by history alone was
effective and safe with either in-person dispensing or mailing of
medications, resulting in outcomes similar to published rates of models
involving ultrasonography or pelvic examination. This approach may
facilitate more equitable access to this essential service by increasing
the types of clinicians and locations offering abortion care. |
|35296505 |BMJ (Clinical research ed.) |NA | |35273936 |Frontiers in
public health |Native Hawaiians are proud and resilient people who have
endured significant impacts from colonization. Despite being in a time
of vibrant cultural revitalization, Native Hawaiians have a shorter life
expectancy than other racial and ethnic groups in Hawaii. The primary
aim of this paper was to share data from the first year of a 5-year
study with Native Hawaiian kpuna (elders) on their experiences with
healthcare, along with barriers to accessing healthcare. Ten kpuna
living in rural areas of Hawaii participated in three interviews each,
which were held in an informal, talk-story style. The first interview
focused on establishing rapport. The second interview focused on the
kpunas strengths, resiliencies, and what they would like to pass to
the next generation. The third interview focused on the elders
experiences with healthcare, which is the focus of this paper. All ten
kpuna reported growing up with limited access to Western healthcare;
rather, their families successfully treated many illnesses and injuries
with lau lapaau (Hawaiian herbal medicine) and other traditional
healing practices, as they had done for generations. As Western medicine
became more prevalent and accessible, they used both, but many preferred
holistic treatments such as prayer, a return to the traditional diet,
and lau lapaau. As a group, the kpuna rated their health as fair to
good; two had diabetes, two had cardiovascular disease, four had
neuropathies, and five were cancer survivors. The kpuna reported high
turnover among providers in rural communities. Limited access to
specialists often required them to travel to Honolulu for care, which
was costly and especially difficult during coronavirus disease 2019
(COVID-19). Regardless of provider ethnicity, the kpuna appreciated
those who took the time to get to know them as people and respected
Hawaiian cultural practices. They advised that Western providers speak
honestly and directly, have compassion, and build connections to
patients and their communities. Copyright  2022 Kawakami, Muneoka,
Burrage, Tanoue, Haitsuka and Braun. | |35263081 |ACS infectious
diseases |FDA-approved and emergency use-authorized vaccines using new
mRNA and viral-vector technology are highly effective in preventing
moderate to severe disease; however, information on their long-term
efficacy and protective breadth against severe acute respiratory
syndrome coronavirus 2 variants of concern (VOCs) is currently scarce.
Here, we describe the durability and broad-spectrum VOC immunity of a
prefusion-stabilized spike (S) protein adjuvanted with liquid or
lyophilized CoVaccine HT in cynomolgus macaques. This recombinant
subunit vaccine is highly immunogenic and induces robust spike-specific
and broadly neutralizing antibody responses effective against
circulating VOCs (B.1.351 [Beta], P.1 [Gamma], and B.1.617 [Delta]) for
at least three months after the final boost. Protective efficacy and
postexposure immunity were evaluated using a heterologous P.1 challenge
nearly three months after the last immunization. Our results indicate
that while immunization with both high and low S doses shorten and
reduce viral loads in the upper and lower respiratory tract, a higher
antigen dose is required to provide durable protection against disease
as vaccine immunity wanes. Histologically, P.1 infection causes similar
COVID-19-like lung pathology as seen with early pandemic isolates.
Postchallenge IgG concentrations were restored to peak immunity levels,
and vaccine-matched and cross-variant neutralizing antibodies were
significantly elevated in immunized macaques indicating an efficient
anamnestic response. Only low levels of P.1-specific neutralizing
antibodies with limited breadth were observed in control (nonvaccinated
but challenged) macaques, suggesting that natural infection may not
prevent reinfection by other VOCs. Overall, these results demonstrate
that a properly dosed and adjuvanted recombinant subunit vaccine can
provide protective immunity against circulating VOCs for at least three
months. | |35252592 |Wellcome open research |Background: Industrialised
countries had varied responses to the COVID-19 pandemic, which may lead
to different death tolls from COVID-19 and other diseases. Methods: We
applied an ensemble of 16 Bayesian probabilistic models to vital
statistics data to estimate the number of weekly deaths if the pandemic
had not occurred for 40 industrialised countries and US states from
mid-February 2020 through mid-February 2021. We subtracted these
estimates from the actual number of deaths to calculate the impacts of
the pandemic on all-cause mortality. Results: Over this year, there were
1,410,300 (95% credible interval 1,267,600-1,579,200) excess deaths in
these countries, equivalent to a 15% (14-17) increase, and 141 (127-158)
additional deaths per 100,000 people. In Iceland, Australia and New
Zealand, mortality was lower than would be expected in the absence of
the pandemic, while South Korea and Norway experienced no detectable
change. The USA, Czechia, Slovakia and Poland experienced &gt;20% higher
mortality. Within the USA, Hawaii experienced no detectable change in
mortality and Maine a 5% increase, contrasting with New Jersey, Arizona,
Mississippi, Texas, California, Louisiana and New York which experienced
&gt;25% higher mortality. Mid-February to the end of May 2020 accounted
for over half of excess deaths in Scotland, Spain, England and Wales,
Canada, Sweden, Belgium, the Netherlands and Cyprus, whereas
mid-September 2020 to mid-February 2021 accounted for &gt;90% of excess
deaths in Bulgaria, Croatia, Czechia, Hungary, Latvia, Montenegro,
Poland, Slovakia and Slovenia. In USA, excess deaths in the northeast
were driven mainly by the first wave, in southern and southwestern
states by the summer wave, and in the northern plains by the
post-September period. Conclusions: Prior to widespread vaccine-acquired
immunity, minimising the overall death toll of the pandemic requires
policies and non-pharmaceutical interventions that delay and reduce
infections, effective treatments for infected patients, and mechanisms
to continue routine health care. Copyright:  2022 Kontis V et al.|
|35182433 |Pacing and clinical electrophysiology : PACE |COVID-19 has
recently been associated with the development of bradyarrhythmias,
although its mechanism is still unclear. We aim to summarize the
existing evidence regarding bradyarrhythmia in COVID-19 and provide
future directions for research. Following the PRISMA Extension for
Scoping Reviews, we searched MEDLINE and EMBASE for all peer-reviewed
articles using keywords includingBradycardia, atrioventricular
block, and COVID-19 from their inception to October 13, 2021.
Forty-three articles, including 11 observational studies and 59 cases
from case reports and series, were included in the systematic review.
Although some observational studies reported increased mortality in
those with bradyarrhythmia and COVID-19, the lack of comparative groups
and small sample sizes hinder the ability to draw definitive
conclusions. Among 59 COVID-19 patients with bradycardia from case
reports and series, bradycardia most often occurred in those with severe
or critical COVID-19, and complete heart block occurred in the majority
of cases despite preserved LVEF (55.9%). Pacemaker insertion was
required in 76.3% of the patients, most of which were permanent implants
(45.8%). This systematic review summarizes the current evidence and
characteristics of bradyarrhythmia in patients with COVID-19. Further
studies are critical to assess the reversibility of bradyarrhythmia in
COVID-19 patients and to clarify potential therapeutic targets including
the need for permanent pacing.  2022 Wiley Periodicals LLC. | |35179422
|AIDS care |City lockdown is critical to successfully contain the
COVID-19 pandemic. The impact of lockdown and COVID-19 pandemic on
healthcare among vulnerable population has yet to be explicated. A
cross-sectional survey was conducted among HIV-infected men who have sex
with men (MSM) in Wuhan with city lockdown and Shanghai without
lockdown, and healthcare interruptions were evaluated and compared. A
logistic regression analysis was employed to examine associates of
HIV-related healthcare interruptions and compromised mental health.
Compared to participants in Shanghai (N = 440), HIV-infected MSM in
Wuhan (N = 503) had significantly higher proportion of untimely
availability of antiretroviral drugs (ARVs) (20.6% vs.8.4%), obtaining
ARVs from outside institutions (29.1% vs.8.1%), postponed non-AIDS
treatment (6.4% vs.2.8%) and untimely follow-up appointments (33.4%
vs.14.5%). HIV-related healthcare interruptions were positively
associated with lockdown (OR = 4.89, 95% CI: 3.49-6.85) and non-local
residence (OR = 1.91, 95% CI: 1.37-2.64). Compromised mental health,
including insomnia and generalized anxiety disorders, was associated
with non-local residence (OR = 1.35, 95% CI: 1.01-1.81) and healthcare
interruptions (OR = 1.34, 95% CI: 1.01-1.79). HIV-infected MSM are
vulnerable to healthcare interruptions and mental health problems during
the COVID-19 pandemic, underscoring the need for tailored intervention
strategies to minimize deleterious health consequences. | |35156056
|Hawaii journal of health &amp; social welfare |NA | |35146208
|American journal of ophthalmology case reports
|<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Optic
capture of sutured scleral fixated posterior chamber intraocular lenses
(PC IOLs) is an occasional complication resulting in blurred vision and
discomfort. <AbstractText Label="METHODS" NlmCategory="METHODS">A
retrospective study of the management of 18 eyes (3.6%) with optic
capture out of 495 eyes with scleral fixated IOLs during the study
period. 54 procedures were performed in the management of optic capture
of sutured scleral fixated PC IOLs. An in-office technique was utilized
to relieve the optic capture by repositioning the optic posterior to the
iris. This technique was performed after topical anesthesia and topical
5% betadine with the patient stably positioned at the slit lamp. Using a
30-gauge needle, sometimes after a 15-degree paracentesis blade, the
needle was advanced in a parallel plane above the iris until the tip
reached the edge of the captured optic. The optic is engaged in the
inferior periphery away from the central visual axis, and pushed gently
posteriorly just enough to reposition the optic posterior to the iris.
In some cases, pilocarpine 2% drops were utilized after the procedure to
decrease the risk of recapture of the optic.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">All 54 procedures
were successfully performed in the office without significant pain or
discomfort. Vision before optic capture, during optic capture, and at
the first office visit after optic capture were comparable. There were
not any cases of endophthalmitis, hyphema, iris trauma, iris prolapse or
keratitis. While eight patients only had one episode of optic capture,
10 patients had multiple episodes of optic capture, all managed with
this in office procedure. Recurrent optic capture occurred more
frequently in eyes with fixation at less than 2 mm from the limbus than
eyes with scleral fixation at 2 mm from the limbus.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Reposition of
the optic after pupillary capture of a scleral fixated PC IOL can be
successfully performed in the office without discomfort or significant
complications and is an alternative management option to a return to the
operating room. This procedure may be especially important when there is
poor access to the operating room or restricted access to the operating
room as during the COVID19 pandemic.  2022 Published by Elsevier Inc.|
|35142835 |JAMA network open |This cross-sectional study analyzes the
association between vaccination rates and COVID-19 incidence by county
from July to August 2021. | |35141345 |Open forum infectious diseases
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Nasopharyngeal
(NP) swabs are the standard for SARS-CoV-2 diagnosis. If less invasive
alternatives to NP swabs (eg, oropharyngeal [OP] or nasal swabs [NS])
are comparably sensitive, the use of these techniques may be preferable
in terms of comfort, convenience, and safety.
<AbstractText Label="METHODS" NlmCategory="METHODS">This study compared
the detection of SARS-CoV-2 in swab samples collected on the same day
among participants with at least one positive PCR test.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Overall, 755
participants had at least one set of paired swabs. Concordance between
NP and other swab types was 75% (NS), 72% (OP), 54% (rectal swabs [RS]),
and 78% (NS/OP combined). Kappa values were moderate for the NS, OP, and
NS/OP comparisons (0.50, 0.45, and 0.54, respectively). Highest
sensitivity relative to NP (0.87) was observed with a combination of
NS/OP tests (positive if either NS or OP was positive). Sensitivity of
the non-NP swab types was highest in the first week postsymptom onset
and decreased thereafter. Similarly, virus RNA quantity was highest in
the NP swabs as compared with NS, OP, and RS within two weeks
postsymptom onset. OP and NS performance decreased as virus RNA quantity
decreased. No differences were noted between NS specimens collected at
home or in clinic.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NP swabs
detected more SARS-CoV-2 cases than non-NP swabs, and the sensitivity of
the non-NP swabs decreased with time postsymptom onset. While other
swabs may be simpler to collect, NP swabs present the best chance of
detecting SARS-CoV-2 RNA, which is essential for clinical care as well
as genomic surveillance. Published by Oxford University Press on behalf
of Infectious Diseases Society of America 2021. | |35123100 |The journal
of allergy and clinical immunology. In practice |NA | |35120186 |PloS
one |Health inequalities based on race are well-documented, and the
COVID-19 pandemic is no exception. Despite the advances in modern
medicine, access to health care remains a primary determinant of health
outcomes, especially for communities of color. African-Americans and
other minorities are disproportionately at risk for infection with
COVID-19, but this problem extends beyond access alone. This study
sought to identify trends in race-based disparities in COVID-19 in the
setting of universal access to care. Tripler Army Medical Center (TAMC)
is a Department of Defense Military Treatment Facility (DoD-MTF) that
provides full access to healthcare to active duty military members,
beneficiaries, and veterans. We evaluated the characteristics of
individuals diagnosed with SARS-CoV-2 infection at TAMC in a
retrospective, case-controlled (1:1) study. Most patients (69%) had
received a COVID-19 test within 3 days of symptom onset. Multivariable
logistic regression analyses were used to identify factors associated
with testing positive and to estimate adjusted odds ratios.
African-American patients and patients who identified asOther
ethnicities were two times more likely to test positive for SARS-CoV-2
relative to Caucasian patients. Other factors associated with testing
positive include: younger age, male gender, previous positive test,
presenting with &gt;3 symptoms, close contact with a COVID-19 positive
patient, and being a member of the US Navy. African-Americans and
patients who identify as Other ethnicities had disproportionately
higher rates of positivity of COVID-19. Although other factors
contribute to increased test positivity across all patient populations,
access to care does not appear to itself explain this discrepancy with
COVID-19. | |35111349 |Forensic sciences research |NA | |35100194
|Critical care medicine |<AbstractText Label="OBJECTIVES">Body
temperature trajectories of infected patients are associated with
specific immune profiles and survival. We determined the association
between temperature trajectories and distinct manifestations of
coronavirus disease 2019. <AbstractText Label="DESIGN">Retrospective
observational study. <AbstractText Label="SETTING">Four hospitals within
an academic healthcare system from March 2020 to February 2021.
<AbstractText Label="PATIENTS">All adult patients hospitalized with
coronavirus disease 2019. <AbstractText Label="INTERVENTIONS">Using a
validated group-based trajectory model, we classified patients into four
previously defined temperature trajectory subphenotypes using oral
temperature measurements from the first 72 hours of hospitalization.
Clinical characteristics, biomarkers, and outcomes were compared between
subphenotypes. <AbstractText Label="MEASUREMENTS AND MAIN RESULTS">The
5,903 hospitalized coronavirus disease 2019 patients were classified
into four subphenotypes: hyperthermic slow resolvers (n = 1,452, 25%),
hyperthermic fast resolvers (1,469, 25%), normothermics (2,126, 36%),
and hypothermics (856, 15%). Hypothermics had abnormal coagulation
markers, with the highest d-dimer and fibrin monomers (p &lt; 0.001) and
the highest prevalence of cerebrovascular accidents (10%, p = 0.001).
The prevalence of venous thromboembolism was significantly different
between subphenotypes (p = 0.005), with the highest rate in hypothermics
(8.5%) and lowest in hyperthermic slow resolvers (5.1%). Hyperthermic
slow resolvers had abnormal inflammatory markers, with the highest
C-reactive protein, ferritin, and interleukin-6 (p &lt; 0.001).
Hyperthermic slow resolvers had increased odds of mechanical
ventilation, vasopressors, and 30-day inpatient mortality (odds ratio,
1.58; 95% CI, 1.13-2.19) compared with hyperthermic fast resolvers. Over
the course of the pandemic, we observed a drastic decrease in the
prevalence of hyperthermic slow resolvers, from representing 53% of
admissions in March 2020 to less than 15% by 2021. We found that
dexamethasone use was associated with significant reduction in
probability of hyperthermic slow resolvers membership (27% reduction;
95% CI, 23-31%; p &lt; 0.001).
<AbstractText Label="CONCLUSIONS">Hypothermics had abnormal coagulation
markers, suggesting a hypercoagulable subphenotype. Hyperthermic slow
resolvers had elevated inflammatory markers and the highest odds of
mortality, suggesting a hyperinflammatory subphenotype. Future work
should investigate whether temperature subphenotypes benefit from
targeted antithrombotic and anti-inflammatory strategies. Copyright 
2022 by the Society of Critical Care Medicine and Wolters Kluwer Health,
Inc.All Rights Reserved. | |35089919 |PloS one
|<AbstractText Label="BACKGROUND">Racial inequities in Coronavirus 2019
(COVID-19) have been reported over the course of the pandemic, with
Black, Hispanic/Latinx, and Native American individuals suffering higher
case rates and more fatalities than their White counterparts.
<AbstractText Label="METHODS">We used a unique statewide dataset of
confirmed COVID-19 cases across Missouri, linked with historical
statewide hospital data. We examined differences by race and ethnicity
in raw population-based case and mortality rates. We used patient-level
regression analyses to calculate the odds of mortality based on race and
ethnicity, controlling for comorbidities and other risk factors.
<AbstractText Label="RESULTS">As of September 10, 2020 there were 73,635
confirmed COVID-19 cases in the State of Missouri. Among the 64,526 case
records (87.7% of all cases) that merged with prior demographic and
health care utilization data, 12,946 (20.1%) were Non-Hispanic (NH)
Black, 44,550 (69.0%) were NH White, 3,822 (5.9%) were NH Other/Unknown
race, and 3,208 (5.0%) were Hispanic. Raw cumulative case rates for NH
Black individuals were 1,713 per 100,000 population, compared with 2,095
for NH Other/Unknown, 903 for NH White, and 1,218 for Hispanic.
Cumulative COVID-19-related death rates for NH Black individuals were
58.3 per 100,000 population, compared with 38.9 for NH Other/Unknown,
19.4 for NH White, and 14.8 for Hispanic. In a model that included
insurance source, history of a social determinant billing code in the
patients claims, census block travel change, population density, Area
Deprivation Index, and clinical comorbidities, NH Black race (OR 1.75,
1.51-2.04, p&lt;0.001) and NH Other/Unknown race (OR 1.83, 1.36-2.46,
p&lt;0.001) remained strongly associated with mortality.
<AbstractText Label="CONCLUSIONS">In Missouri, COVID-19 case rates and
mortality rates were markedly higher among NH Black and NH Other/Unknown
race than among NH White residents, even after accounting for social and
clinical risk, population density, and travel patterns during COVID-19.
| |35076582 |Neurology international |In the approximately two years
since the emergence of COVID-19 (Coronavirus Disease 2019) myriad
neurological symptoms have been reported that are seemingly unrelated to
each other []. | |35059075 |Journal of clinical medicine research |As
the coronavirus disease 2019 (COVID-19) pandemic is still underway, a
range of clinical presentations and pathologies continue to present
themselves in unexpected ways. One such pathology is that of epiploic
appendagitis, an uncommon and underdiagnosed cause of acute abdominal
pain. We present the case of a 50-something-year-old male who presented
with left lower quadrant abdominal pain in the setting of acute COVID-19
infection, found to have acute epiploic appendagitis. After persistent
moderate to severe abdominal pain, epiploic appendagitis was diagnosed
by computed tomography (CT) imaging findings. The patient was managed
for his COVID-19 pneumonia over the course of his hospitalization, as
well as conservatively managed with pain control measures for his
epiploic appendagitis. This is the second reported case in the
literature to the best of our knowledge that shares the case of acute
epiploic appendagitis in a patient presenting with acute abdominal pain,
who is also found to be COVID-19-positive. Procoagulant changes in
coagulation pathways are found in patients with severe COVID-19, and
contribute to venous thromboembolism in this patient population.
Diagnosing and conservatively managing epiploic appendagitis will lead
to decreasing misdiagnosis, preventing invasive or inappropriate
treatments that may increase harm to patients, and more adequately
understanding the complications associated with COVID-19. Copyright
2021, Kaakour et al.| |35047039 |International journal of endocrinology
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Type 2
diabetes (T2D) as a worldwide chronic disease combined with the COVID-19
pandemic prompts the need for improving the management of hospitalized
COVID-19 patients with preexisting T2D to reduce complications and the
risk of death. This study aimed to identify clinical factors associated
with COVID-19 outcomes specifically targeted at T2D patients and build
an individualized risk prediction nomogram for risk stratification and
early clinical intervention to reduce mortality.
<AbstractText Label="METHODS" NlmCategory="METHODS">In this
retrospective study, the clinical characteristics of 382 confirmed
COVID-19 patients, consisting of 108 with and 274 without preexisting
T2D, from January 8 to March 7, 2020, in Tianyou Hospital in Wuhan,
China, were collected and analyzed. Univariate and multivariate Cox
regression models were performed to identify specific clinical factors
associated with mortality of COVID-19 patients with T2D. An
individualized risk prediction nomogram was developed and evaluated by
discrimination and calibration.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Nearly 15% (16/108)
of hospitalized COVID-19 patients with T2D died. Twelve risk factors
predictive of mortality were identified. Older age (HR = 1.076, 95% CI =
1.014-1.143, p=0.016), elevated glucose level (HR = 1.153, 95% CI =
1.038-1.28, p=0.0079), increased serum amyloid A (SAA) (HR = 1.007, 95%
CI = 1.001-1.014, p=0.022), diabetes treatment with only oral diabetes
medication (HR = 0.152, 95%CI = 0.032-0.73, p=0.0036), and oral
medication plus insulin (HR = 0.095, 95%CI = 0.019-0.462, p=0.019) were
independent prognostic factors. A nomogram based on these prognostic
factors was built for early prediction of 7-day, 14-day, and 21-day
survival of diabetes patients. High concordance index (C-index) was
achieved, and the calibration curves showed the model had good
prediction ability within three weeks of COVID-19 onset.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">By
incorporating specific prognostic factors, this study provided a
user-friendly graphical risk prediction tool for clinicians to quickly
identify high-risk T2D patients hospitalized for COVID-19. Copyright 
2022 Yuanyuan Fu et al.| |35028589 |Hawaii journal of health &amp;
social welfare |In March 2020, Hawaii instituted public health measures
to prevent the spread of Coronavirus disease 2019 (COVID-19), including
stay-at-home orders, closure of non-essential businesses and parks, use
of facial coverings, social distancing, and a mandatory 14-day
quarantine for travelers. In response to these measures, Hawaii Pacific
Neuroscience (HPN) modified practice processes to ensure continuity of
neurological treatment. A survey of patients was performed to assess the
impact of the COVID-19 pandemic and pandemic-related practice processes
for quality improvement. Overall, 367 patients seen at HPN between April
22, 2020, and May 18, 2020, were surveyed via telephone. Almost half
(49.6%) participated in a telemedicine appointment, with the majority
finding it easy to use (87.4%) and as valuable as face-to-face
appointments (68.7%). Many (44.5%) patients said they would have missed
a health care appointment without the availability of telemedicine, and
47.3% indicated they might prefer to use telemedicine over in-person
appointments in the future. Many reported new or worsening mental health
problems, including depression (27.6%), anxiety (38.3%), or sleep
disturbances (37.4%). A significant number reported worsening of their
condition, with 33.1% of patients who experience migraines reporting
increased symptom severity or frequency, 45.8% patients with Alzheimers
disease reporting worsened symptoms, 38.5% of patients with Parkinsons
disease who had a recent fall, and 50.0% of patients with multiple
sclerosis experiencing new or worsened symptoms. Insights from this
survey applied to the practices pandemic-related processes include
emphasizing lifestyle modification, screening for changes in mental
health, optimizing treatment plans, and continuing the option of
telemedicine. Copyright 2022 by University Health Partners of Hawaii
(UHP Hawaii). | |35027873 |Journal of biomolecular techniques : JBT
|Controlling the course of the Coronavirus Disease 2019 (COVID-19)
pandemic will require widespread deployment of consistent and accurate
diagnostic testing of the novel Severe Acute Respiratory Syndrome
Coronavirus 2 (SARS-CoV-2). Ideally, tests should detect a minimum viral
load, be minimally invasive, and provide a rapid and simple readout.
Current Food and Drug Administration (FDA)-approved RT-qPCR-based
standard diagnostic approaches require invasive nasopharyngeal swabs and
involve laboratory-based analyses that can delay results. Recently, a
loop-mediated isothermal nucleic acid amplification (LAMP) test that
utilizes colorimetric readout received FDA approval. This approach
utilizes a pH indicator dye to detect drop in pH from nucleotide
hydrolysis during nucleic acid amplification. This method has only been
approved for use with RNA extracted from clinical specimens collected
via nasopharyngeal swabs. In this study, we developed a quantitative
LAMP-based strategy to detect SARS-CoV-2 RNA in saliva. Our detection
system distinguished positive from negative sample types using a
handheld instrument that monitors optical changes throughout the LAMP
reaction. We used this system in a streamlined LAMP testing protocol
that could be completed in less than 2 h to directly detect inactivated
SARS-CoV-2 in minimally processed saliva that bypassed RNA extraction,
with a limit of detection (LOD) of 50 genomes/reaction. The quantitative
method correctly detected virus in 100% of contrived clinical samples
spiked with inactivated SARS-CoV-2 at either 1 (50 genomes/reaction) or
2 (100 genomes/reaction) of the LOD. Importantly, the quantitative
method was based on dynamic optical changes during the reaction and was
able to correctly classify samples that were misclassified by endpoint
observation of color.  2021 ABRF. | |35023402 |The science of diabetes
self-management and care |<AbstractText Label="PURPOSE">The purpose of
the study was to explore experiences of Marshallese adults related to
diabetes self-care behaviors during the COVID-19 pandemic.
<AbstractText Label="METHODS">A qualitative descriptive design was
utilized to understand participants diabetes self-care behaviors during
the pandemic. Nine focus groups with 53 participants were held via
videoconference and conducted in English, Marshallese, or a mixture of
both languages. A priori codes based on diabetes self-care behaviors
provided a framework for analyzing and summarizing participant
experiences. <AbstractText Label="RESULTS">Both increases and decreases
in healthy eating and exercise were described, with improvements in
health behaviors attributed to health education messaging via social
media. Participants reported increased stress and difficulty monitoring
and managing glucose. Difficulty obtaining medication and difficulty
seeing their health care provider regularly was reported and attributed
to health care provider availability and lack of insurance due to job
loss. <AbstractText Label="CONCLUSIONS">The study provides significant
insight into the reach of health education campaigns via social media
and provides important information about the reasons for delays in care,
which extend beyond fear of contracting COVID-19 to structural issues. |
|34967845 |JAMA |This study assesses hip fracture surgery volumes among
older individuals in California during the pandemic compared with
prepandemic rates. | |34946336 |Healthcare (Basel, Switzerland) |Due to
the unprecedented COVID-19 pandemic, there may be overuse of telemetry
monitoring compared to the pre-pandemic period. We compared the
frequency of inappropriate telemetry use in the pre-COVID-19 period (1
November 2019 to 28 February 2020) versus the peri-COVID-19 period (1
March 2020 to 30 June 2020) at a major academic hospital in Honolulu,
Hawaii, by a retrospective chart review to assess for the
appropriateness of the telemetry orders during this period, based on the
2017 American College of Cardiology/American Heart Association
guidelines. Compared to the pre-COVID-19 period, there was a significant
increase in inappropriate telemetry use during the peri-COVID-19 period
(X2 (1, N = 11,727) = 6.59, p = 0.0103). However, there was no increase
in the proportions of respiratory failure (4.0%) or pneumonia (2.7%)
during the peri-COVID-19 period. The increase in inappropriate telemetry
use may be related to the uncertainty in clinical care and decision
making amid the pandemic of the new virus. Appropriate utilization of
telemetry monitoring is increasingly important during the pandemic due
to the limited availability of resources. Further investigation is
needed to clarify the relationship between the pandemic and trends in
telemetry ordering. | |34940870 |JAMA network open |This randomized
clinical trial examines the effect of digital contact tracing using
smartphone app nudges to increase downloads of Pennsylvanias COVID
Alert PA app. | |34936687 |PloS one
|<AbstractText Label="INTRODUCTION">In December 2020, the first two
COVID-19 vaccines were approved in the United States (U.S.) and
recommended for distribution to front-line personnel, including nurses.
Nursing students are being prepared to fill critical gaps in the health
care workforce and have played important supportive roles during the
current pandemic. Research has focused on vaccine intentions of current
health care providers and less is known about students intentions to
vaccinate for COVID-19. <AbstractText Label="METHODS">A national sample
of undergraduate nursing students were recruited across five nursing
schools in five U.S. regions in December 2020. The survey measured
perceived risk/threat of COVID-19, COVID-19 vaccine attitudes, perceived
safety and efficacy of COVID-19 vaccines, sources for vaccine
information and level of intention to become vaccinated [primary,
secondary (i.e., delayed), or no intention to vaccinate].
<AbstractText Label="RESULTS">The final sample consisted of 772
students. The majority (83.6%) had intentions to be vaccinated, however
of those 31.1% indicated secondary intention, a delay in intention or
increased hesitancy). The strongest predictors of primary intention were
positive attitudes (OR = 6.86; CI = 4.39-10.72), having lower safety
concerns (OR = 0.26; CI = 0.18-0.36), and consulting social media as a
source of information (OR = 1.56; CI = 1.23-1.97). Asian (OR = 0.47; CI
= 0.23-0.97) and Black (OR 0.26; CI = 0.08-0.80) students were more
likely to indicate secondary intention as compared to primary intention.
Students in the Midwest were most likely to indicate no intention as
compared to secondary intention (OR = 4.6; CI = 1.32-16.11).
<AbstractText Label="CONCLUSIONS">As the first two COVID-19 vaccines
were approved/recommended in the U.S. nursing students had overall high
intentions to vaccinate. Findings can guide development of educational
interventions that reduce concerns of vaccine safety that are delivered
in a way that is supportive and affirming to minoritized populations
while being respectful of geo-political differences. | |34909439 |Open
forum infectious diseases
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">We evaluated
clinical outcomes, functional burden, and complications 1 month after
coronavirus disease 2019 (COVID-19) infection in a prospective US
Military Health System (MHS) cohort of active duty, retiree, and
dependent populations using serial patient-reported outcome surveys and
electronic medical record (EMR) review.
<AbstractText Label="METHODS" NlmCategory="METHODS">MHS beneficiaries
presenting at 9 sites across the United States with a positive severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) test, a
COVID-19-like illness, or a high-risk SARS-CoV-2 exposure were eligible
for enrollment. Medical history and clinical outcomes were collected
through structured interviews and International Classification of
Diseases-based EMR review. Risk factors associated with hospitalization
were determined by multivariate logistic regression.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">A total of 1202
participants were enrolled. There were 1070 laboratory-confirmed
SARS-CoV-2 cases and 132 SARS-CoV-2-negative participants. In the first
month post-symptom onset among the SARS-CoV-2-positive cases, there were
212 hospitalizations, 80% requiring oxygen, 20 ICU admissions, and 10
deaths. Risk factors for COVID-19-associated hospitalization included
race (increased for Asian, Black, and Hispanic compared with
non-Hispanic White), age (age 45-64 and 65+ compared with &lt;45), and
obesity (BMI30 compared with BMI&lt;30). Over 2% of survey respondents
reported the need for supplemental oxygen, and 31% had not returned to
normal daily activities at 1 month post-symptom onset.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Older age,
reporting Asian, Black, or Hispanic race/ethnicity, and obesity are
associated with SARS-CoV-2 hospitalization. A proportion of acute
SARS-CoV-2 infections require long-term oxygen therapy; the impact of
SARS-CoV-2 infection on short-term functional status was substantial. A
significant number of MHS beneficiaries had not yet returned to normal
activities by 1 month.  The Author(s) 2021. Published by Oxford
University Press on behalf of Infectious Diseases Society of America. |
|34901299 |Open forum infectious diseases
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">The inFLUenza
Patient-Reported Outcome Plus (FLU-PRO Plus) is a patient-reported
outcome data collection instrument assessing symptoms of viral
respiratory tract infections across 8 body systems. This study evaluated
the measurement properties of FLU-PRO Plus in a study enrolling
individuals with coronavirus disease 2019 (COVID-19).
<AbstractText Label="METHODS" NlmCategory="METHODS">Data from a
prospective cohort study (EPICC) in US Military Health System
beneficiaries evaluated for COVID-19 was utilized. Adults with
symptomatic severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection with FLU-PRO Plus survey information within 1 week of symptom
onset were included. Reliability of FLU-PRO Plus was estimated using
intraclass correlation coefficient (ICC; 2 days reproducibility).
Known-groups validity was assessed using patient global assessment (PGA)
of disease severity. Patient report of return to usual health was used
to assess responsiveness (day 1-6/7).
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Two hundred
twenty-six SARS-CoV-2-positive participants were included in the
analysis. Reliability among those who reported no change in their
symptoms from one day to the next was high for most domains (ICC range,
0.68-0.94 for day 1 to day 2). Construct validity was demonstrated by
moderate to high correlation between the PGA rating of disease severity
and domain and total scores (eg, total scores correlation: 0.69
[influenza-like illness severity], 0.69 [interference in daily
activities], and -0.58 [physical health]). In addition, FLU-PRO Plus
demonstrated good known-groups validity, with increasing domain and
total scores observed with increasing severity ratings.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">FLU-PRO Plus
performs well in measuring signs and symptoms in SARS-CoV-2 infection
with excellent construct validity, known-groups validity, and
responsiveness to change. Standardized data collection instruments
facilitate meta-analyses, vaccine effectiveness studies, and other
COVID-19 research activities. Published by Oxford University Press on
behalf of Infectious Diseases Society of America 2021. | |34897806 |The
Journal of rural health : official journal of the American Rural Health
Association and the National Rural Health Care Association J Rural
Health</p>
<pre><code>  Mental health at the COVID-19 frontline: An assessment of distress, fear, and coping among staff and attendees at screening clinics of rural/regional settings of Victoria, Australia.
  
    773
    787
    773-787
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1111/jrh.12638
  
    &lt;AbstractText Label=&quot;PURPOSE&quot;&gt;Research examining psychological well-being associated with COVID-19 in rural/regional Australia is limited. This study aimed to assess the extent of psychological distress, fear of COVID-19, and coping strategies among the attendees in COVID-19 screening clinics at 2 rural Victorian settings.
    &lt;AbstractText Label=&quot;METHODS&quot;&gt;A cross-sectional study was conducted during July 2020 to February 2021 inclusive. Participants were invited to fill in an online questionnaire. Kessler Psychological Distress Scale (K-10), Fear of COVID-19 Scale, and Brief Resilient Coping Scale were used to assess psychological distress, fear of COVID-19, and coping, respectively.
    &lt;AbstractText Label=&quot;FINDINGS&quot;&gt;Among 702 total participants, 69% were females and mean age (SD) was 49 (15.8) years. One in 5 participants (156, 22%) experienced high to very high psychological distress, 1 in 10 (72, 10%) experienced high fear, and more than half (397, 57%) had medium to high resilient coping. Participants with mental health issues had higher distress (AOR 10.4, 95% CI: 6.25-17.2) and fear (2.56, 1.41-4.66). Higher distress was also associated with having comorbidities, increased smoking (5.71, 1.04-31.4), and alcohol drinking (2.03, 1.21-3.40). Higher fear was associated with negative financial impact, drinking alcohol (2.15, 1.06-4.37), and increased alcohol drinking. Medium to high resilient coping was associated with being 60 years old (1.84, 1.04-3.24) and completing Bachelor and above levels of education.
    &lt;AbstractText Label=&quot;CONCLUSION&quot;&gt;People who had pre-existing mental health issues, comorbidities, smoked, and consumed alcohol were identified as high-risk groups for poorer psychological well-being in rural/regional Victoria. Specific interventions to support the mental well-being of these vulnerable populations, along with engaging health care providers, should be considered.
     2021 The Authors. The Journal of Rural Health published by Wiley Periodicals LLC on behalf of National Rural Health Association.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Rahman
      Muhammad Aziz
      MA
      
        School of Health, Federation University Australia, Berwick, Victoria, Australia.
      
      
        National Centre for Farmer Health, Deakin University, Hamilton, Victoria, Australia.
      
      
        Faculty of Public Health, Universitas Airlangga, Surabaya, Indonesia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Ford
      Dale
      D
      
        Western District Health Service (WDHS), Hamilton, Victoria, Australia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Sousa
      Grace
      G
      
        South West Healthcare (SWH), Warrnambool, Victoria, Australia.
      
      
        Hawaii Emergency Physicians Associated, Honolulu, Hawaii, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Hedley
      Lorraine
      L
      
        Western District Health Service (WDHS), Hamilton, Victoria, Australia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Greenstock
      Louise
      L
      
        Western Alliance, Warrnambool, Victoria, Australia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Cross
      Wendy M
      WM
      
        School of Health, Federation University Australia, Berwick, Victoria, Australia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Brumby
      Susan
      S
      
        National Centre for Farmer Health, Deakin University, Hamilton, Victoria, Australia.
      
      
        Western District Health Service (WDHS), Hamilton, Victoria, Australia.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
    &lt;PublicationType UI=&quot;D013485&quot;&gt;Research Support, Non-U.S. Gov&#39;t
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2021
    12
    13
  


  England
  J Rural Health
  8508122
  0890-765X

IM

  
    &lt;DescriptorName UI=&quot;D000223&quot; MajorTopicYN=&quot;N&quot;&gt;Adaptation, Psychological
  
  
    &lt;DescriptorName UI=&quot;D000328&quot; MajorTopicYN=&quot;N&quot;&gt;Adult
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;Y&quot;&gt;COVID-19
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D003430&quot; MajorTopicYN=&quot;N&quot;&gt;Cross-Sectional Studies
  
  
    &lt;DescriptorName UI=&quot;D005239&quot; MajorTopicYN=&quot;N&quot;&gt;Fear
    &lt;QualifierName UI=&quot;Q000523&quot; MajorTopicYN=&quot;N&quot;&gt;psychology
  
  
    &lt;DescriptorName UI=&quot;D005260&quot; MajorTopicYN=&quot;N&quot;&gt;Female
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D008297&quot; MajorTopicYN=&quot;N&quot;&gt;Male
  
  
    &lt;DescriptorName UI=&quot;D008603&quot; MajorTopicYN=&quot;N&quot;&gt;Mental Health
  
  
    &lt;DescriptorName UI=&quot;D008875&quot; MajorTopicYN=&quot;N&quot;&gt;Middle Aged
  
  
    &lt;DescriptorName UI=&quot;D014739&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;Victoria
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;COVID-19
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;coping
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;mental health
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;resilience
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;rural




  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2021
    12
    14
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2022
    9
    24
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2021
    12
    13
    13
    45
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;34897806
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1111/jrh.12638


  REFERENCES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                |&lt;AbstractText Label=&quot;PURPOSE&quot;&gt;Research examining psychological well-being associated with COVID-19 in rural/regional Australia is limited. This study aimed to assess the extent of psychological distress, fear of COVID-19, and coping strategies among the attendees in COVID-19 screening clinics at 2 rural Victorian settings. &lt;AbstractText Label=&quot;METHODS&quot;&gt;A cross-sectional study was conducted during July 2020 to February 2021 inclusive. Participants were invited to fill in an online questionnaire. Kessler Psychological Distress Scale (K-10), Fear of COVID-19 Scale, and Brief Resilient Coping Scale were used to assess psychological distress, fear of COVID-19, and coping, respectively. &lt;AbstractText Label=&quot;FINDINGS&quot;&gt;Among 702 total participants, 69% were females and mean age (SD) was 49 (15.8) years. One in 5 participants (156, 22%) experienced high to very high psychological distress, 1 in 10 (72, 10%) experienced high fear, and more than half (397, 57%) had medium to high resilient coping. Participants with mental health issues had higher distress (AOR 10.4, 95% CI: 6.25-17.2) and fear (2.56, 1.41-4.66). Higher distress was also associated with having comorbidities, increased smoking (5.71, 1.04-31.4), and alcohol drinking (2.03, 1.21-3.40). Higher fear was associated with negative financial impact, drinking alcohol (2.15, 1.06-4.37), and increased alcohol drinking. Medium to high resilient coping was associated with being 60 years old (1.84, 1.04-3.24) and completing Bachelor and above levels of education. &lt;AbstractText Label=&quot;CONCLUSION&quot;&gt;People who had pre-existing mental health issues, comorbidities, smoked, and consumed alcohol were identified as high-risk groups for poorer psychological well-being in rural/regional Victoria. Specific interventions to support the mental well-being of these vulnerable populations, along with engaging health care providers, should be considered.  2021 The Authors. The Journal of Rural Health published by Wiley Periodicals LLC on behalf of National Rural Health Association.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                        |</code></pre>
<p>|34896104 |Acta tropica |Monte Verde, a periurban squatter community
near San Pedro Sula, virtually eliminated Aedes aegypti production in
all known larval habitats: wells; water storage containers including
pilas (open concrete water tanks used for laundry), 200-liter drums,
1000-liter plastic cisterns, buckets; and objects collecting
rainwater. The project began in 2016 when Monte Verde was overrun with
dengue, Zika, and chikungunya. During more than a year of
experimentation, Monte Verde residents crafted an effective,
sustainable, and environmentally friendly toolkit that was inexpensive
but required full community participation. Biological control with
copepods, turtles, and tilapia was at the core of the toolkit, along
with a mix of other methods such as getting rid of unnecessary
containers, scrubbing them to remove Ae. aegypti eggs, and covering them
to exclude mosquitoes or rainwater. Environmentally friendly larvicides
also had a limited but crucial role. Key design features: (1) toolkit
components known to be nearly 100% effective at preventing Ae. aegypti
production when fitted to appropriate larval habitats; (2) using Ae.
aegypti larval habitats as a resource by transforming them into egg
sinks to drive Ae. aegypti population decline; (3) dedicated community
volunteers who worked with their neighbors, targeting 100% coverage of
all known Ae. aegypti larval habitats with an appropriate control
method; (4) monthly monitoring in which the volunteers visited every
house to assess progress and improve coverage as an ongoing learning
experience for both volunteers and residents. Taking pupae as an
indicator of Ae. aegypti production, from September 2018 to the end of
the record in December 2021 (except for a brief lapse during COVID
lockdown in 2020), the monthly count of pupae fluctuated between zero
and 0.6% of the 22,984 pupae counted in the baseline survey at the
beginning of the project. Adult Ae. aegypti declined to low numbers but
did not disappear completely. There were no recognizable cases of
dengue, Zika, or chikungunya after June 2018, though the study design
based on a single site did not provide a basis for rigorous confirmation
that Monte Verdes Ae. aegypti control program was responsible.
Nonetheless, Monte Verdes success at eliminating Ae. aegypti production
can serve as a model for extending this approach to other communities.
Key ingredients for success were outside stimulation and facilitation to
foster shared community awareness and commitment regarding the problem
and its solution, enduring commitment of local leadership, compatibility
of the toolkit with the local community, overcoming social obstacles,
rapid results with success breeding success, and building resilience.
Copyright  2021. Published by Elsevier B.V. | |34890263 |Clinical
toxicology (Philadelphia, Pa.) |<AbstractText Label="INTRODUCTION">This
is the 38th Annual Report of the American Association of Poison Control
Centers (AAPCC) National Poison Data System (NPDS). As of 1 January,
2020, all 55 of the nations poison centers (PCs) uploaded case data
automatically to NPDS. The upload interval was 6.15 [4.60, 8.62] (median
[25%, 75%]) minutes, effectuating a near real-time national exposure and
information database and surveillance system.
<AbstractText Label="METHODS">We analyzed the case data tabulating
specific indices from NPDS. The methodology was similar to that of
previous years. Where changes were introduced, the differences are
identified. Cases with medical outcomes of death were evaluated by a
team of medical and clinical toxicologist reviewers using an ordinal
scale of 1-6 to assess the Relative Contribution to Fatality (RCF) of
the exposure. <AbstractText Label="RESULTS">In 2020, 3,316,738 closed
encounters were logged by NPDS: 2,128,198 human exposures, 66,745 animal
exposures, 1,116,568 information requests, and 5,160 human confirmed
nonexposures. Total encounters showed a 28.9% increase from 2019, while
health care facility (HCF) human exposure cases decreased by 10.6%.
While all information requests increased by 218.0%, medication
identification (Drug ID) requests decreased by 31.5%, and human exposure
cases decreased by 0.928%. Medical Information requests showed a
32.6-fold increase, reflecting COVID-19 pandemic calls to PCs. Human
exposures with less serious outcomes have decreased 1.90% per year since
2008, while those with more serious outcomes (moderate, major or death)
have increased 4.59% per year since 2000.Consistent with the previous
year, the top 5 substance classes most frequently involved in all human
exposures were analgesics (10.3%), household cleaning substances
(8.37%), cosmetics/personal care products (6.53%), antidepressants
(5.30%), and sedatives/hypnotics/antipsychotics (4.92%). As a class,
antidepressant exposures increased most rapidly, by 1,793 cases/year
(5.84%/year) over the past 10 years for cases with more serious
outcomes.The top 5 most common exposures in children age 5 years or less
were cosmetics/personal care products (11.8%), household cleaning
substances (11.3%), analgesics (7.57%), foreign
bodies/toys/miscellaneous (6.71%), and dietary
supplements/herbals/homeopathic (6.44%). Drug identification requests
comprised 2.89% of all information contacts. NPDS documented 4,488 human
exposures resulting in death; 3,869 (86.2%) of these were judged as
related (RCF of 1-Undoubtedly responsible, 2-Probably responsible, or
3-Contributory). <AbstractText Label="CONCLUSIONS">These data support
the continued value of PC expertise and need for specialized medical
toxicology information to manage more serious exposures. Unintentional
and intentional exposures continue to be a significant cause of
morbidity and mortality in the US. The near real-time status of NPDS
represents a national public health resource to collect and monitor US
exposure cases and information contacts. The continuing mission of NPDS
is to provide a nationwide infrastructure for surveillance for all types
of exposures (e.g., foreign body, infectious, venomous, chemical agent,
or commercial product), and the identification and tracking of
significant public health events. NPDS is a model system for the near
real-time surveillance of national and global public health. | |34877361
|Open forum infectious diseases
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Early
recognition of high-risk patients with coronavirus disease 2019
(COVID-19) may improve outcomes. Although many predictive scoring
systems exist, their complexity may limit utility in COVID-19. We
assessed the prognostic performance of the National Early Warning Score
(NEWS) and an age-based modification (NEWS+age) among hospitalized
COVID-19 patients enrolled in a prospective, multicenter US Military
Health System (MHS) observational cohort study.
<AbstractText Label="METHODS" NlmCategory="METHODS">Hospitalized adults
with confirmed COVID-19 not requiring invasive mechanical ventilation at
admission and with a baseline NEWS were included. We analyzed each
scoring systems ability to predict key clinical outcomes, including
progression to invasive ventilation or death, stratified by baseline
severity (low [0-3], medium [4-6], and high [7]).
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Among 184 included
participants, those with low baseline NEWS had significantly shorter
hospitalizations (P &lt; .01) and lower maximum illness severity (P &lt;
.001). Most (80.2%) of low NEWS vs 15.8% of high NEWS participants
required no or at most low-flow oxygen supplementation. Low NEWS (3)
had a negative predictive value of 97.2% for progression to invasive
ventilation or death; a high NEWS (7) had high specificity (93.1%) but
low positive predictive value (42.1%) for such progression. NEWS+age
performed similarly to NEWS at predicting invasive ventilation or death
(NEWS+age: area under the receiver operating characteristics curve
[AUROC], 0.69; 95% CI, 0.65-0.73; NEWS: AUROC, 0.70; 95% CI, 0.66-0.75).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">NEWS and
NEWS+age showed similar test characteristics in an MHS COVID-19 cohort.
Notably, low baseline scores had an excellent negative predictive value.
Given their easy applicability, these scoring systems may be useful in
resource-limited settings to identify COVID-19 patients who are unlikely
to progress to critical illness. Published by Oxford University Press on
behalf of Infectious Diseases Society of America 2021. | |34855156
|Academic psychiatry : the journal of the American Association of
Directors of Psychiatric Residency Training and the Association for
Academic Psychiatry
|<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">This report
summarizes findings from a 2020 survey of US child and adolescent
psychiatry training programs that explored the impact of the COVID-19
pandemic on pediatric telepsychiatry training. The authors hypothesized
that telepsychiatry training significantly increased during the
pandemic, in part due to legal and regulatory waivers during the
COVID-19 public health emergency.
<AbstractText Label="METHODS" NlmCategory="METHODS">In August 2020, an
anonymous, 28-question online survey was emailed to all (138) accredited
child psychiatry fellowships on the Accreditation Council for Graduate
Medical Education website. Forty-nine programs responded (36%). This
analysis focuses on three of the 28 questions relevant to the
hypotheses: characteristics of the programs training in telepsychiatry;
perceived impediments to clinical training; and perceived impediments to
didactic training pre-COVID onset vs.post-COVID onset, respectively.
Total scores were created to investigate differences in training
programs and impediments to including telepsychiatry pre- and post-COVID
onset. Paired sample t-tests were used to compare means pre- and
post-COVID onset.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Results provided
support for significant differences between training components related
to telepsychiatry pre- and post-COVID onset, with participants reporting
more training components post-COVID onset (M = 5.69) than pre-COVID
onset (M = 1.80); t(48) = 9.33, p &lt; .001. Participants also reported
significantly fewer barriers to providing clinical experiences in
pediatric telepsychiatry post-COVID onset (M = 2.65) than pre-COVID
onset (M = 4.90); t(48) = - 4.20, p &lt; .001.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">During the
COVID-19 pandemic, pediatric telepsychiatry training in child psychiatry
fellowships increased significantly. Perceived barriers to providing
clinical, but not didactic, training decreased significantly.  2021.
Academic Psychiatry. | |34825050 |Journal of patient experience
|COVID-19 has disproportionally burdened racial and ethnic minorities.
Minority populations report greater COVID-19 vaccine hesitancy; however,
no studies document COVID-19 vaccine willingness among Marshallese or
any Pacific Islander group, who are often underrepresented in research.
This study documents United States (US) Marshallese Pacific Islanders:
willingness to get the COVID-19 vaccine, willingness to participate in
vaccine trials, and sociodemographic factors associated with
willingness. From July 27, 2020-November 22, 2020, a convenience sample
of US Marshallese adults were recruited through e-mail, phone calls, and
a Marshallese community Facebook page to participate in an online
survey. Of those surveyed (n = 120), 32.5% were extremely likely to get
the COVID-19 vaccine; 20.8% were somewhat likely; 14.2% were unlikely or
very unlikely; and 26.7% stated they did not know or were not sure. Only
16.7% stated they were willing to participate in a COVID-19 vaccine
trial. Vaccine willingness was positively associated with older age,
higher income, and longer US residence. Health insurance status and
having a primary care provider were positively associated with vaccine
willingness. Findings demonstrate within-group variation in COVID-19
vaccine willingness.  The Author(s) 2021. | |34815815 |Clinical
simulation in nursing
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">This paper
describes the rapid conversion of a face-to-face interprofessional (IP)
disaster simulation to an online format in response to COVID-19 campus
closures. <AbstractText Label="METHODS" NlmCategory="METHODS">The online
disaster simulation utilized internet-based tools allowing real-time
collaboration between IP students. Team exercises involved disaster
triage, disease outbreak investigation, and disaster response. Surveys
measuring self-assessment of various IP skills and simulation learning
outcomes (SLOs) were compared with responses from previous face-to-face
simulations. <AbstractText Label="RESULTS" NlmCategory="RESULTS">Results
indicated mean scores for IP skills were higher for online students when
compared with in-person simulations, and all SLOs were met.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The online
disaster simulation provided an effective, innovative IP educational
opportunity.  2021 International Nursing Association for Clinical
Simulation and Learning. Published by Elsevier Inc.All rights reserved.
| |34786570 |Lancet regional health. Americas
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Transplant
centers saw a substantial reduction in deceased donor solid organ
transplantation since the beginning of the coronavirus 2019 (COVID-19)
pandemic in the United States. There is limited data on the impact of
COVID-19 on adult and pediatric heart transplant volume and variation in
transplant practices. We hypothesized that heart transplant activity
decreased during COVID-19 with associated increased waitlist mortality.
<AbstractText Label="METHODS" NlmCategory="METHODS">The United Network
for Organ Sharing (UNOS) database was used to identify patients at the
time of listing for heart transplant from 2017-2020. Patients were
categorized as pediatric (&lt;18 years) or adult (18 years) and as
pre-COVID (2017-2019) or post-COVID (2020). Regional and statewide data
were taken from United States Census Bureau. CovidActNow project was
used to obtain COVID-19 mortality rates.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Among pediatric
patients, average time on the waiting list decreased by 28 days. Even
though the average number of pediatric transplants (n=39 per month) did
not change significantly during 2020, there was a temporal decline in
the first quarter of 2020 followed by a sharp increase. Overall absolute
pediatric waitlist mortality decreased from 531 to 473, however female
mortality increased by 2%. Regional differences in pediatric mortality
were observed: Northeast, decreased by 75%; Midwest, decreased by 9%;
West, increased by 35%; and South, increased by 13%. North Dakota
(055), Oklahoma (021) and Hawaii (033) showed higher mortality than
other states per 100,000. In adults, average time on waiting list
increased by 40 days and there was an increase in the number of
transplants from 242 to 266. Adult waitlist mortality had a larger
decrease, 1844 to 1570, with an increase in female mortality of 7%.
Regional differences in adult mortality were also observed: Northeast,
decreased by 3%; Midwest, increased by 55%; West, increased by 45% and
South, decreased by 5%. Iowa (037), Wyoming (022), Arkansas (018) and
Vermont (019) had the highest mortality per 100,000 compared to the
other states.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Pediatric
heart transplant volume declined in early 2020 followed by a later
increase, while adult transplant volume increased all year round.
Although, overall pediatric waitlist mortality decreased, female
waitlist mortality increased for both adults and pediatrics. Regional
differences in waitlist mortality were observed for both pediatrics and
adults. Future studies are needed to understand this initial correlation
and to determine the impact of COVID-19 on heart transplant recipients.
<AbstractText Label="FUNDING" NlmCategory="BACKGROUND">This research
received no specific grant from any funding agency in the public,
commercial or not-for-profit sectors.  2021 The Author(s). | |34778744
|Vaccine: X |The speed at which several COVID-19 vaccines went from
conception to receiving FDA and EMA approval for emergency use is an
achievement unrivaled in the history of vaccine development. Mass
vaccination efforts using the highly effective vaccines are currently
underway to generate sufficient herd immunity and reduce transmission of
the SARS-CoV-2 virus. Despite the most advanced vaccine technology,
global recipient coverage, especially in resource-poor areas remains a
challenge as genetic drift in nave population pockets threatens overall
vaccine efficacy. In this study, we described the production of
insect-cell expressed SARS-CoV-2 spike protein ectodomain constructs and
examined their immunogenicity in mice. We demonstrated that, when
formulated with CoVaccine HTTM adjuvant, an oil-in-water nanoemulsion
compatible with lyophilization, our vaccine candidates elicit a
broad-spectrum IgG response, high neutralizing antibody (NtAb) titers
against SARS-CoV-2 prototype and variants of concern, specifically
B.1.351 (Beta) and P.1. (Gamma), and an antigen-specific IFN- secreting
response in outbred mice. Of note, different ectodomain constructs
yielded variations in NtAb titers against the prototype strain and some
VOC. Dose response experiments indicated that NtAb titers increased with
antigen dose, but not adjuvant dose, and may be higher with a lower
adjuvant dose. Our findings lay the immunological foundation for the
development of a dry-thermostabilized vaccine that is deployable without
refrigeration.  2021 Published by Elsevier Ltd.| |34765988 |Hawaii
journal of health &amp; social welfare |In June 2021, over 200
stakeholders, advocates, and visionaries gathered to launch the Healthy
Hawaii Strategic Plan 2030 (HHSP), a 10-year strategic plan for
improving the health of Hawaii residents by preventing and reducing
chronic disease and advancing health equity. The HHSP is a guide to
enable coordination across common risk factors, program areas,
interventions, and strategies for chronic disease prevention and
control. Developed during the COVID-19 pandemic, which revealed major
areas of susceptibility in our health system infrastructure and
magnified existing disparities, the HHSP prioritizes health equity and
strives to create sustainable change to transform communities, schools,
health care and worksites to support the health of the people of
Hawaii. The HHSP is a living document and partners - present and future
- are invited to work together to achieve a healthier future for the
people of Hawaii. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34765987 |Hawaii journal of health &amp;
social welfare |Reducing Coronavirus disease 2019 (COVID-19)
transmission relies on people quarantining after exposure to COVID-19 or
if they experience COVID-19 symptoms, and isolating from others if
COVID-19 positive. Quarantine and isolation last 10 to 14 days and can
be state-mandated; however, the level of compliance is unknown. The
University of Hawaii Department of Family Medicine clinic called
patients instructed by our physicians to quarantine for exposure risk or
symptoms of potential COVID-19 infection between March 15, 2020, and
April 15, 2020. None of the patients tested positive for COVID-19.
Sixty-nine of 90 (77%) patients completed follow-up calls and
self-reported whether they had stayed home. Of these 69 patients, 32
(46%) broke quarantine to buy groceries (36%), work (9%), visit others
(6%), or for other reasons (12%). For patients living alone, 8 of 11
(73%) left home to buy groceries. For employed patients, 6 of 39 (15%)
returned to work during their quarantine period. Nearly half of our
patients did not quarantine for the entire period. Many persons left
home to buy food or to work. Strong public health messaging is needed to
educate communities about the requirement to quarantine. Clinicians can
help by asking patients about social and financial ability to
quarantine, schedule follow-up appointments to remind patients to stay
home, and link patients to food programs, financial assistance, and
other community resources to successfully quarantine and prevent
COVID-19 transmission. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34757265 |Epilepsy &amp; behavior : E&amp;B
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Telemedicine
clinic visits traditionally originated from spoke clinic sites, but
recent trends have favored home-based telemedicine, particularly in the
time of Covid-19. Our study focused on identification of barriers and
factors influencing perceptions of care with use of home-based
telemedicine in patients with seizures living in rural Hawaii. We
additionally compared characteristics of patients using telemedicine
versus in-person clinic visits prior to the Covid-19 pandemic.
<AbstractText Label="METHODS" NlmCategory="METHODS">For the
retrospective portion of our study, we queried charts of adult
outpatients treated by the two full-time epileptologists at a Level 4
epilepsy center accredited by the National Association of Epilepsy
Centers between November 2018 and December 2019. We included patients
who live on the neighbor islands of Hawaii but not on Oahu, i.e.,
patients who would require air travel to see an epileptologist. There
had been no set protocol at the epilepsy center for telemedicine
referral; our practice had been to offer telemedicine visits to all
neighbor island patients when felt to be appropriate. We collected
demographic and clinic visit data. For the prospective portion we
surveyed neighbor island patients or their caregivers, seen via
home-based telemedicine between March 2020 and December 2020. We
obtained verbal consent for study participation. Survey questions
addressed satisfaction with clinical care, visit preferences, and
potential barriers to care.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In a 14-month period
prior to the Covid-19 pandemic, 75 (61%) neighbor island patients were
seen exclusively in-person in seizure clinic while 47 (39%) had at least
one telemedicine visit. 39% of patients seen only in-person were female
whereas 38% of patients seen by telemedicine were female. Patients seen
in-person had an older median age (47.2 years) compared to those seen at
least once by telemedicine (42.4 years). The no-show rate was 13% for
in-person visits versus 4% for telemedicine visits. Among patients seen
in person, 17% were Asian, 32% Native Hawaiian, and 47% White, whereas
patients seen by telemedicine were 15% Asian, 23% Native Hawaiian, and
57% White. Patients who were seen in person lived in zip codes with
median household income of $68,516 and patients who were seen by
telemedicine lived in zip codes with median household income of $67,089.
Patients who were seen in person lived in zip codes in which 78% of the
population had access to broadband internet, whereas patients who were
seen by telemedicine lived in zip codes in which 79% of the population
had access to broadband internet. During the Covid-19 pandemic, we
surveyed 47 consecutive patients seen by telemedicine, 45% female with
median age of 33 years. Telemedicine connection was set up by the
patient in 74% of cases, or by the patients mother (15%), other family
member (9%), or other caregiver (2 %). Median patient satisfaction score
was 5 (highly satisfied) on a 5-point Likert scale with mean score of
4.6. Telemedicine visit was done using a smartphone by 62% of patients,
a computer by 36% of patients, and a tablet by 2% of patients. A home
WiFi connection was used in 83% of patients.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Home-based
telemedicine visits provide a high-satisfaction method for seizure care
delivery despite some obstacles. Demographic disparities may be an
obstacle to telemedicine care and seem to relate to race and possibly
age, rather than to sex/gender, household income, or access to broadband
internet. Additionally, despite high satisfaction overall, more patients
felt the physical exam was superior at in-person clinic visits and more
patients expressed a preference for in-person visits. During the
Covid-19 pandemic when there may be barriers to in-person clinic visits,
home-based telemedicine is a feasible alternative. Copyright  2021
Elsevier Inc.All rights reserved. | |34744296 |Child &amp; adolescent
social work journal : C &amp; A |Child welfare work is inherently
difficult, and child welfare agencies are known to experience high rates
of turnover. We sought to expand the existing literature on intention to
leave ones child welfare agency and commitment to child welfare work
through examining the coping mechanisms of frontline workers. Having and
utilizing healthy coping mechanisms has proved beneficial to child
welfare workers in previous research. In this paper, we examine specific
coping mechanisms identified in the Comprehensive Organizational Health
Assessment and how they were associated with child welfare workers
intent to leave their agency and their commitment to remain in the field
of child welfare during the SARS CoV-2 (COVID-19) pandemic. We surveyed
over 250 child welfare caseworkers using the COHA instrument. Using both
bivariate analysis and linear regression, we identify specific coping
mechanisms, such as staying present with friends and family, as highly
influential and discuss ways to strengthen these areas.  The Author(s),
under exclusive licence to Springer Science+Business Media, LLC, part of
Springer Nature 2021. | |34739906 |Epidemics
|<AbstractText Label="INTRODUCTION">As of 3rd June 2021, Malaysia is
experiencing a resurgence of COVID-19 cases. In response, the federal
government has implemented various non-pharmaceutical interventions
(NPIs) under a series of Movement Control Orders and, more recently, a
vaccination campaign to regain epidemic control. In this study, we
assessed the potential for the vaccination campaign to control the
epidemic in Malaysia and four high-burden regions of interest, under
various public health response scenarios.
<AbstractText Label="METHODS">A modified
susceptible-exposed-infectious-recovered compartmental model was
developed that included two sequential incubation and infectious
periods, with stratification by clinical state. The model was further
stratified by age and incorporated population mobility to capture NPIs
and micro-distancing (behaviour changes not captured through population
mobility). Emerging variants of concern (VoC) were included as an
additional strain competing with the existing wild-type strain. Several
scenarios that included different vaccination strategies (i.e.vaccines
that reduce disease severity and/or prevent infection, vaccination
coverage) and mobility restrictions were implemented.
<AbstractText Label="RESULTS">The national model and the regional models
all fit well to notification data but underestimated ICU occupancy and
deaths in recent weeks, which may be attributable to increased severity
of VoC or saturation of case detection. However, the true case detection
proportion showed wide credible intervals, highlighting incomplete
understanding of the true epidemic size. The scenario projections
suggested that under current vaccination rates complete relaxation of
all NPIs would trigger a major epidemic. The results emphasise the
importance of micro-distancing, maintaining mobility restrictions during
vaccination roll-out and accelerating the pace of vaccination for future
control. Malaysia is particularly susceptible to a major COVID-19
resurgence resulting from its limited population immunity due to the
countrys historical success in maintaining control throughout much of
2020. Copyright  2021 The Authors. Published by Elsevier B.V. All
rights reserved. | |34736373 |Journal of agromedicine |The goal of this
study was to conduct an exploratory assessment of COVID-19 mitigation
steps and compare workplace experiences during the COVID-19 pandemic
with Marshallese workers in other occupations. Marshallese adults
residing in the continental United States (US) and Hawaii took part in
an online survey. The sample was divided into two categories: food
processing workers and workers in all other occupations. To examine
differences between food processing workers and workers from all other
occupations, we used Wilcoxon-Mann-Whitney U tests and Fishers Exact
tests. Of those employed at the time of the survey (n = 113), 31 were
employed in food processing plants, and 82 were employed in another
occupation. Food processing workers and workers in other occupations
differed significantly on level of education, length of residence in the
US, English-speaking ability, and health literacy. More food processing
workers reported that their employers installed barriers or provided
shields (45%), provided temperature screenings (71%), and tested for
COVID-19 (61%) compared with those in other occupations. A larger
proportion of food processing workers reported having no sick leave
compared with workers in other occupations, although they reported
COVID-19 testing and being insured at similar rates. This is the first
study to examine Marshallese food processing workers experiences during
the COVID-19 pandemic. Our findings show that while some food processing
employers implemented government-recommended guidelines to prevent the
spread of COVID-19, preventative and protective measures were not
comprehensively applied across the food processing industry, despite
efforts by public health agencies and community partners. | |34736125
|Computational biology and chemistry |India, with around 15 million
COVID-19 cases, recently became the second worst-hit nation by the
SARS-CoV-2 pandemic. In this study, we analyzed the mutation and
selection landscape of 516 unique and complete genomes of SARS-CoV-2
isolates from India in a 12-month span (from Jan to Dec 2020) to
understand how the virus is evolving in this geographical region. We
identified 953 genome-wide loci displaying single nucleotide
polymorphism (SNP) and the Principal Component Analysis and mutation
plots of the datasets indicate an increase in genetic variance with
time. The 42% of the polymorphic sites display substitutions in the
third nucleotide position of codons indicating that non-synonymous
substitutions are more prevalent. These isolates displayed strong
evidence of purifying selection in ORF1ab, spike, nucleocapsid, and
membrane glycoprotein. We also find some evidence of localized positive
selections ORF1ab, spike glycoprotein, and nucleocapsid. The CDSs for
ORF3a, ORF8, nucleocapsid phosphoprotein, and spike glycoprotein were
found to evolve at rapid rate. This study will be helpful in
understanding the dynamics of rapidly evolving SARS-CoV-2. Copyright 
2021 Elsevier Ltd.All rights reserved. | |34734403 |Applied clinical
informatics |<AbstractText Label="OBJECTIVE">We describe the design,
implementation, and validation of an online, publicly available tool to
algorithmically triage patients experiencing severe acute respiratory
syndrome coronavirus (SARS-CoV-2)-like symptoms.
<AbstractText Label="METHODS">We conducted a chart review of patients
who completed the triage tool and subsequently contacted our
institutions phone triage hotline to assess tool- and
clinician-assigned triage codes, patient demographics, SARS-CoV-2
(COVID-19) test data, and health care utilization in the 30 days
post-encounter. We calculated the percentage of concordance between
tool- and clinician-assigned triage categories, down-triage (clinician
assigning a less severe category than the triage tool), and up-triage
(clinician assigning a more severe category than the triage tool)
instances. <AbstractText Label="RESULTS">From May 4, 2020 through
January 31, 2021, the triage tool was completed 30,321 times by 20,930
unique patients. Of those 30,321 triage tool completions, 51.7% were
assessed by the triage tool to be asymptomatic, 15.6% low severity,
21.7% moderate severity, and 11.0% high severity. The concordance rate,
where the triage tool and clinician assigned the same clinical severity,
was 29.2%. The down-triage rate was 70.1%. Only six patients were
up-triaged by the clinician. 72.1% received a COVID-19 test administered
by our health care system within 14 days of their encounter, with a
positivity rate of 14.7%. <AbstractText Label="CONCLUSION">The design,
pilot, and validation analysis in this study show that this COVID-19
triage tool can safely triage patients when compared with clinician
triage personnel. This work may signal opportunities for automated
triage of patients for conditions beyond COVID-19 to improve patient
experience by enabling self-service, on-demand, 24/7 triage access.
Thieme. All rights reserved. | |34732841 |Journal of public health
policy |All-cause mortality counts allow public health authorities to
identify populations experiencing excess deaths from pandemics, natural
disasters, and other emergencies. Delays in the completeness of
mortality counts may contribute to misinformation because death counts
take weeks to become accurate. We estimate the timeliness of all-cause
mortality releases during the COVID-19 pandemic for the dates 3 April to
5 September 2020 by estimating the number of weekly data releases of the
NCHS Fluview Mortality Surveillance System until mortality comes within
99% of the counts in the 19 March 19 2021 provisional mortality data
release. States mortality counts take 5 weeks at median (interquartile
range 4-7 weeks) to completion. The fastest states were Maine, New
Hampshire, Vermont, New York, Utah, Idaho, and Hawaii. States that had
not adopted the electronic death registration system (EDRS) were 4.8
weeks slower to achieve complete mortality counts, and each weekly death
per 10^8 was associated with a 0.8 week delay. Emergency planning should
improve the timeliness of mortality data by improving state vital
statistics digital infrastructure.  2021. The Author(s), under
exclusive licence to Springer Nature Limited. | |34704071 |Hawaii
journal of health &amp; social welfare |Sugar-sweetened beverage (SSB)
consumption is associated with increased risk of obesity, diabetes, and
other chronic diseases. SSB consumption is also a health equity issue,
as rates of consumption and related chronic diseases vary by race,
ethnicity, and income in Hawaii. The COVID-19 pandemic has highlighted
the need for greater investment in public health and the well-being of
communities experiencing health disparities because individuals with
chronic diseases are more likely to develop complications from the
virus. It has also created economic hardships for the people of Hawaii,
especially the states most vulnerable populations. Amid this health and
economic crisis, an opportunity exists to implement an SSB fee in
Hawaii. An SSB fee would impose a fee on SSB distributors that would be
passed on to consumers in the form of price increases that influence
purchasing behavior. Jurisdictions with SSB taxes or fees have seen
reductions in SSB purchases and consumption and have generated millions
of dollars in revenues to support health initiatives and reduce
socioeconomic disparities. Models predict that a $0.02 SSB fee in
Hawaii could generate $60.5 million and significantly reduce healthcare
costs and chronic diseases. This commentary will present an SSB fee
policy as a viable model for Hawaii to reduce SSB consumption, lower
chronic disease risks, and generate needed revenues to support health,
reduce inequities, and rebuild the states economy. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii). | |34704070
|Hawaii journal of health &amp; social welfare |Recent studies have
identified high rates of chronic disease in Hawaiis adults and youth.
As the state responds to the COVID-19 pandemic and looks beyond it, the
prevention and management of chronic diseases are critical for community
health and wellbeing. Low health literacy is more common in rural
populations, Filipinos, and Pacific Islanders in HawaiI, older adults,
and many other groups with high rates of chronic disease. Promoting
health literacy can reduce chronic disease burdens for individuals,
families, and communities. Using the framework of the social-ecological
model, which is important for visioning effective chronic disease
management and prevention, this article provides a blueprint of layers
of influence for building a health literate HawaiI generally and around
chronic disease specifically. The article will close with a call to
action informed by the National Action Plan to Improve Health Literacy
for stakeholders and providers to address health literacy in the state
of HawaiI in organizations, systems, and policy. These actions should
address root causes of disease and help build more equitable health
outcomes across the state now and in the future. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii). | |34704069
|Hawaii journal of health &amp; social welfare |The Native Hawaiian and
Pacific Islander community found itself on the front pages of national
news when the COVID-19 pandemic struck the United States. By April 2020,
the small, frequently overlooked community experienced the highest
COVID-19 case rates in 5 states including Hawaii. In response, Native
Hawaiian and Pacific Islander networks across the US were mobilized to
address the crisis. In Hawaii, the Native Hawaiian Pacific Islander
COVID-19 Response, Recovery, and Resilience Team was created. Framed by
Indigenous Pacific based cultural values, protocols, and practices, the
team consists of multiple committees that examine policy; testing,
contract tracing, and isolation; communications; social supports and
resources; and data and research. Inherent in this work are the shared
core values of pono (righteousness, goodness), aloha (love, compassion),
laulima (cooperation), and imua (moving forward with strength) as well
as an ohana/aiga (family)-based, kuleana (responsibility)-centric
approach that acknowledges, honors, and values ike kpuna (ancestral
knowledge). With the burden of not only COVID-19 disparities, but also
chronic diseases and socioeconomic disparities that place Native
Hawaiian and Pacific Islander communities at increased risk for adverse
impacts from COVID-19, an effective response is critical. This article,
authored by members of the Teams Policy Committee, discusses the
development of a cultural framework that guides its advocacy efforts.
The Policy Committees work presents a cultural framework that grounds
and guides their efforts for effectively promoting a strong voice in
governmental and agency policies which would ultimately contribute to a
healthy and thriving Native Hawaiian and Pacific Islander community.
Copyright 2021 by University Health Partners of Hawaii (UHP Hawaii).
| |34704068 |Hawaii journal of health &amp; social welfare |Community
health workers play an instrumental role in the health care system and
are critical partners in pandemic response. In Hawaii, community health
workers are working to reduce the burden of chronic disease among
Pacific Islander, Filipino, and Native Hawaiian populations in
partnership with government agencies and health care organizations. This
commentary reviews the role community health workers in Hawaii are
playing in assisting with the COVID-19 response. Utilizing their skills
and the communitys trust, they are optimally positioned to reach
marginalized and vulnerable populations hit hardest by COVID-19;
community health workers educate, screen, and provide social service
referrals to community members. Copyright 2021 by University Health
Partners of Hawaii (UHP Hawaii). | |34704067 |Hawaii journal of
health &amp; social welfare |Early evidence of disproportionate COVID-19
infection and death rates in Native Hawaiian and Pacific Islander
communities in the continental US raised concerns for similar
disparities in Hawaii, where these communities make up 25% of the
states population. Representatives from more than 40 different
government, academic, institutional and community-based organizations
partnered to form the Hawaii Native Hawaiian and Pacific Islander
COVID-19 Response, Recovery, and Resilience Team. The team consists of 5
committees including the Data &amp; Research Committee. This committee
is tasked with examining issues regarding the acquisition, quality,
public reporting, and utilization of race/ethnicity-related health data
used to inform priorities and guide resource allocation. Problems
addressed by this committee include: inconsistency across agencies in
the use of race identifiers, defaulting to the Office of Management and
Budget standards which aggregated Native Hawaiian and Pacific Islanders,
and methods of data collection and reporting by the Department of
Health. Outcomes include: 2 forms with race categories that reflect the
population of Hawaii; the reporting of disaggregated data by the
Department of Health; and conversations with testing sites,
laboratories, and health institutions urging a standardized form for
race/ethnicity data collection. The collection and reporting of
disaggregated race/ethnicity data is critical to guiding organizations
in addressing underlying inequities in chronic disease and social
determinants of health that can exacerbate the adverse effects of
COVID-19. The Data and Research Committees network offers a
community-based model for collaborative work that honors culture and
ensures Native Hawaiian, Pacific Islander, and other minority
populations are recognized and counted. Copyright 2021 by University
Health Partners of Hawaii (UHP Hawaii). | |34704066 |Hawaii journal
of health &amp; social welfare |Micronesian communities in Hawaii have
a long history of mobilizing to address challenges they encounter as the
most recent and fastest growing Pacific Islander immigrant population in
the state. In particular, community leaders navigate a slew of obstacles
specific to systemic racism and health care access. These hurdles have
become exacerbated by the COVID-19 pandemic, prompting a range of
Micronesian-led responses to the health crisis including strategic
adaptations to existing networks and roles to address essential public
health functions. These community responses have filled many critical
gaps left by the states delayed response to addressing the disparate
impact of COVID-19 on Micronesian communities. This article highlights
and encourages engagement with diverse models of collaboration and
elevation of Micronesian leadership that has resulted in more productive
cooperation with government leaders, agencies, and policymakers. This
work offers insight into pathways forward toward healthier Micronesian
families and communities. Copyright 2021 by University Health Partners
of Hawaii (UHP Hawaii). | |34704065 |Hawaii journal of health &amp;
social welfare |Increasing exclusive breastfeeding rates is an
established public health strategy to reduce chronic disease and protect
infants from illness. The role of breastfeeding in addressing health
disparities takes on new significance as the COVID-19 pandemic has
disproportionately impacted some communities in Hawaii, and those with
chronic conditions face increased risk of hospitalization and death.
However, there are myriad policy, systemic, and environmental barriers
that make it difficult for parents to breastfeed, some of which have
been exacerbated by the COVID-19 pandemic. This editorial discusses the
importance of breastfeeding in reducing chronic disease, reviews the
status of breastfeeding in Hawaii, explores the challenges parents face
in breastfeeding their infants, especially in the time of COVID-19, and
presents opportunities for improved access to lactation care to reduce
health disparities. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34704064 |Hawaii journal of health &amp;
social welfare |The precarious financial status of the majority of
Hawaii residents coupled with the states heavy reliance on tourism
suggests that residents are particularly vulnerable to increased
economic hardship resulting from the COVID-19 pandemic, which
temporarily shut down the tourism industry and continues to erect
barriers for resuming operations. Understanding how Hawaii residents
prioritize access to health care, food economics, care of ina, and
culturally informed community in light of the current and future
economic situation can inform policy actions that will support public
health. To that end, this paper analyzes: (1) Hawaii residents views
on health, specifically food security and healthcare, and their
priorities for the future of these areas; (2) the differences between
Native Hawaiian and non-Native Hawaiian views and priorities; and (3)
the differences in views and priorities between families with higher and
lower levels of economic stability. The authors close with policy
recommendations that can be seen as medicine, or ways to heal Hawaii,
as the state shifts towards a more equitable and sustainable future.
Copyright 2021 by University Health Partners of Hawaii (UHP Hawaii).
| |34704063 |Hawaii journal of health &amp; social welfare |Utilizing
11 waves of data from the Household Pulse Survey collected between April
and November 2020, this study examines disparities in psychological
distress (defined as having symptoms of anxiety/depression) among adult
residents of Hawaii during the COVID-19 pandemic. Results showed that
36.4% of the respondents reported symptoms of distress. Younger age,
female, and lower household income were associated with higher levels of
psychological distress than older age, male, and higher household
income. The prevalence ratios of distress for those aged 18-24, 25-34,
35-44 and females were 43.1%, 47.3%, 44.1%, and 39.3% respectively.
Asians experienced lower prevalence compared to other racial/ethnic
groups. Two practical implications are offered. First, the economic
sequelae of COVID-19 impact psychological distress even when the
community infection rate is stable. Second, disparities in psychosocial
distress demonstrate that social and economic resources are needed by
social groups such as young adults, females, and racial/ethnic
minorities that have experienced the highest impact. Strategies need to
be developed to mitigate the unavoidable local consequences of a
pandemic. Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii). | |34704061 |Hawaii journal of health &amp; social welfare
|NA | |34687321 |European journal of nutrition
|<AbstractText Label="PURPOSE" NlmCategory="OBJECTIVE">In less than one
and a half year, the COVID-19 pandemic has nearly brought to a collapse
our health care and economic systems. The scientific research community
has concentrated all possible efforts to understand the pathogenesis of
this complex disease, and several groups have recently emphasized
recommendations for nutritional support in COVID-19 patients. In this
scoping review, we aim at encouraging a deeper appreciation of magnesium
in clinical nutrition, in view of the vital role of magnesium and the
numerous links between the pathophysiology of SARS-CoV-2 infection and
magnesium-dependent functions.
<AbstractText Label="METHODS" NlmCategory="METHODS">By searching PubMed
and Google Scholar from 1990 to date, we review existing evidence from
experimental and clinical studies on the role of magnesium in chronic
non-communicable diseases and infectious diseases, and we focus on
recent reports of alterations of magnesium homeostasis in COVID-19
patients and their association with disease outcomes. Importantly, we
conduct a census on ongoing clinical trials specifically dedicated to
disclosing the role of magnesium in COVID-19.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Despite many
methodological limitations, existing data seem to corroborate an
association between deranged magnesium homeostasis and COVID-19, and
call for further and better studies to explore the prophylactic or
therapeutic potential of magnesium supplementation.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">We propose to
reconsider the relevance of magnesium, frequently overlooked in clinical
practice. Therefore, magnesemia should be monitored and, in case of
imbalanced magnesium homeostasis, an appropriate nutritional regimen or
supplementation might contribute to protect against SARS-CoV-2
infection, reduce severity of COVID-19 symptoms and facilitate the
recovery after the acute phase.  2021. The Author(s). | |34662333 |PLoS
medicine |<AbstractText Label="BACKGROUND">UNAIDS has established new
program targets for 2025 to achieve the goal of eliminating AIDS as a
public health threat by 2030. This study reports on efforts to use
mathematical models to estimate the impact of achieving those targets.
<AbstractText Label="METHODS AND FINDINGS">We simulated the impact of
achieving the targets at country level using the Goals model, a
mathematical simulation model of HIV epidemic dynamics that includes the
impact of prevention and treatment interventions. For 77 high-burden
countries, we fit the model to surveillance and survey data for 1970 to
2020 and then projected the impact of achieving the targets for the
period 2019 to 2030. Results from these 77 countries were extrapolated
to produce estimates for 96 others. Goals model results were checked by
comparing against projections done with the Optima HIV model and the
AIDS Epidemic Model (AEM) for selected countries. We included estimates
of the impact of societal enablers (access to justice and law reform,
stigma and discrimination elimination, and gender equality) and the
impact of Coronavirus Disease 2019 (COVID-19). Results show that
achieving the 2025 targets would reduce new annual infections by 83%
(71% to 86% across regions) and AIDS-related deaths by 78% (67% to 81%
across regions) by 2025 compared to 2010. Lack of progress on societal
enablers could endanger these achievements and result in as many as 2.6
million (44%) cumulative additional new HIV infections and 440,000 (54%)
more AIDS-related deaths between 2020 and 2030 compared to full
achievement of all targets. COVID-19-related disruptions could increase
new HIV infections and AIDS-related deaths by 10% in the next 2 years,
but targets could still be achieved by 2025. Study limitations include
the reliance on self-reports for most data on behaviors, the use of
intervention effect sizes from published studies that may overstate
intervention impacts outside of controlled study settings, and the use
of proxy countries to estimate the impact in countries with fewer than
4,000 annual HIV infections. <AbstractText Label="CONCLUSIONS">The new
targets for 2025 build on the progress made since 2010 and represent
ambitious short-term goals. Achieving these targets would bring us close
to the goals of reducing new HIV infections and AIDS-related deaths by
90% between 2010 and 2030. By 2025, global new infections and AIDS
deaths would drop to 4.4 and 3.9 per 100,000 population, and the number
of people living with HIV (PLHIV) would be declining. There would be 32
million people on treatment, and they would need continuing support for
their lifetime. Incidence for the total global population would be below
0.15% everywhere. The number of PLHIV would start declining by 2023. |
|34661133 |Hawaii journal of health &amp; social welfare |The Republic
of the Marshall Islands, American Samoa, the Federated States of
Micronesia, and the Republic of Palau have been without any COVID-19
community transmission since the beginning of the global pandemic. The
Commonwealth of the Northern Mariana Islands has experienced modest
community transmission, and Guam has had significant COVID-19 community
transmission and morbidity. Although several of these United States
Affiliated Pacific Island jurisdictions made difficult strategic choices
to prevent the spread of COVID-19 which have been largely successful,
the built environment and the population density in the urban areas of
the Pacific remain inherently conducive to rapid COVID-19 transmission.
Rapid transmission could result in devastating health and economic
consequences in the absence of continued vigilance and long-term
strategic measures. The unique COVID-19 vulnerability of islands in the
Pacific can be modeled through examination of recent outbreaks onboard
several United States Naval ships and other marine vessels. The
environmental characteristics that pose challenges to infection control
on an isolated naval ship are analogous to the environmental
characteristics of these Pacific island communities. Considering a
collection of case studies of COVID-19 transmission on ships and
applying to Pacific Island environments, provides a heuristic, easily
accessible epidemiologic framework to identify methods for interventions
that are practical and reliable towards COVID-19 containment,
prevention, and control. Using accessible evidence based public health
policies, infection risk can be decreased with the objective of
maintaining in-country health and social stability. These case studies
have also been examined for their relevance to current discussions of
health care infrastructure and policy in the Pacific Islands, especially
that of vaccination and repatriation of citizens marooned in other
countries. The need for aggressive preparation on the parts of
territories and nations not yet heavily exposed to the virus is critical
to avoid a rapid burn-through of disease across the islands, which
would likely result in catastrophic consequences. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii). | |34661132
|Hawaii journal of health &amp; social welfare |Hawaiis Pacific
Islander (PI) population has suffered a higher burden of coronavirus
disease 2019 (COVID-19) infections, hospitalizations, and deaths
compared to other groups in the state. The Hawaii Emergency Management
Agency Community Care Outreach Unit conducted an assessment across the
state to gain an understanding of the impact of the COVID-19 pandemic on
the health and social welfare of households. Survey data was collected
from individuals across the state during a period of 3 weeks (August
12-September 5, 2020). The following are resulting recommendations from
the Pacific Island community to mitigate the impact and disparities of
the pandemic as immediate and medium-term structural requests: (1)
ensure that Pacific Island communities are proactively represented in
state and county committees that develop health interventions to ensure
that relevant language and culturally tailored communications and
strategies are included, (2) provide consistent funding and community
centered support to ensure consistent COVID-19 impact services for the
Pacific Island families, (3) enhance the capacity of PI health care
navigators and interpreters through increased funding and program
support, and (4) engage state policy makers immediately to understand
and address the systemic structural barriers to health care and social
services for Pacific Islanders in Hawaii. These recommendations were
developed to address the generational inequities and disparities that
exist for Pacific islanders in Hawaii which were exacerbated by the
COVID-19 pandemic. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34661131 |Hawaii journal of health &amp;
social welfare |Hawaiis Pacific Islander (PI) population has suffered
a higher burden of coronavirus disease 2019 (COVID-19) infections,
hospitalizations, and deaths compared to other groups in the state. The
Hawaii Emergency Management Agency Community Care Outreach Unit
conducted an assessment across the state to gain an understanding of the
impact of the COVID-19 pandemic on the health and social welfare of
households. Survey data was collected from individuals across the state
during a period of 3 weeks (August 12-September 5, 2020). The following
are resulting recommendations from the Pacific Island community to
mitigate the impact and disparities of the pandemic as immediate and
medium-term structural requests: (1) ensure that Pacific Island
communities are proactively represented in state and county committees
that develop health interventions to ensure that relevant language and
culturally tailored communications and strategies are included, (2)
provide consistent funding and community centered support to ensure
consistent COVID-19 impact services for the Pacific Island families, (3)
enhance the capacity of PI health care navigators and interpreters
through increased funding and program support, and (4) engage state
policy makers immediately to understand and address the systemic
structural barriers to health care and social services for Pacific
Islanders in Hawaii. These recommendations were developed to address
the generational inequities and disparities that exist for Pacific
islanders in Hawaii which were exacerbated by the COVID-19 pandemic.
Copyright 2021 by University Health Partners of Hawaii (UHP Hawaii).
| |34661130 |Hawaii journal of health &amp; social welfare |Hawaiis
Filipino community has been deeply impacted by coronavirus disease 2019
(COVID-19). This article reports the findings for the Filipino
population from the Hawaii Emergency Management Agency (HI-EMA)
Community Care Outreach Unit (CCO) Unit evaluation assessment of the
impact of COVID-19 on the health and social welfare of individuals
across the state. The survey was conducted from August-September 2020.
We propose recommendations to mitigate the impact of the pandemic on
this community, including the following actions: (1) developing
linguistically and culturally appropriate support for all COVID-19
related services, especially for the high number of older Filipinos with
limited English proficiency, (2) providing support and resource
information in locations that are accessible to Filipino communities,
and (3) supporting those already doing work to address the deep and
diverse needs in the Filipino community with funding. Building
partnerships between existing Filipino organizations, health and social
service providers, and state agencies will contribute to sustainability
over time. Copyright 2021 by University Health Partners of Hawaii (UHP
Hawaii). | |34661129 |Hawaii journal of health &amp; social welfare
|Native Hawaiians (NHs) are among the most vulnerable groups at greater
risk for coronavirus disease 2019 (COVID-19). To understand the impact
of COVID-19 on the states population, a 35-question cross-sectional
survey was administered across the state of Hawaii. NH data from the
larger report are provided here. The findings indicate that the impact
of COVID-19 is disproportionately affecting NH households in areas of
income and housing stability, chronic disease prevalence, emotional
wellness, and COVID-19 prevention. Short-, medium-, and long-term
recommendations are presented as next steps to addressing the health
inequities among NHs. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34661128 |Hawaii journal of health &amp;
social welfare |The Community Care Outreach Unit of the Hawaii
Emergency Management Agency (HI-EMA) Medical/Public Heath Branch
conducted a survey to gauge the impact, needs, and threats to the health
and social welfare of individuals and their families pertaining to
coronavirus disease 2019 (COVID-19). This article presents key findings
for the County of Maui (MC) in the state. A mixed-methods framework was
utilized for survey distribution and recruitment of participants from
across the state. Recruitment strategies included snowball sampling via
website and social media, and paper surveys. Descriptive analysis of the
data is presented to give a basic overview of the impact of COVID-19 in
MC. A total of 883 participants in MC responded to the survey.
Approximately one-third reported that they or family members experienced
reduced work hours or lost their job because of COVID-19. In all
questions related to paying for essential living needs, the percentage
of participants who expected to have future problems was higher than the
percentage who reported having current problems. Of those preparing for
the fall 2020 school semester, expected challenges included lack of
funds to purchase school supplies, lack of face coverings, and language
barriers. Most participants in MC perceived the severity of COVID-19 to
be moderate to very high, and there was a moderate level of knowledge
about which groups are more at risk for contracting severe COVID-19.
Less than half would know how to provide care for someone in their
family with COVID-19. Several resource barriers for caring for a family
member with COVID-19 were identified. The COVID-19 pandemic has had a
more severe impact on Native Hawaiian and Pacific Islander groups
compared to others in the county. The results may provide a baseline for
understanding the impact, needs, and threats to the health and social
welfare of individuals and their families in MC. Local stakeholders can
utilize this information to develop priorities, strategies, and programs
to address the COVID-19 pandemic response in MC. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii). | |34661127
|Hawaii journal of health &amp; social welfare |The Hawaii Emergency
Management Agency Community Care Outreach Unit (CCO) conducted a survey
to gauge the impact of coronavirus disease 2019 (COVID-19) on the health
and social welfare of individuals and their families across the state of
Hawaii. A mixed-methods framework was utilized for survey distribution.
This article presents a descriptive analysis of the data to provide a
basic overview of the impact of COVID-19 in Kauai County (KC), as
assessed in August/September 2020. A total of 420 participants in KC
responded to the statewide survey. Approximately one-third reported that
they or their family members experienced reduced work hours or lost
their job because of COVID-19. Many reported difficulties paying for
many types of living essentials and expected these difficulties to
increase in the near future. Prevalent challenges for the fall school
semester included access to funds for school supplies and
face-coverings. About one-third reported feeling nervous more than half
the time or nearly every day in the past 2 weeks, and one-fourth
reported feeling worried more than half the time or nearly every day in
the past 2 weeks. The majority perceived the severity of COVID-19 to be
moderate/very high and most had at least a moderate level of knowledge
about risks for contracting severe COVID-19. Less than half said they
would know how to provide care for someone in their family with
COVID-19. Half of the respondents in KC reported maintaining social
distancing usually/all of the time, the majority reported wearing a
face-covering usually/always when needed. The results provide a baseline
for understanding the impact, needs, and threats to the health and
social welfare of households and their families in KC as a result of
COVID-19. Local stakeholders can utilize this information for developing
priorities, strategies, and programs to address the pandemic where
needed and also to assess progress in areas of need. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii). | |34661126
|Hawaii journal of health &amp; social welfare |The Community Care
Outreach Unit (CCO) of the Hawaii Emergency Management Medical/Public
Health Services Branch conducted a survey to gauge the impact of
coronavirus disease 2019 (COVID-19) on the health and social welfare of
individuals and families in the state of Hawaii. A mixed-methods
framework was utilized for survey distribution; 7927 respondents
participated in the survey. This article presents key findings for the
states Hawaii County (HC). It presents a descriptive analysis of the
data to provide a basic overview of the impact of COVID-19 in HC, as
assessed in August-September 2020. A total of 936 participants from HC
responded to the survey. Approximately one-third reported that they or
their family members experienced reduced work hours, and one-fifth lost
their jobs because of COVID-19. Many reported difficulties paying for
many types of living essentials and expected these difficulties to
increase in the near future. Challenges for the fall school semester
included lack of access to funds for school supplies and face-coverings.
The majority perceived the severity of COVID-19 to be moderate/very high
and most had at least a moderate level of knowledge about risks for
developing severe COVID-19. Approximately half reported maintaining
social distancing usually/all of the time, and about two-thirds reported
wearing a face-covering usually/always when needed. Other barriers for
COVID disease prevention and response included a lack of space for
quarantine/isolation of family members, not having enough cleaning
supplies, low knowledge of how to care for a household member with COVID
disease and not having someone available to care for them if they
contracted the virus. The results provide a baseline for understanding
the impact, needs, and threats to the health and social welfare of
individuals and their families as a result of COVID-19 in HC. Local
stakeholders can utilize this information when developing priorities,
strategies, and programs to address the pandemic where needed.
Copyright 2021 by University Health Partners of Hawaii (UHP Hawaii).
| |34661125 |Hawaii journal of health &amp; social welfare |To address
the impact of COVID-19 in the state of Hawaii, the Hawaii Emergency
Management Agency Medical Public Health Branch activated its Community
Care Outreach Unit (CCO Unit). A team from this unit developed a survey
to assess the impact, needs, and threats to the health and social
welfare of individuals and their families as they pertain to COVID-19.
This article presents key findings for the City and County of Honolulu
(CCH). A total of 5598 CCH residents responded. Approximately half of
these respondents reported they or their household members experienced
reduced work hours or lost their job as a result of COVID-19. In all
questions related to paying for essential living costs, at the time of
the survey, the percentage of participants who expected to have future
problems nearly doubled. Those preparing for school in the fall school
semester expected challenges centered on insufficient funds to purchase
school supplies, lack of available face-coverings, and language
barriers. Financial assistance, rental assistance, and food assistance
seemed to be more difficult to apply for compared to health care
services. The most common reasons for difficulty with applications noted
by residents included that they could not figure out how to complete the
form, did not have all the documents, or could not get through on the
telephone. About one-half of CCH participants reported feeling nervous
more than half of the days or nearly every day in the past 2 weeks. Most
perceived the severity of COVID-19 to be moderate to very high. Less
than half reported knowing how to provide care for someone in their
family with COVID-19. Half of the CCH participants reported that they
practice social distancing usually or all of the time, and the majority
reported wearing a face-covering usually or always when outside of the
home. A significant portion of respondents reported barriers for
providing care for a household member exposed or infected with COVID-19.
Such barriers included a lack of space in their home for isolation; not
having enough cleaning supplies; no working thermometer in the home, or
no family member available to care for them. The results presented may
provide a baseline for understanding the impact, needs, and threats to
the health and social welfare of individuals and their families in CCH
and across the state of Hawaii. Local stakeholders can utilize this
information in developing priorities, strategies, and programs to
address the pandemic as it continues to unfold and learn lessons for
future pandemics. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34661124 |Hawaii journal of health &amp;
social welfare |The coronavirus disease 2019 (COVID-19) pandemic has had
a profound impact on the world. To address the impact of COVID-19 in the
state of Hawaii, the Hawaii Emergency Management Agency (HI-EMA)
Community Care Outreach Unit conducted an assessment survey to determine
the impact of COVID-19 on the health and social welfare of individuals
and their families across the state. This article presents key statewide
findings from this assessment, including areas of need and
community-based recommendations to help mitigate the impact of the
pandemic, particularly for vulnerable groups. A total of 7927
participants responded to the assessment survey from across the states
counties. In all questions related to paying for essentials, the
percentage of participants that expect to have problems in the future,
as compared to now, almost doubled. Slightly higher than one-third
reported that they would know how to care for a family member in the
home with COVID-19, and half of the respondents reported a lack of space
for isolation in their home. About half reported that if they got
COVID-19, they would have someone available to care for them. Overall,
Native Hawaiian, Pacific Islander, and Filipino groups reported greater
burden in almost all areas surveyed. The results presented provide a
baseline in understanding the impact, needs, and threats to the health
and social welfare of individuals and their families across the state of
Hawaii. Local stakeholders can utilize this information when developing
priorities, strategies, and programs to address current and future
pandemics in the state. Copyright 2021 by University Health Partners of
Hawaii (UHP Hawaii). | |34661123 |Hawaii journal of health &amp;
social welfare |Health and social service organizations across Hawaii
were surveyed between April 29 and May 11, 2020 by the Community Care
Outreach Unit of the Hawaii Emergency Management Agency. This article
contextualizes and describes some of the major findings of that survey
that reveal the impact of coronavirus disease 2019 (COVID-19) on Hawaii
community agencies, service organizations, and the individuals they
serve. Major issues for individuals served by the responding
organizations included securing basic needs such as food and housing as
well as access to health services, mental health needs, and COVID-19
concerns (such as inadequate personal protective equipment, cleaning
supplies, quarantine, and testing issues). Respondents reported that job
loss and the resulting financial problems were a root cause of personal
strain among clients served. Community-level stress was related to the
distressed economy and store closures. Fulfilling immediate and future
needs of health and social service agencies and the individuals they
serve, as articulated in this report, could dampen the effect of
COVID-19, promote population wellbeing, and support community
resilience. Copyright 2021 by University Health Partners of Hawaii
(UHP Hawaii). | |34661122 |Hawaii journal of health &amp; social
welfare |NA | |34661121 |Hawaii journal of health &amp; social welfare
|NA | |34621978 |Alzheimers &amp; dementia (New York, N. Y.)
|<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Recent
clinical trials are considering inclusion of more than just
apolipoprotein E (APOE) 4 genotype as a way of reducing variability in
analysis of outcomes.
<AbstractText Label="METHODS" NlmCategory="METHODS">Case-control data
were used to compare the capacity of age, sex, and 58 Alzheimers
disease (AD)-associated single nucleotide polymorphisms (SNPs) to
predict AD status using several statistical models. Model performance
was assessed with Brier scores and tenfold cross-validation. Genotype
and sex  age estimates from the best performing model were combined
with age and intercept estimates from the general population to develop
a personalized genetic risk score, termed age, and sex-adjusted
GenoRisk. <AbstractText Label="RESULTS" NlmCategory="RESULTS">The
elastic net model that included age, age x sex interaction, allelic APOE
terms, and 29 additional SNPs performed the best. This model explained
an additional 19% of the heritable risk compared to APOE genotype alone
and achieved an area under the curve of 0.747.
<AbstractText Label="DISCUSSION" NlmCategory="CONCLUSIONS">GenoRisk
could improve the risk assessment of individuals identified for
prevention studies.  2021 The Authors. Alzheimers &amp; Dementia:
Diagnosis, Assessment &amp; Disease Monitoring published by Wiley
Periodicals, LLC on behalf of Alzheimers Association. | |34562997
|Infectious disease reports
|<AbstractText Label="INTRODUCTION" NlmCategory="BACKGROUND">Given that
the success of vaccines against coronavirus disease 2019 (COVID-19)
relies on herd immunity, identifying patients at risk for vaccine
hesitancy is imperative-particularly for those at high risk for severe
COVID-19 (i.e., minorities and patients with neurological disorders).
<AbstractText Label="METHODS" NlmCategory="METHODS">Among patients from
a large neuroscience institute in Hawaii, vaccine hesitancy was
investigated in relation to over 30 sociodemographic variables and
medical comorbidities, via a telephone quality improvement survey
conducted between 23 January 2021 and 13 February 2021.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Vaccine willingness
(n = 363) was 81.3%. Univariate analysis identified that the odds of
vaccine acceptance reduced for patients who do not regard COVID-19 as a
severe illness, are of younger age, have a lower Charlson Comorbidity
Index, use illicit drugs, or carry Medicaid insurance. Multivariable
logistic regression identified the best predictors of vaccine hesitancy
to be: social media use to obtain COVID-19 information, concerns
regarding vaccine safety, self-perception of a preexisting medical
condition contraindicated with vaccination, not having received the
annual influenza vaccine, having some high school education only, being
a current smoker, and not having a prior cerebrovascular accident.
Unique amongst males, a conservative political view strongly predicted
vaccine hesitancy. Specifically for Asians, a higher body mass index,
while for Native Hawaiians and other Pacific Islanders (NHPI), a
positive depression screen, both reduced the odds of vaccine acceptance.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Upon
identifying the variables associated with vaccine hesitancy amongst
patients with neurological disorders, our clinic is now able to
efficiently provide ancillary COVID-19 education to sub-populations at
risk for vaccine hesitancy. While our results may be limited to the
sub-population of patients with neurological disorders, the findings
nonetheless provide valuable insight to understanding vaccine hesitancy.
| |34559481 |The primary care companion for CNS disorders |NA |
|34545941 |CA: a cancer journal for clinicians CA Cancer J Clin</p>
<pre><code>  Cancer statistics for the US Hispanic/Latino population, 2021.
  
    466
    487
    466-487
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.3322/caac.21695
  
    The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanic individuals in the United States using the most recent population-based data. An estimated 176,600 new cancer cases and 46,500 cancer deaths will occur among Hispanic individuals in the continental United States and Hawaii in 2021. Compared to non-Hispanic Whites (NHWs), Hispanic men and women had 25%-30% lower incidence (2014-2018) and mortality (2015-2019) rates for all cancers combined and lower rates for the most common cancers, although this gap is diminishing. For example, the colorectal cancer (CRC) incidence rate ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95% CI, 0.73-0.78) in 1995 to 0.91 (95% CI, 0.89-0.93) in 2018, reflecting delayed declines in CRC rates among Hispanic individuals in part because of slower uptake of screening. In contrast, Hispanic individuals have higher rates of infection-related cancers, including approximately two-fold higher incidence of liver and stomach cancer. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to NHW women, yet is largely preventable through screening. Less access to care may be similarly reflected in the low prevalence of localized-stage breast cancer among Hispanic women, 59% versus 67% among NHW women. Evidence-based strategies for decreasing the cancer burden among the Hispanic population include the use of culturally appropriate lay health advisors and patient navigators and targeted, community-based intervention programs to facilitate access to screening and promote healthy behaviors. In addition, the impact of the COVID-19 pandemic on cancer trends and disparities in the Hispanic population should be closely monitored.
     2021 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Miller
      Kimberly D
      KD
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-2609-2260
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Ortiz
      Ana P
      AP
      
        Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Pinheiro
      Paulo S
      PS
      
        Sylvester Comprehensive Cancer Center, University of Miami Health System, Miami, Florida.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Bandi
      Priti
      P
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Minihan
      Adair
      A
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Fuchs
      Hannah E
      HE
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Martinez Tyson
      Dinorah
      D
      
        College of Public Health, University of South Florida, Tampa, Florida.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Tortolero-Luna
      Guillermo
      G
      
        Cancer Control and Population Sciences, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Fedewa
      Stacey A
      SA
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Jemal
      Ahmedin M
      AM
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Siegel
      Rebecca L
      RL
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0001-5247-8522
      
        Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
    &lt;PublicationType UI=&quot;D052061&quot;&gt;Research Support, N.I.H., Extramural
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2021
    09
    21
  


  United States
  CA Cancer J Clin
  0370647
  0007-9235

IM

  
    &lt;DescriptorName UI=&quot;D000293&quot; MajorTopicYN=&quot;N&quot;&gt;Adolescent
  
  
    &lt;DescriptorName UI=&quot;D000328&quot; MajorTopicYN=&quot;N&quot;&gt;Adult
  
  
    &lt;DescriptorName UI=&quot;D000368&quot; MajorTopicYN=&quot;N&quot;&gt;Aged
  
  
    &lt;DescriptorName UI=&quot;D055088&quot; MajorTopicYN=&quot;N&quot;&gt;Early Detection of Cancer
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;Y&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D005260&quot; MajorTopicYN=&quot;N&quot;&gt;Female
  
  
    &lt;DescriptorName UI=&quot;D006297&quot; MajorTopicYN=&quot;N&quot;&gt;Health Services Accessibility
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;Y&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D006630&quot; MajorTopicYN=&quot;N&quot;&gt;Hispanic or Latino
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;Y&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D015994&quot; MajorTopicYN=&quot;N&quot;&gt;Incidence
  
  
    &lt;DescriptorName UI=&quot;D008297&quot; MajorTopicYN=&quot;N&quot;&gt;Male
  
  
    &lt;DescriptorName UI=&quot;D008875&quot; MajorTopicYN=&quot;N&quot;&gt;Middle Aged
  
  
    &lt;DescriptorName UI=&quot;D009369&quot; MajorTopicYN=&quot;N&quot;&gt;Neoplasms
    &lt;QualifierName UI=&quot;Q000208&quot; MajorTopicYN=&quot;Y&quot;&gt;ethnology
    &lt;QualifierName UI=&quot;Q000401&quot; MajorTopicYN=&quot;N&quot;&gt;mortality
    &lt;QualifierName UI=&quot;Q000517&quot; MajorTopicYN=&quot;N&quot;&gt;prevention &amp;amp; control
  
  
    &lt;DescriptorName UI=&quot;D011647&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;Puerto Rico
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D012307&quot; MajorTopicYN=&quot;N&quot;&gt;Risk Factors
  
  
    &lt;DescriptorName UI=&quot;D015996&quot; MajorTopicYN=&quot;N&quot;&gt;Survival Rate
  
  
    &lt;DescriptorName UI=&quot;D014481&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;United States
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D044465&quot; MajorTopicYN=&quot;N&quot;&gt;White People
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;N&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D055815&quot; MajorTopicYN=&quot;N&quot;&gt;Young Adult
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;Hispanics
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;Latinos
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;statistics
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;surveillance




  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2021
    8
    4
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2021
    8
    4
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2021
    9
    22
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2021
    11
    16
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2021
    9
    21
    8
    46
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;34545941
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.3322/caac.21695


  References                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                       |The Hispanic/Latino population is the second largest racial/ethnic group in the continental United States and Hawaii, accounting for 18% (60.6 million) of the total population. An additional 3 million Hispanic Americans live in Puerto Rico. Every 3 years, the American Cancer Society reports on cancer occurrence, risk factors, and screening for Hispanic individuals in the United States using the most recent population-based data. An estimated 176,600 new cancer cases and 46,500 cancer deaths will occur among Hispanic individuals in the continental United States and Hawaii in 2021. Compared to non-Hispanic Whites (NHWs), Hispanic men and women had 25%-30% lower incidence (2014-2018) and mortality (2015-2019) rates for all cancers combined and lower rates for the most common cancers, although this gap is diminishing. For example, the colorectal cancer (CRC) incidence rate ratio for Hispanic compared with NHW individuals narrowed from 0.75 (95% CI, 0.73-0.78) in 1995 to 0.91 (95% CI, 0.89-0.93) in 2018, reflecting delayed declines in CRC rates among Hispanic individuals in part because of slower uptake of screening. In contrast, Hispanic individuals have higher rates of infection-related cancers, including approximately two-fold higher incidence of liver and stomach cancer. Cervical cancer incidence is 32% higher among Hispanic women in the continental US and Hawaii and 78% higher among women in Puerto Rico compared to NHW women, yet is largely preventable through screening. Less access to care may be similarly reflected in the low prevalence of localized-stage breast cancer among Hispanic women, 59% versus 67% among NHW women. Evidence-based strategies for decreasing the cancer burden among the Hispanic population include the use of culturally appropriate lay health advisors and patient navigators and targeted, community-based intervention programs to facilitate access to screening and promote healthy behaviors. In addition, the impact of the COVID-19 pandemic on cancer trends and disparities in the Hispanic population should be closely monitored.  2021 The Authors. CA: A Cancer Journal for Clinicians published by Wiley Periodicals LLC on behalf of American Cancer Society.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |</code></pre>
<p>|34536350 |The Lancet. Infectious diseases |NA | |34532685 |NAM
perspectives |NA | |34529634 |MMWR. Morbidity and mortality weekly
report |Native Hawaiian and Pacific Islander populations have been
disproportionately affected by COVID-19 (1-3). Native Hawaiian, Pacific
Islander, and Asian populations vary in language; cultural practices;
and social, economic, and environmental experiences, which can affect
health outcomes (4). However, data from these populations are often
aggregated in analyses. Although data aggregation is often used as an
approach to increase sample size and statistical power when analyzing
data from smaller population groups, it can limit the understanding of
disparities among diverse Native Hawaiian, Pacific Islander, and Asian
subpopulations (4-7). To assess disparities in COVID-19 outcomes among
Native Hawaiian, Pacific Islander, and Asian populations, a
disaggregated, descriptive analysis, informed by recommendations from
these communities,** was performed using race data from 21,005 COVID-19
cases and 449 COVID-19-associated deaths reported to the Hawaii State
Department of Health (HDOH) during March 1, 2020-February 28, 2021. In
Hawaii, COVID-19 incidence and mortality rates per 100,000 population
were 1,477 and 32, respectively during this period. In analyses with
race categories that were not mutually exclusive, including persons of
one race alone or in combination with one or more races, Pacific
Islander persons, who account for 5% of Hawaiis population, represented
22% of COVID-19 cases and deaths (COVID-19 incidence of 7,070 and
mortality rate of 150). Native Hawaiian persons experienced an incidence
of 1,181 and a mortality rate of 15. Among subcategories of Asian
populations, the highest incidences were experienced by Filipino persons
(1,247) and Vietnamese persons (1,200). Disaggregating Native Hawaiian,
Pacific Islander, and Asian race data can aid in identifying racial
disparities among specific subpopulations and highlights the importance
of partnering with communities to develop culturally responsive outreach
teams and tailored public health interventions and vaccination
campaigns to more effectively address health disparities. | |34491990
|PLoS computational biology |Accurate estimates of infection prevalence
and seroprevalence are essential for evaluating and informing public
health responses and vaccination coverage needed to address the ongoing
spread of COVID-19 in each United States (U.S.) state. However,
reliable, timely data based on representative population sampling are
unavailable, and reported case and test positivity rates are highly
biased. A simple data-driven Bayesian semi-empirical modeling framework
was developed and used to evaluate state-level prevalence and
seroprevalence of COVID-19 using daily reported cases and test
positivity ratios. The model was calibrated to and validated using
published state-wide seroprevalence data, and further compared against
two independent data-driven mathematical models. The prevalence of
undiagnosed COVID-19 infections is found to be well-approximated by a
geometrically weighted average of the positivity rate and the reported
case rate. Our model accurately fits state-level seroprevalence data
from across the U.S. Prevalence estimates of our semi-empirical model
compare favorably to those from two data-driven epidemiological models.
As of December 31, 2020, we estimate nation-wide a prevalence of 1.4%
[Credible Interval (CrI): 1.0%-1.9%] and a seroprevalence of 13.2% [CrI:
12.3%-14.2%], with state-level prevalence ranging from 0.2% [CrI:
0.1%-0.3%] in Hawaii to 2.8% [CrI: 1.8%-4.1%] in Tennessee, and
seroprevalence from 1.5% [CrI: 1.2%-2.0%] in Vermont to 23% [CrI:
20%-28%] in New York. Cumulatively, reported cases correspond to only
one third of actual infections. The use of this simple and
easy-to-communicate approach to estimating COVID-19 prevalence and
seroprevalence will improve the ability to make public health decisions
that effectively respond to the ongoing COVID-19 pandemic. | |34481278
|Public health
|<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">During the
COVID-19 pandemic, the prevalence of psychological distress rose from
11% in 2019 to more than 40% in 2020. This study aims to examine the
disparities among US adult men and women.
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">We used 21
waves of cross-sectional data from the Household Pulse Survey that were
collected between April and December 2020 for the study. The Household
Pulse Survey was developed by the U.S. Census Bureau to document the
social and economic impact of COVID-19.
<AbstractText Label="METHODS" NlmCategory="METHODS">The study population
included four groups of adults: emerging adults (18-24 years); young
adults (25-44 years); middle-aged adults (45-64 years); and older adults
(65-88 years). Psychological distress was measured by their Generalized
Anxiety Disorder score and the Patient Health Questionnaire. The
prevalence of psychological stress was calculated using logistic models
adjusted for socio-demographic variables including race/ethnicity,
education, household income, and household structure. All descriptive
and regression analysis considered survey weights.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Younger age groups
experienced higher prevalence of psychological distress than older age
groups. Among emerging adults, the prevalence of anxiety (42.6%) and
depression (39.5%) was more than twice as high as older adults who
experienced prevalence of anxiety at 20% and depression at 16.6%. Gender
differences were also more apparent in emerging adults. Women between 18
and 24 years reported higher differential rates of anxiety and
depression than those with men (anxiety: 43.9% vs.28.3%; depression:
33.3% vs.24.9%).
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Understanding
the complex dynamics between COVID-19 and psychological distress has
emerged as a public health priority. Mitigating the negative mental
health consequences associated with the COVID-19 pandemic, for younger
generations and females in particular, will require local efforts to
rebuild capacity for social integration and social connection. Copyright
 2021 The Royal Society for Public Health. Published by Elsevier
Ltd.All rights reserved. | |34473201 |JAMA
|<AbstractText Label="IMPORTANCE">People who have been infected with or
vaccinated against SARS-CoV-2 have reduced risk of subsequent infection,
but the proportion of people in the US with SARS-CoV-2 antibodies from
infection or vaccination is uncertain.
<AbstractText Label="OBJECTIVE">To estimate trends in SARS-CoV-2
seroprevalence related to infection and vaccination in the US
population. <AbstractText Label="DESIGN, SETTING, AND PARTICIPANTS">In a
repeated cross-sectional study conducted each month during July 2020
through May 2021, 17 blood collection organizations with blood donations
from all 50 US states; Washington, DC; and Puerto Rico were organized
into 66 study-specific regions, representing a catchment of 74% of the
US population. For each study region, specimens from a median of
approximately 2000 blood donors were selected and tested each month; a
total of 1 594 363 specimens were initially selected and tested. The
final date of blood donation collection was May 31, 2021.
<AbstractText Label="EXPOSURE">Calendar time.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">Proportion of persons
with detectable SARS-CoV-2 spike and nucleocapsid antibodies.
Seroprevalence was weighted for demographic differences between the
blood donor sample and general population. Infection-induced
seroprevalence was defined as the prevalence of the population with both
spike and nucleocapsid antibodies. Combined infection- and
vaccination-induced seroprevalence was defined as the prevalence of the
population with spike antibodies. The seroprevalence estimates were
compared with cumulative COVID-19 case report incidence rates.
<AbstractText Label="RESULTS">Among 1 443 519 specimens included, 733
052 (50.8%) were from women, 174 842 (12.1%) were from persons aged 16
to 29 years, 292 258 (20.2%) were from persons aged 65 years and older,
36 654 (2.5%) were from non-Hispanic Black persons, and 88 773 (6.1%)
were from Hispanic persons. The overall infection-induced SARS-CoV-2
seroprevalence estimate increased from 3.5% (95% CI, 3.2%-3.8%) in July
2020 to 20.2% (95% CI, 19.9%-20.6%) in May 2021; the combined infection-
and vaccination-induced seroprevalence estimate in May 2021 was 83.3%
(95% CI, 82.9%-83.7%). By May 2021, 2.1 SARS-CoV-2 infections (95% CI,
2.0-2.1) per reported COVID-19 case were estimated to have occurred.
<AbstractText Label="CONCLUSIONS AND RELEVANCE">Based on a sample of
blood donations in the US from July 2020 through May 2021, vaccine- and
infection-induced SARS-CoV-2 seroprevalence increased over time and
varied by age, race and ethnicity, and geographic region. Despite
weighting to adjust for demographic differences, these findings from a
national sample of blood donors may not be representative of the entire
US population. | |34448649 |Clinical toxicology (Philadelphia, Pa.)
|<AbstractText Label="OBJECTIVES">Our six goals are: 1) describe the
relationship between the National Strategy for the COVID-19 Response and
Pandemic Preparedness and the 55 US poison centers (PCs); 2) detail FDA
emergency Use Authorization (EUA) COVID-19 vaccine-related regulatory
procedures and associated acronyms; 3) list availability of specific
vaccine clinical information to support PC staff COVID-19 vaccination
and adverse event (AE) data collection; 4) describe required health care
practitioner COVID-19 vaccine AE reporting to the Vaccine AE Reporting
System (VAERS) and PC reporting options; 5) document public and health
care professionals use of PCs for COVID-19 vaccine information; and 6)
propose strategy to maximize PCs contribution to the pandemic solution.
<AbstractText Label="METHODS">We reviewed 13-Feb-2020 through
15-Apr-2021 National Poison Data System (NPDS) COVID-19 records for
changes over time. We examined NPDS cases and VAERS COVID-19 vaccine
reports 1-Nov-2020 through 2-Apr-2021 for vaccine manufacturer, patient
characteristics, state, and clinical effects.
<AbstractText Label="RESULTS">PCs reported 1,052,174 COVID-19 contacts;
maximum (peak) contacts/day (12,163) on 16-Mar-2020. As of 5-Apr-2021
the US reported &gt;167 million administrations of COVID-19 vaccines
(Pfizer-BioNTech, Moderna or Janssen). US PCs reported 162,052 COVID-19
vaccine contacts. Most (61.1%) were medical information calls, 34.9%
were drug information, and 2.58% were exposures. Over the same period
VAERS reported 49,078 COVID-19 vaccine cases reporting 226,205 symptoms
- headache most frequent, ranging from 20% to 40% across the 3 vaccines.
<AbstractText Label="CONCLUSIONS AND RECOMMENDATIONS">Although
differences exist between the intent and content of the 2 data sets,
NPDS volume is compelling. The PC nationwide 800 number facilitates data
collection and suggests comingling the 2 data streams has merit. PC
professionals received tens of thousands of calls and can: 1) support
fact-based vaccine information; 2) contribute vaccine AE follow-up
information: 3) advocate for best-case coding and reporting, especially
for vaccine adverse experiences. | |34417121 |Paediatric respiratory
reviews |Mathematical modelling has played a pivotal role in
understanding the epidemiology of and guiding public health responses to
the ongoing coronavirus disease of 2019 (COVID-19) pandemic. Here, we
review the role of epidemiological models in understanding evolving
epidemic characteristics, including the effects of vaccination and
Variants of Concern (VoC). We highlight ways in which models continue to
provide important insights, including (1) calculating the herd immunity
threshold and evaluating its limitations; (2) verifying that nascent
vaccines can prevent severe disease, infection, and transmission but may
be less efficacious against VoC; (3) determining optimal vaccine
allocation strategies under efficacy and supply constraints; and (4)
determining that VoC are more transmissible and lethal than previously
circulating strains, and that immune escape may jeopardize
vaccine-induced herd immunity. Finally, we explore how models can help
us anticipate and prepare for future stages of COVID-19 epidemiology
(and that of other diseases) through forecasts and scenario projections,
given current uncertainties and data limitations. Copyright  2021.
Published by Elsevier Ltd.| |34406840 |Health affairs (Project Hope)
|COVID-19 vaccination campaigns continue in the United States, with the
expectation that vaccines will slow transmission of the virus, save
lives, and enable a return to normal life in due course. However, the
extent to which faster vaccine administration has affected
COVID-19-related deaths is unknown. We assessed the association between
US state-level vaccination rates and COVID-19 deaths during the first
five months of vaccine availability. We estimated that by May 9, 2021,
the US vaccination campaign was associated with a reduction of 139,393
COVID-19 deaths. The association varied in different states. In New
York, for example, vaccinations led to an estimated 11.7 fewer COVID-19
deaths per 10,000, whereas Hawaii observed the smallest reduction, with
an estimated 1.1 fewer deaths per 10,000. Overall, our analysis suggests
that the early COVID-19 vaccination campaign was associated with
reductions in COVID-19 deaths. As of May 9, 2021, reductions in COVID-19
deaths associated with vaccines had translated to value of statistical
life benefit ranging between $625 billion and $1.4 trillion. | |34391908
|International journal of infectious diseases : IJID : official
publication of the International Society for Infectious Diseases
|<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">To evaluate
the impact of the World Antimicrobial Awareness Week (WAAW) on public
awareness of antimicrobial resistance using Google Trends analysis.
<AbstractText Label="METHODS" NlmCategory="METHODS">The impact of WAAW
on public awareness of antimicrobial resistance (AMR),
antibacterial, and antibiotics in Japan, the UK, the United States,
and worldwide from 2015 to 2020 was analyzed, using the relative search
volume (RSV) of Google Trends as a surrogate. A joinpoint regression
analysis was performed to identify a statistically significant time
point of a change in trend.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">No joinpoints around
WAAW were identified in Japan, the United Kingdom, or the United States
from 2015 to 2020 with RSVs of AMR, whereas increasing RSVs were noted
worldwide in 2017 and 2020. Further, there were decreasing RSVs of
antibiotics in the first half of 2020, which could be due to the
COVID-19 pandemic. The study results suggest that WAAW did little to
improve public awareness of AMR in the selected countries despite its
contribution worldwide.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">This study
implies that we need to develop a more effective method to improve
public awareness to fight against AMR. Copyright  2021 The Author(s).
Published by Elsevier Ltd.. All rights reserved. | |34367726 |Clinical
&amp; experimental pharmacology |The impact of COVID-19 disease on
health and economy has been global, and the magnitude of devastation is
unparalleled in modern history. Any potential course of action to manage
this complex disease requires the systematic and efficient analysis of
data that can delineate the underlying pathogenesis. We have developed a
mathematical model of disease progression to predict the clinical
outcome, utilizing a set of causal factors known to contribute to
COVID-19 pathology such as age, comorbidities, and certain viral and
immunological parameters. Viral load and selected indicators of a
dysfunctional immune response, such as cytokines IL-6 and IFN which
contribute to the cytokine storm and fever, parameters of inflammation
D-Dimer and Ferritin, aberrations in lymphocyte number, lymphopenia, and
neutralizing antibodies were included for the analysis. The model
provides a framework to unravel the multi-factorial complexities of the
immune response manifested in SARS-CoV-2 infected individuals. Further,
this model can be valuable to predict clinical outcome at an individual
level, and to develop strategies for allocating appropriate resources to
manage severe cases at a population level. | |34355196 |Hawaii journal
of health &amp; social welfare |Native Hawaiian and Pacific Islander
(NHPI) populations suffer from disproportionately higher rates of
chronic conditions, such as type 2 diabetes, that arises from metabolic
dysfunction and are often associated with obesity and inflammation. In
addition, the global coronavirus disease 2019 pandemic has further
compounded the effect of health inequities observed in Indigenous
populations, including NHPI communities. Reversible lifestyle habits,
such as diet, may either be protective of or contribute to the
increasing prevalence of health inequities in these populations via the
immunoepigenetic-microbiome axis. This axis offers insight into the
connection between diet, epigenetics, the microbiome composition, immune
function, and response to viral infection. Epigenetic mechanisms that
regulate inflammatory states associated with metabolic diseases,
including diabetes, are impacted by diet. Furthermore, diet may modulate
the gut microbiome by influencing microbial diversity and richness;
dysbiosis of the microbiome is associated with chronic disease. A high
fiber diet facilitates a favorable microbiome composition and in turn
increases production of intermediate metabolites named short-chain fatty
acids (SCFAs) that act on metabolic and immune pathways. In contrast,
low fiber diets typically associated with a westernized lifestyle
decreases the abundance of microbial derived SCFAs. This decreased
abundance is characteristic of metabolic syndromes and activation of
chronic inflammatory states, having larger implications in disease
pathogenesis of both communicable and non-communicable diseases. Native
Hawaiians and Pacific Islanders that once thrived on healthy traditional
diets may be more sensitive than non-indigenous peoples to the metabolic
perturbation of westernized diets that impinge on the
immunoepigenetic-gut microbiome axis. Recent studies conducted in the
Maunakea lab at the University of Hawaii at Mnoa John A. Burns School
of Medicine have helped elucidate the connections between diet,
microbiome composition, metabolic syndrome, and epigenetic regulation of
immune function to better understand disease pathogenesis. Potentially,
this research could point to ways to prevent pre-disease conditions
through novel biomarker discovery using community-based approaches.
Copyright 2021 by University Health Partners of Hawaii (UHP Hawaii).
| |34352507 |Social science &amp; medicine (1982) |The United States
experienced three surges of COVID-19 community infection since the World
Health Organization declared the pandemic on March 11, 2020. The
prevalence of psychological distress among U.S. adults increased from 11
% in 2019 to 35.9 % in April 2020 when New York City become the
epicenter of the COVID-19 outbreak. Analyzing 21 waves of the Household
Pulse Survey data collected between April 2020 and December 2020, this
study aimed to examine the distress level in the 15 most populated
metropolitan areas in the U.S. Our study found that, as the pandemic
swept from East to South and soared in the West, 39.9%-52.3 % U.S.
adults living in these 15 metropolitan areas reported symptoms of
psychological distress. The highest distress levels were found within
the Western areas including Riverside-San Bernardino-Ontario (52.3 % in
July 2020, 95 % CI: 44.9%-59.6 %) and Los Angeles-Long Beach-Anaheim
(49.9 % in December 2020, 95 % CI: 44.5%-55.4 %). The lowest distress
level was observed in Washington-Arlington-Alexandria ranging from 29.1
% in May 2020 to 39.9 % in November 2020. COVID-19 and its complex
ecology of social and economic stressors have engaged high levels of
sustained psychological distress. Our findings will support the efforts
of local, state and national leadership to plan interventions by
addressing not only the medical, but also the economic and social
conditions associated with the pandemic. Copyright  2021 Elsevier
Ltd.All rights reserved. | |34334985 |Seminars in arthroplasty
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Although the
COVID-19 pandemic has disrupted elective shoulder arthroplasty
throughput, traumatic shoulder arthroplasty procedures are less apt to
be postponed. We sought to evaluate shoulder arthroplasty utilization
for fracture during the COVID-19 pandemic and Californias associated
shelter-in-place order compared to historical controls.
<AbstractText Label="METHODS" NlmCategory="METHODS">We conducted a
cohort study with historical controls, identifying patients who
underwent shoulder arthroplasty for proximal humerus fracture in
California using our integrated electronic health record. The time
period of interest was following the implementation of the statewide
shelter-in-place order: March 19, 2020-May 31, 2020. This was compared
to three historical periods: January 1, 2020-March 18, 2020, March 18,
2019-May 31, 2019, and January 1, 2019-March 18, 2019. Procedure volume,
patient characteristics, in-hospital length of stay, and 30-day events
(emergency department visit, readmission, infection, pneumonia, and
death) were reported. Changes over time were analyzed using linear
regression adjusted for usual seasonal and yearly changes and age, sex,
comorbidities, and postadmission factors.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Surgical volume
dropped from an average of 4.4, 5.2, and 2.6 surgeries per week in the
historical time periods, respectively, to 2.4 surgeries per week after
shelter-in-place. While no more than 30% of all shoulder arthroplasty
procedures performed during any given week were for fracture during the
historical time periods, arthroplasties performed for fracture was the
overwhelming primary indication immediately after the shelter-in-place
order. More patients were discharged the day of surgery (+33.2%, P =
.019) after the shelter-in-place order, but we did not observe a change
in any of the corresponding 30-day events.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">The volume
of shoulder arthroplasty for fracture dropped during the time of
COVID-19. The reduction in volume could be due to less shoulder trauma
due to shelter-in-place or a change in the indications for arthroplasty
given the perceived higher risks associated with intubation and surgical
care. We noted more patients undergoing shoulder arthroplasty for
fracture were safely discharged on the day of surgery, suggesting this
may be a safe practice that can be adopted moving forward.
<AbstractText Label="LEVEL OF EVIDENCE" NlmCategory="METHODS">Level III;
Retrospective Case-control Comparative Study.  2021 American Shoulder
and Elbow Surgeons. Published by Elsevier Inc.All rights reserved. |
|34331541 |The Journal of infectious diseases
|<AbstractText Label="BACKGROUND">The mechanisms underlying the
association between obesity and coronavirus disease 2019 (COVID-19)
severity remain unclear. After verifying that obesity was a correlate of
severe COVID-19 in US Military Health System (MHS) beneficiaries, we
compared immunological and virological phenotypes of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in both obese
and nonobese participants.
<AbstractText Label="METHODS">COVID-19-infected MHS beneficiaries were
enrolled, and anthropometric, clinical, and demographic data were
collected. We compared the SARS-CoV-2 peak IgG humoral response and
reverse-transcription polymerase chain reaction viral load in obese and
nonobese patients, stratified by hospitalization, utilizing logistic
regression models. <AbstractText Label="RESULTS">Data from 511 COVID-19
patients were analyzed, among whom 24% were obese and 14% severely
obese. Obesity was independently associated with hospitalization
(adjusted odds ratio [aOR], 1.91; 95% confidence interval [CI],
1.15-3.18) and need for oxygen therapy (aOR, 3.39; 95% CI, 1.61-7.11).
In outpatients, severely obese had a log10 (1.89) higher nucleocapsid
(N1) genome equivalents (GE)/reaction and log10 (2.62) higher N2
GE/reaction than nonobese (P = 0.03 and P &lt; .001, respectively). We
noted a correlation between body mass index and peak anti-spike protein
IgG in inpatients and outpatients (coefficient = 5.48, P &lt; .001).
<AbstractText Label="CONCLUSIONS">Obesity is a strong correlate of
COVID-19 severity in MHS beneficiaries. These findings offer new
pathophysiological insights into the relationship between obesity and
COVID-19 severity.  The Author(s) 2021. Published by Oxford University
Press for the Infectious Diseases Society of America. All rights
reserved. For permissions, e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>. | |34314211 |American
journal of public health |As of March 2021, Native Hawaiians and Pacific
Islanders (NHPIs) in the United States have lost more than 800 lives to
COVID-19-the highest per capita death rate in 18 of 20 US states
reporting NHPI deaths. However, NHPI risks are overlooked in policy
discussions. We discuss the NHPI COVID-19 Data Policy Lab and dashboard,
featuring the disproportionate COVID-19 mortality burden for NHPIs. The
Lab democratized NHPI data, developed community infrastructure and
resources, and informed testing site and outreach policies related to
health equity. | |34308400 |The Lancet regional health. Western Pacific
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">COVID-19
initially caused less severe outbreaks in many low- and middle-income
countries (LMIC) compared with many high-income countries, possibly
because of differing demographics, socioeconomics, surveillance, and
policy responses. Here, we investigate the role of multiple factors on
COVID-19 dynamics in the Philippines, a LMIC that has had a relatively
severe COVID-19 outbreak.
<AbstractText Label="METHODS" NlmCategory="METHODS">We applied an
age-structured compartmental model that incorporated time-varying
mobility, testing, and personal protective behaviors (through a Minimum
Health Standards policy, MHS) to represent the first wave of the
Philippines COVID-19 epidemic nationally and for three highly affected
regions (Calabarzon, Central Visayas, and the National Capital Region).
We estimated effects of control measures, key epidemiological
parameters, and interventions.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Population age
structure, contact rates, mobility, testing, and MHS were sufficient to
explain the Philippines epidemic based on the good fit between modelled
and reported cases, hospitalisations, and deaths. The model indicated
that MHS reduced the probability of transmission per contact by 13-27%.
The February 2021 case detection rate was estimated at ~8%, population
recovered at ~9%, and scenario projections indicated high sensitivity to
MHS adherence.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">COVID-19
dynamics in the Philippines are driven by age, contact structure,
mobility, and MHS adherence. Continued compliance with low-cost MHS
should help the Philippines control the epidemic until vaccines are
widely distributed, but disease resurgence may be occurring due to a
combination of low population immunity and detection rates and new
variants of concern.  2021 Published by Elsevier Ltd.| |34308322
|EClinicalMedicine
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">There is
limited prior investigation of the combined influence of personal and
community-level socioeconomic factors on racial/ethnic disparities in
individual risk of coronavirus disease 2019 (COVID-19).
<AbstractText Label="METHODS" NlmCategory="METHODS">We performed a
cross-sectional analysis nested within a prospective cohort of 2,102,364
participants from March 29, 2020 in the United States (US) and March 24,
2020 in the United Kingdom (UK) through December 02, 2020 via the COVID
Symptom Study smartphone application. We examined the contribution of
community-level deprivation using the Neighborhood Deprivation Index
(NDI) and the Index of Multiple Deprivation (IMD) to observe
racial/ethnic disparities in COVID-19 incidence. ClinicalTrials.gov
registration: NCT04331509.
<AbstractText Label="FINDINGS" NlmCategory="RESULTS">Compared with
non-Hispanic White participants, the risk for a positive COVID-19 test
was increased in the US for non-Hispanic Black (multivariable-adjusted
odds ratio [OR], 1.32; 95% confidence interval [CI], 1.18-1.47) and
Hispanic participants (OR, 1.42; 95% CI, 1.33-1.52) and in the UK for
Black (OR, 1.17; 95% CI, 1.02-1.34), South Asian (OR, 1.39; 95% CI,
1.30-1.49), and Middle Eastern participants (OR, 1.38; 95% CI,
1.18-1.61). This elevated risk was associated with living in more
deprived communities according to the NDI/IMD. After accounting for
downstream mediators of COVID-19 risk, community-level deprivation still
mediated 16.6% and 7.7% of the excess risk in Black compared to White
participants in the US and the UK, respectively.
<AbstractText Label="INTERPRETATION" NlmCategory="CONCLUSIONS">Our
results illustrate the critical role of social determinants of health in
the disproportionate COVID-19 risk experienced by racial and ethnic
minorities.  2021 The Author(s). | |34291832 |Journal of traumatic
stress |The onset of the COVID-19 pandemic disrupted many aspects of
daily life and required a rapid and unprecedented shift in psychotherapy
delivery from in-person to telemental health. In the present study, we
explored the impact of the pandemic on individuals ability to
participate in posttraumatic stress disorder (PTSD) psychotherapy and
the association between the impact of COVID-19 impact on health and
financial well-being and psychotherapy participation. Participants (N =
161, 63.2% male, Mage = 42.7 years) were United States military veterans
(n = 108), active duty military personnel (n = 12), and civilians (n =
6), who were participating in one of nine PTSD treatment trials. The
results indicate a predominately negative COVID-19 impact on therapy
participation, although some participants (26.1%) found attending
therapy sessions through telehealth to be easier than in-person therapy.
Most participants (66.7%) reported that completing in vivo exposure
homework became harder during the pandemic. Moreover, the impact of the
pandemic on PTSD symptom severity and daily stress were each associated
with increased difficulty with aspects of therapy participation. The
findings highlight the unique challenges to engaging in PTSD treatment
during the pandemic as well as a negative impact on daily stress and
PTSD severity, both of which were related to treatment engagement
difficulties.  2021 International Society for Traumatic Stress Studies.
| |34287651 |Journal of travel medicine |NA | |34287159 |Journal of the
American Medical Directors Association |NA | |34283939 |Journal of child
and adolescent psychopharmacology |Objectives: Our goal was to develop
an open access nationally disseminated online curriculum for use in
graduate and continuing medical education on the topic of pediatric
telepsychiatry to enhance the uptake of telepsychiatry among child
psychiatry training programs and improve access to mental health care
for youth and families. Methods: Following Kerns 6-stage model of
curriculum development, we identified a core problem, conducted a needs
assessment, developed broad goals and measurable objectives in a
competency-based model, and developed educational content and methods.
The curriculum was reviewed by experts and feedback incorporated. Given
the urgent need for such a curriculum due to the COVID-19 pandemic, the
curriculum was immediately posted on the American Academy of Child and
Adolescent Psychiatry and American Association of Directors of
Psychiatric Residency Training websites. Further evaluation will be
conducted over the next year. Results: The curriculum covers the six
areas of core competence adapted for pediatric telepsychiatry and
includes teaching content and resources, evaluation tools, and
information about other resources. Conclusion: This online curriculum is
available online and provides an important resource and set of standards
for pediatric telepsychiatry training. Its online format allows for
ongoing revision as the telepsychiatry landscape changes. | |34254888
|Human vaccines &amp; immunotherapeutics |Nurses are the largest single
occupation of health care providers and at greatest risk for exposure to
and acquisition of Coronavirus Disease 2019 (COVID-19). In December
2020, nurses in Hawaii were recruited for an online survey that measured
perceived risk/threat of COVID-19, vaccine attitudes, and perceived
safety of COVID-19 vaccines, as well as level of intention: primary,
secondary (i.e., delayed), or no intention to vaccinate. The final
sample consisted of 423 nurses. Participants were primarily Asian
(27.9%) and White (45.2%). The majority were 18-50 years (65.5%) and
female (87.0%), held an RN license (91.7%), and identified as a staff
nurse (57.7%) in the hospital setting (56.7%). Among participants, 52.3%
indicated primary intention, 27.9% secondary intention, and 19.9% no
intention to vaccinate. The strongest predictors of any level of
intention were greater positive attitudes toward COVID-19 vaccination
and lower concerns related to COVID-19 vaccine safety. Findings can
guide interventions to support vaccine acceptance for those who
initially decline vaccination. | |34228774 |JAMA
|<AbstractText Label="IMPORTANCE">Clinical trials assessing the efficacy
of IL-6 antagonists in patients hospitalized for COVID-19 have variously
reported benefit, no effect, and harm.
<AbstractText Label="OBJECTIVE">To estimate the association between
administration of IL-6 antagonists compared with usual care or placebo
and 28-day all-cause mortality and other outcomes.
<AbstractText Label="DATA SOURCES">Trials were identified through
systematic searches of electronic databases between October 2020 and
January 2021. Searches were not restricted by trial status or language.
Additional trials were identified through contact with experts.
<AbstractText Label="STUDY SELECTION">Eligible trials randomly assigned
patients hospitalized for COVID-19 to a group in whom IL-6 antagonists
were administered and to a group in whom neither IL-6 antagonists nor
any other immunomodulators except corticosteroids were administered.
Among 72 potentially eligible trials, 27 (37.5%) met study selection
criteria. <AbstractText Label="DATA EXTRACTION AND SYNTHESIS">In this
prospective meta-analysis, risk of bias was assessed using the Cochrane
Risk of Bias Assessment Tool. Inconsistency among trial results was
assessed using the I2 statistic. The primary analysis was an inverse
variance-weighted fixed-effects meta-analysis of odds ratios (ORs) for
28-day all-cause mortality.
<AbstractText Label="MAIN OUTCOMES AND MEASURES">The primary outcome
measure was all-cause mortality at 28 days after randomization. There
were 9 secondary outcomes including progression to invasive mechanical
ventilation or death and risk of secondary infection by 28 days.
<AbstractText Label="RESULTS">A total of 10 930 patients (median age, 61
years [range of medians, 52-68 years]; 3560 [33%] were women)
participating in 27 trials were included. By 28 days, there were 1407
deaths among 6449 patients randomized to IL-6 antagonists and 1158
deaths among 4481 patients randomized to usual care or placebo (summary
OR, 0.86 [95% CI, 0.79-0.95]; P = .003 based on a fixed-effects
meta-analysis). This corresponds to an absolute mortality risk of 22%
for IL-6 antagonists compared with an assumed mortality risk of 25% for
usual care or placebo. The corresponding summary ORs were 0.83 (95% CI,
0.74-0.92; P &lt; .001) for tocilizumab and 1.08 (95% CI, 0.86-1.36; P =
.52) for sarilumab. The summary ORs for the association with mortality
compared with usual care or placebo in those receiving corticosteroids
were 0.77 (95% CI, 0.68-0.87) for tocilizumab and 0.92 (95% CI,
0.61-1.38) for sarilumab. The ORs for the association with progression
to invasive mechanical ventilation or death, compared with usual care or
placebo, were 0.77 (95% CI, 0.70-0.85) for all IL-6 antagonists, 0.74
(95% CI, 0.66-0.82) for tocilizumab, and 1.00 (95% CI, 0.74-1.34) for
sarilumab. Secondary infections by 28 days occurred in 21.9% of patients
treated with IL-6 antagonists vs 17.6% of patients treated with usual
care or placebo (OR accounting for trial sample sizes, 0.99; 95% CI,
0.85-1.16). <AbstractText Label="CONCLUSIONS AND RELEVANCE">In this
prospective meta-analysis of clinical trials of patients hospitalized
for COVID-19, administration of IL-6 antagonists, compared with usual
care or placebo, was associated with lower 28-day all-cause mortality.
<AbstractText Label="TRIAL REGISTRATION">PROSPERO Identifier:
CRD42021230155. | |34226774 |Optimal control applications &amp; methods
|In this work, we develop and analyze a mathematical model for the
dynamics of COVID-19 with re-infection in order to assess the impact of
prior comorbidity (specifically, diabetes mellitus) on COVID-19
complications. The model is simulated using data relevant to the
dynamics of the diseases in Lagos, Nigeria, making predictions for the
attainment of peak periods in the presence or absence of comorbidity.
The model is shown to undergo the phenomenon of backward bifurcation
caused by the parameter accounting for increased susceptibility to
COVID-19 infection by comorbid susceptibles as well as the rate of
reinfection by those who have recovered from a previous COVID-19
infection. Simulations of the cumulative number of active cases
(including those with comorbidity), at different reinfection rates, show
infection peaks reducing with decreasing reinfection of those who have
recovered from a previous COVID-19 infection. In addition, optimal
control and cost-effectiveness analysis of the model reveal that the
strategy that prevents COVID-19 infection by comorbid susceptibles is
the most cost-effective of all the control strategies for the prevention
of COVID-19.  2021 John Wiley &amp; Sons Ltd.| |34210370 |Epidemiology
and infection |We estimate the delay-adjusted all-cause excess deaths
across 53 US jurisdictions. Using provisional data collected from
September through December 2020, we first identify a common mean
reporting delay of 2.8 weeks, whereas four jurisdictions have prolonged
reporting delays compared to the others: Connecticut (mean 5.8 weeks),
North Carolina (mean 10.4 weeks), Puerto Rico (mean 4.7 weeks) and West
Virginia (mean 5.5 weeks). After adjusting for reporting delays, we
estimate the percent change in all-cause excess mortality from March to
December 2020 with range from 0.2 to 3.6 in Hawaii to 58.4 to 62.4 in
New York City. Comparing the March-December with September-December 2020
periods, the highest increases in excess mortality are observed in South
Dakota (36.9-54.0), North Dakota (33.9-50.7) and Missouri (27.8-33.9).
Our findings indicate that analysis of provisional data requires caution
in interpreting the death counts in recent weeks, while one needs also
to account for heterogeneity in reporting delays of excess deaths among
US jurisdictions. | |34195618 |Hawaii journal of health &amp; social
welfare |This report describes the rapid implementation of a statewide
observational surveillance program to monitor the publics wearing of
face masks in public spaces during community spread of Coronavirus
disease 2019 (COVID-19). It describes how the Hawaii State Department
of Health partnered with University of Hawaii faculty to develop and
implement the surveillance program. The surveillance program involved
organizing volunteers to conduct weekly direct observations in
designated locations. A smartphone application (app) was created to
record real-time observational surveillance data. From September 5,
2020, to March 13, 2021, a total of 84 577 observations were conducted
across the state. Eighty-three percent of those observed were correctly
wearing a face mask, 7% were wearing a face mask incorrectly, and 10%
were not wearing a mask. Following the 2-week pilot phase of the
project, volunteers were surveyed regarding facilitators and barriers
for conducting observations and motivations for volunteering. Feedback
was used to refine project procedures. With few states having
implemented such a surveillance program, the information reported in
this article may inform communities interested in tracking mask-wearing
behaviors in the context of the COVID-19 pandemic. Copyright 2021 by
University Health Partners of Hawaii (UHP Hawaii). | |34189029
|International journal of disaster risk reduction : IJDRR |COVID-19
pandemic is devastating the health, social, and economic well-being of
citizens worldwide. The high rates of morbidity and mortality and the
absence of vaccines cause fear among the people regardless of age,
gender, or social status. Peoples fear is heightened by misinformation
spread across all media types, especially on social media. Filipino
college students are one of the top Internet users worldwide and are
very active in social media. Hence they are very prone to
misinformation. This paper aims to ascertain the levels of knowledge,
precaution, and fear of COVID-19 of the college students in Iloilo,
Philippines, and determine the effects of their information-seeking
behavior on the variables above. This paper is a cross-sectional survey
that used a qualitative-quantitative method and snowball sampling
technique. Data were gathered among 228 college students using an online
survey instrument a few months after the pandemic began. College
students were knowledgeable of the basic facts about the highly
infectious COVID-19. However, the majority were inclined to believe the
myths and misinformation regarding the pandemic. Television was the
primary, most believable, and preferred source when seeking information.
The Internet as a preferred source of information was significantly
associated with a high level of knowledge. In contrast, the information
sourced from interpersonal channels were found to make college students
very cautious. The local presence of COVID-19 cases had caused college
students to fear, likely exacerbated by the plethora of information
about the pandemic, mostly from Facebook. This is the first study
conducted on the effects of the information-seeking behavior on the
levels of knowledge, precaution, and fear of COVID-19 of the college
students in Iloilo, Philippines.  2021 Elsevier Ltd.All rights
reserved. | |34183789 |Genetics in medicine : official journal of the
American College of Medical Genetics |<AbstractText Label="PURPOSE">It
is critical to identify putative causal targets for SARS coronavirus 2,
which may guide drug repurposing options to reduce the public health
burden of COVID-19. <AbstractText Label="METHODS">We applied
complementary methods and multiphased design to pinpoint the most likely
causal genes for COVID-19 severity. First, we applied cross-methylome
omnibus (CMO) test and leveraged data from the COVID-19 Host Genetics
Initiative (HGI) comparing 9,986 hospitalized COVID-19 patients and
1,877,672 population controls. Second, we evaluated associations using
the complementary S-PrediXcan method and leveraging blood and lung
tissue gene expression prediction models. Third, we assessed
associations of the identified genes with another COVID-19 phenotype,
comparing very severe respiratory confirmed COVID versus population
controls. Finally, we applied a fine-mapping method, fine-mapping of
gene sets (FOGS), to prioritize putative causal genes.
<AbstractText Label="RESULTS">Through analyses of the COVID-19 HGI using
complementary CMO and S-PrediXcan methods along with fine-mapping, XCR1,
CCR2, SACM1L, OAS3, NSF, WNT3, NAPSA, and IFNAR2 are identified as
putative causal genes for COVID-19 severity.
<AbstractText Label="CONCLUSION">We identified eight genes at five
genomic loci as putative causal genes for COVID-19 severity.  2021. The
Author(s), under exclusive licence to the American College of Medical
Genetics and Genomics. | |34183411 |Proceedings of the National Academy
of Sciences of the United States of America |In this perspective, we
draw on recent scientific research on the coffee leaf rust (CLR)
epidemic that severely impacted several countries across Latin America
and the Caribbean over the last decade, to explore how the socioeconomic
impacts from COVID-19 could lead to the reemergence of another rust
epidemic. We describe how past CLR outbreaks have been linked to reduced
crop care and investment in coffee farms, as evidenced in the years
following the 2008 global financial crisis. We discuss relationships
between CLR incidence, farmer-scale agricultural practices, and economic
signals transferred through global and local effects. We contextualize
how current COVID-19 impacts on labor, unemployment, stay-at-home
orders, and international border policies could affect farmer
investments in coffee plants and in turn create conditions favorable for
future shocks. We conclude by arguing that COVID-19s socioeconomic
disruptions are likely to drive the coffee industry into another severe
production crisis. While this argument illustrates the vulnerabilities
that come from a globalized coffee system, it also highlights the
necessity of ensuring the well-being of all. By increasing investments
in coffee institutions and paying smallholders more, we can create a
fairer and healthier system that is more resilient to future
social-ecological shocks. | |34183191 |Nursing outlook
|<AbstractText Label="BACKGROUND">In 2020, nursing educational programs
were abruptly interrupted and largely moved online due to the COVID-19
pandemic. <AbstractText Label="PURPOSE">To explore nursing students
perspectives about the effects of the pandemic on their education and
intention to join the nursing workforce.
<AbstractText Label="METHODS">Undergraduate nursing students from 5
universities across 5 United States regions were invited to participate
in an online survey to elicit both quantitative and qualitative data.
<AbstractText Label="FINDINGS">The final sample included quantitative
data on 772 students and qualitative data on 540 students. Largely
(65.1%), students reported that the pandemic strengthened their desire
to become a nurse; only 11% had considered withdrawing from school.
Qualitatively, students described the effect of the pandemic on their
psychosocial wellbeing, adjustment to online learning, and challenges to
clinical experiences. <AbstractText Label="CONCLUSION">Findings
highlighted the need to develop emergency education preparedness plans
that address student wellbeing and novel collaborative partnerships
between schools and clinical partners. Copyright  2021 Elsevier
Inc.All rights reserved. | |34180390 |Cardiology in the young |Two
adolescent males presented within 3 days after the first and second dose
of the BNT162b2 vaccine with chest pain. Elevated troponin levels, ST
segment elevation, and enhancement of the myocardium in cardiac MRI
suggested myocarditis. Left ventricular function remained normal,
symptoms resolved, and patients were discharged in 4 days. BNT162b2
vaccine may be associated with self-limited myocarditis in youth. |
|34140009 |BMC public health |<AbstractText Label="BACKGROUND">Influenza
immunization is a highly effective method of reducing illness,
hospitalization and mortality from this disease. However, influenza
vaccination rates in the U.S. remain below public health targets and
persistent structural inequities reduce the likelihood that Black,
American Indian and Alaska Native, Latina/o, Asian groups, and
populations of low socioeconomic status will receive the influenza
vaccine. <AbstractText Label="METHODS">We analyzed correlates of
influenza vaccination rates using the 2019 Behavioral Risk Factor
Surveillance System (BRFSS) in the year 2020. Our analysis compared
influenza vaccination as the outcome of interest with the variables age,
sex, race, education, income, geographic location, health insurance
status, access to primary care, history of delaying care due to cost,
and comorbidities such as: asthma, cardiovascular disease, hypertension,
body mass index, cancer and diabetes.
<AbstractText Label="RESULTS">Non-Hispanic White (46.5%) and Asian
(44.1%) participants are more likely to receive the influenza vaccine
compared to Non-Hispanic Black (36.7%), Hispanic (33.9%), American
Indian/Alaskan Native (36.6%), and Native Hawaiian/Other Pacific
Islander (37.9%) participants. We found persistent structural inequities
that predict influenza vaccination, within and across racial and ethnic
groups, including not having health insurance [OR: 0.51 (0.47-0.55)],
not having regular access to primary care [OR: 0.50 (0.48-0.52)], and
the need to delay medical care due to cost [OR: 0.75 (0.71-0.79)].
<AbstractText Label="CONCLUSION">As COVID-19 vaccination efforts evolve,
it is important for physicians and policymakers to identify the
structural impediments to equitable U.S. influenza vaccination so that
future vaccination campaigns are not impeded by these barriers to
immunization. | |34125658 |Emerging microbes &amp; infections |The
SARS-CoV-2 B.1.1.7 lineage is highly infectious and as of April 2021
accounted for 92% of COVID-19 cases in Europe and 59% of COVID-19 cases
in the U.S. It is defined by the N501Y mutation in the receptor-binding
domain (RBD) of the Spike (S) protein, and a few other mutations. These
include two mutations in the N terminal domain (NTD) of the S protein,
HV69-70del and Y144del (also known as Y145del due to the presence of
tyrosine at both positions). We recently identified several emerging
SARS-CoV-2 variants of concerns, characterized by Membrane (M) protein
mutations, including I82T and V70L. We now identify a sub-lineage of
B.1.1.7 that emerged through sequential acquisitions of M:V70L in
November 2020 followed by a novel S:D178H mutation first observed in
early February 2021. The percentage of B.1.1.7 isolates in the US that
belong to this sub-lineage increased from 0.15% in February 2021 to 1.8%
in April 2021. To date, this sub-lineage appears to be U.S.-specific
with reported cases in 31 states, including Hawaii. As of April 2021, it
constituted 36.8% of all B.1.1.7 isolates in Washington. Phylogenetic
analysis and transmission inference with Nextstrain suggest this
sub-lineage likely originated in either California or Washington.
Structural analysis revealed that the S:D178H mutation is in the NTD of
the S protein and close to two other signature mutations of B.1.1.7,
HV69-70del and Y144del. It is surface exposed and may alter NTD tertiary
configuration or accessibility, and thus has the potential to affect
neutralization by NTD directed antibodies. | |34117878 |Clinical
infectious diseases : an official publication of the Infectious Diseases
Society of America |Little is known about severe acute respiratory
syndrome coronavirus 2 vaccine-breakthrough infections (VBIs). Here we
characterize 24 VBIs in predominantly young healthy persons. While none
required hospitalization, a proportion endorsed severe symptoms and shed
live virus as high as 4.13  103 plaque-forming units/mL. Infecting
genotypes included both variant-of-concern (VOC) and non-VOC strains. 
The Author(s) 2021. Published by Oxford University Press for the
Infectious Diseases Society of America. | |34108898 |Frontiers in
psychiatry |Background: Social distancing and school suspension due to
the coronavirus pandemic (COVID-19) may have a negative impact on
childrens behavior and well-being. Problematic smartphone use (PSU),
problematic social media use (PSMU) and perceived weight stigma (PWS)
are particularly important issues for children, yet we have a poor
understanding of how these may have been affected by lockdowns and
physical isolation resulting from COVID-19. This research aimed to
understand how these psychosocial and behavioral variables may be
associated with psychological distress, and how these associations may
have changed during the COVID-19 pandemic. Methods: A total of 489
children completed a three-wave longitudinal study from January 2020 to
June 2020. The first wave was conducted before the COVID-19 outbreak.
The second wave was conducted during the outbreak. The third wave was
conducted during post-COVID-19 lockdown. Questionnaires measured
psychological distress, PSU, PSMU, and PWS. Results: PSU, PSMU, PWS and
psychological distress were all significantly associated with each
other. PSU was significantly higher during outbreak. PWS was
significantly higher before outbreak. We found an increased association
between PSMU and PWS across three waves in all three models. The
association between PSU and depression/anxiety decreased across three
waves; however, association between PSMU and depression/anxiety
increased across three waves. Conclusions: COVID-19 initiated school
suspension and associated lockdowns appear to have exacerbated PSU and
depression among children. However, PWS was reduced during this period.
Children should use smartphones and social media safely and cautiously,
and be aware of the potential exposure to weight stigmatization.
Copyright  2021 Fung, Siu, Potenza, OBrien, Latner, Chen, Chen and
Lin. | |34102878 |Future oncology (London, England) |Aim: To assess the
perception of telehealth visits among a multiracial cancer population
during the coronavirus disease 2019 pandemic. Methods: This
cross-sectional study was conducted at outpatient cancer clinics in
Hawaii between March and August 2020. Patients were invited to
participate in the survey either by phone or email. Results: Of the 212
survey respondents, 61.3% were Asian, 23.6% were White and 15.1% were
Native Hawaiians or Pacific Islanders. Asians, Native Hawaiians and
Pacific Islanders were less likely to desire future telehealth visits
compared with Whites. Predictors with regard to preferring future
telehealth visits included lower income and hematopoietic cancers.
Conclusion: The authors found racial differences in preference for
telehealth. Future studies aimed at overcoming these racial disparities
are needed to provide equitable oncology care. | |34091576 |Journal of
occupational and environmental medicine
|<AbstractText Label="OBJECTIVE">To investigate associations between
adverse changes in employment status and physical and mental health
among US adults (aged 18 years or older) during the COVID-19 pandemic.
<AbstractText Label="METHODS">Data from participants (N = 2565) of a
national Internet panel (June 2020) were assessed using path analyses to
test associations between changes in self-reported employment status and
hours worked and physical and mental health outcomes.
<AbstractText Label="RESULTS">Respondents who lost a job after March 1,
2020 (vs those who did not) reported more than twice the number of
mentally unhealthy days. Females and those lacking social support had
significantly worse physical and mental health outcomes. Participants in
the lowest, pre-pandemic household income groups reported experiencing
worse mental health. <AbstractText Label="CONCLUSIONS">Results
demonstrate the importance of providing economic and social support
services to US adults experiencing poor mental and physical health
during the COVID-19 pandemic. Copyright  2021 American College of
Occupational and Environmental Medicine. | |34062806 |International
journal of environmental research and public health |Studies documenting
coronavirus disease 2019 (COVID-19) racial/ethnic disparities in the
United States were limited to data from the initial few months of the
pandemic, did not account for changes over time, and focused primarily
on Black and Hispanic minority groups. To fill these gaps, we examined
time trends in racial/ethnic disparities in COVID-19 infection and
mortality. We used the Veteran Health Administrations (VHA) national
database of veteran COVID-19 infections over three time periods:
3/1/2020-5/31/2020 (spring); 6/1/2020-8/31/2020 (summer); and
9/1/2020-11/25/2020 (fall). We calculated COVID-19 infection and
mortality predicted probabilities from logistic regression models that
included time period-by-race/ethnicity interaction terms, and controlled
for age, gender, and prior diagnosis of CDC risk factors. Racial/ethnic
groups at higher risk for COVID-19 infection and mortality changed over
time. American Indian/Alaskan Natives (AI/AN), Blacks, Hispanics, and
Native Hawaiians/Other Pacific Islanders experienced higher COVID-19
infections compared to Whites during the summertime. There were
mortality disparities for Blacks in springtime, and AI/ANs, Asians, and
Hispanics in summertime. Policy makers should consider the dynamic
nature of racial/ethnic disparities as the pandemic evolves, and
potential effects of risk mitigation and other (e.g., economic) policies
on these disparities. Researchers should consider how trends in
disparities change over time in other samples. | |33990619 |Nature
communications |NA | |33982008 |Hawaii journal of health &amp; social
welfare |NA | |33980567 |BMJ case reports |A novel coronaravirus,
identified as SARS-CoV-2, spread throughout the world in 2020. The
COVID-19 pandemic has led to many discoveries and clinical
manifestations. A young patient is presented with new, self-resolving
neutropenia presenting weeks after a prolonged hospital stay for
COVID-19 pneumonia. Workup included analysis for underlying infection,
nutritional abnormalities, malignancy, medication and toxin exposure,
all of which were negative. From 2020 to the present, few reports have
described neutropenia associated with a recent COVID-19 infection. In
particular, no reports have described a delayed presentation of
neutropenia. The authors would like to propose that the significant
inflammatory response associated with COVID-19 is likely what led to
this patients postviral neutropenia. Furthermore, in young healthy
patients, bone marrow biopsy may be deferred and a watchful-waiting
approach may be taken to assess for neutropenia resolution.  BMJ
Publishing Group Limited 2021. No commercial re-use. See rights and
permissions. Published by BMJ. | |33973241 |The Journal of school health
J Sch Health</p>
<pre><code>  Five Years and Moving Forward: A Successful Joint Academic-Practice Public Partnership to Improve the Health of Hawaii&#39;s Schoolchildren.
  
    584
    591
    584-591
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1111/josh.13034
  
    &lt;AbstractText Label=&quot;BACKGROUND&quot;&gt;In 2014, the Hawaii Department of Education (DOE), the only statewide school system in the United States, predominately enrolled children (keiki) from underserved communities and lacked school nurses or a school health program. Chronic absenteeism due to health concerns was identified as a barrier to academic success.
    &lt;AbstractText Label=&quot;METHODS&quot;&gt;The DOE and a public university created Hawaii Keiki: Healthy and Ready to Learn (HK), a program to provide school-based services for 170 Title 1 schools in urban and rural settings and build momentum for statewide collective action. HK has maintained support from public and private entities to address student health.
    &lt;AbstractText Label=&quot;RESULTS&quot;&gt;This paper describes 5years of program development, implementation, and continuing challenges. Most recently in 2020-2021, HK pivoted in the face of school campus closings due to COVID-19 with strategic plans, including telehealth, to move forward in this changed school environment.
    &lt;AbstractText Label=&quot;CONCLUSIONS&quot;&gt;The HK program has increased awareness of students&#39; needs and is addressing the imperative to build health services within public schools. The multipronged approach of building awareness of need, providing direct services, educating future care providers, and supporting sound policy development, has an impact that goes beyond any one individual area.
     2021 American School Health Association.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Davis
      Katherine Finn
      KF
      &lt;Identifier Source=&quot;ORCID&quot;&gt;0000-0002-9203-4990
      
        School of Nursing and Dental Hygiene, University of Hawaii at Manoa, 2528 McCarthy Mall, Webster Hall 410, Honolulu, HI, 96822, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Loos
      Joanne R
      JR
      
        School of Nursing and Dental Hygiene, University of Hawaii at Manoa, 2528 McCarthy Mall, Webster Hall 440, Honolulu, HI, 96822, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Boland
      Mary G
      MG
      
        School of Nursing and Dental Hygiene, University of Hawaii at Manoa, 2528 McCarthy Mall, Webster Hall 402, Honolulu, HI, 96822, USA.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
    &lt;PublicationType UI=&quot;D013485&quot;&gt;Research Support, Non-U.S. Gov&#39;t
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2021
    05
    10
  


  United States
  J Sch Health
  0376370
  0022-4391

IM

  
    &lt;DescriptorName UI=&quot;D000293&quot; MajorTopicYN=&quot;N&quot;&gt;Adolescent
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;N&quot;&gt;COVID-19
    &lt;QualifierName UI=&quot;Q000517&quot; MajorTopicYN=&quot;N&quot;&gt;prevention &amp;amp; control
  
  
    &lt;DescriptorName UI=&quot;D002648&quot; MajorTopicYN=&quot;N&quot;&gt;Child
  
  
    &lt;DescriptorName UI=&quot;D000067576&quot; MajorTopicYN=&quot;N&quot;&gt;Child Health
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;Y&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D002669&quot; MajorTopicYN=&quot;N&quot;&gt;Child Welfare
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;Y&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D019058&quot; MajorTopicYN=&quot;N&quot;&gt;Community Networks
    &lt;QualifierName UI=&quot;Q000458&quot; MajorTopicYN=&quot;Y&quot;&gt;organization &amp;amp; administration
  
  
    &lt;DescriptorName UI=&quot;D003299&quot; MajorTopicYN=&quot;N&quot;&gt;Cooperative Behavior
  
  
    &lt;DescriptorName UI=&quot;D006254&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;Hawaii
  
  
    &lt;DescriptorName UI=&quot;D006293&quot; MajorTopicYN=&quot;N&quot;&gt;Health Promotion
    &lt;QualifierName UI=&quot;Q000458&quot; MajorTopicYN=&quot;Y&quot;&gt;organization &amp;amp; administration
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D015397&quot; MajorTopicYN=&quot;N&quot;&gt;Program Evaluation
  
  
    &lt;DescriptorName UI=&quot;D012572&quot; MajorTopicYN=&quot;N&quot;&gt;School Health Services
    &lt;QualifierName UI=&quot;Q000458&quot; MajorTopicYN=&quot;Y&quot;&gt;organization &amp;amp; administration
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;child and adolescent health
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;chronic absenteeism
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;health data
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;school health program implementation
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;school health services
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;school nursing services




  &lt;PubMedPubDate PubStatus=&quot;revised&quot;&gt;
    2020
    11
    23
  
  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2020
    6
    16
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2020
    11
    24
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2021
    5
    12
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2021
    6
    22
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2021
    5
    11
    6
    45
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;33973241
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1111/josh.13034


  REFERENCES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |&lt;AbstractText Label=&quot;BACKGROUND&quot;&gt;In 2014, the Hawaii Department of Education (DOE), the only statewide school system in the United States, predominately enrolled children (keiki) from underserved communities and lacked school nurses or a school health program. Chronic absenteeism due to health concerns was identified as a barrier to academic success. &lt;AbstractText Label=&quot;METHODS&quot;&gt;The DOE and a public university created Hawaii Keiki: Healthy and Ready to Learn (HK), a program to provide school-based services for 170 Title 1 schools in urban and rural settings and build momentum for statewide collective action. HK has maintained support from public and private entities to address student health. &lt;AbstractText Label=&quot;RESULTS&quot;&gt;This paper describes 5 years of program development, implementation, and continuing challenges. Most recently in 2020-2021, HK pivoted in the face of school campus closings due to COVID-19 with strategic plans, including telehealth, to move forward in this changed school environment. &lt;AbstractText Label=&quot;CONCLUSIONS&quot;&gt;The HK program has increased awareness of students&#39; needs and is addressing the imperative to build health services within public schools. The multipronged approach of building awareness of need, providing direct services, educating future care providers, and supporting sound policy development, has an impact that goes beyond any one individual area.  2021 American School Health Association.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |</code></pre>
<p>|33971389 |Advances in colloid and interface science |Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus responsible
for the novel coronavirus disease 2019 (COVID-19), has caused a global
pandemic on a scale not seen for over a century. Increasing evidence
suggests that respiratory droplets and aerosols are likely the most
common route of transmission for SARS-CoV-2. Since the virus can be
spread by presymptomatic and asymptomatic individuals, universal face
masking has been recommended as a straightforward and low-cost strategy
to mitigate virus transmission. Numerous governments and public health
agencies around the world have advocated for or mandated the wearing of
masks in public settings, especially in situations where social
distancing is not possible. However, the efficacy of wearing a mask
remains controversial. This interdisciplinary review summarizes the
current, state-of-the-art understanding of mask usage against COVID-19.
It covers three main aspects of mask usage amid the pandemic: quality
standards for various face masks and their fundamental filtration
mechanisms, empirical methods for quantitatively determining mask
integrity and particle filtration efficiency, and decontamination
methods that allow for the reuse of traditionally disposable N95 and
surgical masks. The focus is given to the fundamental physicochemical
and engineering sciences behind each aspect covered in this review,
providing novel insights into the current understanding of mask usage to
curb COVID-19 spread. Copyright  2021 Elsevier B.V. All rights
reserved. | |33966879 |The Journal of surgical research |NA | |33938253
|Asia-Pacific journal of public health |NA | |33929934 |Emerging
microbes &amp; infections |Neutralizing antibodies to SARS-CoV-2 have
been shown to correlate with protection in animals and humans, disease
severity, survival, and vaccine efficacy. With the ongoing large-scale
vaccination in different countries and continuous surge of new variants
of global concerns, a convenient, cost-effective and high-throughput
neutralization test is urgently needed. Conventional SARS-CoV-2
neutralization test is tedious, time-consuming and requires a biosafety
level 3 laboratory. Despite recent reports of neutralizations using
different pseudoviruses with a luciferase or green fluorescent protein
reporter, the laborious steps, inter-assay variability or high
background limit their high-throughput potential. In this study we
generated lentivirus-based pseudoviruses containing a monomeric infrared
fluorescent protein reporter to develop neutralization assays. Similar
tropism, infection kinetics and mechanism of entry through
receptor-mediated endocytosis were found in the three pseudoviruses
generated. Compared with pseudovirus D614, pseudovirus with D614G
mutation had decreased shedding and higher density of S1 protein present
on particles. The 50% neutralization titers to pseudoviruses D614 or
D614G correlated with the plaque reduction neutralization titers to live
SARS-CoV-2. The turn-around time of 48-72 h, minimal autofluorescence,
one-step image quantification, expandable to 384-well, sequential
readouts and dual quantifications by flow cytometry support its
high-throughput and versatile applications at a non-reference and
biosafety level 2 laboratory, in particular for assessing the
neutralization sensitivity of new variants by sera from natural
infection or different vaccinations during our fight against the
pandemic. | |33926498 |Patient safety in surgery |At the time of writing
of this article, there have been over 110 million cases and 2.4 million
deaths worldwide since the start of the Coronavirus Disease 2019
(COVID-19) pandemic, postponing millions of non-urgent surgeries.
Existing literature explores the complexities of rationing medical care.
However, implications of non-urgent surgery postponement during the
COVID-19 pandemic have not yet been analyzed within the context of the
four pillars of medical ethics. The objective of this review is to
discuss the ethics of elective surgery cancellation during the COVID-19
pandemic in relation to beneficence, non-maleficence, justice, and
autonomy. This review hypothesizes that a more equitable decision-making
algorithm can be formulated by analyzing the ethical dilemmas of
elective surgical care during the pandemic through the lens of these
four pillars. This papers analysis shows that non-urgent surgeries
treat conditions that can become urgent if left untreated. Postponement
of these surgeries can cause cumulative harm downstream. An improved
algorithm can address these issues of beneficence by weighing local
pandemic stressors within predictive algorithms to appropriately
increase surgeries. Additionally, the potential harms of performing
non-urgent surgeries extend beyond the patient. Non-maleficence is
maintained through using enhanced screening protocols and modifying
surgical techniques to reduce risks to patients and clinicians. This
model proposes a system to transfer patients from areas of high to low
burden, addressing the challenge of justice by considering facility
burden rather than value judgments concerning the nature of a particular
surgery, such as cosmetic surgeries. Autonomy can be respected by giving
patients the option to cancel or postpone non-urgent surgeries. However,
in the context of limited resources in a global pandemic, autonomy is
not absolute. Non-urgent surgeries can ethically be postponed in
opposition to the patients preference. The proposed algorithm attempts
to uphold the four principles of medical ethics in rationing non-urgent
surgical care by building upon existing decision models, using
additional measures of resource burden and surgical safety to increase
health care access and decrease long-term harm as much as possible. The
next global health crisis will undoubtedly present its own unique
challenges. This model may serve as a comprehensive starting point in
determining future guidelines for non-urgent surgical care. | |33900192
|Emerging infectious diseases |We examined disparities in cumulative
incidence of severe acute respiratory syndrome coronavirus 2 by
race/ethnicity, age, and sex in the United States during January
1-October 1, 2020. Hispanic/Latino and non-Hispanic Black, American
Indian/Alaskan Native, and Native Hawaiian/other Pacific Islander
persons had a substantially higher incidence of infection than
non-Hispanic White persons. | |33897904 |Sustainability science |Because
of ethnic and cultural violence in Myanmar, approximately a million
Rohingya fled to neighboring Bangladesh starting from August 2017, in
what the UN has called a textbook example of ethnic cleansing. Those
arriving in Bangladesh were able to escape decade-long ethnic violence
in Myanmar, but the Rohingyas immediate destination, Coxs Bazar
district is one of the most climate-vulnerable and disaster-prone areas
in Bangladesh. Currently, they have been subjected to extreme rainfalls,
landslides, and flashfloods. With the COVID-19 pandemic, they continue
to face fear and further marginalization in resource-constrained
Bangladesh, as well as increased vulnerability due to tropical cyclones,
flashfloods, and landslides. The Rohingya in southeast Bangladesh are
now at the epicenter of a humanitarian and sustainability crisis.
However, their situation is not entirely unique. Millions of displaced,
stateless or refugees around the world are facing multi-dimensional
crises in various complex geopolitical, and climatic situations. Using
the theoretical lens of political ecology and critical development
studies, this paper analyzes the sustainability-peace nexus for millions
of Rohingya in Myanmar and in Bangladesh. This paper is based on
information from various sources, including three ethnographic field
visits in recent years, which helped to get local insights into the
current sustainability challenges in this humanitarian context. The core
arguments of this paper suggest that sustainability-peace nexus will
especially be compromised in climate-vulnerable resource-constrained
conditions. To overcome this challenge, decolonizing Rohingya solutions
would be critical, by engaging the Rohingya in the process of
development and meaningful change, which can affect their lives,
livelihoods, and wellbeing. Even though this paper has a specific
geographical focus, the insights are relevant in parts of the world
facing similar social, economic, political, and environmental
challenges.  The Author(s), under exclusive licence to Springer Japan
KK, part of Springer Nature 2021. | |33894385 |Annals of epidemiology
|<AbstractText Label="PURPOSE">There is a growing concern about the
COVID-19 epidemic intensifying in rural areas in the United States
(U.S.). In this study, we described the dynamics of COVID-19 cases and
deaths in rural and urban counties in the U.S.
<AbstractText Label="METHODS">Using data from April 1 to November 12,
2020, from Johns Hopkins University, we estimated COVID-19 incidence and
mortality rates and conducted comparisons between urban and rural areas
in three time periods at the national level, and in states with higher
and lower COVID-19 incidence rates.
<AbstractText Label="RESULTS">Results at the national level showed
greater COVID-19 incidence rates in urban compared to rural counties in
the Northeast and Mid-Atlantic regions of the U.S. at the beginning of
the epidemic. However, the intensity of the epidemic has shifted to a
rapid surge in rural areas. In particular, high incidence states located
in the Mid-west of the country had more than 3,400 COVID-19 cases per
100,000 people compared to 1,284 cases per 100,000 people in urban
counties nationwide during the third period (August 30 to November 12).
<AbstractText Label="CONCLUSIONS">Overall, the current epicenter of the
epidemic is located in states with higher infection rates and mortality
in rural areas. Infection prevention and control efforts including
healthcare capacity should be scaled up in these vulnerable rural areas.
Copyright  2021. Published by Elsevier Inc.| |33889849 |Hawaii
journal of health &amp; social welfare |NA | |33889848 |Hawaii journal
of health &amp; social welfare |NA | |33859192 |Nature communications
|Substantial COVID-19 research investment has been allocated to
randomized clinical trials (RCTs) on hydroxychloroquine/chloroquine,
which currently face recruitment challenges or early discontinuation. We
aim to estimate the effects of hydroxychloroquine and chloroquine on
survival in COVID-19 from all currently available RCT evidence,
published and unpublished. We present a rapid meta-analysis of ongoing,
completed, or discontinued RCTs on hydroxychloroquine or chloroquine
treatment for any COVID-19 patients (protocol: <a href="https://osf.io/QESV4/" class="uri">https://osf.io/QESV4/</a> ). We
systematically identified unpublished RCTs (ClinicalTrials.gov, WHO
International Clinical Trials Registry Platform, Cochrane COVID-registry
up to June 11, 2020), and published RCTs (PubMed, medRxiv and bioRxiv up
to October 16, 2020). All-cause mortality has been extracted
(publications/preprints) or requested from investigators and combined in
random-effects meta-analyses, calculating odds ratios (ORs) with 95%
confidence intervals (CIs), separately for hydroxychloroquine and
chloroquine. Prespecified subgroup analyses include patient setting,
diagnostic confirmation, control type, and publication status.
Sixty-three trials were potentially eligible. We included 14 unpublished
trials (1308 patients) and 14 publications/preprints (9011 patients).
Results for hydroxychloroquine are dominated by RECOVERY and WHO
SOLIDARITY, two highly pragmatic trials, which employed relatively high
doses and included 4716 and 1853 patients, respectively (67% of the
total sample size). The combined OR on all-cause mortality for
hydroxychloroquine is 1.11 (95% CI: 1.02, 1.20; I = 0%; 26 trials;
10,012 patients) and for chloroquine 1.77 (95%CI: 0.15, 21.13, I = 0%;
4 trials; 307 patients). We identified no subgroup effects. We found
that treatment with hydroxychloroquine is associated with increased
mortality in COVID-19 patients, and there is no benefit of chloroquine.
Findings have unclear generalizability to outpatients, children,
pregnant women, and people with comorbidities. | |33856881 |American
journal of public health |The complex and evolving picture of
COVID-19-related mortality highlights the need for data to guide the
response. Yet many countries are struggling to maintain their data
systems, including the civil registration system, which is the
foundation for detailed and continuously available mortality statistics.
We conducted a search of country and development agency Web sites and
partner and media reports describing disruptions to the civil
registration of births and deaths associated with COVID-19 related
restrictions.We found considerable intercountry variation and grouped
countries according to the level of disruption to birth and particularly
death registration. Only a minority of the 66 countries were able to
maintain service continuity during the COVID-19 restrictions. In the
majority, a combination of legal and operational challenges resulted in
declines in birth and death registration. Few countries established
business continuity plans or developed strategies to deal with the
backlog when restrictions are lifted.Civil registration systems and the
vital statistics they generate must be strengthened as essential
services during health emergencies and as core components of the
response to COVID-19. | |33851191 |medRxiv : the preprint server for
health sciences |The impact of COVID-19 disease on health and economy
has been global, and the magnitude of devastation is unparalleled in
modern history. Any potential course of action to manage this complex
disease requires the systematic and efficient analysis of data that can
delineate the underlying pathogenesis. We have developed a mathematical
model of disease progression to predict the clinical outcome, utilizing
a set of causal factors known to contribute to COVID-19 pathology such
as age, comorbidities, and certain viral and immunological parameters.
Viral load and selected indicators of a dysfunctional immune response,
such as cytokines IL-6 and IFN, which contribute to the cytokine storm
and fever, parameters of inflammation d-dimer and ferritin, aberrations
in lymphocyte number, lymphopenia, and neutralizing antibodies were
included for the analysis. The model provides a framework to unravel the
multi-factorial complexities of the immune response manifested in
SARS-CoV-2 infected individuals. Further, this model can be valuable to
predict clinical outcome at an individual level, and to develop
strategies for allocating appropriate resources to mitigate severe cases
at a population level. | |33826985 |Water research |Wastewater is a
pooled sampling instrument that may provide rapid and even early disease
signals in the surveillance of COVID-19 disease at the community level,
yet the fine-scale temporal dynamics of SARS-CoV-2 RNA in wastewater
remains poorly understood. This study tracked the daily dynamics of
SARS-CoV-2 RNA in the wastewater from two wastewater treatment plants
(WWTPs) in Honolulu during a rapidly expanding COVID-19 outbreak and a
responding four-week lockdown that resulted in a rapid decrease of daily
clinical COVID-19 new cases. The wastewater SARS-CoV-2 RNA concentration
from both WWTPs, as measured by three quantification assays (N1, N2, and
E), exhibited both significant inter-day fluctuations (101.2-105.1 gene
copies or GC/L in wastewater liquid fractions, or 101.4-106.2 GC/g in
solid fractions) and an overall downward trend over the lockdown period.
Strong and significant correlation was observed in measured SARS-CoV-2
RNA concentrations between the solid and liquid wastewater fractions,
with the solid fraction containing majority (82.5%-92.5%) of the
SARS-CoV-2 RNA mass and the solid-liquid SARS-CoV-2 RNA concentration
ratios ranging from 103.6 to 104.3 mL/g. The measured wastewater
SARS-CoV-2 RNA concentration was normalized by three endogenous fecal
RNA viruses (F+ RNA coliphages Group II and III, and pepper mild mottle
virus) to account for variations that may occur during the multi-step
wastewater processing and molecular quantification, and the normalized
abundance also exhibited similar daily fluctuations and overall downward
trend over the sampling period. Copyright  2021 Elsevier Ltd.All
rights reserved. | |33821261 |Research square |Using genomics,
bioinformatics and statistics, herein we demonstrate the effect of
statewide and nationwide quarantine on the introduction of SARS-CoV-2
variants of concern (VOC) in Hawaii. To define the origins of
introduced VOC, we analyzed 260 VOC sequences from Hawaii, and 301,646
VOC sequences worldwide, deposited in the GenBank and global initiative
on sharing all influenza data (GISAID), and constructed phylogenetic
trees. The trees define the most recent common ancestor as the origin.
Further, the multiple sequence alignment used to generate the
phylogenetic trees identified the consensus single nucleotide
polymorphisms in the VOC genomes. These consensus sequences allow for
VOC comparison and identification of mutations of interest in relation
to viral immune evasion and host immune activation. Of note is the P71L
substitution within the E protein, the protein sensed by TLR2 to produce
cytokines, found in the B.1.351 VOC may diminish the efficacy of some
vaccines. Based on the phylogenetic trees, the B.1.1.7, B.1.351,
B.1.427, and B.1.429 VOC have been introduced in Hawaii multiple times
since December 2020 from several definable geographic regions. From the
first worldwide report of VOC in GenBank and GISAID, to the first
arrival of VOC in Hawaii, averages 320 days with quarantine, and 132
days without quarantine. As such, the effect of quarantine is shown to
significantly affect the time to arrival of VOC in Hawaii, both during
and following quarantine. Further, the collective 2020 quarantine of
43-states in the United States demonstrates a profound impact in
delaying the arrival of VOC in states that did not practice quarantine,
such as Utah. Our data demonstrates that at least 76% of all definable
SARS-CoV-2 VOC have entered Hawaii from California, with the B.1.351
variant in Hawaii originating exclusively from the United Kingdom.
These data provide a foundation for policy-makers and public-health
officials to apply precision public health genomics to real-world
policies such as mandatory screening and quarantine. | |33789080
|Contraception |<AbstractText Label="OBJECTIVE">To demonstrate the
effectiveness of medication abortion with the implementation of
telemedicine and a no-test protocol in response to the COVID-19
pandemic. <AbstractText Label="STUDY DESIGN">This is a retrospective
cohort study of patients who had a medication abortion up to 77 days
gestation at the University of Hawaii between April and November 2020.
Patients had the option of traditional in clinic care or telemedicine
with either in clinic pickup or mailing of medications. During this
time, a no-test protocol for medication abortion without prior labs or
ultrasound was in place for eligible patients. The primary outcome was
the rate of successful medication abortion without surgical
intervention. Secondary outcomes included abortion-related
complications. <AbstractText Label="RESULTS">A total of 334 patients
were dispensed mifepristone and misoprostol, 149 (44.6%) with
telemedicine with in-person pickup of medications, 75 (22.5%) via
telemedicine with medications mailed, and 110 (32.9%) via traditional in
person visits. The overall rate of complete medication abortion without
surgical intervention was 95.8%, with success rates of 96.8, 97.1, and
93.6% for the clinic pickup, mail, and clinic visit groups,
respectively. Success for those without an ultrasound performed prior to
the procedure was 96.6%, compared to 95.5% for those with ultrasound. We
obtained follow-up data for 87.8% of participants.
<AbstractText Label="CONCLUSIONS">Medication abortion was safe and
effective while offering multiple modes of care delivery including
telemedicine visits without an ultrasound performed prior to dispensing
medications. <AbstractText Label="IMPLICATIONS">Incorporating
telemedicine and a no-test protocol for medication abortion is safe and
has the potential to expand access to abortion care. All care models had
low rates of adverse events, which contradicts the idea that the Risk
Evaluation and Mitigation Strategyincreases the safety of medication
abortion. Copyright  2021 Elsevier Inc.All rights reserved. |
|33781762 |Contraception |<AbstractText Label="OBJECTIVE">To present
updated evidence on the safety, efficacy and acceptability of a
direct-to-patient telemedicine abortion service and describe how the
service functioned during the COVID-19 pandemic.
<AbstractText Label="STUDY DESIGN">We offered the study at 10 sites that
provided the service in 13 states and Washington DC. Interested
individuals obtained any needed preabortion tests locally and had a
videoconference with a study clinician. Sites sent study packages
containing mifepristone and misoprostol by mail and had remote follow-up
consultations within one month by telephone (or by online survey, if the
participant could not be reached) to evaluate abortion completeness. The
analysis was descriptive. <AbstractText Label="RESULTS">We mailed 1390
packages between May 2016 and September 2020. Of the 83% (1157/1390) of
abortions for which we obtained outcome information, 95% (1103/1157)
were completed without a procedure. Participants made 70 unplanned
visits to emergency rooms or urgent care centers for reasons related to
the abortion (6%), and 10 serious adverse events occurred, including 5
transfusions (0.4%). Enrollment increased substantially with the onset
of COVID-19. Although a screening ultrasound was required, sites
determined in 52% (346/669) of abortions that occurred during COVID that
those participants should not get the test to protect their health. Use
of urine pregnancy test to confirm abortion completion increased from
67% (144/214) in the 6 months prior to COVID to 90% (602/669) in the 6
months during COVID. Nearly all satisfaction questionnaires (99%,
1013/1022) recorded that participants were satisfied with the service.
<AbstractText Label="CONCLUSIONS">This direct-to-patient telemedicine
service was safe, effective, and acceptable, and supports the claim that
there is no medical reason for mifepristone to be dispensed in clinics
as required by the Food and Drug Administration. In some cases,
participants did not need to visit any facilities to obtain the service,
which was critical to protecting patient safety during the COVID-19
pandemic. <AbstractText Label="IMPLICATIONS">Medical abortion using
telemedicine and mail is effective and can be safely provided without a
pretreatment ultrasound. This method of service delivery has the
potential to greatly improve access to abortion care in the United
States. Copyright  2021 Elsevier Inc.All rights reserved. | |33781585
|Surgery |NA | |33775167 |Global health promotion |The current COVID-19
pandemic has exposed missing links between health promotion and
national/global health emergency policies. In response, health promotion
initiatives were urgently developed and applied around the world. A
selection of case studies from five countries, based on the
Socio-Ecological Model of Health Promotion, exemplify real-world
action and challenges for health promotion intervention, research, and
policy during the COVID-19 pandemic. Interventions range from a focus on
individuals/families, organizations, communities and in healthcare,
public health, education and media systems, health-promoting settings,
and policy. Lessons learned highlight the need for emphasizing equity,
trust, systems approach, and sustained action in future health promotion
preparedness strategies. Challenges and opportunities are highlighted
regarding the need for rapid response, clear communication based on
health literacy, and collaboration across countries, disciplines, and
health and education systems for meaningful solutions to global health
crises. | |33772441 |Journal of general internal medicine |NA |
|33770003 |Journal of addiction medicine
|<AbstractText Label="BACKGROUND">The outbreak of the coronavirus
disease 2019 (COVID-19) pandemic has generated negative effects on
psychological well-being worldwide, including in schoolchildren.
Government requirements to stay at home and avoid social and school
settings may impact psychological well-being by modifying various
behaviors such as problematic phone and Internet use, yet there is a
paucity of research on this issue. This study examined whether the
COVID-19 outbreak may have impacted problematic smartphone use (PSU),
problematic gaming (PG), and psychological distress, specifically the
pattern of relationships between PSU, PG, and psychological distress in
schoolchildren. <AbstractText Label="METHODS">Longitudinal data on
psychological distress, PSU, and PG were collected from 575 children in
primary schools in 3 waves: Waves 1 and 2 were conducted before the
COVID-19 outbreak and Wave 3 during the outbreak. Cross-lagged panel
models were used to examine relationships between factors across the 3
waves. <AbstractText Label="RESULTS">Cross-lagged models found that
higher levels of PSU were not significantly related prospectively to
greater psychological distress before the COVID-19 outbreak, but this
prospective relationship became significant during the COVID-19
outbreak. Whereas PG was associated prospectively with psychological
distress before the COVID-19 outbreak (ie, between Waves 1 and 2), this
association became nonsignificant during the COVID-19 lockdown (ie,
between Waves 2 and 3). <AbstractText Label="CONCLUSIONS">The COVID-19
outbreak has seemed to change prospective relationships between PSU and
psychological distress and PG and psychological distress in
schoolchildren. Future research should examine whether restrictions on
or information provided to schoolchildren may exacerbate PSUs effects on
psychological distress. Copyright  2021 American Society of Addiction
Medicine. | |33769536 |Translational behavioral medicine |Widespread
uptake of the COVID-19 vaccine is critical to halt the pandemic. At
present, little is known about factors that will affect vaccine uptake,
especially among diverse racial/ethnic communities that have experienced
the highest burden of COVID. We administered an online survey to a
Qualtrics respondent panel of women ages 27-45 years (N = 396) to assess
vaccine intentions and attitudes, and trusted vaccine information
sources. 56.8% intended to be vaccinated and 25.5% were unsure. In
bivariate analyses, a greater percentage of non-Latina White (NLW) and
Chinese women reported that they would be vaccinated, compared with
Latina and non-Latina Black (NLB) women (p &lt; 0.001). Those who were
uninsured, unemployed and those with lower incomes were less likely to
say that they would be vaccinated. In analyses stratified by
race/ethnicity, NLB women remained significantly less likely to report
that they would be vaccinated compared with NLW women (adjusted odds
ratio: 0.47; 95% confidence interval: 0.23, 0.94), controlling for age,
marital status, income, education, employment, and insurance status.
When analyses were additionally controlled for beliefs in vaccine safety
and efficacy, racial/ethnic differences were no longer significant
(adjusted odds ratio: 0.64; 95% confidence interval: 0.31, 1.34). Given
that NLB women were less likely to report the intention to be
vaccinated, targeted efforts will be needed to promote vaccine uptake.
It will be critical to emphasize that the vaccine is safe and effective;
this message may be best delivered by trusted community members.
Published by Oxford University Press on behalf of the Society of
Behavioral Medicine 2021. | |33746047 |Annals of oncology : official
journal of the European Society for Medical Oncology
|<AbstractText Label="BACKGROUND">Patients with cancer may be at high
risk of adverse outcomes from severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) infection. We analyzed a cohort of patients
with cancer and coronavirus 2019 (COVID-19) reported to the COVID-19 and
Cancer Consortium (CCC19) to identify prognostic clinical factors,
including laboratory measurements and anticancer therapies.
<AbstractText Label="PATIENTS AND METHODS">Patients with active or
historical cancer and a laboratory-confirmed SARS-CoV-2 diagnosis
recorded between 17 March and 18 November 2020 were included. The
primary outcome was COVID-19 severity measured on an ordinal scale
(uncomplicated, hospitalized, admitted to intensive care unit,
mechanically ventilated, died within 30 days). Multivariable regression
models included demographics, cancer status, anticancer therapy and
timing, COVID-19-directed therapies, and laboratory measurements (among
hospitalized patients). <AbstractText Label="RESULTS">A total of 4966
patients were included (median age 66 years, 51% female, 50%
non-Hispanic white); 2872 (58%) were hospitalized and 695 (14%) died;
61% had cancer that was present, diagnosed, or treated within the year
prior to COVID-19 diagnosis. Older age, male sex, obesity,
cardiovascular and pulmonary comorbidities, renal disease, diabetes
mellitus, non-Hispanic black race, Hispanic ethnicity, worse Eastern
Cooperative Oncology Group performance status, recent cytotoxic
chemotherapy, and hematologic malignancy were associated with higher
COVID-19 severity. Among hospitalized patients, low or high absolute
lymphocyte count; high absolute neutrophil count; low platelet count;
abnormal creatinine; troponin; lactate dehydrogenase; and C-reactive
protein were associated with higher COVID-19 severity. Patients
diagnosed early in the COVID-19 pandemic (January-April 2020) had worse
outcomes than those diagnosed later. Specific anticancer therapies
(e.g.R-CHOP, platinum combined with etoposide, and DNA
methyltransferase inhibitors) were associated with high 30-day all-cause
mortality. <AbstractText Label="CONCLUSIONS">Clinical factors
(e.g.older age, hematological malignancy, recent chemotherapy) and
laboratory measurements were associated with poor outcomes among
patients with cancer and COVID-19. Although further studies are needed,
caution may be required in utilizing particular anticancer therapies.
<AbstractText Label="CLINICAL TRIAL IDENTIFIER">NCT04354701. Copyright 
2021 The Author(s). Published by Elsevier Ltd.. All rights reserved. |
|33728687 |JPEN. Journal of parenteral and enteral nutrition
|<AbstractText Label="BACKGROUND">Severe acute respiratory syndrome
coronavirus 2 is a respiratory virus that poses risks to the nutrition
status and survival of infected patients, yet there is paucity of data
to inform evidence-based quality care. <AbstractText Label="METHODS">We
collected data on the nutrition care provided to patients with
coronavirus disease 2019 (COVID-19) by registered dietitian
nutritionists (RDNs). <AbstractText Label="RESULTS">Hospitalized
COVID-19 patients (N = 101) in this cohort were older adults and had
elevated body mass index. The most frequent nutrition problems were
inadequate oral intake (46.7%), inadequate energy intake (18.9%), and
malnutrition (18.4%). These problems were managed predominantly with
enteral nutrition, food supplements, and multivitamin-multimineral
supplement therapy. Over 90% of documented problems required a
follow-up. <AbstractText Label="CONCLUSION">This data set is the first
of its kind to report on the types of nutrition diagnoses and
interventions for COVID-19 cases used by RDNs and highlights the need
for increased and continued nutrition care.  2021 American Society for
Parenteral and Enteral Nutrition. | |33718878 |Hawaii journal of health
&amp; social welfare |The COVID-19 pandemic has ravaged the world,
caused over 1.8 million deaths in its first year, and severely affected
the global economy. Hawaii has not been spared from the transmission of
SARS-CoV-2 in the local population, including high infection rates in
racial and ethnic minorities. Early in the pandemic, we described in
this journal various technologies used for the detection of SARS-CoV-2.
Herein we characterize a 969-bp SARS-CoV-2 segment of the S gene
downstream of the receptor-binding domain. At the John A. Burns School
of Medicine Biocontainment Facility, RNA was extracted from an
oropharyngeal swab and a nasal swab from 2 patients from Hawaii who
were infected with SARS-CoV-2 in August 2020. Following PCR, the 2 viral
strains were sequenced using Sanger sequencing, and phylogenetic trees
were generated using MEGAX. Phylogenetic tree results indicate that the
virus has been introduced to Hawaii from multiple sources. Further, we
decoded 13 single nucleotide polymorphisms across 13 unique SARS-CoV-2
genomes within this region of the S gene, with 1 non-synonymous mutation
(P681H) found in the 2 Hawaii strains. The P681H mutation has unique
and emerging characteristics with a significant exponential increase in
worldwide frequency when compared to the plateauing of the now universal
D614G mutation. The P681H mutation is also characteristic of the new
SARS-CoV-2 variants from the United Kingdom and Nigeria. Additionally,
several mutations resulting in cysteine residues were detected,
potentially resulting in disruption of the disulfide bridges in and
around the receptor-binding domain. Targeted sequence characterization
is warranted to determine the origin of multiple introductions of
SARS-CoV-2 circulating in Hawaii. Copyright 2021 by University Health
Partners of Hawaii (UHP Hawaii). | |33717793 |Journal of general and
family medicine |We welcome their additional suggestion that the
government should publish potential causes for and implications of the
additional outbreak beyond the quarantine to the international
scientific community so that similar outbreaks may be swiftly prevented.
However, given the absence of government-driven publications, we
published this report based on our independent investigation, which may
be more reliable considering the inherently sensitive and political
nature of the events.  2020 The Authors. Journal of General and Family
Medicine published by John Wiley &amp; Sons Australia, Ltd on behalf of
Japan Primary Care Association. | |33706209 |Health &amp; place |The
global Coronavirus Disease 2019 (COVID-19) pandemic has led to the
implementation of social distancing measures such as work-from-home
orders that have drastically changed peoples travel-related behavior.
As countries are easing up these measures and people are resuming their
pre-pandemic activities, the second wave of COVID-19 is observed in many
countries. This study proposes a Community Activity Score (CAS) based on
inter-community traffic characteristics (in and out of community traffic
volume and travel distance) to capture the current travel-related
activity level compared to the pre-pandemic baseline and study its
relationship with confirmed COVID-19 cases. Fourteen other
travel-related factors belonging to five categories (Social Distancing
Index, residents staying at home, travel frequency and distance,
mobility trend, and out-of-county visitors) and three social distancing
measures (stay-at-home order, face-covering order, and self-quarantine
for out-of-county travels) are also considered to reflect the likelihood
of exposure to the COVID-19. Considering that it usually takes days from
exposure to confirming the infection, the exposure-to-confirm temporal
delay between the time-varying travel-related factors and their impacts
on the number of confirmed COVID-19 cases is considered in this study.
Honolulu County in the State of Hawaii is used as a case study to
evaluate the proposed CAS and other factors on confirmed COVID-19 cases
with various temporal delays at a county-level. Negative Binomial models
were chosen to study the impacts of travel-related factors and social
distancing measures on COVID-19 cases. The case study results show that
CAS and other factors are correlated with COVID-19 spread, and models
that factor in the exposure-to-confirm temporal delay perform better in
forecasting COVID-19 cases later. Policymakers can use the studys
various findings and insights to evaluate the impacts of social
distancing policies on travel and effectively allocate resources for the
possible increase in confirmed COVID-19 cases. Copyright  2021 Elsevier
Ltd.All rights reserved. | |33661861 |MMWR. Morbidity and mortality
weekly report |NA | |33661727 |Preventing chronic disease
|<AbstractText Label="INTRODUCTION">Communication networks among
professionals can be pathways for accelerating the diffusion of
innovations if some local health departments (LHDs) drive the spread of
knowledge. Such a network could prove valuable during public health
emergencies such as the novel coronavirus disease 2019 (COVID-19)
pandemic. Our objective was to determine whether LHDs in the United
States were tied together in an informal network to share information
and advice about innovative community health practices, programs, and
policies. <AbstractText Label="METHODS">In January and February 2020, we
conducted an online survey of 2,303 senior LHD leaders to ask several
questions about their sources of advice. We asked respondents to rank up
to 3 other LHDs whose practices informed their work on new public health
programs, evidence-based practices, and policies intended to improve
community health. We used a social network analysis program to assess
answers. <AbstractText Label="RESULTS">A total of 329 LHDs responded. An
emergent network appeared to operate nationally among 740 LHDs. Eleven
LHDs were repeatedly nominated by peers as sources of advice or examples
(ie, opinion leaders), and 24 acted as relational bridges to hold these
emergent networks together (ie, boundary spanners). Although 2 LHDs
played both roles, most LHDs we surveyed performed neither of these
roles. <AbstractText Label="CONCLUSION">Opinion leading and boundary
spanning health departments can be accessed to increase the likelihood
of affecting the rate of interest in and adoption of innovations.
Decision makers involved in disseminating new public health practices,
programs, or policies may find our results useful both for emergencies
and for practice-as-usual. | |33657176 |PloS one |A newly identified
coronavirus, designated as severe acute respiratory syndrome coronavirus
2 (SARS CoV-2), has spread rapidly from its epicenter in China to more
than 150 countries across six continents. In this study, we have
designed three reverse-transcription loop-mediated isothermal
amplification (RT-LAMP) primer sets to detect the RNA-dependent RNA
polymerase (RdRP), Envelope (E) and Nucleocapsid protein (N) genes of
SARS CoV-2. For one tube reaction, the detection limits for five
combination SARS CoV-2 LAMP primer sets (RdRP/E, RdRP/N, E/N, RdRP/E/N
and RdRP/N/Internal control (actin beta)) were evaluated with a clinical
nasopharyngeal swab sample. Among the five combination, the RdRP/E and
RdRP/N/IC multiplex LAMP assays showed low detection limits. The
sensitivity and specificity of the RT-LAMP assay were evaluated and
compared to that of the widely used Allplex 2019-nCoV Assay (Seegene,
Inc., Seoul, South Korea) and PowerChek 2019-nCoV Real-time PCR kit
(Kogenebiotech, Seoul, South Korea) for 130 clinical samples from 91
SARS CoV-2 patients and 162 NP specimens from individuals with (72) and
without (90) viral respiratory infections. The multiplex RdRP (FAM)/N
(CY5)/IC (Hex) RT-LAMP assay showed comparable sensitivities (RdRP:
93.85%, N: 94.62% and RdRP/N: 96.92%) to that of the Allplex 2019-nCoV
Assay (100%) and superior to those of PowerChek 2019-nCoV Real-time PCR
kit (RdRP: 92.31%, E: 93.85% and RdRP/E: 95.38%). | |33655229 |The
Lancet. Microbe |NA | |33607081 |The Brazilian journal of infectious
diseases : an official publication of the Brazilian Society of
Infectious Diseases |In the pandemic, rapid and accurate detection of
SARS-CoV-2 is crucial in controlling the outbreak. Recent studies have
shown a high detection rate using saliva/oral fluids as specimens for
laboratory detection of the virus. We intended to evaluate the test
performance of the Xpert Xpress SARS-CoV-2 cartridge assay in comparison
to a conventional qRT-PCR testing, using saliva as biological specimen.
Forty saliva samples from symptomatic participants were collected.
Conventional qRT-PCR was performed for amplification of E and RdRp genes
and the Xpert Xpress SARS-CoV-2 assay amplified E and N2 genes. In the
conventional assay, the median cycle threshold value of the E gene was
34.9, and of the RdRp gene was 38.3. In the Xpert Xpress assay, the
median cycle threshold value of the E gene was 29.7, and of the N2 gene
was 31.6. These results can allow a broaden use of molecular tests for
management of COVID-19 pandemic, especially in resources-limited
settings. Copyright  2021 Sociedade Brasileira de Infectologia.
Published by Elsevier Espaa, S.L.U. All rights reserved. | |33606666
|The American journal of tropical medicine and hygiene |An outbreak of
SARS-CoV-2 has led to a global pandemic affecting virtually every
country. As of August 31, 2020, globally, there have been approximately
25,500,000 confirmed cases and 850,000 deaths; in the United States (50
states plus District of Columbia), there have been more than 6,000,000
confirmed cases and 183,000 deaths. We propose a Bayesian mixture model
to predict and monitor COVID-19 mortality across the United States. The
model captures skewed unimodal (prolonged recovery) or multimodal
(multiple surges) curves. The results show that across all states, the
first peak dates of mortality varied between April 4, 2020 for Alaska
and June 18, 2020 for Arkansas. As of August 31, 2020, 31 states had a
clear bimodal curve showing a strong second surge. The peak date for a
second surge ranged from July 1, 2020 for Virginia to September 12, 2020
for Hawaii. The first peak for the United States occurred about April
16, 2020-dominated by New York and New Jersey-and a second peak on
August 6, 2020-dominated by California, Texas, and Florida. Reliable
models for predicting the COVID-19 pandemic are essential to informing
resource allocation and intervention strategies. A Bayesian mixture
model was able to more accurately predict the shape of the mortality
curves across the United States than other models, including the timing
of multiple peaks. However, given the dynamic nature of the pandemic, it
is important that the results be updated regularly to identify and
better monitor future waves, and characterize the epidemiology of the
pandemic. | |33606656 |Journal of medical Internet research
|<AbstractText Label="BACKGROUND">The COVID-19 pandemic has
significantly impacted mental health and well-being. Mobile mental
health apps can be scalable and useful tools in large-scale disaster
responses and are particularly promising for reaching vulnerable
populations. COVID Coach is a free, evidence-informed mobile app
designed specifically to provide tools and resources for addressing
COVID-19-related stress. <AbstractText Label="OBJECTIVE">The purpose of
this study was to characterize the overall usage of COVID Coach, explore
retention and return usage, and assess whether the app was reaching
individuals who may benefit from mental health resources.
<AbstractText Label="METHODS">Anonymous usage data collected from COVID
Coach between May 1, 2020, through October 31, 2020, were extracted and
analyzed for this study. The sample included 49,287 unique user codes
and 3,368,931 in-app events. <AbstractText Label="RESULTS">Usage of
interactive tools for coping and stress management comprised the
majority of key app events (n=325,691, 70.4%), and the majority of app
users tried a tool for managing stress (n=28,009, 58.8%). COVID Coach
was utilized for 3 days by 80.9% (n=34,611) of the sample whose first
day of app use occurred within the 6-month observation window. Usage of
the key content in COVID Coach predicted returning to the app for a
second day. Among those who tried at least one coping tool on their
first day of app use, 57.2% (n=11,444) returned for a second visit;
whereas only 46.3% (n=10,546) of those who did not try a tool returned
(P&lt;.001). Symptoms of anxiety, depression, and posttraumatic stress
disorder (PTSD) were prevalent among app users. For example, among app
users who completed an anxiety assessment on their first day of app use
(n=4870, 11.4% of users), 55.1% (n=2680) reported levels of anxiety that
were moderate to severe, and 29.9% (n=1455) of scores fell into the
severe symptom range. On average, those with moderate levels of
depression on their first day of app use returned to the app for a
greater number of days (mean 3.72 days) than those with minimal symptoms
(mean 3.08 days; t1=3.01, P=.003). Individuals with significant PTSD
symptoms on their first day of app use utilized the app for a
significantly greater number of days (mean 3.79 days) than those with
fewer symptoms (mean 3.13 days; t1=2.29, P=.02).
<AbstractText Label="CONCLUSIONS">As the mental health impacts of the
pandemic continue to be widespread and increasing, digital health
resources, such as apps like COVID Coach, are a scalable way to provide
evidence-informed tools and resources. Future research is needed to
better understand for whom and under what conditions the app is most
helpful and how to increase and sustain engagement. Beth K Jaworski,
Katherine Taylor, Kelly M Ramsey, Adrienne Heinz, Sarah Steinmetz, Ian
Pagano, Giovanni Moraja, Jason E Owen. Originally published in the
Journal of Medical Internet Research (<a href="http://www.jmir.org" class="uri">http://www.jmir.org</a>), 01.03.2021. | |33587873 |Annals of
internal medicine |NA | |33495523 |International journal of obesity
(2005) |<AbstractText Label="OBJECTIVE">The novel coronavirus disease
2019 (COVID-19) pandemic, and its resulting social policy changes may
result in psychological distress among schoolchildren with overweight.
This study thus aimed to (1) compare psychological distress (including
fear of COVID-19 infection, stress, anxiety, and depression), perceived
weight stigma, and problematic internet-related behaviors between
schoolchildren with and without overweight; (2) assess whether perceived
weight stigma and problematic internet-related behaviors explained
psychological distress. <AbstractText Label="METHODS">Schoolchildren (n
= 1357; mean age = 10.7 years) with overweight (n = 236) and without
overweight (n = 1121) completed an online survey assessing their fear of
COVID-19 infection, stress, anxiety, depression, perceived weight
stigma, problematic smartphone application use, problematic social media
use, and problematic gaming.
<AbstractText Label="RESULTS">Schoolchildren with overweight had
significantly higher levels of COVID-19 infection fear, stress,
depression, perceived weight stigma, and problematic social media use
than those without overweight. Regression models showed that perceived
weight stigma and problematic internet-related behaviors were
significant predictors of psychological distress among schoolchildren
with overweight. <AbstractText Label="CONCLUSION">Strategies to manage
perceived weight stigma and problematic internet-related behaviors may
have a positive influence on mental health among schoolchildren with
overweight under health-threatening circumstances, such as the current
COVID-19 pandemic. | |33482708 |Global health promotion |Shortly after a
healthy default beverage (HDB) law took effect in Hawaii, requiring
restaurants that serve childrens meals to offer healthy beverages with
the meals, the COVID-19 pandemic struck. Efforts to contain the virus
resulted in changes to restaurants operations and disrupted HDB
implementation efforts. Economic repercussions from containment efforts
have exacerbated food insecurity, limited access to healthy foods, and
created obstacles to chronic disease management. Promoting healthy
default options is critical at a time when engaging in healthy behaviors
is difficult, but important, to both prevent and manage chronic disease
and decrease COVID-19 risk. This commentary discusses COVID-19s impact
on restaurant operations and healthy eating, and the resulting
challenges and opportunities for this promising health promotion
intervention. | |33471778 |JMIR public health and surveillance
|<AbstractText Label="BACKGROUND">The COVID-19 pandemic has greatly
limited patients access to care for spine-related symptoms and
disorders. However, physical distancing between clinicians and patients
with spine-related symptoms is not solely limited to restrictions
imposed by pandemic-related lockdowns. In most low- and middle-income
countries, as well as many underserved marginalized communities in
high-income countries, there is little to no access to clinicians
trained in evidence-based care for people experiencing spinal pain.
<AbstractText Label="OBJECTIVE">The aim of this study is to describe the
development and present the components of evidence-based patient and
clinician guides for the management of spinal disorders where in-person
care is not available. <AbstractText Label="METHODS">Ultimately, two
sets of guides were developed (one for patients and one for clinicians)
by extracting information from the published Global Spine Care
Initiative (GSCI) papers. An international, interprofessional team of 29
participants from 10 countries on 4 continents participated. The team
included practitioners in family medicine, neurology, physiatry,
rheumatology, psychology, chiropractic, physical therapy, and yoga, as
well as epidemiologists, research methodologists, and laypeople. The
participants were invited to review, edit, and comment on the guides in
an open iterative consensus process. <AbstractText Label="RESULTS">The
Patient Guide is a simple 2-step process. The first step describes the
nature of the symptoms or concerns. The second step provides information
that a patient can use when considering self-care, determining whether
to contact a clinician, or considering seeking emergency care. The
Clinician Guide is a 5-step process: (1) Obtain and document patient
demographics, location of primary clinical symptoms, and psychosocial
information. (2) Review the symptoms noted in the patient guide. (3)
Determine the GSCI classification of the patients spine-related
complaints. (4) Ask additional questions to determine the GSCI
subclassification of the symptom pattern. (5) Consider appropriate
treatment interventions. <AbstractText Label="CONCLUSIONS">The Patient
and Clinician Guides are designed to be sufficiently clear to be useful
to all patients and clinicians, irrespective of their location,
education, professional qualifications, and experience. However, they
are comprehensive enough to provide guidance on the management of all
spine-related symptoms or disorders, including triage for serious and
specific diseases. They are consistent with widely accepted
evidence-based clinical practice guidelines. They also allow for
adequate documentation and medical record keeping. These guides should
be of value during periods of government-mandated physical or social
distancing due to infectious diseases, such as during the COVID-19
pandemic. They should also be of value in underserved communities in
high-, middle-, and low-income countries where there is a dearth of
accessible trained spine care clinicians. These guides have the
potential to reduce the overutilization of unnecessary and expensive
interventions while empowering patients to self-manage uncomplicated
spinal pain with the assistance of their clinician, either through
direct in-person consultation or via telehealth communication. Scott
Haldeman, Margareta Nordin, Patricia Tavares, Rajani Mullerpatan,
Deborah Kopansky-Giles, Vincent Setlhare, Roger Chou, Eric Hurwitz,
Caroline Treanor, Jan Hartvigsen, Michael Schneider, Ralph Gay, Jean
Moss, Joan Haldeman, David Gryfe, Adam Wilkey, Richard Brown, Geoff
Outerbridge, Stefan Eberspaecher, Linda Carroll, Reginald Engelbrecht,
Kait Graham, Nathan Cashion, Stefanie Ince, Erin Moon. Originally
published in JMIR Public Health and Surveillance (<a href="http://publichealth.jmir.org" class="uri">http://publichealth.jmir.org</a>), 17.02.2021. | |33464637
|Journal of leukocyte biology |The global pandemic caused by the severe
acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a highly
pathogenic RNA virus causing coronavirus disease 2019 (COVID-19) in
humans. Although most patients with COVID-19 have mild illness and may
be asymptomatic, some will develop severe pneumonia, acute respiratory
distress syndrome, multi-organ failure, and death. RNA viruses such as
SARS-CoV-2 are capable of hijacking the epigenetic landscape of host
immune cells to evade antiviral defense. Yet, there remain considerable
gaps in our understanding of immune cell epigenetic changes associated
with severe SARS-CoV-2 infection pathology. Here, we examined
genome-wide DNA methylation (DNAm) profiles of peripheral blood
mononuclear cells from 9 terminally-ill, critical COVID-19 patients with
confirmed SARS-CoV-2 plasma viremia compared with uninfected,
hospitalized influenza, untreated primary HIV infection, and
mild/moderate COVID-19 HIV coinfected individuals. Cell-type
deconvolution analyses confirmed lymphopenia in severe COVID-19 and
revealed a high percentage of estimated neutrophils suggesting
perturbations to DNAm associated with granulopoiesis. We observed a
distinct DNAm signature of severe COVID-19 characterized by
hypermethylation of IFN-related genes and hypomethylation of
inflammatory genes, reinforcing observations in infection models and
single-cell transcriptional studies of severe COVID-19. Epigenetic clock
analyses revealed severe COVID-19 was associated with an increased DNAm
age and elevated mortality risk according to GrimAge, further validating
the epigenetic clock as a predictor of disease and mortality risk. Our
epigenetic results reveal a discovery DNAm signature of severe COVID-19
in blood potentially useful for corroborating clinical assessments,
informing pathogenic mechanisms, and revealing new therapeutic targets
against SARS-CoV-2. 2021 Society for Leukocyte Biology. | |33442699
|bioRxiv : the preprint server for biology |COVID-19 pandemic has
ravaged the world, caused over 1.8 million deaths in the first year, and
severely affected the global economy. Hawaii is not spared from the
transmission of SARS-CoV-2 in the local population, including high
infection rates in racial and ethnic minorities. Early in the pandemic,
we described in this journal various technologies used for the detection
of SARS-CoV-2. Herein we characterize a 969-bp SARS-CoV-2 segment of the
S gene downstream of the receptor-binding domain. At the John A. Burns
School of Medicine Biocontainment Facility, RNA was extracted from an
oropharyngeal swab and a nasal swab from two patients from Hawaii who
were infected with the SARS-CoV-2 in August 2020. Following PCR, the two
viral strains were sequenced using Sanger sequencing, and phylogenetic
trees were generated using MEGAX. Phylogenetic tree results indicate
that the virus has been introduced to Hawaii from multiple sources.
Further, we decoded 13 single nucleotide polymorphisms across 13 unique
SARS-CoV-2 genomes within this region of the S gene, with one
non-synonymous mutation (P681H) found in the two Hawaii strains. The
P681H mutation has unique and emerging characteristics with a
significant exponential increase in worldwide frequency when compared to
the plateauing of the now universal D614G mutation. The P681H mutation
is also characteristic of the new SARS-CoV-2 variants from the United
Kingdom and Nigeria. Additionally, several mutations resulting in
cysteine residues were detected, potentially resulting in disruption of
the disulfide bridges in and around the receptor-binding domain.
Targeted sequence characterization is warranted to determine the origin
of multiple introductions of SARS-CoV-2 circulating in Hawaii. |
|33422679 |Journal of thoracic oncology : official publication of the
International Association for the Study of Lung Cancer |Severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) spreads mainly by means
of aerosols (microdroplets) in enclosed environments, especially those
in which temperature and humidity are regulated by means of
air-conditioning. About 30% of individuals infected with SARS-CoV-2
develop coronavirus disease 2019 (COVID-19) disease. Among them,
approximately 25% require hospitalization. In medicine, cases are
identified as those who become ill.During this pandemic, cases have
been identified as those with a positive SARS-CoV-2 polymerase chain
reaction test, including approximately 70% who were asymptomatic-this
has caused unnecessary anxiety. Individuals more than 65 years old,
those affected by obesity, diabetes, asthma, or are immune-depressed
owing to cancer and other conditions, are at a higher risk of
hospitalization and of dying of COVID-19. Healthy individuals younger
than 40 years very rarely die of COVID-19. Estimates of the COVID-19
mortality rate vary because the definition of COVID-19-related deaths
varies. Belgium has the highest death rate at 154.9 per 100,000 persons,
because it includes anyone who died with symptoms compatible with
COVID-19, even those never tested for SARS-CoV-2. The United States
includes all patients who died with a positive test, whether they died
because of, or with, SARS-CoV-2. Countries that include only patients in
which COVID-19 was the main cause of death, rather than a cofactor, have
lower death rates. Numerous therapies are being developed, and rapid
improvements are anticipated. Because of disinformation, only
approximately 50% of the U.S. population plans to receive a COVID-19
vaccine. By sharing accurate information, physicians, health
professionals, and scientists play a key role in addressing myths and
anxiety, help public health officials enact measures to decrease
infections, and provide the best care for those who become sick. In this
article, we discuss these issues. Copyright  2021 International
Association for the Study of Lung Cancer. Published by Elsevier Inc.All
rights reserved. | |33422626 |Journal of the American Academy of
Dermatology |<AbstractText Label="OBJECTIVE">To update guidance
regarding the management of psoriatic disease during the COVID-19
pandemic. <AbstractText Label="STUDY DESIGN">The task force (TF)
includes 18 physician voting members with expertise in dermatology,
rheumatology, epidemiology, infectious diseases, and critical care. The
TF was supplemented by nonvoting members, which included fellows and
National Psoriasis Foundation staff. Clinical questions relevant to the
psoriatic disease community were informed by inquiries received by the
National Psoriasis Foundation. A Delphi process was conducted.
<AbstractText Label="RESULTS">The TF updated evidence for the original
22 statements and added 5 new recommendations. The average of the votes
was within the category of agreement for all statements, 13 with high
consensus and 14 with moderate consensus.
<AbstractText Label="LIMITATIONS">The evidence behind many guidance
statements is variable in quality and/or quantity.
<AbstractText Label="CONCLUSIONS">These statements provide guidance for
the treatment of patients with psoriatic disease on topics including how
the disease and its treatments affect COVID-19 risk, how medical care
can be optimized during the pandemic, what patients should do to lower
their risk of getting infected with severe acute respiratory syndrome
coronavirus 2 (including novel vaccination), and what they should do if
they develop COVID-19. The guidance is a living document that is
continuously updated by the TF as data emerge. Copyright  2021 American
Academy of Dermatology, Inc.Published by Elsevier Inc.All rights
reserved. | |33417334 |ASAIO journal (American Society for Artificial
Internal Organs : 1992) |NA | |33407957 |Cardiology in the young |A
12-year-old girl presented with fever and signs of systemic
inflammation, and was found to have junctional tachycardia. She was
subsequently diagnosed with Multisystem Inflammatory Syndrome in
Children and treated with intravenous immunoglobulin and steroids, which
led to resolution of the arrhythmia. | |35412644 |Journal of emergency
management (Weston, Mass.) |During the COVID-19 pandemic, some nonprofit
organizations (NPOs) have been struggling to maintain their operations,
while others are able to coordinate with partners to provide programs
and services locally and globally. This study explores how NPOs are able
to survive and actively engage in local and global COVID-19 responses by
investigating the organizational capacities of the Tzu Chi Foundation, a
Taiwan-based international NPO. This study employs interview data and
secondary data from a variety of sources to answer the research
questions. Through this case study, we find that Tzu Chi Foundations
capacity to coordinate local and global COVID-19 issues quickly,
broadly, and effectively can be attributed to three main factors: (1)
clear mission and charismatic leadership, (2) rich experience of
disaster relief and recovery strategies, and (3) committed and active
volunteers. Moreover, we find that financial management capacity and
adaptive capacity are two crucial kinds of capacity for enabling the Tzu
Chi Foundation to survive and continuously engage in emergency responses
during the pandemic. We conclude with implications for future nonprofit
capacity and emergency management research. | |33331197 |Expert review
of respiratory medicine |<AbstractText Label="INTRODUCTION">The dramatic
impact of COVID-19 on humans worldwide has initiated an extraordinary
search for effective treatment approaches. One of these is the
administration of exogenous surfactant, which is being tested in ongoing
clinical trials. <AbstractText Label="AREAS COVERED">Exogenous
surfactant is a life-saving treatment for premature infants with
neonatal respiratory distress syndrome. This treatment has also been
tested for acute respiratory distress syndrome (ARDS) with limited
success possibly due to the complexity of that syndrome. The 60-year
history of successes and failures associated with surfactant therapy
distinguishes it from many other treatments currently being tested for
COVID-19 and provides the opportunity to discuss the factors that may
influence the success of this therapy.
<AbstractText Label="EXPERT OPINION">Clinical data provide a strong
rationale for using exogenous surfactant in COVID-19 patients. Success
of this therapy may be influenced by the mechanical ventilation
strategy, the timing of treatment, the doses delivered, the method of
delivery and the preparations utilized. In addition, future development
of enhanced preparations may improve this treatment approach. Overall,
results from ongoing trials may not only provide data to indicate if
this therapy is effective for COVID-19 patients, but also lead to
further scientific understanding and improved treatment strategies. |
|33316097 |Headache Headache</p>
<pre><code>  Early impact of the COVID-19 pandemic on outpatient migraine care in Hawaii: Results of a quality improvement survey.
  
    149
    156
    149-156
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1111/head.14030
  
    &lt;AbstractText Label=&quot;OBJECTIVE&quot;&gt;A survey was implemented for early assessment of pandemic-related practice processes and quality improvement (QI).
    &lt;AbstractText Label=&quot;BACKGROUND&quot;&gt;In response to the public health measures in Hawaii to curtail the coronavirus 2019 pandemic, Hawaii Pacific Neuroscience (HPN) adapted their patient care to ensure continuity of neurological treatment.
    &lt;AbstractText Label=&quot;METHODS&quot;&gt;The telephone survey was conducted on patients seen at HPN during the period of April 22, 2020-May 18, 2020 to address four areas related to patients&#39; outpatient experience: delivery of care, general well-being, experience with telemedicine, and disease-specific questions.
    &lt;AbstractText Label=&quot;RESULTS&quot;&gt;A total of 928 patients were contacted of which 429 (46.2%) patients responded and 367 (85.5%) agreed to participate. A total of 133 patients with migraine and 234 patients with other neurological conditions provided responses. Our migraine patients&#39; survey responses suggest that their well-being was disproportionately negatively affected by the pandemic. Survey respondents with migraine were significantly more likely than their non-migraine peers to report worsening anxiety and sleep problems [62/132 (47.0%) vs. 78/234 (33.3%), 2 =6.64, p=0.010, and 64/132 (48.5%) vs. 73/234 (31.2%), 2 =10.77, p=0.001]; migraine patients also reported worsening of depression as a result of the pandemic more than patients with other diagnoses, though this was not statistically significant [44/132 (33.3%) vs. 57/234 (24.4%), 2 =3.40, p=0.065]. In regard to access to healthcare, significantly more migraine patients reported running out of medications than those with other diagnoses [20/133 (15.0%) vs. 18/234 (7.7%), 2 =4.93, p=0.026]. More avoided seeking medical help for new health problems because of the pandemic [30/133 (22.6%) vs. 30/234 (12.8%), 2 =5.88, p=0.015]. Migraine patients were also significantly impacted economically by the pandemic; 43/132 (32.4%) of migraine patients reported losing their jobs as the result of the pandemic versus 34/234 (14.5%) of their peers (2 =11.20, p&amp;lt;0.001). An increase in headache severity or frequency was reported in 39/118 (33.1%) of respondents and 19/118 (16.1%) reported to using more abortive therapy than usual. Telemedicine was well received by almost all patients who took advantage of the option. Most of those patients found telemedicine to be easy to use and as valuable as an in-person visit. Migraine patients indicated with more frequency that without the telemedicine option, they would have missed their medical appointments [37/68 (54.4%) vs. 56/144 (38.6%), 2 =4.31, p=0.038]; a majority would prefer or consider telemedicine for future appointments over in-person visits.
    &lt;AbstractText Label=&quot;CONCLUSIONS&quot;&gt;Insights gained from this QI survey to the practice&#39;s new pandemic-related processes include stressing lifestyle modification, optimizing treatment plans, and continuing the option of telemedicine.
     2020 American Headache Society.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Smith
      Maiya
      M
      
        John Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Nakamoto
      Max
      M
      
        John Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Crocker
      Julie
      J
      
        John Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Tiffany Morden
      Frances
      F
      
        John Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Liu
      Keke
      K
      
        John Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Ma
      Enze
      E
      
        John Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Chong
      Ariel
      A
      
        Undergraduate Education, University of Hawaii at Manoa, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Van
      Nicholas
      N
      
        Undergraduate Education, University of Hawaii at Manoa, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Vajjala
      Vimala
      V
      
        Headache &amp;amp; Facial Pain Center, Hawaii Pacific Neuroscience, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Carrazana
      Enrique
      E
      
        Clinical Research Center, Brain Research, Innovation &amp;amp; Translation Labs, Hawaii Pacific Neuroscience, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Viereck
      Jason
      J
      
        Clinical Research Center, Brain Research, Innovation &amp;amp; Translation Labs, Hawaii Pacific Neuroscience, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Liow
      Kore
      K
      
        Clinical Research Center, Brain Research, Innovation &amp;amp; Translation Labs, Hawaii Pacific Neuroscience, Honolulu, HI, USA.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
  
  &lt;ArticleDate DateType=&quot;Electronic&quot;&gt;
    2020
    12
    14
  


  United States
  Headache
  2985091R
  0017-8748

IM

  
    &lt;DescriptorName UI=&quot;D000293&quot; MajorTopicYN=&quot;N&quot;&gt;Adolescent
  
  
    &lt;DescriptorName UI=&quot;D000328&quot; MajorTopicYN=&quot;N&quot;&gt;Adult
  
  
    &lt;DescriptorName UI=&quot;D000368&quot; MajorTopicYN=&quot;N&quot;&gt;Aged
  
  
    &lt;DescriptorName UI=&quot;D000553&quot; MajorTopicYN=&quot;Y&quot;&gt;Ambulatory Care
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;Y&quot;&gt;COVID-19
  
  
    &lt;DescriptorName UI=&quot;D002648&quot; MajorTopicYN=&quot;N&quot;&gt;Child
  
  
    &lt;DescriptorName UI=&quot;D005260&quot; MajorTopicYN=&quot;N&quot;&gt;Female
  
  
    &lt;DescriptorName UI=&quot;D006254&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;Hawaii
  
  
    &lt;DescriptorName UI=&quot;D006297&quot; MajorTopicYN=&quot;Y&quot;&gt;Health Services Accessibility
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D008297&quot; MajorTopicYN=&quot;N&quot;&gt;Male
  
  
    &lt;DescriptorName UI=&quot;D008875&quot; MajorTopicYN=&quot;N&quot;&gt;Middle Aged
  
  
    &lt;DescriptorName UI=&quot;D008881&quot; MajorTopicYN=&quot;Y&quot;&gt;Migraine Disorders
  
  
    &lt;DescriptorName UI=&quot;D010342&quot; MajorTopicYN=&quot;Y&quot;&gt;Patient Acceptance of Health Care
    &lt;QualifierName UI=&quot;Q000706&quot; MajorTopicYN=&quot;N&quot;&gt;statistics &amp;amp; numerical data
  
  
    &lt;DescriptorName UI=&quot;D058996&quot; MajorTopicYN=&quot;N&quot;&gt;Quality Improvement
  
  
    &lt;DescriptorName UI=&quot;D000086402&quot; MajorTopicYN=&quot;N&quot;&gt;SARS-CoV-2
  
  
    &lt;DescriptorName UI=&quot;D011795&quot; MajorTopicYN=&quot;N&quot;&gt;Surveys and Questionnaires
  
  
    &lt;DescriptorName UI=&quot;D017216&quot; MajorTopicYN=&quot;N&quot;&gt;Telemedicine
    &lt;QualifierName UI=&quot;Q000379&quot; MajorTopicYN=&quot;N&quot;&gt;methods
  
  
    &lt;DescriptorName UI=&quot;D055815&quot; MajorTopicYN=&quot;N&quot;&gt;Young Adult
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;coronavirus 2019
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;migraine
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;neurology
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;telemedicine




  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2020
    6
    19
  
  &lt;PubMedPubDate PubStatus=&quot;revised&quot;&gt;
    2020
    8
    30
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2020
    9
    4
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2020
    12
    15
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2021
    2
    26
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2020
    12
    14
    17
    15
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;33316097
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1111/head.14030


  REFERENCES                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |&lt;AbstractText Label=&quot;OBJECTIVE&quot;&gt;A survey was implemented for early assessment of pandemic-related practice processes and quality improvement (QI). &lt;AbstractText Label=&quot;BACKGROUND&quot;&gt;In response to the public health measures in Hawaii to curtail the coronavirus 2019 pandemic, Hawaii Pacific Neuroscience (HPN) adapted their patient care to ensure continuity of neurological treatment. &lt;AbstractText Label=&quot;METHODS&quot;&gt;The telephone survey was conducted on patients seen at HPN during the period of April 22, 2020-May 18, 2020 to address four areas related to patients&#39; outpatient experience: delivery of care, general well-being, experience with telemedicine, and disease-specific questions. &lt;AbstractText Label=&quot;RESULTS&quot;&gt;A total of 928 patients were contacted of which 429 (46.2%) patients responded and 367 (85.5%) agreed to participate. A total of 133 patients with migraine and 234 patients with other neurological conditions provided responses. Our migraine patients&#39; survey responses suggest that their well-being was disproportionately negatively affected by the pandemic. Survey respondents with migraine were significantly more likely than their non-migraine peers to report worsening anxiety and sleep problems [62/132 (47.0%) vs. 78/234 (33.3%), 2 = 6.64, p = 0.010, and 64/132 (48.5%) vs. 73/234 (31.2%), 2 = 10.77, p = 0.001]; migraine patients also reported worsening of depression as a result of the pandemic more than patients with other diagnoses, though this was not statistically significant [44/132 (33.3%) vs. 57/234 (24.4%), 2 = 3.40, p = 0.065]. In regard to access to healthcare, significantly more migraine patients reported running out of medications than those with other diagnoses [20/133 (15.0%) vs. 18/234 (7.7%), 2 = 4.93, p = 0.026]. More avoided seeking medical help for new health problems because of the pandemic [30/133 (22.6%) vs. 30/234 (12.8%), 2 = 5.88, p = 0.015]. Migraine patients were also significantly impacted economically by the pandemic; 43/132 (32.4%) of migraine patients reported losing their jobs as the result of the pandemic versus 34/234 (14.5%) of their peers (2 = 11.20, p &amp;lt; 0.001). An increase in headache severity or frequency was reported in 39/118 (33.1%) of respondents and 19/118 (16.1%) reported to using more abortive therapy than usual. Telemedicine was well received by almost all patients who took advantage of the option. Most of those patients found telemedicine to be easy to use and as valuable as an in-person visit. Migraine patients indicated with more frequency that without the telemedicine option, they would have missed their medical appointments [37/68 (54.4%) vs. 56/144 (38.6%), 2 = 4.31, p = 0.038]; a majority would prefer or consider telemedicine for future appointments over in-person visits. &lt;AbstractText Label=&quot;CONCLUSIONS&quot;&gt;Insights gained from this QI survey to the practice&#39;s new pandemic-related processes include stressing lifestyle modification, optimizing treatment plans, and continuing the option of telemedicine.  2020 American Headache Society.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |</code></pre>
<p>|33308888 |Vaccine | It is imperative that vaccine development and
deployment include pregnant individuals because:  They are at equal, if
not greater, risk of severe COVID-19 illness than nonpregnant patients.
 Vertical transmission of SARS-CoV-2 to the fetus has been documented.
 Placental injury from SARS-CoV-2 may lead to stillbirth and poor
neonatal outcome. | |33301024 |Annals of behavioral medicine : a
publication of the Society of Behavioral Medicine
|<AbstractText Label="BACKGROUND">Investigating antecedents of
behaviors, such as wearing face coverings, is critical for developing
strategies to prevent SARS-CoV-2 transmission.
<AbstractText Label="PURPOSE">The purpose of this study was to determine
associations between theory-based behavioral predictors of intention to
wear a face covering and actual wearing of a face covering in public.
<AbstractText Label="METHODS">Data from a cross-sectional panel survey
of U.S. adults conducted in May and June 2020 (N = 1,004) were used to
test a theory-based behavioral path model. We (a) examined predictors of
intention to wear a face covering, (b) reported use of cloth face
coverings, and (c) reported use of other face masks (e.g., a surgical
mask or N95 respirator) in public. <AbstractText Label="RESULTS">We
found that being female, perceived importance of others wanting the
respondent to wear a face covering, confidence to wear a face covering,
and perceived importance of personal face covering use was positively
associated with intention to wear a face covering in public. Intention
to wear a face covering was positively associated with self-reported
wearing of a cloth face covering if other people were observed wearing
cloth face coverings in public at least rarely (aOR = 1.43), with
stronger associations if they reported sometimes (aOR = 1.83), often
(aOR = 2.32), or always (aOR = 2.96). For other types of face masks, a
positive association between intention and behavior was only present
when observing others wearing face masks often (aOR = 1.25) or
always (aOR = 1.48). <AbstractText Label="CONCLUSIONS">Intention to
wear face coverings and observing other people wearing them are
important behavioral predictors of adherence to the CDC recommendation
to wear face coverings in public. Published by Oxford University Press
on behalf of the Society of Behavioral Medicine 2020. | |33276110
|International journal of infectious diseases : IJID : official
publication of the International Society for Infectious Diseases |This
is a brief report on an unusual observation regarding COVID-19 cases.
The State of Hawaii is one of the most remote of the Pacific islands and
the population is approximately 1.4 million. The racial and ethnic
diversity is very high. For example, white Caucasians comprise 25%,
Asians including Japanese, Chinese, and other Asians account for 30%,
Hawaiians for 20%, and Pacific Islanders mostly from Micronesia and
Samoa comprise 4%. We discovered that the COVID-19 rate in the latter
group was up to 10 times that in all of the other groups combined and
they accounted for almost 30% of cases. Moreover, we are unaware of
COVID-19 transmission from Pacific Islanders to islanders with other
ethnicities. Thus, there is an epidemic within the epidemic in Hawaii.
Copyright  2020 The Author(s). Published by Elsevier Ltd.. All rights
reserved. | |33270782 |PloS one |<AbstractText Label="BACKGROUND">The
purpose of this analysis was to assess the variations in COVID-19
related mortality in relation to the time differences in the
commencement of virus circulation and containment measures in the
European Region. <AbstractText Label="METHODS">The data for the current
analysis (N = 50 countries) were retrieved from the John Hopkins
University dataset on the 7th of May 2020, with countries as study
units. A piecewise regression analysis was conducted with mortality and
cumulative incidence rates introduced as dependent variables and time
interval (days from the 22nd of January to the date when 100 first cases
were reported) as the main predictor. The country average life
expectancy at birth and outpatient contacts per person per year were
statistically adjusted for in the regression model.
<AbstractText Label="RESULTS">Mortality and incidence were strongly and
inversely intercorrelated with days from January 22, respectively -0.83
(p&lt;0.001) and -0.73 (p&lt;0.001). Adjusting for average life
expectancy and outpatients contacts per person per year, between days 33
to 50 from the 22nd of the January, the average mortality rate decreased
by 30.1/million per day (95% CI: 22.7, 37.6, p&lt;0.001). During
interval 51 to 73 days, the change in mortality was no longer
statistically significant but still showed a decreasing trend. A similar
relationship with time interval was found for incidence. Life expectancy
and outpatients contacts per person per year were not associated with
mortality rate. <AbstractText Label="CONCLUSION">Countries in Europe
that had the earliest COVID-19 circulation suffered the worst
consequences in terms of health outcomes, specifically mortality. The
drastic social isolation measures, quickly undertaken in response to
those initial outbreaks appear effective, especially in Eastern European
countries, where community circulation started after March 11th. The
study demonstrates that efforts to delay the early spread of the virus
may have saved an average 30 deaths daily per one million inhabitants. |
|33251328 |Applied network science |Deterministic epidemic models, such
as the Susceptible-Infected-Recovered (SIR) model, are immensely useful
even if they lack the nuance and complexity of social contacts at the
heart of network science modeling. Here we present a simple modification
of the SIR equations to include the heterogeneity of social connection
networks. A typical power-law model of social interactions from network
science reproduces the observation that individuals with a high number
of contacts, hubs or superspreaders, can become the primary conduits
for transmission. Conversely, once the tail of the distribution is
saturated, herd immunity sets in at a smaller overall recovered fraction
than in the analogous SIR model. The new dynamical equations suggest
that cutting off the tail of the social connection distribution, i.e.,
stopping superspreaders, is an efficient non-pharmaceutical intervention
to slow the spread of a pandemic, such as the Coronavirus Disease 2019
(COVID-19).  The Author(s) 2020. | |33244071 |Scientific reports |Since
the first case of the novel coronavirus disease (COVID-19) was confirmed
in Wuhan, China, social distancing has been promoted worldwide,
including in the United States, as a major community mitigation
strategy. However, our understanding remains limited in how people would
react to such control measures, as well as how people would resume their
normal behaviours when those orders were relaxed. We utilize an
integrated dataset of real-time mobile device location data involving
100 million devices in the contiguous United States (plus Alaska and
Hawaii) from February 2, 2020 to May 30, 2020. Built upon the common
human mobility metrics, we construct a Social Distancing Index (SDI) to
evaluate peoples mobility pattern changes along with the spread of
COVID-19 at different geographic levels. We find that both government
orders and local outbreak severity significantly contribute to the
strength of social distancing. As people tend to practice less social
distancing immediately after they observe a sign of local mitigation, we
identify several states and counties with higher risks of continuous
community transmission and a second outbreak. Our proposed index could
help policymakers and researchers monitor peoples real-time mobility
behaviours, understand the influence of government orders, and evaluate
the risk of local outbreaks. | |33236896 |ACS nano |Coronavirus disease
2019 (COVID-19), due to infection by the severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), is now causing a global pandemic.
Aerosol transmission of COVID-19, although plausible, has not been
confirmed by the World Health Organization (WHO) as a general
transmission route. Considering the rapid spread of SARS-CoV-2,
especially nosocomial outbreaks and other superspreading events, there
is an urgent need to study the possibility of airborne transmission and
its impact on the lung, the primary body organ attacked by the virus.
Here, we review the complete pathway of airborne transmission of
SARS-CoV-2 from aerosol dispersion in air to subsequent biological
uptake after inhalation. In particular, we first review the aerodynamic
and colloidal mechanisms by which aerosols disperse and transmit in air
and deposit onto surfaces. We then review the fundamental mechanisms
that govern regional deposition of micro- and nanoparticles in the lung.
Focus is given to biophysical interactions between particles and the
pulmonary surfactant film, the initial alveolar-capillary barrier and
first-line host defense system against inhaled particles and pathogens.
Finally, we summarize the current understanding about the structural
dynamics of the SARS-CoV-2 spike protein and its interactions with
receptors at the atomistic and molecular scales, primarily as revealed
by molecular dynamics simulations. This review provides urgent and
multidisciplinary knowledge toward understanding the airborne
transmission of SARS-CoV-2 and its health impact on the respiratory
system. | |33229999 |Quality management in health care
|<AbstractText Label="BACKGROUND AND OBJECTIVES">The coronavirus
disease-2019 (COVID-19) pandemic is transforming the health care sector.
As health care organizations move from crisis mobilization to a new
landscape of health and social needs, organizational health literacy
offers practical building blocks to provide high-quality, efficient, and
meaningful care to patients and their families. Organizational health
literacy is defined by the Institute of Medicine as the degree to which
an organization implements policies, practices, and systems that make it
easier for people to navigate, understand, and use information and
services to take care of their health.
<AbstractText Label="METHODS">This article synthesizes insights from
organizational health literacy in the context of current major health
care challenges and toward the goal of innovation in patient-centered
care. We first provide a brief overview of the origins and outlines of
organizational health literacy research and practice. Second, using an
established patient-centered innovation framework, we show how the
existing work on organizational health literacy can offer a menu of
effective, patient-centered innovative options for care delivery systems
to improve systems and outcomes. Finally, we consider the high value of
management focusing on organizational health literacy efforts,
specifically for patients in health care transitions and in the rapid
transformation of care into myriad distance modalities.
<AbstractText Label="RESULTS">This article provides practical guidance
for systems and informs decisions around resource allocation and
organizational priorities to best meet the needs of patient populations
even in the face of financial and workforce disruption.
<AbstractText Label="CONCLUSIONS">Organizational health literacy
principles and guidelines provide a road map for promoting
patient-centered care even in this time of crisis, change, and
transformation. Health system leaders seeking innovative approaches can
have access to well-established tool kits, guiding models, and materials
toward many organizational health literacy goals across treatment,
diagnosis, prevention, education, research, and outreach. Copyright 
2020 Wolters Kluwer Health, Inc.All rights reserved. | |33216726
|Journal of medical Internet research
|<AbstractText Label="BACKGROUND">The emergence of SARS-CoV-2, the virus
that causes COVID-19, has led to a global pandemic. The United States
has been severely affected, accounting for the most COVID-19 cases and
deaths worldwide. Without a coordinated national public health plan
informed by surveillance with actionable metrics, the United States has
been ineffective at preventing and mitigating the escalating COVID-19
pandemic. Existing surveillance has incomplete ascertainment and is
limited by the use of standard surveillance metrics. Although many
COVID-19 data sources track infection rates, informing prevention
requires capturing the relevant dynamics of the pandemic.
<AbstractText Label="OBJECTIVE">The aim of this study is to develop
dynamic metrics for public health surveillance that can inform worldwide
COVID-19 prevention efforts. Advanced surveillance techniques are
essential to inform public health decision making and to identify where
and when corrective action is required to prevent outbreaks.
<AbstractText Label="METHODS">Using a longitudinal trend analysis study
design, we extracted COVID-19 data from global public health registries.
We used an empirical difference equation to measure daily case numbers
for our use case in 50 US states and the District of Colombia as a
function of the prior number of cases, the level of testing, and weekly
shift variables based on a dynamic panel model that was estimated using
the generalized method of moments approach by implementing the
Arellano-Bond estimator in R. <AbstractText Label="RESULTS">Examination
of the United States and state data demonstrated that most US states are
experiencing outbreaks as measured by these new metrics of speed,
acceleration, jerk, and persistence. Larger US states have high COVID-19
caseloads as a function of population size, density, and deficits in
adherence to public health guidelines early in the epidemic, and other
states have alarming rates of speed, acceleration, jerk, and 7-day
persistence in novel infections. North and South Dakota have had the
highest rates of COVID-19 transmission combined with positive
acceleration, jerk, and 7-day persistence. Wisconsin and Illinois also
have alarming indicators and already lead the nation in daily new
COVID-19 infections. As the United States enters its third wave of
COVID-19, all 50 states and the District of Colombia have positive rates
of speed between 7.58 (Hawaii) and 175.01 (North Dakota), and
persistence, ranging from 4.44 (Vermont) to 195.35 (North Dakota) new
infections per 100,000 people.
<AbstractText Label="CONCLUSIONS">Standard surveillance techniques such
as daily and cumulative infections and deaths are helpful but only
provide a static view of what has already occurred in the pandemic and
are less helpful in prevention. Public health policy that is informed by
dynamic surveillance can shift the country from reacting to COVID-19
transmissions to being proactive and taking corrective action when
indicators of speed, acceleration, jerk, and persistence remain positive
week over week. Implicit within our dynamic surveillance is an early
warning system that indicates when there is problematic growth in
COVID-19 transmissions as well as signals when growth will become
explosive without action. A public health approach that focuses on
prevention can prevent major outbreaks in addition to endorsing
effective public health policies. Moreover, subnational analyses on the
dynamics of the pandemic allow us to zero in on where transmissions are
increasing, meaning corrective action can be applied with precision in
problematic areas. Dynamic public health surveillance can inform
specific geographies where quarantines are necessary while preserving
the economy in other US areas. Lori Ann Post, Tariq Ziad Issa, Michael
J Boctor, Charles B Moss, Robert L Murphy, Michael G Ison, Chad J
Achenbach, Danielle Resnick, Lauren Nadya Singh, Janine White, Joshua
Marco Mitchell Faber, Kasen Culler, Cynthia A Brandt, James Francis
Oehmke. Originally published in the Journal of Medical Internet Research
(<a href="http://www.jmir.org" class="uri">http://www.jmir.org</a>),
03.12.2020. | |33193454 |Frontiers in immunology |The current COVID-19
pandemic has claimed hundreds of thousands of lives and its causative
agent, SARS-CoV-2, has infected millions, globally. The highly
contagious nature of this respiratory virus has spurred massive global
efforts to develop vaccines at record speeds. In addition to enhanced
immunogen delivery, adjuvants may greatly impact protective efficacy of
a SARS-CoV-2 vaccine. To investigate adjuvant suitability, we formulated
protein subunit vaccines consisting of the recombinant S1 domain of
SARS-CoV-2 Spike protein alone or in combination with either CoVaccine
HT or Alhydrogel. CoVaccine HT induced high titres of antigen-binding
IgG after a single dose, facilitated affinity maturation and class
switching to a greater extent than Alhydrogel and elicited potent
cell-mediated immunity as well as virus neutralizing antibody titres.
Data presented here suggests that adjuvantation with CoVaccine HT can
rapidly induce a comprehensive and protective immune response to
SARS-CoV-2. Copyright  2020 Haun, Lai, Williams, Wong, Lieberman,
Pessaint, Andersen and Lehrer. | |33186704 |International journal of
infectious diseases : IJID : official publication of the International
Society for Infectious Diseases
|<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">Infection with
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is now a
global pandemic. Emerging results indicate a dysregulated immune
response. Given the role of CCR5 in immune cell migration and
inflammation, we investigated the impact of CCR5 blockade via the
CCR5-specific antibody leronlimab on clinical, immunological, and
virological parameters in severe COVID-19 patients.
<AbstractText Label="METHODS" NlmCategory="METHODS">In March 2020, 10
terminally ill, critical COVID-19 patients received two doses of
leronlimab via individual emergency use indication. We analyzed changes
in clinical presentation, immune cell populations, inflammation, as well
as SARS-CoV-2 plasma viremia before and 14 days after treatment.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Over the 14-day
study period, six patients survived, two were extubated, and one
discharged. We observed complete CCR5 receptor occupancy in all donors
by day 7. Compared with the baseline, we observed a concomitant
statistically significant reduction in plasma IL-6, restoration of the
CD4/CD8 ratio, and resolution of SARS-CoV2 plasma viremia (pVL).
Furthermore, the increase in the CD8 percentage was inversely correlated
with the reduction in pVL (r = -0.77, p = 0.0013).
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Our study
design precludes clinical efficacy inferences but the results implicate
CCR5 as a therapeutic target for COVID-19 and they form the basis for
ongoing randomized clinical trials. Copyright  2020 The Authors.
Published by Elsevier Ltd.. All rights reserved. | |33176077 |The New
England journal of medicine |<AbstractText Label="BACKGROUND">An
outbreak of coronavirus disease 2019 (Covid-19) occurred on the U.S.S.
Theodore Roosevelt, a nuclear-powered aircraft carrier with a crew of
4779 personnel. <AbstractText Label="METHODS">We obtained clinical and
demographic data for all crew members, including results of testing by
real-time reverse-transcriptase polymerase chain reaction (rRT-PCR). All
crew members were followed up for a minimum of 10 weeks, regardless of
test results or the absence of symptoms.
<AbstractText Label="RESULTS">The crew was predominantly young (mean
age, 27 years) and was in general good health, meeting U.S. Navy
standards for sea duty. Over the course of the outbreak, 1271 crew
members (26.6% of the crew) tested positive for severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) infection by rRT-PCR testing, and
more than 1000 infections were identified within 5 weeks after the first
laboratory-confirmed infection. An additional 60 crew members had
suspected Covid-19 (i.e., illness that met Council of State and
Territorial Epidemiologists clinical criteria for Covid-19 without a
positive test result). Among the crew members with laboratory-confirmed
infection, 76.9% (978 of 1271) had no symptoms at the time that they
tested positive and 55.0% had symptoms develop at any time during the
clinical course. Among the 1331 crew members with suspected or confirmed
Covid-19, 23 (1.7%) were hospitalized, 4 (0.3%) received intensive care,
and 1 died. Crew members who worked in confined spaces appeared more
likely to become infected. <AbstractText Label="CONCLUSIONS">SARS-CoV-2
spread quickly among the crew of the U.S.S. Theodore Roosevelt.
Transmission was facilitated by close-quarters conditions and by
asymptomatic and presymptomatic infected crew members. Nearly half of
those who tested positive for the virus never had symptoms. Copyright 
2020 Massachusetts Medical Society. | |33139866 |Pediatric research |NA
| |33098971 |Journal of ethnopharmacology
|<AbstractText Label="ETHNOPHARMACOLOGICAL RELEVANCE" NlmCategory="BACKGROUND">Traditional
pharmacopeias have been developed by multiple cultures and evaluated for
efficacy and safety through both historical/empirical iteration and more
recently through controlled studies using Western scientific paradigms
and an increasing emphasis on data science methodologies for network
pharmacology. Traditional medicines represent likely sources of
relatively inexpensive drugs for symptomatic management as well as
potential libraries of new therapeutic approaches. Leveraging this
potential requires hard evidence for efficacy that separates science
from pseudoscience.
<AbstractText Label="MATERIALS AND METHODS" NlmCategory="METHODS">We
performed a review of non-Western medical systems and developed case
studies that illustrate the epistemological and practical translative
barriers that hamper their transition to integration with Western
approaches. We developed a new data analytics approach, in silico
convergence analysis, to deconvolve modes of action, and potentially
predict desirable components of TM-derived formulations based on
computational consensus analysis across cultures and medical systems.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">Abstraction,
simplification and altered dose and delivery modalities were identified
as factors that influence actual and perceived efficacy once a medicine
is moved from a non-Western to Western setting. Case studies on these
factors highlighted issues with translation between non-Western and
Western epistemologies, including those where epistemological and
medicinal systems drive markets that can be epicenters for zoonoses such
as the novel Coronavirus. The proposed novel data science approach
demonstrated the ability to identify and predict desirable medicinal
components for a test indication, pain.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Relegation
of traditional therapies to the relatively unregulated nutraceutical
industry may lead healthcare providers and patients to underestimate the
therapeutic potential of these medicines. We suggest three areas of
emphasis for this field: First, vertical integration and embedding of
traditional medicines into healthcare systems would subject them to
appropriate regulation and evidence-based practice, as viable
integrative implementation mode. Second, we offer a new
Bradford-Hill-like framework for setting research priorities and
evaluating efficacy, with the goal of rescuing potentially valuable
therapies from the nutraceutical market and discrediting those that are
pseudoscience. Third, data analytics pipelines offer new capacity to
generate new types of TMS-inspired medicines that are
rationally-designed based on integrated knowledge across cultures, and
also provide an evaluative framework against which to test claims of
fidelity and efficacy to TMS made for nutraceuticals. Copyright  2020
The Author(s). Published by Elsevier B.V. All rights reserved. |
|33096099 |Gastroenterology |NA | |33087192 |Prehospital and disaster
medicine |This two-part article examines the global public health (GPH)
information system deficits emerging in the coronavirus disease 2019
(COVID-19) pandemic. It surveys past, missed opportunities for public
health (PH) information system and operational improvements, examines
current megatrend changes to information management, and describes a new
multi-disciplinary model for population-based management (PBM) supported
by a GPH Database applicable to pandemics and GPH crises. | |33083826
|The Journal of infectious diseases |It is critical to identify
potential causal targets for SARS-CoV-2, which may guide drug
repurposing options. We assessed the associations between genetically
predicted protein levels and COVID-19 severity. Leveraging data from the
COVID-19 Host Genetics Initiative comparing 6492 hospitalized COVID-19
patients and 1 012 809 controls, we identified 18 proteins with
genetically predicted levels to be associated with COVID-19 severity at
a false discovery rate of &lt;0.05, including 12 that showed an
association even after Bonferroni correction. Of the 18 proteins, 6
showed positive associations and 12 showed inverse associations. In
conclusion, we identified 18 candidate proteins for COVID-19 severity. 
The Author(s) 2020. Published by Oxford University Press for the
Infectious Diseases Society of America. All rights reserved. For
permissions, e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>. | |33043445 |Acta
neurologica Scandinavica |NA | |33027604 |Journal of applied physiology
(Bethesda, Md. : 1985) |NA | |32984015 |Frontiers in oncology |On March
11, 2020, the WHO has declared the coronavirus disease 2019 (COVID-19) a
global pandemic. As the last few months have profoundly changed the
delivery of health care in the world, we should recognize the effort of
numerous comprehensive cancer centers to share experiences and knowledge
to develop best practices to care for oncological patients during the
COVID-19 pandemic. Patients as well as physicians must be aware of all
these constraints and profound social, personal, and medical challenges
posed by the tackling of this deadly disease in everyday life in order
to adjust to such a completely novel scenario. This review will discuss
facing the challenges and the current approaches that cancer centers in
Italy and United States are adopting in order to cope with clinical and
research activities. Copyright  2020 Terracciano, Buonerba, Scafuri, De
Berardinis, Calin, Ferrajoli, Fabbri and Cimmino. | |32969950 |Journal
of public health management and practice : JPHMP |NA | |32921878 |World
development |Coffee supports the livelihoods of millions of smallholder
farmers in more than 52 countries, and generates billions of dollars in
revenue. The threats that COVID-19 pose to the global coffee sector is
daunting with profound implications for coffee production. The financial
impacts will be long-lived and uneven, and smallholders will be among
the hardest hit. We argue that the impacts are rooted in the systemic
vulnerability of the coffee production system and the unequal ways the
sector is organized: Large revenues from the sale of coffee in the
Global North are made possible by mostly impoverished smallholders in
the Global South. COVID-19 will accentuate the existing vulnerabilities
and create new ones, forcing many smallholders into alternative
livelihoods. This outcome, however, is not inevitable. COVID-19 presents
an opportunity to rebalance the system that currently creates large
profits on one end of the supply chain and great vulnerability on the
other.  2020 Elsevier Ltd.All rights reserved. | |32914097 |Hawaii
journal of health &amp; social welfare |NA | |32914093 |Hawaii journal
of health &amp; social welfare |Infections with the SARS-CoV-2 virus are
increasing in Hawaii at alarming rates. In the absence of a SARS-CoV-2
virus vaccine, the options for control include social distancing,
improved hygiene, and face mask use. There is evidence that mask use may
decrease the rates of viral transmission. The rate of effective face
mask use has not yet been established in Hawaii. The authors performed
an observational study at 2 locations in Honolulu and evaluated outdoor
face mask use compliance in 200 people. Simultaneous observations were
performed in a downtown Honolulu business area and in Waikiki, an area
focusing on tourism. Overall, 77% of all subjects used face masks in an
appropriate fashion, covering their nose and mouth, while 23% were
either incorrectly masked or not masked. The rate of compliance with
correct public mask use in downtown Honolulu (88%) was significantly
higher than in Waikiki (66%) (P=.0003, Odds Ratio [95% Confidence
Interval]=3.78 [1.82, 7.85]) These findings suggest that there are
opportunities for improvement in rates of public face mask use and a
potential decrease in the spread of COVID-19 in our population. Four
proposed actions are suggested, including a reassessment of the face
mask exemption requirements, enhanced mask compliance education,
non-threatening communication for non-compliance, and centralization of
information of the public compliance with face mask use. Copyright 2020
by University Health Partners of Hawaii (UHP Hawaii). | |32912595
|Journal of psychiatric research |NA | |32907823 |BMJ (Clinical research
ed.) |NA | |32907673 |Disaster medicine and public health preparedness
|<AbstractText Label="OBJECTIVES">The objectives of this study is to
predict the possible trajectory of coronavirus disease 2019 (COVID-19)
spread in the United States. Prediction and severity ratings of COVID-19
are essential for pandemic control and economic reopening in the United
States. <AbstractText Label="METHOD">In this study, we apply the
logistic and Gompertz model to evaluate possible turning points of the
COVID-19 pandemic in different regions. By combining uncertainty and
severity factors, this study constructed an indicator to assess the
severity of the coronavirus outbreak in various states.
<AbstractText Label="RESULTS">Based on the index of severity ratings,
different regions of the United States are classified into 4 categories.
The result shows that it is possible to identify the first turning point
in Montana and Hawaii. It is unclear when the rest of the states will
reach the first peak. However, it can be inferred that 75% of regions
will not reach the first peak of coronavirus before August 2, 2020.
<AbstractText Label="CONCLUSION">It is still essential for the majority
of states to take proactive steps to fight against COVID-19 before
August 2, 2020. | |32891785 |Journal of the American Academy of
Dermatology |<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">To
provide guidance about management of psoriatic disease during the
coronavirus disease 2019 (COVID-19) pandemic.
<AbstractText Label="STUDY DESIGN" NlmCategory="METHODS">A task force
(TF) of 18 physician voting members with expertise in dermatology,
rheumatology, epidemiology, infectious diseases, and critical care was
convened. The TF was supplemented by nonvoting members, which included
fellows and National Psoriasis Foundation (NPF) staff. Clinical
questions relevant to the psoriatic disease community were informed by
questions received by the NPF. A Delphi process was conducted.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The TF approved 22
guidance statements. The average of the votes was within the category of
agreement for all statements. All guidance statements proposed were
recommended, 9 with high consensus and 13 with moderate consensus.
<AbstractText Label="LIMITATIONS" NlmCategory="CONCLUSIONS">The evidence
behind many guidance statements is limited in quality.
<AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">These
statements provide guidance for the management of patients with
psoriatic disease on topics ranging from how the disease and its
treatments impact COVID-19 risk and outcome, how medical care can be
optimized during the pandemic, what patients should do to lower their
risk of getting infected with severe acute respiratory syndrome
coronavirus 2 and what they should do if they develop COVID-19. The
guidance is intended to be a living document that will be updated by the
TF as data emerge. Copyright  2020 American Academy of Dermatology,
Inc.Published by Elsevier Inc.All rights reserved. | |32888905 |The
Brazilian journal of infectious diseases : an official publication of
the Brazilian Society of Infectious Diseases
|<AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Severe Acute
Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is the cause of
Coronavirus Disease 2019 (COVID-19). Although Real Time Reverse
Transcription Polymerase Chain Reaction (qRT-PCR) of respiratory
specimens is the gold standard test for detection of SARS-CoV-2
infection, collecting nasopharyngeal swabs causes discomfort to patients
and may represent considerable risk for healthcare workers. The use of
saliva as a diagnostic sample has several advantages.
<AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">The aim of this
study was to validate the use of saliva as a biological sample for
diagnosis of COVID-19.
<AbstractText Label="METHODS" NlmCategory="METHODS">This study was
conducted at Infectious Diseases Research Laboratory (LAPI), in
Salvador, Brazil. Participants presenting with signs/symptoms suggesting
SARS-CoV-2 infection underwent a nasopharyngeal swab (NPS) and/or
oropharyngeal swab (OPS), and saliva collection. Saliva samples were
diluted in PBS, followed by RNA isolation and RT-Real Time PCR for
SARS-CoV-2. Results of conventional vs saliva samples testing were
compared. Statistical analyses were performed using Statistical Package
for the Social Sciences software (SPSS) version 18.0.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">One hundred
fifty-five participants were recruited and samples pairs of NPS/OPS and
saliva were collected. The sensitivity and specificity of RT-PCR using
saliva samples were 94.4% (95% CI 86.4-97.8) and 97.62% (95% CI
91.7-99.3), respectively. There was an overall high agreement (96.1%)
between the two tests.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Use of
self-collected saliva samples is an easy, convenient, and low-cost
alternative to conventional NP swab-based molecular tests. These results
may allow a broader use of molecular tests for management of COVID19
pandemic, especially in resources-limited settings. Copyright  2020
Sociedade Brasileira de Infectologia. Published by Elsevier Espaa,
S.L.U. All rights reserved. | |32881116 |Journal of traumatic stress
|Leveraging technology to provide evidence-based therapy for
posttraumatic stress disorder (PTSD), such as prolonged exposure (PE),
during the COVID-19 pandemic helps ensure continued access to first-line
PTSD treatment. Clinical video teleconferencing (CVT) technology can be
used to effectively deliver PE while reducing the risk of COVID-19
exposure during the pandemic for both providers and patients. However,
provider knowledge, experience, and comfort level with delivering mental
health care services, such as PE, via CVT is critical to ensure a
smooth, safe, and effective transition to virtual care. Further, some of
the limitations associated with the pandemic, including stay-at-home
orders and physical distancing, require that providers become adept at
applying principles of exposure therapy with more flexibility and
creativity, such as when assigning in vivo exposures. The present paper
provides the rationale and guidelines for implementing PE via CVT during
COVID-19 and includes practical suggestions and clinical
recommendations. Published 2020. This article is a U.S. Government work
and is in the public domain in the USA. | |32837709 |Behavior analysis
in practice |Applied behavior analysis (ABA) services have been provided
primarily in the fields of health care and education across various
settings using an in-person service delivery model. Due to the COVID-19
pandemic, the necessity of and demand for ABA services using telehealth
have increased. The purpose of the present article was to cross-examine
the ethical codes and guidelines of different, but related fields of
practice and to discuss potential implications for telehealth-based ABA
service delivery. We reviewed the telehealth-specific ethical codes and
guidelines of the American Psychological Association, the American
Academy of Pediatrics, and the National Association of Social Workers,
along with the related ABA literature. These organizations addressed
several useful and unique ethical concerns that have not been addressed
in ABA literature. We also developed a brief checklist for ABA
practitioners to evaluate their telehealth readiness by meeting the
legal, professional, and ethical requirements of ABA services. 
Association for Behavior Analysis International 2020. | |32837535 |Oral
surgery |NA | |32763956 |RMD open |Reactive arthritis (ReA) is typically
preceded by sexually transmitted disease or gastrointestinal infection.
An association has also been reported with bacterial and viral
respiratory infections. Herein, we report the first case of ReA after
the he severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)
infection. This male patient is in his 50s who was admitted with
COVID-19 pneumonia. On the second day of admission, SARS-CoV-2 PCR was
positive from nasopharyngeal swab specimen. Despite starting standard
dose of favipiravir, his respiratory condition deteriorated during
hospitalisation. On the fourth hospital day, he developed acute
respiratory distress syndrome and was intubated. On day 11, he was
successfully extubated, subsequently completing a 14-day course of
favipiravir. On day 21, 1 day after starting physical therapy, he
developed acute bilateral arthritis in his ankles, with mild enthesitis
in his right Achilles tendon, without rash, conjunctivitis, or preceding
diarrhoea or urethritis. Arthrocentesis of his left ankle revealed mild
inflammatory fluid without monosodium urate or calcium pyrophosphate
crystals. Culture of synovial fluid was negative. Plain X-rays of his
ankles and feet showed no erosive changes or enthesophytes. Tests for
syphilis, HIV, anti-streptolysin O (ASO), Mycoplasma, Chlamydia
pneumoniae, antinuclear antibody, rheumatoid factor, anticyclic
citrullinated peptide antibody and Human Leukocyte Antigen-B27 (HLA-B27)
were negative. Gonococcal and Chlamydia trachomatis urine PCR were also
negative. He was diagnosed with ReA. Nonsteroidal Anti-Inflammatory Drug
(NSAID)s and intra-articular corticosteroid injection resulted in
moderate improvement.  Author(s) (or their employer(s)) 2020. Re-use
permitted under CC BY-NC. No commercial re-use. See rights and
permissions. Published by BMJ. | |32763350 |American journal of
infection control |<AbstractText Label="BACKGROUND">Anesthesia providers
are at risk for contracting COVID-19 due to close patient contact,
especially during shortages of personal protective equipment. We present
an easy to follow and detailed protocol for producing 3D printed face
shields and an effective decontamination protocol, allowing their reuse.
<AbstractText Label="METHODS">The University of Nebraska Medical Center
(UNMC) produced face shields using a combination of 3D printing and
assembly with commonly available products, and produced a simple
decontamination protocol to allow their reuse. To evaluate the
effectiveness of the decontamination protocol, we inoculated bacterial
suspensions of E. coli and S. aureus on to the face shield components,
performed the decontamination procedure, and finally swabbed and
enumerated organisms onto plates that were incubated for 12-24 hours.
Decontamination effectiveness was evaluated using the average log10
reduction in colony counts. <AbstractText Label="RESULTS">Approximately
112 face shields were constructed and made available for use in 72
hours. These methods were successfully implemented for in-house
production at UNMC and at Tripler Army Medical Center (Honolulu,
Hawaii). Overall, the decontamination protocol was highly effective
against both E. coli and S. aureus, achieving a 4 log10 (99.99%)
reduction in colony counts for every replicate from each component of
the face shield unit. <AbstractText Label="DISCUSSION">Face shields not
only act as a barrier against the soiling of N95 face masks, they also
serve as more effective eye protection from respiratory droplets over
standard eye shields. Implementation of decontamination protocols
successfully allowed face shield and N95 mask reuse, offering a higher
level of protection for anesthesiology providers at the onset of the
COVID-19 pandemic. <AbstractText Label="CONCLUSIONS">In a time of urgent
need, our protocol enabled the rapid production of face shields by
individuals with little to no 3D printing experience, and provided a
simple and effective decontamination protocol allowing reuse of the face
shields. Copyright  2020 Association for Professionals in Infection
Control and Epidemiology, Inc.All rights reserved. | |32745072 |Journal
of perinatal medicine J Perinat Med</p>
<pre><code>  Obstetric hospital preparedness for a pandemic: an obstetric critical care perspective in response to COVID-19.
  
    874
    882
    874-882
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1515/jpm-2020-0281
  
    The Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic has had a rapid and deadly onset, spreading quickly throughout the world. Pregnant patients have had high mortality rates, perinatal losses, and Intensive Care Unit (ICU) admissions from acute respiratory syndrome Coronavirus (SARS-CoV) and Middle East respiratory syndrome Coronavirus (MERS-CoV) in the past. Potentially, a surge of patients may require hospitalization and ICU care beyond the capacity of the health care system. This article is to provide institutional guidance on how to prepare an obstetric hospital service for a pandemic, mass casualty, or natural disaster by identifying a care model and resources for a large surge of critically ill pregnant patients over a short time. We recommend a series of protocols, education, and simulation training, with a structured and tiered approach to match the needs for the patients, for hospitals specialized in obstetrics.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Harvey
      Scott
      S
      
        University of Hawaii at Manoa, John A Burns School of Medicine, Department of Obstetrics, Gynecology and Women&#39;s Health, Honolulu, Hawaii, USA.
      
      
        Kapiolani Medical Center for Women and Children, Department of Obstetrics/Gynecology and Womens Health1319 Punahou Street Suite 824, Honolulu, Hawaii 96816, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Zalud
      Ivica
      I
      
        University of Hawaii at Manoa, John A Burns School of Medicine, Department of Obstetrics, Gynecology and Women&#39;s Health, Honolulu, Hawaii, USA.
      
      
        Kapiolani Medical Center for Women and Children, Department of Obstetrics/Gynecology and Womens Health1319 Punahou Street Suite 824, Honolulu, Hawaii 96816, USA.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
  


  Germany
  J Perinat Med
  0361031
  0300-5577

IM

  
    &lt;DescriptorName UI=&quot;D000073640&quot; MajorTopicYN=&quot;Y&quot;&gt;Betacoronavirus
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;N&quot;&gt;COVID-19
  
  
    &lt;DescriptorName UI=&quot;D018352&quot; MajorTopicYN=&quot;N&quot;&gt;Coronavirus Infections
    &lt;QualifierName UI=&quot;Q000150&quot; MajorTopicYN=&quot;Y&quot;&gt;complications
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
    &lt;QualifierName UI=&quot;Q000628&quot; MajorTopicYN=&quot;N&quot;&gt;therapy
  
  
    &lt;DescriptorName UI=&quot;D003422&quot; MajorTopicYN=&quot;Y&quot;&gt;Critical Care
  
  
    &lt;DescriptorName UI=&quot;D016638&quot; MajorTopicYN=&quot;N&quot;&gt;Critical Illness
    &lt;QualifierName UI=&quot;Q000628&quot; MajorTopicYN=&quot;N&quot;&gt;therapy
  
  
    &lt;DescriptorName UI=&quot;D004189&quot; MajorTopicYN=&quot;N&quot;&gt;Disaster Planning
  
  
    &lt;DescriptorName UI=&quot;D004632&quot; MajorTopicYN=&quot;N&quot;&gt;Emergency Medical Services
    &lt;QualifierName UI=&quot;Q000941&quot; MajorTopicYN=&quot;N&quot;&gt;ethics
    &lt;QualifierName UI=&quot;Q000458&quot; MajorTopicYN=&quot;N&quot;&gt;organization &amp;amp; administration
  
  
    &lt;DescriptorName UI=&quot;D005260&quot; MajorTopicYN=&quot;N&quot;&gt;Female
  
  
    &lt;DescriptorName UI=&quot;D006771&quot; MajorTopicYN=&quot;N&quot;&gt;Hospitals, Maternity
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D009774&quot; MajorTopicYN=&quot;N&quot;&gt;Obstetrics
    &lt;QualifierName UI=&quot;Q000379&quot; MajorTopicYN=&quot;Y&quot;&gt;methods
  
  
    &lt;DescriptorName UI=&quot;D058873&quot; MajorTopicYN=&quot;Y&quot;&gt;Pandemics
  
  
    &lt;DescriptorName UI=&quot;D010561&quot; MajorTopicYN=&quot;N&quot;&gt;Personnel Staffing and Scheduling
  
  
    &lt;DescriptorName UI=&quot;D011024&quot; MajorTopicYN=&quot;N&quot;&gt;Pneumonia, Viral
    &lt;QualifierName UI=&quot;Q000150&quot; MajorTopicYN=&quot;Y&quot;&gt;complications
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
    &lt;QualifierName UI=&quot;Q000628&quot; MajorTopicYN=&quot;N&quot;&gt;therapy
  
  
    &lt;DescriptorName UI=&quot;D011247&quot; MajorTopicYN=&quot;N&quot;&gt;Pregnancy
  
  
    &lt;DescriptorName UI=&quot;D011251&quot; MajorTopicYN=&quot;N&quot;&gt;Pregnancy Complications, Infectious
    &lt;QualifierName UI=&quot;Q000628&quot; MajorTopicYN=&quot;N&quot;&gt;therapy
    &lt;QualifierName UI=&quot;Q000821&quot; MajorTopicYN=&quot;Y&quot;&gt;virology
  
  
    &lt;DescriptorName UI=&quot;D000086402&quot; MajorTopicYN=&quot;N&quot;&gt;SARS-CoV-2
  
  
    &lt;DescriptorName UI=&quot;D055872&quot; MajorTopicYN=&quot;N&quot;&gt;Surge Capacity
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;COVID-19
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;disaster manual
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;hospital preparedness
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;isolation
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;obstetric
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;pandemic




  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2020
    6
    18
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2020
    6
    24
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2020
    8
    4
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2020
    11
    21
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2020
    8
    4
    6
    0
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;32745072
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1515/jpm-2020-0281
  &lt;ArticleId IdType=&quot;pii&quot;&gt;jpm-2020-0281


  References                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                    |The Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus-2 (SARS-CoV-2) pandemic has had a rapid and deadly onset, spreading quickly throughout the world. Pregnant patients have had high mortality rates, perinatal losses, and Intensive Care Unit (ICU) admissions from acute respiratory syndrome Coronavirus (SARS-CoV) and Middle East respiratory syndrome Coronavirus (MERS-CoV) in the past. Potentially, a surge of patients may require hospitalization and ICU care beyond the capacity of the health care system. This article is to provide institutional guidance on how to prepare an obstetric hospital service for a pandemic, mass casualty, or natural disaster by identifying a care model and resources for a large surge of critically ill pregnant patients over a short time. We recommend a series of protocols, education, and simulation training, with a structured and tiered approach to match the needs for the patients, for hospitals specialized in obstetrics.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |</code></pre>
<p>|32742897 |Journal of general and family medicine |NA | |32692706
|Journal of perinatal medicine J Perinat Med</p>
<pre><code>  Academic clinical learning environment in obstetrics and gynecology during the COVID-19 pandemic: responses and lessons learned.
  
    1013
    1016
    1013-1016
  
  &lt;ELocationID EIdType=&quot;doi&quot; ValidYN=&quot;Y&quot;&gt;10.1515/jpm-2020-0239
  
    COVID-19 pandemic is changing profoundly the obstetrics and gynecology (OB/GYN) academic clinical learning environment in many different ways. Rapid developments affecting our learners, patients, faculty and staff require unprecedented collaboration and quick, deeply consequential readjustments, almost on a daily basis. We summarized here our experiences, opportunities, challenges and lessons learned and outline how to move forward. The COVID-19 pandemic taught us there is a clear need for collaboration in implementing the most current evidence-based medicine, rapidly assess and improve the everchanging healthcare environment by problem solving and &quot;how to&quot; instead of &quot;should we&quot; approach. In addition, as a community with very limited resources we have to rely heavily on internal expertise, ingenuity and innovation. The key points to succeed are efficient and timely communication, transparency in decision making and reengagement. As time continues to pass, it is certain that more lessons will emerge.
  
  &lt;AuthorList CompleteYN=&quot;Y&quot;&gt;
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Olson
      Holly L
      HL
      
        Department of OB/GYN and Women&#39;s Health, John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Towner
      Dena
      D
      
        Department of OB/GYN and Women&#39;s Health, John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Hiraoka
      Mark
      M
      
        Department of OB/GYN and Women&#39;s Health, John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Savala
      Michael
      M
      
        Department of OB/GYN and Women&#39;s Health, John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
    &lt;Author ValidYN=&quot;Y&quot;&gt;
      Zalud
      Ivica
      I
      
        Department of OB/GYN and Women&#39;s Health, John A Burns School of Medicine, University of Hawaii, Honolulu, HI, USA.
      
    
  
  eng
  
    &lt;PublicationType UI=&quot;D016428&quot;&gt;Journal Article
  


  Germany
  J Perinat Med
  0361031
  0300-5577

IM

  
    &lt;DescriptorName UI=&quot;D000073640&quot; MajorTopicYN=&quot;Y&quot;&gt;Betacoronavirus
  
  
    &lt;DescriptorName UI=&quot;D000086382&quot; MajorTopicYN=&quot;N&quot;&gt;COVID-19
  
  
    &lt;DescriptorName UI=&quot;D002982&quot; MajorTopicYN=&quot;N&quot;&gt;Clinical Clerkship
  
  
    &lt;DescriptorName UI=&quot;D018352&quot; MajorTopicYN=&quot;N&quot;&gt;Coronavirus Infections
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;Y&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D003479&quot; MajorTopicYN=&quot;N&quot;&gt;Curriculum
  
  
    &lt;DescriptorName UI=&quot;D003695&quot; MajorTopicYN=&quot;N&quot;&gt;Delivery of Health Care
    &lt;QualifierName UI=&quot;Q000639&quot; MajorTopicYN=&quot;N&quot;&gt;trends
  
  
    &lt;DescriptorName UI=&quot;D019317&quot; MajorTopicYN=&quot;N&quot;&gt;Evidence-Based Medicine
  
  
    &lt;DescriptorName UI=&quot;D005257&quot; MajorTopicYN=&quot;N&quot;&gt;Fellowships and Scholarships
  
  
    &lt;DescriptorName UI=&quot;D005260&quot; MajorTopicYN=&quot;N&quot;&gt;Female
  
  
    &lt;DescriptorName UI=&quot;D006176&quot; MajorTopicYN=&quot;N&quot;&gt;Gynecology
    &lt;QualifierName UI=&quot;Q000193&quot; MajorTopicYN=&quot;Y&quot;&gt;education
  
  
    &lt;DescriptorName UI=&quot;D006254&quot; MajorTopicYN=&quot;N&quot; Type=&quot;Geographic&quot;&gt;Hawaii
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;N&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D006801&quot; MajorTopicYN=&quot;N&quot;&gt;Humans
  
  
    &lt;DescriptorName UI=&quot;D007396&quot; MajorTopicYN=&quot;N&quot;&gt;Internship and Residency
  
  
    &lt;DescriptorName UI=&quot;D009774&quot; MajorTopicYN=&quot;N&quot;&gt;Obstetrics
    &lt;QualifierName UI=&quot;Q000193&quot; MajorTopicYN=&quot;Y&quot;&gt;education
  
  
    &lt;DescriptorName UI=&quot;D058873&quot; MajorTopicYN=&quot;Y&quot;&gt;Pandemics
  
  
    &lt;DescriptorName UI=&quot;D011024&quot; MajorTopicYN=&quot;N&quot;&gt;Pneumonia, Viral
    &lt;QualifierName UI=&quot;Q000453&quot; MajorTopicYN=&quot;Y&quot;&gt;epidemiology
  
  
    &lt;DescriptorName UI=&quot;D011247&quot; MajorTopicYN=&quot;N&quot;&gt;Pregnancy
  
  
    &lt;DescriptorName UI=&quot;D000086402&quot; MajorTopicYN=&quot;N&quot;&gt;SARS-CoV-2
  
  
    &lt;DescriptorName UI=&quot;D013337&quot; MajorTopicYN=&quot;N&quot;&gt;Students, Medical
  

&lt;KeywordList Owner=&quot;NOTNLM&quot;&gt;
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;COVID-19 pandemic
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;academic learning in obstetrics and gynecology
  &lt;Keyword MajorTopicYN=&quot;N&quot;&gt;on-line learning




  &lt;PubMedPubDate PubStatus=&quot;received&quot;&gt;
    2020
    5
    28
  
  &lt;PubMedPubDate PubStatus=&quot;accepted&quot;&gt;
    2020
    7
    2
  
  &lt;PubMedPubDate PubStatus=&quot;pubmed&quot;&gt;
    2020
    7
    22
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;medline&quot;&gt;
    2020
    11
    21
    6
    0
  
  &lt;PubMedPubDate PubStatus=&quot;entrez&quot;&gt;
    2020
    7
    22
    6
    0
  

ppublish

  &lt;ArticleId IdType=&quot;pubmed&quot;&gt;32692706
  &lt;ArticleId IdType=&quot;doi&quot;&gt;10.1515/jpm-2020-0239
  &lt;ArticleId IdType=&quot;pii&quot;&gt;jpm-2020-0239


  References                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |COVID-19 pandemic is changing profoundly the obstetrics and gynecology (OB/GYN) academic clinical learning environment in many different ways. Rapid developments affecting our learners, patients, faculty and staff require unprecedented collaboration and quick, deeply consequential readjustments, almost on a daily basis. We summarized here our experiences, opportunities, challenges and lessons learned and outline how to move forward. The COVID-19 pandemic taught us there is a clear need for collaboration in implementing the most current evidence-based medicine, rapidly assess and improve the everchanging healthcare environment by problem solving and &quot;how to&quot; instead of &quot;should we&quot; approach. In addition, as a community with very limited resources we have to rely heavily on internal expertise, ingenuity and innovation. The key points to succeed are efficient and timely communication, transparency in decision making and reengagement. As time continues to pass, it is certain that more lessons will emerge.                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                             |</code></pre>
<p>|32690354 |Paediatric respiratory reviews |Models have played an
important role in policy development to address the COVID-19 outbreak
from its emergence in China to the current global pandemic. Early
projections of international spread influenced travel restrictions and
border closures. Model projections based on the viruss infectiousness
demonstrated its pandemic potential, which guided the global response to
and prepared countries for increases in hospitalisations and deaths.
Tracking the impact of distancing and movement policies and behaviour
changes has been critical in evaluating these decisions. Models have
provided insights into the epidemiological differences between higher
and lower income countries, as well as vulnerable population groups
within countries to help design fit-for-purpose policies. Economic
evaluation and policies have combined epidemic models and traditional
economic models to address the economic consequences of COVID-19, which
have informed policy calls for easing restrictions. Social contact and
mobility models have allowed evaluation of the pathways to safely relax
mobility restrictions and distancing measures. Finally, models can
consider future end-game scenarios, including how suppression can be
achieved and the impact of different vaccination strategies. Copyright 
2020. Published by Elsevier Ltd.| |32680824 |Paediatric respiratory
reviews |Coronavirus disease 2019 (COVID-19) is a newly emerged
infectious disease caused by the severe acute respiratory syndrome
coronavirus-2 (SARS-CoV-2) that was declared a pandemic by the World
Health Organization on 11th March, 2020. Response to this ongoing
pandemic requires extensive collaboration across the scientific
community in an attempt to contain its impact and limit further
transmission. Mathematical modelling has been at the forefront of these
response efforts by: (1) providing initial estimates of the SARS-CoV-2
reproduction rate, R0 (of approximately 2-3); (2) updating these
estimates following the implementation of various interventions (with
significantly reduced, often sub-critical, transmission rates); (3)
assessing the potential for global spread before significant case
numbers had been reported internationally; and (4) quantifying the
expected disease severity and burden of COVID-19, indicating that the
likely true infection rate is often orders of magnitude greater than
estimates based on confirmed case counts alone. In this review, we
highlight the critical role played by mathematical modelling to
understand COVID-19 thus far, the challenges posed by data availability
and uncertainty, and the continuing utility of modelling-based
approaches to guide decision making and inform the public health
response. Unless otherwise stated, all bracketed error margins
correspond to the 95% credible interval (CrI) for reported estimates.
Copyright  2020. Published by Elsevier Ltd.| |32666058 |Hawaii
journal of health &amp; social welfare |NA | |32649272 |Journal of the
American College of Nutrition |Background: In December 2019, the viral
pandemic of respiratory illness caused by COVID-19 began sweeping its
way across the globe. Several aspects of this infectious disease mimic
metabolic events shown to occur during latent subclinical magnesium
deficiency. Hypomagnesemia is a relatively common clinical occurrence
that often goes unrecognized since magnesium levels are rarely monitored
in the clinical setting. Magnesium is the second most abundant
intracellular cation after potassium. It is involved in &gt;600
enzymatic reactions in the body, including those contributing to the
exaggerated immune and inflammatory responses exhibited by COVID-19
patients.Methods: A summary of experimental findings and knowledge of
the biochemical role magnesium may play in the pathogenesis of COVID-19
is presented in this perspective. The National Academy of Medicines
Standards for Systematic Reviews were independently employed to identify
clinical and prospective cohort studies assessing the relationship of
magnesium with interleukin-6, a prominent drug target for treating
COVID-19.Results: Clinical recommendations are given for prevention and
treatment of COVID-19. Constant monitoring of ionized magnesium status
with subsequent repletion, when appropriate, may be an effective
strategy to influence disease contraction and progression. The
peer-reviewed literature supports that several aspects of magnesium
nutrition warrant clinical consideration. Mechanisms include its
calcium-channel blocking effects that lead to downstream suppression
of nuclear factor-K, interleukin-6, c-reactive protein, and other
related endocrine disrupters; its role in regulating renal potassium
loss; and its ability to activate and enhance the functionality of
vitamin D, among others.Conclusion: As the world awaits an effective
vaccine, nutrition plays an important and safe role in helping mitigate
patient morbidity and mortality. Our group is working with the Academy
of Nutrition and Dietetics to collect patient-level data from intensive
care units across the United States to better understand nutrition care
practices that lead to better outcomes. | |32596689 |Hawaii journal of
health &amp; social welfare |NA | |32592394 |The American journal of
clinical nutrition |NA | |32584245 |Journal of hospital medicine |NA |
|32501143 |Journal of gerontological social work |NA | |32486844
|Journal of diabetes science and technology |NA | |32462545 |Infectious
diseases and therapy |The emergence of SARS-CoV-2/2019 novel coronavirus
(COVID-19) has created a global pandemic with no approved treatments or
vaccines. Many treatments have already been administered to COVID-19
patients but have not been systematically evaluated. We performed a
systematic literature review to identify all treatments reported to be
administered to COVID-19 patients and to assess time to clinically
meaningful response for treatments with sufficient data. We searched
PubMed, BioRxiv, MedRxiv, and ChinaXiv for articles reporting treatments
for COVID-19 patients published between 1 December 2019 and 27 March
2020. Data were analyzed descriptively. Of the 2706 articles identified,
155 studies met the inclusion criteria, comprising 9152 patients. The
cohort was 45.4% female and 98.3% hospitalized, and mean (SD) age was
44.4 years (SD 21.0). The most frequently administered drug classes were
antivirals, antibiotics, and corticosteroids, and of the 115 reported
drugs, the most frequently administered was combination
lopinavir/ritonavir, which was associated with a time to clinically
meaningful response (complete symptom resolution or hospital discharge)
of 11.7 (1.09) days. There were insufficient data to compare across
treatments. Many treatments have been administered to the first 9152
reported cases of COVID-19. These data serve as the basis for an
open-source registry of all reported treatments given to COVID-19
patients at www.CDCN.org/CORONA . Further work is needed to prioritize
drugs for investigation in well-controlled clinical trials and treatment
protocols. | |32432219 |Hawaii journal of health &amp; social welfare
|Globally, coronavirus disease 2019 (COVID-19) is threatening human
health and changing the way people live. With the increasing evidence
showing comorbidities of COVID-19 and non-communicable diseases (NCDs),
the Pacific region, where approximately 75% of deaths are due to NCDs,
is significantly vulnerable during this crisis unless urgent action is
taken. Whilst enforcing the critical mitigation measures of the COVID-19
pandemic in the Pacific, it is also paramount to incorporate and
strengthen NCD prevention and control measures to safeguard people with
NCDs and the general population; keep people healthy and minimise the
impact of COVID-19. To sustain wellbeing of health, social
relationships, and the economy in the Pacific, it is a critical time for
all governments, development partners and civil societies to show
regional solidarity in the fight against emerging COVID-19 health crisis
and existing Pacific NCDs crisis through a whole of government and whole
of society approach. Copyright 2020 by University Health Partners of
Hawaii (UHP Hawaii). | |32432218 |Hawaii journal of health &amp;
social welfare |NA | |32432217 |Hawaii journal of health &amp; social
welfare |Nationwide shortages of tests that detect severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2) and diagnose coronavirus
disease 2019 (COVID-19) have led the US Food and Drug Administration
(FDA) to significantly relax regulations regarding COVID-19 diagnostic
testing. To date the FDA has given emergency use authorization (EUA) to
48 COVID-19 in vitro diagnostic tests and 21 high complexity
molecular-based laboratory developed tests, as well as implemented
policies that give broad authority to clinical laboratories and
commercial manufacturers in the development, distribution, and use of
COVID-19 diagnostic tests. Currently, there are 2 types of diagnostic
tests available for the detection of SARS-CoV-2: (1) molecular and (2)
serological tests. Molecular detection of nucleic acid (RNA or DNA)
sequences relating to the suspected pathogen is indicative of an active
infection with the suspected pathogen. Serological tests detect
antibodies against the suspected pathogen, which are produced by an
individuals immune system. A positive serological test result indicates
recent exposure to the suspected pathogen but cannot be used to
determine if the individual is actively infected with the pathogen or
immune to reinfection. In this article, the SARS-CoV-2 diagnostic tests
currently approved by the FDA under EUA are reviewed, and other
diagnostic tests that researchers are developing to detect SARS-CoV-2
infection are discussed. Copyright 2020 by University Health Partners
of Hawaii (UHP Hawaii). | |32427288 |Biology of reproduction
|Expression of angiotensin-converting enzyme 2, receptor of severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2), is high in the testes,
therefore SARS-CoV-2 infection and its association with male
reproductive health should be investigated in male coronavirus disease
2019 patients. | |32420720 |Pediatric critical care medicine : a journal
of the Society of Critical Care Medicine and the World Federation of
Pediatric Intensive and Critical Care Societies
|<AbstractText Label="OBJECTIVE">In the midst of the severe acute
respiratory syndrome coronavirus 2 pandemic, which causes coronavirus
disease 2019, there is a recognized need to expand critical care
services and beds beyond the traditional boundaries. There is
considerable concern that widespread infection will result in a surge of
critically ill patients that will overwhelm our present adult ICU
capacity. In this setting, one proposal to add surge capacity has been
the use of PICU beds and physicians to care for these critically ill
adults. <AbstractText Label="DESIGN">Narrative review/perspective.
<AbstractText Label="SETTING">Not applicable.
<AbstractText Label="PATIENTS">Not applicable.
<AbstractText Label="INTERVENTIONS">None.
<AbstractText Label="MEASUREMENTS AND MAIN RESULTS">The viruss high
infectivity and prolonged asymptomatic shedding have resulted in an
exponential growth in the number of cases in the United States within
the past weeks with many (up to 6%) developing acute respiratory
distress syndrome mandating critical care services. Coronavirus disease
2019 critical illness appears to be primarily occurring in adults.
Although pediatric intensivists are well versed in the care of acute
respiratory distress syndrome from viral pneumonia, the care of
differing aged adult populations presents some unique challenges. In
this statement, a team of adult and pediatric-trained critical care
physicians provides guidance on common adult issues that may be
encountered in the care of these patients and how they can best be
managed in a PICU. <AbstractText Label="CONCLUSIONS">This concise
scientific statement includes references to the most recent and relevant
guidelines and clinical trials that shape management decisions. The
intention is to assist PICUs and intensivists in rapidly preparing for
care of adult coronavirus disease 2019 patients should the need arise. |
|32386898 |American journal of otolaryngology
|<AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">The 2019 novel
coronavirus (COVID-19) is disproportionately impacting older individuals
and healthcare workers. Otolaryngologists are especially susceptible
with the elevated risk of aerosolization and corresponding high viral
loads. This study utilizes a geospatial analysis to illustrate the
comparative risks of older otolaryngologists across the United States
during the COVID-19 pandemic.
<AbstractText Label="METHODS AND MATERIALS" NlmCategory="METHODS">Demographic
and state population data were extracted from the State Physician
Workforce Reports published by the AAMC for the year 2018. A geospatial
heat map of the United States was then constructed to illustrate the
location of COVID-19 confirmed case counts and the distributions of ENTs
over 60 years for each state.
<AbstractText Label="RESULTS" NlmCategory="RESULTS">In 2018, out of a
total of 9578 practicing U.S. ENT surgeons, 3081 were older than 60
years (32.2%). The states with the highest proportion of ENTs over 60
were Maine, Delaware, Hawaii, and Louisiana. The states with the highest
ratios of confirmed COVID-19 cases to the number of total ENTs over 60
were New York, New Jersey, Massachusetts, and Michigan.
<AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Based on our
models, New York, New Jersey, Massachusetts, and Michigan represent
states where older ENTs may be the most susceptible to developing severe
complications from nosocomial transmission of COVID-19 due to a
combination of high COVID-19 case volumes and a high proportion of ENTs
over 60 years. Copyright  2020 Elsevier Inc.All rights reserved. |
|32371624 |American journal of physical medicine &amp; rehabilitation
|The global outbreak of coronavirus disease 2019 has created an
unprecedented challenge to the society. Currently, the United States
stands as the most affected country, and the entire healthcare system is
affected, from emergency department, intensive care unit, postacute
care, outpatient, to home care. Considering the debility, neurological,
pulmonary, neuromuscular, and cognitive complications, rehabilitation
professionals can play an important role in the recovery process for
individuals with coronavirus disease 2019. Clinicians across the
nations rehabilitation system have already begun working to initiate
intensive care unit-based rehabilitation care and develop programs,
settings, and specialized care to meet the short- and long-term needs of
these individuals. We describe the anticipated rehabilitation demands
and the strategies to meet the needs of this population. The
complications from coronavirus disease 2019 can be reduced by (1)
delivering interdisciplinary rehabilitation that is initiated early and
continued throughout the acute hospital stay, (2) providing
patient/family education for self-care after discharge from inpatient
rehabilitation at either acute or subacute settings, and (3) continuing
rehabilitation care in the outpatient setting and at home through
ongoing therapy either in-person or via telehealth. | |32371551 |Cancer
epidemiology, biomarkers &amp; prevention : a publication of the
American Association for Cancer Research, cosponsored by the American
Society of Preventive Oncology |The rapid pace of the severe acute
respiratory syndrome coronavirus 2 (SARS-CoV-2; COVID-19) pandemic
presents challenges to the real-time collection of population-scale data
to inform near-term public health needs as well as future
investigations. We established the COronavirus Pandemic Epidemiology
(COPE) consortium to address this unprecedented crisis on behalf of the
epidemiology research community. As a central component of this
initiative, we have developed a COVID Symptom Study (previously known as
the COVID Symptom Tracker) mobile application as a common data
collection tool for epidemiologic cohort studies with active study
participants. This mobile application collects information on risk
factors, daily symptoms, and outcomes through a user-friendly interface
that minimizes participant burden. Combined with our efforts within the
general population, data collected from nearly 3 million participants in
the United States and United Kingdom are being used to address critical
needs in the emergency response, including identifying potential hot
spots of disease and clinically actionable risk factors. The linkage of
symptom data collected in the app with information and biospecimens
already collected in epidemiology cohorts will position us to address
key questions related to diet, lifestyle, environmental, and
socioeconomic factors on susceptibility to COVID-19, clinical outcomes
related to infection, and long-term physical, mental health, and
financial sequalae. We call upon additional epidemiology cohorts to join
this collective effort to strengthen our impact on the current health
crisis and generate a new model for a collaborative and nimble research
infrastructure that will lead to more rapid translation of our work for
the betterment of public health. 2020 American Association for Cancer
Research. | |32361738 |Clinical infectious diseases : an official
publication of the Infectious Diseases Society of America
|<AbstractText Label="BACKGROUND">With evidence of sustained
transmission in more than 190 countries, coronavirus disease 2019
(COVID-19) has been declared a global pandemic. Data are urgently needed
about risk factors associated with clinical outcomes.
<AbstractText Label="METHODS">A retrospective review of 323 hospitalized
patients with COVID-19 in Wuhan was conducted. Patients were classified
into 3 disease severity groups (nonsevere, severe, and critical), based
on initial clinical presentation. Clinical outcomes were designated as
favorable and unfavorable, based on disease progression and response to
treatments. Logistic regression models were performed to identify risk
factors associated with clinical outcomes, and log-rank test was
conducted for the association with clinical progression.
<AbstractText Label="RESULTS">Current standard treatments did not show
significant improvement in patient outcomes. By univariate logistic
regression analysis, 27 risk factors were significantly associated with
clinical outcomes. Multivariate regression indicated age &gt;65 years (P
&lt; .001), smoking (P = .001), critical disease status (P = .002),
diabetes (P = .025), high hypersensitive troponin I (&gt;0.04 pg/mL, P =
.02), leukocytosis (&gt;10  109/L, P &lt; .001), and neutrophilia
(&gt;75  109/L, P &lt; .001) predicted unfavorable clinical outcomes.
In contrast, the administration of hypnotics was significantly
associated with favorable outcomes (P &lt; .001), which was confirmed by
survival analysis. <AbstractText Label="CONCLUSIONS">Hypnotics may be an
effective ancillary treatment for COVID-19. We also found novel risk
factors, such as higher hypersensitive troponin I, predicted poor
clinical outcomes. Overall, our study provides useful data to guide
early clinical decision making to reduce mortality and improve clinical
outcomes of COVID-19.  The Author(s) 2020. Published by Oxford
University Press for the Infectious Diseases Society of America. All
rights reserved. For permissions, e-mail: <a href="mailto:journals.permissions@oup.com" class="email">journals.permissions@oup.com</a>. | |32326959 |Critical
care (London, England) |NA | |32323016 |Surgical endoscopy |The
unprecedented pandemic of COVID-19 has impacted many lives and affects
the whole healthcare systems globally. In addition to the considerable
workload challenges, surgeons are faced with a number of uncertainties
regarding their own safety, practice, and overall patient care. This
guide has been drafted at short notice to advise on specific issues
related to surgical service provision and the safety of minimally
invasive surgery during the COVID-19 pandemic. Although laparoscopy can
theoretically lead to aerosolization of blood borne viruses, there is no
evidence available to confirm this is the case with COVID-19. The
ultimate decision on the approach should be made after considering the
proven benefits of laparoscopic techniques versus the potential
theoretical risks of aerosolization. Nevertheless, erring on the side of
safety would warrant treating the coronavirus as exhibiting similar
aerosolization properties and all members of the OR staff should use
personal protective equipment (PPE) in all surgical procedures during
the pandemic regardless of known or suspected COVID status.
Pneumoperitoneum should be safely evacuated via a filtration system
before closure, trocar removal, specimen extraction, or conversion to
open. All emergent endoscopic procedures performed during the pandemic
should be considered as high risk and PPE must be used by all endoscopy
staff. | |32314954 |Disaster medicine and public health preparedness
|All levels of government are authorized to apply coronavirus disease
2019 (COVID-19) protection measures; however, they must consider how and
when to ease lockdown restrictions to limit long-term societal harm and
societal instability. Leaders that use a well-considered framework with
an incremental approach will be able to gradually restart society while
simultaneously maintaining the public health benefits achieved through
lockdown measures. Economically vulnerable populations cannot endure
long-term lockdown, and most countries lack the ability to maintain a
full nationwide relief operation. Decision-makers need to understand
this risk and how the Maslow hierarchy of needs and the social
determinants of health can guide whole of society policies. Aligning
decisions with societal needs will help ensure all segments of society
are catered to and met while managing the crisis. This must inform the
process of incremental easing of lockdowns to facilitate the resumption
of community foundations, such as commerce, education, and employment in
a manner that protects those most vulnerable to COVID-19. This study
proposes a framework for identifying a path forward. It reflects on
baseline requirements, regulations and recommendations, triggers, and
implementation. Those desiring a successful recovery from the COVID-19
pandemic need to adopt an evidence-based framework now to ensure
community stabilization and sustainability. | |32300051 |Journal for
immunotherapy of cancer |NA | |32259247 |Pain medicine (Malden, Mass.)
|<AbstractText Label="BACKGROUND">It is nearly impossible to
overestimate the burden of chronic pain, which is associated with
enormous personal and socioeconomic costs. Chronic pain is the leading
cause of disability in the world, is associated with multiple
psychiatric comorbidities, and has been causally linked to the opioid
crisis. Access to pain treatment has been called a fundamental human
right by numerous organizations. The current COVID-19 pandemic has
strained medical resources, creating a dilemma for physicians charged
with the responsibility to limit spread of the contagion and to treat
the patients they are entrusted to care for.
<AbstractText Label="METHODS">To address these issues, an expert panel
was convened that included pain management experts from the military,
Veterans Health Administration, and academia. Endorsement from
stakeholder societies was sought upon completion of the document within
a one-week period. <AbstractText Label="RESULTS">In these guidelines, we
provide a framework for pain practitioners and institutions to balance
the often-conflicting goals of risk mitigation for health care
providers, risk mitigation for patients, conservation of resources, and
access to pain management services. Specific issues discussed include
general and intervention-specific risk mitigation, patient flow issues
and staffing plans, telemedicine options, triaging recommendations,
strategies to reduce psychological sequelae in health care providers,
and resource utilization. <AbstractText Label="CONCLUSIONS">The COVID-19
public health crisis has strained health care systems, creating a
conundrum for patients, pain medicine practitioners, hospital leaders,
and regulatory officials. Although this document provides a framework
for pain management services, systems-wide and individual decisions must
take into account clinical considerations, regional health conditions,
government and hospital directives, resource availability, and the
welfare of health care providers. The Author(s) 2020. Published by
Oxford University Press on behalf of the American Academy of Pain
Medicine. This work is written by a US Government employee and is in the
public domain in the US. | |32151778 |Journal of thoracic oncology :
official publication of the International Association for the Study of
Lung Cancer |NA |</p>
<p>Done! Knit the document, commit, and push.</p>
</div>
<div id="final-pro-tip-optional" class="section level2">
<h2>Final Pro Tip (optional)</h2>
<p>You can still share the HTML document on github. You can include a
link in your <code>README.md</code> file as the following:</p>
<pre class="md"><code>View [here](https://cdn.jsdelivr.net/gh/:user/:repo@:tag/:file) </code></pre>
<p>For example, if we wanted to add a direct link the HTML page of
lecture 6, we could do something like the following:</p>
<pre class="md"><code>View Week 6 Lecture [here]()</code></pre>
</div>
</div>




</div>

<script>

// add bootstrap table styles to pandoc tables
function bootstrapStylePandocTables() {
  $('tr.odd').parent('tbody').parent('table').addClass('table table-condensed');
}
$(document).ready(function () {
  bootstrapStylePandocTables();
});


</script>

<!-- tabsets -->

<script>
$(document).ready(function () {
  window.buildTabsets("TOC");
});

$(document).ready(function () {
  $('.tabset-dropdown > .nav-tabs > li').click(function () {
    $(this).parent().toggleClass('nav-tabs-open');
  });
});
</script>

<!-- code folding -->


<!-- dynamically load mathjax for compatibility with self-contained -->
<script>
  (function () {
    var script = document.createElement("script");
    script.type = "text/javascript";
    script.src  = "https://mathjax.rstudio.com/latest/MathJax.js?config=TeX-AMS-MML_HTMLorMML";
    document.getElementsByTagName("head")[0].appendChild(script);
  })();
</script>

</body>
</html>
